data_1c7v_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1c7v _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 . . . . . 0 N--CA 1.5 2.026 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.61 HG23 ' HB3' ' A' ' 148' ' ' MET . 2.0 mp -68.84 -48.3 71.48 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.43 0 CA-C-O 116.762 -1.59 . . . . 0.0 109.92 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.5 pp -62.92 -38.43 90.95 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 121.559 1.981 . . . . 0.0 110.372 176.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -56.88 -58.0 10.06 Favored 'General case' 0 CA--C 1.574 1.883 0 CA-C-N 120.945 1.702 . . . . 0.0 109.429 174.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.85 -57.72 11.24 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 117.283 -1.342 . . . . 0.0 114.337 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -57.23 -46.42 82.98 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 119.905 1.23 . . . . 0.0 112.518 177.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -62.41 -35.3 78.81 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-O 116.037 -1.935 . . . . 0.0 112.363 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.2 t -66.6 -43.28 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 CA-C-N 122.451 2.387 . . . . 0.0 107.935 170.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -55.82 -41.24 73.93 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.434 ' C ' ' H ' ' A' ' 100' ' ' ASN . 5.6 t0 -66.07 114.17 5.02 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 174.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.29 50.83 0.66 Allowed 'General case' 0 N--CA 1.507 2.397 0 CA-C-O 123.304 1.526 . . . . 0.0 111.577 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.434 ' H ' ' C ' ' A' ' 98' ' ' ASP 0.296 10.1 t-20 84.9 -61.93 0.08 Allowed 'General case' 0 CA--C 1.57 1.716 0 C-N-CA 128.699 2.799 . . . . 0.0 103.968 -170.783 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 28.97 15.23 0.0 OUTLIER Glycine 0 C--N 1.357 1.699 1 N-CA-C 125.074 4.79 . . . . 0.0 125.074 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.2 p30 64.51 13.34 8.11 Favored 'General case' 0 CA--C 1.597 2.783 0 CA-C-N 121.74 2.77 . . . . 0.0 112.269 -169.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.85 -6.49 54.49 Favored Glycine 0 CA--C 1.559 2.84 0 CA-C-O 115.968 -2.573 . . . . 0.0 111.264 -171.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -101.86 144.44 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.709 0 CA-C-N 121.818 2.809 . . . . 0.0 113.985 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 57.3 mt -111.78 128.68 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-N 113.196 -1.82 . . . . 0.0 108.681 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -106.58 -176.72 3.16 Favored 'General case' 0 CA--C 1.572 1.822 0 CA-C-O 121.739 0.78 . . . . 0.0 112.102 176.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -70.69 -49.63 45.19 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.861 -1.15 . . . . 0.0 113.793 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -62.49 -42.91 99.82 Favored 'General case' 0 CA--C 1.578 2.052 0 CA-C-O 117.427 -1.273 . . . . 0.0 111.461 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -54.13 -44.81 71.68 Favored 'General case' 0 CA--C 1.573 1.842 0 CA-C-N 121.558 1.981 . . . . 0.0 112.332 173.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -69.38 -49.53 54.56 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -58.75 -15.86 14.08 Favored 'General case' 0 CA--C 1.58 2.1 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 173.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -93.33 -53.32 4.14 Favored 'General case' 0 CA--C 1.582 2.18 0 CA-C-N 120.129 1.331 . . . . 0.0 110.995 173.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.48 -23.12 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 120.13 3.382 . . . . 0.0 120.13 -175.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.502 2.142 0 C-N-CA 125.034 1.334 . . . . 0.0 112.078 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 10.4 p . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.96 -34.82 75.96 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 113.239 -1.8 . . . . 0.0 115.468 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.24 -39.79 76.29 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -59.85 -49.47 77.59 Favored 'General case' 0 CA--C 1.584 2.285 0 CA-C-O 122.261 1.029 . . . . 0.0 112.317 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.3 t -64.54 -50.44 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.793 0 C-N-CA 126.101 1.76 . . . . 0.0 111.184 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -58.3 -42.99 87.86 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 123.52 0.728 . . . . 0.0 112.674 176.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -61.41 -51.15 69.96 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.531 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.18 -45.32 93.53 Favored 'General case' 0 CA--C 1.561 1.393 0 N-CA-C 115.435 1.642 . . . . 0.0 115.435 177.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.6 ttt -71.44 -42.1 68.66 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 117.328 -1.32 . . . . 0.0 111.748 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.46 -43.85 84.35 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 120.907 1.685 . . . . 0.0 110.744 174.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.59 -30.11 68.79 Favored 'General case' 0 CA--C 1.581 2.146 0 CA-C-N 121.165 1.802 . . . . 0.0 113.043 174.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.37 -23.51 37.65 Favored 'General case' 0 CA--C 1.582 2.183 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.622 ' OD2' ' HA2' ' A' ' 140' ' ' GLY . 17.8 t0 -84.72 108.17 17.28 Favored 'General case' 0 CA--C 1.578 2.043 0 N-CA-C 104.079 -2.563 . . . . 0.0 104.079 171.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -76.09 -29.05 57.78 Favored 'General case' 0 CA--C 1.587 2.382 0 CA-C-N 120.556 1.525 . . . . 0.0 113.515 177.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.274 0.1 OUTLIER -166.02 -75.93 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.376 1 N-CA-C 99.075 -4.416 . . . . 0.0 99.075 177.127 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 34.15 30.13 0.01 OUTLIER Glycine 0 C--N 1.372 2.531 0 CA-C-N 123.309 2.777 . . . . 0.0 119.399 175.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.38 -3.21 0.68 Allowed 'General case' 0 CA--C 1.593 2.615 0 CA-C-N 119.629 1.715 . . . . 0.0 114.438 -172.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.622 ' HA2' ' OD2' ' A' ' 135' ' ' ASP . . . 106.41 -23.34 28.75 Favored Glycine 0 CA--C 1.559 2.817 0 CA-C-N 122.983 2.629 . . . . 0.0 113.78 -175.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . 0.257 27.8 m -118.6 133.43 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 103.542 -2.762 . . . . 0.0 103.542 178.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.03 126.93 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 117.492 2.404 . . . . 0.0 117.492 -172.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.4 p30 -90.76 156.2 18.23 Favored 'General case' 0 CA--C 1.564 1.502 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 172.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 5.5 mt -55.72 -49.31 93.56 Favored Pre-proline 0 CA--C 1.574 1.886 0 CA-C-O 114.482 -2.675 . . . . 0.0 114.191 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -52.26 -31.62 47.21 Favored 'Trans proline' 0 C--N 1.374 1.908 0 CA-C-N 125.434 2.977 . . . . 0.0 116.444 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -63.21 -61.06 2.62 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 121.142 1.792 . . . . 0.0 114.326 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -53.26 -50.78 64.12 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 120.179 1.354 . . . . 0.0 113.682 177.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.61 ' HB3' HG23 ' A' ' 90' ' ' ILE 0.255 0.1 OUTLIER -68.77 -47.23 66.74 Favored 'General case' 0 C--N 1.352 0.711 0 CA-C-O 113.924 -2.941 . . . . 0.0 111.18 179.229 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.28 -29.45 69.87 Favored 'General case' 0 CA--C 1.586 2.345 0 CA-C-N 125.585 3.812 . . . . 0.0 112.715 175.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . 0.291 5.3 tt -57.98 -40.95 81.94 Favored 'General case' 0 CA--C 1.575 1.922 0 C-N-CA 125.711 1.605 . . . . 0.0 109.799 172.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 55.7 mt -90.4 -64.73 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.604 3.034 0 CA-C-N 120.312 1.414 . . . . 0.0 109.941 173.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.591 2.556 0 N-CA-C 121.018 3.71 . . . . 0.0 121.018 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.571 1.753 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.871 HG22 HD13 ' A' ' 151' ' ' ILE . 6.7 mt -69.22 -52.67 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.118 0 CA-C-O 116.153 -1.879 . . . . 0.0 110.986 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.2 pp -55.66 -43.66 76.5 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 121.555 1.98 . . . . 0.0 108.84 176.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -54.67 -49.31 70.93 Favored 'General case' 0 CA--C 1.571 1.782 0 CA-C-N 121.184 1.811 . . . . 0.0 112.69 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.95 -56.72 10.27 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-O 116.03 -1.938 . . . . 0.0 114.666 178.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.402 ' HB2' ' CE2' ' A' ' 147' ' ' PHE . 10.1 t80 -64.83 -42.3 95.05 Favored 'General case' 0 N--CA 1.509 2.479 0 CA-C-N 122.47 2.396 . . . . 0.0 112.734 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.466 ' HZ3' ' HA2' ' A' ' 103' ' ' GLY 0.285 6.1 mmpt? -62.56 -30.44 71.32 Favored 'General case' 0 CA--C 1.577 1.995 0 CA-C-O 117.625 -1.178 . . . . 0.0 110.869 179.138 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.8 t -71.69 -50.16 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-N 120.451 1.478 . . . . 0.0 108.324 169.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -58.0 -37.91 75.14 Favored 'General case' 0 CA--C 1.579 2.063 0 N-CA-C 116.728 2.121 . . . . 0.0 116.728 -177.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.297 6.5 t0 -59.33 90.6 0.02 OUTLIER 'General case' 0 CA--C 1.571 1.761 0 C-N-CA 128.495 2.718 . . . . 0.0 109.967 176.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.07 -49.06 66.33 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.534 -0.729 . . . . 0.0 112.106 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -48.68 -24.86 1.52 Allowed 'General case' 0 CA--C 1.585 2.298 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 175.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.59 8.59 86.76 Favored Glycine 0 CA--C 1.56 2.884 0 CA-C-N 122.04 2.2 . . . . 0.0 116.953 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.06 86.61 2.22 Favored 'General case' 0 N--CA 1.473 0.723 1 CA-C-O 110.533 -4.556 . . . . 0.0 107.039 176.596 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.466 ' HA2' ' HZ3' ' A' ' 95' ' ' LYS . . . 54.72 -25.11 0.01 OUTLIER Glycine 0 N--CA 1.489 2.214 2 N-CA-C 130.798 7.079 . . . . 0.0 130.798 162.459 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.7 p -114.39 151.95 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.811 0 CA-C-O 122.726 1.25 . . . . 0.0 112.887 -178.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 63.4 mt -129.34 136.25 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 CA-C-N 113.55 -1.659 . . . . 0.0 111.317 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -115.75 -177.8 3.24 Favored 'General case' 0 CA--C 1.589 2.471 0 C-N-CA 124.087 0.955 . . . . 0.0 110.062 174.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -74.21 -47.25 36.66 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 -176.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -61.65 -42.78 99.37 Favored 'General case' 0 N--CA 1.514 2.729 0 CA-C-N 122.256 2.298 . . . . 0.0 113.539 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -56.03 -39.89 72.63 Favored 'General case' 0 N--CA 1.504 2.243 0 CA-C-N 119.325 0.966 . . . . 0.0 111.678 173.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -63.38 -46.57 85.85 Favored 'General case' 0 CA--C 1.571 1.787 0 C-N-CA 124.914 1.286 . . . . 0.0 109.36 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -53.5 -50.86 64.5 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 123.89 0.876 . . . . 0.0 111.668 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -57.77 -53.83 53.78 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 176.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.5 tt -74.0 -29.3 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 119.366 3.099 . . . . 0.0 119.366 -176.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.492 ' SD ' ' HA ' ' A' ' 127' ' ' VAL . 6.3 tpt . . . . . 0 N--CA 1.498 1.957 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 CA--C 1.557 1.239 0 N-CA-C 102.273 -3.232 . . . . 0.0 102.273 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -67.6 -34.75 77.64 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 115.925 1.824 . . . . 0.0 115.925 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.75 -38.7 75.81 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-O 116.74 -1.6 . . . . 0.0 113.279 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -68.29 -39.46 82.08 Favored 'General case' 0 CA--C 1.572 1.812 0 CA-C-N 121.442 1.928 . . . . 0.0 112.456 176.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.492 ' HA ' ' SD ' ' A' ' 114' ' ' MET . 0.4 OUTLIER -70.39 -48.56 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 119.216 0.916 . . . . 0.0 112.32 177.766 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -66.59 -49.4 66.46 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 116.77 -1.586 . . . . 0.0 109.504 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -55.98 -47.96 76.71 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 122.256 2.298 . . . . 0.0 113.526 176.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.78 -46.2 89.12 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-O 117.644 -1.169 . . . . 0.0 113.85 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 14.8 ttt -77.21 -37.21 53.9 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 116.478 -1.725 . . . . 0.0 110.658 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -32.9 69.83 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 123.927 3.058 . . . . 0.0 109.977 172.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -73.3 -44.22 59.5 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-O 116.309 -1.805 . . . . 0.0 110.477 176.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.419 ' HA ' HD12 ' A' ' 150' ' ' LEU . . . -80.73 -35.38 33.53 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 117.611 2.448 . . . . 0.0 117.611 178.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -90.3 119.81 30.92 Favored 'General case' 0 N--CA 1.514 2.771 1 O-C-N 116.099 -4.126 . . . . 0.0 106.069 176.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -75.27 -32.9 61.18 Favored 'General case' 0 CA--C 1.58 2.109 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 177.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.301 0.1 OUTLIER 175.75 -73.49 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.368 1 N-CA-C 96.516 -5.364 . . . . 0.0 96.516 178.771 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 34.92 32.16 0.02 OUTLIER Glycine 0 C--N 1.373 2.616 0 CA-C-N 123.681 2.946 . . . . 0.0 118.696 174.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 55.0 17.79 2.0 Favored 'General case' 0 CA--C 1.592 2.59 0 CA-C-O 115.739 -2.077 . . . . 0.0 115.18 -173.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 92.81 -22.36 34.29 Favored Glycine 0 C--N 1.38 3.009 0 CA-C-N 124.486 3.312 . . . . 0.0 114.979 -176.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.27 146.68 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 176.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.7 mt -123.1 131.42 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 112.594 -2.094 . . . . 0.0 110.375 -177.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 42.3 p30 -97.88 158.64 15.41 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 105.199 -2.149 . . . . 0.0 105.199 171.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.441 HD12 ' HE3' ' A' ' 95' ' ' LYS . 0.9 OUTLIER -56.33 -44.57 99.78 Favored Pre-proline 0 CA--C 1.587 2.385 0 CA-C-O 114.971 -2.442 . . . . 0.0 112.833 -179.373 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.18 -36.15 35.75 Favored 'Trans proline' 0 C--N 1.382 2.342 0 C-N-CA 124.294 3.329 . . . . 0.0 117.107 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -65.61 -56.17 13.67 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 121.623 2.01 . . . . 0.0 110.835 175.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.422 ' CE2' HG21 ' A' ' 90' ' ' ILE . 21.4 t80 -55.38 -50.14 70.49 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.753 ' HB3' HG23 ' A' ' 90' ' ' ILE 0.257 4.0 ptp -66.34 -41.73 89.16 Favored 'General case' 0 CA--C 1.577 2.019 0 CA-C-O 117.478 -1.249 . . . . 0.0 111.316 178.204 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -60.2 -35.07 74.57 Favored 'General case' 0 N--CA 1.508 2.46 0 CA-C-N 121.018 1.736 . . . . 0.0 114.258 173.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 134' ' ' ALA 0.356 6.8 tt -69.15 -34.73 75.44 Favored 'General case' 0 CA--C 1.567 1.627 0 C-N-CA 127.838 2.455 . . . . 0.0 110.302 176.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.871 HD13 HG22 ' A' ' 90' ' ' ILE . 79.2 mt -69.52 -48.79 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 CA-C-N 121.051 1.751 . . . . 0.0 106.879 171.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.581 2.135 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 . . . . . 0 CA--C 1.581 2.145 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.452 HG23 ' HA ' ' A' ' 148' ' ' MET . 0.7 OUTLIER -78.12 -52.71 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -178.341 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -63.51 -50.32 70.08 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 115.754 -2.069 . . . . 0.0 111.258 -177.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.97 -28.89 63.73 Favored 'General case' 0 CA--C 1.571 1.775 0 CA-C-O 114.374 -2.727 . . . . 0.0 111.243 176.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.98 -53.2 53.92 Favored 'General case' 0 C--N 1.38 1.925 0 CA-C-N 124.5 3.318 . . . . 0.0 111.378 174.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -62.03 -42.9 99.67 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 119.81 1.186 . . . . 0.0 112.821 176.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.602 ' HE2' HD12 ' A' ' 144' ' ' ILE . 58.1 mttt -63.68 -34.51 78.01 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 116.589 -1.672 . . . . 0.0 111.9 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -70.34 -44.84 77.14 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.197 0 CA-C-N 121.711 2.05 . . . . 0.0 108.557 171.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -56.34 -31.94 64.22 Favored 'General case' 0 CA--C 1.576 1.967 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -60.33 118.97 7.07 Favored 'General case' 0 CA--C 1.575 1.927 0 C-N-CA 125.812 1.645 . . . . 0.0 111.951 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.413 ' CB ' ' HG2' ' A' ' 109' ' ' GLU . . . -77.33 -52.51 9.04 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 -178.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.9 p30 -72.74 -8.67 56.52 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 117.88 2.548 . . . . 0.0 117.88 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.2 8.92 87.16 Favored Glycine 0 CA--C 1.555 2.539 0 N-CA-C 119.523 2.569 . . . . 0.0 119.523 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.6 p30 -114.4 -12.56 12.35 Favored 'General case' 0 CA--C 1.575 1.928 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 177.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.34 22.21 5.92 Favored Glycine 0 CA--C 1.548 2.132 0 CA-C-O 116.325 -2.375 . . . . 0.0 115.985 -178.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.4 HG11 ' O ' ' A' ' 142' ' ' ILE . 2.3 t -132.61 138.74 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-N 121.366 2.583 . . . . 0.0 109.734 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.0 mt -119.76 136.71 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 126.059 1.744 . . . . 0.0 110.746 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -99.13 -175.08 2.92 Favored 'General case' 0 CA--C 1.576 1.969 0 C-N-CA 124.083 0.953 . . . . 0.0 112.678 176.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -82.23 -51.66 7.72 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 119.961 -1.712 . . . . 0.0 113.833 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -62.28 -46.33 89.27 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 119.681 1.128 . . . . 0.0 112.59 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.413 ' HG2' ' CB ' ' A' ' 99' ' ' ALA . 37.1 tp10 -63.81 -35.49 80.77 Favored 'General case' 0 CA--C 1.57 1.723 0 CA-C-N 119.68 1.127 . . . . 0.0 113.064 176.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -61.07 -48.85 79.82 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 119.845 1.202 . . . . 0.0 107.815 171.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.42 ' HZ3' ' CD ' ' A' ' 128' ' ' GLU . 56.6 tttt -64.64 -9.27 18.41 Favored 'General case' 0 CA--C 1.581 2.164 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 174.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -94.37 -50.05 5.42 Favored 'General case' 0 CA--C 1.593 2.601 0 C-N-CA 125.336 1.454 . . . . 0.0 111.017 171.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.6 tt -80.21 -28.31 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 120.889 3.663 . . . . 0.0 120.889 -175.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 1.1 tpt . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 -178.883 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 30.6 p . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 122.952 1.358 . . . . 0.0 107.47 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -59.16 -37.99 78.67 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 112.223 -2.262 . . . . 0.0 115.369 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.27 -39.37 90.12 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-O 117.243 -1.36 . . . . 0.0 114.305 177.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -61.28 -52.89 62.84 Favored 'General case' 0 CA--C 1.577 1.982 0 CA-C-N 120.967 1.712 . . . . 0.0 112.631 177.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.6 t -69.43 -49.92 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 CA-C-O 117.529 -1.224 . . . . 0.0 112.255 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.42 ' CD ' ' HZ3' ' A' ' 111' ' ' LYS . 0.6 OUTLIER -62.19 -44.18 97.17 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 116.688 -1.625 . . . . 0.0 110.486 177.074 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -59.3 -52.04 67.35 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 122.488 2.404 . . . . 0.0 112.199 176.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.62 -44.56 95.98 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.527 ' SD ' HD13 ' A' ' 142' ' ' ILE . 18.4 tpt -73.56 -37.44 65.53 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 115.94 -1.981 . . . . 0.0 111.992 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -60.15 -49.12 78.89 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 122.92 2.6 . . . . 0.0 110.788 174.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -69.67 -26.94 64.62 Favored 'General case' 0 CA--C 1.575 1.936 0 CA-C-O 118.048 -0.977 . . . . 0.0 112.761 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.15 -21.34 27.62 Favored 'General case' 0 CA--C 1.58 2.108 0 CA-C-N 119.996 1.271 . . . . 0.0 114.347 175.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -88.46 109.28 19.9 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 122.757 2.526 . . . . 0.0 105.234 171.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -77.31 -25.17 50.98 Favored 'General case' 0 CA--C 1.576 1.958 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -86.61 -16.31 37.1 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 118.206 2.669 . . . . 0.0 118.206 -176.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.61 5.23 90.06 Favored Glycine 0 CA--C 1.565 3.173 0 CA-C-N 119.936 1.244 . . . . 0.0 115.367 -174.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -86.82 -29.82 21.96 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-N 119.167 1.483 . . . . 0.0 114.885 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 104.93 23.35 7.82 Favored Glycine 0 CA--C 1.554 2.497 0 CA-C-N 120.581 1.537 . . . . 0.0 116.607 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.88 152.69 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 123.543 1.64 . . . . 0.0 107.858 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.527 HD13 ' SD ' ' A' ' 131' ' ' MET . 0.8 OUTLIER -136.82 130.78 46.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 112.535 -2.121 . . . . 0.0 112.06 -177.504 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 34.1 p30 -97.67 162.27 13.36 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 104.72 -2.326 . . . . 0.0 104.72 170.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.602 HD12 ' HE2' ' A' ' 95' ' ' LYS . 4.4 mt -56.22 -49.25 94.33 Favored Pre-proline 0 CA--C 1.582 2.194 0 CA-C-O 113.413 -3.184 . . . . 0.0 110.905 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -47.73 -31.63 15.09 Favored 'Trans proline' 0 C--N 1.377 2.035 0 CA-C-N 127.011 3.54 . . . . 0.0 120.555 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -71.62 -66.34 0.64 Allowed 'General case' 0 N--CA 1.506 2.331 0 CA-C-N 122.663 2.483 . . . . 0.0 110.053 177.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -51.04 -41.76 60.05 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 124.596 1.158 . . . . 0.0 112.884 173.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.452 ' HA ' HG23 ' A' ' 90' ' ' ILE 0.268 0.0 OUTLIER -70.65 -45.21 65.55 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-O 113.658 -3.068 . . . . 0.0 110.808 -179.538 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.78 -44.25 90.63 Favored 'General case' 0 CA--C 1.583 2.232 0 CA-C-N 124.051 3.114 . . . . 0.0 111.776 175.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 7.9 tt -50.98 -47.59 61.4 Favored 'General case' 0 C--N 1.365 1.279 0 C-N-CA 126.216 1.807 . . . . 0.0 112.701 176.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 45.8 mt -90.24 -33.06 5.72 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.212 0 CA-C-N 121.099 1.772 . . . . 0.0 110.992 176.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt . . . . . 0 N--CA 1.503 2.193 0 CA-C-N 120.836 1.653 . . . . 0.0 114.599 176.343 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 . . . . . 0 CA--C 1.564 1.486 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.607 HG23 ' HG2' ' A' ' 148' ' ' MET . 3.6 mp -74.68 -58.37 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 CA-C-N 122.274 2.306 . . . . 0.0 109.334 177.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . 0.254 0.3 OUTLIER -62.92 -42.01 99.66 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 121.843 2.11 . . . . 0.0 110.038 179.167 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -60.88 -52.73 63.81 Favored 'General case' 0 CA--C 1.572 1.815 0 CA-C-N 121.921 2.146 . . . . 0.0 110.772 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.31 -54.94 16.21 Favored 'General case' 0 C--N 1.363 1.166 0 CA-C-O 116.009 -1.948 . . . . 0.0 115.49 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -63.32 -50.79 68.65 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 121.74 2.064 . . . . 0.0 112.28 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.332 78.5 mttt -64.52 -22.78 67.06 Favored 'General case' 0 CA--C 1.591 2.536 0 CA-C-O 117.372 -1.299 . . . . 0.0 111.199 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -73.14 -49.85 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 CA-C-N 121.266 1.848 . . . . 0.0 108.233 168.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -50.13 -37.62 35.13 Favored 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -61.2 115.72 4.02 Favored 'General case' 0 CA--C 1.578 2.024 0 C-N-CA 125.558 1.543 . . . . 0.0 112.722 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -77.65 -51.62 10.32 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.4 p30 -68.92 -13.19 62.28 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 117.777 2.51 . . . . 0.0 117.777 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.5 7.51 88.47 Favored Glycine 0 CA--C 1.553 2.422 0 N-CA-C 119.559 2.584 . . . . 0.0 119.559 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.1 p30 -104.33 -15.13 15.53 Favored 'General case' 0 CA--C 1.576 1.977 0 CA-C-N 119.535 1.667 . . . . 0.0 114.773 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.59 20.83 6.73 Favored Glycine 0 CA--C 1.545 1.941 0 CA-C-O 116.201 -2.444 . . . . 0.0 116.415 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -131.8 137.04 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 121.654 2.727 . . . . 0.0 110.856 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 58.8 mt -109.35 139.74 31.01 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 CA-C-N 112.058 -2.337 . . . . 0.0 108.36 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -118.83 -173.7 2.54 Favored 'General case' 0 CA--C 1.574 1.881 0 C-N-CA 124.242 1.017 . . . . 0.0 111.215 176.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -72.27 -53.42 12.54 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.657 -1.277 . . . . 0.0 113.877 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -56.61 -47.26 80.01 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 118.278 0.49 . . . . 0.0 112.305 177.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.26 -50.49 67.12 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 174.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.96 -51.77 66.76 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 124.621 1.168 . . . . 0.0 110.419 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.24 -8.95 50.61 Favored 'General case' 0 CA--C 1.577 1.991 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 176.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -92.08 -40.57 10.98 Favored 'General case' 0 CA--C 1.584 2.27 0 C-N-CA 124.902 1.281 . . . . 0.0 110.711 172.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.6 tt -91.41 -36.33 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 121.317 3.821 . . . . 0.0 121.317 -174.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 7.1 tpt . . . . . 0 N--CA 1.499 1.986 0 N-CA-C 117.525 2.416 . . . . 0.0 117.525 -176.114 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 16.8 p . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 122.401 1.096 . . . . 0.0 108.507 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -59.67 -38.02 80.35 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 116.963 2.209 . . . . 0.0 116.963 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.0 -45.37 79.07 Favored 'General case' 0 CA--C 1.554 1.12 0 O-C-N 124.493 1.121 . . . . 0.0 113.612 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -57.88 -50.79 72.14 Favored 'General case' 0 CA--C 1.579 2.068 0 CA-C-O 122.287 1.041 . . . . 0.0 112.517 176.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.9 t -67.51 -41.49 85.99 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.612 0 CA-C-N 114.003 -1.453 . . . . 0.0 112.162 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -63.66 -46.46 85.52 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 120.415 1.462 . . . . 0.0 109.91 175.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -57.54 -51.1 70.86 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 120.753 1.615 . . . . 0.0 112.199 175.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.4 -46.68 88.0 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.5 ttt -69.05 -39.24 79.27 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.806 177.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.87 -41.43 95.96 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 121.423 1.92 . . . . 0.0 109.827 174.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -64.64 -32.76 74.56 Favored 'General case' 0 CA--C 1.584 2.288 0 CA-C-N 121.017 1.735 . . . . 0.0 112.146 173.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.61 -26.72 34.64 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -78.97 109.43 13.25 Favored 'General case' 0 N--CA 1.516 2.861 0 CA-C-N 123.188 2.722 . . . . 0.0 109.98 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -86.58 -19.74 28.95 Favored 'General case' 0 CA--C 1.58 2.129 0 N-CA-C 117.142 2.275 . . . . 0.0 117.142 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -85.01 -14.42 47.46 Favored 'General case' 0 N--CA 1.507 2.409 1 N-CA-C 122.641 4.312 . . . . 0.0 122.641 -171.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.68 6.34 85.63 Favored Glycine 0 CA--C 1.57 3.507 0 CA-C-N 121.032 1.742 . . . . 0.0 114.958 -172.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -88.11 -51.41 5.81 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.187 1.395 . . . . 0.0 110.478 175.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 110.76 -20.18 24.91 Favored Glycine 0 CA--C 1.543 1.799 0 CA-C-O 115.695 -2.725 . . . . 0.0 115.894 -177.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . 0.259 13.0 m -126.64 124.06 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 101.152 -3.647 . . . . 0.0 101.152 176.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -77.77 124.72 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 -172.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -93.05 160.21 14.96 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 171.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.6 mt -57.32 -42.82 97.95 Favored Pre-proline 0 CA--C 1.579 2.081 0 CA-C-O 114.859 -2.496 . . . . 0.0 113.352 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.51 -38.45 74.82 Favored 'Trans proline' 0 C--N 1.376 1.99 0 CA-C-N 125.202 2.894 . . . . 0.0 116.703 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -68.17 -38.44 82.06 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 122.215 2.28 . . . . 0.0 113.947 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -64.9 -47.12 78.93 Favored 'General case' 0 CA--C 1.578 2.044 0 CA-C-N 121.411 1.914 . . . . 0.0 110.659 172.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.607 ' HG2' HG23 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -59.22 -44.07 92.31 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-N 118.45 0.568 . . . . 0.0 111.964 176.141 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -65.11 -44.95 87.07 Favored 'General case' 0 CA--C 1.568 1.672 0 C-N-CA 124.356 1.062 . . . . 0.0 109.85 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.28 -45.27 65.4 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.781 1.232 . . . . 0.0 111.915 174.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 97.0 mt -77.86 -50.57 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-O 116.862 -1.542 . . . . 0.0 114.187 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 84.3 mttt . . . . . 0 CA--C 1.565 1.542 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -176.615 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 . . . . . 0 CA--C 1.62 3.657 0 CA-C-O 127.938 3.732 . . . . 0.0 111.461 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.705 HG23 ' HE1' ' A' ' 148' ' ' MET . 13.9 mm -70.71 -43.98 76.88 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.642 0 CA-C-N 109.066 -3.697 . . . . 0.0 109.167 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.35 -43.53 88.39 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 121.826 2.103 . . . . 0.0 109.476 175.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.2 mmt-85 -55.25 -51.37 66.85 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 122.326 2.33 . . . . 0.0 107.536 175.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.83 -65.06 0.72 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 117.604 2.446 . . . . 0.0 117.604 177.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.486 ' HB2' ' CD2' ' A' ' 147' ' ' PHE . 18.3 t80 -67.36 -48.76 66.5 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.369 1.4 mmmp? -69.08 -19.2 64.07 Favored 'General case' 0 CA--C 1.589 2.443 0 CA-C-O 115.07 -2.395 . . . . 0.0 109.229 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -73.57 -45.99 49.62 Favored 'Isoleucine or valine' 0 C--N 1.394 2.532 0 CA-C-N 124.388 3.267 . . . . 0.0 105.597 166.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -52.73 -35.66 56.37 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 176.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.4 105.68 0.79 Allowed 'General case' 0 CA--C 1.577 2.005 0 C-N-CA 125.106 1.362 . . . . 0.0 109.432 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.07 -44.43 97.39 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 115.764 1.765 . . . . 0.0 115.764 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -69.62 -19.31 63.64 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 117.647 2.462 . . . . 0.0 117.647 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.62 21.35 64.22 Favored Glycine 0 CA--C 1.558 2.755 0 N-CA-C 118.14 2.016 . . . . 0.0 118.14 -177.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.58 -28.1 7.27 Favored 'General case' 0 CA--C 1.578 2.026 0 CA-C-N 119.388 1.594 . . . . 0.0 114.402 177.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 121.33 21.3 3.1 Favored Glycine 0 CA--C 1.548 2.11 0 CA-C-O 116.943 -2.031 . . . . 0.0 117.232 -175.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 p -124.69 150.61 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.668 0 CA-C-N 120.581 2.191 . . . . 0.0 109.379 173.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 96.3 mt -122.02 132.92 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-N 114.249 -1.341 . . . . 0.0 109.061 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.44 ' HB2' HG13 ' A' ' 141' ' ' VAL . 0.5 OUTLIER -109.75 179.12 4.21 Favored 'General case' 0 CA--C 1.582 2.173 0 CA-C-O 121.983 0.897 . . . . 0.0 111.749 175.196 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.29 -47.59 23.16 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.645 -1.284 . . . . 0.0 114.33 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -61.75 -38.72 89.0 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 117.706 -1.14 . . . . 0.0 110.443 175.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -65.01 -36.4 84.27 Favored 'General case' 0 CA--C 1.576 1.945 0 CA-C-N 121.022 1.737 . . . . 0.0 111.346 173.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -62.94 -48.48 78.71 Favored 'General case' 0 C--N 1.376 1.759 0 CA-C-N 120.99 1.723 . . . . 0.0 109.433 175.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 35.0 mttp -54.99 -52.12 64.09 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 123.9 0.88 . . . . 0.0 111.656 174.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -52.43 -47.95 66.05 Favored 'General case' 0 CA--C 1.571 1.763 0 C-N-CA 124.332 1.053 . . . . 0.0 113.518 175.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -81.47 -14.17 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 12.8 tpt . . . . . 0 N--CA 1.493 1.688 0 C-N-CA 125.575 1.55 . . . . 0.0 109.536 176.13 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 38.0 p . . . . . 0 N--CA 1.486 1.332 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.77 -37.14 85.51 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.52 -35.89 61.18 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -62.06 -55.67 26.74 Favored 'General case' 0 CA--C 1.587 2.393 0 CA-C-N 120.458 1.481 . . . . 0.0 111.659 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.1 t -63.47 -47.35 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 124.846 1.259 . . . . 0.0 111.216 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -57.77 -48.59 79.23 Favored 'General case' 0 CA--C 1.559 1.319 0 CA-C-O 118.101 -0.952 . . . . 0.0 111.887 176.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -58.53 -48.13 81.9 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 120.211 1.369 . . . . 0.0 112.489 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.96 -51.61 68.92 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -68.49 -34.42 75.89 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 115.263 -2.303 . . . . 0.0 112.113 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -65.26 -39.45 92.64 Favored 'General case' 0 CA--C 1.57 1.747 0 CA-C-N 122.739 2.518 . . . . 0.0 110.243 173.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -59.41 -40.74 87.62 Favored 'General case' 0 CA--C 1.574 1.874 0 CA-C-N 122.085 2.22 . . . . 0.0 110.559 173.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.421 ' HA ' HD22 ' A' ' 150' ' ' LEU . . . -78.38 -25.34 46.21 Favored 'General case' 0 CA--C 1.577 1.993 0 N-CA-C 116.872 2.175 . . . . 0.0 116.872 175.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -89.43 115.43 26.87 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 118.938 -2.351 . . . . 0.0 107.191 175.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -76.48 -27.73 56.22 Favored 'General case' 0 CA--C 1.566 1.567 0 N-CA-C 117.779 2.511 . . . . 0.0 117.779 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -105.88 -12.54 15.81 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 119.293 3.071 . . . . 0.0 119.293 -174.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.65 4.69 90.22 Favored Glycine 0 CA--C 1.572 3.627 0 CA-C-N 120.129 1.331 . . . . 0.0 113.623 -172.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -71.73 -45.94 60.15 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 125.282 1.433 . . . . 0.0 110.661 175.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 110.83 -4.88 29.1 Favored Glycine 0 CA--C 1.541 1.661 0 CA-C-O 115.075 -3.069 . . . . 0.0 117.598 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.44 HG13 ' HB2' ' A' ' 106' ' ' ASP 0.336 0.9 OUTLIER -136.91 118.85 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-N 123.093 3.446 . . . . 0.0 104.362 175.507 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.9 mt -85.21 130.88 35.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 109.385 -3.552 . . . . 0.0 111.835 -175.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 41.4 p30 -94.22 155.1 17.21 Favored 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 171.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -53.55 -44.98 98.76 Favored Pre-proline 0 CA--C 1.586 2.364 0 CA-C-O 114.427 -2.702 . . . . 0.0 113.468 -178.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -46.08 -37.82 18.31 Favored 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 124.634 3.556 . . . . 0.0 117.211 177.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -61.37 -55.29 33.23 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 119.364 0.983 . . . . 0.0 112.029 175.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.486 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 66.7 t80 -57.61 -45.38 85.43 Favored 'General case' 0 CA--C 1.577 1.996 0 C-N-CA 125.805 1.642 . . . . 0.0 112.721 175.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.705 ' HE1' HG23 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -62.9 -36.25 82.73 Favored 'General case' 0 CA--C 1.586 2.337 0 CA-C-O 117.865 -1.064 . . . . 0.0 110.142 177.289 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -70.71 -40.33 72.9 Favored 'General case' 0 CA--C 1.583 2.216 0 CA-C-N 120.58 1.537 . . . . 0.0 110.797 172.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' A' ' 134' ' ' ALA . 1.4 mm? -50.66 -45.41 57.98 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 126.037 1.735 . . . . 0.0 109.254 173.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 62.2 mt -83.14 -63.05 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.484 0 CA-C-N 119.847 1.203 . . . . 0.0 112.18 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt . . . . . 0 N--CA 1.493 1.707 0 N-CA-C 117.62 2.452 . . . . 0.0 117.62 -177.12 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 . . . . . 0 N--CA 1.501 2.086 0 N-CA-C 115.378 1.621 . . . . 0.0 115.378 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.9 HD12 ' HE2' ' A' ' 152' ' ' LYS . 0.1 OUTLIER -70.82 -54.43 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-O 117.168 -1.396 . . . . 0.0 113.331 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . 0.279 0.0 OUTLIER -61.3 -40.05 92.71 Favored 'General case' 0 CA--C 1.568 1.663 0 CA-C-N 120.117 1.326 . . . . 0.0 110.315 -178.607 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.05 -57.93 9.74 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-N 120.767 1.621 . . . . 0.0 110.786 175.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.66 -57.41 8.16 Favored 'General case' 0 C--N 1.364 1.21 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -64.01 -47.69 79.28 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 117.141 -1.409 . . . . 0.0 113.091 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.293 31.1 mttm -66.3 -24.32 66.52 Favored 'General case' 0 CA--C 1.582 2.18 0 CA-C-O 117.008 -1.472 . . . . 0.0 110.601 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.6 t -68.88 -50.01 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-N 121.719 2.054 . . . . 0.0 108.167 168.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.54 -37.8 73.66 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 116.739 2.126 . . . . 0.0 116.739 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 1.218 ' OD2' ' HA ' ' A' ' 102' ' ' ASP . 12.1 t0 -62.46 111.21 1.94 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 126.103 1.761 . . . . 0.0 112.461 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.42 -28.2 41.74 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -76.23 8.98 2.84 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.0 7.0 84.38 Favored Glycine 0 CA--C 1.564 3.115 0 N-CA-C 120.03 2.772 . . . . 0.0 120.03 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 1.218 ' HA ' ' OD2' ' A' ' 98' ' ' ASP 0.79 0.2 OUTLIER 116.75 126.04 0.0 OUTLIER 'General case' 0 CA--C 1.584 2.273 0 C-N-CA 130.27 3.428 . . . . 0.0 118.025 171.092 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 114.81 12.25 10.44 Favored Glycine 0 N--CA 1.441 -1.032 2 C-N-CA 134.471 5.796 . . . . 0.0 115.291 176.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.743 ' O ' ' OD1' ' A' ' 98' ' ' ASP . 0.5 OUTLIER -170.53 156.4 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.571 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 179.225 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 78.5 mt -133.03 130.3 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 127.013 2.125 . . . . 0.0 107.77 175.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -108.72 171.47 7.41 Favored 'General case' 0 CA--C 1.595 2.696 0 C-N-CA 123.806 0.843 . . . . 0.0 110.532 175.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.47 ' HA ' ' SD ' ' A' ' 131' ' ' MET . 27.0 t80 -64.07 -60.41 3.27 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 117.787 2.514 . . . . 0.0 117.787 -176.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -59.84 -27.33 66.54 Favored 'General case' 0 N--CA 1.508 2.425 0 CA-C-N 119.823 1.192 . . . . 0.0 112.713 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -63.55 -42.17 98.4 Favored 'General case' 0 CA--C 1.578 2.023 0 CA-C-N 119.462 1.028 . . . . 0.0 110.455 172.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -62.41 -53.0 61.34 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 125.555 1.542 . . . . 0.0 109.65 174.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -51.23 -44.53 61.71 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 175.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -66.55 -53.83 30.34 Favored 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 125.515 1.526 . . . . 0.0 112.686 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -67.75 -21.87 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 -178.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.505 2.291 0 CA-C-N 119.283 0.947 . . . . 0.0 111.099 172.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.4 p . . . . . 0 CA--C 1.566 1.593 0 N-CA-C 102.351 -3.203 . . . . 0.0 102.351 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -54.74 -33.96 61.86 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.444 -1.41 . . . . 0.0 114.792 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.21 -46.05 88.84 Favored 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 124.259 1.024 . . . . 0.0 112.63 175.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -64.21 -40.0 95.15 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 119.682 1.128 . . . . 0.0 112.252 176.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.9 p -67.52 -37.62 79.14 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.908 0 CA-C-N 119.85 1.204 . . . . 0.0 110.648 176.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -66.02 -45.04 82.93 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 119.661 1.119 . . . . 0.0 111.771 175.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -66.63 -41.17 88.74 Favored 'General case' 0 CA--C 1.574 1.884 0 O-C-N 120.894 -1.129 . . . . 0.0 113.249 176.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.93 -48.28 79.61 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.686 176.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.47 ' SD ' ' HA ' ' A' ' 107' ' ' PHE . 21.2 ttt -67.42 -36.2 80.78 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 115.415 -2.231 . . . . 0.0 110.792 175.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.18 -36.7 84.48 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 123.358 2.799 . . . . 0.0 111.868 175.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -62.37 -44.61 96.05 Favored 'General case' 0 CA--C 1.583 2.217 0 CA-C-N 119.531 1.06 . . . . 0.0 109.883 172.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -72.99 -26.73 61.44 Favored 'General case' 0 CA--C 1.583 2.233 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 176.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -80.36 111.71 17.01 Favored 'General case' 0 CA--C 1.56 1.36 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 175.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -72.68 -20.71 61.19 Favored 'General case' 0 CA--C 1.579 2.059 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -91.19 -17.22 26.42 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 117.68 2.474 . . . . 0.0 117.68 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.07 5.45 89.69 Favored Glycine 0 CA--C 1.563 3.085 0 CA-C-N 120.17 1.35 . . . . 0.0 115.905 -175.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 53.5 p-10 -87.54 -32.54 19.33 Favored 'General case' 0 CA--C 1.568 1.666 0 CA-C-N 119.408 1.604 . . . . 0.0 115.101 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 107.92 20.11 8.63 Favored Glycine 0 CA--C 1.559 2.797 0 N-CA-C 116.926 1.53 . . . . 0.0 116.926 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.19 152.63 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.4 mt -137.5 131.33 44.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 112.164 -2.289 . . . . 0.0 111.743 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 51.3 p30 -96.39 163.74 12.93 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 171.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 3.3 mt -56.76 -45.76 99.91 Favored Pre-proline 0 CA--C 1.582 2.203 0 CA-C-O 114.225 -2.798 . . . . 0.0 112.181 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -48.45 -38.01 34.26 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 124.216 3.277 . . . . 0.0 117.474 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -67.57 -52.27 40.7 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 120.751 1.614 . . . . 0.0 111.632 177.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -58.23 -48.17 81.21 Favored 'General case' 0 CA--C 1.569 1.7 0 CA-C-N 120.589 1.54 . . . . 0.0 112.577 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 2.0 ptp -64.19 -39.79 94.73 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-O 116.984 -1.484 . . . . 0.0 113.523 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -68.8 -33.95 74.72 Favored 'General case' 0 CA--C 1.585 2.305 0 CA-C-N 121.053 1.751 . . . . 0.0 109.312 172.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.02 -46.39 71.8 Favored 'General case' 0 CA--C 1.576 1.975 0 CA-C-N 120.15 1.341 . . . . 0.0 111.368 174.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 82.6 mt -80.52 -62.46 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.58 2.125 0 C-N-CA 123.472 0.709 . . . . 0.0 111.725 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.9 ' HE2' HD12 ' A' ' 90' ' ' ILE . 22.9 mttm . . . . . 0 CA--C 1.583 2.242 0 N-CA-C 118.952 2.945 . . . . 0.0 118.952 -177.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 . . . . . 0 CA--C 1.569 1.7 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.429 HD12 HG23 ' A' ' 151' ' ' ILE . 0.1 OUTLIER -67.97 -58.7 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-N 119.855 1.207 . . . . 0.0 109.129 177.597 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.5 pp -59.39 -49.02 79.4 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 117.904 -1.046 . . . . 0.0 112.087 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -64.83 -45.07 87.73 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-N 120.327 1.421 . . . . 0.0 112.902 178.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.36 -54.85 16.92 Favored 'General case' 0 C--N 1.365 1.265 0 CA-C-O 115.355 -2.26 . . . . 0.0 112.172 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.422 ' CE2' HD11 ' A' ' 105' ' ' ILE . 6.9 t80 -60.74 -47.2 87.36 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 121.707 2.049 . . . . 0.0 112.719 177.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.25 91.3 mttt -62.13 -31.38 71.85 Favored 'General case' 0 CA--C 1.58 2.132 0 CA-C-O 117.276 -1.345 . . . . 0.0 111.909 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.4 t -70.01 -48.15 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 CA-C-N 121.166 1.803 . . . . 0.0 108.956 170.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -53.52 -36.69 62.03 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 -178.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -65.29 93.47 0.14 Allowed 'General case' 0 CA--C 1.57 1.712 0 C-N-CA 126.161 1.784 . . . . 0.0 110.802 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.01 -42.71 80.28 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -65.19 -28.05 69.12 Favored 'General case' 0 CA--C 1.581 2.149 0 CA-C-O 117.344 -1.312 . . . . 0.0 113.839 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.02 3.82 90.62 Favored Glycine 0 CA--C 1.554 2.509 0 CA-C-N 121.903 2.138 . . . . 0.0 118.276 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 27.1 p-10 -97.7 -5.26 35.57 Favored 'General case' 0 CA--C 1.581 2.151 0 CA-C-N 120.788 2.294 . . . . 0.0 114.084 174.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.13 8.46 21.78 Favored Glycine 0 CA--C 1.551 2.295 0 CA-C-O 115.756 -2.691 . . . . 0.0 115.999 -177.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -126.14 153.21 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-N 121.865 2.833 . . . . 0.0 114.153 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.422 HD11 ' CE2' ' A' ' 94' ' ' PHE . 74.0 mt -116.24 132.2 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 112.11 -2.314 . . . . 0.0 108.876 177.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -108.83 -169.61 1.52 Allowed 'General case' 0 CA--C 1.581 2.159 0 C-N-CA 122.977 0.511 . . . . 0.0 110.374 174.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -80.31 -47.16 14.94 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.065 -1.647 . . . . 0.0 114.353 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -57.01 -44.95 83.3 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 123.042 0.537 . . . . 0.0 112.259 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -61.51 -42.25 98.53 Favored 'General case' 0 CA--C 1.583 2.228 0 CA-C-N 119.094 0.861 . . . . 0.0 112.613 174.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -54.83 -49.15 71.76 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 125.124 1.37 . . . . 0.0 109.809 174.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.0 mmmt -59.09 -60.94 3.05 Favored 'General case' 0 CA--C 1.57 1.718 0 CA-C-O 118.256 -0.878 . . . . 0.0 109.382 174.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -41.89 -41.22 2.36 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 116.845 2.165 . . . . 0.0 116.845 177.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 10.7 mt -93.61 -45.63 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 N-CA-C 119.287 3.069 . . . . 0.0 119.287 -177.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 3.5 tpt . . . . . 0 N--CA 1.498 1.93 0 N-CA-C 119.63 3.196 . . . . 0.0 119.63 -175.509 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.499 ' C ' ' H ' ' A' ' 125' ' ' ALA 0.28 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.854 0 N-CA-C 118.621 2.822 . . . . 0.0 118.621 . . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -0.53 -7.07 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.974 2 N-CA-C 125.343 5.312 . . . . 0.0 125.343 -164.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.499 ' H ' ' C ' ' A' ' 123' ' ' THR . . . -76.33 -48.67 19.18 Favored 'General case' 0 CA--C 1.564 1.509 0 C-N-CA 126.359 1.864 . . . . 0.0 108.3 173.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.1 -41.65 75.54 Favored 'General case' 0 CA--C 1.579 2.068 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 174.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.7 t -68.22 -49.33 68.14 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 C-N-CA 126.108 1.763 . . . . 0.0 109.692 178.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -58.37 -43.41 88.45 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 119.952 1.251 . . . . 0.0 111.754 175.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.01 -54.05 49.66 Favored 'General case' 0 CA--C 1.576 1.954 0 CA-C-N 120.573 1.533 . . . . 0.0 111.644 176.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.68 -43.79 93.88 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.58 -40.89 69.61 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 116.806 -1.568 . . . . 0.0 110.616 177.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -37.95 82.49 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 121.621 2.009 . . . . 0.0 110.319 173.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -69.95 -34.54 73.57 Favored 'General case' 0 CA--C 1.571 1.75 0 CA-C-N 120.744 1.611 . . . . 0.0 112.316 175.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -78.94 -25.94 43.59 Favored 'General case' 0 CA--C 1.578 2.021 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -87.71 98.45 11.45 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 102.869 -3.011 . . . . 0.0 102.869 171.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -83.0 -13.71 55.41 Favored 'General case' 0 CA--C 1.579 2.07 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -91.18 -14.53 30.91 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 118.763 2.875 . . . . 0.0 118.763 -175.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.15 6.2 89.02 Favored Glycine 0 CA--C 1.565 3.186 0 CA-C-O 118.454 -1.192 . . . . 0.0 115.115 -174.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.93 -50.11 15.89 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 119.454 1.627 . . . . 0.0 110.984 176.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 111.66 -15.54 26.7 Favored Glycine 0 CA--C 1.546 1.978 0 CA-C-O 115.78 -2.678 . . . . 0.0 116.773 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . 0.302 3.8 m -133.34 120.63 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 100.823 -3.769 . . . . 0.0 100.823 175.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.3 mt -77.87 125.88 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 111.489 -2.596 . . . . 0.0 115.755 -172.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 36.5 p30 -91.68 152.9 20.01 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 172.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -51.34 -42.43 81.65 Favored Pre-proline 0 CA--C 1.583 2.239 0 CA-C-O 114.802 -2.523 . . . . 0.0 113.706 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.66 -29.5 80.02 Favored 'Trans proline' 0 C--N 1.376 1.998 0 CA-C-N 125.454 2.983 . . . . 0.0 116.991 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -66.97 -54.84 17.93 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 122.83 2.559 . . . . 0.0 111.446 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -61.89 -45.88 91.81 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-N 120.202 1.365 . . . . 0.0 110.515 175.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.411 ' HG2' HG23 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -55.26 -47.22 75.78 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-O 116.359 -1.781 . . . . 0.0 111.089 176.715 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.65 -36.86 76.45 Favored 'General case' 0 CA--C 1.574 1.876 0 CA-C-N 122.288 2.313 . . . . 0.0 113.437 177.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.48 -41.89 81.57 Favored 'General case' 0 CA--C 1.57 1.738 0 C-N-CA 124.84 1.256 . . . . 0.0 110.503 174.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.429 HG23 HD12 ' A' ' 90' ' ' ILE . 5.4 mm -80.0 -43.52 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.8 0 CA-C-O 116.263 -1.827 . . . . 0.0 109.363 176.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 8.7 mttp . . . . . 0 N--CA 1.511 2.592 0 CA-C-N 122.426 2.375 . . . . 0.0 112.589 176.973 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.435 ' CD ' HH21 ' A' ' 92' ' ' ARG . 6.2 tp10 . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.513 HD12 HG23 ' A' ' 151' ' ' ILE . 1.3 mp -72.78 -45.83 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-O 115.625 -2.131 . . . . 0.0 108.71 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.0 pp -59.66 -46.94 87.52 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 123.111 2.687 . . . . 0.0 110.329 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.435 HH21 ' CD ' ' A' ' 89' ' ' GLU . 52.1 ttp180 -57.09 -58.88 6.28 Favored 'General case' 0 CA--C 1.568 1.647 0 C-N-CA 124.286 1.034 . . . . 0.0 112.378 176.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.46 -58.15 9.7 Favored 'General case' 0 C--N 1.353 0.735 0 CA-C-O 115.711 -2.09 . . . . 0.0 113.346 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -55.66 -50.96 68.83 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 121.551 1.978 . . . . 0.0 113.228 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -62.6 -33.19 74.48 Favored 'General case' 0 CA--C 1.562 1.412 0 CA-C-O 116.307 -1.806 . . . . 0.0 112.553 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -72.35 -44.39 63.13 Favored 'Isoleucine or valine' 0 CA--C 1.59 2.496 0 CA-C-N 121.854 2.115 . . . . 0.0 109.626 171.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -51.7 -35.72 43.89 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 127.098 2.159 . . . . 0.0 115.094 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.255 1.3 t0 -67.26 96.52 0.48 Allowed 'General case' 0 CA--C 1.576 1.967 0 C-N-CA 126.202 1.801 . . . . 0.0 107.342 177.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.04 -49.7 71.34 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.273 1.582 . . . . 0.0 115.273 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -62.33 -24.05 67.11 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.35 7.98 87.7 Favored Glycine 0 CA--C 1.551 2.32 0 N-CA-C 120.327 2.891 . . . . 0.0 120.327 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.8 p30 -96.97 -11.33 24.72 Favored 'General case' 0 CA--C 1.575 1.932 0 CA-C-N 119.78 1.79 . . . . 0.0 115.563 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.49 18.4 8.07 Favored Glycine 0 CA--C 1.552 2.396 0 CA-C-O 116.781 -2.122 . . . . 0.0 114.594 -176.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.45 154.98 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.501 0 CA-C-N 120.826 2.313 . . . . 0.0 111.78 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 79.1 mt -126.54 127.06 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-N 112.368 -2.196 . . . . 0.0 108.217 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -106.21 179.03 4.39 Favored 'General case' 0 CA--C 1.578 2.042 0 CA-C-O 121.857 0.837 . . . . 0.0 110.673 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -69.73 -42.32 74.12 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.15 -45.25 93.7 Favored 'General case' 0 N--CA 1.505 2.281 0 CA-C-N 120.566 1.53 . . . . 0.0 113.829 177.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -63.52 -46.3 86.69 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.917 0.887 . . . . 0.0 112.139 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -62.76 -50.96 68.99 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 117.0 -1.476 . . . . 0.0 110.983 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.0 pptp? -58.27 -39.9 80.44 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 121.235 1.834 . . . . 0.0 114.318 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -65.31 -49.32 69.9 Favored 'General case' 0 CA--C 1.575 1.909 0 C-N-CA 123.407 0.683 . . . . 0.0 112.385 175.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -79.56 -32.37 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 118.723 2.86 . . . . 0.0 118.723 -177.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.42 ' HG2' HG21 ' A' ' 127' ' ' VAL . 14.0 tpt . . . . . 0 N--CA 1.488 1.434 0 C-N-CA 125.692 1.597 . . . . 0.0 114.548 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 10.0 p . . . . . 0 N--CA 1.485 1.314 1 N-CA-C 99.775 -4.157 . . . . 0.0 99.775 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -53.47 -38.36 63.55 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 118.565 2.802 . . . . 0.0 118.565 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.44 -42.16 91.28 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 117.052 -1.452 . . . . 0.0 113.597 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -55.19 -53.43 56.11 Favored 'General case' 0 CA--C 1.573 1.842 0 CA-C-N 120.255 1.388 . . . . 0.0 112.63 176.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.42 HG21 ' HG2' ' A' ' 114' ' ' MET . 18.2 t -73.74 -53.79 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-O 117.197 -1.382 . . . . 0.0 113.829 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -64.2 -40.72 96.68 Favored 'General case' 0 CA--C 1.564 1.514 0 CA-C-N 120.061 1.3 . . . . 0.0 112.52 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -69.56 -43.87 72.04 Favored 'General case' 0 CA--C 1.574 1.891 0 CA-C-N 120.036 1.289 . . . . 0.0 111.228 176.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.57 -46.51 89.58 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 120.616 1.553 . . . . 0.0 113.247 176.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 19.8 ttt -70.27 -39.12 75.12 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 114.818 -2.515 . . . . 0.0 111.761 177.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -64.52 -35.38 80.78 Favored 'General case' 0 CA--C 1.574 1.872 0 CA-C-N 123.99 3.086 . . . . 0.0 111.595 175.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -62.85 -48.43 79.07 Favored 'General case' 0 CA--C 1.579 2.08 0 CA-C-N 121.654 2.025 . . . . 0.0 109.083 172.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.46 -25.08 63.91 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 177.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -90.06 100.57 13.37 Favored 'General case' 0 CA--C 1.573 1.856 0 N-CA-C 103.071 -2.937 . . . . 0.0 103.071 171.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -72.88 -16.56 61.57 Favored 'General case' 0 CA--C 1.579 2.095 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -98.55 -14.57 19.9 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 119.016 2.969 . . . . 0.0 119.016 -175.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.03 5.9 89.33 Favored Glycine 0 CA--C 1.57 3.482 0 CA-C-N 120.411 1.46 . . . . 0.0 115.138 -173.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -75.82 -47.18 26.7 Favored 'General case' 0 CA--C 1.563 1.466 0 C-N-CA 125.441 1.496 . . . . 0.0 112.195 176.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 111.84 -25.04 13.66 Favored Glycine 0 CA--C 1.553 2.455 0 CA-C-O 117.354 -1.803 . . . . 0.0 114.311 -176.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -100.68 143.16 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 N-CA-C 103.725 -2.694 . . . . 0.0 103.725 174.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.7 mt -121.84 124.87 72.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 111.982 -2.372 . . . . 0.0 112.665 -176.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 39.0 p30 -91.43 155.06 18.72 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 170.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.4 mt -52.13 -42.45 86.08 Favored Pre-proline 0 CA--C 1.583 2.237 0 CA-C-O 114.902 -2.475 . . . . 0.0 113.285 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -58.59 -17.8 36.8 Favored 'Trans proline' 0 C--N 1.376 1.992 0 CA-C-N 125.27 2.918 . . . . 0.0 117.976 176.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -72.53 -63.22 1.2 Allowed 'General case' 0 N--CA 1.505 2.28 0 CA-C-N 123.102 2.683 . . . . 0.0 109.469 176.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.422 ' CD1' HG22 ' A' ' 90' ' ' ILE . 0.7 OUTLIER -54.55 -49.05 71.24 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 125.128 1.371 . . . . 0.0 110.908 173.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.411 ' CE ' ' HB ' ' A' ' 90' ' ' ILE . 1.3 mmt -64.6 -34.93 79.43 Favored 'General case' 0 CA--C 1.565 1.556 0 CA-C-O 115.454 -2.212 . . . . 0.0 111.868 175.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -66.67 -46.49 75.52 Favored 'General case' 0 N--CA 1.507 2.382 0 CA-C-N 125.537 3.79 . . . . 0.0 109.14 174.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -46.89 -54.63 9.57 Favored 'General case' 0 C--N 1.368 1.386 0 C-N-CA 126.189 1.795 . . . . 0.0 111.215 176.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.513 HG23 HD12 ' A' ' 90' ' ' ILE . 33.8 mt -98.36 -28.52 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-N 121.648 2.022 . . . . 0.0 116.318 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.734 0 N-CA-C 118.659 2.837 . . . . 0.0 118.659 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.0 mp -58.14 -44.77 88.25 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.753 0 CA-C-N 112.036 -2.347 . . . . 0.0 108.963 172.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -39.03 86.04 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 116.322 -1.799 . . . . 0.0 111.685 176.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.22 -53.26 60.09 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 122.863 2.574 . . . . 0.0 107.888 176.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.71 -66.14 0.6 Allowed 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -66.62 -51.91 51.11 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.502 ' HD3' HD12 ' A' ' 144' ' ' ILE 0.382 7.7 mttt -67.81 -17.54 64.55 Favored 'General case' 0 CA--C 1.589 2.446 0 CA-C-O 114.821 -2.514 . . . . 0.0 110.234 -177.603 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.19 -46.5 44.56 Favored 'Isoleucine or valine' 0 C--N 1.395 2.547 0 CA-C-N 124.582 3.355 . . . . 0.0 106.186 167.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -53.61 -35.88 61.39 Favored 'General case' 0 CA--C 1.582 2.185 0 N-CA-C 117.23 2.308 . . . . 0.0 117.23 178.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -56.51 110.06 0.72 Allowed 'General case' 0 CA--C 1.575 1.905 0 C-N-CA 126.14 1.776 . . . . 0.0 115.469 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.682 ' HB1' ' HG2' ' A' ' 109' ' ' GLU . . . -73.76 -51.77 15.39 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -67.21 -24.53 65.85 Favored 'General case' 0 CA--C 1.578 2.052 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.8 1.71 90.31 Favored Glycine 0 CA--C 1.562 2.992 0 CA-C-N 121.773 2.079 . . . . 0.0 116.987 -175.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -107.19 0.64 23.47 Favored 'General case' 0 CA--C 1.587 2.382 0 CA-C-N 120.027 1.914 . . . . 0.0 112.419 172.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 114.06 -20.09 17.22 Favored Glycine 0 CA--C 1.547 2.083 0 CA-C-O 115.459 -2.856 . . . . 0.0 115.262 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.6 m -83.74 138.15 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.612 0 CA-C-N 123.797 3.799 . . . . 0.0 114.306 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 88.2 mt -116.25 123.36 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 101.713 -3.44 . . . . 0.0 101.713 174.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -91.88 162.64 14.34 Favored 'General case' 0 CA--C 1.56 1.329 0 CA-C-O 122.433 1.111 . . . . 0.0 111.577 176.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.77 -47.23 78.91 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.762 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -61.37 -44.2 97.56 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 117.906 -1.045 . . . . 0.0 111.546 176.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.682 ' HG2' ' HB1' ' A' ' 99' ' ' ALA . 34.4 tp10 -63.67 -37.76 88.55 Favored 'General case' 0 CA--C 1.569 1.701 0 CA-C-N 121.097 1.771 . . . . 0.0 112.521 174.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -62.76 -52.3 63.74 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 120.113 1.324 . . . . 0.0 108.143 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.517 ' HA ' HG12 ' A' ' 127' ' ' VAL . 10.5 ptpp? -56.58 -38.54 72.13 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 116.139 -1.886 . . . . 0.0 111.606 175.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -61.76 -54.52 41.25 Favored 'General case' 0 CA--C 1.579 2.072 0 CA-C-N 121.267 1.849 . . . . 0.0 112.788 174.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 tt -73.2 -11.93 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 119.091 2.997 . . . . 0.0 119.091 -177.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 9.2 tpt . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 177.551 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 30.6 p . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 122.656 1.217 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -66.12 -40.88 91.03 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 177.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.52 -43.59 72.04 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -46.5 82.67 Favored 'General case' 0 CA--C 1.584 2.253 0 CA-C-N 120.187 1.358 . . . . 0.0 113.847 177.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 111' ' ' LYS . 15.7 t -66.08 -48.97 79.77 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.496 0 C-N-CA 125.126 1.37 . . . . 0.0 110.884 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -57.3 -49.95 74.47 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 117.093 -1.432 . . . . 0.0 110.061 176.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -55.16 -51.33 66.82 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 120.737 1.608 . . . . 0.0 112.568 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.91 -48.0 83.48 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 116.123 1.897 . . . . 0.0 116.123 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -44.32 50.31 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 115.8 -2.048 . . . . 0.0 111.277 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.33 -37.18 69.62 Favored 'General case' 0 CA--C 1.575 1.92 0 CA-C-N 122.466 2.394 . . . . 0.0 110.954 174.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -70.91 -39.46 72.72 Favored 'General case' 0 CA--C 1.578 2.024 0 CA-C-N 121.04 1.746 . . . . 0.0 111.94 175.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.08 -25.0 63.32 Favored 'General case' 0 CA--C 1.579 2.068 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 174.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -79.7 110.98 15.55 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 116.579 -3.826 . . . . 0.0 108.068 175.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -75.46 -22.75 57.01 Favored 'General case' 0 CA--C 1.57 1.723 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -107.11 -9.59 16.12 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 118.742 2.867 . . . . 0.0 118.742 -174.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.12 3.76 90.62 Favored Glycine 0 CA--C 1.569 3.408 0 CA-C-O 117.811 -1.55 . . . . 0.0 112.832 -172.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -92.75 42.84 1.11 Allowed 'General case' 0 C--N 1.367 1.335 1 CA-C-O 107.484 -6.008 . . . . 0.0 110.391 175.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 57.92 -23.21 0.02 OUTLIER Glycine 0 N--CA 1.503 3.107 3 O-C-N 105.214 -10.929 . . . . 0.0 129.104 162.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.4 m -134.04 140.97 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-N 121.196 2.498 . . . . 0.0 107.029 178.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.1 mt -104.23 131.02 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 113.861 -1.518 . . . . 0.0 112.899 -175.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -97.45 153.34 18.18 Favored 'General case' 0 CA--C 1.559 1.311 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 170.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.502 HD12 ' HD3' ' A' ' 95' ' ' LYS . 2.4 mt -52.68 -43.3 92.54 Favored Pre-proline 0 CA--C 1.583 2.247 0 CA-C-O 114.768 -2.539 . . . . 0.0 113.181 -178.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -51.37 -35.21 53.42 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.877 3.052 . . . . 0.0 115.802 176.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -59.93 -53.97 51.61 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 120.101 1.319 . . . . 0.0 110.81 174.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -56.21 -46.32 79.51 Favored 'General case' 0 CA--C 1.57 1.743 0 C-N-CA 125.041 1.336 . . . . 0.0 111.895 175.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.17 -45.13 83.93 Favored 'General case' 0 CA--C 1.591 2.548 0 C-N-CA 123.349 0.66 . . . . 0.0 110.708 176.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.1 -40.25 94.32 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 119.715 1.143 . . . . 0.0 112.111 176.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.55 -47.11 80.16 Favored 'General case' 0 CA--C 1.569 1.699 0 C-N-CA 124.538 1.135 . . . . 0.0 108.458 173.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 88.4 mt -61.78 -40.13 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 CA-C-N 120.389 1.45 . . . . 0.0 110.807 175.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.7 pttt . . . . . 0 CA--C 1.586 2.342 0 CA-C-N 120.642 1.564 . . . . 0.0 112.499 175.842 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 . . . . . 0 CA--C 1.581 2.164 0 CA-C-O 117.511 -1.233 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.637 HG23 ' HE2' ' A' ' 148' ' ' MET . 37.9 mt -71.01 -63.22 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.369 1.446 0 CA-C-O 115.686 -2.102 . . . . 0.0 107.05 174.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 pp -49.85 -47.77 51.51 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-N 122.472 2.396 . . . . 0.0 111.967 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.8 mtm105 -62.82 -55.19 28.54 Favored 'General case' 0 CA--C 1.571 1.787 0 CA-C-O 118.532 -0.746 . . . . 0.0 112.163 176.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.61 -59.47 3.92 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 114.59 -2.624 . . . . 0.0 113.685 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -54.89 -48.6 72.79 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 122.627 2.467 . . . . 0.0 112.437 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.252 93.0 mttt -64.83 -30.91 71.93 Favored 'General case' 0 CA--C 1.581 2.165 0 CA-C-N 119.796 1.18 . . . . 0.0 111.361 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.7 t -65.86 -48.96 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.507 0 CA-C-N 121.54 1.973 . . . . 0.0 108.534 169.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.1 -30.94 60.76 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 117.446 2.387 . . . . 0.0 117.446 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.318 0.0 OUTLIER -52.47 -14.28 0.47 Allowed 'General case' 0 CA--C 1.578 2.05 0 N-CA-C 119.895 3.295 . . . . 0.0 119.895 -177.404 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.666 ' HB1' ' HG2' ' A' ' 109' ' ' GLU . . . 75.35 -70.69 0.14 Allowed 'General case' 0 N--CA 1.502 2.167 0 CA-C-N 122.654 2.479 . . . . 0.0 116.33 176.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -76.35 -17.95 59.14 Favored 'General case' 0 CA--C 1.571 1.758 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 -177.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.02 3.92 90.21 Favored Glycine 0 CA--C 1.568 3.39 0 CA-C-O 117.437 -1.757 . . . . 0.0 114.333 -172.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 46.9 p-10 -98.47 -17.05 18.96 Favored 'General case' 0 CA--C 1.579 2.061 0 CA-C-N 120.881 2.341 . . . . 0.0 113.647 174.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.52 22.65 6.0 Favored Glycine 0 CA--C 1.546 2.002 0 CA-C-O 115.474 -2.848 . . . . 0.0 116.48 -178.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.422 HG11 ' O ' ' A' ' 142' ' ' ILE . 2.6 t -134.39 121.96 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 CA-C-N 122.669 3.235 . . . . 0.0 112.555 -178.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.474 ' O ' HG11 ' A' ' 141' ' ' VAL . 62.3 mt -93.54 135.25 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 C-N-CA 126.432 1.893 . . . . 0.0 112.789 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -105.11 173.76 6.17 Favored 'General case' 0 CA--C 1.574 1.875 0 C-N-CA 124.193 0.997 . . . . 0.0 111.863 175.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -70.45 -50.15 41.24 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -62.94 -45.91 90.25 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 118.282 -0.866 . . . . 0.0 112.341 178.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.666 ' HG2' ' HB1' ' A' ' 99' ' ' ALA . 37.6 tp10 -61.21 -39.55 90.66 Favored 'General case' 0 CA--C 1.569 1.709 0 CA-C-N 120.49 1.495 . . . . 0.0 112.05 175.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -58.83 -53.66 55.93 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 120.127 1.331 . . . . 0.0 110.042 175.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -51.0 -42.68 60.51 Favored 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -73.2 -55.34 6.59 Favored 'General case' 0 CA--C 1.577 1.986 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 176.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.6 tt -67.98 -34.77 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 118.726 2.862 . . . . 0.0 118.726 -176.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 40.2 ttp . . . . . 0 N--CA 1.503 2.215 0 N-CA-C 117.936 2.569 . . . . 0.0 117.936 -179.629 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 67.6 p . . . . . 0 N--CA 1.499 1.982 0 CA-C-O 119.377 -0.344 . . . . 0.0 111.61 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -42.0 -49.12 4.68 Favored 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 177.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.81 -48.51 76.54 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 112.292 -2.231 . . . . 0.0 111.429 176.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -61.52 -29.02 69.73 Favored 'General case' 0 CA--C 1.576 1.959 0 CA-C-N 120.438 1.472 . . . . 0.0 112.737 174.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.5 t -70.36 -57.66 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 CA-C-N 121.374 1.897 . . . . 0.0 109.043 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -64.22 -38.98 93.0 Favored 'General case' 0 N--CA 1.508 2.442 0 CA-C-N 120.24 1.382 . . . . 0.0 113.263 178.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -65.08 -44.59 88.41 Favored 'General case' 0 CA--C 1.567 1.614 0 CA-C-O 117.839 -1.076 . . . . 0.0 112.02 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -64.31 -45.33 88.38 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 120.012 1.278 . . . . 0.0 112.234 176.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 19.6 ttt -70.24 -41.83 73.03 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 114.238 -2.791 . . . . 0.0 111.055 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -64.51 -33.24 75.45 Favored 'General case' 0 CA--C 1.576 1.978 0 CA-C-N 125.087 3.585 . . . . 0.0 111.293 175.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -62.49 -44.02 97.4 Favored 'General case' 0 CA--C 1.585 2.31 0 CA-C-N 122.023 2.192 . . . . 0.0 110.376 171.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.44 -29.36 56.96 Favored 'General case' 0 CA--C 1.576 1.961 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 178.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -90.77 100.16 13.06 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 103.12 -2.919 . . . . 0.0 103.12 172.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -56.48 -29.62 61.98 Favored 'General case' 0 CA--C 1.593 2.61 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.407 54.2 t0 160.88 -22.96 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.676 1 CA-C-O 108.925 -5.321 . . . . 0.0 103.811 175.808 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 11.04 5.88 0.0 OUTLIER Glycine 0 CA--C 1.564 3.136 3 O-C-N 99.065 -14.772 . . . . 0.0 125.131 160.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . 0.423 ' OD1' HG21 ' A' ' 141' ' ' VAL . 2.3 p-10 79.03 15.14 1.06 Allowed 'General case' 0 CA--C 1.595 2.674 0 CA-C-N 121.3 2.55 . . . . 0.0 111.626 -172.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 97.38 -22.88 38.4 Favored Glycine 0 CA--C 1.563 3.042 0 CA-C-N 122.974 2.624 . . . . 0.0 115.636 -176.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.474 HG11 ' O ' ' A' ' 105' ' ' ILE . 0.1 OUTLIER -105.46 146.52 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.378 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 178.396 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.422 ' O ' HG11 ' A' ' 104' ' ' VAL . 0.9 OUTLIER -115.22 129.72 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 113.815 -1.539 . . . . 0.0 114.513 -176.492 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 47.9 p30 -92.18 164.86 13.41 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 171.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 7.6 mt -55.96 -42.95 98.75 Favored Pre-proline 0 CA--C 1.585 2.327 0 CA-C-O 115.028 -2.415 . . . . 0.0 112.584 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -59.16 -22.53 64.96 Favored 'Trans proline' 0 C--N 1.376 2.007 0 CA-C-N 125.338 2.942 . . . . 0.0 119.74 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -69.92 0.3 Allowed 'General case' 0 CA--C 1.562 1.407 0 CA-C-N 122.996 2.635 . . . . 0.0 110.357 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.524 ' CE2' HG22 ' A' ' 90' ' ' ILE . 77.8 t80 -49.54 -43.39 45.73 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 124.716 1.206 . . . . 0.0 113.468 174.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.637 ' HE2' HG23 ' A' ' 90' ' ' ILE . 5.8 mtp -67.37 -40.35 85.76 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-O 114.898 -2.477 . . . . 0.0 112.004 177.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -63.83 -43.67 95.52 Favored 'General case' 0 N--CA 1.505 2.281 0 CA-C-N 124.458 3.299 . . . . 0.0 109.626 173.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.95 -47.89 21.64 Favored 'General case' 0 CA--C 1.575 1.916 0 C-N-CA 127.173 2.189 . . . . 0.0 112.07 174.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.426 ' HB ' HD12 ' A' ' 90' ' ' ILE . 68.0 mt -89.06 -34.47 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.891 0 CA-C-O 117.286 -1.34 . . . . 0.0 111.513 177.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 41.2 mmtt . . . . . 0 N--CA 1.503 2.217 0 CA-C-N 122.126 2.239 . . . . 0.0 112.739 176.143 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 . . . . . 0 N--CA 1.501 2.078 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.585 HG23 ' HG2' ' A' ' 148' ' ' MET . 1.6 mp -66.38 -45.71 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 116.748 -1.596 . . . . 0.0 109.995 177.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.46 -46.13 84.0 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 121.617 2.008 . . . . 0.0 110.541 177.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.91 -55.96 28.42 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 117.326 -1.321 . . . . 0.0 110.574 176.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.83 -57.62 6.66 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.406 ' CE2' HD11 ' A' ' 105' ' ' ILE . 15.8 t80 -64.97 -50.53 66.02 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 120.899 1.681 . . . . 0.0 113.401 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.335 65.8 mttt -68.07 -22.4 64.94 Favored 'General case' 0 CA--C 1.59 2.515 0 CA-C-O 116.495 -1.717 . . . . 0.0 110.455 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.9 t -71.25 -48.87 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.421 0 CA-C-N 122.818 2.554 . . . . 0.0 107.213 168.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -49.02 -34.75 13.91 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.11 102.15 0.35 Allowed 'General case' 0 CA--C 1.576 1.976 0 C-N-CA 126.038 1.735 . . . . 0.0 109.191 176.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.28 -43.03 71.27 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.9 p30 -69.91 -8.03 45.33 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 117.236 2.31 . . . . 0.0 117.236 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.79 29.4 71.09 Favored Glycine 0 CA--C 1.558 2.75 0 CA-C-N 120.823 1.647 . . . . 0.0 116.418 -177.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.19 76.04 1.53 Allowed 'General case' 0 N--CA 1.477 0.882 1 CA-C-O 109.068 -5.253 . . . . 0.0 106.606 178.631 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 52.88 -30.24 0.01 OUTLIER Glycine 0 N--CA 1.491 2.305 2 N-CA-C 127.952 5.941 . . . . 0.0 127.952 165.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.6 p -107.15 155.05 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.455 0 CA-C-O 122.692 1.234 . . . . 0.0 114.112 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.406 HD11 ' CE2' ' A' ' 94' ' ' PHE . 87.8 mt -115.6 134.7 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-N 113.09 -1.868 . . . . 0.0 108.855 177.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.403 ' H ' ' CG ' ' A' ' 109' ' ' GLU . 0.9 OUTLIER -108.94 -179.29 3.82 Favored 'General case' 0 CA--C 1.576 1.972 0 CA-C-N 119.86 1.209 . . . . 0.0 112.965 175.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -74.78 -51.57 13.77 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.445 -1.409 . . . . 0.0 113.601 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.39 -33.63 75.97 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 178.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.403 ' CG ' ' H ' ' A' ' 106' ' ' ASP . 0.0 OUTLIER -68.18 -40.92 82.12 Favored 'General case' 0 CA--C 1.581 2.147 0 CA-C-N 120.44 1.473 . . . . 0.0 110.765 174.686 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.448 ' HD1' HG21 ' A' ' 127' ' ' VAL . 0.7 OUTLIER -58.74 -46.66 86.9 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 117.521 -1.228 . . . . 0.0 108.892 172.26 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.57 ' HA ' HG22 ' A' ' 127' ' ' VAL . 2.9 tppt? -52.05 -61.82 2.02 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 125.012 1.325 . . . . 0.0 109.12 174.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -48.81 -48.51 41.42 Favored 'General case' 0 CA--C 1.575 1.929 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 176.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -82.14 -13.68 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 118.059 2.614 . . . . 0.0 118.059 -178.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.425 ' SD ' HG21 ' A' ' 127' ' ' VAL . 9.4 tpt . . . . . 0 N--CA 1.485 1.288 0 N-CA-C 119.246 3.054 . . . . 0.0 119.246 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.2 p . . . . . 0 CA--C 1.55 0.969 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.38 -20.54 58.91 Favored 'General case' 0 CA--C 1.577 1.982 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.741 174.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -58.04 -40.1 80.04 Favored 'General case' 0 CA--C 1.561 1.381 0 CA-C-O 117.023 -1.465 . . . . 0.0 111.424 174.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -54.56 -53.9 48.33 Favored 'General case' 0 CA--C 1.585 2.323 0 CA-C-N 120.419 1.463 . . . . 0.0 111.477 175.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.57 HG22 ' HA ' ' A' ' 111' ' ' LYS 0.251 4.2 p -73.43 -41.33 56.78 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -178.201 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -68.86 -45.78 70.17 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 120.675 1.58 . . . . 0.0 110.205 176.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -62.74 -48.85 77.42 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-N 121.341 1.882 . . . . 0.0 112.019 176.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -64.2 -45.85 86.49 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-N 120.378 1.445 . . . . 0.0 114.692 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -73.98 -34.34 64.18 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 115.934 -1.984 . . . . 0.0 112.767 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.12 -32.61 67.12 Favored 'General case' 0 CA--C 1.566 1.59 0 CA-C-N 122.64 2.473 . . . . 0.0 110.755 173.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.96 -35.51 80.12 Favored 'General case' 0 CA--C 1.58 2.126 0 CA-C-N 123.388 2.813 . . . . 0.0 110.495 172.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.99 -30.9 27.81 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 176.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -90.81 105.71 18.01 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 122.339 2.336 . . . . 0.0 107.115 174.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -62.65 -32.49 73.55 Favored 'General case' 0 CA--C 1.598 2.825 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 175.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.391 57.1 t0 163.54 -21.9 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.041 1 CA-C-O 108.768 -5.396 . . . . 0.0 103.326 176.673 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 13.03 8.04 0.0 OUTLIER Glycine 0 N--CA 1.5 2.928 3 O-C-N 98.666 -15.021 . . . . 0.0 125.028 161.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 77.84 4.58 2.92 Favored 'General case' 0 CA--C 1.581 2.145 0 CA-C-N 121.622 2.711 . . . . 0.0 111.179 -172.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 95.34 -12.09 68.3 Favored Glycine 0 C--N 1.372 2.561 0 CA-C-N 123.746 2.976 . . . . 0.0 114.584 -175.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . 0.298 3.4 m -130.24 121.11 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 102.181 -3.266 . . . . 0.0 102.181 175.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.62 125.62 38.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 111.299 -2.682 . . . . 0.0 114.001 -173.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -92.88 151.99 19.65 Favored 'General case' 0 CA--C 1.558 1.251 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 172.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.4 mt -53.32 -41.7 87.77 Favored Pre-proline 0 CA--C 1.582 2.176 0 CA-C-O 114.615 -2.612 . . . . 0.0 112.628 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -55.63 -26.23 54.45 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 123.93 3.087 . . . . 0.0 116.511 176.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -63.85 -62.41 1.66 Allowed 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 122.051 2.205 . . . . 0.0 108.918 174.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.53 ' CE2' HG22 ' A' ' 90' ' ' ILE . 87.2 t80 -55.22 -47.08 75.85 Favored 'General case' 0 CA--C 1.57 1.739 0 C-N-CA 125.638 1.575 . . . . 0.0 113.842 173.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.585 ' HG2' HG23 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -59.12 -39.03 81.01 Favored 'General case' 0 CA--C 1.588 2.418 0 CA-C-O 117.673 -1.156 . . . . 0.0 109.857 174.749 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -67.15 -47.47 70.94 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 121.214 1.825 . . . . 0.0 110.104 173.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.33 -44.58 11.74 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 127.608 2.363 . . . . 0.0 112.26 176.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 58.5 mt -92.61 -56.23 5.39 Favored 'Isoleucine or valine' 0 C--N 1.366 1.295 0 CA-C-O 116.911 -1.519 . . . . 0.0 113.933 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt . . . . . 0 N--CA 1.482 1.175 0 N-CA-C 118.368 2.729 . . . . 0.0 118.368 -176.66 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.625 HG23 ' HG2' ' A' ' 148' ' ' MET . 5.3 mp -72.04 -48.1 51.51 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 CA-C-O 117.053 -1.451 . . . . 0.0 112.496 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.21 -51.93 67.85 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 121.671 2.032 . . . . 0.0 110.266 178.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -65.18 -46.77 79.45 Favored 'General case' 0 CA--C 1.566 1.595 0 CA-C-O 116.532 -1.699 . . . . 0.0 111.146 178.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.28 -61.59 1.73 Allowed 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 121.925 2.148 . . . . 0.0 114.404 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -59.15 -50.94 72.14 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 121.979 2.172 . . . . 0.0 112.858 178.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.353 71.7 mttt -67.78 -23.82 65.25 Favored 'General case' 0 CA--C 1.591 2.53 0 CA-C-O 116.558 -1.687 . . . . 0.0 110.262 -177.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.8 t -69.66 -48.23 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.485 0 CA-C-N 122.732 2.515 . . . . 0.0 107.491 167.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -48.28 -33.95 9.63 Favored 'General case' 0 CA--C 1.577 1.991 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.42 95.9 0.48 Allowed 'General case' 0 CA--C 1.577 1.983 0 C-N-CA 126.936 2.094 . . . . 0.0 107.873 175.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.92 -46.49 71.4 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.633 -0.667 . . . . 0.0 112.322 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -47.94 -24.55 1.07 Allowed 'General case' 0 CA--C 1.583 2.233 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 176.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.14 7.43 87.78 Favored Glycine 0 CA--C 1.563 3.036 0 CA-C-N 122.216 2.28 . . . . 0.0 117.34 -176.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.67 78.21 1.69 Allowed 'General case' 0 N--CA 1.478 0.932 1 CA-C-O 109.938 -4.839 . . . . 0.0 104.76 175.356 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 52.68 -26.93 0.01 OUTLIER Glycine 0 N--CA 1.486 2.028 2 N-CA-C 129.079 6.392 . . . . 0.0 129.079 166.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.7 t -103.03 136.19 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-N 118.919 1.359 . . . . 0.0 113.036 -177.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 67.5 mt -111.04 133.59 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 113.082 -1.872 . . . . 0.0 110.347 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -110.51 173.04 6.52 Favored 'General case' 0 CA--C 1.571 1.76 0 C-N-CA 124.378 1.071 . . . . 0.0 111.49 176.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -64.01 -45.52 88.6 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 116.82 -1.562 . . . . 0.0 114.504 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -61.56 -46.87 88.08 Favored 'General case' 0 N--CA 1.508 2.457 0 CA-C-N 121.196 1.816 . . . . 0.0 112.185 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -51.53 -50.3 60.29 Favored 'General case' 0 CA--C 1.574 1.892 0 C-N-CA 124.557 1.143 . . . . 0.0 112.059 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -64.38 -52.6 57.44 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 125.986 1.714 . . . . 0.0 109.791 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 19.1 ttpt -46.87 -49.93 19.45 Favored 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 124.85 1.26 . . . . 0.0 113.534 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -70.57 -53.54 15.63 Favored 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 176.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -70.88 -27.29 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 119.302 3.075 . . . . 0.0 119.302 -175.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 15.3 tmm? . . . . . 0 N--CA 1.498 1.973 0 C-N-CA 126.518 1.927 . . . . 0.0 109.577 178.376 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.485 1.284 1 N-CA-C 99.36 -4.311 . . . . 0.0 99.36 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -62.19 -33.45 74.57 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 116.99 2.219 . . . . 0.0 116.99 -177.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.48 -40.28 96.68 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 117.418 -1.277 . . . . 0.0 113.624 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -59.56 -52.11 66.98 Favored 'General case' 0 CA--C 1.572 1.81 0 CA-C-N 120.633 1.56 . . . . 0.0 113.036 178.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.8 t -73.73 -48.36 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-O 117.001 -1.476 . . . . 0.0 112.464 -178.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -65.0 -44.57 88.83 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-N 120.768 1.622 . . . . 0.0 111.356 177.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -64.82 -43.51 92.86 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-N 121.464 1.938 . . . . 0.0 112.084 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.0 -47.62 82.34 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 120.662 1.574 . . . . 0.0 112.92 176.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.631 ' SD ' HD13 ' A' ' 142' ' ' ILE . 13.3 tpt -67.65 -37.67 82.74 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 115.189 -2.338 . . . . 0.0 112.075 176.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -66.64 -43.08 85.63 Favored 'General case' 0 CA--C 1.567 1.609 0 CA-C-N 123.053 2.66 . . . . 0.0 110.712 174.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -59.94 -41.39 91.72 Favored 'General case' 0 CA--C 1.578 2.053 0 CA-C-N 122.568 2.44 . . . . 0.0 110.351 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.59 -16.65 62.87 Favored 'General case' 0 CA--C 1.581 2.148 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.572 ' OD2' ' N ' ' A' ' 140' ' ' GLY . 7.3 t0 -91.8 103.25 15.82 Favored 'General case' 0 CA--C 1.586 2.327 0 N-CA-C 101.679 -3.452 . . . . 0.0 101.679 164.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -73.81 -21.12 60.26 Favored 'General case' 0 CA--C 1.58 2.125 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 178.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -91.82 -11.87 35.32 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 119.514 3.153 . . . . 0.0 119.514 -175.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.13 5.96 89.24 Favored Glycine 0 CA--C 1.573 3.709 0 CA-C-N 120.241 1.382 . . . . 0.0 115.323 -173.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.38 -44.86 20.65 Favored 'General case' 0 CA--C 1.573 1.849 0 C-N-CA 126.139 1.776 . . . . 0.0 113.33 176.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.572 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . 111.13 20.25 7.21 Favored Glycine 0 CA--C 1.558 2.73 0 N-CA-C 116.891 1.516 . . . . 0.0 116.891 -178.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.27 158.73 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-N 118.676 1.238 . . . . 0.0 108.041 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.631 HD13 ' SD ' ' A' ' 131' ' ' MET . 1.1 mt -136.91 128.83 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 117.702 2.482 . . . . 0.0 117.702 -174.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 33.1 p30 -95.74 153.98 17.46 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 170.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.3 mt -51.17 -43.08 84.38 Favored Pre-proline 0 CA--C 1.586 2.339 0 CA-C-O 115.006 -2.426 . . . . 0.0 114.198 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -56.01 -29.8 75.47 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 123.787 2.991 . . . . 0.0 117.646 177.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -61.8 -62.51 1.75 Allowed 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 120.831 1.65 . . . . 0.0 110.926 176.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.516 ' CE2' HG22 ' A' ' 90' ' ' ILE . 57.9 t80 -54.85 -42.56 72.13 Favored 'General case' 0 CA--C 1.578 2.04 0 C-N-CA 123.989 0.915 . . . . 0.0 112.809 174.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.625 ' HG2' HG23 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -56.89 -42.27 79.54 Favored 'General case' 0 CA--C 1.583 2.22 0 CA-C-O 117.403 -1.284 . . . . 0.0 109.716 174.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.52 -33.63 73.09 Favored 'General case' 0 CA--C 1.577 1.992 0 CA-C-N 121.187 1.812 . . . . 0.0 110.736 174.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.3 mp -58.52 -45.74 88.2 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 120.661 1.573 . . . . 0.0 111.542 174.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 66.6 mt -79.9 -45.62 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 120.445 1.475 . . . . 0.0 110.982 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 94.4 mttt . . . . . 0 CA--C 1.575 1.915 0 CA-C-N 120.931 1.696 . . . . 0.0 114.702 177.98 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.507 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 13.0 pt-20 . . . . . 0 CA--C 1.548 0.9 0 N-CA-C 114.827 1.418 . . . . 0.0 114.827 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.66 HG23 ' CE ' ' A' ' 148' ' ' MET . 4.2 mp -76.83 -67.61 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 114.42 -2.705 . . . . 0.0 114.572 -177.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . 0.336 0.0 OUTLIER -73.95 -33.63 63.97 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 123.546 2.885 . . . . 0.0 110.36 -178.247 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 46.9 mtt180 -69.04 -45.69 69.8 Favored 'General case' 0 CA--C 1.58 2.133 0 CA-C-N 125.52 3.782 . . . . 0.0 108.992 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.507 ' HB2' ' O ' ' A' ' 89' ' ' GLU . . . -70.79 -57.25 4.84 Favored 'General case' 0 C--N 1.384 2.09 0 CA-C-N 122.376 2.353 . . . . 0.0 112.121 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.467 ' CE2' HD11 ' A' ' 105' ' ' ILE . 4.8 t80 -57.07 -51.59 68.67 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 121.919 2.145 . . . . 0.0 113.267 178.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.532 ' HE2' HD12 ' A' ' 144' ' ' ILE . 56.0 mttt -62.01 -31.0 71.34 Favored 'General case' 0 CA--C 1.576 1.948 0 CA-C-O 115.491 -2.195 . . . . 0.0 111.548 -178.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -69.2 -45.23 79.86 Favored 'Isoleucine or valine' 0 CA--C 1.591 2.523 0 CA-C-N 123.604 2.911 . . . . 0.0 109.355 170.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.91 -31.13 38.27 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.978 ' OD2' ' HA ' ' A' ' 102' ' ' ASP . 1.7 t0 -56.9 125.39 22.32 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 119.997 1.271 . . . . 0.0 109.087 177.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.46 28.35 0.03 OUTLIER 'General case' 0 N--CA 1.527 3.422 0 N-CA-C 120.445 3.498 . . . . 0.0 120.445 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.483 ' H ' ' C ' ' A' ' 98' ' ' ASP 0.422 13.7 t-20 72.44 148.23 0.09 Allowed 'General case' 0 CA--C 1.604 3.033 2 C-N-CA 135.223 5.409 . . . . 0.0 101.825 -175.813 . . . . . . . . 4 3 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 109.39 60.49 0.52 Allowed Glycine 0 C--N 1.285 -2.254 2 C-N-CA 135.547 6.308 . . . . 0.0 109.621 -177.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.978 ' HA ' ' OD2' ' A' ' 98' ' ' ASP 0.832 0.2 OUTLIER -30.13 113.5 0.09 Allowed 'General case' 0 C--N 1.393 2.474 0 CA-C-O 127.626 3.584 . . . . 0.0 118.268 -174.511 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 126.62 28.92 0.93 Allowed Glycine 0 N--CA 1.43 -1.724 1 CA-C-N 103.376 -6.284 . . . . 0.0 110.716 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . 0.273 0.0 OUTLIER -166.67 142.57 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 N-CA-C 118.376 2.732 . . . . 0.0 118.376 177.306 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.467 HD11 ' CE2' ' A' ' 94' ' ' PHE . 96.1 mt -136.64 134.58 48.98 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.676 0 C-N-CA 128.331 2.652 . . . . 0.0 104.99 175.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -105.01 -178.56 3.69 Favored 'General case' 0 CA--C 1.569 1.692 0 C-N-CA 124.462 1.105 . . . . 0.0 111.621 175.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.49 -46.62 25.96 Favored 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -178.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -62.95 -53.09 59.49 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 117.023 -1.465 . . . . 0.0 111.328 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -58.03 -30.72 66.36 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 121.838 2.108 . . . . 0.0 113.124 175.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -66.97 -51.65 52.56 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 120.554 1.524 . . . . 0.0 109.187 176.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.1 tppt? -54.98 -35.33 64.21 Favored 'General case' 0 CA--C 1.58 2.118 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 174.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 11.3 m-30 -74.76 -57.98 3.57 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 125.699 1.6 . . . . 0.0 113.043 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.9 -36.4 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 125.814 1.645 . . . . 0.0 113.684 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.588 2.432 0 CA-C-O 121.157 0.503 . . . . 0.0 110.198 171.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 78.3 p . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 121.665 0.745 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -60.09 -37.58 80.35 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.37 -36.84 71.73 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 117.346 -1.311 . . . . 0.0 114.478 176.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -61.76 -51.11 69.66 Favored 'General case' 0 CA--C 1.58 2.133 0 CA-C-N 120.786 1.63 . . . . 0.0 111.841 175.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.2 t -63.53 -51.83 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 C-N-CA 125.804 1.642 . . . . 0.0 110.706 178.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.3 -38.78 84.71 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-O 117.569 -1.205 . . . . 0.0 111.314 176.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -62.87 -50.45 70.87 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 121.673 2.033 . . . . 0.0 112.094 175.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.49 -47.26 86.92 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 177.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.496 ' SD ' HD13 ' A' ' 142' ' ' ILE . 12.8 tpt -70.02 -38.72 75.98 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 115.434 -2.222 . . . . 0.0 111.303 176.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -36.16 83.37 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 123.724 2.965 . . . . 0.0 111.372 175.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -61.78 -49.21 77.26 Favored 'General case' 0 CA--C 1.573 1.848 0 CA-C-O 118.121 -0.942 . . . . 0.0 109.478 173.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -77.33 -23.82 50.87 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 117.724 2.49 . . . . 0.0 117.724 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -91.29 116.67 29.01 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 103.356 -2.831 . . . . 0.0 103.356 170.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -61.59 -22.33 65.12 Favored 'General case' 0 CA--C 1.586 2.347 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.281 29.6 t0 96.97 159.68 0.02 OUTLIER 'General case' 0 CA--C 1.609 3.218 0 CA-C-O 127.402 3.477 . . . . 0.0 103.085 178.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 94.48 36.79 5.52 Favored Glycine 0 CA--C 1.567 3.319 2 C-N-CA 132.006 4.622 . . . . 0.0 102.492 -173.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -173.7 -65.43 0.01 OUTLIER 'General case' 0 C--N 1.399 2.722 0 CA-C-N 121.821 2.811 . . . . 0.0 115.488 -174.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 87.39 20.6 51.5 Favored Glycine 0 CA--C 1.574 3.751 0 CA-C-N 119.31 0.959 . . . . 0.0 114.384 -174.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.88 168.25 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 128.053 2.541 . . . . 0.0 104.227 -178.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.496 HD13 ' SD ' ' A' ' 131' ' ' MET . 0.9 OUTLIER -144.75 133.06 17.4 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 O-C-N 120.979 -1.075 . . . . 0.0 112.816 -178.385 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 53.6 p30 -103.58 155.65 18.38 Favored 'General case' 0 CA--C 1.561 1.384 0 N-CA-C 104.467 -2.42 . . . . 0.0 104.467 169.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.656 HD13 ' CG ' ' A' ' 102' ' ' ASP . 0.6 OUTLIER -52.45 -44.89 95.3 Favored Pre-proline 0 N--CA 1.492 1.669 0 CA-C-O 115.184 -2.341 . . . . 0.0 113.219 -178.4 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -55.51 -21.21 29.67 Favored 'Trans proline' 0 C--N 1.375 1.942 0 CA-C-O 114.139 -2.526 . . . . 0.0 116.455 177.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.66 -56.21 6.97 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 123.217 2.735 . . . . 0.0 110.488 175.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -61.45 -44.76 96.54 Favored 'General case' 0 CA--C 1.591 2.552 0 CA-C-O 123.727 1.727 . . . . 0.0 111.99 175.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.66 ' CE ' HG23 ' A' ' 90' ' ' ILE . 2.1 mmt -56.62 -45.14 81.67 Favored 'General case' 0 CA--C 1.56 1.36 0 CA-C-O 115.111 -2.376 . . . . 0.0 108.884 173.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.97 -27.33 67.37 Favored 'General case' 0 CA--C 1.567 1.599 0 CA-C-N 122.468 2.394 . . . . 0.0 112.115 173.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.5 mp -52.32 -41.04 62.64 Favored 'General case' 0 N--CA 1.504 2.262 0 CA-C-N 121.98 2.173 . . . . 0.0 106.324 168.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -81.34 -69.46 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.612 3.348 0 CA-C-O 122.481 1.134 . . . . 0.0 111.447 173.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? . . . . . 0 CA--C 1.579 2.081 2 C-N-CA 133.249 4.62 . . . . 0.0 122.55 -178.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 . . . . . 0 CA--C 1.58 2.107 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.513 HG23 ' HG2' ' A' ' 148' ' ' MET . 3.6 mp -64.79 -42.88 96.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-O 117.467 -1.254 . . . . 0.0 110.405 177.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.12 -45.38 93.71 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 120.938 1.699 . . . . 0.0 109.278 175.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 76.8 mtt180 -52.97 -62.67 1.5 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 120.107 1.321 . . . . 0.0 110.283 176.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.86 -58.78 4.34 Favored 'General case' 0 C--N 1.358 0.968 0 CA-C-O 115.871 -2.014 . . . . 0.0 116.185 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -63.23 -52.66 61.26 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 121.42 1.918 . . . . 0.0 113.723 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.367 58.1 mttt -66.51 -19.53 65.81 Favored 'General case' 0 CA--C 1.596 2.719 0 CA-C-O 116.614 -1.66 . . . . 0.0 110.354 -177.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.7 t -72.64 -50.97 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 CA-C-N 122.566 2.439 . . . . 0.0 107.383 166.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -51.06 -30.39 15.6 Favored 'General case' 0 CA--C 1.568 1.655 0 N-CA-C 117.508 2.41 . . . . 0.0 117.508 -178.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.265 0.0 OUTLIER -55.04 115.52 2.26 Favored 'General case' 0 CA--C 1.585 2.299 0 C-N-CA 126.272 1.829 . . . . 0.0 110.274 178.335 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.9 -54.7 41.5 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 117.678 2.473 . . . . 0.0 117.678 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.6 p30 -88.66 6.28 39.16 Favored 'General case' 0 CA--C 1.562 1.442 0 N-CA-C 118.622 2.823 . . . . 0.0 118.622 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.65 29.13 71.48 Favored Glycine 0 CA--C 1.568 3.358 0 CA-C-N 121.078 1.763 . . . . 0.0 115.462 -175.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -143.3 78.29 1.6 Allowed 'General case' 0 N--CA 1.476 0.825 1 CA-C-O 109.544 -5.027 . . . . 0.0 107.362 178.829 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 54.82 -25.83 0.01 OUTLIER Glycine 0 N--CA 1.491 2.348 3 N-CA-C 129.504 6.562 . . . . 0.0 129.504 164.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.8 p -107.4 153.26 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.089 0 CA-C-N 119.129 1.465 . . . . 0.0 112.426 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 83.6 mt -123.19 137.39 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 C-N-CA 126.281 1.832 . . . . 0.0 108.909 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -108.69 -170.51 1.68 Allowed 'General case' 0 CA--C 1.589 2.459 0 C-N-CA 124.154 0.982 . . . . 0.0 112.34 176.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -80.64 -52.98 6.95 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -57.88 -47.4 82.86 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 123.021 0.528 . . . . 0.0 112.23 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -56.0 -48.52 75.73 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 118.033 -0.984 . . . . 0.0 111.157 174.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -60.37 -50.9 71.77 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 117.39 -1.29 . . . . 0.0 112.497 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -56.9 -39.24 74.05 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 120.342 1.428 . . . . 0.0 114.433 176.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -69.18 -45.49 69.82 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 175.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -91.07 -24.21 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 1 N-CA-C 122.054 4.094 . . . . 0.0 122.054 -174.496 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 1.4 tpt . . . . . 0 N--CA 1.505 2.294 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 -179.017 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.429 ' HG1' ' HG3' ' A' ' 126' ' ' GLU . 46.5 p . . . . . 0 CA--C 1.554 1.11 0 N-CA-C 103.697 -2.705 . . . . 0.0 103.697 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -61.05 -41.53 96.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.91 -1.119 . . . . 0.0 112.149 176.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.49 -45.82 82.1 Favored 'General case' 0 CA--C 1.554 1.103 0 CA-C-O 116.929 -1.51 . . . . 0.0 113.338 176.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.429 ' HG3' ' HG1' ' A' ' 123' ' ' THR . 1.0 OUTLIER -63.82 -39.76 94.99 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 121.659 2.027 . . . . 0.0 112.965 176.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 90.0 t -69.99 -50.72 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.613 0 CA-C-O 117.739 -1.124 . . . . 0.0 109.307 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.68 -45.55 89.19 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 120.154 1.343 . . . . 0.0 111.718 176.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -61.61 -47.06 87.18 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 119.701 1.137 . . . . 0.0 112.621 176.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.21 -46.14 90.76 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 119.396 0.998 . . . . 0.0 112.975 176.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 9.6 ttt -70.84 -43.56 68.26 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 115.74 -2.076 . . . . 0.0 111.189 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.444 ' HZ3' ' CD ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -60.17 -35.63 75.77 Favored 'General case' 0 CA--C 1.578 2.052 0 CA-C-N 122.899 2.59 . . . . 0.0 110.685 174.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.444 ' CD ' ' HZ3' ' A' ' 132' ' ' LYS . 0.6 OUTLIER -65.48 -42.68 91.92 Favored 'General case' 0 CA--C 1.571 1.774 0 CA-C-N 121.633 2.015 . . . . 0.0 110.557 172.79 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -72.21 -24.5 61.41 Favored 'General case' 0 CA--C 1.576 1.946 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 176.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -81.3 108.53 15.0 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 103.041 -2.948 . . . . 0.0 103.041 172.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -72.71 -14.64 61.61 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -108.95 -11.61 14.96 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 119.257 3.058 . . . . 0.0 119.257 -174.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.63 5.6 89.76 Favored Glycine 0 CA--C 1.571 3.561 0 CA-C-N 120.447 1.476 . . . . 0.0 114.618 -173.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -72.03 -44.62 63.12 Favored 'General case' 0 CA--C 1.565 1.547 0 C-N-CA 125.342 1.457 . . . . 0.0 113.39 176.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 102.98 3.77 48.53 Favored Glycine 0 CA--C 1.563 3.035 0 N-CA-C 117.312 1.685 . . . . 0.0 117.312 -177.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 1.8 t -135.43 141.85 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 101.592 -3.484 . . . . 0.0 101.592 176.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.2 mt -120.58 124.48 72.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 111.967 -2.379 . . . . 0.0 112.789 -176.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 53.7 p30 -92.48 157.67 16.44 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 170.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.8 mt -52.75 -41.2 82.93 Favored Pre-proline 0 CA--C 1.585 2.302 0 CA-C-O 115.126 -2.369 . . . . 0.0 112.967 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -57.08 -31.25 89.73 Favored 'Trans proline' 0 C--N 1.38 2.214 0 C-N-CA 123.702 2.935 . . . . 0.0 116.813 176.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -67.2 -46.57 73.5 Favored 'General case' 0 N--CA 1.505 2.291 0 CA-C-N 123.074 2.67 . . . . 0.0 111.279 176.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -63.28 -45.16 92.72 Favored 'General case' 0 CA--C 1.583 2.222 0 CA-C-N 120.643 1.565 . . . . 0.0 110.761 173.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.513 ' HG2' HG23 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -60.0 -41.36 91.93 Favored 'General case' 0 CA--C 1.579 2.06 0 CA-C-O 117.064 -1.446 . . . . 0.0 109.725 175.17 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.23 -25.06 63.21 Favored 'General case' 0 CA--C 1.579 2.067 0 CA-C-N 121.714 2.052 . . . . 0.0 111.783 173.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.1 tp -62.41 -47.13 85.45 Favored 'General case' 0 CA--C 1.573 1.828 0 CA-C-N 120.797 1.635 . . . . 0.0 108.875 172.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . 0.276 31.7 mt -68.12 -46.78 80.81 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.597 0 CA-C-N 119.13 0.877 . . . . 0.0 109.567 175.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt . . . . . 0 CA--C 1.606 3.127 0 C-N-CA 127.334 2.254 . . . . 0.0 116.807 174.047 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.42 ' CD ' HH21 ' A' ' 92' ' ' ARG . 6.9 tp10 . . . . . 0 CA--C 1.574 1.888 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.705 HG23 ' HE2' ' A' ' 148' ' ' MET . 4.1 mp -64.99 -55.22 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 116.226 -1.845 . . . . 0.0 109.635 178.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . 0.259 0.6 OUTLIER -62.75 -34.07 76.44 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 122.011 2.187 . . . . 0.0 111.225 177.148 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.42 HH21 ' CD ' ' A' ' 89' ' ' GLU . 28.0 mtm-85 -52.88 -62.3 1.74 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 121.175 1.807 . . . . 0.0 108.397 173.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.64 -61.54 1.84 Allowed 'General case' 0 C--N 1.355 0.822 0 CA-C-O 114.07 -2.871 . . . . 0.0 115.696 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.493 ' HB2' ' CD2' ' A' ' 147' ' ' PHE . 3.7 t80 -69.04 -52.86 24.21 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 124.387 3.267 . . . . 0.0 114.128 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.375 26.0 mttt -63.04 -16.34 59.53 Favored 'General case' 0 CA--C 1.593 2.63 0 CA-C-O 115.51 -2.186 . . . . 0.0 111.368 -176.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -84.8 -46.83 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.598 2.823 0 CA-C-N 123.188 2.722 . . . . 0.0 108.558 167.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.427 ' CE1' HG23 ' A' ' 113' ' ' ILE . 1.1 t80 -57.71 -24.32 56.26 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 119.076 2.991 . . . . 0.0 119.076 -178.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -39.24 -45.09 1.32 Allowed 'General case' 0 CA--C 1.589 2.443 0 CA-C-N 121.718 2.054 . . . . 0.0 116.421 176.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 65.29 -58.04 0.29 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 117.792 2.516 . . . . 0.0 117.792 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.623 HD22 HG11 ' A' ' 104' ' ' VAL . 55.8 p30 -68.54 -13.52 62.39 Favored 'General case' 0 CA--C 1.577 1.994 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.59 8.58 86.77 Favored Glycine 0 CA--C 1.551 2.319 0 N-CA-C 120.66 3.024 . . . . 0.0 120.66 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -114.58 -10.39 12.53 Favored 'General case' 0 CA--C 1.578 2.036 0 CA-C-N 119.366 1.583 . . . . 0.0 114.764 177.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 110.41 0.63 29.49 Favored Glycine 0 CA--C 1.55 2.266 0 CA-C-O 116.144 -2.476 . . . . 0.0 116.49 -178.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.623 HG11 HD22 ' A' ' 100' ' ' ASN . 0.5 OUTLIER -115.55 153.26 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 CA-C-N 121.471 2.636 . . . . 0.0 112.199 179.541 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.47 HD11 ' CE2' ' A' ' 94' ' ' PHE . 97.5 mt -121.38 130.57 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-N 112.402 -2.181 . . . . 0.0 106.709 178.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -106.43 -173.27 2.26 Favored 'General case' 0 CA--C 1.573 1.829 0 CA-C-O 122.033 0.92 . . . . 0.0 110.582 176.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -72.31 -38.33 68.74 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.829 -1.17 . . . . 0.0 112.588 178.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -58.76 -46.02 88.42 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 123.542 0.737 . . . . 0.0 112.057 175.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -62.04 -37.79 86.25 Favored 'General case' 0 CA--C 1.586 2.35 0 CA-C-N 120.675 1.58 . . . . 0.0 112.364 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -60.51 -44.89 95.53 Favored 'General case' 0 CA--C 1.571 1.768 0 C-N-CA 124.202 1.001 . . . . 0.0 109.557 173.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -55.43 -46.59 76.69 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 125.049 1.34 . . . . 0.0 112.014 173.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -60.38 -53.39 58.22 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 176.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.427 HG23 ' CE1' ' A' ' 97' ' ' PHE . 0.2 OUTLIER -73.99 -28.13 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 -177.485 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 7.3 tpt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.909 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.485 1.32 0 N-CA-C 102.081 -3.303 . . . . 0.0 102.081 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -57.62 -40.31 78.89 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 117.324 2.342 . . . . 0.0 117.324 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.94 -38.79 76.59 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 114.708 1.374 . . . . 0.0 114.708 178.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -63.83 -51.99 62.16 Favored 'General case' 0 CA--C 1.574 1.868 0 CA-C-N 120.41 1.459 . . . . 0.0 112.713 177.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.1 t -70.98 -46.32 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-O 118.004 -0.998 . . . . 0.0 111.734 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -60.98 -49.14 78.65 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 117.067 -1.444 . . . . 0.0 110.611 176.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -61.91 -43.32 99.08 Favored 'General case' 0 CA--C 1.561 1.368 0 CA-C-N 120.927 1.694 . . . . 0.0 112.977 178.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.7 -45.48 78.64 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-N 120.612 1.551 . . . . 0.0 114.399 177.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -37.87 62.14 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 120.592 1.542 . . . . 0.0 111.903 178.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -63.83 -45.78 88.03 Favored 'General case' 0 CA--C 1.57 1.729 0 CA-C-N 121.71 2.05 . . . . 0.0 109.228 174.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -34.46 78.0 Favored 'General case' 0 CA--C 1.58 2.101 0 CA-C-N 122.229 2.286 . . . . 0.0 112.211 175.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.439 ' HA ' HD22 ' A' ' 150' ' ' LEU . . . -76.17 -32.03 58.83 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 176.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -77.99 114.21 16.64 Favored 'General case' 0 N--CA 1.513 2.676 0 O-C-N 117.408 -3.307 . . . . 0.0 109.454 175.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -82.06 -30.49 31.33 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 117.419 2.377 . . . . 0.0 117.419 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -86.3 -14.12 44.62 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 121.124 3.75 . . . . 0.0 121.124 -172.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.99 5.2 90.31 Favored Glycine 0 CA--C 1.572 3.61 0 CA-C-N 120.152 1.342 . . . . 0.0 113.895 -172.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -80.6 -51.36 8.83 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 119.145 1.472 . . . . 0.0 110.986 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 110.27 -7.95 30.76 Favored Glycine 0 CA--C 1.548 2.12 0 CA-C-O 115.965 -2.575 . . . . 0.0 116.907 -177.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . 0.307 3.4 m -134.97 121.04 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 101.402 -3.555 . . . . 0.0 101.402 174.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.0 mt -82.18 128.83 38.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 110.672 -2.967 . . . . 0.0 116.592 -172.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 39.3 p30 -93.95 155.5 17.12 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 172.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.61 -43.87 99.37 Favored Pre-proline 0 CA--C 1.583 2.224 0 CA-C-O 114.951 -2.452 . . . . 0.0 112.679 -178.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.37 -32.1 70.85 Favored 'Trans proline' 0 C--N 1.381 2.275 0 CA-C-N 125.1 2.857 . . . . 0.0 115.393 176.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -62.24 -57.87 9.83 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 116.743 -1.599 . . . . 0.0 110.18 175.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.493 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 75.5 t80 -53.14 -41.46 65.12 Favored 'General case' 0 N--CA 1.504 2.249 0 CA-C-N 120.624 1.556 . . . . 0.0 114.54 176.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.705 ' HE2' HG23 ' A' ' 90' ' ' ILE . 1.3 mtp -65.73 -49.16 69.47 Favored 'General case' 0 CA--C 1.573 1.862 0 O-C-N 121.591 -0.693 . . . . 0.0 110.623 176.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.458 ' CG ' ' HZ3' ' A' ' 152' ' ' LYS . 0.9 OUTLIER -61.67 -37.28 83.51 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 123.451 0.7 . . . . 0.0 112.789 175.721 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.439 HD22 ' HA ' ' A' ' 134' ' ' ALA . 1.4 tm? -57.66 -49.17 77.37 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 128.437 2.695 . . . . 0.0 110.491 173.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 91.0 mt -68.82 -40.32 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-N 119.698 1.135 . . . . 0.0 110.636 176.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.458 ' HZ3' ' CG ' ' A' ' 149' ' ' ASP . 1.7 ttpm? . . . . . 0 CA--C 1.578 2.052 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 177.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.262 1.4 tm-20 . . . . . 0 CA--C 1.584 2.272 0 CA-C-O 113.76 -3.019 . . . . 0.0 109.534 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.424 HG23 ' HE2' ' A' ' 148' ' ' MET 0.381 1.2 mp -68.67 -58.43 5.84 Favored 'Isoleucine or valine' 0 C--N 1.389 2.305 1 CA-C-N 128.832 5.287 . . . . 0.0 103.275 170.95 . . . . . . . . 4 3 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 pp -56.99 -49.58 75.32 Favored 'General case' 0 N--CA 1.503 2.19 0 CA-C-N 121.576 1.989 . . . . 0.0 113.034 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 43.9 mtt85 -67.56 -40.38 84.93 Favored 'General case' 0 CA--C 1.567 1.634 0 CA-C-O 117.397 -1.287 . . . . 0.0 114.013 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.44 -50.62 43.95 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 115.098 -2.382 . . . . 0.0 111.64 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.431 ' HD2' ' CD2' ' A' ' 147' ' ' PHE . 1.1 t80 -62.42 -49.26 76.18 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 122.766 2.53 . . . . 0.0 110.136 176.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -60.07 -34.47 73.49 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 116.87 -1.538 . . . . 0.0 114.524 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -77.07 -43.95 31.56 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.949 0 CA-C-N 121.248 1.84 . . . . 0.0 109.729 173.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -49.01 -44.26 41.15 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 125.525 1.53 . . . . 0.0 109.864 177.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -54.63 98.79 0.02 OUTLIER 'General case' 0 CA--C 1.58 2.114 0 C-N-CA 125.65 1.58 . . . . 0.0 110.962 175.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -77.24 -36.69 54.4 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.1 p30 -67.36 -14.68 63.14 Favored 'General case' 0 CA--C 1.579 2.074 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.78 9.64 85.23 Favored Glycine 0 CA--C 1.551 2.334 0 N-CA-C 120.897 3.119 . . . . 0.0 120.897 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 26.7 p30 -115.45 -8.76 12.18 Favored 'General case' 0 CA--C 1.577 2.019 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 177.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 110.58 20.6 7.25 Favored Glycine 0 CA--C 1.552 2.359 0 CA-C-O 117.095 -1.947 . . . . 0.0 114.589 -177.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.543 HG11 ' O ' ' A' ' 142' ' ' ILE . 3.5 t -133.34 143.29 39.53 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.718 0 CA-C-N 120.605 2.202 . . . . 0.0 111.446 -177.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 79.3 mt -106.57 136.16 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 126.477 1.911 . . . . 0.0 108.194 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -108.78 -175.8 2.87 Favored 'General case' 0 CA--C 1.575 1.935 0 C-N-CA 123.299 0.639 . . . . 0.0 112.299 176.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -72.03 -52.73 15.56 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 117.126 -1.416 . . . . 0.0 114.64 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -59.05 -37.96 78.26 Favored 'General case' 0 N--CA 1.515 2.803 0 CA-C-N 120.416 1.462 . . . . 0.0 113.864 177.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . 0.362 0.9 OUTLIER -58.29 -48.32 80.84 Favored 'General case' 0 CA--C 1.598 2.8 0 CA-C-O 124.286 1.993 . . . . 0.0 112.4 174.266 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.421 ' CD1' HG21 ' A' ' 127' ' ' VAL . 0.4 OUTLIER -61.18 -46.41 90.6 Favored 'General case' 0 CA--C 1.574 1.885 0 CA-C-O 116.582 -1.675 . . . . 0.0 107.212 172.376 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.439 ' O ' ' SD ' ' A' ' 114' ' ' MET . 60.8 mttt -51.0 -32.52 21.45 Favored 'General case' 0 N--CA 1.515 2.777 0 CA-C-N 122.078 2.217 . . . . 0.0 112.899 172.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -71.86 -49.92 34.01 Favored 'General case' 0 CA--C 1.583 2.235 0 C-N-CA 123.774 0.83 . . . . 0.0 111.92 174.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.7 mt -90.08 -7.64 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.738 0 N-CA-C 118.077 2.621 . . . . 0.0 118.077 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.439 ' SD ' ' O ' ' A' ' 111' ' ' LYS . 13.9 ptm . . . . . 0 N--CA 1.488 1.428 1 N-CA-C 123.485 4.624 . . . . 0.0 123.485 -178.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 75.0 p . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 121.581 0.705 . . . . 0.0 111.377 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -69.4 -27.98 65.76 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -55.56 -42.1 74.2 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-O 117.689 -1.148 . . . . 0.0 110.762 174.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -53.44 -50.33 65.49 Favored 'General case' 0 CA--C 1.57 1.728 0 CA-C-N 119.299 0.954 . . . . 0.0 112.996 174.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.421 HG21 ' CD1' ' A' ' 110' ' ' PHE . 9.1 p -71.04 -43.48 76.18 Favored 'Isoleucine or valine' 0 C--N 1.359 0.981 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.37 -49.08 70.67 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 120.037 1.29 . . . . 0.0 110.656 177.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -62.13 -49.43 75.92 Favored 'General case' 0 CA--C 1.573 1.841 0 CA-C-O 118.093 -0.956 . . . . 0.0 112.868 177.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.74 -45.05 90.55 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 177.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 15.9 ttt -69.68 -38.8 77.18 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 116.104 -1.903 . . . . 0.0 111.709 176.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -59.08 -42.07 89.53 Favored 'General case' 0 CA--C 1.576 1.973 0 CA-C-N 122.719 2.509 . . . . 0.0 110.485 173.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -57.45 -44.62 84.9 Favored 'General case' 0 CA--C 1.578 2.054 0 CA-C-N 120.099 1.318 . . . . 0.0 111.351 174.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.33 -18.79 40.94 Favored 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 118.311 2.708 . . . . 0.0 118.311 178.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.47 ' OD2' ' N ' ' A' ' 140' ' ' GLY . 23.0 t0 -82.41 102.99 11.64 Favored 'General case' 0 CA--C 1.574 1.874 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 174.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -81.89 -19.7 40.33 Favored 'General case' 0 CA--C 1.58 2.122 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 177.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -88.03 -14.34 39.26 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 119.128 3.01 . . . . 0.0 119.128 -175.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.94 5.11 90.03 Favored Glycine 0 CA--C 1.568 3.354 0 CA-C-N 119.964 1.256 . . . . 0.0 115.221 -174.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -80.72 -48.09 13.05 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 118.942 1.371 . . . . 0.0 111.353 175.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.47 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . 111.43 -20.12 23.47 Favored Glycine 0 CA--C 1.546 2.028 0 CA-C-O 116.27 -2.406 . . . . 0.0 115.346 -177.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . 0.303 5.7 m -122.28 122.22 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-N 121.438 2.619 . . . . 0.0 103.999 178.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.543 ' O ' HG11 ' A' ' 104' ' ' VAL . 0.3 OUTLIER -79.51 130.83 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 117.488 2.403 . . . . 0.0 117.488 -173.035 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 32.7 p30 -93.95 161.69 14.2 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 170.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 17.4 mt -54.99 -48.4 96.09 Favored Pre-proline 0 CA--C 1.579 2.077 0 CA-C-O 113.994 -2.908 . . . . 0.0 113.73 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -51.45 -27.22 23.81 Favored 'Trans proline' 0 C--N 1.373 1.85 0 CA-C-N 125.932 3.154 . . . . 0.0 119.849 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -72.18 -64.8 0.87 Allowed 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 121.237 1.835 . . . . 0.0 111.012 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.431 ' CD2' ' HD2' ' A' ' 94' ' ' PHE . 0.1 OUTLIER -48.81 -53.59 18.58 Favored 'General case' 0 N--CA 1.506 2.346 0 C-N-CA 124.717 1.207 . . . . 0.0 110.729 173.738 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.48 ' O ' ' HB2' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -60.82 -40.25 92.04 Favored 'General case' 0 C--N 1.358 0.957 0 CA-C-O 113.681 -3.057 . . . . 0.0 113.938 -179.775 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.02 -48.18 79.86 Favored 'General case' 0 CA--C 1.594 2.651 0 CA-C-N 125.01 3.55 . . . . 0.0 111.533 174.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . 0.295 0.3 OUTLIER -44.55 -47.73 10.24 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 127.851 2.46 . . . . 0.0 111.072 176.937 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 9.6 mt -92.09 -44.14 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.238 0 CA-C-O 117.527 -1.225 . . . . 0.0 111.157 175.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 148' ' ' MET . 33.1 mttp . . . . . 0 N--CA 1.504 2.244 0 N-CA-C 118.453 2.76 . . . . 0.0 118.453 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 . . . . . 0 N--CA 1.506 2.333 0 CA-C-O 122.455 1.121 . . . . 0.0 113.718 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 mp -55.65 -53.38 37.57 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.711 0 C-N-CA 126.452 1.901 . . . . 0.0 110.412 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.9 -46.03 74.77 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.878 1.671 . . . . 0.0 110.656 175.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.8 mtm105 -57.82 -55.57 33.21 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-N 121.011 1.732 . . . . 0.0 110.44 176.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.84 -55.81 15.11 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.411 ' HB2' ' CE2' ' A' ' 147' ' ' PHE . 18.1 t80 -64.16 -50.58 67.61 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.342 36.2 mttt -67.13 -22.02 65.81 Favored 'General case' 0 CA--C 1.585 2.309 0 CA-C-O 116.556 -1.688 . . . . 0.0 110.068 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.6 t -69.6 -49.73 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 CA-C-N 122.394 2.361 . . . . 0.0 107.534 167.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -54.47 -34.91 62.42 Favored 'General case' 0 CA--C 1.58 2.113 0 N-CA-C 118.09 2.626 . . . . 0.0 118.09 -178.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.271 2.3 t0 -55.92 134.39 52.09 Favored 'General case' 0 CA--C 1.585 2.321 0 C-N-CA 127.513 2.325 . . . . 0.0 115.561 178.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.442 ' HB1' ' HG2' ' A' ' 109' ' ' GLU . . . -67.65 -60.79 2.26 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -76.21 -19.17 58.64 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 117.598 2.444 . . . . 0.0 117.598 -177.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.92 3.74 90.34 Favored Glycine 0 CA--C 1.568 3.346 0 CA-C-N 120.843 1.656 . . . . 0.0 114.754 -173.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -91.48 -17.55 25.54 Favored 'General case' 0 CA--C 1.58 2.126 0 CA-C-N 120.532 2.166 . . . . 0.0 113.395 173.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 113.36 24.46 4.75 Favored Glycine 0 CA--C 1.54 1.64 0 CA-C-O 115.541 -2.81 . . . . 0.0 116.987 -178.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.3 t -127.51 138.69 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 121.826 2.813 . . . . 0.0 109.783 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 61.5 mt -118.5 138.79 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 126.573 1.949 . . . . 0.0 109.582 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -110.22 -169.82 1.53 Allowed 'General case' 0 CA--C 1.585 2.308 0 C-N-CA 125.001 1.32 . . . . 0.0 110.834 176.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -81.59 -54.97 4.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.134 -1.604 . . . . 0.0 114.318 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -60.63 -43.87 97.03 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 117.534 -1.222 . . . . 0.0 112.807 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.442 ' HG2' ' HB1' ' A' ' 99' ' ' ALA . 11.2 tp10 -59.49 -44.44 93.08 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 121.025 1.739 . . . . 0.0 111.268 174.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.96 -51.75 68.34 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 119.486 1.039 . . . . 0.0 109.777 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -52.52 -42.25 64.19 Favored 'General case' 0 CA--C 1.573 1.864 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 175.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -69.75 -53.66 17.35 Favored 'General case' 0 CA--C 1.577 1.994 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 176.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.9 tt -72.72 -29.08 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 118.7 2.852 . . . . 0.0 118.7 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 6.2 tpt . . . . . 0 N--CA 1.491 1.623 0 C-N-CA 125.035 1.334 . . . . 0.0 112.342 178.116 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.654 ' HG1' ' HG3' ' A' ' 126' ' ' GLU . 18.8 p . . . . . 0 CA--C 1.565 1.544 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.64 -36.81 85.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.792 -1.192 . . . . 0.0 111.934 175.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.61 -49.65 67.95 Favored 'General case' 0 CA--C 1.56 1.329 0 CA-C-O 117.557 -1.211 . . . . 0.0 112.848 176.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.654 ' HG3' ' HG1' ' A' ' 123' ' ' THR . 17.5 mt-10 -58.09 -46.14 86.01 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-N 120.309 1.413 . . . . 0.0 112.483 176.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 62.4 t -69.34 -43.43 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.346 0 CA-C-O 116.627 -1.654 . . . . 0.0 110.992 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -63.46 -43.73 96.51 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 121.871 2.123 . . . . 0.0 112.467 177.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -64.73 -52.97 54.24 Favored 'General case' 0 CA--C 1.572 1.797 0 CA-C-N 119.517 1.053 . . . . 0.0 110.617 175.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.26 -43.36 96.22 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 177.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -69.68 -42.26 74.37 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 117.318 -1.325 . . . . 0.0 111.521 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -64.96 -36.74 85.38 Favored 'General case' 0 CA--C 1.572 1.813 0 CA-C-N 120.621 1.555 . . . . 0.0 111.252 175.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -64.88 -41.03 95.98 Favored 'General case' 0 CA--C 1.581 2.157 0 CA-C-N 120.884 1.674 . . . . 0.0 109.719 172.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.41 -23.88 67.06 Favored 'General case' 0 CA--C 1.576 1.965 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 174.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -88.39 100.85 13.35 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 171.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -62.13 -16.18 50.83 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 117.912 2.56 . . . . 0.0 117.912 177.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.94 -2.95 20.71 Favored 'General case' 0 N--CA 1.491 1.577 1 N-CA-C 121.958 4.059 . . . . 0.0 121.958 -173.75 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.35 6.98 88.97 Favored Glycine 0 CA--C 1.556 2.633 0 N-CA-C 118.289 2.076 . . . . 0.0 118.289 -178.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -78.56 -36.77 44.1 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 120.246 2.023 . . . . 0.0 114.083 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 96.85 21.92 19.63 Favored Glycine 0 CA--C 1.555 2.584 0 N-CA-C 117.063 1.585 . . . . 0.0 117.063 -177.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -149.67 145.22 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 103.383 -2.821 . . . . 0.0 103.383 176.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.19 133.9 64.91 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -176.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 19.3 p30 -103.83 165.01 11.31 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 169.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.6 mt -53.19 -45.17 98.44 Favored Pre-proline 0 N--CA 1.505 2.317 0 O-C-N 118.071 -2.893 . . . . 0.0 112.812 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -50.2 -35.03 41.68 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 123.937 3.091 . . . . 0.0 118.601 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -72.98 -45.79 55.95 Favored 'General case' 0 CA--C 1.591 2.53 0 CA-C-N 122.614 2.461 . . . . 0.0 112.937 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.411 ' CE2' ' HB2' ' A' ' 94' ' ' PHE . 4.7 t80 -56.32 -52.13 65.66 Favored 'General case' 0 N--CA 1.506 2.331 0 CA-C-N 120.726 1.603 . . . . 0.0 110.932 172.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . 0.259 4.1 ptp -60.59 -39.12 86.93 Favored 'General case' 0 CA--C 1.589 2.452 0 CA-C-O 121.499 0.666 . . . . 0.0 111.057 176.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.414 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 17.6 t0 -52.65 -54.34 34.65 Favored 'General case' 0 N--CA 1.492 1.632 1 CA-C-O 109.296 -5.145 . . . . 0.0 106.006 171.823 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.43 -43.39 23.8 Favored 'General case' 0 N--CA 1.515 2.783 0 CA-C-N 123.699 2.954 . . . . 0.0 112.502 174.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.1 mt -73.76 30.26 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.613 3.376 0 C-N-CA 127.12 2.168 . . . . 0.0 109.61 169.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 149' ' ' ASP . 1.3 mmpt? . . . . . 0 N--CA 1.525 3.301 2 C-N-CA 132.888 4.475 . . . . 0.0 122.146 -167.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 . . . . . 0 N--CA 1.5 2.041 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.636 ' CG2' ' HE2' ' A' ' 148' ' ' MET 0.297 1.1 mp -58.26 -50.9 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-O 117.164 -1.398 . . . . 0.0 111.209 178.004 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 pp -59.58 -42.89 93.53 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 116.967 -1.492 . . . . 0.0 111.668 177.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.86 -54.96 40.96 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 121.273 1.851 . . . . 0.0 111.43 176.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.13 -57.72 11.62 Favored 'General case' 0 C--N 1.358 0.961 0 CA-C-O 116.091 -1.909 . . . . 0.0 114.048 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.671 ' HB2' ' HE3' ' A' ' 148' ' ' MET . 19.2 t80 -58.97 -46.71 87.41 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 120.862 1.665 . . . . 0.0 114.336 178.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -63.72 -34.64 78.34 Favored 'General case' 0 CA--C 1.568 1.664 0 CA-C-O 116.341 -1.79 . . . . 0.0 111.483 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 75.1 t -64.73 -43.78 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 CA-C-N 122.146 2.248 . . . . 0.0 108.181 169.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.56 -31.19 63.96 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 117.272 2.323 . . . . 0.0 117.272 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -75.71 119.26 19.48 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 174.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.85 -71.57 0.06 Allowed 'General case' 0 N--CA 1.514 2.727 0 CA-C-O 123.908 1.813 . . . . 0.0 106.833 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -134.03 -55.3 0.87 Allowed 'General case' 0 CA--C 1.577 2.006 0 CA-C-N 109.682 -3.417 . . . . 0.0 103.977 167.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 30.87 9.58 0.0 OUTLIER Glycine 0 C--N 1.355 1.586 1 N-CA-C 125.548 4.979 . . . . 0.0 125.548 -175.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.2 p30 63.72 12.99 7.05 Favored 'General case' 0 CA--C 1.59 2.517 0 CA-C-N 122.231 3.015 . . . . 0.0 113.047 -171.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 110.76 -15.85 28.79 Favored Glycine 0 CA--C 1.57 3.478 0 CA-C-O 115.796 -2.669 . . . . 0.0 109.211 -170.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -99.59 138.89 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-N 122.436 3.118 . . . . 0.0 116.416 -179.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 18.6 mt -105.98 132.32 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 C-N-CA 125.108 1.363 . . . . 0.0 109.806 178.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.54 -174.89 2.64 Favored 'General case' 0 CA--C 1.584 2.263 0 CA-C-O 122.0 0.905 . . . . 0.0 112.398 176.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -72.41 -46.65 54.21 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.672 -1.267 . . . . 0.0 114.021 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -57.54 -49.01 77.75 Favored 'General case' 0 N--CA 1.504 2.273 0 CA-C-O 117.925 -1.036 . . . . 0.0 112.451 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -54.49 -43.72 72.03 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 120.201 1.364 . . . . 0.0 112.948 173.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.61 -55.14 33.94 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 116.981 -1.485 . . . . 0.0 107.642 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.495 ' HA ' ' SD ' ' A' ' 114' ' ' MET . 33.5 mtmm -55.54 -29.15 58.43 Favored 'General case' 0 N--CA 1.503 2.185 0 CA-C-N 121.131 1.787 . . . . 0.0 115.264 176.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -74.91 -53.59 8.76 Favored 'General case' 0 CA--C 1.574 1.902 0 C-N-CA 124.505 1.122 . . . . 0.0 110.746 175.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 tt -79.01 -16.56 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 118.492 2.775 . . . . 0.0 118.492 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.495 ' SD ' ' HA ' ' A' ' 111' ' ' LYS . 15.1 ptm . . . . . 0 N--CA 1.501 2.079 0 N-CA-C 118.062 2.615 . . . . 0.0 118.062 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 41.6 p . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 122.595 1.188 . . . . 0.0 110.631 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -71.44 -31.24 66.98 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-N 113.276 -1.784 . . . . 0.0 114.601 178.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.46 -40.85 75.54 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.52 1.128 . . . . 0.0 113.893 176.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -58.2 -48.78 79.28 Favored 'General case' 0 CA--C 1.584 2.284 0 CA-C-O 122.989 1.376 . . . . 0.0 112.567 176.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.0 t -63.17 -49.69 82.22 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.483 0 C-N-CA 126.852 2.061 . . . . 0.0 111.129 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -58.78 -42.99 90.31 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 124.253 1.021 . . . . 0.0 112.601 176.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -64.51 -48.02 76.72 Favored 'General case' 0 CA--C 1.577 1.989 0 CA-C-N 119.531 1.06 . . . . 0.0 111.828 176.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.57 -44.51 93.29 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 176.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 23.1 ttt -67.35 -39.46 85.76 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 116.866 -1.54 . . . . 0.0 112.412 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -62.07 -39.64 93.11 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 121.283 1.856 . . . . 0.0 111.093 175.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -62.87 -43.46 98.74 Favored 'General case' 0 CA--C 1.58 2.103 0 CA-C-N 119.565 1.075 . . . . 0.0 111.11 172.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -85.73 -8.08 58.39 Favored 'General case' 0 N--CA 1.486 1.338 1 N-CA-C 122.873 4.397 . . . . 0.0 122.873 -179.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.424 ' OD2' ' HA2' ' A' ' 140' ' ' GLY . 24.6 t0 -78.05 114.48 16.97 Favored 'General case' 0 N--CA 1.506 2.328 1 CA-C-O 96.312 -11.327 . . . . 0.0 109.467 177.255 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -81.07 26.49 0.43 Allowed 'General case' 0 C--N 1.26 -3.309 2 O-C-N 62.843 -37.411 . . . . 0.0 116.029 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.419 ' C ' ' H ' ' A' ' 139' ' ' ASN 0.372 32.8 t0 92.14 -103.2 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 101.907 -3.368 . . . . 0.0 101.907 -177.291 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 37.64 7.65 0.0 OUTLIER Glycine 0 CA--C 1.557 2.668 0 N-CA-C 120.564 2.985 . . . . 0.0 120.564 -174.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . 0.518 ' OD1' HG21 ' A' ' 141' ' ' VAL . 5.0 t-20 157.45 -49.32 0.0 OUTLIER 'General case' 0 CA--C 1.572 1.813 0 C-N-CA 126.856 2.062 . . . . 0.0 114.337 -173.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.424 ' HA2' ' OD2' ' A' ' 135' ' ' ASP . . . 112.65 -23.46 15.09 Favored Glycine 0 CA--C 1.561 2.963 0 CA-C-N 123.241 2.746 . . . . 0.0 113.76 -173.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.518 HG21 ' OD1' ' A' ' 139' ' ' ASN . 19.7 m -115.63 127.55 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 101.921 -3.363 . . . . 0.0 101.921 176.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.6 mt -79.64 126.77 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 N-CA-C 118.366 2.728 . . . . 0.0 118.366 -172.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -94.0 149.78 20.93 Favored 'General case' 0 CA--C 1.561 1.393 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 171.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -49.58 -46.62 79.05 Favored Pre-proline 0 CA--C 1.574 1.869 0 CA-C-O 115.035 -2.412 . . . . 0.0 114.434 -177.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -57.42 -26.72 72.61 Favored 'Trans proline' 0 C--N 1.371 1.723 0 CA-C-N 124.926 2.795 . . . . 0.0 116.401 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -68.71 -54.86 13.63 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 123.138 2.699 . . . . 0.0 112.113 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -60.48 -46.47 89.97 Favored 'General case' 0 CA--C 1.578 2.057 0 CA-C-N 121.756 2.071 . . . . 0.0 112.612 176.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.671 ' HE3' ' HB2' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -62.4 -41.25 98.52 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-O 116.895 -1.526 . . . . 0.0 111.684 176.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -68.91 -38.41 79.54 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 121.873 2.124 . . . . 0.0 111.902 175.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.09 -43.36 77.98 Favored 'General case' 0 CA--C 1.565 1.558 0 C-N-CA 126.011 1.725 . . . . 0.0 110.708 175.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 66.7 mt -87.31 -51.83 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 121.279 1.854 . . . . 0.0 112.368 177.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 -178.815 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 . . . . . 0 N--CA 1.504 2.23 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.822 HG23 ' HE2' ' A' ' 148' ' ' MET . 1.6 mp -65.1 -35.79 76.25 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.013 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 172.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.0 -45.8 71.57 Favored 'General case' 0 N--CA 1.515 2.793 0 CA-C-N 124.048 3.113 . . . . 0.0 109.384 173.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.7 mtm105 -59.81 -56.15 25.37 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 120.642 1.564 . . . . 0.0 110.65 176.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.77 -59.93 3.94 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 116.074 -1.917 . . . . 0.0 114.904 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -59.65 -49.13 78.96 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 121.087 1.767 . . . . 0.0 113.297 178.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.371 36.5 mttt -69.11 -23.63 64.02 Favored 'General case' 0 CA--C 1.583 2.227 0 CA-C-O 116.631 -1.652 . . . . 0.0 110.333 -178.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.1 t -68.73 -48.91 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 CA-C-N 122.15 2.25 . . . . 0.0 107.103 166.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -53.3 -33.21 52.33 Favored 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.256 3.7 t0 -67.22 -3.62 8.27 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 117.83 2.53 . . . . 0.0 117.83 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 50.04 24.63 1.43 Allowed 'General case' 0 N--CA 1.524 3.258 0 CA-C-N 124.533 3.333 . . . . 0.0 115.404 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . 0.284 11.4 t-20 82.49 -53.1 0.21 Allowed 'General case' 0 CA--C 1.575 1.915 0 C-N-CA 129.834 3.254 . . . . 0.0 105.795 -170.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 30.94 20.55 0.0 OUTLIER Glycine 0 C--N 1.363 2.034 1 N-CA-C 125.272 4.869 . . . . 0.0 125.272 178.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 67.04 14.08 9.7 Favored 'General case' 0 CA--C 1.593 2.612 0 CA-C-N 120.821 2.311 . . . . 0.0 113.61 -173.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.89 -5.89 56.67 Favored Glycine 0 CA--C 1.568 3.373 0 CA-C-O 116.688 -2.173 . . . . 0.0 111.127 -172.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.4 t -117.37 136.42 54.57 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.94 0 CA-C-N 121.059 2.429 . . . . 0.0 113.385 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 67.9 mt -92.23 140.56 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 C-N-CA 126.587 1.955 . . . . 0.0 108.282 176.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.3 p30 -110.12 179.52 4.08 Favored 'General case' 0 CA--C 1.572 1.803 0 CA-C-O 122.666 1.222 . . . . 0.0 110.795 175.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -70.94 -43.01 69.09 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 117.391 -1.29 . . . . 0.0 114.437 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -63.62 -45.89 88.21 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 120.124 1.329 . . . . 0.0 112.157 177.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -58.86 -48.54 81.03 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 121.464 1.938 . . . . 0.0 112.731 175.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -59.1 -49.02 79.46 Favored 'General case' 0 CA--C 1.568 1.661 0 C-N-CA 123.502 0.721 . . . . 0.0 109.36 175.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.404 ' HA ' HG12 ' A' ' 127' ' ' VAL . 21.8 tptp -62.73 -12.81 26.28 Favored 'General case' 0 CA--C 1.577 2.01 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 175.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -93.3 -43.55 8.75 Favored 'General case' 0 CA--C 1.584 2.266 0 O-C-N 120.448 -1.407 . . . . 0.0 111.334 173.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -92.66 -29.24 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 1 N-CA-C 122.064 4.098 . . . . 0.0 122.064 -174.906 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 19.3 tpt . . . . . 0 N--CA 1.492 1.66 0 C-N-CA 126.001 1.72 . . . . 0.0 115.166 -176.775 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 38.0 p . . . . . 0 N--CA 1.487 1.41 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.17 -32.53 70.52 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.43 -44.45 96.4 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-O 116.594 -1.67 . . . . 0.0 113.619 177.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -43.36 97.19 Favored 'General case' 0 CA--C 1.577 1.996 0 CA-C-N 121.557 1.98 . . . . 0.0 113.68 178.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 111' ' ' LYS . 6.5 t -70.62 -52.77 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-O 117.667 -1.159 . . . . 0.0 112.174 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -60.84 -47.15 87.65 Favored 'General case' 0 CA--C 1.558 1.272 0 CA-C-N 119.672 1.124 . . . . 0.0 111.451 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -61.57 -46.91 87.89 Favored 'General case' 0 CA--C 1.57 1.735 0 CA-C-N 120.653 1.57 . . . . 0.0 112.417 177.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.3 -43.77 96.91 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 177.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 17.5 ttt -73.7 -36.48 65.27 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 116.594 -1.67 . . . . 0.0 112.163 177.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -61.36 -44.15 97.67 Favored 'General case' 0 CA--C 1.569 1.692 0 CA-C-N 122.116 2.234 . . . . 0.0 109.982 173.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -64.74 -42.63 95.05 Favored 'General case' 0 CA--C 1.577 2.016 0 CA-C-N 120.922 1.692 . . . . 0.0 111.81 175.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -77.08 -21.15 54.79 Favored 'General case' 0 CA--C 1.564 1.484 0 N-CA-C 118.431 2.752 . . . . 0.0 118.431 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -87.53 113.46 23.25 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 103.66 -2.718 . . . . 0.0 103.66 175.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . 0.256 5.9 mt-10 -80.27 -18.17 50.08 Favored 'General case' 0 CA--C 1.576 1.948 0 CA-C-N 113.523 -1.672 . . . . 0.0 115.312 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -92.13 -15.61 27.44 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 117.035 2.235 . . . . 0.0 117.035 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.14 5.97 89.72 Favored Glycine 0 CA--C 1.564 3.108 0 CA-C-N 120.196 1.362 . . . . 0.0 116.081 -175.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -93.39 -45.85 7.61 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-O 117.267 -1.349 . . . . 0.0 114.088 177.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 114.29 22.63 5.12 Favored Glycine 0 CA--C 1.561 2.95 0 N-CA-C 118.111 2.004 . . . . 0.0 118.111 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.97 143.49 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.527 0 N-CA-C 102.836 -3.024 . . . . 0.0 102.836 174.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.69 139.97 48.55 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -175.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 59.6 p30 -96.96 165.57 12.02 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 170.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.3 mt -56.13 -43.64 99.34 Favored Pre-proline 0 N--CA 1.5 2.048 0 CA-C-O 115.007 -2.425 . . . . 0.0 112.826 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -55.25 -40.74 84.08 Favored 'Trans proline' 0 C--N 1.372 1.816 0 CA-C-N 124.491 2.64 . . . . 0.0 116.124 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -65.23 -52.85 51.95 Favored 'General case' 0 N--CA 1.505 2.276 0 CA-C-N 124.507 3.322 . . . . 0.0 113.321 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.671 ' CE2' HG22 ' A' ' 90' ' ' ILE . 22.9 t80 -54.33 -52.13 62.51 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 120.265 1.393 . . . . 0.0 113.053 172.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.822 ' HE2' HG23 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -68.62 -34.91 76.57 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 117.734 -1.127 . . . . 0.0 113.405 179.36 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -64.3 -35.25 80.23 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 119.478 1.035 . . . . 0.0 111.346 171.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -58.44 -52.13 66.91 Favored 'General case' 0 CA--C 1.562 1.431 0 C-N-CA 125.295 1.438 . . . . 0.0 110.07 173.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 95.9 mt -70.08 -53.5 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-O 117.592 -1.194 . . . . 0.0 113.321 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 17.5 pttm . . . . . 0 CA--C 1.569 1.704 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -179.598 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 . . . . . 0 N--CA 1.498 1.962 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.631 HG23 ' CE ' ' A' ' 148' ' ' MET . 2.7 mp -61.58 -55.65 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 124.338 1.055 . . . . 0.0 111.482 178.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.1 pp -59.28 -41.97 90.16 Favored 'General case' 0 CA--C 1.556 1.211 0 CA-C-O 118.732 -0.652 . . . . 0.0 112.139 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 25.4 ttp85 -57.29 -55.47 34.37 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 117.617 -1.182 . . . . 0.0 110.008 176.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.34 -59.76 3.69 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.497 ' HB2' ' CE2' ' A' ' 147' ' ' PHE . 5.3 t80 -69.69 -48.7 58.75 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 121.652 2.024 . . . . 0.0 114.285 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.326 47.5 mttt -64.16 -20.48 66.02 Favored 'General case' 0 CA--C 1.586 2.36 0 CA-C-O 115.635 -2.126 . . . . 0.0 110.737 -178.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -80.29 -46.73 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.403 0 CA-C-N 123.09 2.677 . . . . 0.0 108.497 169.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -54.78 -38.45 67.28 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -49.35 110.2 0.35 Allowed 'General case' 0 CA--C 1.575 1.909 0 C-N-CA 126.258 1.823 . . . . 0.0 112.262 178.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -41.97 -75.59 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 -177.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -94.55 0.69 55.43 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 117.425 2.38 . . . . 0.0 117.425 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.94 6.49 88.33 Favored Glycine 0 CA--C 1.554 2.518 0 CA-C-O 116.476 -2.291 . . . . 0.0 118.316 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -88.96 -3.72 58.65 Favored 'General case' 0 CA--C 1.585 2.301 0 CA-C-N 121.902 2.851 . . . . 0.0 113.987 174.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.14 -22.31 18.47 Favored Glycine 0 CA--C 1.54 1.595 0 CA-C-O 115.814 -2.659 . . . . 0.0 116.869 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.1 m -92.52 140.64 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.358 0 CA-C-N 122.333 3.066 . . . . 0.0 112.371 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 89.7 mt -110.35 121.56 63.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 N-CA-C 100.477 -3.897 . . . . 0.0 100.477 172.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -92.93 169.13 10.68 Favored 'General case' 0 CA--C 1.559 1.305 0 CA-C-O 122.31 1.052 . . . . 0.0 113.327 178.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -67.67 -45.0 76.47 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 117.661 -1.161 . . . . 0.0 113.501 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -65.65 -45.86 81.38 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 117.284 -1.341 . . . . 0.0 112.224 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -64.42 -40.67 96.21 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 121.439 1.927 . . . . 0.0 112.409 176.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -63.38 -51.78 64.44 Favored 'General case' 0 CA--C 1.577 2.017 0 CA-C-N 120.26 1.391 . . . . 0.0 108.838 175.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -49.01 -42.83 39.4 Favored 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 125.384 1.474 . . . . 0.0 112.709 175.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -68.54 -60.47 2.4 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 123.675 0.79 . . . . 0.0 111.441 175.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.7 tt -62.16 -16.29 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 117.508 2.41 . . . . 0.0 117.508 -177.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 13.7 tpt . . . . . 0 N--CA 1.493 1.701 0 C-N-CA 125.202 1.401 . . . . 0.0 109.006 175.488 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 18.4 p . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 103.118 -2.919 . . . . 0.0 103.118 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -64.12 -30.83 71.87 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 116.817 2.155 . . . . 0.0 116.817 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.18 -36.91 83.31 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-O 117.297 -1.335 . . . . 0.0 113.54 177.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -59.94 -51.11 71.06 Favored 'General case' 0 CA--C 1.576 1.963 0 CA-C-N 120.269 1.395 . . . . 0.0 112.595 177.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 24.4 t -68.28 -51.77 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.311 0 C-N-CA 124.617 1.167 . . . . 0.0 111.936 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -60.01 -46.4 89.62 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 120.057 1.299 . . . . 0.0 112.22 178.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -62.42 -43.1 99.61 Favored 'General case' 0 CA--C 1.57 1.748 0 CA-C-N 120.087 1.312 . . . . 0.0 111.928 176.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.7 -47.81 79.67 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-N 119.904 1.229 . . . . 0.0 114.113 176.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 14.7 ttt -70.46 -39.41 74.31 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 114.417 -2.706 . . . . 0.0 109.874 177.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -58.5 -39.27 79.59 Favored 'General case' 0 CA--C 1.582 2.199 0 CA-C-N 124.867 3.485 . . . . 0.0 110.224 173.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -60.7 -45.27 94.85 Favored 'General case' 0 CA--C 1.582 2.178 0 CA-C-N 121.494 1.952 . . . . 0.0 110.954 173.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.65 -11.44 59.08 Favored 'General case' 0 CA--C 1.58 2.104 0 N-CA-C 117.173 2.286 . . . . 0.0 117.173 178.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -91.84 115.2 27.86 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 101.22 -3.622 . . . . 0.0 101.22 167.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -69.18 -20.6 64.0 Favored 'General case' 0 CA--C 1.561 1.38 0 N-CA-C 119.846 3.276 . . . . 0.0 119.846 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -145.96 25.93 1.26 Allowed 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 120.99 3.7 . . . . 0.0 120.99 -174.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.29 7.68 88.31 Favored Glycine 0 CA--C 1.555 2.59 0 N-CA-C 117.237 1.655 . . . . 0.0 117.237 -177.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -66.78 -44.8 80.37 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-N 120.303 2.052 . . . . 0.0 112.99 176.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 103.0 -21.43 40.15 Favored Glycine 0 CA--C 1.55 2.254 0 N-CA-C 117.032 1.573 . . . . 0.0 117.032 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 13.8 m -126.12 138.6 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 103.693 -2.706 . . . . 0.0 103.693 176.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.1 mt -104.71 133.7 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 114.032 -1.44 . . . . 0.0 113.622 -174.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 28.0 p30 -95.44 152.12 18.69 Favored 'General case' 0 CA--C 1.565 1.52 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 171.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -52.28 -45.16 94.62 Favored Pre-proline 0 CA--C 1.583 2.241 0 CA-C-O 114.772 -2.537 . . . . 0.0 114.001 -177.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.43 -29.65 78.56 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 123.735 2.957 . . . . 0.0 117.716 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -60.01 -55.57 32.34 Favored 'General case' 0 N--CA 1.505 2.286 0 CA-C-N 121.209 1.822 . . . . 0.0 112.125 176.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.538 ' CE2' HG21 ' A' ' 90' ' ' ILE . 36.4 t80 -55.67 -51.91 65.63 Favored 'General case' 0 CA--C 1.577 2.005 0 C-N-CA 126.61 1.964 . . . . 0.0 111.075 173.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.631 ' CE ' HG23 ' A' ' 90' ' ' ILE . 4.7 mtp -56.59 -46.84 80.62 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 117.015 -1.469 . . . . 0.0 111.793 177.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.25 -35.75 74.02 Favored 'General case' 0 CA--C 1.576 1.949 0 CA-C-N 120.837 1.653 . . . . 0.0 111.016 176.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.46 -35.87 65.96 Favored 'General case' 0 CA--C 1.577 2.016 0 CA-C-N 120.327 1.421 . . . . 0.0 110.205 172.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 85.7 mt -82.57 -59.6 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.451 0 CA-C-N 120.572 1.533 . . . . 0.0 109.987 175.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 96.8 mttt . . . . . 0 CA--C 1.578 2.028 1 N-CA-C 122.243 4.164 . . . . 0.0 122.243 -176.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 117.58 2.437 . . . . 0.0 117.58 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -57.16 -46.33 82.86 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 -176.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.19 -42.36 96.69 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 120.132 1.333 . . . . 0.0 114.524 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.61 HG23 ' HB3' ' A' ' 148' ' ' MET . 2.0 mp -68.84 -48.3 71.48 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.43 0 CA-C-O 116.762 -1.59 . . . . 0.0 109.92 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.5 pp -62.92 -38.43 90.95 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 121.559 1.981 . . . . 0.0 110.372 176.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -56.88 -58.0 10.06 Favored 'General case' 0 CA--C 1.574 1.883 0 CA-C-N 120.945 1.702 . . . . 0.0 109.429 174.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.85 -57.72 11.24 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 117.283 -1.342 . . . . 0.0 114.337 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -57.23 -46.42 82.98 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 119.905 1.23 . . . . 0.0 112.518 177.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -62.41 -35.3 78.81 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-O 116.037 -1.935 . . . . 0.0 112.363 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.2 t -66.6 -43.28 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 CA-C-N 122.451 2.387 . . . . 0.0 107.935 170.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -55.82 -41.24 73.93 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.434 ' C ' ' H ' ' A' ' 100' ' ' ASN . 5.6 t0 -66.07 114.17 5.02 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 174.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.29 50.83 0.66 Allowed 'General case' 0 N--CA 1.507 2.397 0 CA-C-O 123.304 1.526 . . . . 0.0 111.577 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.434 ' H ' ' C ' ' A' ' 98' ' ' ASP 0.296 10.1 t-20 84.9 -61.93 0.08 Allowed 'General case' 0 CA--C 1.57 1.716 0 C-N-CA 128.699 2.799 . . . . 0.0 103.968 -170.783 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 28.97 15.23 0.0 OUTLIER Glycine 0 C--N 1.357 1.699 1 N-CA-C 125.074 4.79 . . . . 0.0 125.074 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.2 p30 64.51 13.34 8.11 Favored 'General case' 0 CA--C 1.597 2.783 0 CA-C-N 121.74 2.77 . . . . 0.0 112.269 -169.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.85 -6.49 54.49 Favored Glycine 0 CA--C 1.559 2.84 0 CA-C-O 115.968 -2.573 . . . . 0.0 111.264 -171.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -101.86 144.44 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.709 0 CA-C-N 121.818 2.809 . . . . 0.0 113.985 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 57.3 mt -111.78 128.68 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-N 113.196 -1.82 . . . . 0.0 108.681 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -106.58 -176.72 3.16 Favored 'General case' 0 CA--C 1.572 1.822 0 CA-C-O 121.739 0.78 . . . . 0.0 112.102 176.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -70.69 -49.63 45.19 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.861 -1.15 . . . . 0.0 113.793 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -62.49 -42.91 99.82 Favored 'General case' 0 CA--C 1.578 2.052 0 CA-C-O 117.427 -1.273 . . . . 0.0 111.461 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -54.13 -44.81 71.68 Favored 'General case' 0 CA--C 1.573 1.842 0 CA-C-N 121.558 1.981 . . . . 0.0 112.332 173.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -69.38 -49.53 54.56 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -58.75 -15.86 14.08 Favored 'General case' 0 CA--C 1.58 2.1 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 173.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -93.33 -53.32 4.14 Favored 'General case' 0 CA--C 1.582 2.18 0 CA-C-N 120.129 1.331 . . . . 0.0 110.995 173.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.48 -23.12 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 120.13 3.382 . . . . 0.0 120.13 -175.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -44.76 -56.28 4.6 Favored 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 125.034 1.334 . . . . 0.0 112.078 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.538 ' HG2' ' HA ' ' A' ' 121' ' ' PRO . 36.6 mm-40 -94.5 88.1 5.36 Favored 'General case' 0 CA--C 1.562 1.437 0 N-CA-C 103.179 -2.897 . . . . 0.0 103.179 174.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -32.71 -29.76 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.724 1 N-CA-C 122.236 4.162 . . . . 0.0 122.236 -179.767 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 26.1 t -91.76 94.32 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-N 122.186 2.267 . . . . 0.0 108.046 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.05 -140.67 45.69 Favored Glycine 0 CA--C 1.549 2.16 0 N-CA-C 116.143 1.217 . . . . 0.0 116.143 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -89.73 47.75 1.5 Allowed 'General case' 0 CA--C 1.581 2.15 0 N-CA-C 114.86 1.429 . . . . 0.0 114.86 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.303 55.0 tt0 -77.42 -16.59 0.26 Allowed Pre-proline 0 CA--C 1.575 1.926 0 CA-C-O 111.944 -3.884 . . . . 0.0 117.693 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.538 ' HA ' ' HG2' ' A' ' 115' ' ' GLN . 27.2 Cg_exo -52.05 99.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.386 2.548 1 CA-C-N 128.462 4.058 . . . . 0.0 115.735 177.854 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.4 0.0 OUTLIER -74.18 -56.95 4.3 Favored 'General case' 0 CA--C 1.576 1.969 0 CA-C-N 109.706 -3.406 . . . . 0.0 114.717 -174.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 10.4 p -112.87 125.78 54.73 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 125.918 3.963 . . . . 0.0 104.89 175.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.96 -34.82 75.96 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 113.239 -1.8 . . . . 0.0 115.468 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.24 -39.79 76.29 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -59.85 -49.47 77.59 Favored 'General case' 0 CA--C 1.584 2.285 0 CA-C-O 122.261 1.029 . . . . 0.0 112.317 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.3 t -64.54 -50.44 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.793 0 C-N-CA 126.101 1.76 . . . . 0.0 111.184 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -58.3 -42.99 87.86 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 123.52 0.728 . . . . 0.0 112.674 176.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -61.41 -51.15 69.96 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.531 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.18 -45.32 93.53 Favored 'General case' 0 CA--C 1.561 1.393 0 N-CA-C 115.435 1.642 . . . . 0.0 115.435 177.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.6 ttt -71.44 -42.1 68.66 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 117.328 -1.32 . . . . 0.0 111.748 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.46 -43.85 84.35 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 120.907 1.685 . . . . 0.0 110.744 174.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.59 -30.11 68.79 Favored 'General case' 0 CA--C 1.581 2.146 0 CA-C-N 121.165 1.802 . . . . 0.0 113.043 174.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.37 -23.51 37.65 Favored 'General case' 0 CA--C 1.582 2.183 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.622 ' OD2' ' HA2' ' A' ' 140' ' ' GLY . 17.8 t0 -84.72 108.17 17.28 Favored 'General case' 0 CA--C 1.578 2.043 0 N-CA-C 104.079 -2.563 . . . . 0.0 104.079 171.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -76.09 -29.05 57.78 Favored 'General case' 0 CA--C 1.587 2.382 0 CA-C-N 120.556 1.525 . . . . 0.0 113.515 177.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.274 0.1 OUTLIER -166.02 -75.93 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.376 1 N-CA-C 99.075 -4.416 . . . . 0.0 99.075 177.127 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 34.15 30.13 0.01 OUTLIER Glycine 0 C--N 1.372 2.531 0 CA-C-N 123.309 2.777 . . . . 0.0 119.399 175.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.38 -3.21 0.68 Allowed 'General case' 0 CA--C 1.593 2.615 0 CA-C-N 119.629 1.715 . . . . 0.0 114.438 -172.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.622 ' HA2' ' OD2' ' A' ' 135' ' ' ASP . . . 106.41 -23.34 28.75 Favored Glycine 0 CA--C 1.559 2.817 0 CA-C-N 122.983 2.629 . . . . 0.0 113.78 -175.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . 0.257 27.8 m -118.6 133.43 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 103.542 -2.762 . . . . 0.0 103.542 178.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.03 126.93 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 117.492 2.404 . . . . 0.0 117.492 -172.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.4 p30 -90.76 156.2 18.23 Favored 'General case' 0 CA--C 1.564 1.502 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 172.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 5.5 mt -55.72 -49.31 93.56 Favored Pre-proline 0 CA--C 1.574 1.886 0 CA-C-O 114.482 -2.675 . . . . 0.0 114.191 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -52.26 -31.62 47.21 Favored 'Trans proline' 0 C--N 1.374 1.908 0 CA-C-N 125.434 2.977 . . . . 0.0 116.444 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -63.21 -61.06 2.62 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 121.142 1.792 . . . . 0.0 114.326 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -53.26 -50.78 64.12 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 120.179 1.354 . . . . 0.0 113.682 177.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.61 ' HB3' HG23 ' A' ' 90' ' ' ILE 0.255 0.1 OUTLIER -68.77 -47.23 66.74 Favored 'General case' 0 C--N 1.352 0.711 0 CA-C-O 113.924 -2.941 . . . . 0.0 111.18 179.229 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.28 -29.45 69.87 Favored 'General case' 0 CA--C 1.586 2.345 0 CA-C-N 125.585 3.812 . . . . 0.0 112.715 175.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . 0.291 5.3 tt -57.98 -40.95 81.94 Favored 'General case' 0 CA--C 1.575 1.922 0 C-N-CA 125.711 1.605 . . . . 0.0 109.799 172.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 55.7 mt -90.4 -64.73 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.604 3.034 0 CA-C-N 120.312 1.414 . . . . 0.0 109.941 173.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.24 7.76 2.03 Favored 'General case' 0 CA--C 1.591 2.556 0 N-CA-C 121.018 3.71 . . . . 0.0 121.018 -179.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -12.89 -8.04 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.886 1 N-CA-C 129.212 6.745 . . . . 0.0 129.212 -172.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 52.2 m . . . . . 0 N--CA 1.502 2.143 0 C-N-CA 124.072 0.949 . . . . 0.0 110.109 175.918 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 . . . . . 0 N--CA 1.5 2.027 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -62.0 -54.17 45.41 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 120.543 1.52 . . . . 0.0 112.835 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.42 -44.3 84.51 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.871 HG22 HD13 ' A' ' 151' ' ' ILE . 6.7 mt -69.22 -52.67 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.118 0 CA-C-O 116.153 -1.879 . . . . 0.0 110.986 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.2 pp -55.66 -43.66 76.5 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 121.555 1.98 . . . . 0.0 108.84 176.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -54.67 -49.31 70.93 Favored 'General case' 0 CA--C 1.571 1.782 0 CA-C-N 121.184 1.811 . . . . 0.0 112.69 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.95 -56.72 10.27 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-O 116.03 -1.938 . . . . 0.0 114.666 178.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.402 ' HB2' ' CE2' ' A' ' 147' ' ' PHE . 10.1 t80 -64.83 -42.3 95.05 Favored 'General case' 0 N--CA 1.509 2.479 0 CA-C-N 122.47 2.396 . . . . 0.0 112.734 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.466 ' HZ3' ' HA2' ' A' ' 103' ' ' GLY 0.285 6.1 mmpt? -62.56 -30.44 71.32 Favored 'General case' 0 CA--C 1.577 1.995 0 CA-C-O 117.625 -1.178 . . . . 0.0 110.869 179.138 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.8 t -71.69 -50.16 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-N 120.451 1.478 . . . . 0.0 108.324 169.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -58.0 -37.91 75.14 Favored 'General case' 0 CA--C 1.579 2.063 0 N-CA-C 116.728 2.121 . . . . 0.0 116.728 -177.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.297 6.5 t0 -59.33 90.6 0.02 OUTLIER 'General case' 0 CA--C 1.571 1.761 0 C-N-CA 128.495 2.718 . . . . 0.0 109.967 176.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.07 -49.06 66.33 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.534 -0.729 . . . . 0.0 112.106 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -48.68 -24.86 1.52 Allowed 'General case' 0 CA--C 1.585 2.298 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 175.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.59 8.59 86.76 Favored Glycine 0 CA--C 1.56 2.884 0 CA-C-N 122.04 2.2 . . . . 0.0 116.953 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.06 86.61 2.22 Favored 'General case' 0 N--CA 1.473 0.723 1 CA-C-O 110.533 -4.556 . . . . 0.0 107.039 176.596 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.466 ' HA2' ' HZ3' ' A' ' 95' ' ' LYS . . . 54.72 -25.11 0.01 OUTLIER Glycine 0 N--CA 1.489 2.214 2 N-CA-C 130.798 7.079 . . . . 0.0 130.798 162.459 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.7 p -114.39 151.95 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.811 0 CA-C-O 122.726 1.25 . . . . 0.0 112.887 -178.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 63.4 mt -129.34 136.25 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 CA-C-N 113.55 -1.659 . . . . 0.0 111.317 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -115.75 -177.8 3.24 Favored 'General case' 0 CA--C 1.589 2.471 0 C-N-CA 124.087 0.955 . . . . 0.0 110.062 174.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -74.21 -47.25 36.66 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 -176.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -61.65 -42.78 99.37 Favored 'General case' 0 N--CA 1.514 2.729 0 CA-C-N 122.256 2.298 . . . . 0.0 113.539 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -56.03 -39.89 72.63 Favored 'General case' 0 N--CA 1.504 2.243 0 CA-C-N 119.325 0.966 . . . . 0.0 111.678 173.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -63.38 -46.57 85.85 Favored 'General case' 0 CA--C 1.571 1.787 0 C-N-CA 124.914 1.286 . . . . 0.0 109.36 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -53.5 -50.86 64.5 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 123.89 0.876 . . . . 0.0 111.668 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -57.77 -53.83 53.78 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 176.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.5 tt -74.0 -29.3 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 119.366 3.099 . . . . 0.0 119.366 -176.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.492 ' SD ' ' HA ' ' A' ' 127' ' ' VAL . 6.3 tpt -48.56 -49.04 38.12 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 177.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -66.4 35.84 0.02 OUTLIER 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 121.487 3.884 . . . . 0.0 121.487 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 31.07 -85.34 0.0 OUTLIER 'General case' 0 N--CA 1.531 3.582 0 N-CA-C 118.439 2.755 . . . . 0.0 118.439 174.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.6 t -117.48 95.36 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 82.83 -144.57 23.03 Favored Glycine 0 CA--C 1.547 2.072 0 CA-C-N 114.819 -1.082 . . . . 0.0 113.478 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 54.96 167.2 0.02 OUTLIER 'General case' 0 N--CA 1.511 2.584 0 N-CA-C 116.323 1.972 . . . . 0.0 116.323 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -144.75 112.8 4.96 Favored Pre-proline 0 CA--C 1.576 1.969 0 CA-C-O 113.407 -3.187 . . . . 0.0 107.804 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . 0.49 0.1 OUTLIER 20.25 47.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.393 2.876 0 CA-C-N 127.823 3.83 . . . . 0.0 121.989 -174.51 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.415 2.2 tm? -63.28 -71.28 0.17 Allowed 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 109.004 -3.725 . . . . 0.0 105.493 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.4 p -92.76 116.28 28.88 Favored 'General case' 0 CA--C 1.557 1.239 0 N-CA-C 102.273 -3.232 . . . . 0.0 102.273 171.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -67.6 -34.75 77.64 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 115.925 1.824 . . . . 0.0 115.925 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.75 -38.7 75.81 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-O 116.74 -1.6 . . . . 0.0 113.279 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -68.29 -39.46 82.08 Favored 'General case' 0 CA--C 1.572 1.812 0 CA-C-N 121.442 1.928 . . . . 0.0 112.456 176.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.492 ' HA ' ' SD ' ' A' ' 114' ' ' MET . 0.4 OUTLIER -70.39 -48.56 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 119.216 0.916 . . . . 0.0 112.32 177.766 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -66.59 -49.4 66.46 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 116.77 -1.586 . . . . 0.0 109.504 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -55.98 -47.96 76.71 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 122.256 2.298 . . . . 0.0 113.526 176.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.78 -46.2 89.12 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-O 117.644 -1.169 . . . . 0.0 113.85 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 14.8 ttt -77.21 -37.21 53.9 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 116.478 -1.725 . . . . 0.0 110.658 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -32.9 69.83 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 123.927 3.058 . . . . 0.0 109.977 172.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -73.3 -44.22 59.5 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-O 116.309 -1.805 . . . . 0.0 110.477 176.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.419 ' HA ' HD12 ' A' ' 150' ' ' LEU . . . -80.73 -35.38 33.53 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 117.611 2.448 . . . . 0.0 117.611 178.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -90.3 119.81 30.92 Favored 'General case' 0 N--CA 1.514 2.771 1 O-C-N 116.099 -4.126 . . . . 0.0 106.069 176.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -75.27 -32.9 61.18 Favored 'General case' 0 CA--C 1.58 2.109 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 177.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.301 0.1 OUTLIER 175.75 -73.49 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.368 1 N-CA-C 96.516 -5.364 . . . . 0.0 96.516 178.771 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 34.92 32.16 0.02 OUTLIER Glycine 0 C--N 1.373 2.616 0 CA-C-N 123.681 2.946 . . . . 0.0 118.696 174.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 55.0 17.79 2.0 Favored 'General case' 0 CA--C 1.592 2.59 0 CA-C-O 115.739 -2.077 . . . . 0.0 115.18 -173.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 92.81 -22.36 34.29 Favored Glycine 0 C--N 1.38 3.009 0 CA-C-N 124.486 3.312 . . . . 0.0 114.979 -176.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.27 146.68 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 176.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.7 mt -123.1 131.42 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 112.594 -2.094 . . . . 0.0 110.375 -177.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 42.3 p30 -97.88 158.64 15.41 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 105.199 -2.149 . . . . 0.0 105.199 171.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.441 HD12 ' HE3' ' A' ' 95' ' ' LYS . 0.9 OUTLIER -56.33 -44.57 99.78 Favored Pre-proline 0 CA--C 1.587 2.385 0 CA-C-O 114.971 -2.442 . . . . 0.0 112.833 -179.373 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.18 -36.15 35.75 Favored 'Trans proline' 0 C--N 1.382 2.342 0 C-N-CA 124.294 3.329 . . . . 0.0 117.107 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -65.61 -56.17 13.67 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 121.623 2.01 . . . . 0.0 110.835 175.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.422 ' CE2' HG21 ' A' ' 90' ' ' ILE . 21.4 t80 -55.38 -50.14 70.49 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.753 ' HB3' HG23 ' A' ' 90' ' ' ILE 0.257 4.0 ptp -66.34 -41.73 89.16 Favored 'General case' 0 CA--C 1.577 2.019 0 CA-C-O 117.478 -1.249 . . . . 0.0 111.316 178.204 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -60.2 -35.07 74.57 Favored 'General case' 0 N--CA 1.508 2.46 0 CA-C-N 121.018 1.736 . . . . 0.0 114.258 173.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 134' ' ' ALA 0.356 6.8 tt -69.15 -34.73 75.44 Favored 'General case' 0 CA--C 1.567 1.627 0 C-N-CA 127.838 2.455 . . . . 0.0 110.302 176.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.871 HD13 HG22 ' A' ' 90' ' ' ILE . 79.2 mt -69.52 -48.79 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 CA-C-N 121.051 1.751 . . . . 0.0 106.879 171.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.71 -56.2 15.12 Favored 'General case' 0 CA--C 1.581 2.135 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 177.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -96.42 -70.74 0.7 Allowed 'General case' 0 CA--C 1.565 1.527 0 C-N-CA 125.122 1.369 . . . . 0.0 113.752 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.529 3.479 0 C-N-CA 126.228 1.811 . . . . 0.0 108.785 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.508 2.429 0 N-CA-C 115.954 1.835 . . . . 0.0 115.954 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -39.77 -47.84 2.13 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 127.496 2.318 . . . . 0.0 114.545 174.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -45.45 -73.07 0.05 OUTLIER 'General case' 0 CA--C 1.581 2.145 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.452 HG23 ' HA ' ' A' ' 148' ' ' MET . 0.7 OUTLIER -78.12 -52.71 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -178.341 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -63.51 -50.32 70.08 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 115.754 -2.069 . . . . 0.0 111.258 -177.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.97 -28.89 63.73 Favored 'General case' 0 CA--C 1.571 1.775 0 CA-C-O 114.374 -2.727 . . . . 0.0 111.243 176.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.98 -53.2 53.92 Favored 'General case' 0 C--N 1.38 1.925 0 CA-C-N 124.5 3.318 . . . . 0.0 111.378 174.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -62.03 -42.9 99.67 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 119.81 1.186 . . . . 0.0 112.821 176.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.602 ' HE2' HD12 ' A' ' 144' ' ' ILE . 58.1 mttt -63.68 -34.51 78.01 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 116.589 -1.672 . . . . 0.0 111.9 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -70.34 -44.84 77.14 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.197 0 CA-C-N 121.711 2.05 . . . . 0.0 108.557 171.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -56.34 -31.94 64.22 Favored 'General case' 0 CA--C 1.576 1.967 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -60.33 118.97 7.07 Favored 'General case' 0 CA--C 1.575 1.927 0 C-N-CA 125.812 1.645 . . . . 0.0 111.951 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.413 ' CB ' ' HG2' ' A' ' 109' ' ' GLU . . . -77.33 -52.51 9.04 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 -178.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.9 p30 -72.74 -8.67 56.52 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 117.88 2.548 . . . . 0.0 117.88 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.2 8.92 87.16 Favored Glycine 0 CA--C 1.555 2.539 0 N-CA-C 119.523 2.569 . . . . 0.0 119.523 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.6 p30 -114.4 -12.56 12.35 Favored 'General case' 0 CA--C 1.575 1.928 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 177.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.34 22.21 5.92 Favored Glycine 0 CA--C 1.548 2.132 0 CA-C-O 116.325 -2.375 . . . . 0.0 115.985 -178.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.4 HG11 ' O ' ' A' ' 142' ' ' ILE . 2.3 t -132.61 138.74 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-N 121.366 2.583 . . . . 0.0 109.734 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.0 mt -119.76 136.71 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 126.059 1.744 . . . . 0.0 110.746 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -99.13 -175.08 2.92 Favored 'General case' 0 CA--C 1.576 1.969 0 C-N-CA 124.083 0.953 . . . . 0.0 112.678 176.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -82.23 -51.66 7.72 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 119.961 -1.712 . . . . 0.0 113.833 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -62.28 -46.33 89.27 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 119.681 1.128 . . . . 0.0 112.59 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.413 ' HG2' ' CB ' ' A' ' 99' ' ' ALA . 37.1 tp10 -63.81 -35.49 80.77 Favored 'General case' 0 CA--C 1.57 1.723 0 CA-C-N 119.68 1.127 . . . . 0.0 113.064 176.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -61.07 -48.85 79.82 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 119.845 1.202 . . . . 0.0 107.815 171.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.42 ' HZ3' ' CD ' ' A' ' 128' ' ' GLU . 56.6 tttt -64.64 -9.27 18.41 Favored 'General case' 0 CA--C 1.581 2.164 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 174.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -94.37 -50.05 5.42 Favored 'General case' 0 CA--C 1.593 2.601 0 C-N-CA 125.336 1.454 . . . . 0.0 111.017 171.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.6 tt -80.21 -28.31 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 120.889 3.663 . . . . 0.0 120.889 -175.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 1.1 tpt -40.36 -48.2 2.66 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.522 ' H ' ' HG3' ' A' ' 121' ' ' PRO . 47.0 mm-40 -91.68 84.61 5.48 Favored 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 27.1 mmtt -88.52 35.48 0.77 Allowed 'General case' 0 N--CA 1.51 2.53 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 172.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 91.4 t -151.61 93.94 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.351 1 N-CA-C 97.174 -5.121 . . . . 0.0 97.174 176.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.7 92.3 0.33 Allowed Glycine 0 CA--C 1.552 2.396 0 N-CA-C 106.617 -2.593 . . . . 0.0 106.617 -174.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -66.96 79.1 0.12 Allowed 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 117.003 2.223 . . . . 0.0 117.003 -176.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -168.03 94.19 0.62 Allowed Pre-proline 0 CA--C 1.566 1.591 0 CA-C-O 117.551 -1.214 . . . . 0.0 112.307 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.522 ' HG3' ' H ' ' A' ' 115' ' ' GLN . 51.3 Cg_exo -77.16 77.22 3.88 Favored 'Trans proline' 0 N--CA 1.509 2.439 0 CA-C-O 125.271 2.113 . . . . 0.0 109.294 174.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.312 3.2 tm? -72.01 -59.54 2.69 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 109.386 -3.552 . . . . 0.0 118.728 -173.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 30.6 p -77.93 122.27 25.27 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 125.397 3.726 . . . . 0.0 107.47 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -59.16 -37.99 78.67 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 112.223 -2.262 . . . . 0.0 115.369 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.27 -39.37 90.12 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-O 117.243 -1.36 . . . . 0.0 114.305 177.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -61.28 -52.89 62.84 Favored 'General case' 0 CA--C 1.577 1.982 0 CA-C-N 120.967 1.712 . . . . 0.0 112.631 177.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.6 t -69.43 -49.92 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 CA-C-O 117.529 -1.224 . . . . 0.0 112.255 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.42 ' CD ' ' HZ3' ' A' ' 111' ' ' LYS . 0.6 OUTLIER -62.19 -44.18 97.17 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 116.688 -1.625 . . . . 0.0 110.486 177.074 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -59.3 -52.04 67.35 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 122.488 2.404 . . . . 0.0 112.199 176.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.62 -44.56 95.98 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.527 ' SD ' HD13 ' A' ' 142' ' ' ILE . 18.4 tpt -73.56 -37.44 65.53 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 115.94 -1.981 . . . . 0.0 111.992 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -60.15 -49.12 78.89 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 122.92 2.6 . . . . 0.0 110.788 174.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -69.67 -26.94 64.62 Favored 'General case' 0 CA--C 1.575 1.936 0 CA-C-O 118.048 -0.977 . . . . 0.0 112.761 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.15 -21.34 27.62 Favored 'General case' 0 CA--C 1.58 2.108 0 CA-C-N 119.996 1.271 . . . . 0.0 114.347 175.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -88.46 109.28 19.9 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 122.757 2.526 . . . . 0.0 105.234 171.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -77.31 -25.17 50.98 Favored 'General case' 0 CA--C 1.576 1.958 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -86.61 -16.31 37.1 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 118.206 2.669 . . . . 0.0 118.206 -176.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.61 5.23 90.06 Favored Glycine 0 CA--C 1.565 3.173 0 CA-C-N 119.936 1.244 . . . . 0.0 115.367 -174.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -86.82 -29.82 21.96 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-N 119.167 1.483 . . . . 0.0 114.885 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 104.93 23.35 7.82 Favored Glycine 0 CA--C 1.554 2.497 0 CA-C-N 120.581 1.537 . . . . 0.0 116.607 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.88 152.69 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 123.543 1.64 . . . . 0.0 107.858 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.527 HD13 ' SD ' ' A' ' 131' ' ' MET . 0.8 OUTLIER -136.82 130.78 46.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 112.535 -2.121 . . . . 0.0 112.06 -177.504 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 34.1 p30 -97.67 162.27 13.36 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 104.72 -2.326 . . . . 0.0 104.72 170.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.602 HD12 ' HE2' ' A' ' 95' ' ' LYS . 4.4 mt -56.22 -49.25 94.33 Favored Pre-proline 0 CA--C 1.582 2.194 0 CA-C-O 113.413 -3.184 . . . . 0.0 110.905 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -47.73 -31.63 15.09 Favored 'Trans proline' 0 C--N 1.377 2.035 0 CA-C-N 127.011 3.54 . . . . 0.0 120.555 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -71.62 -66.34 0.64 Allowed 'General case' 0 N--CA 1.506 2.331 0 CA-C-N 122.663 2.483 . . . . 0.0 110.053 177.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -51.04 -41.76 60.05 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 124.596 1.158 . . . . 0.0 112.884 173.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.452 ' HA ' HG23 ' A' ' 90' ' ' ILE 0.268 0.0 OUTLIER -70.65 -45.21 65.55 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-O 113.658 -3.068 . . . . 0.0 110.808 -179.538 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.78 -44.25 90.63 Favored 'General case' 0 CA--C 1.583 2.232 0 CA-C-N 124.051 3.114 . . . . 0.0 111.776 175.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 7.9 tt -50.98 -47.59 61.4 Favored 'General case' 0 C--N 1.365 1.279 0 C-N-CA 126.216 1.807 . . . . 0.0 112.701 176.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 45.8 mt -90.24 -33.06 5.72 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.212 0 CA-C-N 121.099 1.772 . . . . 0.0 110.992 176.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -50.88 -37.09 41.4 Favored 'General case' 0 N--CA 1.503 2.193 0 CA-C-N 120.836 1.653 . . . . 0.0 114.599 176.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -45.82 -42.16 11.93 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 60.5 p . . . . . 0 CA--C 1.578 2.048 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 176.88 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.5 2.053 0 N-CA-C 120.47 3.508 . . . . 0.0 120.47 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -50.43 -64.39 0.82 Allowed 'General case' 0 CA--C 1.564 1.482 0 O-C-N 123.777 0.673 . . . . 0.0 111.801 176.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -74.55 -26.13 59.76 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.607 HG23 ' HG2' ' A' ' 148' ' ' MET . 3.6 mp -74.68 -58.37 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 CA-C-N 122.274 2.306 . . . . 0.0 109.334 177.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . 0.254 0.3 OUTLIER -62.92 -42.01 99.66 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 121.843 2.11 . . . . 0.0 110.038 179.167 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -60.88 -52.73 63.81 Favored 'General case' 0 CA--C 1.572 1.815 0 CA-C-N 121.921 2.146 . . . . 0.0 110.772 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.31 -54.94 16.21 Favored 'General case' 0 C--N 1.363 1.166 0 CA-C-O 116.009 -1.948 . . . . 0.0 115.49 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -63.32 -50.79 68.65 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 121.74 2.064 . . . . 0.0 112.28 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.332 78.5 mttt -64.52 -22.78 67.06 Favored 'General case' 0 CA--C 1.591 2.536 0 CA-C-O 117.372 -1.299 . . . . 0.0 111.199 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -73.14 -49.85 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 CA-C-N 121.266 1.848 . . . . 0.0 108.233 168.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -50.13 -37.62 35.13 Favored 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -61.2 115.72 4.02 Favored 'General case' 0 CA--C 1.578 2.024 0 C-N-CA 125.558 1.543 . . . . 0.0 112.722 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -77.65 -51.62 10.32 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.4 p30 -68.92 -13.19 62.28 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 117.777 2.51 . . . . 0.0 117.777 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.5 7.51 88.47 Favored Glycine 0 CA--C 1.553 2.422 0 N-CA-C 119.559 2.584 . . . . 0.0 119.559 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.1 p30 -104.33 -15.13 15.53 Favored 'General case' 0 CA--C 1.576 1.977 0 CA-C-N 119.535 1.667 . . . . 0.0 114.773 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.59 20.83 6.73 Favored Glycine 0 CA--C 1.545 1.941 0 CA-C-O 116.201 -2.444 . . . . 0.0 116.415 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -131.8 137.04 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 121.654 2.727 . . . . 0.0 110.856 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 58.8 mt -109.35 139.74 31.01 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 CA-C-N 112.058 -2.337 . . . . 0.0 108.36 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -118.83 -173.7 2.54 Favored 'General case' 0 CA--C 1.574 1.881 0 C-N-CA 124.242 1.017 . . . . 0.0 111.215 176.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -72.27 -53.42 12.54 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.657 -1.277 . . . . 0.0 113.877 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -56.61 -47.26 80.01 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 118.278 0.49 . . . . 0.0 112.305 177.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.26 -50.49 67.12 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 174.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.96 -51.77 66.76 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 124.621 1.168 . . . . 0.0 110.419 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.24 -8.95 50.61 Favored 'General case' 0 CA--C 1.577 1.991 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 176.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -92.08 -40.57 10.98 Favored 'General case' 0 CA--C 1.584 2.27 0 C-N-CA 124.902 1.281 . . . . 0.0 110.711 172.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.6 tt -91.41 -36.33 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 121.317 3.821 . . . . 0.0 121.317 -174.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 7.1 tpt -37.75 -53.51 1.26 Allowed 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 117.525 2.416 . . . . 0.0 117.525 -176.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.761 ' H ' ' HG3' ' A' ' 121' ' ' PRO . 67.8 mm-40 -74.39 -43.17 57.58 Favored 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 117.538 2.422 . . . . 0.0 117.538 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 9.9 mptt 77.63 -72.39 0.09 Allowed 'General case' 0 N--CA 1.521 3.106 0 C-N-CA 126.397 1.879 . . . . 0.0 113.062 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.9 p -123.61 144.75 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 CA-C-N 120.092 1.315 . . . . 0.0 111.579 -178.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.65 80.87 0.5 Allowed Glycine 0 CA--C 1.539 1.573 0 CA-C-O 118.929 -0.928 . . . . 0.0 111.4 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 69.54 122.14 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 124.419 1.088 . . . . 0.0 110.636 -177.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -70.26 -177.69 0.45 Allowed Pre-proline 0 CA--C 1.571 1.781 0 CA-C-O 116.559 -1.686 . . . . 0.0 114.966 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.761 ' HG3' ' H ' ' A' ' 115' ' ' GLN . 17.0 Cg_exo -76.95 81.98 2.46 Favored 'Trans proline' 0 N--CA 1.507 2.313 0 CA-C-O 127.015 2.84 . . . . 0.0 107.948 175.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.453 7.4 tp -63.01 -65.91 0.62 Allowed 'General case' 0 CA--C 1.564 1.505 1 CA-C-N 106.548 -4.842 . . . . 0.0 115.092 -173.357 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 16.8 p -83.04 126.32 32.42 Favored 'General case' 0 N--CA 1.491 1.579 1 CA-C-N 126.183 4.083 . . . . 0.0 108.507 177.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -59.67 -38.02 80.35 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 116.963 2.209 . . . . 0.0 116.963 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.0 -45.37 79.07 Favored 'General case' 0 CA--C 1.554 1.12 0 O-C-N 124.493 1.121 . . . . 0.0 113.612 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -57.88 -50.79 72.14 Favored 'General case' 0 CA--C 1.579 2.068 0 CA-C-O 122.287 1.041 . . . . 0.0 112.517 176.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.9 t -67.51 -41.49 85.99 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.612 0 CA-C-N 114.003 -1.453 . . . . 0.0 112.162 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -63.66 -46.46 85.52 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 120.415 1.462 . . . . 0.0 109.91 175.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -57.54 -51.1 70.86 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 120.753 1.615 . . . . 0.0 112.199 175.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.4 -46.68 88.0 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.5 ttt -69.05 -39.24 79.27 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.806 177.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.87 -41.43 95.96 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 121.423 1.92 . . . . 0.0 109.827 174.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -64.64 -32.76 74.56 Favored 'General case' 0 CA--C 1.584 2.288 0 CA-C-N 121.017 1.735 . . . . 0.0 112.146 173.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.61 -26.72 34.64 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -78.97 109.43 13.25 Favored 'General case' 0 N--CA 1.516 2.861 0 CA-C-N 123.188 2.722 . . . . 0.0 109.98 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -86.58 -19.74 28.95 Favored 'General case' 0 CA--C 1.58 2.129 0 N-CA-C 117.142 2.275 . . . . 0.0 117.142 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -85.01 -14.42 47.46 Favored 'General case' 0 N--CA 1.507 2.409 1 N-CA-C 122.641 4.312 . . . . 0.0 122.641 -171.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.68 6.34 85.63 Favored Glycine 0 CA--C 1.57 3.507 0 CA-C-N 121.032 1.742 . . . . 0.0 114.958 -172.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -88.11 -51.41 5.81 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.187 1.395 . . . . 0.0 110.478 175.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 110.76 -20.18 24.91 Favored Glycine 0 CA--C 1.543 1.799 0 CA-C-O 115.695 -2.725 . . . . 0.0 115.894 -177.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . 0.259 13.0 m -126.64 124.06 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 101.152 -3.647 . . . . 0.0 101.152 176.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -77.77 124.72 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 -172.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -93.05 160.21 14.96 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 171.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.6 mt -57.32 -42.82 97.95 Favored Pre-proline 0 CA--C 1.579 2.081 0 CA-C-O 114.859 -2.496 . . . . 0.0 113.352 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.51 -38.45 74.82 Favored 'Trans proline' 0 C--N 1.376 1.99 0 CA-C-N 125.202 2.894 . . . . 0.0 116.703 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -68.17 -38.44 82.06 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 122.215 2.28 . . . . 0.0 113.947 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -64.9 -47.12 78.93 Favored 'General case' 0 CA--C 1.578 2.044 0 CA-C-N 121.411 1.914 . . . . 0.0 110.659 172.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.607 ' HG2' HG23 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -59.22 -44.07 92.31 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-N 118.45 0.568 . . . . 0.0 111.964 176.141 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -65.11 -44.95 87.07 Favored 'General case' 0 CA--C 1.568 1.672 0 C-N-CA 124.356 1.062 . . . . 0.0 109.85 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.28 -45.27 65.4 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.781 1.232 . . . . 0.0 111.915 174.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 97.0 mt -77.86 -50.57 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-O 116.862 -1.542 . . . . 0.0 114.187 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -90.95 -47.12 7.77 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -176.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -105.52 -75.83 0.62 Allowed 'General case' 0 N--CA 1.505 2.29 1 N-CA-C 121.905 4.039 . . . . 0.0 121.905 -177.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 43.9 t . . . . . 0 N--CA 1.503 2.218 0 N-CA-C 120.96 3.689 . . . . 0.0 120.96 -175.047 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 . . . . . 0 CA--C 1.592 2.571 0 CA-C-O 117.207 -1.378 . . . . 0.0 109.115 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -20.56 -43.54 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.221 0 C-N-CA 130.652 3.581 . . . . 0.0 120.304 -172.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -53.31 -71.1 0.08 Allowed 'General case' 0 CA--C 1.62 3.657 0 CA-C-O 127.938 3.732 . . . . 0.0 111.461 174.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.705 HG23 ' HE1' ' A' ' 148' ' ' MET . 13.9 mm -70.71 -43.98 76.88 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.642 0 CA-C-N 109.066 -3.697 . . . . 0.0 109.167 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.35 -43.53 88.39 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 121.826 2.103 . . . . 0.0 109.476 175.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.2 mmt-85 -55.25 -51.37 66.85 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 122.326 2.33 . . . . 0.0 107.536 175.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.83 -65.06 0.72 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 117.604 2.446 . . . . 0.0 117.604 177.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.486 ' HB2' ' CD2' ' A' ' 147' ' ' PHE . 18.3 t80 -67.36 -48.76 66.5 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.369 1.4 mmmp? -69.08 -19.2 64.07 Favored 'General case' 0 CA--C 1.589 2.443 0 CA-C-O 115.07 -2.395 . . . . 0.0 109.229 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -73.57 -45.99 49.62 Favored 'Isoleucine or valine' 0 C--N 1.394 2.532 0 CA-C-N 124.388 3.267 . . . . 0.0 105.597 166.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -52.73 -35.66 56.37 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 176.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.4 105.68 0.79 Allowed 'General case' 0 CA--C 1.577 2.005 0 C-N-CA 125.106 1.362 . . . . 0.0 109.432 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.07 -44.43 97.39 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 115.764 1.765 . . . . 0.0 115.764 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -69.62 -19.31 63.64 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 117.647 2.462 . . . . 0.0 117.647 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.62 21.35 64.22 Favored Glycine 0 CA--C 1.558 2.755 0 N-CA-C 118.14 2.016 . . . . 0.0 118.14 -177.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.58 -28.1 7.27 Favored 'General case' 0 CA--C 1.578 2.026 0 CA-C-N 119.388 1.594 . . . . 0.0 114.402 177.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 121.33 21.3 3.1 Favored Glycine 0 CA--C 1.548 2.11 0 CA-C-O 116.943 -2.031 . . . . 0.0 117.232 -175.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 p -124.69 150.61 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.668 0 CA-C-N 120.581 2.191 . . . . 0.0 109.379 173.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 96.3 mt -122.02 132.92 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-N 114.249 -1.341 . . . . 0.0 109.061 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.44 ' HB2' HG13 ' A' ' 141' ' ' VAL . 0.5 OUTLIER -109.75 179.12 4.21 Favored 'General case' 0 CA--C 1.582 2.173 0 CA-C-O 121.983 0.897 . . . . 0.0 111.749 175.196 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.29 -47.59 23.16 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.645 -1.284 . . . . 0.0 114.33 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -61.75 -38.72 89.0 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 117.706 -1.14 . . . . 0.0 110.443 175.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -65.01 -36.4 84.27 Favored 'General case' 0 CA--C 1.576 1.945 0 CA-C-N 121.022 1.737 . . . . 0.0 111.346 173.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -62.94 -48.48 78.71 Favored 'General case' 0 C--N 1.376 1.759 0 CA-C-N 120.99 1.723 . . . . 0.0 109.433 175.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 35.0 mttp -54.99 -52.12 64.09 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 123.9 0.88 . . . . 0.0 111.656 174.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -52.43 -47.95 66.05 Favored 'General case' 0 CA--C 1.571 1.763 0 C-N-CA 124.332 1.053 . . . . 0.0 113.518 175.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -81.47 -14.17 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 12.8 tpt -62.77 -58.99 5.51 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 125.575 1.55 . . . . 0.0 109.536 176.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -101.79 103.7 14.44 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 103.172 -2.899 . . . . 0.0 103.172 175.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.465 ' HD2' ' H ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -59.12 -27.8 65.94 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -178.424 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.9 p -82.11 132.92 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.773 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 175.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -48.4 130.99 20.69 Favored Glycine 0 CA--C 1.55 2.277 0 N-CA-C 119.366 2.506 . . . . 0.0 119.366 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 56.91 79.59 0.18 Allowed 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 124.928 1.291 . . . . 0.0 114.371 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -144.44 -31.05 0.0 OUTLIER Pre-proline 0 CA--C 1.566 1.576 1 CA-C-O 109.051 -5.261 . . . . 0.0 117.605 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER -36.31 94.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.39 2.739 1 CA-C-N 131.797 5.249 . . . . 0.0 118.079 -179.599 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.381 36.6 tp -76.69 -84.91 0.06 Allowed 'General case' 0 CA--C 1.559 1.31 0 CA-C-N 110.417 -3.083 . . . . 0.0 112.297 -175.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 38.0 p -84.84 124.01 31.11 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 124.69 3.405 . . . . 0.0 106.287 177.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.77 -37.14 85.51 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.52 -35.89 61.18 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -62.06 -55.67 26.74 Favored 'General case' 0 CA--C 1.587 2.393 0 CA-C-N 120.458 1.481 . . . . 0.0 111.659 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.1 t -63.47 -47.35 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 124.846 1.259 . . . . 0.0 111.216 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -57.77 -48.59 79.23 Favored 'General case' 0 CA--C 1.559 1.319 0 CA-C-O 118.101 -0.952 . . . . 0.0 111.887 176.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -58.53 -48.13 81.9 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 120.211 1.369 . . . . 0.0 112.489 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.96 -51.61 68.92 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -68.49 -34.42 75.89 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 115.263 -2.303 . . . . 0.0 112.113 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -65.26 -39.45 92.64 Favored 'General case' 0 CA--C 1.57 1.747 0 CA-C-N 122.739 2.518 . . . . 0.0 110.243 173.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -59.41 -40.74 87.62 Favored 'General case' 0 CA--C 1.574 1.874 0 CA-C-N 122.085 2.22 . . . . 0.0 110.559 173.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.421 ' HA ' HD22 ' A' ' 150' ' ' LEU . . . -78.38 -25.34 46.21 Favored 'General case' 0 CA--C 1.577 1.993 0 N-CA-C 116.872 2.175 . . . . 0.0 116.872 175.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -89.43 115.43 26.87 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 118.938 -2.351 . . . . 0.0 107.191 175.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -76.48 -27.73 56.22 Favored 'General case' 0 CA--C 1.566 1.567 0 N-CA-C 117.779 2.511 . . . . 0.0 117.779 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -105.88 -12.54 15.81 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 119.293 3.071 . . . . 0.0 119.293 -174.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.65 4.69 90.22 Favored Glycine 0 CA--C 1.572 3.627 0 CA-C-N 120.129 1.331 . . . . 0.0 113.623 -172.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -71.73 -45.94 60.15 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 125.282 1.433 . . . . 0.0 110.661 175.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 110.83 -4.88 29.1 Favored Glycine 0 CA--C 1.541 1.661 0 CA-C-O 115.075 -3.069 . . . . 0.0 117.598 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.44 HG13 ' HB2' ' A' ' 106' ' ' ASP 0.336 0.9 OUTLIER -136.91 118.85 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-N 123.093 3.446 . . . . 0.0 104.362 175.507 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.9 mt -85.21 130.88 35.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 109.385 -3.552 . . . . 0.0 111.835 -175.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 41.4 p30 -94.22 155.1 17.21 Favored 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 171.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -53.55 -44.98 98.76 Favored Pre-proline 0 CA--C 1.586 2.364 0 CA-C-O 114.427 -2.702 . . . . 0.0 113.468 -178.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -46.08 -37.82 18.31 Favored 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 124.634 3.556 . . . . 0.0 117.211 177.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -61.37 -55.29 33.23 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 119.364 0.983 . . . . 0.0 112.029 175.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.486 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 66.7 t80 -57.61 -45.38 85.43 Favored 'General case' 0 CA--C 1.577 1.996 0 C-N-CA 125.805 1.642 . . . . 0.0 112.721 175.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.705 ' HE1' HG23 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -62.9 -36.25 82.73 Favored 'General case' 0 CA--C 1.586 2.337 0 CA-C-O 117.865 -1.064 . . . . 0.0 110.142 177.289 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -70.71 -40.33 72.9 Favored 'General case' 0 CA--C 1.583 2.216 0 CA-C-N 120.58 1.537 . . . . 0.0 110.797 172.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' A' ' 134' ' ' ALA . 1.4 mm? -50.66 -45.41 57.98 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 126.037 1.735 . . . . 0.0 109.254 173.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 62.2 mt -83.14 -63.05 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.484 0 CA-C-N 119.847 1.203 . . . . 0.0 112.18 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -62.79 -43.76 97.95 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 117.62 2.452 . . . . 0.0 117.62 -177.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -95.48 -71.4 0.67 Allowed 'General case' 0 CA--C 1.561 1.371 0 N-CA-C 119.961 3.319 . . . . 0.0 119.961 -176.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 97.3 p . . . . . 0 N--CA 1.502 2.145 1 N-CA-C 124.208 4.892 . . . . 0.0 124.208 -171.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 . . . . . 0 N--CA 1.5 2.062 0 N-CA-C 118.083 2.623 . . . . 0.0 118.083 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.94 -50.76 63.37 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 120.694 1.588 . . . . 0.0 114.711 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -45.63 -60.2 2.33 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 115.378 1.621 . . . . 0.0 115.378 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.9 HD12 ' HE2' ' A' ' 152' ' ' LYS . 0.1 OUTLIER -70.82 -54.43 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-O 117.168 -1.396 . . . . 0.0 113.331 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . 0.279 0.0 OUTLIER -61.3 -40.05 92.71 Favored 'General case' 0 CA--C 1.568 1.663 0 CA-C-N 120.117 1.326 . . . . 0.0 110.315 -178.607 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.05 -57.93 9.74 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-N 120.767 1.621 . . . . 0.0 110.786 175.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.66 -57.41 8.16 Favored 'General case' 0 C--N 1.364 1.21 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -64.01 -47.69 79.28 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 117.141 -1.409 . . . . 0.0 113.091 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.293 31.1 mttm -66.3 -24.32 66.52 Favored 'General case' 0 CA--C 1.582 2.18 0 CA-C-O 117.008 -1.472 . . . . 0.0 110.601 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.6 t -68.88 -50.01 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-N 121.719 2.054 . . . . 0.0 108.167 168.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.54 -37.8 73.66 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 116.739 2.126 . . . . 0.0 116.739 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 1.218 ' OD2' ' HA ' ' A' ' 102' ' ' ASP . 12.1 t0 -62.46 111.21 1.94 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 126.103 1.761 . . . . 0.0 112.461 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.42 -28.2 41.74 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -76.23 8.98 2.84 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.0 7.0 84.38 Favored Glycine 0 CA--C 1.564 3.115 0 N-CA-C 120.03 2.772 . . . . 0.0 120.03 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 1.218 ' HA ' ' OD2' ' A' ' 98' ' ' ASP 0.79 0.2 OUTLIER 116.75 126.04 0.0 OUTLIER 'General case' 0 CA--C 1.584 2.273 0 C-N-CA 130.27 3.428 . . . . 0.0 118.025 171.092 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 114.81 12.25 10.44 Favored Glycine 0 N--CA 1.441 -1.032 2 C-N-CA 134.471 5.796 . . . . 0.0 115.291 176.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.743 ' O ' ' OD1' ' A' ' 98' ' ' ASP . 0.5 OUTLIER -170.53 156.4 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.571 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 179.225 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 78.5 mt -133.03 130.3 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 127.013 2.125 . . . . 0.0 107.77 175.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -108.72 171.47 7.41 Favored 'General case' 0 CA--C 1.595 2.696 0 C-N-CA 123.806 0.843 . . . . 0.0 110.532 175.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.47 ' HA ' ' SD ' ' A' ' 131' ' ' MET . 27.0 t80 -64.07 -60.41 3.27 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 117.787 2.514 . . . . 0.0 117.787 -176.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -59.84 -27.33 66.54 Favored 'General case' 0 N--CA 1.508 2.425 0 CA-C-N 119.823 1.192 . . . . 0.0 112.713 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -63.55 -42.17 98.4 Favored 'General case' 0 CA--C 1.578 2.023 0 CA-C-N 119.462 1.028 . . . . 0.0 110.455 172.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -62.41 -53.0 61.34 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 125.555 1.542 . . . . 0.0 109.65 174.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -51.23 -44.53 61.71 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 175.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -66.55 -53.83 30.34 Favored 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 125.515 1.526 . . . . 0.0 112.686 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -67.75 -21.87 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 -178.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -50.68 -46.76 58.89 Favored 'General case' 0 N--CA 1.505 2.291 0 CA-C-N 119.283 0.947 . . . . 0.0 111.099 172.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -105.59 106.09 16.42 Favored 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 125.589 1.555 . . . . 0.0 109.49 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.569 ' H ' ' HD3' ' A' ' 116' ' ' LYS . 1.3 mppt? -92.2 -60.55 1.82 Allowed 'General case' 0 CA--C 1.565 1.549 0 CA-C-N 113.681 -1.6 . . . . 0.0 114.878 -177.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.5 p -147.9 105.54 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.16 54.32 33.68 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 115.42 0.928 . . . . 0.0 115.42 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -138.47 144.12 39.92 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 124.663 1.185 . . . . 0.0 111.796 -177.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -156.3 66.87 4.4 Favored Pre-proline 0 CA--C 1.58 2.108 0 C-N-CA 123.299 0.64 . . . . 0.0 109.999 175.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -102.22 51.93 0.03 OUTLIER 'Trans proline' 0 CA--C 1.56 1.821 0 C-N-CA 123.086 2.524 . . . . 0.0 109.59 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.284 2.8 tt -160.92 162.03 31.89 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 -169.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.4 p -134.6 144.42 47.91 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 102.351 -3.203 . . . . 0.0 102.351 172.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -54.74 -33.96 61.86 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.444 -1.41 . . . . 0.0 114.792 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.21 -46.05 88.84 Favored 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 124.259 1.024 . . . . 0.0 112.63 175.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -64.21 -40.0 95.15 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 119.682 1.128 . . . . 0.0 112.252 176.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.9 p -67.52 -37.62 79.14 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.908 0 CA-C-N 119.85 1.204 . . . . 0.0 110.648 176.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -66.02 -45.04 82.93 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 119.661 1.119 . . . . 0.0 111.771 175.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -66.63 -41.17 88.74 Favored 'General case' 0 CA--C 1.574 1.884 0 O-C-N 120.894 -1.129 . . . . 0.0 113.249 176.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.93 -48.28 79.61 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.686 176.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.47 ' SD ' ' HA ' ' A' ' 107' ' ' PHE . 21.2 ttt -67.42 -36.2 80.78 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 115.415 -2.231 . . . . 0.0 110.792 175.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.18 -36.7 84.48 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 123.358 2.799 . . . . 0.0 111.868 175.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -62.37 -44.61 96.05 Favored 'General case' 0 CA--C 1.583 2.217 0 CA-C-N 119.531 1.06 . . . . 0.0 109.883 172.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -72.99 -26.73 61.44 Favored 'General case' 0 CA--C 1.583 2.233 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 176.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -80.36 111.71 17.01 Favored 'General case' 0 CA--C 1.56 1.36 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 175.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -72.68 -20.71 61.19 Favored 'General case' 0 CA--C 1.579 2.059 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -91.19 -17.22 26.42 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 117.68 2.474 . . . . 0.0 117.68 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.07 5.45 89.69 Favored Glycine 0 CA--C 1.563 3.085 0 CA-C-N 120.17 1.35 . . . . 0.0 115.905 -175.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 53.5 p-10 -87.54 -32.54 19.33 Favored 'General case' 0 CA--C 1.568 1.666 0 CA-C-N 119.408 1.604 . . . . 0.0 115.101 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 107.92 20.11 8.63 Favored Glycine 0 CA--C 1.559 2.797 0 N-CA-C 116.926 1.53 . . . . 0.0 116.926 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.19 152.63 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.4 mt -137.5 131.33 44.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 112.164 -2.289 . . . . 0.0 111.743 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 51.3 p30 -96.39 163.74 12.93 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 171.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 3.3 mt -56.76 -45.76 99.91 Favored Pre-proline 0 CA--C 1.582 2.203 0 CA-C-O 114.225 -2.798 . . . . 0.0 112.181 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -48.45 -38.01 34.26 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 124.216 3.277 . . . . 0.0 117.474 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -67.57 -52.27 40.7 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 120.751 1.614 . . . . 0.0 111.632 177.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -58.23 -48.17 81.21 Favored 'General case' 0 CA--C 1.569 1.7 0 CA-C-N 120.589 1.54 . . . . 0.0 112.577 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 2.0 ptp -64.19 -39.79 94.73 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-O 116.984 -1.484 . . . . 0.0 113.523 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -68.8 -33.95 74.72 Favored 'General case' 0 CA--C 1.585 2.305 0 CA-C-N 121.053 1.751 . . . . 0.0 109.312 172.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.02 -46.39 71.8 Favored 'General case' 0 CA--C 1.576 1.975 0 CA-C-N 120.15 1.341 . . . . 0.0 111.368 174.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 82.6 mt -80.52 -62.46 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.58 2.125 0 C-N-CA 123.472 0.709 . . . . 0.0 111.725 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.9 ' HE2' HD12 ' A' ' 90' ' ' ILE . 22.9 mttm -79.75 5.85 12.4 Favored 'General case' 0 CA--C 1.583 2.242 0 N-CA-C 118.952 2.945 . . . . 0.0 118.952 -177.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -19.09 -18.96 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.191 1 N-CA-C 127.205 6.002 . . . . 0.0 127.205 -174.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.525 3.28 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 177.867 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.465 ' HA ' HD11 ' A' ' 90' ' ' ILE . 12.5 tt0 . . . . . 0 N--CA 1.514 2.756 0 N-CA-C 118.049 2.611 . . . . 0.0 118.049 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -58.77 -45.29 90.1 Favored 'General case' 0 CA--C 1.575 1.924 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.444 174.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -61.9 -32.97 73.41 Favored 'General case' 0 CA--C 1.569 1.7 0 CA-C-N 119.435 1.016 . . . . 0.0 113.011 175.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.465 HD11 ' HA ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -67.97 -58.7 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-N 119.855 1.207 . . . . 0.0 109.129 177.597 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.5 pp -59.39 -49.02 79.4 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 117.904 -1.046 . . . . 0.0 112.087 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -64.83 -45.07 87.73 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-N 120.327 1.421 . . . . 0.0 112.902 178.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.36 -54.85 16.92 Favored 'General case' 0 C--N 1.365 1.265 0 CA-C-O 115.355 -2.26 . . . . 0.0 112.172 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.422 ' CE2' HD11 ' A' ' 105' ' ' ILE . 6.9 t80 -60.74 -47.2 87.36 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 121.707 2.049 . . . . 0.0 112.719 177.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.25 91.3 mttt -62.13 -31.38 71.85 Favored 'General case' 0 CA--C 1.58 2.132 0 CA-C-O 117.276 -1.345 . . . . 0.0 111.909 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.4 t -70.01 -48.15 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 CA-C-N 121.166 1.803 . . . . 0.0 108.956 170.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -53.52 -36.69 62.03 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 -178.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -65.29 93.47 0.14 Allowed 'General case' 0 CA--C 1.57 1.712 0 C-N-CA 126.161 1.784 . . . . 0.0 110.802 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.01 -42.71 80.28 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -65.19 -28.05 69.12 Favored 'General case' 0 CA--C 1.581 2.149 0 CA-C-O 117.344 -1.312 . . . . 0.0 113.839 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.02 3.82 90.62 Favored Glycine 0 CA--C 1.554 2.509 0 CA-C-N 121.903 2.138 . . . . 0.0 118.276 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 27.1 p-10 -97.7 -5.26 35.57 Favored 'General case' 0 CA--C 1.581 2.151 0 CA-C-N 120.788 2.294 . . . . 0.0 114.084 174.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.13 8.46 21.78 Favored Glycine 0 CA--C 1.551 2.295 0 CA-C-O 115.756 -2.691 . . . . 0.0 115.999 -177.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -126.14 153.21 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-N 121.865 2.833 . . . . 0.0 114.153 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.422 HD11 ' CE2' ' A' ' 94' ' ' PHE . 74.0 mt -116.24 132.2 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 112.11 -2.314 . . . . 0.0 108.876 177.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -108.83 -169.61 1.52 Allowed 'General case' 0 CA--C 1.581 2.159 0 C-N-CA 122.977 0.511 . . . . 0.0 110.374 174.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -80.31 -47.16 14.94 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.065 -1.647 . . . . 0.0 114.353 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -57.01 -44.95 83.3 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 123.042 0.537 . . . . 0.0 112.259 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -61.51 -42.25 98.53 Favored 'General case' 0 CA--C 1.583 2.228 0 CA-C-N 119.094 0.861 . . . . 0.0 112.613 174.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -54.83 -49.15 71.76 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 125.124 1.37 . . . . 0.0 109.809 174.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.0 mmmt -59.09 -60.94 3.05 Favored 'General case' 0 CA--C 1.57 1.718 0 CA-C-O 118.256 -0.878 . . . . 0.0 109.382 174.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -41.89 -41.22 2.36 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 116.845 2.165 . . . . 0.0 116.845 177.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 10.7 mt -93.61 -45.63 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 N-CA-C 119.287 3.069 . . . . 0.0 119.287 -177.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 3.5 tpt -33.71 -52.73 0.42 Allowed 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 119.63 3.196 . . . . 0.0 119.63 -175.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -71.9 -49.0 41.6 Favored 'General case' 0 N--CA 1.508 2.464 0 N-CA-C 117.401 2.371 . . . . 0.0 117.401 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 9.2 mptt 74.02 -63.43 0.43 Allowed 'General case' 0 N--CA 1.523 3.212 0 C-N-CA 125.547 1.539 . . . . 0.0 112.928 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.6 t -81.23 112.39 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 CA-C-N 119.653 1.115 . . . . 0.0 110.854 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.48 -123.55 11.89 Favored Glycine 0 CA--C 1.543 1.829 0 N-CA-C 116.911 1.524 . . . . 0.0 116.911 178.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -58.36 155.47 11.76 Favored 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.51 179.34 1.56 Allowed Pre-proline 0 CA--C 1.579 2.089 0 CA-C-O 116.515 -1.707 . . . . 0.0 113.731 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.426 ' HB2' HG23 ' A' ' 127' ' ' VAL . 33.7 Cg_exo -77.57 74.91 4.95 Favored 'Trans proline' 0 C--N 1.381 2.264 0 CA-C-N 124.845 2.766 . . . . 0.0 111.255 177.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.474 1.1 tt -64.34 13.81 0.03 OUTLIER 'General case' 0 CA--C 1.583 2.242 1 CA-C-N 106.957 -4.656 . . . . 0.0 117.659 -177.83 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.499 ' C ' ' H ' ' A' ' 125' ' ' ALA 0.28 0.2 OUTLIER -130.6 13.85 5.43 Favored 'General case' 0 C--N 1.356 0.865 0 N-CA-C 118.621 2.822 . . . . 0.0 118.621 -179.682 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -0.53 -7.07 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.974 2 N-CA-C 125.343 5.312 . . . . 0.0 125.343 -164.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.499 ' H ' ' C ' ' A' ' 123' ' ' THR . . . -76.33 -48.67 19.18 Favored 'General case' 0 CA--C 1.564 1.509 0 C-N-CA 126.359 1.864 . . . . 0.0 108.3 173.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.1 -41.65 75.54 Favored 'General case' 0 CA--C 1.579 2.068 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 174.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.426 HG23 ' HB2' ' A' ' 121' ' ' PRO . 1.7 t -68.22 -49.33 68.14 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 C-N-CA 126.108 1.763 . . . . 0.0 109.692 178.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -58.37 -43.41 88.45 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 119.952 1.251 . . . . 0.0 111.754 175.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.01 -54.05 49.66 Favored 'General case' 0 CA--C 1.576 1.954 0 CA-C-N 120.573 1.533 . . . . 0.0 111.644 176.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.68 -43.79 93.88 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.58 -40.89 69.61 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 116.806 -1.568 . . . . 0.0 110.616 177.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -37.95 82.49 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 121.621 2.009 . . . . 0.0 110.319 173.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -69.95 -34.54 73.57 Favored 'General case' 0 CA--C 1.571 1.75 0 CA-C-N 120.744 1.611 . . . . 0.0 112.316 175.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -78.94 -25.94 43.59 Favored 'General case' 0 CA--C 1.578 2.021 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -87.71 98.45 11.45 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 102.869 -3.011 . . . . 0.0 102.869 171.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -83.0 -13.71 55.41 Favored 'General case' 0 CA--C 1.579 2.07 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -91.18 -14.53 30.91 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 118.763 2.875 . . . . 0.0 118.763 -175.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.15 6.2 89.02 Favored Glycine 0 CA--C 1.565 3.186 0 CA-C-O 118.454 -1.192 . . . . 0.0 115.115 -174.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.93 -50.11 15.89 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 119.454 1.627 . . . . 0.0 110.984 176.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 111.66 -15.54 26.7 Favored Glycine 0 CA--C 1.546 1.978 0 CA-C-O 115.78 -2.678 . . . . 0.0 116.773 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . 0.302 3.8 m -133.34 120.63 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 100.823 -3.769 . . . . 0.0 100.823 175.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.3 mt -77.87 125.88 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 111.489 -2.596 . . . . 0.0 115.755 -172.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 36.5 p30 -91.68 152.9 20.01 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 172.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -51.34 -42.43 81.65 Favored Pre-proline 0 CA--C 1.583 2.239 0 CA-C-O 114.802 -2.523 . . . . 0.0 113.706 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.66 -29.5 80.02 Favored 'Trans proline' 0 C--N 1.376 1.998 0 CA-C-N 125.454 2.983 . . . . 0.0 116.991 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -66.97 -54.84 17.93 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 122.83 2.559 . . . . 0.0 111.446 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -61.89 -45.88 91.81 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-N 120.202 1.365 . . . . 0.0 110.515 175.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.411 ' HG2' HG23 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -55.26 -47.22 75.78 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-O 116.359 -1.781 . . . . 0.0 111.089 176.715 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.65 -36.86 76.45 Favored 'General case' 0 CA--C 1.574 1.876 0 CA-C-N 122.288 2.313 . . . . 0.0 113.437 177.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.48 -41.89 81.57 Favored 'General case' 0 CA--C 1.57 1.738 0 C-N-CA 124.84 1.256 . . . . 0.0 110.503 174.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.429 HG23 HD12 ' A' ' 90' ' ' ILE . 5.4 mm -80.0 -43.52 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.8 0 CA-C-O 116.263 -1.827 . . . . 0.0 109.363 176.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -48.81 -49.69 37.83 Favored 'General case' 0 N--CA 1.511 2.592 0 CA-C-N 122.426 2.375 . . . . 0.0 112.589 176.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -66.4 -39.06 88.79 Favored 'General case' 0 CA--C 1.566 1.578 0 CA-C-O 117.833 -1.079 . . . . 0.0 113.157 176.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.527 3.4 0 CA-C-N 119.525 1.057 . . . . 0.0 110.345 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 . . . . . 0 N--CA 1.493 1.708 0 N-CA-C 119.354 3.094 . . . . 0.0 119.354 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -52.91 -46.24 67.94 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 116.752 2.13 . . . . 0.0 116.752 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.435 ' CD ' HH21 ' A' ' 92' ' ' ARG . 6.2 tp10 -68.46 -38.2 80.89 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.513 HD12 HG23 ' A' ' 151' ' ' ILE . 1.3 mp -72.78 -45.83 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-O 115.625 -2.131 . . . . 0.0 108.71 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.0 pp -59.66 -46.94 87.52 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 123.111 2.687 . . . . 0.0 110.329 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.435 HH21 ' CD ' ' A' ' 89' ' ' GLU . 52.1 ttp180 -57.09 -58.88 6.28 Favored 'General case' 0 CA--C 1.568 1.647 0 C-N-CA 124.286 1.034 . . . . 0.0 112.378 176.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.46 -58.15 9.7 Favored 'General case' 0 C--N 1.353 0.735 0 CA-C-O 115.711 -2.09 . . . . 0.0 113.346 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -55.66 -50.96 68.83 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 121.551 1.978 . . . . 0.0 113.228 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -62.6 -33.19 74.48 Favored 'General case' 0 CA--C 1.562 1.412 0 CA-C-O 116.307 -1.806 . . . . 0.0 112.553 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -72.35 -44.39 63.13 Favored 'Isoleucine or valine' 0 CA--C 1.59 2.496 0 CA-C-N 121.854 2.115 . . . . 0.0 109.626 171.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -51.7 -35.72 43.89 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 127.098 2.159 . . . . 0.0 115.094 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.255 1.3 t0 -67.26 96.52 0.48 Allowed 'General case' 0 CA--C 1.576 1.967 0 C-N-CA 126.202 1.801 . . . . 0.0 107.342 177.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.04 -49.7 71.34 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.273 1.582 . . . . 0.0 115.273 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -62.33 -24.05 67.11 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.35 7.98 87.7 Favored Glycine 0 CA--C 1.551 2.32 0 N-CA-C 120.327 2.891 . . . . 0.0 120.327 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.8 p30 -96.97 -11.33 24.72 Favored 'General case' 0 CA--C 1.575 1.932 0 CA-C-N 119.78 1.79 . . . . 0.0 115.563 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.49 18.4 8.07 Favored Glycine 0 CA--C 1.552 2.396 0 CA-C-O 116.781 -2.122 . . . . 0.0 114.594 -176.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.45 154.98 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.501 0 CA-C-N 120.826 2.313 . . . . 0.0 111.78 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 79.1 mt -126.54 127.06 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-N 112.368 -2.196 . . . . 0.0 108.217 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -106.21 179.03 4.39 Favored 'General case' 0 CA--C 1.578 2.042 0 CA-C-O 121.857 0.837 . . . . 0.0 110.673 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -69.73 -42.32 74.12 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.15 -45.25 93.7 Favored 'General case' 0 N--CA 1.505 2.281 0 CA-C-N 120.566 1.53 . . . . 0.0 113.829 177.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -63.52 -46.3 86.69 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.917 0.887 . . . . 0.0 112.139 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -62.76 -50.96 68.99 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 117.0 -1.476 . . . . 0.0 110.983 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.0 pptp? -58.27 -39.9 80.44 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 121.235 1.834 . . . . 0.0 114.318 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -65.31 -49.32 69.9 Favored 'General case' 0 CA--C 1.575 1.909 0 C-N-CA 123.407 0.683 . . . . 0.0 112.385 175.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -79.56 -32.37 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 118.723 2.86 . . . . 0.0 118.723 -177.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.42 ' HG2' HG21 ' A' ' 127' ' ' VAL . 14.0 tpt -53.09 -53.42 50.65 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.692 1.597 . . . . 0.0 114.548 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.422 ' HB3' ' HB2' ' A' ' 119' ' ' GLU . 24.2 mm-40 -76.53 47.83 0.51 Allowed 'General case' 0 CA--C 1.579 2.066 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . 0.284 0.0 OUTLIER 25.58 -110.36 0.02 OUTLIER 'General case' 0 N--CA 1.519 2.999 0 N-CA-C 118.715 2.857 . . . . 0.0 118.715 173.137 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 42.9 t -77.21 107.54 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 CA-C-N 121.387 1.903 . . . . 0.0 107.639 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.37 -141.22 38.65 Favored Glycine 0 CA--C 1.549 2.19 0 N-CA-C 111.671 -0.572 . . . . 0.0 111.671 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.422 ' HB2' ' HB3' ' A' ' 115' ' ' GLN . 32.2 mt-10 52.34 170.03 0.01 OUTLIER 'General case' 0 CA--C 1.589 2.453 0 N-CA-C 118.958 2.947 . . . . 0.0 118.958 176.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -168.18 133.0 1.47 Allowed Pre-proline 0 N--CA 1.502 2.165 0 CA-C-O 113.396 -3.192 . . . . 0.0 107.318 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.514 ' HG3' HG23 ' A' ' 127' ' ' VAL 0.371 0.1 OUTLIER 9.94 58.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.388 2.632 0 N-CA-C 121.683 3.686 . . . . 0.0 121.683 -176.26 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.469 0.3 OUTLIER -74.31 -72.05 0.3 Allowed 'General case' 0 CA--C 1.566 1.589 0 CA-C-N 109.836 -3.347 . . . . 0.0 103.668 -177.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 10.0 p -95.46 112.75 24.41 Favored 'General case' 0 C--N 1.37 1.464 2 CA-C-N 126.44 4.2 . . . . 0.0 99.775 169.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -53.47 -38.36 63.55 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 118.565 2.802 . . . . 0.0 118.565 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.44 -42.16 91.28 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 117.052 -1.452 . . . . 0.0 113.597 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -55.19 -53.43 56.11 Favored 'General case' 0 CA--C 1.573 1.842 0 CA-C-N 120.255 1.388 . . . . 0.0 112.63 176.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.514 HG23 ' HG3' ' A' ' 121' ' ' PRO . 18.2 t -73.74 -53.79 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-O 117.197 -1.382 . . . . 0.0 113.829 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -64.2 -40.72 96.68 Favored 'General case' 0 CA--C 1.564 1.514 0 CA-C-N 120.061 1.3 . . . . 0.0 112.52 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -69.56 -43.87 72.04 Favored 'General case' 0 CA--C 1.574 1.891 0 CA-C-N 120.036 1.289 . . . . 0.0 111.228 176.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.57 -46.51 89.58 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 120.616 1.553 . . . . 0.0 113.247 176.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 19.8 ttt -70.27 -39.12 75.12 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 114.818 -2.515 . . . . 0.0 111.761 177.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -64.52 -35.38 80.78 Favored 'General case' 0 CA--C 1.574 1.872 0 CA-C-N 123.99 3.086 . . . . 0.0 111.595 175.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -62.85 -48.43 79.07 Favored 'General case' 0 CA--C 1.579 2.08 0 CA-C-N 121.654 2.025 . . . . 0.0 109.083 172.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.46 -25.08 63.91 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 177.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -90.06 100.57 13.37 Favored 'General case' 0 CA--C 1.573 1.856 0 N-CA-C 103.071 -2.937 . . . . 0.0 103.071 171.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -72.88 -16.56 61.57 Favored 'General case' 0 CA--C 1.579 2.095 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -98.55 -14.57 19.9 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 119.016 2.969 . . . . 0.0 119.016 -175.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.03 5.9 89.33 Favored Glycine 0 CA--C 1.57 3.482 0 CA-C-N 120.411 1.46 . . . . 0.0 115.138 -173.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -75.82 -47.18 26.7 Favored 'General case' 0 CA--C 1.563 1.466 0 C-N-CA 125.441 1.496 . . . . 0.0 112.195 176.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 111.84 -25.04 13.66 Favored Glycine 0 CA--C 1.553 2.455 0 CA-C-O 117.354 -1.803 . . . . 0.0 114.311 -176.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -100.68 143.16 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 N-CA-C 103.725 -2.694 . . . . 0.0 103.725 174.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.7 mt -121.84 124.87 72.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 111.982 -2.372 . . . . 0.0 112.665 -176.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 39.0 p30 -91.43 155.06 18.72 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 170.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.4 mt -52.13 -42.45 86.08 Favored Pre-proline 0 CA--C 1.583 2.237 0 CA-C-O 114.902 -2.475 . . . . 0.0 113.285 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -58.59 -17.8 36.8 Favored 'Trans proline' 0 C--N 1.376 1.992 0 CA-C-N 125.27 2.918 . . . . 0.0 117.976 176.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -72.53 -63.22 1.2 Allowed 'General case' 0 N--CA 1.505 2.28 0 CA-C-N 123.102 2.683 . . . . 0.0 109.469 176.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.422 ' CD1' HG22 ' A' ' 90' ' ' ILE . 0.7 OUTLIER -54.55 -49.05 71.24 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 125.128 1.371 . . . . 0.0 110.908 173.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.411 ' CE ' ' HB ' ' A' ' 90' ' ' ILE . 1.3 mmt -64.6 -34.93 79.43 Favored 'General case' 0 CA--C 1.565 1.556 0 CA-C-O 115.454 -2.212 . . . . 0.0 111.868 175.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.935 ' OD2' ' HD2' ' A' ' 153' ' ' LYS . 6.7 t70 -66.67 -46.49 75.52 Favored 'General case' 0 N--CA 1.507 2.382 0 CA-C-N 125.537 3.79 . . . . 0.0 109.14 174.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -46.89 -54.63 9.57 Favored 'General case' 0 C--N 1.368 1.386 0 C-N-CA 126.189 1.795 . . . . 0.0 111.215 176.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.513 HG23 HD12 ' A' ' 90' ' ' ILE . 33.8 mt -98.36 -28.52 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-N 121.648 2.022 . . . . 0.0 116.318 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.39 -18.37 23.38 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 118.659 2.837 . . . . 0.0 118.659 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.935 ' HD2' ' OD2' ' A' ' 149' ' ' ASP . 74.6 tttt -74.48 -9.71 58.85 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 121.64 3.941 . . . . 0.0 121.64 -176.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 84.7 p . . . . . 0 N--CA 1.532 3.633 0 N-CA-C 120.93 3.678 . . . . 0.0 120.93 -179.966 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.424 ' C ' ' H ' ' A' ' 89' ' ' GLU . 54.1 mt-10 . . . . . 0 CA--C 1.617 3.527 0 N-CA-C 104.143 -2.54 . . . . 0.0 104.143 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -10.62 -28.96 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.657 2 C-N-CA 133.845 4.858 . . . . 0.0 122.105 -170.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.424 ' H ' ' C ' ' A' ' 87' ' ' GLU . 0.5 OUTLIER -72.26 -66.85 0.6 Allowed 'General case' 0 N--CA 1.51 2.532 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 170.658 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.0 mp -58.14 -44.77 88.25 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.753 0 CA-C-N 112.036 -2.347 . . . . 0.0 108.963 172.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -39.03 86.04 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 116.322 -1.799 . . . . 0.0 111.685 176.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.22 -53.26 60.09 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 122.863 2.574 . . . . 0.0 107.888 176.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.71 -66.14 0.6 Allowed 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -66.62 -51.91 51.11 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.502 ' HD3' HD12 ' A' ' 144' ' ' ILE 0.382 7.7 mttt -67.81 -17.54 64.55 Favored 'General case' 0 CA--C 1.589 2.446 0 CA-C-O 114.821 -2.514 . . . . 0.0 110.234 -177.603 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.19 -46.5 44.56 Favored 'Isoleucine or valine' 0 C--N 1.395 2.547 0 CA-C-N 124.582 3.355 . . . . 0.0 106.186 167.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -53.61 -35.88 61.39 Favored 'General case' 0 CA--C 1.582 2.185 0 N-CA-C 117.23 2.308 . . . . 0.0 117.23 178.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -56.51 110.06 0.72 Allowed 'General case' 0 CA--C 1.575 1.905 0 C-N-CA 126.14 1.776 . . . . 0.0 115.469 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.682 ' HB1' ' HG2' ' A' ' 109' ' ' GLU . . . -73.76 -51.77 15.39 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -67.21 -24.53 65.85 Favored 'General case' 0 CA--C 1.578 2.052 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.8 1.71 90.31 Favored Glycine 0 CA--C 1.562 2.992 0 CA-C-N 121.773 2.079 . . . . 0.0 116.987 -175.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -107.19 0.64 23.47 Favored 'General case' 0 CA--C 1.587 2.382 0 CA-C-N 120.027 1.914 . . . . 0.0 112.419 172.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 114.06 -20.09 17.22 Favored Glycine 0 CA--C 1.547 2.083 0 CA-C-O 115.459 -2.856 . . . . 0.0 115.262 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.6 m -83.74 138.15 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.612 0 CA-C-N 123.797 3.799 . . . . 0.0 114.306 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 88.2 mt -116.25 123.36 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 101.713 -3.44 . . . . 0.0 101.713 174.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -91.88 162.64 14.34 Favored 'General case' 0 CA--C 1.56 1.329 0 CA-C-O 122.433 1.111 . . . . 0.0 111.577 176.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.77 -47.23 78.91 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.762 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -61.37 -44.2 97.56 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 117.906 -1.045 . . . . 0.0 111.546 176.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.682 ' HG2' ' HB1' ' A' ' 99' ' ' ALA . 34.4 tp10 -63.67 -37.76 88.55 Favored 'General case' 0 CA--C 1.569 1.701 0 CA-C-N 121.097 1.771 . . . . 0.0 112.521 174.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -62.76 -52.3 63.74 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 120.113 1.324 . . . . 0.0 108.143 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.517 ' HA ' HG12 ' A' ' 127' ' ' VAL . 10.5 ptpp? -56.58 -38.54 72.13 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 116.139 -1.886 . . . . 0.0 111.606 175.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -61.76 -54.52 41.25 Favored 'General case' 0 CA--C 1.579 2.072 0 CA-C-N 121.267 1.849 . . . . 0.0 112.788 174.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 tt -73.2 -11.93 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 119.091 2.997 . . . . 0.0 119.091 -177.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 9.2 tpt -42.27 -58.29 2.22 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -126.04 98.89 5.68 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 124.576 1.173 . . . . 0.0 114.144 -177.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -108.69 58.47 0.61 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 92.7 t -142.28 82.98 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 1 N-CA-C 98.539 -4.615 . . . . 0.0 98.539 175.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.14 109.76 0.19 Allowed Glycine 0 CA--C 1.55 2.23 0 N-CA-C 106.117 -2.793 . . . . 0.0 106.117 -173.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -51.56 109.62 0.37 Allowed 'General case' 0 N--CA 1.505 2.316 0 CA-C-N 119.873 1.836 . . . . 0.0 114.305 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -134.69 -29.3 0.02 OUTLIER Pre-proline 0 CA--C 1.574 1.875 2 N-CA-C 122.958 4.429 . . . . 0.0 122.958 -175.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . 0.297 0.1 OUTLIER 7.15 68.42 0.0 OUTLIER 'Trans proline' 0 N--CA 1.522 3.153 1 CA-C-N 128.774 4.169 . . . . 0.0 119.793 -175.617 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.332 1.4 tm? -78.87 -85.0 0.08 Allowed 'General case' 0 CA--C 1.562 1.421 0 CA-C-N 110.708 -2.951 . . . . 0.0 117.729 -171.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 30.6 p -82.98 127.88 33.96 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 125.502 3.774 . . . . 0.0 109.454 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -66.12 -40.88 91.03 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 177.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.52 -43.59 72.04 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -46.5 82.67 Favored 'General case' 0 CA--C 1.584 2.253 0 CA-C-N 120.187 1.358 . . . . 0.0 113.847 177.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 111' ' ' LYS . 15.7 t -66.08 -48.97 79.77 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.496 0 C-N-CA 125.126 1.37 . . . . 0.0 110.884 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -57.3 -49.95 74.47 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 117.093 -1.432 . . . . 0.0 110.061 176.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -55.16 -51.33 66.82 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 120.737 1.608 . . . . 0.0 112.568 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.91 -48.0 83.48 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 116.123 1.897 . . . . 0.0 116.123 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -44.32 50.31 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 115.8 -2.048 . . . . 0.0 111.277 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.33 -37.18 69.62 Favored 'General case' 0 CA--C 1.575 1.92 0 CA-C-N 122.466 2.394 . . . . 0.0 110.954 174.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -70.91 -39.46 72.72 Favored 'General case' 0 CA--C 1.578 2.024 0 CA-C-N 121.04 1.746 . . . . 0.0 111.94 175.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.08 -25.0 63.32 Favored 'General case' 0 CA--C 1.579 2.068 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 174.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -79.7 110.98 15.55 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 116.579 -3.826 . . . . 0.0 108.068 175.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -75.46 -22.75 57.01 Favored 'General case' 0 CA--C 1.57 1.723 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -107.11 -9.59 16.12 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 118.742 2.867 . . . . 0.0 118.742 -174.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.12 3.76 90.62 Favored Glycine 0 CA--C 1.569 3.408 0 CA-C-O 117.811 -1.55 . . . . 0.0 112.832 -172.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -92.75 42.84 1.11 Allowed 'General case' 0 C--N 1.367 1.335 1 CA-C-O 107.484 -6.008 . . . . 0.0 110.391 175.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 57.92 -23.21 0.02 OUTLIER Glycine 0 N--CA 1.503 3.107 3 O-C-N 105.214 -10.929 . . . . 0.0 129.104 162.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.4 m -134.04 140.97 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-N 121.196 2.498 . . . . 0.0 107.029 178.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.1 mt -104.23 131.02 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 113.861 -1.518 . . . . 0.0 112.899 -175.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -97.45 153.34 18.18 Favored 'General case' 0 CA--C 1.559 1.311 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 170.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.502 HD12 ' HD3' ' A' ' 95' ' ' LYS . 2.4 mt -52.68 -43.3 92.54 Favored Pre-proline 0 CA--C 1.583 2.247 0 CA-C-O 114.768 -2.539 . . . . 0.0 113.181 -178.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -51.37 -35.21 53.42 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.877 3.052 . . . . 0.0 115.802 176.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -59.93 -53.97 51.61 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 120.101 1.319 . . . . 0.0 110.81 174.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -56.21 -46.32 79.51 Favored 'General case' 0 CA--C 1.57 1.743 0 C-N-CA 125.041 1.336 . . . . 0.0 111.895 175.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.17 -45.13 83.93 Favored 'General case' 0 CA--C 1.591 2.548 0 C-N-CA 123.349 0.66 . . . . 0.0 110.708 176.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.1 -40.25 94.32 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 119.715 1.143 . . . . 0.0 112.111 176.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.55 -47.11 80.16 Favored 'General case' 0 CA--C 1.569 1.699 0 C-N-CA 124.538 1.135 . . . . 0.0 108.458 173.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 88.4 mt -61.78 -40.13 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 CA-C-N 120.389 1.45 . . . . 0.0 110.807 175.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -59.1 -49.71 76.85 Favored 'General case' 0 CA--C 1.586 2.342 0 CA-C-N 120.642 1.564 . . . . 0.0 112.499 175.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.777 ' HG3' ' H ' ' A' ' 154' ' ' SER . 59.4 pttt -94.53 -72.6 0.61 Allowed 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.777 ' H ' ' HG3' ' A' ' 153' ' ' LYS . 26.2 p . . . . . 0 N--CA 1.502 2.133 0 C-N-CA 124.662 1.185 . . . . 0.0 108.6 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.563 ' HA ' HD13 ' A' ' 90' ' ' ILE 0.262 55.8 tt0 . . . . . 0 N--CA 1.495 1.777 0 N-CA-C 117.366 2.358 . . . . 0.0 117.366 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -63.54 -40.34 96.76 Favored 'General case' 0 CA--C 1.586 2.346 0 CA-C-N 120.255 1.389 . . . . 0.0 109.529 173.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -60.39 -29.09 68.73 Favored 'General case' 0 CA--C 1.581 2.164 0 CA-C-O 117.511 -1.233 . . . . 0.0 110.568 172.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.637 HG23 ' HE2' ' A' ' 148' ' ' MET . 37.9 mt -71.01 -63.22 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.369 1.446 0 CA-C-O 115.686 -2.102 . . . . 0.0 107.05 174.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 pp -49.85 -47.77 51.51 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-N 122.472 2.396 . . . . 0.0 111.967 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.8 mtm105 -62.82 -55.19 28.54 Favored 'General case' 0 CA--C 1.571 1.787 0 CA-C-O 118.532 -0.746 . . . . 0.0 112.163 176.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.61 -59.47 3.92 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 114.59 -2.624 . . . . 0.0 113.685 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -54.89 -48.6 72.79 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 122.627 2.467 . . . . 0.0 112.437 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.252 93.0 mttt -64.83 -30.91 71.93 Favored 'General case' 0 CA--C 1.581 2.165 0 CA-C-N 119.796 1.18 . . . . 0.0 111.361 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.7 t -65.86 -48.96 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.507 0 CA-C-N 121.54 1.973 . . . . 0.0 108.534 169.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.1 -30.94 60.76 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 117.446 2.387 . . . . 0.0 117.446 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.318 0.0 OUTLIER -52.47 -14.28 0.47 Allowed 'General case' 0 CA--C 1.578 2.05 0 N-CA-C 119.895 3.295 . . . . 0.0 119.895 -177.404 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.666 ' HB1' ' HG2' ' A' ' 109' ' ' GLU . . . 75.35 -70.69 0.14 Allowed 'General case' 0 N--CA 1.502 2.167 0 CA-C-N 122.654 2.479 . . . . 0.0 116.33 176.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -76.35 -17.95 59.14 Favored 'General case' 0 CA--C 1.571 1.758 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 -177.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.02 3.92 90.21 Favored Glycine 0 CA--C 1.568 3.39 0 CA-C-O 117.437 -1.757 . . . . 0.0 114.333 -172.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 46.9 p-10 -98.47 -17.05 18.96 Favored 'General case' 0 CA--C 1.579 2.061 0 CA-C-N 120.881 2.341 . . . . 0.0 113.647 174.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.52 22.65 6.0 Favored Glycine 0 CA--C 1.546 2.002 0 CA-C-O 115.474 -2.848 . . . . 0.0 116.48 -178.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.422 HG11 ' O ' ' A' ' 142' ' ' ILE . 2.6 t -134.39 121.96 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 CA-C-N 122.669 3.235 . . . . 0.0 112.555 -178.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.474 ' O ' HG11 ' A' ' 141' ' ' VAL . 62.3 mt -93.54 135.25 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 C-N-CA 126.432 1.893 . . . . 0.0 112.789 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -105.11 173.76 6.17 Favored 'General case' 0 CA--C 1.574 1.875 0 C-N-CA 124.193 0.997 . . . . 0.0 111.863 175.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -70.45 -50.15 41.24 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -62.94 -45.91 90.25 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 118.282 -0.866 . . . . 0.0 112.341 178.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.666 ' HG2' ' HB1' ' A' ' 99' ' ' ALA . 37.6 tp10 -61.21 -39.55 90.66 Favored 'General case' 0 CA--C 1.569 1.709 0 CA-C-N 120.49 1.495 . . . . 0.0 112.05 175.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -58.83 -53.66 55.93 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 120.127 1.331 . . . . 0.0 110.042 175.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -51.0 -42.68 60.51 Favored 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -73.2 -55.34 6.59 Favored 'General case' 0 CA--C 1.577 1.986 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 176.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.6 tt -67.98 -34.77 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 118.726 2.862 . . . . 0.0 118.726 -176.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.502 ' HE1' HE21 ' A' ' 115' ' ' GLN . 40.2 ttp -27.39 -43.23 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 117.936 2.569 . . . . 0.0 117.936 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.502 HE21 ' HE1' ' A' ' 114' ' ' MET . 42.9 mt-30 -94.8 72.76 3.56 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-N 113.825 -1.534 . . . . 0.0 113.097 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.642 ' H ' ' HD3' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -128.87 -58.03 1.16 Allowed 'General case' 0 CA--C 1.575 1.935 0 CA-C-N 112.928 -1.942 . . . . 0.0 115.57 -179.009 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.8 p -176.81 128.32 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.572 1.812 0 CA-C-N 120.702 1.592 . . . . 0.0 107.916 -177.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 94.24 -117.05 5.42 Favored Glycine 0 CA--C 1.542 1.721 0 N-CA-C 116.341 1.296 . . . . 0.0 116.341 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.32 103.93 4.9 Favored 'General case' 0 CA--C 1.57 1.746 0 CA-C-O 122.69 1.233 . . . . 0.0 112.172 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.5 84.09 6.0 Favored Pre-proline 0 CA--C 1.58 2.127 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 -177.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -83.82 63.8 7.22 Favored 'Trans proline' 0 CA--C 1.574 2.495 0 C-N-CA 123.491 2.794 . . . . 0.0 109.456 175.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.293 7.2 tt -51.91 -43.47 63.41 Favored 'General case' 0 CA--C 1.563 1.468 0 N-CA-C 120.868 3.655 . . . . 0.0 120.868 -175.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 67.6 p -69.37 150.59 47.14 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 124.577 3.353 . . . . 0.0 111.61 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -42.0 -49.12 4.68 Favored 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 177.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.81 -48.51 76.54 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 112.292 -2.231 . . . . 0.0 111.429 176.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -61.52 -29.02 69.73 Favored 'General case' 0 CA--C 1.576 1.959 0 CA-C-N 120.438 1.472 . . . . 0.0 112.737 174.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.5 t -70.36 -57.66 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 CA-C-N 121.374 1.897 . . . . 0.0 109.043 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -64.22 -38.98 93.0 Favored 'General case' 0 N--CA 1.508 2.442 0 CA-C-N 120.24 1.382 . . . . 0.0 113.263 178.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -65.08 -44.59 88.41 Favored 'General case' 0 CA--C 1.567 1.614 0 CA-C-O 117.839 -1.076 . . . . 0.0 112.02 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -64.31 -45.33 88.38 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 120.012 1.278 . . . . 0.0 112.234 176.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 19.6 ttt -70.24 -41.83 73.03 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 114.238 -2.791 . . . . 0.0 111.055 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -64.51 -33.24 75.45 Favored 'General case' 0 CA--C 1.576 1.978 0 CA-C-N 125.087 3.585 . . . . 0.0 111.293 175.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -62.49 -44.02 97.4 Favored 'General case' 0 CA--C 1.585 2.31 0 CA-C-N 122.023 2.192 . . . . 0.0 110.376 171.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.44 -29.36 56.96 Favored 'General case' 0 CA--C 1.576 1.961 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 178.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -90.77 100.16 13.06 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 103.12 -2.919 . . . . 0.0 103.12 172.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -56.48 -29.62 61.98 Favored 'General case' 0 CA--C 1.593 2.61 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.407 54.2 t0 160.88 -22.96 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.676 1 CA-C-O 108.925 -5.321 . . . . 0.0 103.811 175.808 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 11.04 5.88 0.0 OUTLIER Glycine 0 CA--C 1.564 3.136 3 O-C-N 99.065 -14.772 . . . . 0.0 125.131 160.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.423 ' OD1' HG21 ' A' ' 141' ' ' VAL . 2.3 p-10 79.03 15.14 1.06 Allowed 'General case' 0 CA--C 1.595 2.674 0 CA-C-N 121.3 2.55 . . . . 0.0 111.626 -172.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 97.38 -22.88 38.4 Favored Glycine 0 CA--C 1.563 3.042 0 CA-C-N 122.974 2.624 . . . . 0.0 115.636 -176.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.474 HG11 ' O ' ' A' ' 105' ' ' ILE . 0.1 OUTLIER -105.46 146.52 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.378 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 178.396 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.422 ' O ' HG11 ' A' ' 104' ' ' VAL . 0.9 OUTLIER -115.22 129.72 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 113.815 -1.539 . . . . 0.0 114.513 -176.492 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 47.9 p30 -92.18 164.86 13.41 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 171.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 7.6 mt -55.96 -42.95 98.75 Favored Pre-proline 0 CA--C 1.585 2.327 0 CA-C-O 115.028 -2.415 . . . . 0.0 112.584 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -59.16 -22.53 64.96 Favored 'Trans proline' 0 C--N 1.376 2.007 0 CA-C-N 125.338 2.942 . . . . 0.0 119.74 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -69.92 0.3 Allowed 'General case' 0 CA--C 1.562 1.407 0 CA-C-N 122.996 2.635 . . . . 0.0 110.357 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.524 ' CE2' HG22 ' A' ' 90' ' ' ILE . 77.8 t80 -49.54 -43.39 45.73 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 124.716 1.206 . . . . 0.0 113.468 174.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.637 ' HE2' HG23 ' A' ' 90' ' ' ILE . 5.8 mtp -67.37 -40.35 85.76 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-O 114.898 -2.477 . . . . 0.0 112.004 177.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.807 ' OD1' ' HE3' ' A' ' 153' ' ' LYS . 1.9 t0 -63.83 -43.67 95.52 Favored 'General case' 0 N--CA 1.505 2.281 0 CA-C-N 124.458 3.299 . . . . 0.0 109.626 173.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.95 -47.89 21.64 Favored 'General case' 0 CA--C 1.575 1.916 0 C-N-CA 127.173 2.189 . . . . 0.0 112.07 174.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.426 ' HB ' HD12 ' A' ' 90' ' ' ILE . 68.0 mt -89.06 -34.47 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.891 0 CA-C-O 117.286 -1.34 . . . . 0.0 111.513 177.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 41.2 mmtt -53.49 -42.06 66.89 Favored 'General case' 0 N--CA 1.503 2.217 0 CA-C-N 122.126 2.239 . . . . 0.0 112.739 176.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.807 ' HE3' ' OD1' ' A' ' 149' ' ' ASP . 96.1 mttt -63.49 -53.6 49.54 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 119.016 0.825 . . . . 0.0 112.137 176.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 177.691 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 . . . . . 0 CA--C 1.586 2.347 0 CA-C-O 118.012 -0.994 . . . . 0.0 113.101 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -43.87 -55.35 4.6 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 118.213 2.672 . . . . 0.0 118.213 -177.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -58.88 -54.2 49.76 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.585 HG23 ' HG2' ' A' ' 148' ' ' MET . 1.6 mp -66.38 -45.71 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 116.748 -1.596 . . . . 0.0 109.995 177.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.46 -46.13 84.0 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 121.617 2.008 . . . . 0.0 110.541 177.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.91 -55.96 28.42 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 117.326 -1.321 . . . . 0.0 110.574 176.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.83 -57.62 6.66 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.406 ' CE2' HD11 ' A' ' 105' ' ' ILE . 15.8 t80 -64.97 -50.53 66.02 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 120.899 1.681 . . . . 0.0 113.401 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.335 65.8 mttt -68.07 -22.4 64.94 Favored 'General case' 0 CA--C 1.59 2.515 0 CA-C-O 116.495 -1.717 . . . . 0.0 110.455 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.9 t -71.25 -48.87 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.421 0 CA-C-N 122.818 2.554 . . . . 0.0 107.213 168.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -49.02 -34.75 13.91 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.11 102.15 0.35 Allowed 'General case' 0 CA--C 1.576 1.976 0 C-N-CA 126.038 1.735 . . . . 0.0 109.191 176.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.28 -43.03 71.27 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.9 p30 -69.91 -8.03 45.33 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 117.236 2.31 . . . . 0.0 117.236 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.79 29.4 71.09 Favored Glycine 0 CA--C 1.558 2.75 0 CA-C-N 120.823 1.647 . . . . 0.0 116.418 -177.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.19 76.04 1.53 Allowed 'General case' 0 N--CA 1.477 0.882 1 CA-C-O 109.068 -5.253 . . . . 0.0 106.606 178.631 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 52.88 -30.24 0.01 OUTLIER Glycine 0 N--CA 1.491 2.305 2 N-CA-C 127.952 5.941 . . . . 0.0 127.952 165.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.6 p -107.15 155.05 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.455 0 CA-C-O 122.692 1.234 . . . . 0.0 114.112 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.406 HD11 ' CE2' ' A' ' 94' ' ' PHE . 87.8 mt -115.6 134.7 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-N 113.09 -1.868 . . . . 0.0 108.855 177.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.403 ' H ' ' CG ' ' A' ' 109' ' ' GLU . 0.9 OUTLIER -108.94 -179.29 3.82 Favored 'General case' 0 CA--C 1.576 1.972 0 CA-C-N 119.86 1.209 . . . . 0.0 112.965 175.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -74.78 -51.57 13.77 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.445 -1.409 . . . . 0.0 113.601 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.39 -33.63 75.97 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 178.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.403 ' CG ' ' H ' ' A' ' 106' ' ' ASP . 0.0 OUTLIER -68.18 -40.92 82.12 Favored 'General case' 0 CA--C 1.581 2.147 0 CA-C-N 120.44 1.473 . . . . 0.0 110.765 174.686 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.448 ' HD1' HG21 ' A' ' 127' ' ' VAL . 0.7 OUTLIER -58.74 -46.66 86.9 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 117.521 -1.228 . . . . 0.0 108.892 172.26 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.57 ' HA ' HG22 ' A' ' 127' ' ' VAL . 2.9 tppt? -52.05 -61.82 2.02 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 125.012 1.325 . . . . 0.0 109.12 174.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -48.81 -48.51 41.42 Favored 'General case' 0 CA--C 1.575 1.929 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 176.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -82.14 -13.68 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 118.059 2.614 . . . . 0.0 118.059 -178.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.425 ' SD ' HG21 ' A' ' 127' ' ' VAL . 9.4 tpt -52.1 -49.59 63.3 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 119.246 3.054 . . . . 0.0 119.246 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -64.24 14.41 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 121.355 3.835 . . . . 0.0 121.355 -174.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.5 mptt 60.35 -90.14 0.03 OUTLIER 'General case' 0 N--CA 1.524 3.248 0 C-N-CA 124.465 1.106 . . . . 0.0 112.658 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.7 p -94.63 109.08 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.463 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 85.12 -178.28 50.83 Favored Glycine 0 CA--C 1.549 2.157 0 N-CA-C 115.596 0.998 . . . . 0.0 115.596 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -90.15 -140.09 0.15 Allowed 'General case' 0 CA--C 1.582 2.204 0 CA-C-N 114.32 -0.94 . . . . 0.0 112.457 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.265 8.1 pt-20 57.57 67.7 2.28 Favored Pre-proline 0 N--CA 1.5 2.069 0 N-CA-C 121.014 3.709 . . . . 0.0 121.014 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo -65.73 79.86 0.26 Allowed 'Trans proline' 0 C--N 1.377 2.026 0 C-N-CA 124.678 3.585 . . . . 0.0 114.706 174.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.411 7.7 tt -74.73 -59.19 2.85 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 109.213 -3.631 . . . . 0.0 110.892 -177.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.2 p -94.43 123.68 38.0 Favored 'General case' 0 C--N 1.37 1.479 0 CA-C-N 125.604 3.82 . . . . 0.0 107.558 176.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.38 -20.54 58.91 Favored 'General case' 0 CA--C 1.577 1.982 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.741 174.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -58.04 -40.1 80.04 Favored 'General case' 0 CA--C 1.561 1.381 0 CA-C-O 117.023 -1.465 . . . . 0.0 111.424 174.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -54.56 -53.9 48.33 Favored 'General case' 0 CA--C 1.585 2.323 0 CA-C-N 120.419 1.463 . . . . 0.0 111.477 175.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.57 HG22 ' HA ' ' A' ' 111' ' ' LYS 0.251 4.2 p -73.43 -41.33 56.78 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -178.201 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -68.86 -45.78 70.17 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 120.675 1.58 . . . . 0.0 110.205 176.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -62.74 -48.85 77.42 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-N 121.341 1.882 . . . . 0.0 112.019 176.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -64.2 -45.85 86.49 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-N 120.378 1.445 . . . . 0.0 114.692 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -73.98 -34.34 64.18 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 115.934 -1.984 . . . . 0.0 112.767 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.12 -32.61 67.12 Favored 'General case' 0 CA--C 1.566 1.59 0 CA-C-N 122.64 2.473 . . . . 0.0 110.755 173.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.96 -35.51 80.12 Favored 'General case' 0 CA--C 1.58 2.126 0 CA-C-N 123.388 2.813 . . . . 0.0 110.495 172.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.99 -30.9 27.81 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 176.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -90.81 105.71 18.01 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 122.339 2.336 . . . . 0.0 107.115 174.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -62.65 -32.49 73.55 Favored 'General case' 0 CA--C 1.598 2.825 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 175.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.391 57.1 t0 163.54 -21.9 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.041 1 CA-C-O 108.768 -5.396 . . . . 0.0 103.326 176.673 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 13.03 8.04 0.0 OUTLIER Glycine 0 N--CA 1.5 2.928 3 O-C-N 98.666 -15.021 . . . . 0.0 125.028 161.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 77.84 4.58 2.92 Favored 'General case' 0 CA--C 1.581 2.145 0 CA-C-N 121.622 2.711 . . . . 0.0 111.179 -172.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 95.34 -12.09 68.3 Favored Glycine 0 C--N 1.372 2.561 0 CA-C-N 123.746 2.976 . . . . 0.0 114.584 -175.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . 0.298 3.4 m -130.24 121.11 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 102.181 -3.266 . . . . 0.0 102.181 175.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.62 125.62 38.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 111.299 -2.682 . . . . 0.0 114.001 -173.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -92.88 151.99 19.65 Favored 'General case' 0 CA--C 1.558 1.251 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 172.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.4 mt -53.32 -41.7 87.77 Favored Pre-proline 0 CA--C 1.582 2.176 0 CA-C-O 114.615 -2.612 . . . . 0.0 112.628 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -55.63 -26.23 54.45 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 123.93 3.087 . . . . 0.0 116.511 176.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -63.85 -62.41 1.66 Allowed 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 122.051 2.205 . . . . 0.0 108.918 174.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.53 ' CE2' HG22 ' A' ' 90' ' ' ILE . 87.2 t80 -55.22 -47.08 75.85 Favored 'General case' 0 CA--C 1.57 1.739 0 C-N-CA 125.638 1.575 . . . . 0.0 113.842 173.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.585 ' HG2' HG23 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -59.12 -39.03 81.01 Favored 'General case' 0 CA--C 1.588 2.418 0 CA-C-O 117.673 -1.156 . . . . 0.0 109.857 174.749 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -67.15 -47.47 70.94 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 121.214 1.825 . . . . 0.0 110.104 173.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.33 -44.58 11.74 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 127.608 2.363 . . . . 0.0 112.26 176.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 58.5 mt -92.61 -56.23 5.39 Favored 'Isoleucine or valine' 0 C--N 1.366 1.295 0 CA-C-O 116.911 -1.519 . . . . 0.0 113.933 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -90.31 -41.97 11.22 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 118.368 2.729 . . . . 0.0 118.368 -176.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -100.09 -78.01 0.52 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 118.886 2.921 . . . . 0.0 118.886 -174.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.527 3.377 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 -174.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.405 ' CD ' ' HZ3' ' A' ' 95' ' ' LYS . 14.3 tt0 . . . . . 0 CA--C 1.604 3.022 0 CA-C-O 118.88 -0.581 . . . . 0.0 112.296 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -28.04 -70.92 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 130.797 3.639 . . . . 0.0 118.112 -177.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -56.31 -50.52 71.19 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.625 HG23 ' HG2' ' A' ' 148' ' ' MET . 5.3 mp -72.04 -48.1 51.51 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 CA-C-O 117.053 -1.451 . . . . 0.0 112.496 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.21 -51.93 67.85 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 121.671 2.032 . . . . 0.0 110.266 178.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -65.18 -46.77 79.45 Favored 'General case' 0 CA--C 1.566 1.595 0 CA-C-O 116.532 -1.699 . . . . 0.0 111.146 178.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.28 -61.59 1.73 Allowed 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 121.925 2.148 . . . . 0.0 114.404 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -59.15 -50.94 72.14 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 121.979 2.172 . . . . 0.0 112.858 178.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.405 ' HZ3' ' CD ' ' A' ' 87' ' ' GLU 0.353 71.7 mttt -67.78 -23.82 65.25 Favored 'General case' 0 CA--C 1.591 2.53 0 CA-C-O 116.558 -1.687 . . . . 0.0 110.262 -177.42 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.8 t -69.66 -48.23 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.485 0 CA-C-N 122.732 2.515 . . . . 0.0 107.491 167.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -48.28 -33.95 9.63 Favored 'General case' 0 CA--C 1.577 1.991 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.42 95.9 0.48 Allowed 'General case' 0 CA--C 1.577 1.983 0 C-N-CA 126.936 2.094 . . . . 0.0 107.873 175.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.92 -46.49 71.4 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.633 -0.667 . . . . 0.0 112.322 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -47.94 -24.55 1.07 Allowed 'General case' 0 CA--C 1.583 2.233 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 176.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.14 7.43 87.78 Favored Glycine 0 CA--C 1.563 3.036 0 CA-C-N 122.216 2.28 . . . . 0.0 117.34 -176.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.67 78.21 1.69 Allowed 'General case' 0 N--CA 1.478 0.932 1 CA-C-O 109.938 -4.839 . . . . 0.0 104.76 175.356 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 52.68 -26.93 0.01 OUTLIER Glycine 0 N--CA 1.486 2.028 2 N-CA-C 129.079 6.392 . . . . 0.0 129.079 166.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.7 t -103.03 136.19 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-N 118.919 1.359 . . . . 0.0 113.036 -177.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 67.5 mt -111.04 133.59 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 113.082 -1.872 . . . . 0.0 110.347 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -110.51 173.04 6.52 Favored 'General case' 0 CA--C 1.571 1.76 0 C-N-CA 124.378 1.071 . . . . 0.0 111.49 176.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -64.01 -45.52 88.6 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 116.82 -1.562 . . . . 0.0 114.504 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -61.56 -46.87 88.08 Favored 'General case' 0 N--CA 1.508 2.457 0 CA-C-N 121.196 1.816 . . . . 0.0 112.185 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -51.53 -50.3 60.29 Favored 'General case' 0 CA--C 1.574 1.892 0 C-N-CA 124.557 1.143 . . . . 0.0 112.059 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -64.38 -52.6 57.44 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 125.986 1.714 . . . . 0.0 109.791 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 19.1 ttpt -46.87 -49.93 19.45 Favored 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 124.85 1.26 . . . . 0.0 113.534 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -70.57 -53.54 15.63 Favored 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 176.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -70.88 -27.29 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 119.302 3.075 . . . . 0.0 119.302 -175.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.447 ' HE3' HE21 ' A' ' 115' ' ' GLN . 15.3 tmm? -45.53 -68.0 0.23 Allowed 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 126.518 1.927 . . . . 0.0 109.577 178.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.447 HE21 ' HE3' ' A' ' 114' ' ' MET 0.289 11.6 pt20 -118.2 84.08 2.11 Favored 'General case' 0 CA--C 1.579 2.076 0 N-CA-C 101.733 -3.432 . . . . 0.0 101.733 171.826 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.426 ' N ' ' HZ1' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -23.62 -68.61 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.8 1 N-CA-C 123.711 4.708 . . . . 0.0 123.711 -176.896 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.8 p -87.96 80.19 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -175.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.08 -13.18 2.71 Favored Glycine 0 CA--C 1.545 1.929 0 N-CA-C 123.0 3.96 . . . . 0.0 123.0 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.34 26.23 0.67 Allowed 'General case' 0 CA--C 1.597 2.762 0 CA-C-N 122.684 3.242 . . . . 0.0 115.729 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -39.29 157.04 0.13 Allowed Pre-proline 0 N--CA 1.504 2.264 0 N-CA-C 120.883 3.66 . . . . 0.0 120.883 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . 0.315 0.1 OUTLIER -3.66 65.55 0.0 OUTLIER 'Trans proline' 0 C--N 1.394 2.964 1 C-N-CA 126.327 4.685 . . . . 0.0 122.209 179.987 . . . . . . . . 4 3 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.508 2.2 tt -79.19 -73.09 0.36 Allowed 'General case' 0 CA--C 1.563 1.473 1 CA-C-N 107.891 -4.231 . . . . 0.0 103.042 -178.728 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.3 p -92.66 112.1 23.93 Favored 'General case' 0 C--N 1.374 1.653 2 CA-C-N 126.771 4.351 . . . . 0.0 99.36 169.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -62.19 -33.45 74.57 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 116.99 2.219 . . . . 0.0 116.99 -177.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.48 -40.28 96.68 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 117.418 -1.277 . . . . 0.0 113.624 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -59.56 -52.11 66.98 Favored 'General case' 0 CA--C 1.572 1.81 0 CA-C-N 120.633 1.56 . . . . 0.0 113.036 178.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.8 t -73.73 -48.36 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-O 117.001 -1.476 . . . . 0.0 112.464 -178.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -65.0 -44.57 88.83 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-N 120.768 1.622 . . . . 0.0 111.356 177.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -64.82 -43.51 92.86 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-N 121.464 1.938 . . . . 0.0 112.084 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.0 -47.62 82.34 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 120.662 1.574 . . . . 0.0 112.92 176.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.631 ' SD ' HD13 ' A' ' 142' ' ' ILE . 13.3 tpt -67.65 -37.67 82.74 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 115.189 -2.338 . . . . 0.0 112.075 176.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -66.64 -43.08 85.63 Favored 'General case' 0 CA--C 1.567 1.609 0 CA-C-N 123.053 2.66 . . . . 0.0 110.712 174.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -59.94 -41.39 91.72 Favored 'General case' 0 CA--C 1.578 2.053 0 CA-C-N 122.568 2.44 . . . . 0.0 110.351 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.59 -16.65 62.87 Favored 'General case' 0 CA--C 1.581 2.148 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.572 ' OD2' ' N ' ' A' ' 140' ' ' GLY . 7.3 t0 -91.8 103.25 15.82 Favored 'General case' 0 CA--C 1.586 2.327 0 N-CA-C 101.679 -3.452 . . . . 0.0 101.679 164.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -73.81 -21.12 60.26 Favored 'General case' 0 CA--C 1.58 2.125 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 178.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -91.82 -11.87 35.32 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 119.514 3.153 . . . . 0.0 119.514 -175.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.13 5.96 89.24 Favored Glycine 0 CA--C 1.573 3.709 0 CA-C-N 120.241 1.382 . . . . 0.0 115.323 -173.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.38 -44.86 20.65 Favored 'General case' 0 CA--C 1.573 1.849 0 C-N-CA 126.139 1.776 . . . . 0.0 113.33 176.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.572 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . 111.13 20.25 7.21 Favored Glycine 0 CA--C 1.558 2.73 0 N-CA-C 116.891 1.516 . . . . 0.0 116.891 -178.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.27 158.73 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-N 118.676 1.238 . . . . 0.0 108.041 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.631 HD13 ' SD ' ' A' ' 131' ' ' MET . 1.1 mt -136.91 128.83 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 117.702 2.482 . . . . 0.0 117.702 -174.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 33.1 p30 -95.74 153.98 17.46 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 170.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.3 mt -51.17 -43.08 84.38 Favored Pre-proline 0 CA--C 1.586 2.339 0 CA-C-O 115.006 -2.426 . . . . 0.0 114.198 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -56.01 -29.8 75.47 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 123.787 2.991 . . . . 0.0 117.646 177.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -61.8 -62.51 1.75 Allowed 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 120.831 1.65 . . . . 0.0 110.926 176.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.516 ' CE2' HG22 ' A' ' 90' ' ' ILE . 57.9 t80 -54.85 -42.56 72.13 Favored 'General case' 0 CA--C 1.578 2.04 0 C-N-CA 123.989 0.915 . . . . 0.0 112.809 174.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.625 ' HG2' HG23 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -56.89 -42.27 79.54 Favored 'General case' 0 CA--C 1.583 2.22 0 CA-C-O 117.403 -1.284 . . . . 0.0 109.716 174.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.52 -33.63 73.09 Favored 'General case' 0 CA--C 1.577 1.992 0 CA-C-N 121.187 1.812 . . . . 0.0 110.736 174.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.3 mp -58.52 -45.74 88.2 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 120.661 1.573 . . . . 0.0 111.542 174.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 66.6 mt -79.9 -45.62 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 120.445 1.475 . . . . 0.0 110.982 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -62.87 -49.71 73.78 Favored 'General case' 0 CA--C 1.575 1.915 0 CA-C-N 120.931 1.696 . . . . 0.0 114.702 177.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -93.2 -71.16 0.67 Allowed 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 124.807 1.243 . . . . 0.0 111.926 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.528 3.447 0 C-N-CA 126.999 2.119 . . . . 0.0 113.322 179.721 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 . . . . . 0 CA--C 1.574 1.889 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -40.7 -69.9 0.12 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.762 2.025 . . . . 0.0 115.884 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.507 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 13.0 pt-20 -58.54 -45.1 89.61 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 114.827 1.418 . . . . 0.0 114.827 -177.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.66 HG23 ' CE ' ' A' ' 148' ' ' MET . 4.2 mp -76.83 -67.61 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 114.42 -2.705 . . . . 0.0 114.572 -177.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . 0.336 0.0 OUTLIER -73.95 -33.63 63.97 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 123.546 2.885 . . . . 0.0 110.36 -178.247 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 46.9 mtt180 -69.04 -45.69 69.8 Favored 'General case' 0 CA--C 1.58 2.133 0 CA-C-N 125.52 3.782 . . . . 0.0 108.992 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.507 ' HB2' ' O ' ' A' ' 89' ' ' GLU . . . -70.79 -57.25 4.84 Favored 'General case' 0 C--N 1.384 2.09 0 CA-C-N 122.376 2.353 . . . . 0.0 112.121 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.467 ' CE2' HD11 ' A' ' 105' ' ' ILE . 4.8 t80 -57.07 -51.59 68.67 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 121.919 2.145 . . . . 0.0 113.267 178.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.532 ' HE2' HD12 ' A' ' 144' ' ' ILE . 56.0 mttt -62.01 -31.0 71.34 Favored 'General case' 0 CA--C 1.576 1.948 0 CA-C-O 115.491 -2.195 . . . . 0.0 111.548 -178.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -69.2 -45.23 79.86 Favored 'Isoleucine or valine' 0 CA--C 1.591 2.523 0 CA-C-N 123.604 2.911 . . . . 0.0 109.355 170.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.91 -31.13 38.27 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.978 ' OD2' ' HA ' ' A' ' 102' ' ' ASP . 1.7 t0 -56.9 125.39 22.32 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 119.997 1.271 . . . . 0.0 109.087 177.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.46 28.35 0.03 OUTLIER 'General case' 0 N--CA 1.527 3.422 0 N-CA-C 120.445 3.498 . . . . 0.0 120.445 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.483 ' H ' ' C ' ' A' ' 98' ' ' ASP 0.422 13.7 t-20 72.44 148.23 0.09 Allowed 'General case' 0 CA--C 1.604 3.033 2 C-N-CA 135.223 5.409 . . . . 0.0 101.825 -175.813 . . . . . . . . 4 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 109.39 60.49 0.52 Allowed Glycine 0 C--N 1.285 -2.254 2 C-N-CA 135.547 6.308 . . . . 0.0 109.621 -177.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.978 ' HA ' ' OD2' ' A' ' 98' ' ' ASP 0.832 0.2 OUTLIER -30.13 113.5 0.09 Allowed 'General case' 0 C--N 1.393 2.474 0 CA-C-O 127.626 3.584 . . . . 0.0 118.268 -174.511 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 126.62 28.92 0.93 Allowed Glycine 0 N--CA 1.43 -1.724 1 CA-C-N 103.376 -6.284 . . . . 0.0 110.716 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . 0.273 0.0 OUTLIER -166.67 142.57 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 N-CA-C 118.376 2.732 . . . . 0.0 118.376 177.306 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.467 HD11 ' CE2' ' A' ' 94' ' ' PHE . 96.1 mt -136.64 134.58 48.98 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.676 0 C-N-CA 128.331 2.652 . . . . 0.0 104.99 175.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -105.01 -178.56 3.69 Favored 'General case' 0 CA--C 1.569 1.692 0 C-N-CA 124.462 1.105 . . . . 0.0 111.621 175.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.49 -46.62 25.96 Favored 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -178.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -62.95 -53.09 59.49 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 117.023 -1.465 . . . . 0.0 111.328 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -58.03 -30.72 66.36 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 121.838 2.108 . . . . 0.0 113.124 175.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -66.97 -51.65 52.56 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 120.554 1.524 . . . . 0.0 109.187 176.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.1 tppt? -54.98 -35.33 64.21 Favored 'General case' 0 CA--C 1.58 2.118 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 174.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 11.3 m-30 -74.76 -57.98 3.57 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 125.699 1.6 . . . . 0.0 113.043 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.9 -36.4 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 125.814 1.645 . . . . 0.0 113.684 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -53.97 -48.16 70.62 Favored 'General case' 0 CA--C 1.588 2.432 0 CA-C-O 121.157 0.503 . . . . 0.0 110.198 171.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -102.65 72.35 1.23 Allowed 'General case' 0 CA--C 1.58 2.113 0 C-N-CA 126.594 1.957 . . . . 0.0 114.477 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.6 mmtt -99.53 142.16 31.38 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 119.733 -1.854 . . . . 0.0 111.795 177.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.3 p 48.67 95.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 C-N-CA 126.355 1.862 . . . . 0.0 112.028 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 97.56 -43.05 2.02 Favored Glycine 0 CA--C 1.554 2.518 0 CA-C-O 119.065 -0.853 . . . . 0.0 113.012 -176.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 75.08 102.54 0.07 Allowed 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 125.758 1.623 . . . . 0.0 112.866 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -125.09 -34.38 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.619 1 CA-C-O 111.505 -4.093 . . . . 0.0 119.45 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -80.92 74.58 5.47 Favored 'Trans proline' 0 CA--C 1.574 2.491 1 CA-C-N 130.762 4.879 . . . . 0.0 106.681 175.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.264 0.5 OUTLIER -68.82 -33.32 73.64 Favored 'General case' 0 CA--C 1.558 1.263 1 N-CA-C 123.121 4.489 . . . . 0.0 123.121 -171.478 . . . . . . . . 4 3 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 78.3 p -78.92 140.11 38.14 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 123.7 2.954 . . . . 0.0 110.124 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -60.09 -37.58 80.35 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.37 -36.84 71.73 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 117.346 -1.311 . . . . 0.0 114.478 176.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -61.76 -51.11 69.66 Favored 'General case' 0 CA--C 1.58 2.133 0 CA-C-N 120.786 1.63 . . . . 0.0 111.841 175.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.2 t -63.53 -51.83 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 C-N-CA 125.804 1.642 . . . . 0.0 110.706 178.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.3 -38.78 84.71 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-O 117.569 -1.205 . . . . 0.0 111.314 176.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -62.87 -50.45 70.87 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 121.673 2.033 . . . . 0.0 112.094 175.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.49 -47.26 86.92 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 177.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.496 ' SD ' HD13 ' A' ' 142' ' ' ILE . 12.8 tpt -70.02 -38.72 75.98 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 115.434 -2.222 . . . . 0.0 111.303 176.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -36.16 83.37 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 123.724 2.965 . . . . 0.0 111.372 175.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -61.78 -49.21 77.26 Favored 'General case' 0 CA--C 1.573 1.848 0 CA-C-O 118.121 -0.942 . . . . 0.0 109.478 173.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -77.33 -23.82 50.87 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 117.724 2.49 . . . . 0.0 117.724 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -91.29 116.67 29.01 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 103.356 -2.831 . . . . 0.0 103.356 170.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -61.59 -22.33 65.12 Favored 'General case' 0 CA--C 1.586 2.347 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.281 29.6 t0 96.97 159.68 0.02 OUTLIER 'General case' 0 CA--C 1.609 3.218 0 CA-C-O 127.402 3.477 . . . . 0.0 103.085 178.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 94.48 36.79 5.52 Favored Glycine 0 CA--C 1.567 3.319 2 C-N-CA 132.006 4.622 . . . . 0.0 102.492 -173.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -173.7 -65.43 0.01 OUTLIER 'General case' 0 C--N 1.399 2.722 0 CA-C-N 121.821 2.811 . . . . 0.0 115.488 -174.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 87.39 20.6 51.5 Favored Glycine 0 CA--C 1.574 3.751 0 CA-C-N 119.31 0.959 . . . . 0.0 114.384 -174.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.88 168.25 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 128.053 2.541 . . . . 0.0 104.227 -178.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.496 HD13 ' SD ' ' A' ' 131' ' ' MET . 0.9 OUTLIER -144.75 133.06 17.4 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 O-C-N 120.979 -1.075 . . . . 0.0 112.816 -178.385 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 53.6 p30 -103.58 155.65 18.38 Favored 'General case' 0 CA--C 1.561 1.384 0 N-CA-C 104.467 -2.42 . . . . 0.0 104.467 169.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.656 HD13 ' CG ' ' A' ' 102' ' ' ASP . 0.6 OUTLIER -52.45 -44.89 95.3 Favored Pre-proline 0 N--CA 1.492 1.669 0 CA-C-O 115.184 -2.341 . . . . 0.0 113.219 -178.4 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -55.51 -21.21 29.67 Favored 'Trans proline' 0 C--N 1.375 1.942 0 CA-C-O 114.139 -2.526 . . . . 0.0 116.455 177.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.66 -56.21 6.97 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 123.217 2.735 . . . . 0.0 110.488 175.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -61.45 -44.76 96.54 Favored 'General case' 0 CA--C 1.591 2.552 0 CA-C-O 123.727 1.727 . . . . 0.0 111.99 175.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.66 ' CE ' HG23 ' A' ' 90' ' ' ILE . 2.1 mmt -56.62 -45.14 81.67 Favored 'General case' 0 CA--C 1.56 1.36 0 CA-C-O 115.111 -2.376 . . . . 0.0 108.884 173.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.97 -27.33 67.37 Favored 'General case' 0 CA--C 1.567 1.599 0 CA-C-N 122.468 2.394 . . . . 0.0 112.115 173.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.5 mp -52.32 -41.04 62.64 Favored 'General case' 0 N--CA 1.504 2.262 0 CA-C-N 121.98 2.173 . . . . 0.0 106.324 168.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -81.34 -69.46 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.612 3.348 0 CA-C-O 122.481 1.134 . . . . 0.0 111.447 173.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -72.94 8.44 1.55 Allowed 'General case' 0 CA--C 1.579 2.081 2 C-N-CA 133.249 4.62 . . . . 0.0 122.55 -178.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 59.8 pttt 3.04 2.55 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.699 1 N-CA-C 128.607 6.521 . . . . 0.0 128.607 -166.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 35.9 m . . . . . 0 N--CA 1.5 2.034 0 C-N-CA 123.994 0.918 . . . . 0.0 112.486 175.883 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.522 3.138 0 N-CA-C 117.924 2.564 . . . . 0.0 117.924 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.89 -53.11 61.75 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-N 124.608 3.367 . . . . 0.0 111.732 177.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -64.44 -46.49 82.94 Favored 'General case' 0 CA--C 1.58 2.107 0 O-C-N 120.136 -1.602 . . . . 0.0 114.353 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.513 HG23 ' HG2' ' A' ' 148' ' ' MET . 3.6 mp -64.79 -42.88 96.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-O 117.467 -1.254 . . . . 0.0 110.405 177.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.12 -45.38 93.71 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 120.938 1.699 . . . . 0.0 109.278 175.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 76.8 mtt180 -52.97 -62.67 1.5 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 120.107 1.321 . . . . 0.0 110.283 176.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.86 -58.78 4.34 Favored 'General case' 0 C--N 1.358 0.968 0 CA-C-O 115.871 -2.014 . . . . 0.0 116.185 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -63.23 -52.66 61.26 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 121.42 1.918 . . . . 0.0 113.723 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.367 58.1 mttt -66.51 -19.53 65.81 Favored 'General case' 0 CA--C 1.596 2.719 0 CA-C-O 116.614 -1.66 . . . . 0.0 110.354 -177.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.7 t -72.64 -50.97 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 CA-C-N 122.566 2.439 . . . . 0.0 107.383 166.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -51.06 -30.39 15.6 Favored 'General case' 0 CA--C 1.568 1.655 0 N-CA-C 117.508 2.41 . . . . 0.0 117.508 -178.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.265 0.0 OUTLIER -55.04 115.52 2.26 Favored 'General case' 0 CA--C 1.585 2.299 0 C-N-CA 126.272 1.829 . . . . 0.0 110.274 178.335 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.9 -54.7 41.5 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 117.678 2.473 . . . . 0.0 117.678 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.6 p30 -88.66 6.28 39.16 Favored 'General case' 0 CA--C 1.562 1.442 0 N-CA-C 118.622 2.823 . . . . 0.0 118.622 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.65 29.13 71.48 Favored Glycine 0 CA--C 1.568 3.358 0 CA-C-N 121.078 1.763 . . . . 0.0 115.462 -175.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -143.3 78.29 1.6 Allowed 'General case' 0 N--CA 1.476 0.825 1 CA-C-O 109.544 -5.027 . . . . 0.0 107.362 178.829 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 54.82 -25.83 0.01 OUTLIER Glycine 0 N--CA 1.491 2.348 3 N-CA-C 129.504 6.562 . . . . 0.0 129.504 164.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.8 p -107.4 153.26 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.089 0 CA-C-N 119.129 1.465 . . . . 0.0 112.426 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 83.6 mt -123.19 137.39 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 C-N-CA 126.281 1.832 . . . . 0.0 108.909 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -108.69 -170.51 1.68 Allowed 'General case' 0 CA--C 1.589 2.459 0 C-N-CA 124.154 0.982 . . . . 0.0 112.34 176.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -80.64 -52.98 6.95 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -57.88 -47.4 82.86 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 123.021 0.528 . . . . 0.0 112.23 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -56.0 -48.52 75.73 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 118.033 -0.984 . . . . 0.0 111.157 174.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -60.37 -50.9 71.77 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 117.39 -1.29 . . . . 0.0 112.497 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -56.9 -39.24 74.05 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 120.342 1.428 . . . . 0.0 114.433 176.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -69.18 -45.49 69.82 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 175.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -91.07 -24.21 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 1 N-CA-C 122.054 4.094 . . . . 0.0 122.054 -174.496 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 1.4 tpt -29.34 -48.69 0.08 Allowed 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.444 ' HB2' ' HA ' ' A' ' 119' ' ' GLU . 0.0 OUTLIER -120.59 93.1 3.93 Favored 'General case' 0 CA--C 1.556 1.19 0 CA-C-N 112.821 -1.99 . . . . 0.0 110.704 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -75.87 -72.2 0.33 Allowed 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 113.772 -1.558 . . . . 0.0 114.032 -177.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.6 p -100.3 106.4 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 83.29 94.05 0.61 Allowed Glycine 0 CA--C 1.543 1.781 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.444 ' HA ' ' HB2' ' A' ' 115' ' ' GLN . 10.3 pt-20 -64.13 125.26 23.92 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 -178.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -142.15 -52.47 0.02 OUTLIER Pre-proline 0 CA--C 1.581 2.165 0 CA-C-O 112.192 -3.766 . . . . 0.0 121.089 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -76.67 88.33 1.38 Allowed 'Trans proline' 0 N--CA 1.508 2.379 1 CA-C-N 130.405 4.752 . . . . 0.0 103.895 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.277 12.4 tp -127.2 80.52 1.96 Allowed 'General case' 0 CA--C 1.545 0.764 1 N-CA-C 121.978 4.066 . . . . 0.0 121.978 -167.488 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.429 ' HG1' ' HG3' ' A' ' 126' ' ' GLU . 46.5 p -164.84 152.26 11.33 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 103.697 -2.705 . . . . 0.0 103.697 176.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -61.05 -41.53 96.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.91 -1.119 . . . . 0.0 112.149 176.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.49 -45.82 82.1 Favored 'General case' 0 CA--C 1.554 1.103 0 CA-C-O 116.929 -1.51 . . . . 0.0 113.338 176.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.429 ' HG3' ' HG1' ' A' ' 123' ' ' THR . 1.0 OUTLIER -63.82 -39.76 94.99 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 121.659 2.027 . . . . 0.0 112.965 176.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 90.0 t -69.99 -50.72 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.613 0 CA-C-O 117.739 -1.124 . . . . 0.0 109.307 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.68 -45.55 89.19 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 120.154 1.343 . . . . 0.0 111.718 176.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -61.61 -47.06 87.18 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 119.701 1.137 . . . . 0.0 112.621 176.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.21 -46.14 90.76 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 119.396 0.998 . . . . 0.0 112.975 176.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 9.6 ttt -70.84 -43.56 68.26 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 115.74 -2.076 . . . . 0.0 111.189 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.444 ' HZ3' ' CD ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -60.17 -35.63 75.77 Favored 'General case' 0 CA--C 1.578 2.052 0 CA-C-N 122.899 2.59 . . . . 0.0 110.685 174.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.444 ' CD ' ' HZ3' ' A' ' 132' ' ' LYS . 0.6 OUTLIER -65.48 -42.68 91.92 Favored 'General case' 0 CA--C 1.571 1.774 0 CA-C-N 121.633 2.015 . . . . 0.0 110.557 172.79 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -72.21 -24.5 61.41 Favored 'General case' 0 CA--C 1.576 1.946 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 176.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -81.3 108.53 15.0 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 103.041 -2.948 . . . . 0.0 103.041 172.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -72.71 -14.64 61.61 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -108.95 -11.61 14.96 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 119.257 3.058 . . . . 0.0 119.257 -174.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.63 5.6 89.76 Favored Glycine 0 CA--C 1.571 3.561 0 CA-C-N 120.447 1.476 . . . . 0.0 114.618 -173.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -72.03 -44.62 63.12 Favored 'General case' 0 CA--C 1.565 1.547 0 C-N-CA 125.342 1.457 . . . . 0.0 113.39 176.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 102.98 3.77 48.53 Favored Glycine 0 CA--C 1.563 3.035 0 N-CA-C 117.312 1.685 . . . . 0.0 117.312 -177.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 1.8 t -135.43 141.85 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 101.592 -3.484 . . . . 0.0 101.592 176.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.2 mt -120.58 124.48 72.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 111.967 -2.379 . . . . 0.0 112.789 -176.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 53.7 p30 -92.48 157.67 16.44 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 170.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.8 mt -52.75 -41.2 82.93 Favored Pre-proline 0 CA--C 1.585 2.302 0 CA-C-O 115.126 -2.369 . . . . 0.0 112.967 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -57.08 -31.25 89.73 Favored 'Trans proline' 0 C--N 1.38 2.214 0 C-N-CA 123.702 2.935 . . . . 0.0 116.813 176.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -67.2 -46.57 73.5 Favored 'General case' 0 N--CA 1.505 2.291 0 CA-C-N 123.074 2.67 . . . . 0.0 111.279 176.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -63.28 -45.16 92.72 Favored 'General case' 0 CA--C 1.583 2.222 0 CA-C-N 120.643 1.565 . . . . 0.0 110.761 173.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.513 ' HG2' HG23 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -60.0 -41.36 91.93 Favored 'General case' 0 CA--C 1.579 2.06 0 CA-C-O 117.064 -1.446 . . . . 0.0 109.725 175.17 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.23 -25.06 63.21 Favored 'General case' 0 CA--C 1.579 2.067 0 CA-C-N 121.714 2.052 . . . . 0.0 111.783 173.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.1 tp -62.41 -47.13 85.45 Favored 'General case' 0 CA--C 1.573 1.828 0 CA-C-N 120.797 1.635 . . . . 0.0 108.875 172.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . 0.276 31.7 mt -68.12 -46.78 80.81 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.597 0 CA-C-N 119.13 0.877 . . . . 0.0 109.567 175.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -71.94 9.89 0.83 Allowed 'General case' 0 CA--C 1.606 3.127 0 C-N-CA 127.334 2.254 . . . . 0.0 116.807 174.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -3.92 -6.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.769 2 N-CA-C 128.448 6.462 . . . . 0.0 128.448 -171.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.693 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 173.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 . . . . . 0 CA--C 1.572 1.805 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . 0.25 0.4 OUTLIER -49.79 -48.99 50.22 Favored 'General case' 0 CA--C 1.573 1.831 0 CA-C-N 122.454 2.388 . . . . 0.0 116.195 -177.706 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.42 ' CD ' HH21 ' A' ' 92' ' ' ARG . 6.9 tp10 -69.63 -40.46 76.54 Favored 'General case' 0 CA--C 1.574 1.888 0 CA-C-N 120.427 1.467 . . . . 0.0 114.146 177.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.705 HG23 ' HE2' ' A' ' 148' ' ' MET . 4.1 mp -64.99 -55.22 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 116.226 -1.845 . . . . 0.0 109.635 178.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . 0.259 0.6 OUTLIER -62.75 -34.07 76.44 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 122.011 2.187 . . . . 0.0 111.225 177.148 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.42 HH21 ' CD ' ' A' ' 89' ' ' GLU . 28.0 mtm-85 -52.88 -62.3 1.74 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 121.175 1.807 . . . . 0.0 108.397 173.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.64 -61.54 1.84 Allowed 'General case' 0 C--N 1.355 0.822 0 CA-C-O 114.07 -2.871 . . . . 0.0 115.696 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.493 ' HB2' ' CD2' ' A' ' 147' ' ' PHE . 3.7 t80 -69.04 -52.86 24.21 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 124.387 3.267 . . . . 0.0 114.128 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.375 26.0 mttt -63.04 -16.34 59.53 Favored 'General case' 0 CA--C 1.593 2.63 0 CA-C-O 115.51 -2.186 . . . . 0.0 111.368 -176.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -84.8 -46.83 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.598 2.823 0 CA-C-N 123.188 2.722 . . . . 0.0 108.558 167.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.427 ' CE1' HG23 ' A' ' 113' ' ' ILE . 1.1 t80 -57.71 -24.32 56.26 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 119.076 2.991 . . . . 0.0 119.076 -178.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -39.24 -45.09 1.32 Allowed 'General case' 0 CA--C 1.589 2.443 0 CA-C-N 121.718 2.054 . . . . 0.0 116.421 176.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 65.29 -58.04 0.29 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 117.792 2.516 . . . . 0.0 117.792 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.623 HD22 HG11 ' A' ' 104' ' ' VAL . 55.8 p30 -68.54 -13.52 62.39 Favored 'General case' 0 CA--C 1.577 1.994 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.59 8.58 86.77 Favored Glycine 0 CA--C 1.551 2.319 0 N-CA-C 120.66 3.024 . . . . 0.0 120.66 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -114.58 -10.39 12.53 Favored 'General case' 0 CA--C 1.578 2.036 0 CA-C-N 119.366 1.583 . . . . 0.0 114.764 177.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 110.41 0.63 29.49 Favored Glycine 0 CA--C 1.55 2.266 0 CA-C-O 116.144 -2.476 . . . . 0.0 116.49 -178.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.623 HG11 HD22 ' A' ' 100' ' ' ASN . 0.5 OUTLIER -115.55 153.26 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 CA-C-N 121.471 2.636 . . . . 0.0 112.199 179.541 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.47 HD11 ' CE2' ' A' ' 94' ' ' PHE . 97.5 mt -121.38 130.57 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-N 112.402 -2.181 . . . . 0.0 106.709 178.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -106.43 -173.27 2.26 Favored 'General case' 0 CA--C 1.573 1.829 0 CA-C-O 122.033 0.92 . . . . 0.0 110.582 176.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -72.31 -38.33 68.74 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.829 -1.17 . . . . 0.0 112.588 178.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -58.76 -46.02 88.42 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 123.542 0.737 . . . . 0.0 112.057 175.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -62.04 -37.79 86.25 Favored 'General case' 0 CA--C 1.586 2.35 0 CA-C-N 120.675 1.58 . . . . 0.0 112.364 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -60.51 -44.89 95.53 Favored 'General case' 0 CA--C 1.571 1.768 0 C-N-CA 124.202 1.001 . . . . 0.0 109.557 173.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.433 ' HG2' ' HD3' ' A' ' 121' ' ' PRO . 3.1 tmmm? -55.43 -46.59 76.69 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 125.049 1.34 . . . . 0.0 112.014 173.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -60.38 -53.39 58.22 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 176.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.427 HG23 ' CE1' ' A' ' 97' ' ' PHE . 0.2 OUTLIER -73.99 -28.13 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 -177.485 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 7.3 tpt -61.02 -63.78 1.18 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -98.16 99.71 10.97 Favored 'General case' 0 CA--C 1.555 1.135 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 176.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.417 ' H ' ' HD3' ' A' ' 116' ' ' LYS . 0.5 OUTLIER -48.43 -49.64 34.36 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 116.731 2.122 . . . . 0.0 116.731 -178.774 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.6 p -155.32 100.23 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 154.13 -99.09 0.19 Allowed Glycine 0 CA--C 1.54 1.617 0 N-CA-C 113.886 0.315 . . . . 0.0 113.886 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -80.06 -165.31 0.81 Allowed 'General case' 0 CA--C 1.58 2.108 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 -178.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.5 -154.16 0.01 OUTLIER Pre-proline 0 CA--C 1.582 2.193 0 CA-C-O 116.051 -1.928 . . . . 0.0 109.771 178.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.433 ' HD3' ' HG2' ' A' ' 111' ' ' LYS . 1.0 OUTLIER -68.74 77.39 0.75 Allowed 'Trans proline' 0 C--N 1.38 2.205 0 CA-C-N 124.941 2.8 . . . . 0.0 111.493 172.938 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.457 0.5 OUTLIER -66.36 -72.81 0.15 Allowed 'General case' 0 CA--C 1.562 1.412 0 CA-C-N 109.555 -3.475 . . . . 0.0 107.016 -177.568 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.4 p -91.61 118.08 30.31 Favored 'General case' 0 C--N 1.367 1.328 0 CA-C-N 125.709 3.868 . . . . 0.0 102.081 172.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -57.62 -40.31 78.89 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 117.324 2.342 . . . . 0.0 117.324 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.94 -38.79 76.59 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 114.708 1.374 . . . . 0.0 114.708 178.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -63.83 -51.99 62.16 Favored 'General case' 0 CA--C 1.574 1.868 0 CA-C-N 120.41 1.459 . . . . 0.0 112.713 177.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.1 t -70.98 -46.32 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-O 118.004 -0.998 . . . . 0.0 111.734 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -60.98 -49.14 78.65 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 117.067 -1.444 . . . . 0.0 110.611 176.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -61.91 -43.32 99.08 Favored 'General case' 0 CA--C 1.561 1.368 0 CA-C-N 120.927 1.694 . . . . 0.0 112.977 178.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.7 -45.48 78.64 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-N 120.612 1.551 . . . . 0.0 114.399 177.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -37.87 62.14 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 120.592 1.542 . . . . 0.0 111.903 178.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -63.83 -45.78 88.03 Favored 'General case' 0 CA--C 1.57 1.729 0 CA-C-N 121.71 2.05 . . . . 0.0 109.228 174.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -34.46 78.0 Favored 'General case' 0 CA--C 1.58 2.101 0 CA-C-N 122.229 2.286 . . . . 0.0 112.211 175.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.439 ' HA ' HD22 ' A' ' 150' ' ' LEU . . . -76.17 -32.03 58.83 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 176.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -77.99 114.21 16.64 Favored 'General case' 0 N--CA 1.513 2.676 0 O-C-N 117.408 -3.307 . . . . 0.0 109.454 175.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -82.06 -30.49 31.33 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 117.419 2.377 . . . . 0.0 117.419 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -86.3 -14.12 44.62 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 121.124 3.75 . . . . 0.0 121.124 -172.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.99 5.2 90.31 Favored Glycine 0 CA--C 1.572 3.61 0 CA-C-N 120.152 1.342 . . . . 0.0 113.895 -172.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -80.6 -51.36 8.83 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 119.145 1.472 . . . . 0.0 110.986 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 110.27 -7.95 30.76 Favored Glycine 0 CA--C 1.548 2.12 0 CA-C-O 115.965 -2.575 . . . . 0.0 116.907 -177.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . 0.307 3.4 m -134.97 121.04 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 101.402 -3.555 . . . . 0.0 101.402 174.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.0 mt -82.18 128.83 38.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 110.672 -2.967 . . . . 0.0 116.592 -172.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 39.3 p30 -93.95 155.5 17.12 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 172.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.61 -43.87 99.37 Favored Pre-proline 0 CA--C 1.583 2.224 0 CA-C-O 114.951 -2.452 . . . . 0.0 112.679 -178.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.37 -32.1 70.85 Favored 'Trans proline' 0 C--N 1.381 2.275 0 CA-C-N 125.1 2.857 . . . . 0.0 115.393 176.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -62.24 -57.87 9.83 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 116.743 -1.599 . . . . 0.0 110.18 175.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.493 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 75.5 t80 -53.14 -41.46 65.12 Favored 'General case' 0 N--CA 1.504 2.249 0 CA-C-N 120.624 1.556 . . . . 0.0 114.54 176.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.705 ' HE2' HG23 ' A' ' 90' ' ' ILE . 1.3 mtp -65.73 -49.16 69.47 Favored 'General case' 0 CA--C 1.573 1.862 0 O-C-N 121.591 -0.693 . . . . 0.0 110.623 176.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.458 ' CG ' ' HZ3' ' A' ' 152' ' ' LYS . 0.9 OUTLIER -61.67 -37.28 83.51 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 123.451 0.7 . . . . 0.0 112.789 175.721 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.439 HD22 ' HA ' ' A' ' 134' ' ' ALA . 1.4 tm? -57.66 -49.17 77.37 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 128.437 2.695 . . . . 0.0 110.491 173.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 91.0 mt -68.82 -40.32 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-N 119.698 1.135 . . . . 0.0 110.636 176.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.822 ' HE2' ' HE3' ' A' ' 153' ' ' LYS . 1.7 ttpm? -60.38 -66.79 0.47 Allowed 'General case' 0 CA--C 1.578 2.052 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 177.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.822 ' HE3' ' HE2' ' A' ' 152' ' ' LYS . 96.8 mttt -101.12 -71.75 0.7 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 121.639 3.94 . . . . 0.0 121.639 -176.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 54.4 p . . . . . 0 N--CA 1.499 1.977 0 N-CA-C 118.952 2.945 . . . . 0.0 118.952 -172.802 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.725 ' HA ' HD11 ' A' ' 90' ' ' ILE 0.253 3.2 tp10 . . . . . 1 N--CA 1.558 4.934 0 N-CA-C 118.744 2.868 . . . . 0.0 118.744 . . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -58.76 -39.64 81.6 Favored 'General case' 0 CA--C 1.589 2.471 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 170.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.262 1.4 tm-20 -72.0 -18.2 61.99 Favored 'General case' 0 CA--C 1.584 2.272 0 CA-C-O 113.76 -3.019 . . . . 0.0 109.534 171.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.725 HD11 ' HA ' ' A' ' 87' ' ' GLU 0.381 1.2 mp -68.67 -58.43 5.84 Favored 'Isoleucine or valine' 0 C--N 1.389 2.305 1 CA-C-N 128.832 5.287 . . . . 0.0 103.275 170.95 . . . . . . . . 4 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 pp -56.99 -49.58 75.32 Favored 'General case' 0 N--CA 1.503 2.19 0 CA-C-N 121.576 1.989 . . . . 0.0 113.034 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 43.9 mtt85 -67.56 -40.38 84.93 Favored 'General case' 0 CA--C 1.567 1.634 0 CA-C-O 117.397 -1.287 . . . . 0.0 114.013 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.44 -50.62 43.95 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 115.098 -2.382 . . . . 0.0 111.64 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.431 ' HD2' ' CD2' ' A' ' 147' ' ' PHE . 1.1 t80 -62.42 -49.26 76.18 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 122.766 2.53 . . . . 0.0 110.136 176.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -60.07 -34.47 73.49 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 116.87 -1.538 . . . . 0.0 114.524 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -77.07 -43.95 31.56 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.949 0 CA-C-N 121.248 1.84 . . . . 0.0 109.729 173.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -49.01 -44.26 41.15 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 125.525 1.53 . . . . 0.0 109.864 177.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -54.63 98.79 0.02 OUTLIER 'General case' 0 CA--C 1.58 2.114 0 C-N-CA 125.65 1.58 . . . . 0.0 110.962 175.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -77.24 -36.69 54.4 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.1 p30 -67.36 -14.68 63.14 Favored 'General case' 0 CA--C 1.579 2.074 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.78 9.64 85.23 Favored Glycine 0 CA--C 1.551 2.334 0 N-CA-C 120.897 3.119 . . . . 0.0 120.897 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 26.7 p30 -115.45 -8.76 12.18 Favored 'General case' 0 CA--C 1.577 2.019 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 177.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 110.58 20.6 7.25 Favored Glycine 0 CA--C 1.552 2.359 0 CA-C-O 117.095 -1.947 . . . . 0.0 114.589 -177.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.543 HG11 ' O ' ' A' ' 142' ' ' ILE . 3.5 t -133.34 143.29 39.53 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.718 0 CA-C-N 120.605 2.202 . . . . 0.0 111.446 -177.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 79.3 mt -106.57 136.16 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 126.477 1.911 . . . . 0.0 108.194 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -108.78 -175.8 2.87 Favored 'General case' 0 CA--C 1.575 1.935 0 C-N-CA 123.299 0.639 . . . . 0.0 112.299 176.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -72.03 -52.73 15.56 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 117.126 -1.416 . . . . 0.0 114.64 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -59.05 -37.96 78.26 Favored 'General case' 0 N--CA 1.515 2.803 0 CA-C-N 120.416 1.462 . . . . 0.0 113.864 177.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . 0.362 0.9 OUTLIER -58.29 -48.32 80.84 Favored 'General case' 0 CA--C 1.598 2.8 0 CA-C-O 124.286 1.993 . . . . 0.0 112.4 174.266 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.421 ' CD1' HG21 ' A' ' 127' ' ' VAL . 0.4 OUTLIER -61.18 -46.41 90.6 Favored 'General case' 0 CA--C 1.574 1.885 0 CA-C-O 116.582 -1.675 . . . . 0.0 107.212 172.376 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.439 ' O ' ' SD ' ' A' ' 114' ' ' MET . 60.8 mttt -51.0 -32.52 21.45 Favored 'General case' 0 N--CA 1.515 2.777 0 CA-C-N 122.078 2.217 . . . . 0.0 112.899 172.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -71.86 -49.92 34.01 Favored 'General case' 0 CA--C 1.583 2.235 0 C-N-CA 123.774 0.83 . . . . 0.0 111.92 174.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.7 mt -90.08 -7.64 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.738 0 N-CA-C 118.077 2.621 . . . . 0.0 118.077 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.439 ' SD ' ' O ' ' A' ' 111' ' ' LYS . 13.9 ptm -34.74 -31.91 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.428 1 N-CA-C 123.485 4.624 . . . . 0.0 123.485 -178.172 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 36.9 mm-40 -82.45 20.94 1.01 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 118.055 2.613 . . . . 0.0 118.055 -177.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 4.2 mptt 58.69 -88.33 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.249 0 C-N-CA 124.79 1.236 . . . . 0.0 113.301 175.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.0 p -82.12 110.15 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.91 -139.73 22.39 Favored Glycine 0 CA--C 1.545 1.953 0 N-CA-C 111.076 -0.809 . . . . 0.0 111.076 -177.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -164.07 117.32 1.42 Allowed 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.908 0.861 . . . . 0.0 111.784 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.4 ' N ' ' HD2' ' A' ' 121' ' ' PRO . 6.6 tt0 -126.79 8.34 0.05 OUTLIER Pre-proline 0 CA--C 1.581 2.166 0 CA-C-O 114.168 -2.825 . . . . 0.0 117.096 176.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 120' ' ' GLU 0.328 57.0 Cg_exo 15.77 58.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.388 2.619 1 C-N-CA 126.872 5.048 . . . . 0.0 118.944 -176.867 . . . . . . . . 4 3 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.351 12.9 tp -90.39 -94.98 0.12 Allowed 'General case' 0 CA--C 1.556 1.196 0 CA-C-N 110.885 -2.87 . . . . 0.0 112.622 -174.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 75.0 p -92.73 130.91 38.21 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 123.045 2.657 . . . . 0.0 111.377 -178.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -69.4 -27.98 65.76 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -55.56 -42.1 74.2 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-O 117.689 -1.148 . . . . 0.0 110.762 174.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -53.44 -50.33 65.49 Favored 'General case' 0 CA--C 1.57 1.728 0 CA-C-N 119.299 0.954 . . . . 0.0 112.996 174.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.421 HG21 ' CD1' ' A' ' 110' ' ' PHE . 9.1 p -71.04 -43.48 76.18 Favored 'Isoleucine or valine' 0 C--N 1.359 0.981 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.37 -49.08 70.67 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 120.037 1.29 . . . . 0.0 110.656 177.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -62.13 -49.43 75.92 Favored 'General case' 0 CA--C 1.573 1.841 0 CA-C-O 118.093 -0.956 . . . . 0.0 112.868 177.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.74 -45.05 90.55 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 177.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 15.9 ttt -69.68 -38.8 77.18 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 116.104 -1.903 . . . . 0.0 111.709 176.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -59.08 -42.07 89.53 Favored 'General case' 0 CA--C 1.576 1.973 0 CA-C-N 122.719 2.509 . . . . 0.0 110.485 173.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -57.45 -44.62 84.9 Favored 'General case' 0 CA--C 1.578 2.054 0 CA-C-N 120.099 1.318 . . . . 0.0 111.351 174.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.33 -18.79 40.94 Favored 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 118.311 2.708 . . . . 0.0 118.311 178.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.47 ' OD2' ' N ' ' A' ' 140' ' ' GLY . 23.0 t0 -82.41 102.99 11.64 Favored 'General case' 0 CA--C 1.574 1.874 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 174.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -81.89 -19.7 40.33 Favored 'General case' 0 CA--C 1.58 2.122 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 177.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -88.03 -14.34 39.26 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 119.128 3.01 . . . . 0.0 119.128 -175.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.94 5.11 90.03 Favored Glycine 0 CA--C 1.568 3.354 0 CA-C-N 119.964 1.256 . . . . 0.0 115.221 -174.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -80.72 -48.09 13.05 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 118.942 1.371 . . . . 0.0 111.353 175.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.47 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . 111.43 -20.12 23.47 Favored Glycine 0 CA--C 1.546 2.028 0 CA-C-O 116.27 -2.406 . . . . 0.0 115.346 -177.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . 0.303 5.7 m -122.28 122.22 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-N 121.438 2.619 . . . . 0.0 103.999 178.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.543 ' O ' HG11 ' A' ' 104' ' ' VAL . 0.3 OUTLIER -79.51 130.83 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 117.488 2.403 . . . . 0.0 117.488 -173.035 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 32.7 p30 -93.95 161.69 14.2 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 170.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 17.4 mt -54.99 -48.4 96.09 Favored Pre-proline 0 CA--C 1.579 2.077 0 CA-C-O 113.994 -2.908 . . . . 0.0 113.73 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -51.45 -27.22 23.81 Favored 'Trans proline' 0 C--N 1.373 1.85 0 CA-C-N 125.932 3.154 . . . . 0.0 119.849 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -72.18 -64.8 0.87 Allowed 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 121.237 1.835 . . . . 0.0 111.012 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.431 ' CD2' ' HD2' ' A' ' 94' ' ' PHE . 0.1 OUTLIER -48.81 -53.59 18.58 Favored 'General case' 0 N--CA 1.506 2.346 0 C-N-CA 124.717 1.207 . . . . 0.0 110.729 173.738 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.48 ' O ' ' HB2' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -60.82 -40.25 92.04 Favored 'General case' 0 C--N 1.358 0.957 0 CA-C-O 113.681 -3.057 . . . . 0.0 113.938 -179.775 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.02 -48.18 79.86 Favored 'General case' 0 CA--C 1.594 2.651 0 CA-C-N 125.01 3.55 . . . . 0.0 111.533 174.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . 0.295 0.3 OUTLIER -44.55 -47.73 10.24 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 127.851 2.46 . . . . 0.0 111.072 176.937 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 9.6 mt -92.09 -44.14 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.238 0 CA-C-O 117.527 -1.225 . . . . 0.0 111.157 175.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 148' ' ' MET . 33.1 mttp -56.63 -10.1 0.92 Allowed 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 118.453 2.76 . . . . 0.0 118.453 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -39.54 -50.32 2.18 Favored 'General case' 0 N--CA 1.513 2.702 0 CA-C-N 123.518 2.872 . . . . 0.0 111.194 172.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.509 2.499 0 C-N-CA 126.452 1.901 . . . . 0.0 109.909 171.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 . . . . . 0 CA--C 1.547 0.844 0 CA-C-O 115.647 -2.12 . . . . 0.0 113.535 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -24.16 -60.79 0.05 Allowed 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 119.59 3.181 . . . . 0.0 119.59 -173.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -67.16 -58.7 4.37 Favored 'General case' 0 N--CA 1.506 2.333 0 CA-C-O 122.455 1.121 . . . . 0.0 113.718 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.1 mp -55.65 -53.38 37.57 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.711 0 C-N-CA 126.452 1.901 . . . . 0.0 110.412 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.9 -46.03 74.77 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.878 1.671 . . . . 0.0 110.656 175.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.8 mtm105 -57.82 -55.57 33.21 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-N 121.011 1.732 . . . . 0.0 110.44 176.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.84 -55.81 15.11 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.411 ' HB2' ' CE2' ' A' ' 147' ' ' PHE . 18.1 t80 -64.16 -50.58 67.61 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.342 36.2 mttt -67.13 -22.02 65.81 Favored 'General case' 0 CA--C 1.585 2.309 0 CA-C-O 116.556 -1.688 . . . . 0.0 110.068 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.6 t -69.6 -49.73 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 CA-C-N 122.394 2.361 . . . . 0.0 107.534 167.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -54.47 -34.91 62.42 Favored 'General case' 0 CA--C 1.58 2.113 0 N-CA-C 118.09 2.626 . . . . 0.0 118.09 -178.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.271 2.3 t0 -55.92 134.39 52.09 Favored 'General case' 0 CA--C 1.585 2.321 0 C-N-CA 127.513 2.325 . . . . 0.0 115.561 178.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.442 ' HB1' ' HG2' ' A' ' 109' ' ' GLU . . . -67.65 -60.79 2.26 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -76.21 -19.17 58.64 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 117.598 2.444 . . . . 0.0 117.598 -177.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.92 3.74 90.34 Favored Glycine 0 CA--C 1.568 3.346 0 CA-C-N 120.843 1.656 . . . . 0.0 114.754 -173.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -91.48 -17.55 25.54 Favored 'General case' 0 CA--C 1.58 2.126 0 CA-C-N 120.532 2.166 . . . . 0.0 113.395 173.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 113.36 24.46 4.75 Favored Glycine 0 CA--C 1.54 1.64 0 CA-C-O 115.541 -2.81 . . . . 0.0 116.987 -178.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.3 t -127.51 138.69 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 121.826 2.813 . . . . 0.0 109.783 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 61.5 mt -118.5 138.79 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 126.573 1.949 . . . . 0.0 109.582 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -110.22 -169.82 1.53 Allowed 'General case' 0 CA--C 1.585 2.308 0 C-N-CA 125.001 1.32 . . . . 0.0 110.834 176.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -81.59 -54.97 4.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.134 -1.604 . . . . 0.0 114.318 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -60.63 -43.87 97.03 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 117.534 -1.222 . . . . 0.0 112.807 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.442 ' HG2' ' HB1' ' A' ' 99' ' ' ALA . 11.2 tp10 -59.49 -44.44 93.08 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 121.025 1.739 . . . . 0.0 111.268 174.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.96 -51.75 68.34 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 119.486 1.039 . . . . 0.0 109.777 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -52.52 -42.25 64.19 Favored 'General case' 0 CA--C 1.573 1.864 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 175.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -69.75 -53.66 17.35 Favored 'General case' 0 CA--C 1.577 1.994 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 176.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.9 tt -72.72 -29.08 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 118.7 2.852 . . . . 0.0 118.7 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 6.2 tpt -45.92 -50.68 14.31 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.035 1.334 . . . . 0.0 112.342 178.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -100.46 88.4 3.64 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-O 123.781 1.753 . . . . 0.0 110.515 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.599 ' H ' ' HD3' ' A' ' 116' ' ' LYS . 0.5 OUTLIER -54.69 -52.24 63.01 Favored 'General case' 0 CA--C 1.57 1.74 0 CA-C-N 112.156 -2.293 . . . . 0.0 114.079 178.059 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 8.2 p -153.5 107.23 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.409 0 N-CA-C 104.53 -2.396 . . . . 0.0 104.53 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 108.5 -148.75 16.84 Favored Glycine 0 CA--C 1.546 2.0 0 C-N-CA 123.623 0.63 . . . . 0.0 114.247 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -126.22 135.01 51.07 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 124.138 0.975 . . . . 0.0 112.967 -178.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.34 10.3 pt-20 -144.63 -120.62 0.0 OUTLIER Pre-proline 0 CA--C 1.587 2.404 0 CA-C-O 111.704 -3.998 . . . . 0.0 106.695 178.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -81.87 87.49 1.42 Allowed 'Trans proline' 0 C--N 1.385 2.486 1 CA-C-N 132.107 5.36 . . . . 0.0 105.376 176.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.257 0.2 OUTLIER -110.11 77.72 1.07 Allowed 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 -172.771 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.654 ' HG1' ' HG3' ' A' ' 126' ' ' GLU . 18.8 p -165.62 158.08 15.19 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 175.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.64 -36.81 85.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.792 -1.192 . . . . 0.0 111.934 175.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.61 -49.65 67.95 Favored 'General case' 0 CA--C 1.56 1.329 0 CA-C-O 117.557 -1.211 . . . . 0.0 112.848 176.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.654 ' HG3' ' HG1' ' A' ' 123' ' ' THR . 17.5 mt-10 -58.09 -46.14 86.01 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-N 120.309 1.413 . . . . 0.0 112.483 176.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 62.4 t -69.34 -43.43 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.346 0 CA-C-O 116.627 -1.654 . . . . 0.0 110.992 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -63.46 -43.73 96.51 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 121.871 2.123 . . . . 0.0 112.467 177.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -64.73 -52.97 54.24 Favored 'General case' 0 CA--C 1.572 1.797 0 CA-C-N 119.517 1.053 . . . . 0.0 110.617 175.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.26 -43.36 96.22 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 177.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -69.68 -42.26 74.37 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 117.318 -1.325 . . . . 0.0 111.521 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -64.96 -36.74 85.38 Favored 'General case' 0 CA--C 1.572 1.813 0 CA-C-N 120.621 1.555 . . . . 0.0 111.252 175.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -64.88 -41.03 95.98 Favored 'General case' 0 CA--C 1.581 2.157 0 CA-C-N 120.884 1.674 . . . . 0.0 109.719 172.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.41 -23.88 67.06 Favored 'General case' 0 CA--C 1.576 1.965 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 174.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -88.39 100.85 13.35 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 171.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -62.13 -16.18 50.83 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 117.912 2.56 . . . . 0.0 117.912 177.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.94 -2.95 20.71 Favored 'General case' 0 N--CA 1.491 1.577 1 N-CA-C 121.958 4.059 . . . . 0.0 121.958 -173.75 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.35 6.98 88.97 Favored Glycine 0 CA--C 1.556 2.633 0 N-CA-C 118.289 2.076 . . . . 0.0 118.289 -178.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -78.56 -36.77 44.1 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 120.246 2.023 . . . . 0.0 114.083 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 96.85 21.92 19.63 Favored Glycine 0 CA--C 1.555 2.584 0 N-CA-C 117.063 1.585 . . . . 0.0 117.063 -177.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -149.67 145.22 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 103.383 -2.821 . . . . 0.0 103.383 176.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.19 133.9 64.91 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -176.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 19.3 p30 -103.83 165.01 11.31 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 169.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.6 mt -53.19 -45.17 98.44 Favored Pre-proline 0 N--CA 1.505 2.317 0 O-C-N 118.071 -2.893 . . . . 0.0 112.812 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -50.2 -35.03 41.68 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 123.937 3.091 . . . . 0.0 118.601 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -72.98 -45.79 55.95 Favored 'General case' 0 CA--C 1.591 2.53 0 CA-C-N 122.614 2.461 . . . . 0.0 112.937 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.411 ' CE2' ' HB2' ' A' ' 94' ' ' PHE . 4.7 t80 -56.32 -52.13 65.66 Favored 'General case' 0 N--CA 1.506 2.331 0 CA-C-N 120.726 1.603 . . . . 0.0 110.932 172.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 1.051 ' HE3' ' HZ1' ' A' ' 153' ' ' LYS 0.259 4.1 ptp -60.59 -39.12 86.93 Favored 'General case' 0 CA--C 1.589 2.452 0 CA-C-O 121.499 0.666 . . . . 0.0 111.057 176.737 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.414 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 17.6 t0 -52.65 -54.34 34.65 Favored 'General case' 0 N--CA 1.492 1.632 1 CA-C-O 109.296 -5.145 . . . . 0.0 106.006 171.823 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.43 -43.39 23.8 Favored 'General case' 0 N--CA 1.515 2.783 0 CA-C-N 123.699 2.954 . . . . 0.0 112.502 174.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.1 mt -73.76 30.26 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.613 3.376 0 C-N-CA 127.12 2.168 . . . . 0.0 109.61 169.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 149' ' ' ASP . 1.3 mmpt? 28.98 27.24 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.301 2 C-N-CA 132.888 4.475 . . . . 0.0 122.146 -167.326 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 1.051 ' HZ1' ' HE3' ' A' ' 148' ' ' MET . 85.3 tttt -87.94 -73.38 0.49 Allowed 'General case' 0 CA--C 1.573 1.858 0 CA-C-N 110.641 -2.982 . . . . 0.0 115.99 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.534 3.741 0 C-N-CA 124.916 1.286 . . . . 0.0 111.711 -178.494 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 . . . . . 0 CA--C 1.559 1.299 0 N-CA-C 114.295 1.221 . . . . 0.0 114.295 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -52.63 -44.41 66.05 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 117.921 2.563 . . . . 0.0 117.921 -177.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -64.0 -60.72 2.9 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 121.693 2.042 . . . . 0.0 113.413 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.636 ' CG2' ' HE2' ' A' ' 148' ' ' MET 0.297 1.1 mp -58.26 -50.9 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-O 117.164 -1.398 . . . . 0.0 111.209 178.004 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 pp -59.58 -42.89 93.53 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 116.967 -1.492 . . . . 0.0 111.668 177.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.86 -54.96 40.96 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 121.273 1.851 . . . . 0.0 111.43 176.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.13 -57.72 11.62 Favored 'General case' 0 C--N 1.358 0.961 0 CA-C-O 116.091 -1.909 . . . . 0.0 114.048 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.671 ' HB2' ' HE3' ' A' ' 148' ' ' MET . 19.2 t80 -58.97 -46.71 87.41 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 120.862 1.665 . . . . 0.0 114.336 178.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -63.72 -34.64 78.34 Favored 'General case' 0 CA--C 1.568 1.664 0 CA-C-O 116.341 -1.79 . . . . 0.0 111.483 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 75.1 t -64.73 -43.78 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 CA-C-N 122.146 2.248 . . . . 0.0 108.181 169.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.56 -31.19 63.96 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 117.272 2.323 . . . . 0.0 117.272 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -75.71 119.26 19.48 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 174.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.85 -71.57 0.06 Allowed 'General case' 0 N--CA 1.514 2.727 0 CA-C-O 123.908 1.813 . . . . 0.0 106.833 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -134.03 -55.3 0.87 Allowed 'General case' 0 CA--C 1.577 2.006 0 CA-C-N 109.682 -3.417 . . . . 0.0 103.977 167.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 30.87 9.58 0.0 OUTLIER Glycine 0 C--N 1.355 1.586 1 N-CA-C 125.548 4.979 . . . . 0.0 125.548 -175.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.2 p30 63.72 12.99 7.05 Favored 'General case' 0 CA--C 1.59 2.517 0 CA-C-N 122.231 3.015 . . . . 0.0 113.047 -171.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 110.76 -15.85 28.79 Favored Glycine 0 CA--C 1.57 3.478 0 CA-C-O 115.796 -2.669 . . . . 0.0 109.211 -170.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -99.59 138.89 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-N 122.436 3.118 . . . . 0.0 116.416 -179.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 18.6 mt -105.98 132.32 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 C-N-CA 125.108 1.363 . . . . 0.0 109.806 178.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.54 -174.89 2.64 Favored 'General case' 0 CA--C 1.584 2.263 0 CA-C-O 122.0 0.905 . . . . 0.0 112.398 176.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -72.41 -46.65 54.21 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.672 -1.267 . . . . 0.0 114.021 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -57.54 -49.01 77.75 Favored 'General case' 0 N--CA 1.504 2.273 0 CA-C-O 117.925 -1.036 . . . . 0.0 112.451 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -54.49 -43.72 72.03 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 120.201 1.364 . . . . 0.0 112.948 173.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.61 -55.14 33.94 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 116.981 -1.485 . . . . 0.0 107.642 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.495 ' HA ' ' SD ' ' A' ' 114' ' ' MET . 33.5 mtmm -55.54 -29.15 58.43 Favored 'General case' 0 N--CA 1.503 2.185 0 CA-C-N 121.131 1.787 . . . . 0.0 115.264 176.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -74.91 -53.59 8.76 Favored 'General case' 0 CA--C 1.574 1.902 0 C-N-CA 124.505 1.122 . . . . 0.0 110.746 175.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 tt -79.01 -16.56 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 118.492 2.775 . . . . 0.0 118.492 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.495 ' SD ' ' HA ' ' A' ' 111' ' ' LYS . 15.1 ptm -36.25 -38.37 0.14 Allowed 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 118.062 2.615 . . . . 0.0 118.062 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.81 98.39 3.11 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 102.739 -3.06 . . . . 0.0 102.739 176.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.455 ' HD2' ' H ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -62.17 -22.55 65.97 Favored 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 120.969 3.692 . . . . 0.0 120.969 -176.331 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 8.9 p -75.56 108.16 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-N 120.345 1.43 . . . . 0.0 110.982 -178.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.6 -113.87 5.57 Favored Glycine 0 CA--C 1.542 1.755 0 C-N-CA 123.589 0.614 . . . . 0.0 113.971 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -138.08 64.45 1.5 Allowed 'General case' 0 CA--C 1.57 1.732 0 CA-C-O 122.934 1.35 . . . . 0.0 109.765 178.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -76.91 -55.9 1.39 Allowed Pre-proline 0 CA--C 1.573 1.844 0 CA-C-O 112.697 -3.525 . . . . 0.0 116.885 -178.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . 0.282 61.4 Cg_exo 19.72 66.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.387 2.604 1 C-N-CA 125.487 4.125 . . . . 0.0 120.279 179.842 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.335 61.7 tp -79.92 -94.23 0.04 OUTLIER 'General case' 0 CA--C 1.563 1.474 0 CA-C-O 114.752 -2.547 . . . . 0.0 114.356 -175.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 41.6 p -103.72 126.12 50.65 Favored 'General case' 0 C--N 1.365 1.26 0 CA-C-N 124.73 3.423 . . . . 0.0 110.631 -178.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -71.44 -31.24 66.98 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-N 113.276 -1.784 . . . . 0.0 114.601 178.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.46 -40.85 75.54 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.52 1.128 . . . . 0.0 113.893 176.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -58.2 -48.78 79.28 Favored 'General case' 0 CA--C 1.584 2.284 0 CA-C-O 122.989 1.376 . . . . 0.0 112.567 176.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.0 t -63.17 -49.69 82.22 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.483 0 C-N-CA 126.852 2.061 . . . . 0.0 111.129 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -58.78 -42.99 90.31 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 124.253 1.021 . . . . 0.0 112.601 176.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -64.51 -48.02 76.72 Favored 'General case' 0 CA--C 1.577 1.989 0 CA-C-N 119.531 1.06 . . . . 0.0 111.828 176.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.57 -44.51 93.29 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 176.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 23.1 ttt -67.35 -39.46 85.76 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 116.866 -1.54 . . . . 0.0 112.412 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -62.07 -39.64 93.11 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 121.283 1.856 . . . . 0.0 111.093 175.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -62.87 -43.46 98.74 Favored 'General case' 0 CA--C 1.58 2.103 0 CA-C-N 119.565 1.075 . . . . 0.0 111.11 172.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -85.73 -8.08 58.39 Favored 'General case' 0 N--CA 1.486 1.338 1 N-CA-C 122.873 4.397 . . . . 0.0 122.873 -179.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.424 ' OD2' ' HA2' ' A' ' 140' ' ' GLY . 24.6 t0 -78.05 114.48 16.97 Favored 'General case' 0 N--CA 1.506 2.328 1 CA-C-O 96.312 -11.327 . . . . 0.0 109.467 177.255 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -81.07 26.49 0.43 Allowed 'General case' 0 C--N 1.26 -3.309 2 O-C-N 62.843 -37.411 . . . . 0.0 116.029 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.419 ' C ' ' H ' ' A' ' 139' ' ' ASN 0.372 32.8 t0 92.14 -103.2 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 101.907 -3.368 . . . . 0.0 101.907 -177.291 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 37.64 7.65 0.0 OUTLIER Glycine 0 CA--C 1.557 2.668 0 N-CA-C 120.564 2.985 . . . . 0.0 120.564 -174.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.518 ' OD1' HG21 ' A' ' 141' ' ' VAL . 5.0 t-20 157.45 -49.32 0.0 OUTLIER 'General case' 0 CA--C 1.572 1.813 0 C-N-CA 126.856 2.062 . . . . 0.0 114.337 -173.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.424 ' HA2' ' OD2' ' A' ' 135' ' ' ASP . . . 112.65 -23.46 15.09 Favored Glycine 0 CA--C 1.561 2.963 0 CA-C-N 123.241 2.746 . . . . 0.0 113.76 -173.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.518 HG21 ' OD1' ' A' ' 139' ' ' ASN . 19.7 m -115.63 127.55 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 101.921 -3.363 . . . . 0.0 101.921 176.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.6 mt -79.64 126.77 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 N-CA-C 118.366 2.728 . . . . 0.0 118.366 -172.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -94.0 149.78 20.93 Favored 'General case' 0 CA--C 1.561 1.393 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 171.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -49.58 -46.62 79.05 Favored Pre-proline 0 CA--C 1.574 1.869 0 CA-C-O 115.035 -2.412 . . . . 0.0 114.434 -177.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -57.42 -26.72 72.61 Favored 'Trans proline' 0 C--N 1.371 1.723 0 CA-C-N 124.926 2.795 . . . . 0.0 116.401 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -68.71 -54.86 13.63 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 123.138 2.699 . . . . 0.0 112.113 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -60.48 -46.47 89.97 Favored 'General case' 0 CA--C 1.578 2.057 0 CA-C-N 121.756 2.071 . . . . 0.0 112.612 176.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.671 ' HE3' ' HB2' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -62.4 -41.25 98.52 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-O 116.895 -1.526 . . . . 0.0 111.684 176.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.737 ' O ' ' HG2' ' A' ' 153' ' ' LYS . 2.3 t70 -68.91 -38.41 79.54 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 121.873 2.124 . . . . 0.0 111.902 175.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.09 -43.36 77.98 Favored 'General case' 0 CA--C 1.565 1.558 0 C-N-CA 126.011 1.725 . . . . 0.0 110.708 175.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 66.7 mt -87.31 -51.83 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 121.279 1.854 . . . . 0.0 112.368 177.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -65.62 -49.49 68.55 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.737 ' HG2' ' O ' ' A' ' 149' ' ' ASP . 59.5 pttt -94.38 -59.27 1.99 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 116.385 1.995 . . . . 0.0 116.385 -178.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.437 ' N ' ' HG3' ' A' ' 153' ' ' LYS . 11.4 p . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 -176.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.453 ' C ' ' H ' ' A' ' 89' ' ' GLU . 6.3 mt-10 . . . . . 0 CA--C 1.61 3.25 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -4.89 -20.18 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.455 2 C-N-CA 133.478 4.711 . . . . 0.0 123.47 -169.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.453 ' H ' ' C ' ' A' ' 87' ' ' GLU . 64.5 mm-40 -79.3 -68.42 0.66 Allowed 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 174.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.822 HG23 ' HE2' ' A' ' 148' ' ' MET . 1.6 mp -65.1 -35.79 76.25 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.013 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 172.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.0 -45.8 71.57 Favored 'General case' 0 N--CA 1.515 2.793 0 CA-C-N 124.048 3.113 . . . . 0.0 109.384 173.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.7 mtm105 -59.81 -56.15 25.37 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 120.642 1.564 . . . . 0.0 110.65 176.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.77 -59.93 3.94 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 116.074 -1.917 . . . . 0.0 114.904 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -59.65 -49.13 78.96 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 121.087 1.767 . . . . 0.0 113.297 178.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.371 36.5 mttt -69.11 -23.63 64.02 Favored 'General case' 0 CA--C 1.583 2.227 0 CA-C-O 116.631 -1.652 . . . . 0.0 110.333 -178.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.1 t -68.73 -48.91 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 CA-C-N 122.15 2.25 . . . . 0.0 107.103 166.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -53.3 -33.21 52.33 Favored 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.256 3.7 t0 -67.22 -3.62 8.27 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 117.83 2.53 . . . . 0.0 117.83 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 50.04 24.63 1.43 Allowed 'General case' 0 N--CA 1.524 3.258 0 CA-C-N 124.533 3.333 . . . . 0.0 115.404 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . 0.284 11.4 t-20 82.49 -53.1 0.21 Allowed 'General case' 0 CA--C 1.575 1.915 0 C-N-CA 129.834 3.254 . . . . 0.0 105.795 -170.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 30.94 20.55 0.0 OUTLIER Glycine 0 C--N 1.363 2.034 1 N-CA-C 125.272 4.869 . . . . 0.0 125.272 178.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 67.04 14.08 9.7 Favored 'General case' 0 CA--C 1.593 2.612 0 CA-C-N 120.821 2.311 . . . . 0.0 113.61 -173.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.89 -5.89 56.67 Favored Glycine 0 CA--C 1.568 3.373 0 CA-C-O 116.688 -2.173 . . . . 0.0 111.127 -172.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.4 t -117.37 136.42 54.57 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.94 0 CA-C-N 121.059 2.429 . . . . 0.0 113.385 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 67.9 mt -92.23 140.56 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 C-N-CA 126.587 1.955 . . . . 0.0 108.282 176.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.3 p30 -110.12 179.52 4.08 Favored 'General case' 0 CA--C 1.572 1.803 0 CA-C-O 122.666 1.222 . . . . 0.0 110.795 175.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -70.94 -43.01 69.09 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 117.391 -1.29 . . . . 0.0 114.437 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -63.62 -45.89 88.21 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 120.124 1.329 . . . . 0.0 112.157 177.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -58.86 -48.54 81.03 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 121.464 1.938 . . . . 0.0 112.731 175.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -59.1 -49.02 79.46 Favored 'General case' 0 CA--C 1.568 1.661 0 C-N-CA 123.502 0.721 . . . . 0.0 109.36 175.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.404 ' HA ' HG12 ' A' ' 127' ' ' VAL . 21.8 tptp -62.73 -12.81 26.28 Favored 'General case' 0 CA--C 1.577 2.01 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 175.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -93.3 -43.55 8.75 Favored 'General case' 0 CA--C 1.584 2.266 0 O-C-N 120.448 -1.407 . . . . 0.0 111.334 173.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -92.66 -29.24 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 1 N-CA-C 122.064 4.098 . . . . 0.0 122.064 -174.906 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 19.3 tpt -37.31 -65.25 0.32 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 126.001 1.72 . . . . 0.0 115.166 -176.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -97.31 77.11 2.64 Favored 'General case' 0 CA--C 1.569 1.686 0 CA-C-O 124.554 2.121 . . . . 0.0 110.746 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.37 153.37 1.55 Allowed 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 118.847 2.906 . . . . 0.0 118.847 177.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 41.1 t 60.54 98.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 C-N-CA 125.56 1.544 . . . . 0.0 112.917 177.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 81.03 -79.81 1.77 Allowed Glycine 0 CA--C 1.54 1.625 0 N-CA-C 116.013 1.165 . . . . 0.0 116.013 178.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.45 78.3 0.77 Allowed 'General case' 0 CA--C 1.568 1.644 0 CA-C-O 112.109 -3.805 . . . . 0.0 114.583 -178.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -97.62 131.03 27.77 Favored Pre-proline 0 N--CA 1.527 3.416 1 O-C-N 83.992 -24.193 . . . . 0.0 113.074 -170.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . 2.514 10.0 Cg_endo 35.21 43.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.505 2.175 0 N-CA-C 122.252 3.904 . . . . 0.0 122.252 -178.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.454 0.8 OUTLIER -91.68 -76.16 0.46 Allowed 'General case' 0 CA--C 1.564 1.507 0 CA-C-O 113.484 -3.151 . . . . 0.0 110.849 -175.204 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 38.0 p -84.86 127.12 34.0 Favored 'General case' 0 N--CA 1.487 1.41 1 CA-C-N 127.082 4.492 . . . . 0.0 107.313 177.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.17 -32.53 70.52 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.43 -44.45 96.4 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-O 116.594 -1.67 . . . . 0.0 113.619 177.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -43.36 97.19 Favored 'General case' 0 CA--C 1.577 1.996 0 CA-C-N 121.557 1.98 . . . . 0.0 113.68 178.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' A' ' 111' ' ' LYS . 6.5 t -70.62 -52.77 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-O 117.667 -1.159 . . . . 0.0 112.174 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -60.84 -47.15 87.65 Favored 'General case' 0 CA--C 1.558 1.272 0 CA-C-N 119.672 1.124 . . . . 0.0 111.451 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -61.57 -46.91 87.89 Favored 'General case' 0 CA--C 1.57 1.735 0 CA-C-N 120.653 1.57 . . . . 0.0 112.417 177.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.3 -43.77 96.91 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 177.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 17.5 ttt -73.7 -36.48 65.27 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 116.594 -1.67 . . . . 0.0 112.163 177.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -61.36 -44.15 97.67 Favored 'General case' 0 CA--C 1.569 1.692 0 CA-C-N 122.116 2.234 . . . . 0.0 109.982 173.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -64.74 -42.63 95.05 Favored 'General case' 0 CA--C 1.577 2.016 0 CA-C-N 120.922 1.692 . . . . 0.0 111.81 175.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -77.08 -21.15 54.79 Favored 'General case' 0 CA--C 1.564 1.484 0 N-CA-C 118.431 2.752 . . . . 0.0 118.431 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -87.53 113.46 23.25 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 103.66 -2.718 . . . . 0.0 103.66 175.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . 0.256 5.9 mt-10 -80.27 -18.17 50.08 Favored 'General case' 0 CA--C 1.576 1.948 0 CA-C-N 113.523 -1.672 . . . . 0.0 115.312 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -92.13 -15.61 27.44 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 117.035 2.235 . . . . 0.0 117.035 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.14 5.97 89.72 Favored Glycine 0 CA--C 1.564 3.108 0 CA-C-N 120.196 1.362 . . . . 0.0 116.081 -175.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -93.39 -45.85 7.61 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-O 117.267 -1.349 . . . . 0.0 114.088 177.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 114.29 22.63 5.12 Favored Glycine 0 CA--C 1.561 2.95 0 N-CA-C 118.111 2.004 . . . . 0.0 118.111 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.97 143.49 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.527 0 N-CA-C 102.836 -3.024 . . . . 0.0 102.836 174.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.69 139.97 48.55 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -175.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 59.6 p30 -96.96 165.57 12.02 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 170.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.3 mt -56.13 -43.64 99.34 Favored Pre-proline 0 N--CA 1.5 2.048 0 CA-C-O 115.007 -2.425 . . . . 0.0 112.826 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -55.25 -40.74 84.08 Favored 'Trans proline' 0 C--N 1.372 1.816 0 CA-C-N 124.491 2.64 . . . . 0.0 116.124 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -65.23 -52.85 51.95 Favored 'General case' 0 N--CA 1.505 2.276 0 CA-C-N 124.507 3.322 . . . . 0.0 113.321 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.671 ' CE2' HG22 ' A' ' 90' ' ' ILE . 22.9 t80 -54.33 -52.13 62.51 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 120.265 1.393 . . . . 0.0 113.053 172.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.822 ' HE2' HG23 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -68.62 -34.91 76.57 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 117.734 -1.127 . . . . 0.0 113.405 179.36 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -64.3 -35.25 80.23 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 119.478 1.035 . . . . 0.0 111.346 171.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -58.44 -52.13 66.91 Favored 'General case' 0 CA--C 1.562 1.431 0 C-N-CA 125.295 1.438 . . . . 0.0 110.07 173.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 95.9 mt -70.08 -53.5 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-O 117.592 -1.194 . . . . 0.0 113.321 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 17.5 pttm -67.87 -50.14 58.1 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -97.19 -65.88 0.94 Allowed 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 4.6 t . . . . . 0 N--CA 1.521 3.089 0 N-CA-C 103.716 -2.698 . . . . 0.0 103.716 -176.148 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 . . . . . 0 CA--C 1.579 2.064 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -48.06 -54.05 14.38 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 117.183 2.29 . . . . 0.0 117.183 -177.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -59.1 -52.28 66.4 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.631 HG23 ' CE ' ' A' ' 148' ' ' MET . 2.7 mp -61.58 -55.65 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 124.338 1.055 . . . . 0.0 111.482 178.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.1 pp -59.28 -41.97 90.16 Favored 'General case' 0 CA--C 1.556 1.211 0 CA-C-O 118.732 -0.652 . . . . 0.0 112.139 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 25.4 ttp85 -57.29 -55.47 34.37 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 117.617 -1.182 . . . . 0.0 110.008 176.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.34 -59.76 3.69 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.497 ' HB2' ' CE2' ' A' ' 147' ' ' PHE . 5.3 t80 -69.69 -48.7 58.75 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 121.652 2.024 . . . . 0.0 114.285 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.326 47.5 mttt -64.16 -20.48 66.02 Favored 'General case' 0 CA--C 1.586 2.36 0 CA-C-O 115.635 -2.126 . . . . 0.0 110.737 -178.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -80.29 -46.73 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.403 0 CA-C-N 123.09 2.677 . . . . 0.0 108.497 169.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -54.78 -38.45 67.28 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -49.35 110.2 0.35 Allowed 'General case' 0 CA--C 1.575 1.909 0 C-N-CA 126.258 1.823 . . . . 0.0 112.262 178.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -41.97 -75.59 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 -177.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -94.55 0.69 55.43 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 117.425 2.38 . . . . 0.0 117.425 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.94 6.49 88.33 Favored Glycine 0 CA--C 1.554 2.518 0 CA-C-O 116.476 -2.291 . . . . 0.0 118.316 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -88.96 -3.72 58.65 Favored 'General case' 0 CA--C 1.585 2.301 0 CA-C-N 121.902 2.851 . . . . 0.0 113.987 174.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.14 -22.31 18.47 Favored Glycine 0 CA--C 1.54 1.595 0 CA-C-O 115.814 -2.659 . . . . 0.0 116.869 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.1 m -92.52 140.64 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.358 0 CA-C-N 122.333 3.066 . . . . 0.0 112.371 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 89.7 mt -110.35 121.56 63.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 N-CA-C 100.477 -3.897 . . . . 0.0 100.477 172.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -92.93 169.13 10.68 Favored 'General case' 0 CA--C 1.559 1.305 0 CA-C-O 122.31 1.052 . . . . 0.0 113.327 178.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -67.67 -45.0 76.47 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 117.661 -1.161 . . . . 0.0 113.501 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -65.65 -45.86 81.38 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 117.284 -1.341 . . . . 0.0 112.224 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -64.42 -40.67 96.21 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 121.439 1.927 . . . . 0.0 112.409 176.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -63.38 -51.78 64.44 Favored 'General case' 0 CA--C 1.577 2.017 0 CA-C-N 120.26 1.391 . . . . 0.0 108.838 175.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -49.01 -42.83 39.4 Favored 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 125.384 1.474 . . . . 0.0 112.709 175.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -68.54 -60.47 2.4 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 123.675 0.79 . . . . 0.0 111.441 175.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.7 tt -62.16 -16.29 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 117.508 2.41 . . . . 0.0 117.508 -177.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 13.7 tpt -63.26 -68.24 0.36 Allowed 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 125.202 1.401 . . . . 0.0 109.006 175.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -133.73 115.22 14.31 Favored 'General case' 0 CA--C 1.566 1.595 1 N-CA-C 99.291 -4.337 . . . . 0.0 99.291 175.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.94 65.7 0.66 Allowed 'General case' 0 CA--C 1.573 1.846 1 N-CA-C 122.552 4.278 . . . . 0.0 122.552 -171.803 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -135.2 83.26 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 101.553 -3.499 . . . . 0.0 101.553 173.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.87 -126.99 18.31 Favored Glycine 0 CA--C 1.552 2.365 0 N-CA-C 107.327 -2.309 . . . . 0.0 107.327 -175.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -99.52 69.4 1.64 Allowed 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 174.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -68.83 -30.62 2.45 Favored Pre-proline 0 CA--C 1.56 1.336 1 CA-C-O 110.173 -4.727 . . . . 0.0 117.212 -177.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -38.88 90.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.385 2.471 1 CA-C-N 128.737 4.156 . . . . 0.0 117.823 178.491 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.396 2.7 tm? -69.75 -76.9 0.09 Allowed 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 109.583 -3.462 . . . . 0.0 110.779 -175.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 18.4 p -88.38 115.13 25.67 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 125.619 3.827 . . . . 0.0 103.118 175.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -64.12 -30.83 71.87 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 116.817 2.155 . . . . 0.0 116.817 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.18 -36.91 83.31 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-O 117.297 -1.335 . . . . 0.0 113.54 177.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -59.94 -51.11 71.06 Favored 'General case' 0 CA--C 1.576 1.963 0 CA-C-N 120.269 1.395 . . . . 0.0 112.595 177.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 24.4 t -68.28 -51.77 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.311 0 C-N-CA 124.617 1.167 . . . . 0.0 111.936 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -60.01 -46.4 89.62 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 120.057 1.299 . . . . 0.0 112.22 178.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -62.42 -43.1 99.61 Favored 'General case' 0 CA--C 1.57 1.748 0 CA-C-N 120.087 1.312 . . . . 0.0 111.928 176.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.7 -47.81 79.67 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-N 119.904 1.229 . . . . 0.0 114.113 176.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 14.7 ttt -70.46 -39.41 74.31 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 114.417 -2.706 . . . . 0.0 109.874 177.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -58.5 -39.27 79.59 Favored 'General case' 0 CA--C 1.582 2.199 0 CA-C-N 124.867 3.485 . . . . 0.0 110.224 173.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -60.7 -45.27 94.85 Favored 'General case' 0 CA--C 1.582 2.178 0 CA-C-N 121.494 1.952 . . . . 0.0 110.954 173.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.65 -11.44 59.08 Favored 'General case' 0 CA--C 1.58 2.104 0 N-CA-C 117.173 2.286 . . . . 0.0 117.173 178.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -91.84 115.2 27.86 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 101.22 -3.622 . . . . 0.0 101.22 167.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -69.18 -20.6 64.0 Favored 'General case' 0 CA--C 1.561 1.38 0 N-CA-C 119.846 3.276 . . . . 0.0 119.846 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -145.96 25.93 1.26 Allowed 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 120.99 3.7 . . . . 0.0 120.99 -174.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.29 7.68 88.31 Favored Glycine 0 CA--C 1.555 2.59 0 N-CA-C 117.237 1.655 . . . . 0.0 117.237 -177.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -66.78 -44.8 80.37 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-N 120.303 2.052 . . . . 0.0 112.99 176.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 103.0 -21.43 40.15 Favored Glycine 0 CA--C 1.55 2.254 0 N-CA-C 117.032 1.573 . . . . 0.0 117.032 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 13.8 m -126.12 138.6 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 103.693 -2.706 . . . . 0.0 103.693 176.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.1 mt -104.71 133.7 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 114.032 -1.44 . . . . 0.0 113.622 -174.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 28.0 p30 -95.44 152.12 18.69 Favored 'General case' 0 CA--C 1.565 1.52 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 171.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -52.28 -45.16 94.62 Favored Pre-proline 0 CA--C 1.583 2.241 0 CA-C-O 114.772 -2.537 . . . . 0.0 114.001 -177.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.43 -29.65 78.56 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 123.735 2.957 . . . . 0.0 117.716 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -60.01 -55.57 32.34 Favored 'General case' 0 N--CA 1.505 2.286 0 CA-C-N 121.209 1.822 . . . . 0.0 112.125 176.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.538 ' CE2' HG21 ' A' ' 90' ' ' ILE . 36.4 t80 -55.67 -51.91 65.63 Favored 'General case' 0 CA--C 1.577 2.005 0 C-N-CA 126.61 1.964 . . . . 0.0 111.075 173.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.631 ' CE ' HG23 ' A' ' 90' ' ' ILE . 4.7 mtp -56.59 -46.84 80.62 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 117.015 -1.469 . . . . 0.0 111.793 177.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.25 -35.75 74.02 Favored 'General case' 0 CA--C 1.576 1.949 0 CA-C-N 120.837 1.653 . . . . 0.0 111.016 176.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.46 -35.87 65.96 Favored 'General case' 0 CA--C 1.577 2.016 0 CA-C-N 120.327 1.421 . . . . 0.0 110.205 172.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 85.7 mt -82.57 -59.6 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.451 0 CA-C-N 120.572 1.533 . . . . 0.0 109.987 175.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -85.74 6.32 28.36 Favored 'General case' 0 CA--C 1.578 2.028 1 N-CA-C 122.243 4.164 . . . . 0.0 122.243 -176.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -25.5 -38.11 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 121.292 3.812 . . . . 0.0 121.292 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 12.0 t . . . . . 0 N--CA 1.512 2.66 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 175.899 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 . . . . . 0 N--CA 1.5 2.026 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.636 HG23 ' CE2' ' A' ' 147' ' ' PHE . 2.0 mp -68.84 -48.3 71.48 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.43 0 CA-C-O 116.762 -1.59 . . . . 0.0 109.92 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.5 pp -62.92 -38.43 90.95 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 121.559 1.981 . . . . 0.0 110.372 176.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -56.88 -58.0 10.06 Favored 'General case' 0 CA--C 1.574 1.883 0 CA-C-N 120.945 1.702 . . . . 0.0 109.429 174.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.85 -57.72 11.24 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 117.283 -1.342 . . . . 0.0 114.337 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.468 ' CE2' HD12 ' A' ' 105' ' ' ILE . 18.1 t80 -57.23 -46.42 82.98 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 119.905 1.23 . . . . 0.0 112.518 177.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -62.41 -35.3 78.81 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-O 116.037 -1.935 . . . . 0.0 112.363 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.2 t -66.6 -43.28 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 CA-C-N 122.451 2.387 . . . . 0.0 107.935 170.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -55.82 -41.24 73.93 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -66.07 114.17 5.02 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 174.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.29 50.83 0.66 Allowed 'General case' 0 N--CA 1.507 2.397 0 CA-C-O 123.304 1.526 . . . . 0.0 111.577 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . 0.296 10.1 t-20 84.9 -61.93 0.08 Allowed 'General case' 0 CA--C 1.57 1.716 0 C-N-CA 128.699 2.799 . . . . 0.0 103.968 -170.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 28.97 15.23 0.0 OUTLIER Glycine 0 C--N 1.357 1.699 1 N-CA-C 125.074 4.79 . . . . 0.0 125.074 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.2 p30 64.51 13.34 8.11 Favored 'General case' 0 CA--C 1.597 2.783 0 CA-C-N 121.74 2.77 . . . . 0.0 112.269 -169.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.85 -6.49 54.49 Favored Glycine 0 CA--C 1.559 2.84 0 CA-C-O 115.968 -2.573 . . . . 0.0 111.264 -171.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -101.86 144.44 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.709 0 CA-C-N 121.818 2.809 . . . . 0.0 113.985 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.468 HD12 ' CE2' ' A' ' 94' ' ' PHE . 57.3 mt -111.78 128.68 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-N 113.196 -1.82 . . . . 0.0 108.681 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -106.58 -176.72 3.16 Favored 'General case' 0 CA--C 1.572 1.822 0 CA-C-O 121.739 0.78 . . . . 0.0 112.102 176.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -70.69 -49.63 45.19 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.861 -1.15 . . . . 0.0 113.793 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -62.49 -42.91 99.82 Favored 'General case' 0 CA--C 1.578 2.052 0 CA-C-O 117.427 -1.273 . . . . 0.0 111.461 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -54.13 -44.81 71.68 Favored 'General case' 0 CA--C 1.573 1.842 0 CA-C-N 121.558 1.981 . . . . 0.0 112.332 173.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -69.38 -49.53 54.56 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -58.75 -15.86 14.08 Favored 'General case' 0 CA--C 1.58 2.1 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 173.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -93.33 -53.32 4.14 Favored 'General case' 0 CA--C 1.582 2.18 0 CA-C-N 120.129 1.331 . . . . 0.0 110.995 173.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.48 -23.12 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 120.13 3.382 . . . . 0.0 120.13 -175.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.502 2.142 0 C-N-CA 125.034 1.334 . . . . 0.0 112.078 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 10.4 p . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.96 -34.82 75.96 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 113.239 -1.8 . . . . 0.0 115.468 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.24 -39.79 76.29 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -59.85 -49.47 77.59 Favored 'General case' 0 CA--C 1.584 2.285 0 CA-C-O 122.261 1.029 . . . . 0.0 112.317 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.3 t -64.54 -50.44 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.793 0 C-N-CA 126.101 1.76 . . . . 0.0 111.184 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -58.3 -42.99 87.86 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 123.52 0.728 . . . . 0.0 112.674 176.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -61.41 -51.15 69.96 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.531 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.18 -45.32 93.53 Favored 'General case' 0 CA--C 1.561 1.393 0 N-CA-C 115.435 1.642 . . . . 0.0 115.435 177.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.6 ttt -71.44 -42.1 68.66 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 117.328 -1.32 . . . . 0.0 111.748 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.46 -43.85 84.35 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 120.907 1.685 . . . . 0.0 110.744 174.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.59 -30.11 68.79 Favored 'General case' 0 CA--C 1.581 2.146 0 CA-C-N 121.165 1.802 . . . . 0.0 113.043 174.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.37 -23.51 37.65 Favored 'General case' 0 CA--C 1.582 2.183 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.603 ' OD2' ' HA2' ' A' ' 140' ' ' GLY . 17.8 t0 -84.72 108.17 17.28 Favored 'General case' 0 CA--C 1.578 2.043 0 N-CA-C 104.079 -2.563 . . . . 0.0 104.079 171.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -76.09 -29.05 57.78 Favored 'General case' 0 CA--C 1.587 2.382 0 CA-C-N 120.556 1.525 . . . . 0.0 113.515 177.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.274 0.1 OUTLIER -166.02 -75.93 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.376 1 N-CA-C 99.075 -4.416 . . . . 0.0 99.075 177.127 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 34.15 30.13 0.01 OUTLIER Glycine 0 C--N 1.372 2.531 0 CA-C-N 123.309 2.777 . . . . 0.0 119.399 175.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.38 -3.21 0.68 Allowed 'General case' 0 CA--C 1.593 2.615 0 CA-C-N 119.629 1.715 . . . . 0.0 114.438 -172.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.603 ' HA2' ' OD2' ' A' ' 135' ' ' ASP . . . 106.41 -23.34 28.75 Favored Glycine 0 CA--C 1.559 2.817 0 CA-C-N 122.983 2.629 . . . . 0.0 113.78 -175.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . 0.257 27.8 m -118.6 133.43 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 103.542 -2.762 . . . . 0.0 103.542 178.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.03 126.93 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 117.492 2.404 . . . . 0.0 117.492 -172.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.4 p30 -90.76 156.2 18.23 Favored 'General case' 0 CA--C 1.564 1.502 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 172.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 5.5 mt -55.72 -49.31 93.56 Favored Pre-proline 0 CA--C 1.574 1.886 0 CA-C-O 114.482 -2.675 . . . . 0.0 114.191 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -52.26 -31.62 47.21 Favored 'Trans proline' 0 C--N 1.374 1.908 0 CA-C-N 125.434 2.977 . . . . 0.0 116.444 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -63.21 -61.06 2.62 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 121.142 1.792 . . . . 0.0 114.326 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.636 ' CE2' HG23 ' A' ' 90' ' ' ILE . 27.9 t80 -53.26 -50.78 64.12 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 120.179 1.354 . . . . 0.0 113.682 177.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . 0.255 0.1 OUTLIER -68.77 -47.23 66.74 Favored 'General case' 0 C--N 1.352 0.711 0 CA-C-O 113.924 -2.941 . . . . 0.0 111.18 179.229 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.28 -29.45 69.87 Favored 'General case' 0 CA--C 1.586 2.345 0 CA-C-N 125.585 3.812 . . . . 0.0 112.715 175.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . 0.291 5.3 tt -57.98 -40.95 81.94 Favored 'General case' 0 CA--C 1.575 1.922 0 C-N-CA 125.711 1.605 . . . . 0.0 109.799 172.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 55.7 mt -90.4 -64.73 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.604 3.034 0 CA-C-N 120.312 1.414 . . . . 0.0 109.941 173.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.591 2.556 0 N-CA-C 121.018 3.71 . . . . 0.0 121.018 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.571 1.753 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.654 HG21 ' HB3' ' A' ' 148' ' ' MET . 6.7 mt -69.22 -52.67 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.118 0 CA-C-O 116.153 -1.879 . . . . 0.0 110.986 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.2 pp -55.66 -43.66 76.5 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 121.555 1.98 . . . . 0.0 108.84 176.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -54.67 -49.31 70.93 Favored 'General case' 0 CA--C 1.571 1.782 0 CA-C-N 121.184 1.811 . . . . 0.0 112.69 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.95 -56.72 10.27 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-O 116.03 -1.938 . . . . 0.0 114.666 178.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.482 ' CE2' HD12 ' A' ' 105' ' ' ILE . 10.1 t80 -64.83 -42.3 95.05 Favored 'General case' 0 N--CA 1.509 2.479 0 CA-C-N 122.47 2.396 . . . . 0.0 112.734 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.285 6.1 mmpt? -62.56 -30.44 71.32 Favored 'General case' 0 CA--C 1.577 1.995 0 CA-C-O 117.625 -1.178 . . . . 0.0 110.869 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.8 t -71.69 -50.16 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-N 120.451 1.478 . . . . 0.0 108.324 169.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -58.0 -37.91 75.14 Favored 'General case' 0 CA--C 1.579 2.063 0 N-CA-C 116.728 2.121 . . . . 0.0 116.728 -177.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.297 6.5 t0 -59.33 90.6 0.02 OUTLIER 'General case' 0 CA--C 1.571 1.761 0 C-N-CA 128.495 2.718 . . . . 0.0 109.967 176.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.07 -49.06 66.33 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.534 -0.729 . . . . 0.0 112.106 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -48.68 -24.86 1.52 Allowed 'General case' 0 CA--C 1.585 2.298 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 175.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.59 8.59 86.76 Favored Glycine 0 CA--C 1.56 2.884 0 CA-C-N 122.04 2.2 . . . . 0.0 116.953 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.06 86.61 2.22 Favored 'General case' 0 N--CA 1.473 0.723 1 CA-C-O 110.533 -4.556 . . . . 0.0 107.039 176.596 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 54.72 -25.11 0.01 OUTLIER Glycine 0 N--CA 1.489 2.214 2 N-CA-C 130.798 7.079 . . . . 0.0 130.798 162.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.7 p -114.39 151.95 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.811 0 CA-C-O 122.726 1.25 . . . . 0.0 112.887 -178.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.482 HD12 ' CE2' ' A' ' 94' ' ' PHE . 63.4 mt -129.34 136.25 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 CA-C-N 113.55 -1.659 . . . . 0.0 111.317 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -115.75 -177.8 3.24 Favored 'General case' 0 CA--C 1.589 2.471 0 C-N-CA 124.087 0.955 . . . . 0.0 110.062 174.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -74.21 -47.25 36.66 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 -176.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -61.65 -42.78 99.37 Favored 'General case' 0 N--CA 1.514 2.729 0 CA-C-N 122.256 2.298 . . . . 0.0 113.539 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -56.03 -39.89 72.63 Favored 'General case' 0 N--CA 1.504 2.243 0 CA-C-N 119.325 0.966 . . . . 0.0 111.678 173.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -63.38 -46.57 85.85 Favored 'General case' 0 CA--C 1.571 1.787 0 C-N-CA 124.914 1.286 . . . . 0.0 109.36 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -53.5 -50.86 64.5 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 123.89 0.876 . . . . 0.0 111.668 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -57.77 -53.83 53.78 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 176.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.5 tt -74.0 -29.3 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 119.366 3.099 . . . . 0.0 119.366 -176.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.443 ' SD ' ' HA ' ' A' ' 127' ' ' VAL . 6.3 tpt . . . . . 0 N--CA 1.498 1.957 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.418 ' OG1' ' HG2' ' A' ' 126' ' ' GLU . 1.4 p . . . . . 0 CA--C 1.557 1.239 0 N-CA-C 102.273 -3.232 . . . . 0.0 102.273 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -67.6 -34.75 77.64 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 115.925 1.824 . . . . 0.0 115.925 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.75 -38.7 75.81 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-O 116.74 -1.6 . . . . 0.0 113.279 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.418 ' HG2' ' OG1' ' A' ' 123' ' ' THR . 9.2 pt-20 -68.29 -39.46 82.08 Favored 'General case' 0 CA--C 1.572 1.812 0 CA-C-N 121.442 1.928 . . . . 0.0 112.456 176.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.443 ' HA ' ' SD ' ' A' ' 114' ' ' MET . 0.4 OUTLIER -70.39 -48.56 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 119.216 0.916 . . . . 0.0 112.32 177.766 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -66.59 -49.4 66.46 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 116.77 -1.586 . . . . 0.0 109.504 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -55.98 -47.96 76.71 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 122.256 2.298 . . . . 0.0 113.526 176.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.78 -46.2 89.12 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-O 117.644 -1.169 . . . . 0.0 113.85 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 14.8 ttt -77.21 -37.21 53.9 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 116.478 -1.725 . . . . 0.0 110.658 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -32.9 69.83 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 123.927 3.058 . . . . 0.0 109.977 172.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -73.3 -44.22 59.5 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-O 116.309 -1.805 . . . . 0.0 110.477 176.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -80.73 -35.38 33.53 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 117.611 2.448 . . . . 0.0 117.611 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -90.3 119.81 30.92 Favored 'General case' 0 N--CA 1.514 2.771 1 O-C-N 116.099 -4.126 . . . . 0.0 106.069 176.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -75.27 -32.9 61.18 Favored 'General case' 0 CA--C 1.58 2.109 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 177.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.301 0.1 OUTLIER 175.75 -73.49 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.368 1 N-CA-C 96.516 -5.364 . . . . 0.0 96.516 178.771 . . . . . . . . 4 3 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 34.92 32.16 0.02 OUTLIER Glycine 0 C--N 1.373 2.616 0 CA-C-N 123.681 2.946 . . . . 0.0 118.696 174.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 55.0 17.79 2.0 Favored 'General case' 0 CA--C 1.592 2.59 0 CA-C-O 115.739 -2.077 . . . . 0.0 115.18 -173.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 92.81 -22.36 34.29 Favored Glycine 0 C--N 1.38 3.009 0 CA-C-N 124.486 3.312 . . . . 0.0 114.979 -176.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.27 146.68 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 176.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.7 mt -123.1 131.42 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 112.594 -2.094 . . . . 0.0 110.375 -177.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 42.3 p30 -97.88 158.64 15.41 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 105.199 -2.149 . . . . 0.0 105.199 171.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -56.33 -44.57 99.78 Favored Pre-proline 0 CA--C 1.587 2.385 0 CA-C-O 114.971 -2.442 . . . . 0.0 112.833 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.18 -36.15 35.75 Favored 'Trans proline' 0 C--N 1.382 2.342 0 C-N-CA 124.294 3.329 . . . . 0.0 117.107 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -65.61 -56.17 13.67 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 121.623 2.01 . . . . 0.0 110.835 175.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.451 ' CE2' ' HB2' ' A' ' 94' ' ' PHE . 21.4 t80 -55.38 -50.14 70.49 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.654 ' HB3' HG21 ' A' ' 90' ' ' ILE 0.257 4.0 ptp -66.34 -41.73 89.16 Favored 'General case' 0 CA--C 1.577 2.019 0 CA-C-O 117.478 -1.249 . . . . 0.0 111.316 178.204 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -60.2 -35.07 74.57 Favored 'General case' 0 N--CA 1.508 2.46 0 CA-C-N 121.018 1.736 . . . . 0.0 114.258 173.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . 0.356 6.8 tt -69.15 -34.73 75.44 Favored 'General case' 0 CA--C 1.567 1.627 0 C-N-CA 127.838 2.455 . . . . 0.0 110.302 176.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 79.2 mt -69.52 -48.79 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 CA-C-N 121.051 1.751 . . . . 0.0 106.879 171.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.581 2.135 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 . . . . . 0 CA--C 1.581 2.145 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.455 ' H ' HD12 ' A' ' 90' ' ' ILE . 0.7 OUTLIER -78.12 -52.71 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -178.341 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -63.51 -50.32 70.08 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 115.754 -2.069 . . . . 0.0 111.258 -177.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.97 -28.89 63.73 Favored 'General case' 0 CA--C 1.571 1.775 0 CA-C-O 114.374 -2.727 . . . . 0.0 111.243 176.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.98 -53.2 53.92 Favored 'General case' 0 C--N 1.38 1.925 0 CA-C-N 124.5 3.318 . . . . 0.0 111.378 174.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.472 ' CE2' HD12 ' A' ' 105' ' ' ILE . 21.1 t80 -62.03 -42.9 99.67 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 119.81 1.186 . . . . 0.0 112.821 176.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.492 ' HE2' HD13 ' A' ' 144' ' ' ILE . 58.1 mttt -63.68 -34.51 78.01 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 116.589 -1.672 . . . . 0.0 111.9 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -70.34 -44.84 77.14 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.197 0 CA-C-N 121.711 2.05 . . . . 0.0 108.557 171.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -56.34 -31.94 64.22 Favored 'General case' 0 CA--C 1.576 1.967 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -60.33 118.97 7.07 Favored 'General case' 0 CA--C 1.575 1.927 0 C-N-CA 125.812 1.645 . . . . 0.0 111.951 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.483 ' CB ' ' HG2' ' A' ' 109' ' ' GLU . . . -77.33 -52.51 9.04 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 -178.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.9 p30 -72.74 -8.67 56.52 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 117.88 2.548 . . . . 0.0 117.88 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.2 8.92 87.16 Favored Glycine 0 CA--C 1.555 2.539 0 N-CA-C 119.523 2.569 . . . . 0.0 119.523 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.6 p30 -114.4 -12.56 12.35 Favored 'General case' 0 CA--C 1.575 1.928 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 177.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.34 22.21 5.92 Favored Glycine 0 CA--C 1.548 2.132 0 CA-C-O 116.325 -2.375 . . . . 0.0 115.985 -178.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.3 t -132.61 138.74 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-N 121.366 2.583 . . . . 0.0 109.734 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.472 HD12 ' CE2' ' A' ' 94' ' ' PHE . 44.0 mt -119.76 136.71 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 126.059 1.744 . . . . 0.0 110.746 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -99.13 -175.08 2.92 Favored 'General case' 0 CA--C 1.576 1.969 0 C-N-CA 124.083 0.953 . . . . 0.0 112.678 176.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -82.23 -51.66 7.72 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 119.961 -1.712 . . . . 0.0 113.833 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -62.28 -46.33 89.27 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 119.681 1.128 . . . . 0.0 112.59 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.483 ' HG2' ' CB ' ' A' ' 99' ' ' ALA . 37.1 tp10 -63.81 -35.49 80.77 Favored 'General case' 0 CA--C 1.57 1.723 0 CA-C-N 119.68 1.127 . . . . 0.0 113.064 176.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -61.07 -48.85 79.82 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 119.845 1.202 . . . . 0.0 107.815 171.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 56.6 tttt -64.64 -9.27 18.41 Favored 'General case' 0 CA--C 1.581 2.164 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 174.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -94.37 -50.05 5.42 Favored 'General case' 0 CA--C 1.593 2.601 0 C-N-CA 125.336 1.454 . . . . 0.0 111.017 171.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.6 tt -80.21 -28.31 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 120.889 3.663 . . . . 0.0 120.889 -175.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 1.1 tpt . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 -178.883 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 30.6 p . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 122.952 1.358 . . . . 0.0 107.47 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -59.16 -37.99 78.67 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 112.223 -2.262 . . . . 0.0 115.369 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.27 -39.37 90.12 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-O 117.243 -1.36 . . . . 0.0 114.305 177.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -61.28 -52.89 62.84 Favored 'General case' 0 CA--C 1.577 1.982 0 CA-C-N 120.967 1.712 . . . . 0.0 112.631 177.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.6 t -69.43 -49.92 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 CA-C-O 117.529 -1.224 . . . . 0.0 112.255 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.19 -44.18 97.17 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 116.688 -1.625 . . . . 0.0 110.486 177.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -59.3 -52.04 67.35 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 122.488 2.404 . . . . 0.0 112.199 176.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.62 -44.56 95.98 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.521 ' SD ' HD11 ' A' ' 142' ' ' ILE . 18.4 tpt -73.56 -37.44 65.53 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 115.94 -1.981 . . . . 0.0 111.992 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -60.15 -49.12 78.89 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 122.92 2.6 . . . . 0.0 110.788 174.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -69.67 -26.94 64.62 Favored 'General case' 0 CA--C 1.575 1.936 0 CA-C-O 118.048 -0.977 . . . . 0.0 112.761 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.15 -21.34 27.62 Favored 'General case' 0 CA--C 1.58 2.108 0 CA-C-N 119.996 1.271 . . . . 0.0 114.347 175.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -88.46 109.28 19.9 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 122.757 2.526 . . . . 0.0 105.234 171.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -77.31 -25.17 50.98 Favored 'General case' 0 CA--C 1.576 1.958 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -86.61 -16.31 37.1 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 118.206 2.669 . . . . 0.0 118.206 -176.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.61 5.23 90.06 Favored Glycine 0 CA--C 1.565 3.173 0 CA-C-N 119.936 1.244 . . . . 0.0 115.367 -174.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -86.82 -29.82 21.96 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-N 119.167 1.483 . . . . 0.0 114.885 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 104.93 23.35 7.82 Favored Glycine 0 CA--C 1.554 2.497 0 CA-C-N 120.581 1.537 . . . . 0.0 116.607 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.88 152.69 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 123.543 1.64 . . . . 0.0 107.858 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.521 HD11 ' SD ' ' A' ' 131' ' ' MET . 0.8 OUTLIER -136.82 130.78 46.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 112.535 -2.121 . . . . 0.0 112.06 -177.504 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 34.1 p30 -97.67 162.27 13.36 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 104.72 -2.326 . . . . 0.0 104.72 170.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.492 HD13 ' HE2' ' A' ' 95' ' ' LYS . 4.4 mt -56.22 -49.25 94.33 Favored Pre-proline 0 CA--C 1.582 2.194 0 CA-C-O 113.413 -3.184 . . . . 0.0 110.905 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -47.73 -31.63 15.09 Favored 'Trans proline' 0 C--N 1.377 2.035 0 CA-C-N 127.011 3.54 . . . . 0.0 120.555 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -71.62 -66.34 0.64 Allowed 'General case' 0 N--CA 1.506 2.331 0 CA-C-N 122.663 2.483 . . . . 0.0 110.053 177.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -51.04 -41.76 60.05 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 124.596 1.158 . . . . 0.0 112.884 173.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.4 ' HA ' HG21 ' A' ' 90' ' ' ILE 0.268 0.0 OUTLIER -70.65 -45.21 65.55 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-O 113.658 -3.068 . . . . 0.0 110.808 -179.538 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.78 -44.25 90.63 Favored 'General case' 0 CA--C 1.583 2.232 0 CA-C-N 124.051 3.114 . . . . 0.0 111.776 175.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 7.9 tt -50.98 -47.59 61.4 Favored 'General case' 0 C--N 1.365 1.279 0 C-N-CA 126.216 1.807 . . . . 0.0 112.701 176.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 45.8 mt -90.24 -33.06 5.72 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.212 0 CA-C-N 121.099 1.772 . . . . 0.0 110.992 176.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt . . . . . 0 N--CA 1.503 2.193 0 CA-C-N 120.836 1.653 . . . . 0.0 114.599 176.343 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 . . . . . 0 CA--C 1.564 1.486 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.592 HG23 ' CE2' ' A' ' 147' ' ' PHE . 3.6 mp -74.68 -58.37 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 CA-C-N 122.274 2.306 . . . . 0.0 109.334 177.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . 0.254 0.3 OUTLIER -62.92 -42.01 99.66 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 121.843 2.11 . . . . 0.0 110.038 179.167 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -60.88 -52.73 63.81 Favored 'General case' 0 CA--C 1.572 1.815 0 CA-C-N 121.921 2.146 . . . . 0.0 110.772 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.31 -54.94 16.21 Favored 'General case' 0 C--N 1.363 1.166 0 CA-C-O 116.009 -1.948 . . . . 0.0 115.49 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.499 ' CE2' HD12 ' A' ' 105' ' ' ILE . 9.8 t80 -63.32 -50.79 68.65 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 121.74 2.064 . . . . 0.0 112.28 178.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.332 78.5 mttt -64.52 -22.78 67.06 Favored 'General case' 0 CA--C 1.591 2.536 0 CA-C-O 117.372 -1.299 . . . . 0.0 111.199 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -73.14 -49.85 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 CA-C-N 121.266 1.848 . . . . 0.0 108.233 168.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -50.13 -37.62 35.13 Favored 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -61.2 115.72 4.02 Favored 'General case' 0 CA--C 1.578 2.024 0 C-N-CA 125.558 1.543 . . . . 0.0 112.722 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -77.65 -51.62 10.32 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.4 p30 -68.92 -13.19 62.28 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 117.777 2.51 . . . . 0.0 117.777 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.5 7.51 88.47 Favored Glycine 0 CA--C 1.553 2.422 0 N-CA-C 119.559 2.584 . . . . 0.0 119.559 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.1 p30 -104.33 -15.13 15.53 Favored 'General case' 0 CA--C 1.576 1.977 0 CA-C-N 119.535 1.667 . . . . 0.0 114.773 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.59 20.83 6.73 Favored Glycine 0 CA--C 1.545 1.941 0 CA-C-O 116.201 -2.444 . . . . 0.0 116.415 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -131.8 137.04 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 121.654 2.727 . . . . 0.0 110.856 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.499 HD12 ' CE2' ' A' ' 94' ' ' PHE . 58.8 mt -109.35 139.74 31.01 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 CA-C-N 112.058 -2.337 . . . . 0.0 108.36 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -118.83 -173.7 2.54 Favored 'General case' 0 CA--C 1.574 1.881 0 C-N-CA 124.242 1.017 . . . . 0.0 111.215 176.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -72.27 -53.42 12.54 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.657 -1.277 . . . . 0.0 113.877 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -56.61 -47.26 80.01 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 118.278 0.49 . . . . 0.0 112.305 177.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.26 -50.49 67.12 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 174.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.96 -51.77 66.76 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 124.621 1.168 . . . . 0.0 110.419 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.24 -8.95 50.61 Favored 'General case' 0 CA--C 1.577 1.991 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 176.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -92.08 -40.57 10.98 Favored 'General case' 0 CA--C 1.584 2.27 0 C-N-CA 124.902 1.281 . . . . 0.0 110.711 172.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.6 tt -91.41 -36.33 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 121.317 3.821 . . . . 0.0 121.317 -174.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 7.1 tpt . . . . . 0 N--CA 1.499 1.986 0 N-CA-C 117.525 2.416 . . . . 0.0 117.525 -176.114 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 16.8 p . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 122.401 1.096 . . . . 0.0 108.507 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -59.67 -38.02 80.35 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 116.963 2.209 . . . . 0.0 116.963 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.0 -45.37 79.07 Favored 'General case' 0 CA--C 1.554 1.12 0 O-C-N 124.493 1.121 . . . . 0.0 113.612 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -57.88 -50.79 72.14 Favored 'General case' 0 CA--C 1.579 2.068 0 CA-C-O 122.287 1.041 . . . . 0.0 112.517 176.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.9 t -67.51 -41.49 85.99 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.612 0 CA-C-N 114.003 -1.453 . . . . 0.0 112.162 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -63.66 -46.46 85.52 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 120.415 1.462 . . . . 0.0 109.91 175.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -57.54 -51.1 70.86 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 120.753 1.615 . . . . 0.0 112.199 175.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.4 -46.68 88.0 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.5 ttt -69.05 -39.24 79.27 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.806 177.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.87 -41.43 95.96 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 121.423 1.92 . . . . 0.0 109.827 174.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -64.64 -32.76 74.56 Favored 'General case' 0 CA--C 1.584 2.288 0 CA-C-N 121.017 1.735 . . . . 0.0 112.146 173.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.61 -26.72 34.64 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -78.97 109.43 13.25 Favored 'General case' 0 N--CA 1.516 2.861 0 CA-C-N 123.188 2.722 . . . . 0.0 109.98 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -86.58 -19.74 28.95 Favored 'General case' 0 CA--C 1.58 2.129 0 N-CA-C 117.142 2.275 . . . . 0.0 117.142 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -85.01 -14.42 47.46 Favored 'General case' 0 N--CA 1.507 2.409 1 N-CA-C 122.641 4.312 . . . . 0.0 122.641 -171.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.68 6.34 85.63 Favored Glycine 0 CA--C 1.57 3.507 0 CA-C-N 121.032 1.742 . . . . 0.0 114.958 -172.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -88.11 -51.41 5.81 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.187 1.395 . . . . 0.0 110.478 175.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 110.76 -20.18 24.91 Favored Glycine 0 CA--C 1.543 1.799 0 CA-C-O 115.695 -2.725 . . . . 0.0 115.894 -177.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . 0.259 13.0 m -126.64 124.06 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 101.152 -3.647 . . . . 0.0 101.152 176.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.436 HG21 HD13 ' A' ' 142' ' ' ILE . 0.5 OUTLIER -77.77 124.72 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 -172.344 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -93.05 160.21 14.96 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 171.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.6 mt -57.32 -42.82 97.95 Favored Pre-proline 0 CA--C 1.579 2.081 0 CA-C-O 114.859 -2.496 . . . . 0.0 113.352 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.51 -38.45 74.82 Favored 'Trans proline' 0 C--N 1.376 1.99 0 CA-C-N 125.202 2.894 . . . . 0.0 116.703 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -68.17 -38.44 82.06 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 122.215 2.28 . . . . 0.0 113.947 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.592 ' CE2' HG23 ' A' ' 90' ' ' ILE . 69.4 t80 -64.9 -47.12 78.93 Favored 'General case' 0 CA--C 1.578 2.044 0 CA-C-N 121.411 1.914 . . . . 0.0 110.659 172.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.574 ' HG2' HG21 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -59.22 -44.07 92.31 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-N 118.45 0.568 . . . . 0.0 111.964 176.141 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -65.11 -44.95 87.07 Favored 'General case' 0 CA--C 1.568 1.672 0 C-N-CA 124.356 1.062 . . . . 0.0 109.85 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.28 -45.27 65.4 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.781 1.232 . . . . 0.0 111.915 174.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 97.0 mt -77.86 -50.57 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-O 116.862 -1.542 . . . . 0.0 114.187 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 84.3 mttt . . . . . 0 CA--C 1.565 1.542 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -176.615 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 . . . . . 0 CA--C 1.62 3.657 0 CA-C-O 127.938 3.732 . . . . 0.0 111.461 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.654 HG23 ' CE2' ' A' ' 147' ' ' PHE . 13.9 mm -70.71 -43.98 76.88 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.642 0 CA-C-N 109.066 -3.697 . . . . 0.0 109.167 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -58.35 -43.53 88.39 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 121.826 2.103 . . . . 0.0 109.476 175.756 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.436 ' O ' ' HB ' ' A' ' 96' ' ' VAL . 9.2 mmt-85 -55.25 -51.37 66.85 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 122.326 2.33 . . . . 0.0 107.536 175.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.83 -65.06 0.72 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 117.604 2.446 . . . . 0.0 117.604 177.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.589 ' HB2' ' CD2' ' A' ' 147' ' ' PHE . 18.3 t80 -67.36 -48.76 66.5 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 91' ' ' LEU 0.369 1.4 mmmp? -69.08 -19.2 64.07 Favored 'General case' 0 CA--C 1.589 2.443 0 CA-C-O 115.07 -2.395 . . . . 0.0 109.229 -179.328 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.436 ' HB ' ' O ' ' A' ' 92' ' ' ARG . 0.8 OUTLIER -73.57 -45.99 49.62 Favored 'Isoleucine or valine' 0 C--N 1.394 2.532 0 CA-C-N 124.388 3.267 . . . . 0.0 105.597 166.726 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -52.73 -35.66 56.37 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 176.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.4 105.68 0.79 Allowed 'General case' 0 CA--C 1.577 2.005 0 C-N-CA 125.106 1.362 . . . . 0.0 109.432 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.07 -44.43 97.39 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 115.764 1.765 . . . . 0.0 115.764 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -69.62 -19.31 63.64 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 117.647 2.462 . . . . 0.0 117.647 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.62 21.35 64.22 Favored Glycine 0 CA--C 1.558 2.755 0 N-CA-C 118.14 2.016 . . . . 0.0 118.14 -177.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.58 -28.1 7.27 Favored 'General case' 0 CA--C 1.578 2.026 0 CA-C-N 119.388 1.594 . . . . 0.0 114.402 177.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 121.33 21.3 3.1 Favored Glycine 0 CA--C 1.548 2.11 0 CA-C-O 116.943 -2.031 . . . . 0.0 117.232 -175.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 p -124.69 150.61 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.668 0 CA-C-N 120.581 2.191 . . . . 0.0 109.379 173.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.5 HD12 ' CE2' ' A' ' 94' ' ' PHE . 96.3 mt -122.02 132.92 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-N 114.249 -1.341 . . . . 0.0 109.061 178.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.498 ' H ' ' HG2' ' A' ' 109' ' ' GLU . 0.5 OUTLIER -109.75 179.12 4.21 Favored 'General case' 0 CA--C 1.582 2.173 0 CA-C-O 121.983 0.897 . . . . 0.0 111.749 175.196 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.29 -47.59 23.16 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.645 -1.284 . . . . 0.0 114.33 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -61.75 -38.72 89.0 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 117.706 -1.14 . . . . 0.0 110.443 175.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.498 ' HG2' ' H ' ' A' ' 106' ' ' ASP . 5.4 pt-20 -65.01 -36.4 84.27 Favored 'General case' 0 CA--C 1.576 1.945 0 CA-C-N 121.022 1.737 . . . . 0.0 111.346 173.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -62.94 -48.48 78.71 Favored 'General case' 0 C--N 1.376 1.759 0 CA-C-N 120.99 1.723 . . . . 0.0 109.433 175.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 35.0 mttp -54.99 -52.12 64.09 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 123.9 0.88 . . . . 0.0 111.656 174.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -52.43 -47.95 66.05 Favored 'General case' 0 CA--C 1.571 1.763 0 C-N-CA 124.332 1.053 . . . . 0.0 113.518 175.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -81.47 -14.17 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 12.8 tpt . . . . . 0 N--CA 1.493 1.688 0 C-N-CA 125.575 1.55 . . . . 0.0 109.536 176.13 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 38.0 p . . . . . 0 N--CA 1.486 1.332 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.77 -37.14 85.51 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.52 -35.89 61.18 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -62.06 -55.67 26.74 Favored 'General case' 0 CA--C 1.587 2.393 0 CA-C-N 120.458 1.481 . . . . 0.0 111.659 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.1 t -63.47 -47.35 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 124.846 1.259 . . . . 0.0 111.216 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -57.77 -48.59 79.23 Favored 'General case' 0 CA--C 1.559 1.319 0 CA-C-O 118.101 -0.952 . . . . 0.0 111.887 176.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -58.53 -48.13 81.9 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 120.211 1.369 . . . . 0.0 112.489 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.96 -51.61 68.92 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -68.49 -34.42 75.89 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 115.263 -2.303 . . . . 0.0 112.113 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -65.26 -39.45 92.64 Favored 'General case' 0 CA--C 1.57 1.747 0 CA-C-N 122.739 2.518 . . . . 0.0 110.243 173.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -59.41 -40.74 87.62 Favored 'General case' 0 CA--C 1.574 1.874 0 CA-C-N 122.085 2.22 . . . . 0.0 110.559 173.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -78.38 -25.34 46.21 Favored 'General case' 0 CA--C 1.577 1.993 0 N-CA-C 116.872 2.175 . . . . 0.0 116.872 175.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -89.43 115.43 26.87 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 118.938 -2.351 . . . . 0.0 107.191 175.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -76.48 -27.73 56.22 Favored 'General case' 0 CA--C 1.566 1.567 0 N-CA-C 117.779 2.511 . . . . 0.0 117.779 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -105.88 -12.54 15.81 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 119.293 3.071 . . . . 0.0 119.293 -174.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.65 4.69 90.22 Favored Glycine 0 CA--C 1.572 3.627 0 CA-C-N 120.129 1.331 . . . . 0.0 113.623 -172.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -71.73 -45.94 60.15 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 125.282 1.433 . . . . 0.0 110.661 175.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 110.83 -4.88 29.1 Favored Glycine 0 CA--C 1.541 1.661 0 CA-C-O 115.075 -3.069 . . . . 0.0 117.598 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . 0.336 0.9 OUTLIER -136.91 118.85 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-N 123.093 3.446 . . . . 0.0 104.362 175.507 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.9 mt -85.21 130.88 35.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 109.385 -3.552 . . . . 0.0 111.835 -175.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 41.4 p30 -94.22 155.1 17.21 Favored 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 171.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -53.55 -44.98 98.76 Favored Pre-proline 0 CA--C 1.586 2.364 0 CA-C-O 114.427 -2.702 . . . . 0.0 113.468 -178.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -46.08 -37.82 18.31 Favored 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 124.634 3.556 . . . . 0.0 117.211 177.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -61.37 -55.29 33.23 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 119.364 0.983 . . . . 0.0 112.029 175.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.654 ' CE2' HG23 ' A' ' 90' ' ' ILE . 66.7 t80 -57.61 -45.38 85.43 Favored 'General case' 0 CA--C 1.577 1.996 0 C-N-CA 125.805 1.642 . . . . 0.0 112.721 175.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.9 -36.25 82.73 Favored 'General case' 0 CA--C 1.586 2.337 0 CA-C-O 117.865 -1.064 . . . . 0.0 110.142 177.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -70.71 -40.33 72.9 Favored 'General case' 0 CA--C 1.583 2.216 0 CA-C-N 120.58 1.537 . . . . 0.0 110.797 172.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -50.66 -45.41 57.98 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 126.037 1.735 . . . . 0.0 109.254 173.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 62.2 mt -83.14 -63.05 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.484 0 CA-C-N 119.847 1.203 . . . . 0.0 112.18 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt . . . . . 0 N--CA 1.493 1.707 0 N-CA-C 117.62 2.452 . . . . 0.0 117.62 -177.12 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 . . . . . 0 N--CA 1.501 2.086 0 N-CA-C 115.378 1.621 . . . . 0.0 115.378 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.777 ' H ' HD12 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -70.82 -54.43 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-O 117.168 -1.396 . . . . 0.0 113.331 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . 0.279 0.0 OUTLIER -61.3 -40.05 92.71 Favored 'General case' 0 CA--C 1.568 1.663 0 CA-C-N 120.117 1.326 . . . . 0.0 110.315 -178.607 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.05 -57.93 9.74 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-N 120.767 1.621 . . . . 0.0 110.786 175.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.66 -57.41 8.16 Favored 'General case' 0 C--N 1.364 1.21 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -64.01 -47.69 79.28 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 117.141 -1.409 . . . . 0.0 113.091 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.293 31.1 mttm -66.3 -24.32 66.52 Favored 'General case' 0 CA--C 1.582 2.18 0 CA-C-O 117.008 -1.472 . . . . 0.0 110.601 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.6 t -68.88 -50.01 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-N 121.719 2.054 . . . . 0.0 108.167 168.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.54 -37.8 73.66 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 116.739 2.126 . . . . 0.0 116.739 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 1.245 ' OD2' ' HA ' ' A' ' 102' ' ' ASP . 12.1 t0 -62.46 111.21 1.94 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 126.103 1.761 . . . . 0.0 112.461 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.42 -28.2 41.74 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -76.23 8.98 2.84 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.0 7.0 84.38 Favored Glycine 0 CA--C 1.564 3.115 0 N-CA-C 120.03 2.772 . . . . 0.0 120.03 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 1.245 ' HA ' ' OD2' ' A' ' 98' ' ' ASP 0.79 0.2 OUTLIER 116.75 126.04 0.0 OUTLIER 'General case' 0 CA--C 1.584 2.273 0 C-N-CA 130.27 3.428 . . . . 0.0 118.025 171.092 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 114.81 12.25 10.44 Favored Glycine 0 N--CA 1.441 -1.032 2 C-N-CA 134.471 5.796 . . . . 0.0 115.291 176.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.743 ' O ' ' OD1' ' A' ' 98' ' ' ASP . 0.5 OUTLIER -170.53 156.4 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.571 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 179.225 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 78.5 mt -133.03 130.3 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 127.013 2.125 . . . . 0.0 107.77 175.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -108.72 171.47 7.41 Favored 'General case' 0 CA--C 1.595 2.696 0 C-N-CA 123.806 0.843 . . . . 0.0 110.532 175.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.414 ' HA ' ' SD ' ' A' ' 131' ' ' MET . 27.0 t80 -64.07 -60.41 3.27 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 117.787 2.514 . . . . 0.0 117.787 -176.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -59.84 -27.33 66.54 Favored 'General case' 0 N--CA 1.508 2.425 0 CA-C-N 119.823 1.192 . . . . 0.0 112.713 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -63.55 -42.17 98.4 Favored 'General case' 0 CA--C 1.578 2.023 0 CA-C-N 119.462 1.028 . . . . 0.0 110.455 172.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -62.41 -53.0 61.34 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 125.555 1.542 . . . . 0.0 109.65 174.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -51.23 -44.53 61.71 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 175.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -66.55 -53.83 30.34 Favored 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 125.515 1.526 . . . . 0.0 112.686 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -67.75 -21.87 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 -178.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.505 2.291 0 CA-C-N 119.283 0.947 . . . . 0.0 111.099 172.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.4 p . . . . . 0 CA--C 1.566 1.593 0 N-CA-C 102.351 -3.203 . . . . 0.0 102.351 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -54.74 -33.96 61.86 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.444 -1.41 . . . . 0.0 114.792 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.21 -46.05 88.84 Favored 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 124.259 1.024 . . . . 0.0 112.63 175.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -64.21 -40.0 95.15 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 119.682 1.128 . . . . 0.0 112.252 176.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.9 p -67.52 -37.62 79.14 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.908 0 CA-C-N 119.85 1.204 . . . . 0.0 110.648 176.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -66.02 -45.04 82.93 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 119.661 1.119 . . . . 0.0 111.771 175.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -66.63 -41.17 88.74 Favored 'General case' 0 CA--C 1.574 1.884 0 O-C-N 120.894 -1.129 . . . . 0.0 113.249 176.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.93 -48.28 79.61 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.686 176.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.414 ' SD ' ' HA ' ' A' ' 107' ' ' PHE . 21.2 ttt -67.42 -36.2 80.78 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 115.415 -2.231 . . . . 0.0 110.792 175.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.18 -36.7 84.48 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 123.358 2.799 . . . . 0.0 111.868 175.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -62.37 -44.61 96.05 Favored 'General case' 0 CA--C 1.583 2.217 0 CA-C-N 119.531 1.06 . . . . 0.0 109.883 172.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -72.99 -26.73 61.44 Favored 'General case' 0 CA--C 1.583 2.233 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 176.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -80.36 111.71 17.01 Favored 'General case' 0 CA--C 1.56 1.36 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 175.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -72.68 -20.71 61.19 Favored 'General case' 0 CA--C 1.579 2.059 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -91.19 -17.22 26.42 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 117.68 2.474 . . . . 0.0 117.68 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.07 5.45 89.69 Favored Glycine 0 CA--C 1.563 3.085 0 CA-C-N 120.17 1.35 . . . . 0.0 115.905 -175.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 53.5 p-10 -87.54 -32.54 19.33 Favored 'General case' 0 CA--C 1.568 1.666 0 CA-C-N 119.408 1.604 . . . . 0.0 115.101 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 107.92 20.11 8.63 Favored Glycine 0 CA--C 1.559 2.797 0 N-CA-C 116.926 1.53 . . . . 0.0 116.926 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.19 152.63 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 142' ' ' ILE . 1.4 mt -137.5 131.33 44.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 112.164 -2.289 . . . . 0.0 111.743 -178.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 51.3 p30 -96.39 163.74 12.93 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 171.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 3.3 mt -56.76 -45.76 99.91 Favored Pre-proline 0 CA--C 1.582 2.203 0 CA-C-O 114.225 -2.798 . . . . 0.0 112.181 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -48.45 -38.01 34.26 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 124.216 3.277 . . . . 0.0 117.474 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -67.57 -52.27 40.7 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 120.751 1.614 . . . . 0.0 111.632 177.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.643 ' CE1' HG23 ' A' ' 90' ' ' ILE . 6.9 t80 -58.23 -48.17 81.21 Favored 'General case' 0 CA--C 1.569 1.7 0 CA-C-N 120.589 1.54 . . . . 0.0 112.577 176.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.666 ' HB3' HG21 ' A' ' 90' ' ' ILE . 2.0 ptp -64.19 -39.79 94.73 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-O 116.984 -1.484 . . . . 0.0 113.523 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -68.8 -33.95 74.72 Favored 'General case' 0 CA--C 1.585 2.305 0 CA-C-N 121.053 1.751 . . . . 0.0 109.312 172.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.02 -46.39 71.8 Favored 'General case' 0 CA--C 1.576 1.975 0 CA-C-N 120.15 1.341 . . . . 0.0 111.368 174.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 82.6 mt -80.52 -62.46 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.58 2.125 0 C-N-CA 123.472 0.709 . . . . 0.0 111.725 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.777 ' HE2' HD11 ' A' ' 90' ' ' ILE . 22.9 mttm . . . . . 0 CA--C 1.583 2.242 0 N-CA-C 118.952 2.945 . . . . 0.0 118.952 -177.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 . . . . . 0 CA--C 1.569 1.7 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.573 HG23 ' CE2' ' A' ' 147' ' ' PHE . 0.1 OUTLIER -67.97 -58.7 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-N 119.855 1.207 . . . . 0.0 109.129 177.597 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.5 pp -59.39 -49.02 79.4 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 117.904 -1.046 . . . . 0.0 112.087 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -64.83 -45.07 87.73 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-N 120.327 1.421 . . . . 0.0 112.902 178.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.36 -54.85 16.92 Favored 'General case' 0 C--N 1.365 1.265 0 CA-C-O 115.355 -2.26 . . . . 0.0 112.172 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.534 ' CE2' HD12 ' A' ' 105' ' ' ILE . 6.9 t80 -60.74 -47.2 87.36 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 121.707 2.049 . . . . 0.0 112.719 177.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.25 91.3 mttt -62.13 -31.38 71.85 Favored 'General case' 0 CA--C 1.58 2.132 0 CA-C-O 117.276 -1.345 . . . . 0.0 111.909 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.4 t -70.01 -48.15 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 CA-C-N 121.166 1.803 . . . . 0.0 108.956 170.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -53.52 -36.69 62.03 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 -178.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -65.29 93.47 0.14 Allowed 'General case' 0 CA--C 1.57 1.712 0 C-N-CA 126.161 1.784 . . . . 0.0 110.802 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.01 -42.71 80.28 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -65.19 -28.05 69.12 Favored 'General case' 0 CA--C 1.581 2.149 0 CA-C-O 117.344 -1.312 . . . . 0.0 113.839 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.02 3.82 90.62 Favored Glycine 0 CA--C 1.554 2.509 0 CA-C-N 121.903 2.138 . . . . 0.0 118.276 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 27.1 p-10 -97.7 -5.26 35.57 Favored 'General case' 0 CA--C 1.581 2.151 0 CA-C-N 120.788 2.294 . . . . 0.0 114.084 174.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.13 8.46 21.78 Favored Glycine 0 CA--C 1.551 2.295 0 CA-C-O 115.756 -2.691 . . . . 0.0 115.999 -177.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -126.14 153.21 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-N 121.865 2.833 . . . . 0.0 114.153 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.534 HD12 ' CE2' ' A' ' 94' ' ' PHE . 74.0 mt -116.24 132.2 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 112.11 -2.314 . . . . 0.0 108.876 177.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -108.83 -169.61 1.52 Allowed 'General case' 0 CA--C 1.581 2.159 0 C-N-CA 122.977 0.511 . . . . 0.0 110.374 174.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -80.31 -47.16 14.94 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.065 -1.647 . . . . 0.0 114.353 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -57.01 -44.95 83.3 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 123.042 0.537 . . . . 0.0 112.259 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -61.51 -42.25 98.53 Favored 'General case' 0 CA--C 1.583 2.228 0 CA-C-N 119.094 0.861 . . . . 0.0 112.613 174.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -54.83 -49.15 71.76 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 125.124 1.37 . . . . 0.0 109.809 174.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.0 mmmt -59.09 -60.94 3.05 Favored 'General case' 0 CA--C 1.57 1.718 0 CA-C-O 118.256 -0.878 . . . . 0.0 109.382 174.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -41.89 -41.22 2.36 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 116.845 2.165 . . . . 0.0 116.845 177.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 10.7 mt -93.61 -45.63 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 N-CA-C 119.287 3.069 . . . . 0.0 119.287 -177.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 3.5 tpt . . . . . 0 N--CA 1.498 1.93 0 N-CA-C 119.63 3.196 . . . . 0.0 119.63 -175.509 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . 0.28 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.854 0 N-CA-C 118.621 2.822 . . . . 0.0 118.621 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -0.53 -7.07 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.974 2 N-CA-C 125.343 5.312 . . . . 0.0 125.343 -164.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.33 -48.67 19.18 Favored 'General case' 0 CA--C 1.564 1.509 0 C-N-CA 126.359 1.864 . . . . 0.0 108.3 173.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.1 -41.65 75.54 Favored 'General case' 0 CA--C 1.579 2.068 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 174.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.7 t -68.22 -49.33 68.14 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 C-N-CA 126.108 1.763 . . . . 0.0 109.692 178.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -58.37 -43.41 88.45 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 119.952 1.251 . . . . 0.0 111.754 175.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.01 -54.05 49.66 Favored 'General case' 0 CA--C 1.576 1.954 0 CA-C-N 120.573 1.533 . . . . 0.0 111.644 176.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.68 -43.79 93.88 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.58 -40.89 69.61 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 116.806 -1.568 . . . . 0.0 110.616 177.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -37.95 82.49 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 121.621 2.009 . . . . 0.0 110.319 173.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -69.95 -34.54 73.57 Favored 'General case' 0 CA--C 1.571 1.75 0 CA-C-N 120.744 1.611 . . . . 0.0 112.316 175.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -78.94 -25.94 43.59 Favored 'General case' 0 CA--C 1.578 2.021 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -87.71 98.45 11.45 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 102.869 -3.011 . . . . 0.0 102.869 171.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -83.0 -13.71 55.41 Favored 'General case' 0 CA--C 1.579 2.07 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -91.18 -14.53 30.91 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 118.763 2.875 . . . . 0.0 118.763 -175.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.15 6.2 89.02 Favored Glycine 0 CA--C 1.565 3.186 0 CA-C-O 118.454 -1.192 . . . . 0.0 115.115 -174.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.93 -50.11 15.89 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 119.454 1.627 . . . . 0.0 110.984 176.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 111.66 -15.54 26.7 Favored Glycine 0 CA--C 1.546 1.978 0 CA-C-O 115.78 -2.678 . . . . 0.0 116.773 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . 0.302 3.8 m -133.34 120.63 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 100.823 -3.769 . . . . 0.0 100.823 175.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.3 mt -77.87 125.88 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 111.489 -2.596 . . . . 0.0 115.755 -172.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 36.5 p30 -91.68 152.9 20.01 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 172.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -51.34 -42.43 81.65 Favored Pre-proline 0 CA--C 1.583 2.239 0 CA-C-O 114.802 -2.523 . . . . 0.0 113.706 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.66 -29.5 80.02 Favored 'Trans proline' 0 C--N 1.376 1.998 0 CA-C-N 125.454 2.983 . . . . 0.0 116.991 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -66.97 -54.84 17.93 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 122.83 2.559 . . . . 0.0 111.446 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.573 ' CE2' HG23 ' A' ' 90' ' ' ILE . 74.2 t80 -61.89 -45.88 91.81 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-N 120.202 1.365 . . . . 0.0 110.515 175.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.26 -47.22 75.78 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-O 116.359 -1.781 . . . . 0.0 111.089 176.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.65 -36.86 76.45 Favored 'General case' 0 CA--C 1.574 1.876 0 CA-C-N 122.288 2.313 . . . . 0.0 113.437 177.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.48 -41.89 81.57 Favored 'General case' 0 CA--C 1.57 1.738 0 C-N-CA 124.84 1.256 . . . . 0.0 110.503 174.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.439 HG21 HD11 ' A' ' 90' ' ' ILE . 5.4 mm -80.0 -43.52 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.8 0 CA-C-O 116.263 -1.827 . . . . 0.0 109.363 176.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 8.7 mttp . . . . . 0 N--CA 1.511 2.592 0 CA-C-N 122.426 2.375 . . . . 0.0 112.589 176.973 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.419 HD11 HG21 ' A' ' 151' ' ' ILE . 1.3 mp -72.78 -45.83 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-O 115.625 -2.131 . . . . 0.0 108.71 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.0 pp -59.66 -46.94 87.52 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 123.111 2.687 . . . . 0.0 110.329 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -57.09 -58.88 6.28 Favored 'General case' 0 CA--C 1.568 1.647 0 C-N-CA 124.286 1.034 . . . . 0.0 112.378 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.46 -58.15 9.7 Favored 'General case' 0 C--N 1.353 0.735 0 CA-C-O 115.711 -2.09 . . . . 0.0 113.346 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -55.66 -50.96 68.83 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 121.551 1.978 . . . . 0.0 113.228 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -62.6 -33.19 74.48 Favored 'General case' 0 CA--C 1.562 1.412 0 CA-C-O 116.307 -1.806 . . . . 0.0 112.553 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -72.35 -44.39 63.13 Favored 'Isoleucine or valine' 0 CA--C 1.59 2.496 0 CA-C-N 121.854 2.115 . . . . 0.0 109.626 171.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -51.7 -35.72 43.89 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 127.098 2.159 . . . . 0.0 115.094 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.255 1.3 t0 -67.26 96.52 0.48 Allowed 'General case' 0 CA--C 1.576 1.967 0 C-N-CA 126.202 1.801 . . . . 0.0 107.342 177.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.04 -49.7 71.34 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.273 1.582 . . . . 0.0 115.273 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -62.33 -24.05 67.11 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.35 7.98 87.7 Favored Glycine 0 CA--C 1.551 2.32 0 N-CA-C 120.327 2.891 . . . . 0.0 120.327 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.8 p30 -96.97 -11.33 24.72 Favored 'General case' 0 CA--C 1.575 1.932 0 CA-C-N 119.78 1.79 . . . . 0.0 115.563 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.49 18.4 8.07 Favored Glycine 0 CA--C 1.552 2.396 0 CA-C-O 116.781 -2.122 . . . . 0.0 114.594 -176.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.45 154.98 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.501 0 CA-C-N 120.826 2.313 . . . . 0.0 111.78 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 79.1 mt -126.54 127.06 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-N 112.368 -2.196 . . . . 0.0 108.217 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -106.21 179.03 4.39 Favored 'General case' 0 CA--C 1.578 2.042 0 CA-C-O 121.857 0.837 . . . . 0.0 110.673 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -69.73 -42.32 74.12 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.15 -45.25 93.7 Favored 'General case' 0 N--CA 1.505 2.281 0 CA-C-N 120.566 1.53 . . . . 0.0 113.829 177.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -63.52 -46.3 86.69 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.917 0.887 . . . . 0.0 112.139 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -62.76 -50.96 68.99 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 117.0 -1.476 . . . . 0.0 110.983 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.0 pptp? -58.27 -39.9 80.44 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 121.235 1.834 . . . . 0.0 114.318 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -65.31 -49.32 69.9 Favored 'General case' 0 CA--C 1.575 1.909 0 C-N-CA 123.407 0.683 . . . . 0.0 112.385 175.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -79.56 -32.37 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 118.723 2.86 . . . . 0.0 118.723 -177.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.495 ' HG2' HG22 ' A' ' 127' ' ' VAL . 14.0 tpt . . . . . 0 N--CA 1.488 1.434 0 C-N-CA 125.692 1.597 . . . . 0.0 114.548 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 10.0 p . . . . . 0 N--CA 1.485 1.314 1 N-CA-C 99.775 -4.157 . . . . 0.0 99.775 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -53.47 -38.36 63.55 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 118.565 2.802 . . . . 0.0 118.565 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.44 -42.16 91.28 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 117.052 -1.452 . . . . 0.0 113.597 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -55.19 -53.43 56.11 Favored 'General case' 0 CA--C 1.573 1.842 0 CA-C-N 120.255 1.388 . . . . 0.0 112.63 176.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.495 HG22 ' HG2' ' A' ' 114' ' ' MET . 18.2 t -73.74 -53.79 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-O 117.197 -1.382 . . . . 0.0 113.829 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -64.2 -40.72 96.68 Favored 'General case' 0 CA--C 1.564 1.514 0 CA-C-N 120.061 1.3 . . . . 0.0 112.52 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -69.56 -43.87 72.04 Favored 'General case' 0 CA--C 1.574 1.891 0 CA-C-N 120.036 1.289 . . . . 0.0 111.228 176.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.57 -46.51 89.58 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 120.616 1.553 . . . . 0.0 113.247 176.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 19.8 ttt -70.27 -39.12 75.12 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 114.818 -2.515 . . . . 0.0 111.761 177.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -64.52 -35.38 80.78 Favored 'General case' 0 CA--C 1.574 1.872 0 CA-C-N 123.99 3.086 . . . . 0.0 111.595 175.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -62.85 -48.43 79.07 Favored 'General case' 0 CA--C 1.579 2.08 0 CA-C-N 121.654 2.025 . . . . 0.0 109.083 172.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.46 -25.08 63.91 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 177.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -90.06 100.57 13.37 Favored 'General case' 0 CA--C 1.573 1.856 0 N-CA-C 103.071 -2.937 . . . . 0.0 103.071 171.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -72.88 -16.56 61.57 Favored 'General case' 0 CA--C 1.579 2.095 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -98.55 -14.57 19.9 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 119.016 2.969 . . . . 0.0 119.016 -175.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.03 5.9 89.33 Favored Glycine 0 CA--C 1.57 3.482 0 CA-C-N 120.411 1.46 . . . . 0.0 115.138 -173.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -75.82 -47.18 26.7 Favored 'General case' 0 CA--C 1.563 1.466 0 C-N-CA 125.441 1.496 . . . . 0.0 112.195 176.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 111.84 -25.04 13.66 Favored Glycine 0 CA--C 1.553 2.455 0 CA-C-O 117.354 -1.803 . . . . 0.0 114.311 -176.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -100.68 143.16 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 N-CA-C 103.725 -2.694 . . . . 0.0 103.725 174.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.7 mt -121.84 124.87 72.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 111.982 -2.372 . . . . 0.0 112.665 -176.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 39.0 p30 -91.43 155.06 18.72 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 170.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.4 mt -52.13 -42.45 86.08 Favored Pre-proline 0 CA--C 1.583 2.237 0 CA-C-O 114.902 -2.475 . . . . 0.0 113.285 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -58.59 -17.8 36.8 Favored 'Trans proline' 0 C--N 1.376 1.992 0 CA-C-N 125.27 2.918 . . . . 0.0 117.976 176.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -72.53 -63.22 1.2 Allowed 'General case' 0 N--CA 1.505 2.28 0 CA-C-N 123.102 2.683 . . . . 0.0 109.469 176.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -54.55 -49.05 71.24 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 125.128 1.371 . . . . 0.0 110.908 173.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.3 mmt -64.6 -34.93 79.43 Favored 'General case' 0 CA--C 1.565 1.556 0 CA-C-O 115.454 -2.212 . . . . 0.0 111.868 175.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -66.67 -46.49 75.52 Favored 'General case' 0 N--CA 1.507 2.382 0 CA-C-N 125.537 3.79 . . . . 0.0 109.14 174.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.461 HD23 HG13 ' A' ' 151' ' ' ILE . 0.2 OUTLIER -46.89 -54.63 9.57 Favored 'General case' 0 C--N 1.368 1.386 0 C-N-CA 126.189 1.795 . . . . 0.0 111.215 176.584 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.461 HG13 HD23 ' A' ' 150' ' ' LEU . 33.8 mt -98.36 -28.52 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-N 121.648 2.022 . . . . 0.0 116.318 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.734 0 N-CA-C 118.659 2.837 . . . . 0.0 118.659 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.6 HG23 ' CE2' ' A' ' 147' ' ' PHE . 4.0 mp -58.14 -44.77 88.25 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.753 0 CA-C-N 112.036 -2.347 . . . . 0.0 108.963 172.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.474 ' HB2' ' HE3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -67.26 -39.03 86.04 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 116.322 -1.799 . . . . 0.0 111.685 176.623 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.445 ' O ' ' HB ' ' A' ' 96' ' ' VAL . 0.0 OUTLIER -57.22 -53.26 60.09 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 122.863 2.574 . . . . 0.0 107.888 176.396 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.71 -66.14 0.6 Allowed 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.496 ' CE2' HD12 ' A' ' 105' ' ' ILE . 9.5 t80 -66.62 -51.91 51.11 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.474 ' HE3' ' HB2' ' A' ' 91' ' ' LEU 0.382 7.7 mttt -67.81 -17.54 64.55 Favored 'General case' 0 CA--C 1.589 2.446 0 CA-C-O 114.821 -2.514 . . . . 0.0 110.234 -177.603 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 92' ' ' ARG . 1.0 OUTLIER -74.19 -46.5 44.56 Favored 'Isoleucine or valine' 0 C--N 1.395 2.547 0 CA-C-N 124.582 3.355 . . . . 0.0 106.186 167.159 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -53.61 -35.88 61.39 Favored 'General case' 0 CA--C 1.582 2.185 0 N-CA-C 117.23 2.308 . . . . 0.0 117.23 178.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -56.51 110.06 0.72 Allowed 'General case' 0 CA--C 1.575 1.905 0 C-N-CA 126.14 1.776 . . . . 0.0 115.469 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.644 ' HB2' ' HG2' ' A' ' 109' ' ' GLU . . . -73.76 -51.77 15.39 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -67.21 -24.53 65.85 Favored 'General case' 0 CA--C 1.578 2.052 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.8 1.71 90.31 Favored Glycine 0 CA--C 1.562 2.992 0 CA-C-N 121.773 2.079 . . . . 0.0 116.987 -175.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -107.19 0.64 23.47 Favored 'General case' 0 CA--C 1.587 2.382 0 CA-C-N 120.027 1.914 . . . . 0.0 112.419 172.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 114.06 -20.09 17.22 Favored Glycine 0 CA--C 1.547 2.083 0 CA-C-O 115.459 -2.856 . . . . 0.0 115.262 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.6 m -83.74 138.15 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.612 0 CA-C-N 123.797 3.799 . . . . 0.0 114.306 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.496 HD12 ' CE2' ' A' ' 94' ' ' PHE . 88.2 mt -116.25 123.36 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 101.713 -3.44 . . . . 0.0 101.713 174.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.491 ' HA ' HG12 ' A' ' 141' ' ' VAL . 2.1 p30 -91.88 162.64 14.34 Favored 'General case' 0 CA--C 1.56 1.329 0 CA-C-O 122.433 1.111 . . . . 0.0 111.577 176.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.77 -47.23 78.91 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.762 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -61.37 -44.2 97.56 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 117.906 -1.045 . . . . 0.0 111.546 176.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.644 ' HG2' ' HB2' ' A' ' 99' ' ' ALA . 34.4 tp10 -63.67 -37.76 88.55 Favored 'General case' 0 CA--C 1.569 1.701 0 CA-C-N 121.097 1.771 . . . . 0.0 112.521 174.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -62.76 -52.3 63.74 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 120.113 1.324 . . . . 0.0 108.143 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.462 ' HA ' HG11 ' A' ' 127' ' ' VAL . 10.5 ptpp? -56.58 -38.54 72.13 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 116.139 -1.886 . . . . 0.0 111.606 175.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -61.76 -54.52 41.25 Favored 'General case' 0 CA--C 1.579 2.072 0 CA-C-N 121.267 1.849 . . . . 0.0 112.788 174.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 tt -73.2 -11.93 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 119.091 2.997 . . . . 0.0 119.091 -177.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 9.2 tpt . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 177.551 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 30.6 p . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 122.656 1.217 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -66.12 -40.88 91.03 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 177.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.52 -43.59 72.04 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -46.5 82.67 Favored 'General case' 0 CA--C 1.584 2.253 0 CA-C-N 120.187 1.358 . . . . 0.0 113.847 177.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.462 HG11 ' HA ' ' A' ' 111' ' ' LYS . 15.7 t -66.08 -48.97 79.77 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.496 0 C-N-CA 125.126 1.37 . . . . 0.0 110.884 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -57.3 -49.95 74.47 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 117.093 -1.432 . . . . 0.0 110.061 176.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -55.16 -51.33 66.82 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 120.737 1.608 . . . . 0.0 112.568 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.91 -48.0 83.48 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 116.123 1.897 . . . . 0.0 116.123 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -44.32 50.31 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 115.8 -2.048 . . . . 0.0 111.277 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.33 -37.18 69.62 Favored 'General case' 0 CA--C 1.575 1.92 0 CA-C-N 122.466 2.394 . . . . 0.0 110.954 174.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -70.91 -39.46 72.72 Favored 'General case' 0 CA--C 1.578 2.024 0 CA-C-N 121.04 1.746 . . . . 0.0 111.94 175.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.08 -25.0 63.32 Favored 'General case' 0 CA--C 1.579 2.068 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 174.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -79.7 110.98 15.55 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 116.579 -3.826 . . . . 0.0 108.068 175.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -75.46 -22.75 57.01 Favored 'General case' 0 CA--C 1.57 1.723 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -107.11 -9.59 16.12 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 118.742 2.867 . . . . 0.0 118.742 -174.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.12 3.76 90.62 Favored Glycine 0 CA--C 1.569 3.408 0 CA-C-O 117.811 -1.55 . . . . 0.0 112.832 -172.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.457 ' O ' ' ND2' ' A' ' 139' ' ' ASN . 0.2 OUTLIER -92.75 42.84 1.11 Allowed 'General case' 0 C--N 1.367 1.335 1 CA-C-O 107.484 -6.008 . . . . 0.0 110.391 175.275 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 57.92 -23.21 0.02 OUTLIER Glycine 0 N--CA 1.503 3.107 3 O-C-N 105.214 -10.929 . . . . 0.0 129.104 162.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.491 HG12 ' HA ' ' A' ' 106' ' ' ASP . 6.4 m -134.04 140.97 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-N 121.196 2.498 . . . . 0.0 107.029 178.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.1 mt -104.23 131.02 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 113.861 -1.518 . . . . 0.0 112.899 -175.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -97.45 153.34 18.18 Favored 'General case' 0 CA--C 1.559 1.311 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 170.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.43 HD13 ' HD3' ' A' ' 95' ' ' LYS . 2.4 mt -52.68 -43.3 92.54 Favored Pre-proline 0 CA--C 1.583 2.247 0 CA-C-O 114.768 -2.539 . . . . 0.0 113.181 -178.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -51.37 -35.21 53.42 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.877 3.052 . . . . 0.0 115.802 176.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -59.93 -53.97 51.61 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 120.101 1.319 . . . . 0.0 110.81 174.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.6 ' CE2' HG23 ' A' ' 90' ' ' ILE . 36.0 t80 -56.21 -46.32 79.51 Favored 'General case' 0 CA--C 1.57 1.743 0 C-N-CA 125.041 1.336 . . . . 0.0 111.895 175.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.51 ' HG2' HG21 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -57.17 -45.13 83.93 Favored 'General case' 0 CA--C 1.591 2.548 0 C-N-CA 123.349 0.66 . . . . 0.0 110.708 176.105 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.1 -40.25 94.32 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 119.715 1.143 . . . . 0.0 112.111 176.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.55 -47.11 80.16 Favored 'General case' 0 CA--C 1.569 1.699 0 C-N-CA 124.538 1.135 . . . . 0.0 108.458 173.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 88.4 mt -61.78 -40.13 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 CA-C-N 120.389 1.45 . . . . 0.0 110.807 175.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.7 pttt . . . . . 0 CA--C 1.586 2.342 0 CA-C-N 120.642 1.564 . . . . 0.0 112.499 175.842 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 . . . . . 0 CA--C 1.581 2.164 0 CA-C-O 117.511 -1.233 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.745 HG21 ' HG2' ' A' ' 148' ' ' MET . 37.9 mt -71.01 -63.22 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.369 1.446 0 CA-C-O 115.686 -2.102 . . . . 0.0 107.05 174.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 pp -49.85 -47.77 51.51 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-N 122.472 2.396 . . . . 0.0 111.967 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.8 mtm105 -62.82 -55.19 28.54 Favored 'General case' 0 CA--C 1.571 1.787 0 CA-C-O 118.532 -0.746 . . . . 0.0 112.163 176.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.61 -59.47 3.92 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 114.59 -2.624 . . . . 0.0 113.685 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.413 ' CE2' HD12 ' A' ' 105' ' ' ILE . 14.7 t80 -54.89 -48.6 72.79 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 122.627 2.467 . . . . 0.0 112.437 178.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.252 93.0 mttt -64.83 -30.91 71.93 Favored 'General case' 0 CA--C 1.581 2.165 0 CA-C-N 119.796 1.18 . . . . 0.0 111.361 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.7 t -65.86 -48.96 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.507 0 CA-C-N 121.54 1.973 . . . . 0.0 108.534 169.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.1 -30.94 60.76 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 117.446 2.387 . . . . 0.0 117.446 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.318 0.0 OUTLIER -52.47 -14.28 0.47 Allowed 'General case' 0 CA--C 1.578 2.05 0 N-CA-C 119.895 3.295 . . . . 0.0 119.895 -177.404 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.761 ' HB2' ' HG2' ' A' ' 109' ' ' GLU . . . 75.35 -70.69 0.14 Allowed 'General case' 0 N--CA 1.502 2.167 0 CA-C-N 122.654 2.479 . . . . 0.0 116.33 176.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -76.35 -17.95 59.14 Favored 'General case' 0 CA--C 1.571 1.758 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 -177.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.02 3.92 90.21 Favored Glycine 0 CA--C 1.568 3.39 0 CA-C-O 117.437 -1.757 . . . . 0.0 114.333 -172.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 46.9 p-10 -98.47 -17.05 18.96 Favored 'General case' 0 CA--C 1.579 2.061 0 CA-C-N 120.881 2.341 . . . . 0.0 113.647 174.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.52 22.65 6.0 Favored Glycine 0 CA--C 1.546 2.002 0 CA-C-O 115.474 -2.848 . . . . 0.0 116.48 -178.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.6 t -134.39 121.96 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 CA-C-N 122.669 3.235 . . . . 0.0 112.555 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.413 HD12 ' CE2' ' A' ' 94' ' ' PHE . 62.3 mt -93.54 135.25 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 C-N-CA 126.432 1.893 . . . . 0.0 112.789 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -105.11 173.76 6.17 Favored 'General case' 0 CA--C 1.574 1.875 0 C-N-CA 124.193 0.997 . . . . 0.0 111.863 175.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -70.45 -50.15 41.24 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -62.94 -45.91 90.25 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 118.282 -0.866 . . . . 0.0 112.341 178.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.761 ' HG2' ' HB2' ' A' ' 99' ' ' ALA . 37.6 tp10 -61.21 -39.55 90.66 Favored 'General case' 0 CA--C 1.569 1.709 0 CA-C-N 120.49 1.495 . . . . 0.0 112.05 175.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -58.83 -53.66 55.93 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 120.127 1.331 . . . . 0.0 110.042 175.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -51.0 -42.68 60.51 Favored 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -73.2 -55.34 6.59 Favored 'General case' 0 CA--C 1.577 1.986 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 176.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.6 tt -67.98 -34.77 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 118.726 2.862 . . . . 0.0 118.726 -176.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.433 ' SD ' HG13 ' A' ' 127' ' ' VAL . 40.2 ttp . . . . . 0 N--CA 1.503 2.215 0 N-CA-C 117.936 2.569 . . . . 0.0 117.936 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 67.6 p . . . . . 0 N--CA 1.499 1.982 0 CA-C-O 119.377 -0.344 . . . . 0.0 111.61 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -42.0 -49.12 4.68 Favored 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 177.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.81 -48.51 76.54 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 112.292 -2.231 . . . . 0.0 111.429 176.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -61.52 -29.02 69.73 Favored 'General case' 0 CA--C 1.576 1.959 0 CA-C-N 120.438 1.472 . . . . 0.0 112.737 174.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.433 HG13 ' SD ' ' A' ' 114' ' ' MET . 1.5 t -70.36 -57.66 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 CA-C-N 121.374 1.897 . . . . 0.0 109.043 177.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -64.22 -38.98 93.0 Favored 'General case' 0 N--CA 1.508 2.442 0 CA-C-N 120.24 1.382 . . . . 0.0 113.263 178.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -65.08 -44.59 88.41 Favored 'General case' 0 CA--C 1.567 1.614 0 CA-C-O 117.839 -1.076 . . . . 0.0 112.02 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -64.31 -45.33 88.38 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 120.012 1.278 . . . . 0.0 112.234 176.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 19.6 ttt -70.24 -41.83 73.03 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 114.238 -2.791 . . . . 0.0 111.055 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -64.51 -33.24 75.45 Favored 'General case' 0 CA--C 1.576 1.978 0 CA-C-N 125.087 3.585 . . . . 0.0 111.293 175.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -62.49 -44.02 97.4 Favored 'General case' 0 CA--C 1.585 2.31 0 CA-C-N 122.023 2.192 . . . . 0.0 110.376 171.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.44 -29.36 56.96 Favored 'General case' 0 CA--C 1.576 1.961 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 178.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -90.77 100.16 13.06 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 103.12 -2.919 . . . . 0.0 103.12 172.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -56.48 -29.62 61.98 Favored 'General case' 0 CA--C 1.593 2.61 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.407 54.2 t0 160.88 -22.96 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.676 1 CA-C-O 108.925 -5.321 . . . . 0.0 103.811 175.808 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 11.04 5.88 0.0 OUTLIER Glycine 0 CA--C 1.564 3.136 3 O-C-N 99.065 -14.772 . . . . 0.0 125.131 160.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.46 ' OD1' HG23 ' A' ' 141' ' ' VAL . 2.3 p-10 79.03 15.14 1.06 Allowed 'General case' 0 CA--C 1.595 2.674 0 CA-C-N 121.3 2.55 . . . . 0.0 111.626 -172.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 97.38 -22.88 38.4 Favored Glycine 0 CA--C 1.563 3.042 0 CA-C-N 122.974 2.624 . . . . 0.0 115.636 -176.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.46 HG23 ' OD1' ' A' ' 139' ' ' ASN . 0.1 OUTLIER -105.46 146.52 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.378 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 178.396 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -115.22 129.72 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 113.815 -1.539 . . . . 0.0 114.513 -176.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 47.9 p30 -92.18 164.86 13.41 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 171.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 7.6 mt -55.96 -42.95 98.75 Favored Pre-proline 0 CA--C 1.585 2.327 0 CA-C-O 115.028 -2.415 . . . . 0.0 112.584 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -59.16 -22.53 64.96 Favored 'Trans proline' 0 C--N 1.376 2.007 0 CA-C-N 125.338 2.942 . . . . 0.0 119.74 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -69.92 0.3 Allowed 'General case' 0 CA--C 1.562 1.407 0 CA-C-N 122.996 2.635 . . . . 0.0 110.357 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.658 ' CE2' HG23 ' A' ' 90' ' ' ILE . 77.8 t80 -49.54 -43.39 45.73 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 124.716 1.206 . . . . 0.0 113.468 174.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.745 ' HG2' HG21 ' A' ' 90' ' ' ILE . 5.8 mtp -67.37 -40.35 85.76 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-O 114.898 -2.477 . . . . 0.0 112.004 177.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -63.83 -43.67 95.52 Favored 'General case' 0 N--CA 1.505 2.281 0 CA-C-N 124.458 3.299 . . . . 0.0 109.626 173.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.95 -47.89 21.64 Favored 'General case' 0 CA--C 1.575 1.916 0 C-N-CA 127.173 2.189 . . . . 0.0 112.07 174.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 68.0 mt -89.06 -34.47 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.891 0 CA-C-O 117.286 -1.34 . . . . 0.0 111.513 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 41.2 mmtt . . . . . 0 N--CA 1.503 2.217 0 CA-C-N 122.126 2.239 . . . . 0.0 112.739 176.143 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 . . . . . 0 N--CA 1.501 2.078 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.662 HG23 ' CE2' ' A' ' 147' ' ' PHE . 1.6 mp -66.38 -45.71 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 116.748 -1.596 . . . . 0.0 109.995 177.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.46 -46.13 84.0 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 121.617 2.008 . . . . 0.0 110.541 177.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.91 -55.96 28.42 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 117.326 -1.321 . . . . 0.0 110.574 176.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.83 -57.62 6.66 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.521 ' CE2' HD12 ' A' ' 105' ' ' ILE . 15.8 t80 -64.97 -50.53 66.02 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 120.899 1.681 . . . . 0.0 113.401 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.424 ' HE2' HD13 ' A' ' 144' ' ' ILE 0.335 65.8 mttt -68.07 -22.4 64.94 Favored 'General case' 0 CA--C 1.59 2.515 0 CA-C-O 116.495 -1.717 . . . . 0.0 110.455 -178.804 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.9 t -71.25 -48.87 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.421 0 CA-C-N 122.818 2.554 . . . . 0.0 107.213 168.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -49.02 -34.75 13.91 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.11 102.15 0.35 Allowed 'General case' 0 CA--C 1.576 1.976 0 C-N-CA 126.038 1.735 . . . . 0.0 109.191 176.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.28 -43.03 71.27 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.9 p30 -69.91 -8.03 45.33 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 117.236 2.31 . . . . 0.0 117.236 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.79 29.4 71.09 Favored Glycine 0 CA--C 1.558 2.75 0 CA-C-N 120.823 1.647 . . . . 0.0 116.418 -177.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.19 76.04 1.53 Allowed 'General case' 0 N--CA 1.477 0.882 1 CA-C-O 109.068 -5.253 . . . . 0.0 106.606 178.631 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 52.88 -30.24 0.01 OUTLIER Glycine 0 N--CA 1.491 2.305 2 N-CA-C 127.952 5.941 . . . . 0.0 127.952 165.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.6 p -107.15 155.05 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.455 0 CA-C-O 122.692 1.234 . . . . 0.0 114.112 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.521 HD12 ' CE2' ' A' ' 94' ' ' PHE . 87.8 mt -115.6 134.7 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-N 113.09 -1.868 . . . . 0.0 108.855 177.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.94 -179.29 3.82 Favored 'General case' 0 CA--C 1.576 1.972 0 CA-C-N 119.86 1.209 . . . . 0.0 112.965 175.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -74.78 -51.57 13.77 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.445 -1.409 . . . . 0.0 113.601 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.39 -33.63 75.97 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 178.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.18 -40.92 82.12 Favored 'General case' 0 CA--C 1.581 2.147 0 CA-C-N 120.44 1.473 . . . . 0.0 110.765 174.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.74 -46.66 86.9 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 117.521 -1.228 . . . . 0.0 108.892 172.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.45 ' HA ' HG21 ' A' ' 127' ' ' VAL . 2.9 tppt? -52.05 -61.82 2.02 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 125.012 1.325 . . . . 0.0 109.12 174.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -48.81 -48.51 41.42 Favored 'General case' 0 CA--C 1.575 1.929 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 176.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -82.14 -13.68 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 118.059 2.614 . . . . 0.0 118.059 -178.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.48 ' SD ' HG23 ' A' ' 127' ' ' VAL . 9.4 tpt . . . . . 0 N--CA 1.485 1.288 0 N-CA-C 119.246 3.054 . . . . 0.0 119.246 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.2 p . . . . . 0 CA--C 1.55 0.969 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.38 -20.54 58.91 Favored 'General case' 0 CA--C 1.577 1.982 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.741 174.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -58.04 -40.1 80.04 Favored 'General case' 0 CA--C 1.561 1.381 0 CA-C-O 117.023 -1.465 . . . . 0.0 111.424 174.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -54.56 -53.9 48.33 Favored 'General case' 0 CA--C 1.585 2.323 0 CA-C-N 120.419 1.463 . . . . 0.0 111.477 175.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.48 HG23 ' SD ' ' A' ' 114' ' ' MET 0.251 4.2 p -73.43 -41.33 56.78 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -178.201 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -68.86 -45.78 70.17 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 120.675 1.58 . . . . 0.0 110.205 176.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -62.74 -48.85 77.42 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-N 121.341 1.882 . . . . 0.0 112.019 176.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -64.2 -45.85 86.49 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-N 120.378 1.445 . . . . 0.0 114.692 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -73.98 -34.34 64.18 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 115.934 -1.984 . . . . 0.0 112.767 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.12 -32.61 67.12 Favored 'General case' 0 CA--C 1.566 1.59 0 CA-C-N 122.64 2.473 . . . . 0.0 110.755 173.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.96 -35.51 80.12 Favored 'General case' 0 CA--C 1.58 2.126 0 CA-C-N 123.388 2.813 . . . . 0.0 110.495 172.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.99 -30.9 27.81 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 176.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -90.81 105.71 18.01 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 122.339 2.336 . . . . 0.0 107.115 174.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -62.65 -32.49 73.55 Favored 'General case' 0 CA--C 1.598 2.825 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 175.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.391 57.1 t0 163.54 -21.9 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.041 1 CA-C-O 108.768 -5.396 . . . . 0.0 103.326 176.673 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 13.03 8.04 0.0 OUTLIER Glycine 0 N--CA 1.5 2.928 3 O-C-N 98.666 -15.021 . . . . 0.0 125.028 161.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 77.84 4.58 2.92 Favored 'General case' 0 CA--C 1.581 2.145 0 CA-C-N 121.622 2.711 . . . . 0.0 111.179 -172.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 95.34 -12.09 68.3 Favored Glycine 0 C--N 1.372 2.561 0 CA-C-N 123.746 2.976 . . . . 0.0 114.584 -175.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . 0.298 3.4 m -130.24 121.11 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 102.181 -3.266 . . . . 0.0 102.181 175.271 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.62 125.62 38.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 111.299 -2.682 . . . . 0.0 114.001 -173.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -92.88 151.99 19.65 Favored 'General case' 0 CA--C 1.558 1.251 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 172.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.424 HD13 ' HE2' ' A' ' 95' ' ' LYS . 1.4 mt -53.32 -41.7 87.77 Favored Pre-proline 0 CA--C 1.582 2.176 0 CA-C-O 114.615 -2.612 . . . . 0.0 112.628 -178.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -55.63 -26.23 54.45 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 123.93 3.087 . . . . 0.0 116.511 176.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -63.85 -62.41 1.66 Allowed 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 122.051 2.205 . . . . 0.0 108.918 174.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.662 ' CE2' HG23 ' A' ' 90' ' ' ILE . 87.2 t80 -55.22 -47.08 75.85 Favored 'General case' 0 CA--C 1.57 1.739 0 C-N-CA 125.638 1.575 . . . . 0.0 113.842 173.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.49 ' HG2' HG21 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -59.12 -39.03 81.01 Favored 'General case' 0 CA--C 1.588 2.418 0 CA-C-O 117.673 -1.156 . . . . 0.0 109.857 174.749 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -67.15 -47.47 70.94 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 121.214 1.825 . . . . 0.0 110.104 173.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.33 -44.58 11.74 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 127.608 2.363 . . . . 0.0 112.26 176.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 58.5 mt -92.61 -56.23 5.39 Favored 'Isoleucine or valine' 0 C--N 1.366 1.295 0 CA-C-O 116.911 -1.519 . . . . 0.0 113.933 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt . . . . . 0 N--CA 1.482 1.175 0 N-CA-C 118.368 2.729 . . . . 0.0 118.368 -176.66 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.753 HG23 ' HE2' ' A' ' 147' ' ' PHE . 5.3 mp -72.04 -48.1 51.51 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 CA-C-O 117.053 -1.451 . . . . 0.0 112.496 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.21 -51.93 67.85 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 121.671 2.032 . . . . 0.0 110.266 178.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -65.18 -46.77 79.45 Favored 'General case' 0 CA--C 1.566 1.595 0 CA-C-O 116.532 -1.699 . . . . 0.0 111.146 178.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.28 -61.59 1.73 Allowed 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 121.925 2.148 . . . . 0.0 114.404 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.517 ' CE2' HD12 ' A' ' 105' ' ' ILE . 19.9 t80 -59.15 -50.94 72.14 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 121.979 2.172 . . . . 0.0 112.858 178.022 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.418 ' HE2' HD13 ' A' ' 144' ' ' ILE 0.353 71.7 mttt -67.78 -23.82 65.25 Favored 'General case' 0 CA--C 1.591 2.53 0 CA-C-O 116.558 -1.687 . . . . 0.0 110.262 -177.42 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.8 t -69.66 -48.23 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.485 0 CA-C-N 122.732 2.515 . . . . 0.0 107.491 167.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -48.28 -33.95 9.63 Favored 'General case' 0 CA--C 1.577 1.991 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.42 95.9 0.48 Allowed 'General case' 0 CA--C 1.577 1.983 0 C-N-CA 126.936 2.094 . . . . 0.0 107.873 175.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.92 -46.49 71.4 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.633 -0.667 . . . . 0.0 112.322 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -47.94 -24.55 1.07 Allowed 'General case' 0 CA--C 1.583 2.233 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 176.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.14 7.43 87.78 Favored Glycine 0 CA--C 1.563 3.036 0 CA-C-N 122.216 2.28 . . . . 0.0 117.34 -176.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.67 78.21 1.69 Allowed 'General case' 0 N--CA 1.478 0.932 1 CA-C-O 109.938 -4.839 . . . . 0.0 104.76 175.356 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 52.68 -26.93 0.01 OUTLIER Glycine 0 N--CA 1.486 2.028 2 N-CA-C 129.079 6.392 . . . . 0.0 129.079 166.073 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.7 t -103.03 136.19 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-N 118.919 1.359 . . . . 0.0 113.036 -177.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.517 HD12 ' CE2' ' A' ' 94' ' ' PHE . 67.5 mt -111.04 133.59 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 113.082 -1.872 . . . . 0.0 110.347 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -110.51 173.04 6.52 Favored 'General case' 0 CA--C 1.571 1.76 0 C-N-CA 124.378 1.071 . . . . 0.0 111.49 176.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -64.01 -45.52 88.6 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 116.82 -1.562 . . . . 0.0 114.504 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -61.56 -46.87 88.08 Favored 'General case' 0 N--CA 1.508 2.457 0 CA-C-N 121.196 1.816 . . . . 0.0 112.185 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -51.53 -50.3 60.29 Favored 'General case' 0 CA--C 1.574 1.892 0 C-N-CA 124.557 1.143 . . . . 0.0 112.059 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -64.38 -52.6 57.44 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 125.986 1.714 . . . . 0.0 109.791 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 19.1 ttpt -46.87 -49.93 19.45 Favored 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 124.85 1.26 . . . . 0.0 113.534 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -70.57 -53.54 15.63 Favored 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 176.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -70.88 -27.29 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 119.302 3.075 . . . . 0.0 119.302 -175.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 15.3 tmm? . . . . . 0 N--CA 1.498 1.973 0 C-N-CA 126.518 1.927 . . . . 0.0 109.577 178.376 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.485 1.284 1 N-CA-C 99.36 -4.311 . . . . 0.0 99.36 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -62.19 -33.45 74.57 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 116.99 2.219 . . . . 0.0 116.99 -177.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.48 -40.28 96.68 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 117.418 -1.277 . . . . 0.0 113.624 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -59.56 -52.11 66.98 Favored 'General case' 0 CA--C 1.572 1.81 0 CA-C-N 120.633 1.56 . . . . 0.0 113.036 178.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.8 t -73.73 -48.36 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-O 117.001 -1.476 . . . . 0.0 112.464 -178.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -65.0 -44.57 88.83 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-N 120.768 1.622 . . . . 0.0 111.356 177.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -64.82 -43.51 92.86 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-N 121.464 1.938 . . . . 0.0 112.084 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.0 -47.62 82.34 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 120.662 1.574 . . . . 0.0 112.92 176.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.583 ' SD ' HD11 ' A' ' 142' ' ' ILE . 13.3 tpt -67.65 -37.67 82.74 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 115.189 -2.338 . . . . 0.0 112.075 176.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -66.64 -43.08 85.63 Favored 'General case' 0 CA--C 1.567 1.609 0 CA-C-N 123.053 2.66 . . . . 0.0 110.712 174.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -59.94 -41.39 91.72 Favored 'General case' 0 CA--C 1.578 2.053 0 CA-C-N 122.568 2.44 . . . . 0.0 110.351 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.59 -16.65 62.87 Favored 'General case' 0 CA--C 1.581 2.148 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.572 ' OD2' ' N ' ' A' ' 140' ' ' GLY . 7.3 t0 -91.8 103.25 15.82 Favored 'General case' 0 CA--C 1.586 2.327 0 N-CA-C 101.679 -3.452 . . . . 0.0 101.679 164.044 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -73.81 -21.12 60.26 Favored 'General case' 0 CA--C 1.58 2.125 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 178.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -91.82 -11.87 35.32 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 119.514 3.153 . . . . 0.0 119.514 -175.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.13 5.96 89.24 Favored Glycine 0 CA--C 1.573 3.709 0 CA-C-N 120.241 1.382 . . . . 0.0 115.323 -173.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.38 -44.86 20.65 Favored 'General case' 0 CA--C 1.573 1.849 0 C-N-CA 126.139 1.776 . . . . 0.0 113.33 176.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.572 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . 111.13 20.25 7.21 Favored Glycine 0 CA--C 1.558 2.73 0 N-CA-C 116.891 1.516 . . . . 0.0 116.891 -178.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.27 158.73 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-N 118.676 1.238 . . . . 0.0 108.041 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.583 HD11 ' SD ' ' A' ' 131' ' ' MET . 1.1 mt -136.91 128.83 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 117.702 2.482 . . . . 0.0 117.702 -174.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 33.1 p30 -95.74 153.98 17.46 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 170.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.418 HD13 ' HE2' ' A' ' 95' ' ' LYS . 2.3 mt -51.17 -43.08 84.38 Favored Pre-proline 0 CA--C 1.586 2.339 0 CA-C-O 115.006 -2.426 . . . . 0.0 114.198 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -56.01 -29.8 75.47 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 123.787 2.991 . . . . 0.0 117.646 177.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -61.8 -62.51 1.75 Allowed 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 120.831 1.65 . . . . 0.0 110.926 176.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.753 ' HE2' HG23 ' A' ' 90' ' ' ILE . 57.9 t80 -54.85 -42.56 72.13 Favored 'General case' 0 CA--C 1.578 2.04 0 C-N-CA 123.989 0.915 . . . . 0.0 112.809 174.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.682 ' HG2' HG21 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -56.89 -42.27 79.54 Favored 'General case' 0 CA--C 1.583 2.22 0 CA-C-O 117.403 -1.284 . . . . 0.0 109.716 174.996 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.52 -33.63 73.09 Favored 'General case' 0 CA--C 1.577 1.992 0 CA-C-N 121.187 1.812 . . . . 0.0 110.736 174.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.3 mp -58.52 -45.74 88.2 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 120.661 1.573 . . . . 0.0 111.542 174.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 66.6 mt -79.9 -45.62 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 120.445 1.475 . . . . 0.0 110.982 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 94.4 mttt . . . . . 0 CA--C 1.575 1.915 0 CA-C-N 120.931 1.696 . . . . 0.0 114.702 177.98 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.52 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 13.0 pt-20 . . . . . 0 CA--C 1.548 0.9 0 N-CA-C 114.827 1.418 . . . . 0.0 114.827 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.416 HG23 ' CD2' ' A' ' 147' ' ' PHE . 4.2 mp -76.83 -67.61 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 114.42 -2.705 . . . . 0.0 114.572 -177.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . 0.336 0.0 OUTLIER -73.95 -33.63 63.97 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 123.546 2.885 . . . . 0.0 110.36 -178.247 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 46.9 mtt180 -69.04 -45.69 69.8 Favored 'General case' 0 CA--C 1.58 2.133 0 CA-C-N 125.52 3.782 . . . . 0.0 108.992 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 89' ' ' GLU . . . -70.79 -57.25 4.84 Favored 'General case' 0 C--N 1.384 2.09 0 CA-C-N 122.376 2.353 . . . . 0.0 112.121 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.595 ' CE2' HD12 ' A' ' 105' ' ' ILE . 4.8 t80 -57.07 -51.59 68.67 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 121.919 2.145 . . . . 0.0 113.267 178.07 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.602 ' HE2' HD13 ' A' ' 144' ' ' ILE . 56.0 mttt -62.01 -31.0 71.34 Favored 'General case' 0 CA--C 1.576 1.948 0 CA-C-O 115.491 -2.195 . . . . 0.0 111.548 -178.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -69.2 -45.23 79.86 Favored 'Isoleucine or valine' 0 CA--C 1.591 2.523 0 CA-C-N 123.604 2.911 . . . . 0.0 109.355 170.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.91 -31.13 38.27 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.965 ' OD2' ' HA ' ' A' ' 102' ' ' ASP . 1.7 t0 -56.9 125.39 22.32 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 119.997 1.271 . . . . 0.0 109.087 177.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.46 28.35 0.03 OUTLIER 'General case' 0 N--CA 1.527 3.422 0 N-CA-C 120.445 3.498 . . . . 0.0 120.445 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.497 ' H ' ' C ' ' A' ' 98' ' ' ASP 0.422 13.7 t-20 72.44 148.23 0.09 Allowed 'General case' 0 CA--C 1.604 3.033 2 C-N-CA 135.223 5.409 . . . . 0.0 101.825 -175.813 . . . . . . . . 4 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 109.39 60.49 0.52 Allowed Glycine 0 C--N 1.285 -2.254 2 C-N-CA 135.547 6.308 . . . . 0.0 109.621 -177.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.965 ' HA ' ' OD2' ' A' ' 98' ' ' ASP 0.832 0.2 OUTLIER -30.13 113.5 0.09 Allowed 'General case' 0 C--N 1.393 2.474 0 CA-C-O 127.626 3.584 . . . . 0.0 118.268 -174.511 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 126.62 28.92 0.93 Allowed Glycine 0 N--CA 1.43 -1.724 1 CA-C-N 103.376 -6.284 . . . . 0.0 110.716 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . 0.273 0.0 OUTLIER -166.67 142.57 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 N-CA-C 118.376 2.732 . . . . 0.0 118.376 177.306 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.595 HD12 ' CE2' ' A' ' 94' ' ' PHE . 96.1 mt -136.64 134.58 48.98 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.676 0 C-N-CA 128.331 2.652 . . . . 0.0 104.99 175.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -105.01 -178.56 3.69 Favored 'General case' 0 CA--C 1.569 1.692 0 C-N-CA 124.462 1.105 . . . . 0.0 111.621 175.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.49 -46.62 25.96 Favored 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -178.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -62.95 -53.09 59.49 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 117.023 -1.465 . . . . 0.0 111.328 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -58.03 -30.72 66.36 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 121.838 2.108 . . . . 0.0 113.124 175.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -66.97 -51.65 52.56 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 120.554 1.524 . . . . 0.0 109.187 176.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.1 tppt? -54.98 -35.33 64.21 Favored 'General case' 0 CA--C 1.58 2.118 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 174.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 11.3 m-30 -74.76 -57.98 3.57 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 125.699 1.6 . . . . 0.0 113.043 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.9 -36.4 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 125.814 1.645 . . . . 0.0 113.684 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.588 2.432 0 CA-C-O 121.157 0.503 . . . . 0.0 110.198 171.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 78.3 p . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 121.665 0.745 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -60.09 -37.58 80.35 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.37 -36.84 71.73 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 117.346 -1.311 . . . . 0.0 114.478 176.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -61.76 -51.11 69.66 Favored 'General case' 0 CA--C 1.58 2.133 0 CA-C-N 120.786 1.63 . . . . 0.0 111.841 175.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.2 t -63.53 -51.83 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 C-N-CA 125.804 1.642 . . . . 0.0 110.706 178.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.3 -38.78 84.71 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-O 117.569 -1.205 . . . . 0.0 111.314 176.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -62.87 -50.45 70.87 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 121.673 2.033 . . . . 0.0 112.094 175.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.49 -47.26 86.92 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 177.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.429 ' SD ' HD11 ' A' ' 142' ' ' ILE . 12.8 tpt -70.02 -38.72 75.98 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 115.434 -2.222 . . . . 0.0 111.303 176.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -36.16 83.37 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 123.724 2.965 . . . . 0.0 111.372 175.348 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -61.78 -49.21 77.26 Favored 'General case' 0 CA--C 1.573 1.848 0 CA-C-O 118.121 -0.942 . . . . 0.0 109.478 173.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -77.33 -23.82 50.87 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 117.724 2.49 . . . . 0.0 117.724 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -91.29 116.67 29.01 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 103.356 -2.831 . . . . 0.0 103.356 170.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -61.59 -22.33 65.12 Favored 'General case' 0 CA--C 1.586 2.347 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.281 29.6 t0 96.97 159.68 0.02 OUTLIER 'General case' 0 CA--C 1.609 3.218 0 CA-C-O 127.402 3.477 . . . . 0.0 103.085 178.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 94.48 36.79 5.52 Favored Glycine 0 CA--C 1.567 3.319 2 C-N-CA 132.006 4.622 . . . . 0.0 102.492 -173.525 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -173.7 -65.43 0.01 OUTLIER 'General case' 0 C--N 1.399 2.722 0 CA-C-N 121.821 2.811 . . . . 0.0 115.488 -174.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 87.39 20.6 51.5 Favored Glycine 0 CA--C 1.574 3.751 0 CA-C-N 119.31 0.959 . . . . 0.0 114.384 -174.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.88 168.25 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 128.053 2.541 . . . . 0.0 104.227 -178.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.429 HD11 ' SD ' ' A' ' 131' ' ' MET . 0.9 OUTLIER -144.75 133.06 17.4 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 O-C-N 120.979 -1.075 . . . . 0.0 112.816 -178.385 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 53.6 p30 -103.58 155.65 18.38 Favored 'General case' 0 CA--C 1.561 1.384 0 N-CA-C 104.467 -2.42 . . . . 0.0 104.467 169.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.602 HD13 ' HE2' ' A' ' 95' ' ' LYS . 0.6 OUTLIER -52.45 -44.89 95.3 Favored Pre-proline 0 N--CA 1.492 1.669 0 CA-C-O 115.184 -2.341 . . . . 0.0 113.219 -178.4 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.44 ' O ' ' HB2' ' A' ' 149' ' ' ASP . 43.1 Cg_exo -55.51 -21.21 29.67 Favored 'Trans proline' 0 C--N 1.375 1.942 0 CA-C-O 114.139 -2.526 . . . . 0.0 116.455 177.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.66 -56.21 6.97 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 123.217 2.735 . . . . 0.0 110.488 175.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.416 ' CD2' HG23 ' A' ' 90' ' ' ILE . 18.6 t80 -61.45 -44.76 96.54 Favored 'General case' 0 CA--C 1.591 2.552 0 CA-C-O 123.727 1.727 . . . . 0.0 111.99 175.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 2.1 mmt -56.62 -45.14 81.67 Favored 'General case' 0 CA--C 1.56 1.36 0 CA-C-O 115.111 -2.376 . . . . 0.0 108.884 173.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 145' ' ' PRO . 1.2 m-20 -66.97 -27.33 67.37 Favored 'General case' 0 CA--C 1.567 1.599 0 CA-C-N 122.468 2.394 . . . . 0.0 112.115 173.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.5 mp -52.32 -41.04 62.64 Favored 'General case' 0 N--CA 1.504 2.262 0 CA-C-N 121.98 2.173 . . . . 0.0 106.324 168.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -81.34 -69.46 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.612 3.348 0 CA-C-O 122.481 1.134 . . . . 0.0 111.447 173.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? . . . . . 0 CA--C 1.579 2.081 2 C-N-CA 133.249 4.62 . . . . 0.0 122.55 -178.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 . . . . . 0 CA--C 1.58 2.107 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.603 HG21 ' HG2' ' A' ' 148' ' ' MET . 3.6 mp -64.79 -42.88 96.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-O 117.467 -1.254 . . . . 0.0 110.405 177.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.12 -45.38 93.71 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 120.938 1.699 . . . . 0.0 109.278 175.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 76.8 mtt180 -52.97 -62.67 1.5 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 120.107 1.321 . . . . 0.0 110.283 176.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.86 -58.78 4.34 Favored 'General case' 0 C--N 1.358 0.968 0 CA-C-O 115.871 -2.014 . . . . 0.0 116.185 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.48 ' CE2' HD12 ' A' ' 105' ' ' ILE . 14.4 t80 -63.23 -52.66 61.26 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 121.42 1.918 . . . . 0.0 113.723 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.367 58.1 mttt -66.51 -19.53 65.81 Favored 'General case' 0 CA--C 1.596 2.719 0 CA-C-O 116.614 -1.66 . . . . 0.0 110.354 -177.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.7 t -72.64 -50.97 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 CA-C-N 122.566 2.439 . . . . 0.0 107.383 166.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -51.06 -30.39 15.6 Favored 'General case' 0 CA--C 1.568 1.655 0 N-CA-C 117.508 2.41 . . . . 0.0 117.508 -178.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.265 0.0 OUTLIER -55.04 115.52 2.26 Favored 'General case' 0 CA--C 1.585 2.299 0 C-N-CA 126.272 1.829 . . . . 0.0 110.274 178.335 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.9 -54.7 41.5 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 117.678 2.473 . . . . 0.0 117.678 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.6 p30 -88.66 6.28 39.16 Favored 'General case' 0 CA--C 1.562 1.442 0 N-CA-C 118.622 2.823 . . . . 0.0 118.622 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.65 29.13 71.48 Favored Glycine 0 CA--C 1.568 3.358 0 CA-C-N 121.078 1.763 . . . . 0.0 115.462 -175.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -143.3 78.29 1.6 Allowed 'General case' 0 N--CA 1.476 0.825 1 CA-C-O 109.544 -5.027 . . . . 0.0 107.362 178.829 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 54.82 -25.83 0.01 OUTLIER Glycine 0 N--CA 1.491 2.348 3 N-CA-C 129.504 6.562 . . . . 0.0 129.504 164.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.8 p -107.4 153.26 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.089 0 CA-C-N 119.129 1.465 . . . . 0.0 112.426 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.48 HD12 ' CE2' ' A' ' 94' ' ' PHE . 83.6 mt -123.19 137.39 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 C-N-CA 126.281 1.832 . . . . 0.0 108.909 178.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -108.69 -170.51 1.68 Allowed 'General case' 0 CA--C 1.589 2.459 0 C-N-CA 124.154 0.982 . . . . 0.0 112.34 176.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -80.64 -52.98 6.95 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -57.88 -47.4 82.86 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 123.021 0.528 . . . . 0.0 112.23 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -56.0 -48.52 75.73 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 118.033 -0.984 . . . . 0.0 111.157 174.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -60.37 -50.9 71.77 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 117.39 -1.29 . . . . 0.0 112.497 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -56.9 -39.24 74.05 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 120.342 1.428 . . . . 0.0 114.433 176.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -69.18 -45.49 69.82 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 175.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -91.07 -24.21 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 1 N-CA-C 122.054 4.094 . . . . 0.0 122.054 -174.496 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 1.4 tpt . . . . . 0 N--CA 1.505 2.294 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 -179.017 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 46.5 p . . . . . 0 CA--C 1.554 1.11 0 N-CA-C 103.697 -2.705 . . . . 0.0 103.697 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -61.05 -41.53 96.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.91 -1.119 . . . . 0.0 112.149 176.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.49 -45.82 82.1 Favored 'General case' 0 CA--C 1.554 1.103 0 CA-C-O 116.929 -1.51 . . . . 0.0 113.338 176.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.82 -39.76 94.99 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 121.659 2.027 . . . . 0.0 112.965 176.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 90.0 t -69.99 -50.72 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.613 0 CA-C-O 117.739 -1.124 . . . . 0.0 109.307 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.68 -45.55 89.19 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 120.154 1.343 . . . . 0.0 111.718 176.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -61.61 -47.06 87.18 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 119.701 1.137 . . . . 0.0 112.621 176.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.21 -46.14 90.76 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 119.396 0.998 . . . . 0.0 112.975 176.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 9.6 ttt -70.84 -43.56 68.26 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 115.74 -2.076 . . . . 0.0 111.189 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -35.63 75.77 Favored 'General case' 0 CA--C 1.578 2.052 0 CA-C-N 122.899 2.59 . . . . 0.0 110.685 174.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.48 -42.68 91.92 Favored 'General case' 0 CA--C 1.571 1.774 0 CA-C-N 121.633 2.015 . . . . 0.0 110.557 172.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -72.21 -24.5 61.41 Favored 'General case' 0 CA--C 1.576 1.946 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 176.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -81.3 108.53 15.0 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 103.041 -2.948 . . . . 0.0 103.041 172.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -72.71 -14.64 61.61 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -108.95 -11.61 14.96 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 119.257 3.058 . . . . 0.0 119.257 -174.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.63 5.6 89.76 Favored Glycine 0 CA--C 1.571 3.561 0 CA-C-N 120.447 1.476 . . . . 0.0 114.618 -173.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -72.03 -44.62 63.12 Favored 'General case' 0 CA--C 1.565 1.547 0 C-N-CA 125.342 1.457 . . . . 0.0 113.39 176.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 102.98 3.77 48.53 Favored Glycine 0 CA--C 1.563 3.035 0 N-CA-C 117.312 1.685 . . . . 0.0 117.312 -177.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 1.8 t -135.43 141.85 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 101.592 -3.484 . . . . 0.0 101.592 176.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.2 mt -120.58 124.48 72.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 111.967 -2.379 . . . . 0.0 112.789 -176.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 53.7 p30 -92.48 157.67 16.44 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 170.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.8 mt -52.75 -41.2 82.93 Favored Pre-proline 0 CA--C 1.585 2.302 0 CA-C-O 115.126 -2.369 . . . . 0.0 112.967 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -57.08 -31.25 89.73 Favored 'Trans proline' 0 C--N 1.38 2.214 0 C-N-CA 123.702 2.935 . . . . 0.0 116.813 176.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -67.2 -46.57 73.5 Favored 'General case' 0 N--CA 1.505 2.291 0 CA-C-N 123.074 2.67 . . . . 0.0 111.279 176.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.591 ' CE2' HG23 ' A' ' 90' ' ' ILE . 31.2 t80 -63.28 -45.16 92.72 Favored 'General case' 0 CA--C 1.583 2.222 0 CA-C-N 120.643 1.565 . . . . 0.0 110.761 173.135 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.603 ' HG2' HG21 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -60.0 -41.36 91.93 Favored 'General case' 0 CA--C 1.579 2.06 0 CA-C-O 117.064 -1.446 . . . . 0.0 109.725 175.17 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.23 -25.06 63.21 Favored 'General case' 0 CA--C 1.579 2.067 0 CA-C-N 121.714 2.052 . . . . 0.0 111.783 173.047 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.1 tp -62.41 -47.13 85.45 Favored 'General case' 0 CA--C 1.573 1.828 0 CA-C-N 120.797 1.635 . . . . 0.0 108.875 172.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . 0.276 31.7 mt -68.12 -46.78 80.81 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.597 0 CA-C-N 119.13 0.877 . . . . 0.0 109.567 175.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt . . . . . 0 CA--C 1.606 3.127 0 C-N-CA 127.334 2.254 . . . . 0.0 116.807 174.047 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 . . . . . 0 CA--C 1.574 1.888 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.51 HG23 ' CE2' ' A' ' 147' ' ' PHE . 4.1 mp -64.99 -55.22 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 116.226 -1.845 . . . . 0.0 109.635 178.017 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.402 ' HA ' ' HG3' ' A' ' 95' ' ' LYS 0.259 0.6 OUTLIER -62.75 -34.07 76.44 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 122.011 2.187 . . . . 0.0 111.225 177.148 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.0 mtm-85 -52.88 -62.3 1.74 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 121.175 1.807 . . . . 0.0 108.397 173.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.64 -61.54 1.84 Allowed 'General case' 0 C--N 1.355 0.822 0 CA-C-O 114.07 -2.871 . . . . 0.0 115.696 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.586 ' CE2' HD12 ' A' ' 105' ' ' ILE . 3.7 t80 -69.04 -52.86 24.21 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 124.387 3.267 . . . . 0.0 114.128 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.402 ' HG3' ' HA ' ' A' ' 91' ' ' LEU 0.375 26.0 mttt -63.04 -16.34 59.53 Favored 'General case' 0 CA--C 1.593 2.63 0 CA-C-O 115.51 -2.186 . . . . 0.0 111.368 -176.586 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -84.8 -46.83 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.598 2.823 0 CA-C-N 123.188 2.722 . . . . 0.0 108.558 167.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -57.71 -24.32 56.26 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 119.076 2.991 . . . . 0.0 119.076 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -39.24 -45.09 1.32 Allowed 'General case' 0 CA--C 1.589 2.443 0 CA-C-N 121.718 2.054 . . . . 0.0 116.421 176.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 65.29 -58.04 0.29 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 117.792 2.516 . . . . 0.0 117.792 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.54 -13.52 62.39 Favored 'General case' 0 CA--C 1.577 1.994 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.59 8.58 86.77 Favored Glycine 0 CA--C 1.551 2.319 0 N-CA-C 120.66 3.024 . . . . 0.0 120.66 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -114.58 -10.39 12.53 Favored 'General case' 0 CA--C 1.578 2.036 0 CA-C-N 119.366 1.583 . . . . 0.0 114.764 177.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 110.41 0.63 29.49 Favored Glycine 0 CA--C 1.55 2.266 0 CA-C-O 116.144 -2.476 . . . . 0.0 116.49 -178.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.55 153.26 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 CA-C-N 121.471 2.636 . . . . 0.0 112.199 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.586 HD12 ' CE2' ' A' ' 94' ' ' PHE . 97.5 mt -121.38 130.57 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-N 112.402 -2.181 . . . . 0.0 106.709 178.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -106.43 -173.27 2.26 Favored 'General case' 0 CA--C 1.573 1.829 0 CA-C-O 122.033 0.92 . . . . 0.0 110.582 176.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -72.31 -38.33 68.74 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.829 -1.17 . . . . 0.0 112.588 178.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -58.76 -46.02 88.42 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 123.542 0.737 . . . . 0.0 112.057 175.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -62.04 -37.79 86.25 Favored 'General case' 0 CA--C 1.586 2.35 0 CA-C-N 120.675 1.58 . . . . 0.0 112.364 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -60.51 -44.89 95.53 Favored 'General case' 0 CA--C 1.571 1.768 0 C-N-CA 124.202 1.001 . . . . 0.0 109.557 173.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -55.43 -46.59 76.69 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 125.049 1.34 . . . . 0.0 112.014 173.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -60.38 -53.39 58.22 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 176.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.99 -28.13 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 -177.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 7.3 tpt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.909 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.485 1.32 0 N-CA-C 102.081 -3.303 . . . . 0.0 102.081 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -57.62 -40.31 78.89 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 117.324 2.342 . . . . 0.0 117.324 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.94 -38.79 76.59 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 114.708 1.374 . . . . 0.0 114.708 178.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -63.83 -51.99 62.16 Favored 'General case' 0 CA--C 1.574 1.868 0 CA-C-N 120.41 1.459 . . . . 0.0 112.713 177.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.1 t -70.98 -46.32 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-O 118.004 -0.998 . . . . 0.0 111.734 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -60.98 -49.14 78.65 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 117.067 -1.444 . . . . 0.0 110.611 176.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -61.91 -43.32 99.08 Favored 'General case' 0 CA--C 1.561 1.368 0 CA-C-N 120.927 1.694 . . . . 0.0 112.977 178.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.7 -45.48 78.64 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-N 120.612 1.551 . . . . 0.0 114.399 177.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -37.87 62.14 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 120.592 1.542 . . . . 0.0 111.903 178.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -63.83 -45.78 88.03 Favored 'General case' 0 CA--C 1.57 1.729 0 CA-C-N 121.71 2.05 . . . . 0.0 109.228 174.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -34.46 78.0 Favored 'General case' 0 CA--C 1.58 2.101 0 CA-C-N 122.229 2.286 . . . . 0.0 112.211 175.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.17 -32.03 58.83 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -77.99 114.21 16.64 Favored 'General case' 0 N--CA 1.513 2.676 0 O-C-N 117.408 -3.307 . . . . 0.0 109.454 175.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -82.06 -30.49 31.33 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 117.419 2.377 . . . . 0.0 117.419 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -86.3 -14.12 44.62 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 121.124 3.75 . . . . 0.0 121.124 -172.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.99 5.2 90.31 Favored Glycine 0 CA--C 1.572 3.61 0 CA-C-N 120.152 1.342 . . . . 0.0 113.895 -172.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -80.6 -51.36 8.83 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 119.145 1.472 . . . . 0.0 110.986 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 110.27 -7.95 30.76 Favored Glycine 0 CA--C 1.548 2.12 0 CA-C-O 115.965 -2.575 . . . . 0.0 116.907 -177.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . 0.307 3.4 m -134.97 121.04 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 101.402 -3.555 . . . . 0.0 101.402 174.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.0 mt -82.18 128.83 38.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 110.672 -2.967 . . . . 0.0 116.592 -172.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 39.3 p30 -93.95 155.5 17.12 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 172.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.61 -43.87 99.37 Favored Pre-proline 0 CA--C 1.583 2.224 0 CA-C-O 114.951 -2.452 . . . . 0.0 112.679 -178.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.37 -32.1 70.85 Favored 'Trans proline' 0 C--N 1.381 2.275 0 CA-C-N 125.1 2.857 . . . . 0.0 115.393 176.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -62.24 -57.87 9.83 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 116.743 -1.599 . . . . 0.0 110.18 175.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.567 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 75.5 t80 -53.14 -41.46 65.12 Favored 'General case' 0 N--CA 1.504 2.249 0 CA-C-N 120.624 1.556 . . . . 0.0 114.54 176.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.3 mtp -65.73 -49.16 69.47 Favored 'General case' 0 CA--C 1.573 1.862 0 O-C-N 121.591 -0.693 . . . . 0.0 110.623 176.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.67 -37.28 83.51 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 123.451 0.7 . . . . 0.0 112.789 175.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -57.66 -49.17 77.37 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 128.437 2.695 . . . . 0.0 110.491 173.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 91.0 mt -68.82 -40.32 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-N 119.698 1.135 . . . . 0.0 110.636 176.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? . . . . . 0 CA--C 1.578 2.052 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 177.888 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.262 1.4 tm-20 . . . . . 0 CA--C 1.584 2.272 0 CA-C-O 113.76 -3.019 . . . . 0.0 109.534 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.485 HG23 ' CE1' ' A' ' 147' ' ' PHE 0.381 1.2 mp -68.67 -58.43 5.84 Favored 'Isoleucine or valine' 0 C--N 1.389 2.305 1 CA-C-N 128.832 5.287 . . . . 0.0 103.275 170.95 . . . . . . . . 4 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 pp -56.99 -49.58 75.32 Favored 'General case' 0 N--CA 1.503 2.19 0 CA-C-N 121.576 1.989 . . . . 0.0 113.034 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 43.9 mtt85 -67.56 -40.38 84.93 Favored 'General case' 0 CA--C 1.567 1.634 0 CA-C-O 117.397 -1.287 . . . . 0.0 114.013 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.44 -50.62 43.95 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 115.098 -2.382 . . . . 0.0 111.64 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -62.42 -49.26 76.18 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 122.766 2.53 . . . . 0.0 110.136 176.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -60.07 -34.47 73.49 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 116.87 -1.538 . . . . 0.0 114.524 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -77.07 -43.95 31.56 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.949 0 CA-C-N 121.248 1.84 . . . . 0.0 109.729 173.098 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -49.01 -44.26 41.15 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 125.525 1.53 . . . . 0.0 109.864 177.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -54.63 98.79 0.02 OUTLIER 'General case' 0 CA--C 1.58 2.114 0 C-N-CA 125.65 1.58 . . . . 0.0 110.962 175.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -77.24 -36.69 54.4 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.1 p30 -67.36 -14.68 63.14 Favored 'General case' 0 CA--C 1.579 2.074 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.78 9.64 85.23 Favored Glycine 0 CA--C 1.551 2.334 0 N-CA-C 120.897 3.119 . . . . 0.0 120.897 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 26.7 p30 -115.45 -8.76 12.18 Favored 'General case' 0 CA--C 1.577 2.019 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 177.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 110.58 20.6 7.25 Favored Glycine 0 CA--C 1.552 2.359 0 CA-C-O 117.095 -1.947 . . . . 0.0 114.589 -177.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.5 t -133.34 143.29 39.53 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.718 0 CA-C-N 120.605 2.202 . . . . 0.0 111.446 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 79.3 mt -106.57 136.16 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 126.477 1.911 . . . . 0.0 108.194 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -108.78 -175.8 2.87 Favored 'General case' 0 CA--C 1.575 1.935 0 C-N-CA 123.299 0.639 . . . . 0.0 112.299 176.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -72.03 -52.73 15.56 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 117.126 -1.416 . . . . 0.0 114.64 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -59.05 -37.96 78.26 Favored 'General case' 0 N--CA 1.515 2.803 0 CA-C-N 120.416 1.462 . . . . 0.0 113.864 177.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . 0.362 0.9 OUTLIER -58.29 -48.32 80.84 Favored 'General case' 0 CA--C 1.598 2.8 0 CA-C-O 124.286 1.993 . . . . 0.0 112.4 174.266 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.18 -46.41 90.6 Favored 'General case' 0 CA--C 1.574 1.885 0 CA-C-O 116.582 -1.675 . . . . 0.0 107.212 172.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.439 ' O ' ' SD ' ' A' ' 114' ' ' MET . 60.8 mttt -51.0 -32.52 21.45 Favored 'General case' 0 N--CA 1.515 2.777 0 CA-C-N 122.078 2.217 . . . . 0.0 112.899 172.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -71.86 -49.92 34.01 Favored 'General case' 0 CA--C 1.583 2.235 0 C-N-CA 123.774 0.83 . . . . 0.0 111.92 174.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.7 mt -90.08 -7.64 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.738 0 N-CA-C 118.077 2.621 . . . . 0.0 118.077 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.439 ' SD ' ' O ' ' A' ' 111' ' ' LYS . 13.9 ptm . . . . . 0 N--CA 1.488 1.428 1 N-CA-C 123.485 4.624 . . . . 0.0 123.485 -178.172 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 75.0 p . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 121.581 0.705 . . . . 0.0 111.377 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -69.4 -27.98 65.76 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -55.56 -42.1 74.2 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-O 117.689 -1.148 . . . . 0.0 110.762 174.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -53.44 -50.33 65.49 Favored 'General case' 0 CA--C 1.57 1.728 0 CA-C-N 119.299 0.954 . . . . 0.0 112.996 174.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.1 p -71.04 -43.48 76.18 Favored 'Isoleucine or valine' 0 C--N 1.359 0.981 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -178.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.37 -49.08 70.67 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 120.037 1.29 . . . . 0.0 110.656 177.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -62.13 -49.43 75.92 Favored 'General case' 0 CA--C 1.573 1.841 0 CA-C-O 118.093 -0.956 . . . . 0.0 112.868 177.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.74 -45.05 90.55 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 177.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 15.9 ttt -69.68 -38.8 77.18 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 116.104 -1.903 . . . . 0.0 111.709 176.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -59.08 -42.07 89.53 Favored 'General case' 0 CA--C 1.576 1.973 0 CA-C-N 122.719 2.509 . . . . 0.0 110.485 173.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -57.45 -44.62 84.9 Favored 'General case' 0 CA--C 1.578 2.054 0 CA-C-N 120.099 1.318 . . . . 0.0 111.351 174.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.33 -18.79 40.94 Favored 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 118.311 2.708 . . . . 0.0 118.311 178.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.43 ' OD2' ' N ' ' A' ' 140' ' ' GLY . 23.0 t0 -82.41 102.99 11.64 Favored 'General case' 0 CA--C 1.574 1.874 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 174.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -81.89 -19.7 40.33 Favored 'General case' 0 CA--C 1.58 2.122 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 177.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -88.03 -14.34 39.26 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 119.128 3.01 . . . . 0.0 119.128 -175.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.94 5.11 90.03 Favored Glycine 0 CA--C 1.568 3.354 0 CA-C-N 119.964 1.256 . . . . 0.0 115.221 -174.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -80.72 -48.09 13.05 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 118.942 1.371 . . . . 0.0 111.353 175.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.43 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . 111.43 -20.12 23.47 Favored Glycine 0 CA--C 1.546 2.028 0 CA-C-O 116.27 -2.406 . . . . 0.0 115.346 -177.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . 0.303 5.7 m -122.28 122.22 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-N 121.438 2.619 . . . . 0.0 103.999 178.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -79.51 130.83 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 117.488 2.403 . . . . 0.0 117.488 -173.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 32.7 p30 -93.95 161.69 14.2 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 170.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 17.4 mt -54.99 -48.4 96.09 Favored Pre-proline 0 CA--C 1.579 2.077 0 CA-C-O 113.994 -2.908 . . . . 0.0 113.73 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -51.45 -27.22 23.81 Favored 'Trans proline' 0 C--N 1.373 1.85 0 CA-C-N 125.932 3.154 . . . . 0.0 119.849 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -72.18 -64.8 0.87 Allowed 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 121.237 1.835 . . . . 0.0 111.012 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.485 ' CE1' HG23 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -48.81 -53.59 18.58 Favored 'General case' 0 N--CA 1.506 2.346 0 C-N-CA 124.717 1.207 . . . . 0.0 110.729 173.738 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.417 ' O ' ' HB2' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -60.82 -40.25 92.04 Favored 'General case' 0 C--N 1.358 0.957 0 CA-C-O 113.681 -3.057 . . . . 0.0 113.938 -179.775 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.02 -48.18 79.86 Favored 'General case' 0 CA--C 1.594 2.651 0 CA-C-N 125.01 3.55 . . . . 0.0 111.533 174.092 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . 0.295 0.3 OUTLIER -44.55 -47.73 10.24 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 127.851 2.46 . . . . 0.0 111.072 176.937 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 9.6 mt -92.09 -44.14 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.238 0 CA-C-O 117.527 -1.225 . . . . 0.0 111.157 175.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 148' ' ' MET . 33.1 mttp . . . . . 0 N--CA 1.504 2.244 0 N-CA-C 118.453 2.76 . . . . 0.0 118.453 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 . . . . . 0 N--CA 1.506 2.333 0 CA-C-O 122.455 1.121 . . . . 0.0 113.718 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.642 HG23 ' CE2' ' A' ' 147' ' ' PHE . 1.1 mp -55.65 -53.38 37.57 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.711 0 C-N-CA 126.452 1.901 . . . . 0.0 110.412 177.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.9 -46.03 74.77 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.878 1.671 . . . . 0.0 110.656 175.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.8 mtm105 -57.82 -55.57 33.21 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-N 121.011 1.732 . . . . 0.0 110.44 176.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.84 -55.81 15.11 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.477 ' CE2' HD12 ' A' ' 105' ' ' ILE . 18.1 t80 -64.16 -50.58 67.61 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.342 36.2 mttt -67.13 -22.02 65.81 Favored 'General case' 0 CA--C 1.585 2.309 0 CA-C-O 116.556 -1.688 . . . . 0.0 110.068 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.6 t -69.6 -49.73 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 CA-C-N 122.394 2.361 . . . . 0.0 107.534 167.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -54.47 -34.91 62.42 Favored 'General case' 0 CA--C 1.58 2.113 0 N-CA-C 118.09 2.626 . . . . 0.0 118.09 -178.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.271 2.3 t0 -55.92 134.39 52.09 Favored 'General case' 0 CA--C 1.585 2.321 0 C-N-CA 127.513 2.325 . . . . 0.0 115.561 178.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.481 ' HB2' ' HG2' ' A' ' 109' ' ' GLU . . . -67.65 -60.79 2.26 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -76.21 -19.17 58.64 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 117.598 2.444 . . . . 0.0 117.598 -177.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.92 3.74 90.34 Favored Glycine 0 CA--C 1.568 3.346 0 CA-C-N 120.843 1.656 . . . . 0.0 114.754 -173.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -91.48 -17.55 25.54 Favored 'General case' 0 CA--C 1.58 2.126 0 CA-C-N 120.532 2.166 . . . . 0.0 113.395 173.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 113.36 24.46 4.75 Favored Glycine 0 CA--C 1.54 1.64 0 CA-C-O 115.541 -2.81 . . . . 0.0 116.987 -178.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.3 t -127.51 138.69 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 121.826 2.813 . . . . 0.0 109.783 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.477 HD12 ' CE2' ' A' ' 94' ' ' PHE . 61.5 mt -118.5 138.79 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 126.573 1.949 . . . . 0.0 109.582 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -110.22 -169.82 1.53 Allowed 'General case' 0 CA--C 1.585 2.308 0 C-N-CA 125.001 1.32 . . . . 0.0 110.834 176.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -81.59 -54.97 4.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.134 -1.604 . . . . 0.0 114.318 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -60.63 -43.87 97.03 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 117.534 -1.222 . . . . 0.0 112.807 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.481 ' HG2' ' HB2' ' A' ' 99' ' ' ALA . 11.2 tp10 -59.49 -44.44 93.08 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 121.025 1.739 . . . . 0.0 111.268 174.155 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.96 -51.75 68.34 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 119.486 1.039 . . . . 0.0 109.777 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -52.52 -42.25 64.19 Favored 'General case' 0 CA--C 1.573 1.864 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 175.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -69.75 -53.66 17.35 Favored 'General case' 0 CA--C 1.577 1.994 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 176.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.9 tt -72.72 -29.08 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 118.7 2.852 . . . . 0.0 118.7 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 6.2 tpt . . . . . 0 N--CA 1.491 1.623 0 C-N-CA 125.035 1.334 . . . . 0.0 112.342 178.116 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 18.8 p . . . . . 0 CA--C 1.565 1.544 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.64 -36.81 85.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.792 -1.192 . . . . 0.0 111.934 175.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.61 -49.65 67.95 Favored 'General case' 0 CA--C 1.56 1.329 0 CA-C-O 117.557 -1.211 . . . . 0.0 112.848 176.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -58.09 -46.14 86.01 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-N 120.309 1.413 . . . . 0.0 112.483 176.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 62.4 t -69.34 -43.43 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.346 0 CA-C-O 116.627 -1.654 . . . . 0.0 110.992 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -63.46 -43.73 96.51 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 121.871 2.123 . . . . 0.0 112.467 177.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -64.73 -52.97 54.24 Favored 'General case' 0 CA--C 1.572 1.797 0 CA-C-N 119.517 1.053 . . . . 0.0 110.617 175.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.26 -43.36 96.22 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 177.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -69.68 -42.26 74.37 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 117.318 -1.325 . . . . 0.0 111.521 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -64.96 -36.74 85.38 Favored 'General case' 0 CA--C 1.572 1.813 0 CA-C-N 120.621 1.555 . . . . 0.0 111.252 175.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -64.88 -41.03 95.98 Favored 'General case' 0 CA--C 1.581 2.157 0 CA-C-N 120.884 1.674 . . . . 0.0 109.719 172.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.41 -23.88 67.06 Favored 'General case' 0 CA--C 1.576 1.965 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 174.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -88.39 100.85 13.35 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 171.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -62.13 -16.18 50.83 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 117.912 2.56 . . . . 0.0 117.912 177.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.94 -2.95 20.71 Favored 'General case' 0 N--CA 1.491 1.577 1 N-CA-C 121.958 4.059 . . . . 0.0 121.958 -173.75 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.35 6.98 88.97 Favored Glycine 0 CA--C 1.556 2.633 0 N-CA-C 118.289 2.076 . . . . 0.0 118.289 -178.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -78.56 -36.77 44.1 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 120.246 2.023 . . . . 0.0 114.083 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 96.85 21.92 19.63 Favored Glycine 0 CA--C 1.555 2.584 0 N-CA-C 117.063 1.585 . . . . 0.0 117.063 -177.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -149.67 145.22 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 103.383 -2.821 . . . . 0.0 103.383 176.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.41 HG22 ' O ' ' A' ' 143' ' ' ASP . 0.3 OUTLIER -129.19 133.9 64.91 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -176.405 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.41 ' O ' HG22 ' A' ' 142' ' ' ILE . 19.3 p30 -103.83 165.01 11.31 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 169.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.6 mt -53.19 -45.17 98.44 Favored Pre-proline 0 N--CA 1.505 2.317 0 O-C-N 118.071 -2.893 . . . . 0.0 112.812 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -50.2 -35.03 41.68 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 123.937 3.091 . . . . 0.0 118.601 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -72.98 -45.79 55.95 Favored 'General case' 0 CA--C 1.591 2.53 0 CA-C-N 122.614 2.461 . . . . 0.0 112.937 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.642 ' CE2' HG23 ' A' ' 90' ' ' ILE . 4.7 t80 -56.32 -52.13 65.66 Favored 'General case' 0 N--CA 1.506 2.331 0 CA-C-N 120.726 1.603 . . . . 0.0 110.932 172.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.488 ' HB3' HG21 ' A' ' 90' ' ' ILE 0.259 4.1 ptp -60.59 -39.12 86.93 Favored 'General case' 0 CA--C 1.589 2.452 0 CA-C-O 121.499 0.666 . . . . 0.0 111.057 176.737 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.53 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 17.6 t0 -52.65 -54.34 34.65 Favored 'General case' 0 N--CA 1.492 1.632 1 CA-C-O 109.296 -5.145 . . . . 0.0 106.006 171.823 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.43 -43.39 23.8 Favored 'General case' 0 N--CA 1.515 2.783 0 CA-C-N 123.699 2.954 . . . . 0.0 112.502 174.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.1 mt -73.76 30.26 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.613 3.376 0 C-N-CA 127.12 2.168 . . . . 0.0 109.61 169.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 149' ' ' ASP . 1.3 mmpt? . . . . . 0 N--CA 1.525 3.301 2 C-N-CA 132.888 4.475 . . . . 0.0 122.146 -167.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 . . . . . 0 N--CA 1.5 2.041 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.625 HG23 ' CE ' ' A' ' 148' ' ' MET 0.297 1.1 mp -58.26 -50.9 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-O 117.164 -1.398 . . . . 0.0 111.209 178.004 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 pp -59.58 -42.89 93.53 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 116.967 -1.492 . . . . 0.0 111.668 177.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.86 -54.96 40.96 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 121.273 1.851 . . . . 0.0 111.43 176.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.13 -57.72 11.62 Favored 'General case' 0 C--N 1.358 0.961 0 CA-C-O 116.091 -1.909 . . . . 0.0 114.048 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.441 ' HB3' ' HE1' ' A' ' 148' ' ' MET . 19.2 t80 -58.97 -46.71 87.41 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 120.862 1.665 . . . . 0.0 114.336 178.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -63.72 -34.64 78.34 Favored 'General case' 0 CA--C 1.568 1.664 0 CA-C-O 116.341 -1.79 . . . . 0.0 111.483 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 75.1 t -64.73 -43.78 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 CA-C-N 122.146 2.248 . . . . 0.0 108.181 169.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.56 -31.19 63.96 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 117.272 2.323 . . . . 0.0 117.272 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -75.71 119.26 19.48 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 174.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.85 -71.57 0.06 Allowed 'General case' 0 N--CA 1.514 2.727 0 CA-C-O 123.908 1.813 . . . . 0.0 106.833 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -134.03 -55.3 0.87 Allowed 'General case' 0 CA--C 1.577 2.006 0 CA-C-N 109.682 -3.417 . . . . 0.0 103.977 167.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 30.87 9.58 0.0 OUTLIER Glycine 0 C--N 1.355 1.586 1 N-CA-C 125.548 4.979 . . . . 0.0 125.548 -175.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.2 p30 63.72 12.99 7.05 Favored 'General case' 0 CA--C 1.59 2.517 0 CA-C-N 122.231 3.015 . . . . 0.0 113.047 -171.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 110.76 -15.85 28.79 Favored Glycine 0 CA--C 1.57 3.478 0 CA-C-O 115.796 -2.669 . . . . 0.0 109.211 -170.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -99.59 138.89 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-N 122.436 3.118 . . . . 0.0 116.416 -179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 18.6 mt -105.98 132.32 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 C-N-CA 125.108 1.363 . . . . 0.0 109.806 178.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.54 -174.89 2.64 Favored 'General case' 0 CA--C 1.584 2.263 0 CA-C-O 122.0 0.905 . . . . 0.0 112.398 176.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -72.41 -46.65 54.21 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.672 -1.267 . . . . 0.0 114.021 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -57.54 -49.01 77.75 Favored 'General case' 0 N--CA 1.504 2.273 0 CA-C-O 117.925 -1.036 . . . . 0.0 112.451 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -54.49 -43.72 72.03 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 120.201 1.364 . . . . 0.0 112.948 173.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.61 -55.14 33.94 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 116.981 -1.485 . . . . 0.0 107.642 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.444 ' HA ' ' SD ' ' A' ' 114' ' ' MET . 33.5 mtmm -55.54 -29.15 58.43 Favored 'General case' 0 N--CA 1.503 2.185 0 CA-C-N 121.131 1.787 . . . . 0.0 115.264 176.203 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -74.91 -53.59 8.76 Favored 'General case' 0 CA--C 1.574 1.902 0 C-N-CA 124.505 1.122 . . . . 0.0 110.746 175.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 tt -79.01 -16.56 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 118.492 2.775 . . . . 0.0 118.492 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.444 ' SD ' ' HA ' ' A' ' 111' ' ' LYS . 15.1 ptm . . . . . 0 N--CA 1.501 2.079 0 N-CA-C 118.062 2.615 . . . . 0.0 118.062 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 41.6 p . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 122.595 1.188 . . . . 0.0 110.631 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -71.44 -31.24 66.98 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-N 113.276 -1.784 . . . . 0.0 114.601 178.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.46 -40.85 75.54 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.52 1.128 . . . . 0.0 113.893 176.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -58.2 -48.78 79.28 Favored 'General case' 0 CA--C 1.584 2.284 0 CA-C-O 122.989 1.376 . . . . 0.0 112.567 176.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.0 t -63.17 -49.69 82.22 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.483 0 C-N-CA 126.852 2.061 . . . . 0.0 111.129 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -58.78 -42.99 90.31 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 124.253 1.021 . . . . 0.0 112.601 176.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -64.51 -48.02 76.72 Favored 'General case' 0 CA--C 1.577 1.989 0 CA-C-N 119.531 1.06 . . . . 0.0 111.828 176.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.57 -44.51 93.29 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 176.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 23.1 ttt -67.35 -39.46 85.76 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 116.866 -1.54 . . . . 0.0 112.412 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -62.07 -39.64 93.11 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 121.283 1.856 . . . . 0.0 111.093 175.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -62.87 -43.46 98.74 Favored 'General case' 0 CA--C 1.58 2.103 0 CA-C-N 119.565 1.075 . . . . 0.0 111.11 172.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -85.73 -8.08 58.39 Favored 'General case' 0 N--CA 1.486 1.338 1 N-CA-C 122.873 4.397 . . . . 0.0 122.873 -179.201 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.422 ' OD2' ' HA2' ' A' ' 140' ' ' GLY . 24.6 t0 -78.05 114.48 16.97 Favored 'General case' 0 N--CA 1.506 2.328 1 CA-C-O 96.312 -11.327 . . . . 0.0 109.467 177.255 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -81.07 26.49 0.43 Allowed 'General case' 0 C--N 1.26 -3.309 2 O-C-N 62.843 -37.411 . . . . 0.0 116.029 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.372 32.8 t0 92.14 -103.2 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 101.907 -3.368 . . . . 0.0 101.907 -177.291 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 37.64 7.65 0.0 OUTLIER Glycine 0 CA--C 1.557 2.668 0 N-CA-C 120.564 2.985 . . . . 0.0 120.564 -174.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 157.45 -49.32 0.0 OUTLIER 'General case' 0 CA--C 1.572 1.813 0 C-N-CA 126.856 2.062 . . . . 0.0 114.337 -173.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.422 ' HA2' ' OD2' ' A' ' 135' ' ' ASP . . . 112.65 -23.46 15.09 Favored Glycine 0 CA--C 1.561 2.963 0 CA-C-N 123.241 2.746 . . . . 0.0 113.76 -173.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 19.7 m -115.63 127.55 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 101.921 -3.363 . . . . 0.0 101.921 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.6 mt -79.64 126.77 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 N-CA-C 118.366 2.728 . . . . 0.0 118.366 -172.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -94.0 149.78 20.93 Favored 'General case' 0 CA--C 1.561 1.393 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 171.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -49.58 -46.62 79.05 Favored Pre-proline 0 CA--C 1.574 1.869 0 CA-C-O 115.035 -2.412 . . . . 0.0 114.434 -177.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -57.42 -26.72 72.61 Favored 'Trans proline' 0 C--N 1.371 1.723 0 CA-C-N 124.926 2.795 . . . . 0.0 116.401 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -68.71 -54.86 13.63 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 123.138 2.699 . . . . 0.0 112.113 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -60.48 -46.47 89.97 Favored 'General case' 0 CA--C 1.578 2.057 0 CA-C-N 121.756 2.071 . . . . 0.0 112.612 176.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.625 ' CE ' HG23 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -62.4 -41.25 98.52 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-O 116.895 -1.526 . . . . 0.0 111.684 176.971 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -68.91 -38.41 79.54 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 121.873 2.124 . . . . 0.0 111.902 175.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.09 -43.36 77.98 Favored 'General case' 0 CA--C 1.565 1.558 0 C-N-CA 126.011 1.725 . . . . 0.0 110.708 175.195 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 66.7 mt -87.31 -51.83 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 121.279 1.854 . . . . 0.0 112.368 177.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 -178.815 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 . . . . . 0 N--CA 1.504 2.23 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.867 HG23 ' HE2' ' A' ' 147' ' ' PHE . 1.6 mp -65.1 -35.79 76.25 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.013 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 172.144 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.0 -45.8 71.57 Favored 'General case' 0 N--CA 1.515 2.793 0 CA-C-N 124.048 3.113 . . . . 0.0 109.384 173.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.7 mtm105 -59.81 -56.15 25.37 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 120.642 1.564 . . . . 0.0 110.65 176.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.77 -59.93 3.94 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 116.074 -1.917 . . . . 0.0 114.904 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.495 ' CE2' HD12 ' A' ' 105' ' ' ILE . 24.4 t80 -59.65 -49.13 78.96 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 121.087 1.767 . . . . 0.0 113.297 178.141 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.371 36.5 mttt -69.11 -23.63 64.02 Favored 'General case' 0 CA--C 1.583 2.227 0 CA-C-O 116.631 -1.652 . . . . 0.0 110.333 -178.083 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.1 t -68.73 -48.91 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 CA-C-N 122.15 2.25 . . . . 0.0 107.103 166.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -53.3 -33.21 52.33 Favored 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.256 3.7 t0 -67.22 -3.62 8.27 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 117.83 2.53 . . . . 0.0 117.83 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 50.04 24.63 1.43 Allowed 'General case' 0 N--CA 1.524 3.258 0 CA-C-N 124.533 3.333 . . . . 0.0 115.404 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . 0.284 11.4 t-20 82.49 -53.1 0.21 Allowed 'General case' 0 CA--C 1.575 1.915 0 C-N-CA 129.834 3.254 . . . . 0.0 105.795 -170.141 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 30.94 20.55 0.0 OUTLIER Glycine 0 C--N 1.363 2.034 1 N-CA-C 125.272 4.869 . . . . 0.0 125.272 178.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 67.04 14.08 9.7 Favored 'General case' 0 CA--C 1.593 2.612 0 CA-C-N 120.821 2.311 . . . . 0.0 113.61 -173.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.89 -5.89 56.67 Favored Glycine 0 CA--C 1.568 3.373 0 CA-C-O 116.688 -2.173 . . . . 0.0 111.127 -172.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.4 t -117.37 136.42 54.57 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.94 0 CA-C-N 121.059 2.429 . . . . 0.0 113.385 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.495 HD12 ' CE2' ' A' ' 94' ' ' PHE . 67.9 mt -92.23 140.56 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 C-N-CA 126.587 1.955 . . . . 0.0 108.282 176.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.3 p30 -110.12 179.52 4.08 Favored 'General case' 0 CA--C 1.572 1.803 0 CA-C-O 122.666 1.222 . . . . 0.0 110.795 175.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -70.94 -43.01 69.09 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 117.391 -1.29 . . . . 0.0 114.437 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -63.62 -45.89 88.21 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 120.124 1.329 . . . . 0.0 112.157 177.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -58.86 -48.54 81.03 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 121.464 1.938 . . . . 0.0 112.731 175.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -59.1 -49.02 79.46 Favored 'General case' 0 CA--C 1.568 1.661 0 C-N-CA 123.502 0.721 . . . . 0.0 109.36 175.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 21.8 tptp -62.73 -12.81 26.28 Favored 'General case' 0 CA--C 1.577 2.01 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 175.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -93.3 -43.55 8.75 Favored 'General case' 0 CA--C 1.584 2.266 0 O-C-N 120.448 -1.407 . . . . 0.0 111.334 173.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -92.66 -29.24 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 1 N-CA-C 122.064 4.098 . . . . 0.0 122.064 -174.906 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 19.3 tpt . . . . . 0 N--CA 1.492 1.66 0 C-N-CA 126.001 1.72 . . . . 0.0 115.166 -176.775 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 38.0 p . . . . . 0 N--CA 1.487 1.41 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.17 -32.53 70.52 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.43 -44.45 96.4 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-O 116.594 -1.67 . . . . 0.0 113.619 177.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -43.36 97.19 Favored 'General case' 0 CA--C 1.577 1.996 0 CA-C-N 121.557 1.98 . . . . 0.0 113.68 178.072 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.5 t -70.62 -52.77 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-O 117.667 -1.159 . . . . 0.0 112.174 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -60.84 -47.15 87.65 Favored 'General case' 0 CA--C 1.558 1.272 0 CA-C-N 119.672 1.124 . . . . 0.0 111.451 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -61.57 -46.91 87.89 Favored 'General case' 0 CA--C 1.57 1.735 0 CA-C-N 120.653 1.57 . . . . 0.0 112.417 177.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.3 -43.77 96.91 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 177.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 17.5 ttt -73.7 -36.48 65.27 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 116.594 -1.67 . . . . 0.0 112.163 177.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -61.36 -44.15 97.67 Favored 'General case' 0 CA--C 1.569 1.692 0 CA-C-N 122.116 2.234 . . . . 0.0 109.982 173.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -64.74 -42.63 95.05 Favored 'General case' 0 CA--C 1.577 2.016 0 CA-C-N 120.922 1.692 . . . . 0.0 111.81 175.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -77.08 -21.15 54.79 Favored 'General case' 0 CA--C 1.564 1.484 0 N-CA-C 118.431 2.752 . . . . 0.0 118.431 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -87.53 113.46 23.25 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 103.66 -2.718 . . . . 0.0 103.66 175.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . 0.256 5.9 mt-10 -80.27 -18.17 50.08 Favored 'General case' 0 CA--C 1.576 1.948 0 CA-C-N 113.523 -1.672 . . . . 0.0 115.312 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -92.13 -15.61 27.44 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 117.035 2.235 . . . . 0.0 117.035 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.14 5.97 89.72 Favored Glycine 0 CA--C 1.564 3.108 0 CA-C-N 120.196 1.362 . . . . 0.0 116.081 -175.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -93.39 -45.85 7.61 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-O 117.267 -1.349 . . . . 0.0 114.088 177.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 114.29 22.63 5.12 Favored Glycine 0 CA--C 1.561 2.95 0 N-CA-C 118.111 2.004 . . . . 0.0 118.111 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.97 143.49 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.527 0 N-CA-C 102.836 -3.024 . . . . 0.0 102.836 174.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.445 HD13 HG21 ' A' ' 142' ' ' ILE . 1.0 OUTLIER -132.69 139.97 48.55 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -175.736 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 59.6 p30 -96.96 165.57 12.02 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 170.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.3 mt -56.13 -43.64 99.34 Favored Pre-proline 0 N--CA 1.5 2.048 0 CA-C-O 115.007 -2.425 . . . . 0.0 112.826 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.441 ' O ' ' HB2' ' A' ' 149' ' ' ASP . 69.2 Cg_exo -55.25 -40.74 84.08 Favored 'Trans proline' 0 C--N 1.372 1.816 0 CA-C-N 124.491 2.64 . . . . 0.0 116.124 178.15 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -65.23 -52.85 51.95 Favored 'General case' 0 N--CA 1.505 2.276 0 CA-C-N 124.507 3.322 . . . . 0.0 113.321 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.867 ' HE2' HG23 ' A' ' 90' ' ' ILE . 22.9 t80 -54.33 -52.13 62.51 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 120.265 1.393 . . . . 0.0 113.053 172.091 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.524 ' HE2' ' HB2' ' A' ' 148' ' ' MET . 0.0 OUTLIER -68.62 -34.91 76.57 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 117.734 -1.127 . . . . 0.0 113.405 179.36 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 145' ' ' PRO . 4.1 t70 -64.3 -35.25 80.23 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 119.478 1.035 . . . . 0.0 111.346 171.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -58.44 -52.13 66.91 Favored 'General case' 0 CA--C 1.562 1.431 0 C-N-CA 125.295 1.438 . . . . 0.0 110.07 173.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 95.9 mt -70.08 -53.5 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-O 117.592 -1.194 . . . . 0.0 113.321 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 17.5 pttm . . . . . 0 CA--C 1.569 1.704 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -179.598 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 . . . . . 0 N--CA 1.498 1.962 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.502 ' H ' HD12 ' A' ' 90' ' ' ILE . 2.7 mp -61.58 -55.65 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 124.338 1.055 . . . . 0.0 111.482 178.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.1 pp -59.28 -41.97 90.16 Favored 'General case' 0 CA--C 1.556 1.211 0 CA-C-O 118.732 -0.652 . . . . 0.0 112.139 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 25.4 ttp85 -57.29 -55.47 34.37 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 117.617 -1.182 . . . . 0.0 110.008 176.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.34 -59.76 3.69 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.535 ' HB2' ' CE2' ' A' ' 147' ' ' PHE . 5.3 t80 -69.69 -48.7 58.75 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 121.652 2.024 . . . . 0.0 114.285 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.455 ' HG2' HD13 ' A' ' 144' ' ' ILE 0.326 47.5 mttt -64.16 -20.48 66.02 Favored 'General case' 0 CA--C 1.586 2.36 0 CA-C-O 115.635 -2.126 . . . . 0.0 110.737 -178.666 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -80.29 -46.73 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.403 0 CA-C-N 123.09 2.677 . . . . 0.0 108.497 169.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -54.78 -38.45 67.28 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -49.35 110.2 0.35 Allowed 'General case' 0 CA--C 1.575 1.909 0 C-N-CA 126.258 1.823 . . . . 0.0 112.262 178.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.466 ' HB2' ' HG2' ' A' ' 109' ' ' GLU . . . -41.97 -75.59 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 -177.4 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -94.55 0.69 55.43 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 117.425 2.38 . . . . 0.0 117.425 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.94 6.49 88.33 Favored Glycine 0 CA--C 1.554 2.518 0 CA-C-O 116.476 -2.291 . . . . 0.0 118.316 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -88.96 -3.72 58.65 Favored 'General case' 0 CA--C 1.585 2.301 0 CA-C-N 121.902 2.851 . . . . 0.0 113.987 174.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.14 -22.31 18.47 Favored Glycine 0 CA--C 1.54 1.595 0 CA-C-O 115.814 -2.659 . . . . 0.0 116.869 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.1 m -92.52 140.64 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.358 0 CA-C-N 122.333 3.066 . . . . 0.0 112.371 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.47 HD12 ' CE2' ' A' ' 94' ' ' PHE . 89.7 mt -110.35 121.56 63.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 N-CA-C 100.477 -3.897 . . . . 0.0 100.477 172.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.438 ' HA ' HG12 ' A' ' 141' ' ' VAL . 2.4 p30 -92.93 169.13 10.68 Favored 'General case' 0 CA--C 1.559 1.305 0 CA-C-O 122.31 1.052 . . . . 0.0 113.327 178.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -67.67 -45.0 76.47 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 117.661 -1.161 . . . . 0.0 113.501 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -65.65 -45.86 81.38 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 117.284 -1.341 . . . . 0.0 112.224 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.466 ' HG2' ' HB2' ' A' ' 99' ' ' ALA . 25.3 tp10 -64.42 -40.67 96.21 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 121.439 1.927 . . . . 0.0 112.409 176.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -63.38 -51.78 64.44 Favored 'General case' 0 CA--C 1.577 2.017 0 CA-C-N 120.26 1.391 . . . . 0.0 108.838 175.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -49.01 -42.83 39.4 Favored 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 125.384 1.474 . . . . 0.0 112.709 175.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -68.54 -60.47 2.4 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 123.675 0.79 . . . . 0.0 111.441 175.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.7 tt -62.16 -16.29 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 117.508 2.41 . . . . 0.0 117.508 -177.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 13.7 tpt . . . . . 0 N--CA 1.493 1.701 0 C-N-CA 125.202 1.401 . . . . 0.0 109.006 175.488 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 18.4 p . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 103.118 -2.919 . . . . 0.0 103.118 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -64.12 -30.83 71.87 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 116.817 2.155 . . . . 0.0 116.817 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.18 -36.91 83.31 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-O 117.297 -1.335 . . . . 0.0 113.54 177.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -59.94 -51.11 71.06 Favored 'General case' 0 CA--C 1.576 1.963 0 CA-C-N 120.269 1.395 . . . . 0.0 112.595 177.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 24.4 t -68.28 -51.77 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.311 0 C-N-CA 124.617 1.167 . . . . 0.0 111.936 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -60.01 -46.4 89.62 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 120.057 1.299 . . . . 0.0 112.22 178.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -62.42 -43.1 99.61 Favored 'General case' 0 CA--C 1.57 1.748 0 CA-C-N 120.087 1.312 . . . . 0.0 111.928 176.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.7 -47.81 79.67 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-N 119.904 1.229 . . . . 0.0 114.113 176.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 14.7 ttt -70.46 -39.41 74.31 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 114.417 -2.706 . . . . 0.0 109.874 177.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -58.5 -39.27 79.59 Favored 'General case' 0 CA--C 1.582 2.199 0 CA-C-N 124.867 3.485 . . . . 0.0 110.224 173.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -60.7 -45.27 94.85 Favored 'General case' 0 CA--C 1.582 2.178 0 CA-C-N 121.494 1.952 . . . . 0.0 110.954 173.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.65 -11.44 59.08 Favored 'General case' 0 CA--C 1.58 2.104 0 N-CA-C 117.173 2.286 . . . . 0.0 117.173 178.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -91.84 115.2 27.86 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 101.22 -3.622 . . . . 0.0 101.22 167.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -69.18 -20.6 64.0 Favored 'General case' 0 CA--C 1.561 1.38 0 N-CA-C 119.846 3.276 . . . . 0.0 119.846 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -145.96 25.93 1.26 Allowed 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 120.99 3.7 . . . . 0.0 120.99 -174.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.29 7.68 88.31 Favored Glycine 0 CA--C 1.555 2.59 0 N-CA-C 117.237 1.655 . . . . 0.0 117.237 -177.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -66.78 -44.8 80.37 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-N 120.303 2.052 . . . . 0.0 112.99 176.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 103.0 -21.43 40.15 Favored Glycine 0 CA--C 1.55 2.254 0 N-CA-C 117.032 1.573 . . . . 0.0 117.032 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.438 HG12 ' HA ' ' A' ' 106' ' ' ASP . 13.8 m -126.12 138.6 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 103.693 -2.706 . . . . 0.0 103.693 176.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.1 mt -104.71 133.7 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 114.032 -1.44 . . . . 0.0 113.622 -174.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 28.0 p30 -95.44 152.12 18.69 Favored 'General case' 0 CA--C 1.565 1.52 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 171.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.455 HD13 ' HG2' ' A' ' 95' ' ' LYS . 0.4 OUTLIER -52.28 -45.16 94.62 Favored Pre-proline 0 CA--C 1.583 2.241 0 CA-C-O 114.772 -2.537 . . . . 0.0 114.001 -177.836 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.43 -29.65 78.56 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 123.735 2.957 . . . . 0.0 117.716 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -60.01 -55.57 32.34 Favored 'General case' 0 N--CA 1.505 2.286 0 CA-C-N 121.209 1.822 . . . . 0.0 112.125 176.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.535 ' CE2' ' HB2' ' A' ' 94' ' ' PHE . 36.4 t80 -55.67 -51.91 65.63 Favored 'General case' 0 CA--C 1.577 2.005 0 C-N-CA 126.61 1.964 . . . . 0.0 111.075 173.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 4.7 mtp -56.59 -46.84 80.62 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 117.015 -1.469 . . . . 0.0 111.793 177.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.25 -35.75 74.02 Favored 'General case' 0 CA--C 1.576 1.949 0 CA-C-N 120.837 1.653 . . . . 0.0 111.016 176.003 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.46 -35.87 65.96 Favored 'General case' 0 CA--C 1.577 2.016 0 CA-C-N 120.327 1.421 . . . . 0.0 110.205 172.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 85.7 mt -82.57 -59.6 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.451 0 CA-C-N 120.572 1.533 . . . . 0.0 109.987 175.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 96.8 mttt . . . . . 0 CA--C 1.578 2.028 1 N-CA-C 122.243 4.164 . . . . 0.0 122.243 -176.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 117.58 2.437 . . . . 0.0 117.58 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -57.16 -46.33 82.86 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 -176.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.19 -42.36 96.69 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 120.132 1.333 . . . . 0.0 114.524 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.636 HG23 ' CE2' ' A' ' 147' ' ' PHE . 2.0 mp -68.84 -48.3 71.48 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.43 0 CA-C-O 116.762 -1.59 . . . . 0.0 109.92 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.5 pp -62.92 -38.43 90.95 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 121.559 1.981 . . . . 0.0 110.372 176.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -56.88 -58.0 10.06 Favored 'General case' 0 CA--C 1.574 1.883 0 CA-C-N 120.945 1.702 . . . . 0.0 109.429 174.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.85 -57.72 11.24 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 117.283 -1.342 . . . . 0.0 114.337 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.468 ' CE2' HD12 ' A' ' 105' ' ' ILE . 18.1 t80 -57.23 -46.42 82.98 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 119.905 1.23 . . . . 0.0 112.518 177.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -62.41 -35.3 78.81 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-O 116.037 -1.935 . . . . 0.0 112.363 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.2 t -66.6 -43.28 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 CA-C-N 122.451 2.387 . . . . 0.0 107.935 170.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -55.82 -41.24 73.93 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -66.07 114.17 5.02 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 174.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.29 50.83 0.66 Allowed 'General case' 0 N--CA 1.507 2.397 0 CA-C-O 123.304 1.526 . . . . 0.0 111.577 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . 0.296 10.1 t-20 84.9 -61.93 0.08 Allowed 'General case' 0 CA--C 1.57 1.716 0 C-N-CA 128.699 2.799 . . . . 0.0 103.968 -170.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 28.97 15.23 0.0 OUTLIER Glycine 0 C--N 1.357 1.699 1 N-CA-C 125.074 4.79 . . . . 0.0 125.074 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.2 p30 64.51 13.34 8.11 Favored 'General case' 0 CA--C 1.597 2.783 0 CA-C-N 121.74 2.77 . . . . 0.0 112.269 -169.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.85 -6.49 54.49 Favored Glycine 0 CA--C 1.559 2.84 0 CA-C-O 115.968 -2.573 . . . . 0.0 111.264 -171.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -101.86 144.44 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.709 0 CA-C-N 121.818 2.809 . . . . 0.0 113.985 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.468 HD12 ' CE2' ' A' ' 94' ' ' PHE . 57.3 mt -111.78 128.68 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-N 113.196 -1.82 . . . . 0.0 108.681 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -106.58 -176.72 3.16 Favored 'General case' 0 CA--C 1.572 1.822 0 CA-C-O 121.739 0.78 . . . . 0.0 112.102 176.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -70.69 -49.63 45.19 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.861 -1.15 . . . . 0.0 113.793 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -62.49 -42.91 99.82 Favored 'General case' 0 CA--C 1.578 2.052 0 CA-C-O 117.427 -1.273 . . . . 0.0 111.461 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -54.13 -44.81 71.68 Favored 'General case' 0 CA--C 1.573 1.842 0 CA-C-N 121.558 1.981 . . . . 0.0 112.332 173.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -69.38 -49.53 54.56 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -58.75 -15.86 14.08 Favored 'General case' 0 CA--C 1.58 2.1 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 173.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -93.33 -53.32 4.14 Favored 'General case' 0 CA--C 1.582 2.18 0 CA-C-N 120.129 1.331 . . . . 0.0 110.995 173.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.48 -23.12 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 120.13 3.382 . . . . 0.0 120.13 -175.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -44.76 -56.28 4.6 Favored 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 125.034 1.334 . . . . 0.0 112.078 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.486 ' H ' ' HG3' ' A' ' 121' ' ' PRO . 36.6 mm-40 -94.5 88.1 5.36 Favored 'General case' 0 CA--C 1.562 1.437 0 N-CA-C 103.179 -2.897 . . . . 0.0 103.179 174.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -32.71 -29.76 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.724 1 N-CA-C 122.236 4.162 . . . . 0.0 122.236 -179.767 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 26.1 t -91.76 94.32 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-N 122.186 2.267 . . . . 0.0 108.046 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.05 -140.67 45.69 Favored Glycine 0 CA--C 1.549 2.16 0 N-CA-C 116.143 1.217 . . . . 0.0 116.143 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -89.73 47.75 1.5 Allowed 'General case' 0 CA--C 1.581 2.15 0 N-CA-C 114.86 1.429 . . . . 0.0 114.86 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.303 55.0 tt0 -77.42 -16.59 0.26 Allowed Pre-proline 0 CA--C 1.575 1.926 0 CA-C-O 111.944 -3.884 . . . . 0.0 117.693 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.486 ' HG3' ' H ' ' A' ' 115' ' ' GLN . 27.2 Cg_exo -52.05 99.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.386 2.548 1 CA-C-N 128.462 4.058 . . . . 0.0 115.735 177.854 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.4 0.0 OUTLIER -74.18 -56.95 4.3 Favored 'General case' 0 CA--C 1.576 1.969 0 CA-C-N 109.706 -3.406 . . . . 0.0 114.717 -174.625 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 10.4 p -112.87 125.78 54.73 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 125.918 3.963 . . . . 0.0 104.89 175.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.96 -34.82 75.96 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 113.239 -1.8 . . . . 0.0 115.468 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.24 -39.79 76.29 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -59.85 -49.47 77.59 Favored 'General case' 0 CA--C 1.584 2.285 0 CA-C-O 122.261 1.029 . . . . 0.0 112.317 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.3 t -64.54 -50.44 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.793 0 C-N-CA 126.101 1.76 . . . . 0.0 111.184 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -58.3 -42.99 87.86 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 123.52 0.728 . . . . 0.0 112.674 176.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -61.41 -51.15 69.96 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.531 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.18 -45.32 93.53 Favored 'General case' 0 CA--C 1.561 1.393 0 N-CA-C 115.435 1.642 . . . . 0.0 115.435 177.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.6 ttt -71.44 -42.1 68.66 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 117.328 -1.32 . . . . 0.0 111.748 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.46 -43.85 84.35 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 120.907 1.685 . . . . 0.0 110.744 174.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.59 -30.11 68.79 Favored 'General case' 0 CA--C 1.581 2.146 0 CA-C-N 121.165 1.802 . . . . 0.0 113.043 174.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.37 -23.51 37.65 Favored 'General case' 0 CA--C 1.582 2.183 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.603 ' OD2' ' HA2' ' A' ' 140' ' ' GLY . 17.8 t0 -84.72 108.17 17.28 Favored 'General case' 0 CA--C 1.578 2.043 0 N-CA-C 104.079 -2.563 . . . . 0.0 104.079 171.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -76.09 -29.05 57.78 Favored 'General case' 0 CA--C 1.587 2.382 0 CA-C-N 120.556 1.525 . . . . 0.0 113.515 177.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.274 0.1 OUTLIER -166.02 -75.93 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.376 1 N-CA-C 99.075 -4.416 . . . . 0.0 99.075 177.127 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 34.15 30.13 0.01 OUTLIER Glycine 0 C--N 1.372 2.531 0 CA-C-N 123.309 2.777 . . . . 0.0 119.399 175.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.38 -3.21 0.68 Allowed 'General case' 0 CA--C 1.593 2.615 0 CA-C-N 119.629 1.715 . . . . 0.0 114.438 -172.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.603 ' HA2' ' OD2' ' A' ' 135' ' ' ASP . . . 106.41 -23.34 28.75 Favored Glycine 0 CA--C 1.559 2.817 0 CA-C-N 122.983 2.629 . . . . 0.0 113.78 -175.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . 0.257 27.8 m -118.6 133.43 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 103.542 -2.762 . . . . 0.0 103.542 178.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.03 126.93 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 117.492 2.404 . . . . 0.0 117.492 -172.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.4 p30 -90.76 156.2 18.23 Favored 'General case' 0 CA--C 1.564 1.502 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 172.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 5.5 mt -55.72 -49.31 93.56 Favored Pre-proline 0 CA--C 1.574 1.886 0 CA-C-O 114.482 -2.675 . . . . 0.0 114.191 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -52.26 -31.62 47.21 Favored 'Trans proline' 0 C--N 1.374 1.908 0 CA-C-N 125.434 2.977 . . . . 0.0 116.444 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -63.21 -61.06 2.62 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 121.142 1.792 . . . . 0.0 114.326 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.636 ' CE2' HG23 ' A' ' 90' ' ' ILE . 27.9 t80 -53.26 -50.78 64.12 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 120.179 1.354 . . . . 0.0 113.682 177.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.461 ' HE3' HG22 ' A' ' 90' ' ' ILE 0.255 0.1 OUTLIER -68.77 -47.23 66.74 Favored 'General case' 0 C--N 1.352 0.711 0 CA-C-O 113.924 -2.941 . . . . 0.0 111.18 179.229 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.28 -29.45 69.87 Favored 'General case' 0 CA--C 1.586 2.345 0 CA-C-N 125.585 3.812 . . . . 0.0 112.715 175.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . 0.291 5.3 tt -57.98 -40.95 81.94 Favored 'General case' 0 CA--C 1.575 1.922 0 C-N-CA 125.711 1.605 . . . . 0.0 109.799 172.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 55.7 mt -90.4 -64.73 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.604 3.034 0 CA-C-N 120.312 1.414 . . . . 0.0 109.941 173.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.24 7.76 2.03 Favored 'General case' 0 CA--C 1.591 2.556 0 N-CA-C 121.018 3.71 . . . . 0.0 121.018 -179.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -12.89 -8.04 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.886 1 N-CA-C 129.212 6.745 . . . . 0.0 129.212 -172.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 52.2 m . . . . . 0 N--CA 1.502 2.143 0 C-N-CA 124.072 0.949 . . . . 0.0 110.109 175.918 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 . . . . . 0 N--CA 1.5 2.027 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -62.0 -54.17 45.41 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 120.543 1.52 . . . . 0.0 112.835 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.42 -44.3 84.51 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.654 HG21 ' HB3' ' A' ' 148' ' ' MET . 6.7 mt -69.22 -52.67 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.118 0 CA-C-O 116.153 -1.879 . . . . 0.0 110.986 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.2 pp -55.66 -43.66 76.5 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 121.555 1.98 . . . . 0.0 108.84 176.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -54.67 -49.31 70.93 Favored 'General case' 0 CA--C 1.571 1.782 0 CA-C-N 121.184 1.811 . . . . 0.0 112.69 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.95 -56.72 10.27 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-O 116.03 -1.938 . . . . 0.0 114.666 178.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.482 ' CE2' HD12 ' A' ' 105' ' ' ILE . 10.1 t80 -64.83 -42.3 95.05 Favored 'General case' 0 N--CA 1.509 2.479 0 CA-C-N 122.47 2.396 . . . . 0.0 112.734 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.285 6.1 mmpt? -62.56 -30.44 71.32 Favored 'General case' 0 CA--C 1.577 1.995 0 CA-C-O 117.625 -1.178 . . . . 0.0 110.869 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.8 t -71.69 -50.16 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-N 120.451 1.478 . . . . 0.0 108.324 169.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -58.0 -37.91 75.14 Favored 'General case' 0 CA--C 1.579 2.063 0 N-CA-C 116.728 2.121 . . . . 0.0 116.728 -177.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.297 6.5 t0 -59.33 90.6 0.02 OUTLIER 'General case' 0 CA--C 1.571 1.761 0 C-N-CA 128.495 2.718 . . . . 0.0 109.967 176.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.07 -49.06 66.33 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.534 -0.729 . . . . 0.0 112.106 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -48.68 -24.86 1.52 Allowed 'General case' 0 CA--C 1.585 2.298 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 175.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.59 8.59 86.76 Favored Glycine 0 CA--C 1.56 2.884 0 CA-C-N 122.04 2.2 . . . . 0.0 116.953 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.06 86.61 2.22 Favored 'General case' 0 N--CA 1.473 0.723 1 CA-C-O 110.533 -4.556 . . . . 0.0 107.039 176.596 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 54.72 -25.11 0.01 OUTLIER Glycine 0 N--CA 1.489 2.214 2 N-CA-C 130.798 7.079 . . . . 0.0 130.798 162.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.7 p -114.39 151.95 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.811 0 CA-C-O 122.726 1.25 . . . . 0.0 112.887 -178.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.482 HD12 ' CE2' ' A' ' 94' ' ' PHE . 63.4 mt -129.34 136.25 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 CA-C-N 113.55 -1.659 . . . . 0.0 111.317 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -115.75 -177.8 3.24 Favored 'General case' 0 CA--C 1.589 2.471 0 C-N-CA 124.087 0.955 . . . . 0.0 110.062 174.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -74.21 -47.25 36.66 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 -176.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -61.65 -42.78 99.37 Favored 'General case' 0 N--CA 1.514 2.729 0 CA-C-N 122.256 2.298 . . . . 0.0 113.539 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -56.03 -39.89 72.63 Favored 'General case' 0 N--CA 1.504 2.243 0 CA-C-N 119.325 0.966 . . . . 0.0 111.678 173.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -63.38 -46.57 85.85 Favored 'General case' 0 CA--C 1.571 1.787 0 C-N-CA 124.914 1.286 . . . . 0.0 109.36 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -53.5 -50.86 64.5 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 123.89 0.876 . . . . 0.0 111.668 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -57.77 -53.83 53.78 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 176.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.5 tt -74.0 -29.3 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 119.366 3.099 . . . . 0.0 119.366 -176.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.443 ' SD ' ' HA ' ' A' ' 127' ' ' VAL . 6.3 tpt -48.56 -49.04 38.12 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 177.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -66.4 35.84 0.02 OUTLIER 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 121.487 3.884 . . . . 0.0 121.487 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 31.07 -85.34 0.0 OUTLIER 'General case' 0 N--CA 1.531 3.582 0 N-CA-C 118.439 2.755 . . . . 0.0 118.439 174.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.6 t -117.48 95.36 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 82.83 -144.57 23.03 Favored Glycine 0 CA--C 1.547 2.072 0 CA-C-N 114.819 -1.082 . . . . 0.0 113.478 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 54.96 167.2 0.02 OUTLIER 'General case' 0 N--CA 1.511 2.584 0 N-CA-C 116.323 1.972 . . . . 0.0 116.323 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -144.75 112.8 4.96 Favored Pre-proline 0 CA--C 1.576 1.969 0 CA-C-O 113.407 -3.187 . . . . 0.0 107.804 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . 0.49 0.1 OUTLIER 20.25 47.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.393 2.876 0 CA-C-N 127.823 3.83 . . . . 0.0 121.989 -174.51 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.415 2.2 tm? -63.28 -71.28 0.17 Allowed 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 109.004 -3.725 . . . . 0.0 105.493 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.418 ' OG1' ' HG2' ' A' ' 126' ' ' GLU . 1.4 p -92.76 116.28 28.88 Favored 'General case' 0 CA--C 1.557 1.239 0 N-CA-C 102.273 -3.232 . . . . 0.0 102.273 171.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -67.6 -34.75 77.64 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 115.925 1.824 . . . . 0.0 115.925 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.75 -38.7 75.81 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-O 116.74 -1.6 . . . . 0.0 113.279 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.418 ' HG2' ' OG1' ' A' ' 123' ' ' THR . 9.2 pt-20 -68.29 -39.46 82.08 Favored 'General case' 0 CA--C 1.572 1.812 0 CA-C-N 121.442 1.928 . . . . 0.0 112.456 176.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.443 ' HA ' ' SD ' ' A' ' 114' ' ' MET . 0.4 OUTLIER -70.39 -48.56 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 119.216 0.916 . . . . 0.0 112.32 177.766 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -66.59 -49.4 66.46 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 116.77 -1.586 . . . . 0.0 109.504 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -55.98 -47.96 76.71 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 122.256 2.298 . . . . 0.0 113.526 176.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.78 -46.2 89.12 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-O 117.644 -1.169 . . . . 0.0 113.85 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 14.8 ttt -77.21 -37.21 53.9 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 116.478 -1.725 . . . . 0.0 110.658 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -32.9 69.83 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 123.927 3.058 . . . . 0.0 109.977 172.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -73.3 -44.22 59.5 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-O 116.309 -1.805 . . . . 0.0 110.477 176.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -80.73 -35.38 33.53 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 117.611 2.448 . . . . 0.0 117.611 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -90.3 119.81 30.92 Favored 'General case' 0 N--CA 1.514 2.771 1 O-C-N 116.099 -4.126 . . . . 0.0 106.069 176.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -75.27 -32.9 61.18 Favored 'General case' 0 CA--C 1.58 2.109 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 177.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.301 0.1 OUTLIER 175.75 -73.49 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.368 1 N-CA-C 96.516 -5.364 . . . . 0.0 96.516 178.771 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 34.92 32.16 0.02 OUTLIER Glycine 0 C--N 1.373 2.616 0 CA-C-N 123.681 2.946 . . . . 0.0 118.696 174.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 55.0 17.79 2.0 Favored 'General case' 0 CA--C 1.592 2.59 0 CA-C-O 115.739 -2.077 . . . . 0.0 115.18 -173.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 92.81 -22.36 34.29 Favored Glycine 0 C--N 1.38 3.009 0 CA-C-N 124.486 3.312 . . . . 0.0 114.979 -176.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.27 146.68 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 176.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.7 mt -123.1 131.42 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 112.594 -2.094 . . . . 0.0 110.375 -177.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 42.3 p30 -97.88 158.64 15.41 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 105.199 -2.149 . . . . 0.0 105.199 171.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -56.33 -44.57 99.78 Favored Pre-proline 0 CA--C 1.587 2.385 0 CA-C-O 114.971 -2.442 . . . . 0.0 112.833 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.18 -36.15 35.75 Favored 'Trans proline' 0 C--N 1.382 2.342 0 C-N-CA 124.294 3.329 . . . . 0.0 117.107 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -65.61 -56.17 13.67 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 121.623 2.01 . . . . 0.0 110.835 175.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.451 ' CE2' ' HB2' ' A' ' 94' ' ' PHE . 21.4 t80 -55.38 -50.14 70.49 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.654 ' HB3' HG21 ' A' ' 90' ' ' ILE 0.257 4.0 ptp -66.34 -41.73 89.16 Favored 'General case' 0 CA--C 1.577 2.019 0 CA-C-O 117.478 -1.249 . . . . 0.0 111.316 178.204 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -60.2 -35.07 74.57 Favored 'General case' 0 N--CA 1.508 2.46 0 CA-C-N 121.018 1.736 . . . . 0.0 114.258 173.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . 0.356 6.8 tt -69.15 -34.73 75.44 Favored 'General case' 0 CA--C 1.567 1.627 0 C-N-CA 127.838 2.455 . . . . 0.0 110.302 176.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 79.2 mt -69.52 -48.79 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 CA-C-N 121.051 1.751 . . . . 0.0 106.879 171.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.71 -56.2 15.12 Favored 'General case' 0 CA--C 1.581 2.135 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 177.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -96.42 -70.74 0.7 Allowed 'General case' 0 CA--C 1.565 1.527 0 C-N-CA 125.122 1.369 . . . . 0.0 113.752 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.529 3.479 0 C-N-CA 126.228 1.811 . . . . 0.0 108.785 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.508 2.429 0 N-CA-C 115.954 1.835 . . . . 0.0 115.954 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -39.77 -47.84 2.13 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 127.496 2.318 . . . . 0.0 114.545 174.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -45.45 -73.07 0.05 OUTLIER 'General case' 0 CA--C 1.581 2.145 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.455 ' H ' HD12 ' A' ' 90' ' ' ILE . 0.7 OUTLIER -78.12 -52.71 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -178.341 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -63.51 -50.32 70.08 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 115.754 -2.069 . . . . 0.0 111.258 -177.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.97 -28.89 63.73 Favored 'General case' 0 CA--C 1.571 1.775 0 CA-C-O 114.374 -2.727 . . . . 0.0 111.243 176.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.98 -53.2 53.92 Favored 'General case' 0 C--N 1.38 1.925 0 CA-C-N 124.5 3.318 . . . . 0.0 111.378 174.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.472 ' CE2' HD12 ' A' ' 105' ' ' ILE . 21.1 t80 -62.03 -42.9 99.67 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 119.81 1.186 . . . . 0.0 112.821 176.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.492 ' HE2' HD13 ' A' ' 144' ' ' ILE . 58.1 mttt -63.68 -34.51 78.01 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 116.589 -1.672 . . . . 0.0 111.9 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -70.34 -44.84 77.14 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.197 0 CA-C-N 121.711 2.05 . . . . 0.0 108.557 171.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -56.34 -31.94 64.22 Favored 'General case' 0 CA--C 1.576 1.967 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -60.33 118.97 7.07 Favored 'General case' 0 CA--C 1.575 1.927 0 C-N-CA 125.812 1.645 . . . . 0.0 111.951 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.483 ' CB ' ' HG2' ' A' ' 109' ' ' GLU . . . -77.33 -52.51 9.04 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 -178.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.9 p30 -72.74 -8.67 56.52 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 117.88 2.548 . . . . 0.0 117.88 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.2 8.92 87.16 Favored Glycine 0 CA--C 1.555 2.539 0 N-CA-C 119.523 2.569 . . . . 0.0 119.523 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.6 p30 -114.4 -12.56 12.35 Favored 'General case' 0 CA--C 1.575 1.928 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 177.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.34 22.21 5.92 Favored Glycine 0 CA--C 1.548 2.132 0 CA-C-O 116.325 -2.375 . . . . 0.0 115.985 -178.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.3 t -132.61 138.74 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-N 121.366 2.583 . . . . 0.0 109.734 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.472 HD12 ' CE2' ' A' ' 94' ' ' PHE . 44.0 mt -119.76 136.71 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 126.059 1.744 . . . . 0.0 110.746 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -99.13 -175.08 2.92 Favored 'General case' 0 CA--C 1.576 1.969 0 C-N-CA 124.083 0.953 . . . . 0.0 112.678 176.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -82.23 -51.66 7.72 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 119.961 -1.712 . . . . 0.0 113.833 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -62.28 -46.33 89.27 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 119.681 1.128 . . . . 0.0 112.59 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.483 ' HG2' ' CB ' ' A' ' 99' ' ' ALA . 37.1 tp10 -63.81 -35.49 80.77 Favored 'General case' 0 CA--C 1.57 1.723 0 CA-C-N 119.68 1.127 . . . . 0.0 113.064 176.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -61.07 -48.85 79.82 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 119.845 1.202 . . . . 0.0 107.815 171.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 56.6 tttt -64.64 -9.27 18.41 Favored 'General case' 0 CA--C 1.581 2.164 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 174.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -94.37 -50.05 5.42 Favored 'General case' 0 CA--C 1.593 2.601 0 C-N-CA 125.336 1.454 . . . . 0.0 111.017 171.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.6 tt -80.21 -28.31 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 120.889 3.663 . . . . 0.0 120.889 -175.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 1.1 tpt -40.36 -48.2 2.66 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 47.0 mm-40 -91.68 84.61 5.48 Favored 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 27.1 mmtt -88.52 35.48 0.77 Allowed 'General case' 0 N--CA 1.51 2.53 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 172.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 91.4 t -151.61 93.94 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.351 1 N-CA-C 97.174 -5.121 . . . . 0.0 97.174 176.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.7 92.3 0.33 Allowed Glycine 0 CA--C 1.552 2.396 0 N-CA-C 106.617 -2.593 . . . . 0.0 106.617 -174.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -66.96 79.1 0.12 Allowed 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 117.003 2.223 . . . . 0.0 117.003 -176.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -168.03 94.19 0.62 Allowed Pre-proline 0 CA--C 1.566 1.591 0 CA-C-O 117.551 -1.214 . . . . 0.0 112.307 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -77.16 77.22 3.88 Favored 'Trans proline' 0 N--CA 1.509 2.439 0 CA-C-O 125.271 2.113 . . . . 0.0 109.294 174.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.312 3.2 tm? -72.01 -59.54 2.69 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 109.386 -3.552 . . . . 0.0 118.728 -173.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 30.6 p -77.93 122.27 25.27 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 125.397 3.726 . . . . 0.0 107.47 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -59.16 -37.99 78.67 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 112.223 -2.262 . . . . 0.0 115.369 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.27 -39.37 90.12 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-O 117.243 -1.36 . . . . 0.0 114.305 177.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -61.28 -52.89 62.84 Favored 'General case' 0 CA--C 1.577 1.982 0 CA-C-N 120.967 1.712 . . . . 0.0 112.631 177.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.6 t -69.43 -49.92 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 CA-C-O 117.529 -1.224 . . . . 0.0 112.255 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.19 -44.18 97.17 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 116.688 -1.625 . . . . 0.0 110.486 177.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -59.3 -52.04 67.35 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 122.488 2.404 . . . . 0.0 112.199 176.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.62 -44.56 95.98 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.521 ' SD ' HD11 ' A' ' 142' ' ' ILE . 18.4 tpt -73.56 -37.44 65.53 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 115.94 -1.981 . . . . 0.0 111.992 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -60.15 -49.12 78.89 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 122.92 2.6 . . . . 0.0 110.788 174.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -69.67 -26.94 64.62 Favored 'General case' 0 CA--C 1.575 1.936 0 CA-C-O 118.048 -0.977 . . . . 0.0 112.761 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.15 -21.34 27.62 Favored 'General case' 0 CA--C 1.58 2.108 0 CA-C-N 119.996 1.271 . . . . 0.0 114.347 175.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -88.46 109.28 19.9 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 122.757 2.526 . . . . 0.0 105.234 171.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -77.31 -25.17 50.98 Favored 'General case' 0 CA--C 1.576 1.958 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -86.61 -16.31 37.1 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 118.206 2.669 . . . . 0.0 118.206 -176.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.61 5.23 90.06 Favored Glycine 0 CA--C 1.565 3.173 0 CA-C-N 119.936 1.244 . . . . 0.0 115.367 -174.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -86.82 -29.82 21.96 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-N 119.167 1.483 . . . . 0.0 114.885 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 104.93 23.35 7.82 Favored Glycine 0 CA--C 1.554 2.497 0 CA-C-N 120.581 1.537 . . . . 0.0 116.607 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.88 152.69 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 123.543 1.64 . . . . 0.0 107.858 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.521 HD11 ' SD ' ' A' ' 131' ' ' MET . 0.8 OUTLIER -136.82 130.78 46.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 112.535 -2.121 . . . . 0.0 112.06 -177.504 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 34.1 p30 -97.67 162.27 13.36 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 104.72 -2.326 . . . . 0.0 104.72 170.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.492 HD13 ' HE2' ' A' ' 95' ' ' LYS . 4.4 mt -56.22 -49.25 94.33 Favored Pre-proline 0 CA--C 1.582 2.194 0 CA-C-O 113.413 -3.184 . . . . 0.0 110.905 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -47.73 -31.63 15.09 Favored 'Trans proline' 0 C--N 1.377 2.035 0 CA-C-N 127.011 3.54 . . . . 0.0 120.555 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -71.62 -66.34 0.64 Allowed 'General case' 0 N--CA 1.506 2.331 0 CA-C-N 122.663 2.483 . . . . 0.0 110.053 177.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -51.04 -41.76 60.05 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 124.596 1.158 . . . . 0.0 112.884 173.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.4 ' HA ' HG21 ' A' ' 90' ' ' ILE 0.268 0.0 OUTLIER -70.65 -45.21 65.55 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-O 113.658 -3.068 . . . . 0.0 110.808 -179.538 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.78 -44.25 90.63 Favored 'General case' 0 CA--C 1.583 2.232 0 CA-C-N 124.051 3.114 . . . . 0.0 111.776 175.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 7.9 tt -50.98 -47.59 61.4 Favored 'General case' 0 C--N 1.365 1.279 0 C-N-CA 126.216 1.807 . . . . 0.0 112.701 176.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 45.8 mt -90.24 -33.06 5.72 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.212 0 CA-C-N 121.099 1.772 . . . . 0.0 110.992 176.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -50.88 -37.09 41.4 Favored 'General case' 0 N--CA 1.503 2.193 0 CA-C-N 120.836 1.653 . . . . 0.0 114.599 176.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -45.82 -42.16 11.93 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 60.5 p . . . . . 0 CA--C 1.578 2.048 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 176.88 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.5 2.053 0 N-CA-C 120.47 3.508 . . . . 0.0 120.47 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -50.43 -64.39 0.82 Allowed 'General case' 0 CA--C 1.564 1.482 0 O-C-N 123.777 0.673 . . . . 0.0 111.801 176.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -74.55 -26.13 59.76 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.592 HG23 ' CE2' ' A' ' 147' ' ' PHE . 3.6 mp -74.68 -58.37 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 CA-C-N 122.274 2.306 . . . . 0.0 109.334 177.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . 0.254 0.3 OUTLIER -62.92 -42.01 99.66 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 121.843 2.11 . . . . 0.0 110.038 179.167 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -60.88 -52.73 63.81 Favored 'General case' 0 CA--C 1.572 1.815 0 CA-C-N 121.921 2.146 . . . . 0.0 110.772 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.31 -54.94 16.21 Favored 'General case' 0 C--N 1.363 1.166 0 CA-C-O 116.009 -1.948 . . . . 0.0 115.49 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.499 ' CE2' HD12 ' A' ' 105' ' ' ILE . 9.8 t80 -63.32 -50.79 68.65 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 121.74 2.064 . . . . 0.0 112.28 178.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.332 78.5 mttt -64.52 -22.78 67.06 Favored 'General case' 0 CA--C 1.591 2.536 0 CA-C-O 117.372 -1.299 . . . . 0.0 111.199 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -73.14 -49.85 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 CA-C-N 121.266 1.848 . . . . 0.0 108.233 168.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -50.13 -37.62 35.13 Favored 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -61.2 115.72 4.02 Favored 'General case' 0 CA--C 1.578 2.024 0 C-N-CA 125.558 1.543 . . . . 0.0 112.722 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -77.65 -51.62 10.32 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.4 p30 -68.92 -13.19 62.28 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 117.777 2.51 . . . . 0.0 117.777 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.5 7.51 88.47 Favored Glycine 0 CA--C 1.553 2.422 0 N-CA-C 119.559 2.584 . . . . 0.0 119.559 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.1 p30 -104.33 -15.13 15.53 Favored 'General case' 0 CA--C 1.576 1.977 0 CA-C-N 119.535 1.667 . . . . 0.0 114.773 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.59 20.83 6.73 Favored Glycine 0 CA--C 1.545 1.941 0 CA-C-O 116.201 -2.444 . . . . 0.0 116.415 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -131.8 137.04 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 121.654 2.727 . . . . 0.0 110.856 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.499 HD12 ' CE2' ' A' ' 94' ' ' PHE . 58.8 mt -109.35 139.74 31.01 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 CA-C-N 112.058 -2.337 . . . . 0.0 108.36 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -118.83 -173.7 2.54 Favored 'General case' 0 CA--C 1.574 1.881 0 C-N-CA 124.242 1.017 . . . . 0.0 111.215 176.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -72.27 -53.42 12.54 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.657 -1.277 . . . . 0.0 113.877 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -56.61 -47.26 80.01 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 118.278 0.49 . . . . 0.0 112.305 177.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.26 -50.49 67.12 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 174.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.96 -51.77 66.76 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 124.621 1.168 . . . . 0.0 110.419 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.24 -8.95 50.61 Favored 'General case' 0 CA--C 1.577 1.991 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 176.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -92.08 -40.57 10.98 Favored 'General case' 0 CA--C 1.584 2.27 0 C-N-CA 124.902 1.281 . . . . 0.0 110.711 172.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.6 tt -91.41 -36.33 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 121.317 3.821 . . . . 0.0 121.317 -174.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.45 ' HB3' ' HG3' ' A' ' 121' ' ' PRO . 7.1 tpt -37.75 -53.51 1.26 Allowed 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 117.525 2.416 . . . . 0.0 117.525 -176.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.573 ' H ' ' HG3' ' A' ' 121' ' ' PRO . 67.8 mm-40 -74.39 -43.17 57.58 Favored 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 117.538 2.422 . . . . 0.0 117.538 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 9.9 mptt 77.63 -72.39 0.09 Allowed 'General case' 0 N--CA 1.521 3.106 0 C-N-CA 126.397 1.879 . . . . 0.0 113.062 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.9 p -123.61 144.75 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 CA-C-N 120.092 1.315 . . . . 0.0 111.579 -178.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.65 80.87 0.5 Allowed Glycine 0 CA--C 1.539 1.573 0 CA-C-O 118.929 -0.928 . . . . 0.0 111.4 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 69.54 122.14 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 124.419 1.088 . . . . 0.0 110.636 -177.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -70.26 -177.69 0.45 Allowed Pre-proline 0 CA--C 1.571 1.781 0 CA-C-O 116.559 -1.686 . . . . 0.0 114.966 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.573 ' HG3' ' H ' ' A' ' 115' ' ' GLN . 17.0 Cg_exo -76.95 81.98 2.46 Favored 'Trans proline' 0 N--CA 1.507 2.313 0 CA-C-O 127.015 2.84 . . . . 0.0 107.948 175.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.453 7.4 tp -63.01 -65.91 0.62 Allowed 'General case' 0 CA--C 1.564 1.505 1 CA-C-N 106.548 -4.842 . . . . 0.0 115.092 -173.357 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 16.8 p -83.04 126.32 32.42 Favored 'General case' 0 N--CA 1.491 1.579 1 CA-C-N 126.183 4.083 . . . . 0.0 108.507 177.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -59.67 -38.02 80.35 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 116.963 2.209 . . . . 0.0 116.963 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.0 -45.37 79.07 Favored 'General case' 0 CA--C 1.554 1.12 0 O-C-N 124.493 1.121 . . . . 0.0 113.612 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -57.88 -50.79 72.14 Favored 'General case' 0 CA--C 1.579 2.068 0 CA-C-O 122.287 1.041 . . . . 0.0 112.517 176.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.9 t -67.51 -41.49 85.99 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.612 0 CA-C-N 114.003 -1.453 . . . . 0.0 112.162 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -63.66 -46.46 85.52 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 120.415 1.462 . . . . 0.0 109.91 175.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -57.54 -51.1 70.86 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 120.753 1.615 . . . . 0.0 112.199 175.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.4 -46.68 88.0 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.5 ttt -69.05 -39.24 79.27 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.806 177.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.87 -41.43 95.96 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 121.423 1.92 . . . . 0.0 109.827 174.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -64.64 -32.76 74.56 Favored 'General case' 0 CA--C 1.584 2.288 0 CA-C-N 121.017 1.735 . . . . 0.0 112.146 173.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.61 -26.72 34.64 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -78.97 109.43 13.25 Favored 'General case' 0 N--CA 1.516 2.861 0 CA-C-N 123.188 2.722 . . . . 0.0 109.98 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -86.58 -19.74 28.95 Favored 'General case' 0 CA--C 1.58 2.129 0 N-CA-C 117.142 2.275 . . . . 0.0 117.142 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -85.01 -14.42 47.46 Favored 'General case' 0 N--CA 1.507 2.409 1 N-CA-C 122.641 4.312 . . . . 0.0 122.641 -171.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.68 6.34 85.63 Favored Glycine 0 CA--C 1.57 3.507 0 CA-C-N 121.032 1.742 . . . . 0.0 114.958 -172.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -88.11 -51.41 5.81 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.187 1.395 . . . . 0.0 110.478 175.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 110.76 -20.18 24.91 Favored Glycine 0 CA--C 1.543 1.799 0 CA-C-O 115.695 -2.725 . . . . 0.0 115.894 -177.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . 0.259 13.0 m -126.64 124.06 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 101.152 -3.647 . . . . 0.0 101.152 176.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.436 HG21 HD13 ' A' ' 142' ' ' ILE . 0.5 OUTLIER -77.77 124.72 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 -172.344 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -93.05 160.21 14.96 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 171.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.6 mt -57.32 -42.82 97.95 Favored Pre-proline 0 CA--C 1.579 2.081 0 CA-C-O 114.859 -2.496 . . . . 0.0 113.352 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.51 -38.45 74.82 Favored 'Trans proline' 0 C--N 1.376 1.99 0 CA-C-N 125.202 2.894 . . . . 0.0 116.703 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -68.17 -38.44 82.06 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 122.215 2.28 . . . . 0.0 113.947 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.592 ' CE2' HG23 ' A' ' 90' ' ' ILE . 69.4 t80 -64.9 -47.12 78.93 Favored 'General case' 0 CA--C 1.578 2.044 0 CA-C-N 121.411 1.914 . . . . 0.0 110.659 172.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.574 ' HG2' HG21 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -59.22 -44.07 92.31 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-N 118.45 0.568 . . . . 0.0 111.964 176.141 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -65.11 -44.95 87.07 Favored 'General case' 0 CA--C 1.568 1.672 0 C-N-CA 124.356 1.062 . . . . 0.0 109.85 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.28 -45.27 65.4 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.781 1.232 . . . . 0.0 111.915 174.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 97.0 mt -77.86 -50.57 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-O 116.862 -1.542 . . . . 0.0 114.187 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -90.95 -47.12 7.77 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -176.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -105.52 -75.83 0.62 Allowed 'General case' 0 N--CA 1.505 2.29 1 N-CA-C 121.905 4.039 . . . . 0.0 121.905 -177.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 43.9 t . . . . . 0 N--CA 1.503 2.218 0 N-CA-C 120.96 3.689 . . . . 0.0 120.96 -175.047 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 . . . . . 0 CA--C 1.592 2.571 0 CA-C-O 117.207 -1.378 . . . . 0.0 109.115 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -20.56 -43.54 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.221 0 C-N-CA 130.652 3.581 . . . . 0.0 120.304 -172.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -53.31 -71.1 0.08 Allowed 'General case' 0 CA--C 1.62 3.657 0 CA-C-O 127.938 3.732 . . . . 0.0 111.461 174.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.654 HG23 ' CE2' ' A' ' 147' ' ' PHE . 13.9 mm -70.71 -43.98 76.88 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.642 0 CA-C-N 109.066 -3.697 . . . . 0.0 109.167 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -58.35 -43.53 88.39 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 121.826 2.103 . . . . 0.0 109.476 175.756 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.436 ' O ' ' HB ' ' A' ' 96' ' ' VAL . 9.2 mmt-85 -55.25 -51.37 66.85 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 122.326 2.33 . . . . 0.0 107.536 175.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.83 -65.06 0.72 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 117.604 2.446 . . . . 0.0 117.604 177.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.589 ' HB2' ' CD2' ' A' ' 147' ' ' PHE . 18.3 t80 -67.36 -48.76 66.5 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 91' ' ' LEU 0.369 1.4 mmmp? -69.08 -19.2 64.07 Favored 'General case' 0 CA--C 1.589 2.443 0 CA-C-O 115.07 -2.395 . . . . 0.0 109.229 -179.328 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.436 ' HB ' ' O ' ' A' ' 92' ' ' ARG . 0.8 OUTLIER -73.57 -45.99 49.62 Favored 'Isoleucine or valine' 0 C--N 1.394 2.532 0 CA-C-N 124.388 3.267 . . . . 0.0 105.597 166.726 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -52.73 -35.66 56.37 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 176.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.4 105.68 0.79 Allowed 'General case' 0 CA--C 1.577 2.005 0 C-N-CA 125.106 1.362 . . . . 0.0 109.432 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.07 -44.43 97.39 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 115.764 1.765 . . . . 0.0 115.764 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -69.62 -19.31 63.64 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 117.647 2.462 . . . . 0.0 117.647 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.62 21.35 64.22 Favored Glycine 0 CA--C 1.558 2.755 0 N-CA-C 118.14 2.016 . . . . 0.0 118.14 -177.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.58 -28.1 7.27 Favored 'General case' 0 CA--C 1.578 2.026 0 CA-C-N 119.388 1.594 . . . . 0.0 114.402 177.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 121.33 21.3 3.1 Favored Glycine 0 CA--C 1.548 2.11 0 CA-C-O 116.943 -2.031 . . . . 0.0 117.232 -175.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 p -124.69 150.61 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.668 0 CA-C-N 120.581 2.191 . . . . 0.0 109.379 173.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.5 HD12 ' CE2' ' A' ' 94' ' ' PHE . 96.3 mt -122.02 132.92 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-N 114.249 -1.341 . . . . 0.0 109.061 178.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.498 ' H ' ' HG2' ' A' ' 109' ' ' GLU . 0.5 OUTLIER -109.75 179.12 4.21 Favored 'General case' 0 CA--C 1.582 2.173 0 CA-C-O 121.983 0.897 . . . . 0.0 111.749 175.196 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.29 -47.59 23.16 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.645 -1.284 . . . . 0.0 114.33 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -61.75 -38.72 89.0 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 117.706 -1.14 . . . . 0.0 110.443 175.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.498 ' HG2' ' H ' ' A' ' 106' ' ' ASP . 5.4 pt-20 -65.01 -36.4 84.27 Favored 'General case' 0 CA--C 1.576 1.945 0 CA-C-N 121.022 1.737 . . . . 0.0 111.346 173.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -62.94 -48.48 78.71 Favored 'General case' 0 C--N 1.376 1.759 0 CA-C-N 120.99 1.723 . . . . 0.0 109.433 175.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 35.0 mttp -54.99 -52.12 64.09 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 123.9 0.88 . . . . 0.0 111.656 174.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -52.43 -47.95 66.05 Favored 'General case' 0 CA--C 1.571 1.763 0 C-N-CA 124.332 1.053 . . . . 0.0 113.518 175.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -81.47 -14.17 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 12.8 tpt -62.77 -58.99 5.51 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 125.575 1.55 . . . . 0.0 109.536 176.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -101.79 103.7 14.44 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 103.172 -2.899 . . . . 0.0 103.172 175.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -27.8 65.94 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.9 p -82.11 132.92 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.773 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 175.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -48.4 130.99 20.69 Favored Glycine 0 CA--C 1.55 2.277 0 N-CA-C 119.366 2.506 . . . . 0.0 119.366 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 56.91 79.59 0.18 Allowed 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 124.928 1.291 . . . . 0.0 114.371 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -144.44 -31.05 0.0 OUTLIER Pre-proline 0 CA--C 1.566 1.576 1 CA-C-O 109.051 -5.261 . . . . 0.0 117.605 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER -36.31 94.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.39 2.739 1 CA-C-N 131.797 5.249 . . . . 0.0 118.079 -179.599 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.381 36.6 tp -76.69 -84.91 0.06 Allowed 'General case' 0 CA--C 1.559 1.31 0 CA-C-N 110.417 -3.083 . . . . 0.0 112.297 -175.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 38.0 p -84.84 124.01 31.11 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 124.69 3.405 . . . . 0.0 106.287 177.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.77 -37.14 85.51 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.52 -35.89 61.18 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -62.06 -55.67 26.74 Favored 'General case' 0 CA--C 1.587 2.393 0 CA-C-N 120.458 1.481 . . . . 0.0 111.659 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.1 t -63.47 -47.35 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 124.846 1.259 . . . . 0.0 111.216 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -57.77 -48.59 79.23 Favored 'General case' 0 CA--C 1.559 1.319 0 CA-C-O 118.101 -0.952 . . . . 0.0 111.887 176.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -58.53 -48.13 81.9 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 120.211 1.369 . . . . 0.0 112.489 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.96 -51.61 68.92 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -68.49 -34.42 75.89 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 115.263 -2.303 . . . . 0.0 112.113 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -65.26 -39.45 92.64 Favored 'General case' 0 CA--C 1.57 1.747 0 CA-C-N 122.739 2.518 . . . . 0.0 110.243 173.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -59.41 -40.74 87.62 Favored 'General case' 0 CA--C 1.574 1.874 0 CA-C-N 122.085 2.22 . . . . 0.0 110.559 173.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -78.38 -25.34 46.21 Favored 'General case' 0 CA--C 1.577 1.993 0 N-CA-C 116.872 2.175 . . . . 0.0 116.872 175.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -89.43 115.43 26.87 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 118.938 -2.351 . . . . 0.0 107.191 175.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -76.48 -27.73 56.22 Favored 'General case' 0 CA--C 1.566 1.567 0 N-CA-C 117.779 2.511 . . . . 0.0 117.779 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -105.88 -12.54 15.81 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 119.293 3.071 . . . . 0.0 119.293 -174.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.65 4.69 90.22 Favored Glycine 0 CA--C 1.572 3.627 0 CA-C-N 120.129 1.331 . . . . 0.0 113.623 -172.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -71.73 -45.94 60.15 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 125.282 1.433 . . . . 0.0 110.661 175.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 110.83 -4.88 29.1 Favored Glycine 0 CA--C 1.541 1.661 0 CA-C-O 115.075 -3.069 . . . . 0.0 117.598 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . 0.336 0.9 OUTLIER -136.91 118.85 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-N 123.093 3.446 . . . . 0.0 104.362 175.507 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.9 mt -85.21 130.88 35.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 109.385 -3.552 . . . . 0.0 111.835 -175.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 41.4 p30 -94.22 155.1 17.21 Favored 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 171.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -53.55 -44.98 98.76 Favored Pre-proline 0 CA--C 1.586 2.364 0 CA-C-O 114.427 -2.702 . . . . 0.0 113.468 -178.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -46.08 -37.82 18.31 Favored 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 124.634 3.556 . . . . 0.0 117.211 177.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -61.37 -55.29 33.23 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 119.364 0.983 . . . . 0.0 112.029 175.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.654 ' CE2' HG23 ' A' ' 90' ' ' ILE . 66.7 t80 -57.61 -45.38 85.43 Favored 'General case' 0 CA--C 1.577 1.996 0 C-N-CA 125.805 1.642 . . . . 0.0 112.721 175.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.9 -36.25 82.73 Favored 'General case' 0 CA--C 1.586 2.337 0 CA-C-O 117.865 -1.064 . . . . 0.0 110.142 177.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -70.71 -40.33 72.9 Favored 'General case' 0 CA--C 1.583 2.216 0 CA-C-N 120.58 1.537 . . . . 0.0 110.797 172.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -50.66 -45.41 57.98 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 126.037 1.735 . . . . 0.0 109.254 173.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 62.2 mt -83.14 -63.05 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.484 0 CA-C-N 119.847 1.203 . . . . 0.0 112.18 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -62.79 -43.76 97.95 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 117.62 2.452 . . . . 0.0 117.62 -177.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -95.48 -71.4 0.67 Allowed 'General case' 0 CA--C 1.561 1.371 0 N-CA-C 119.961 3.319 . . . . 0.0 119.961 -176.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 97.3 p . . . . . 0 N--CA 1.502 2.145 1 N-CA-C 124.208 4.892 . . . . 0.0 124.208 -171.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 . . . . . 0 N--CA 1.5 2.062 0 N-CA-C 118.083 2.623 . . . . 0.0 118.083 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.94 -50.76 63.37 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 120.694 1.588 . . . . 0.0 114.711 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -45.63 -60.2 2.33 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 115.378 1.621 . . . . 0.0 115.378 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.777 ' H ' HD12 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -70.82 -54.43 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-O 117.168 -1.396 . . . . 0.0 113.331 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . 0.279 0.0 OUTLIER -61.3 -40.05 92.71 Favored 'General case' 0 CA--C 1.568 1.663 0 CA-C-N 120.117 1.326 . . . . 0.0 110.315 -178.607 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.05 -57.93 9.74 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-N 120.767 1.621 . . . . 0.0 110.786 175.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.66 -57.41 8.16 Favored 'General case' 0 C--N 1.364 1.21 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -64.01 -47.69 79.28 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 117.141 -1.409 . . . . 0.0 113.091 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.293 31.1 mttm -66.3 -24.32 66.52 Favored 'General case' 0 CA--C 1.582 2.18 0 CA-C-O 117.008 -1.472 . . . . 0.0 110.601 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.6 t -68.88 -50.01 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-N 121.719 2.054 . . . . 0.0 108.167 168.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.54 -37.8 73.66 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 116.739 2.126 . . . . 0.0 116.739 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 1.245 ' OD2' ' HA ' ' A' ' 102' ' ' ASP . 12.1 t0 -62.46 111.21 1.94 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 126.103 1.761 . . . . 0.0 112.461 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.42 -28.2 41.74 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -76.23 8.98 2.84 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.0 7.0 84.38 Favored Glycine 0 CA--C 1.564 3.115 0 N-CA-C 120.03 2.772 . . . . 0.0 120.03 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 1.245 ' HA ' ' OD2' ' A' ' 98' ' ' ASP 0.79 0.2 OUTLIER 116.75 126.04 0.0 OUTLIER 'General case' 0 CA--C 1.584 2.273 0 C-N-CA 130.27 3.428 . . . . 0.0 118.025 171.092 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 114.81 12.25 10.44 Favored Glycine 0 N--CA 1.441 -1.032 2 C-N-CA 134.471 5.796 . . . . 0.0 115.291 176.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.743 ' O ' ' OD1' ' A' ' 98' ' ' ASP . 0.5 OUTLIER -170.53 156.4 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.571 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 179.225 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 78.5 mt -133.03 130.3 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 127.013 2.125 . . . . 0.0 107.77 175.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -108.72 171.47 7.41 Favored 'General case' 0 CA--C 1.595 2.696 0 C-N-CA 123.806 0.843 . . . . 0.0 110.532 175.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.414 ' HA ' ' SD ' ' A' ' 131' ' ' MET . 27.0 t80 -64.07 -60.41 3.27 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 117.787 2.514 . . . . 0.0 117.787 -176.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -59.84 -27.33 66.54 Favored 'General case' 0 N--CA 1.508 2.425 0 CA-C-N 119.823 1.192 . . . . 0.0 112.713 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -63.55 -42.17 98.4 Favored 'General case' 0 CA--C 1.578 2.023 0 CA-C-N 119.462 1.028 . . . . 0.0 110.455 172.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -62.41 -53.0 61.34 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 125.555 1.542 . . . . 0.0 109.65 174.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -51.23 -44.53 61.71 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 175.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -66.55 -53.83 30.34 Favored 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 125.515 1.526 . . . . 0.0 112.686 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -67.75 -21.87 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 -178.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -50.68 -46.76 58.89 Favored 'General case' 0 N--CA 1.505 2.291 0 CA-C-N 119.283 0.947 . . . . 0.0 111.099 172.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -105.59 106.09 16.42 Favored 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 125.589 1.555 . . . . 0.0 109.49 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -92.2 -60.55 1.82 Allowed 'General case' 0 CA--C 1.565 1.549 0 CA-C-N 113.681 -1.6 . . . . 0.0 114.878 -177.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.5 p -147.9 105.54 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.16 54.32 33.68 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 115.42 0.928 . . . . 0.0 115.42 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -138.47 144.12 39.92 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 124.663 1.185 . . . . 0.0 111.796 -177.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -156.3 66.87 4.4 Favored Pre-proline 0 CA--C 1.58 2.108 0 C-N-CA 123.299 0.64 . . . . 0.0 109.999 175.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -102.22 51.93 0.03 OUTLIER 'Trans proline' 0 CA--C 1.56 1.821 0 C-N-CA 123.086 2.524 . . . . 0.0 109.59 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.284 2.8 tt -160.92 162.03 31.89 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 -169.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.4 p -134.6 144.42 47.91 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 102.351 -3.203 . . . . 0.0 102.351 172.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -54.74 -33.96 61.86 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.444 -1.41 . . . . 0.0 114.792 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.21 -46.05 88.84 Favored 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 124.259 1.024 . . . . 0.0 112.63 175.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -64.21 -40.0 95.15 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 119.682 1.128 . . . . 0.0 112.252 176.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.9 p -67.52 -37.62 79.14 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.908 0 CA-C-N 119.85 1.204 . . . . 0.0 110.648 176.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -66.02 -45.04 82.93 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 119.661 1.119 . . . . 0.0 111.771 175.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -66.63 -41.17 88.74 Favored 'General case' 0 CA--C 1.574 1.884 0 O-C-N 120.894 -1.129 . . . . 0.0 113.249 176.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.93 -48.28 79.61 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.686 176.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.414 ' SD ' ' HA ' ' A' ' 107' ' ' PHE . 21.2 ttt -67.42 -36.2 80.78 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 115.415 -2.231 . . . . 0.0 110.792 175.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.18 -36.7 84.48 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 123.358 2.799 . . . . 0.0 111.868 175.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -62.37 -44.61 96.05 Favored 'General case' 0 CA--C 1.583 2.217 0 CA-C-N 119.531 1.06 . . . . 0.0 109.883 172.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -72.99 -26.73 61.44 Favored 'General case' 0 CA--C 1.583 2.233 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 176.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -80.36 111.71 17.01 Favored 'General case' 0 CA--C 1.56 1.36 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 175.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -72.68 -20.71 61.19 Favored 'General case' 0 CA--C 1.579 2.059 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -91.19 -17.22 26.42 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 117.68 2.474 . . . . 0.0 117.68 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.07 5.45 89.69 Favored Glycine 0 CA--C 1.563 3.085 0 CA-C-N 120.17 1.35 . . . . 0.0 115.905 -175.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 53.5 p-10 -87.54 -32.54 19.33 Favored 'General case' 0 CA--C 1.568 1.666 0 CA-C-N 119.408 1.604 . . . . 0.0 115.101 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 107.92 20.11 8.63 Favored Glycine 0 CA--C 1.559 2.797 0 N-CA-C 116.926 1.53 . . . . 0.0 116.926 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.19 152.63 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 142' ' ' ILE . 1.4 mt -137.5 131.33 44.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 112.164 -2.289 . . . . 0.0 111.743 -178.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 51.3 p30 -96.39 163.74 12.93 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 171.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 3.3 mt -56.76 -45.76 99.91 Favored Pre-proline 0 CA--C 1.582 2.203 0 CA-C-O 114.225 -2.798 . . . . 0.0 112.181 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -48.45 -38.01 34.26 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 124.216 3.277 . . . . 0.0 117.474 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -67.57 -52.27 40.7 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 120.751 1.614 . . . . 0.0 111.632 177.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.643 ' CE1' HG23 ' A' ' 90' ' ' ILE . 6.9 t80 -58.23 -48.17 81.21 Favored 'General case' 0 CA--C 1.569 1.7 0 CA-C-N 120.589 1.54 . . . . 0.0 112.577 176.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.666 ' HB3' HG21 ' A' ' 90' ' ' ILE . 2.0 ptp -64.19 -39.79 94.73 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-O 116.984 -1.484 . . . . 0.0 113.523 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -68.8 -33.95 74.72 Favored 'General case' 0 CA--C 1.585 2.305 0 CA-C-N 121.053 1.751 . . . . 0.0 109.312 172.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.02 -46.39 71.8 Favored 'General case' 0 CA--C 1.576 1.975 0 CA-C-N 120.15 1.341 . . . . 0.0 111.368 174.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 82.6 mt -80.52 -62.46 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.58 2.125 0 C-N-CA 123.472 0.709 . . . . 0.0 111.725 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.777 ' HE2' HD11 ' A' ' 90' ' ' ILE . 22.9 mttm -79.75 5.85 12.4 Favored 'General case' 0 CA--C 1.583 2.242 0 N-CA-C 118.952 2.945 . . . . 0.0 118.952 -177.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -19.09 -18.96 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.191 1 N-CA-C 127.205 6.002 . . . . 0.0 127.205 -174.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.525 3.28 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 177.867 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.606 ' HA ' HD13 ' A' ' 90' ' ' ILE . 12.5 tt0 . . . . . 0 N--CA 1.514 2.756 0 N-CA-C 118.049 2.611 . . . . 0.0 118.049 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -58.77 -45.29 90.1 Favored 'General case' 0 CA--C 1.575 1.924 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.444 174.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -61.9 -32.97 73.41 Favored 'General case' 0 CA--C 1.569 1.7 0 CA-C-N 119.435 1.016 . . . . 0.0 113.011 175.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.606 HD13 ' HA ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -67.97 -58.7 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-N 119.855 1.207 . . . . 0.0 109.129 177.597 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.5 pp -59.39 -49.02 79.4 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 117.904 -1.046 . . . . 0.0 112.087 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -64.83 -45.07 87.73 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-N 120.327 1.421 . . . . 0.0 112.902 178.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.36 -54.85 16.92 Favored 'General case' 0 C--N 1.365 1.265 0 CA-C-O 115.355 -2.26 . . . . 0.0 112.172 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.534 ' CE2' HD12 ' A' ' 105' ' ' ILE . 6.9 t80 -60.74 -47.2 87.36 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 121.707 2.049 . . . . 0.0 112.719 177.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.25 91.3 mttt -62.13 -31.38 71.85 Favored 'General case' 0 CA--C 1.58 2.132 0 CA-C-O 117.276 -1.345 . . . . 0.0 111.909 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.4 t -70.01 -48.15 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 CA-C-N 121.166 1.803 . . . . 0.0 108.956 170.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -53.52 -36.69 62.03 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 -178.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -65.29 93.47 0.14 Allowed 'General case' 0 CA--C 1.57 1.712 0 C-N-CA 126.161 1.784 . . . . 0.0 110.802 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.01 -42.71 80.28 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -65.19 -28.05 69.12 Favored 'General case' 0 CA--C 1.581 2.149 0 CA-C-O 117.344 -1.312 . . . . 0.0 113.839 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.02 3.82 90.62 Favored Glycine 0 CA--C 1.554 2.509 0 CA-C-N 121.903 2.138 . . . . 0.0 118.276 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 27.1 p-10 -97.7 -5.26 35.57 Favored 'General case' 0 CA--C 1.581 2.151 0 CA-C-N 120.788 2.294 . . . . 0.0 114.084 174.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.13 8.46 21.78 Favored Glycine 0 CA--C 1.551 2.295 0 CA-C-O 115.756 -2.691 . . . . 0.0 115.999 -177.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -126.14 153.21 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-N 121.865 2.833 . . . . 0.0 114.153 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.534 HD12 ' CE2' ' A' ' 94' ' ' PHE . 74.0 mt -116.24 132.2 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 112.11 -2.314 . . . . 0.0 108.876 177.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -108.83 -169.61 1.52 Allowed 'General case' 0 CA--C 1.581 2.159 0 C-N-CA 122.977 0.511 . . . . 0.0 110.374 174.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -80.31 -47.16 14.94 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.065 -1.647 . . . . 0.0 114.353 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -57.01 -44.95 83.3 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 123.042 0.537 . . . . 0.0 112.259 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -61.51 -42.25 98.53 Favored 'General case' 0 CA--C 1.583 2.228 0 CA-C-N 119.094 0.861 . . . . 0.0 112.613 174.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -54.83 -49.15 71.76 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 125.124 1.37 . . . . 0.0 109.809 174.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.0 mmmt -59.09 -60.94 3.05 Favored 'General case' 0 CA--C 1.57 1.718 0 CA-C-O 118.256 -0.878 . . . . 0.0 109.382 174.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -41.89 -41.22 2.36 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 116.845 2.165 . . . . 0.0 116.845 177.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 10.7 mt -93.61 -45.63 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 N-CA-C 119.287 3.069 . . . . 0.0 119.287 -177.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 3.5 tpt -33.71 -52.73 0.42 Allowed 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 119.63 3.196 . . . . 0.0 119.63 -175.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -71.9 -49.0 41.6 Favored 'General case' 0 N--CA 1.508 2.464 0 N-CA-C 117.401 2.371 . . . . 0.0 117.401 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 9.2 mptt 74.02 -63.43 0.43 Allowed 'General case' 0 N--CA 1.523 3.212 0 C-N-CA 125.547 1.539 . . . . 0.0 112.928 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.6 t -81.23 112.39 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 CA-C-N 119.653 1.115 . . . . 0.0 110.854 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.48 -123.55 11.89 Favored Glycine 0 CA--C 1.543 1.829 0 N-CA-C 116.911 1.524 . . . . 0.0 116.911 178.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -58.36 155.47 11.76 Favored 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.51 179.34 1.56 Allowed Pre-proline 0 CA--C 1.579 2.089 0 CA-C-O 116.515 -1.707 . . . . 0.0 113.731 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -77.57 74.91 4.95 Favored 'Trans proline' 0 C--N 1.381 2.264 0 CA-C-N 124.845 2.766 . . . . 0.0 111.255 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.474 1.1 tt -64.34 13.81 0.03 OUTLIER 'General case' 0 CA--C 1.583 2.242 1 CA-C-N 106.957 -4.656 . . . . 0.0 117.659 -177.83 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . 0.28 0.2 OUTLIER -130.6 13.85 5.43 Favored 'General case' 0 C--N 1.356 0.865 0 N-CA-C 118.621 2.822 . . . . 0.0 118.621 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -0.53 -7.07 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.974 2 N-CA-C 125.343 5.312 . . . . 0.0 125.343 -164.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.33 -48.67 19.18 Favored 'General case' 0 CA--C 1.564 1.509 0 C-N-CA 126.359 1.864 . . . . 0.0 108.3 173.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.1 -41.65 75.54 Favored 'General case' 0 CA--C 1.579 2.068 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 174.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.7 t -68.22 -49.33 68.14 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 C-N-CA 126.108 1.763 . . . . 0.0 109.692 178.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -58.37 -43.41 88.45 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 119.952 1.251 . . . . 0.0 111.754 175.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.01 -54.05 49.66 Favored 'General case' 0 CA--C 1.576 1.954 0 CA-C-N 120.573 1.533 . . . . 0.0 111.644 176.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.68 -43.79 93.88 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.58 -40.89 69.61 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 116.806 -1.568 . . . . 0.0 110.616 177.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -37.95 82.49 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 121.621 2.009 . . . . 0.0 110.319 173.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -69.95 -34.54 73.57 Favored 'General case' 0 CA--C 1.571 1.75 0 CA-C-N 120.744 1.611 . . . . 0.0 112.316 175.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -78.94 -25.94 43.59 Favored 'General case' 0 CA--C 1.578 2.021 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -87.71 98.45 11.45 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 102.869 -3.011 . . . . 0.0 102.869 171.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -83.0 -13.71 55.41 Favored 'General case' 0 CA--C 1.579 2.07 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -91.18 -14.53 30.91 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 118.763 2.875 . . . . 0.0 118.763 -175.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.15 6.2 89.02 Favored Glycine 0 CA--C 1.565 3.186 0 CA-C-O 118.454 -1.192 . . . . 0.0 115.115 -174.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.93 -50.11 15.89 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 119.454 1.627 . . . . 0.0 110.984 176.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 111.66 -15.54 26.7 Favored Glycine 0 CA--C 1.546 1.978 0 CA-C-O 115.78 -2.678 . . . . 0.0 116.773 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . 0.302 3.8 m -133.34 120.63 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 100.823 -3.769 . . . . 0.0 100.823 175.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.3 mt -77.87 125.88 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 111.489 -2.596 . . . . 0.0 115.755 -172.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 36.5 p30 -91.68 152.9 20.01 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 172.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -51.34 -42.43 81.65 Favored Pre-proline 0 CA--C 1.583 2.239 0 CA-C-O 114.802 -2.523 . . . . 0.0 113.706 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.66 -29.5 80.02 Favored 'Trans proline' 0 C--N 1.376 1.998 0 CA-C-N 125.454 2.983 . . . . 0.0 116.991 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -66.97 -54.84 17.93 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 122.83 2.559 . . . . 0.0 111.446 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.573 ' CE2' HG23 ' A' ' 90' ' ' ILE . 74.2 t80 -61.89 -45.88 91.81 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-N 120.202 1.365 . . . . 0.0 110.515 175.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.26 -47.22 75.78 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-O 116.359 -1.781 . . . . 0.0 111.089 176.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.65 -36.86 76.45 Favored 'General case' 0 CA--C 1.574 1.876 0 CA-C-N 122.288 2.313 . . . . 0.0 113.437 177.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.48 -41.89 81.57 Favored 'General case' 0 CA--C 1.57 1.738 0 C-N-CA 124.84 1.256 . . . . 0.0 110.503 174.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.439 HG21 HD11 ' A' ' 90' ' ' ILE . 5.4 mm -80.0 -43.52 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.8 0 CA-C-O 116.263 -1.827 . . . . 0.0 109.363 176.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -48.81 -49.69 37.83 Favored 'General case' 0 N--CA 1.511 2.592 0 CA-C-N 122.426 2.375 . . . . 0.0 112.589 176.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -66.4 -39.06 88.79 Favored 'General case' 0 CA--C 1.566 1.578 0 CA-C-O 117.833 -1.079 . . . . 0.0 113.157 176.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.527 3.4 0 CA-C-N 119.525 1.057 . . . . 0.0 110.345 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 . . . . . 0 N--CA 1.493 1.708 0 N-CA-C 119.354 3.094 . . . . 0.0 119.354 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -52.91 -46.24 67.94 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 116.752 2.13 . . . . 0.0 116.752 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -68.46 -38.2 80.89 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.419 HD11 HG21 ' A' ' 151' ' ' ILE . 1.3 mp -72.78 -45.83 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-O 115.625 -2.131 . . . . 0.0 108.71 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.0 pp -59.66 -46.94 87.52 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 123.111 2.687 . . . . 0.0 110.329 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -57.09 -58.88 6.28 Favored 'General case' 0 CA--C 1.568 1.647 0 C-N-CA 124.286 1.034 . . . . 0.0 112.378 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.46 -58.15 9.7 Favored 'General case' 0 C--N 1.353 0.735 0 CA-C-O 115.711 -2.09 . . . . 0.0 113.346 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -55.66 -50.96 68.83 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 121.551 1.978 . . . . 0.0 113.228 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -62.6 -33.19 74.48 Favored 'General case' 0 CA--C 1.562 1.412 0 CA-C-O 116.307 -1.806 . . . . 0.0 112.553 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -72.35 -44.39 63.13 Favored 'Isoleucine or valine' 0 CA--C 1.59 2.496 0 CA-C-N 121.854 2.115 . . . . 0.0 109.626 171.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -51.7 -35.72 43.89 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 127.098 2.159 . . . . 0.0 115.094 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.255 1.3 t0 -67.26 96.52 0.48 Allowed 'General case' 0 CA--C 1.576 1.967 0 C-N-CA 126.202 1.801 . . . . 0.0 107.342 177.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.04 -49.7 71.34 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.273 1.582 . . . . 0.0 115.273 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -62.33 -24.05 67.11 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.35 7.98 87.7 Favored Glycine 0 CA--C 1.551 2.32 0 N-CA-C 120.327 2.891 . . . . 0.0 120.327 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.8 p30 -96.97 -11.33 24.72 Favored 'General case' 0 CA--C 1.575 1.932 0 CA-C-N 119.78 1.79 . . . . 0.0 115.563 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.49 18.4 8.07 Favored Glycine 0 CA--C 1.552 2.396 0 CA-C-O 116.781 -2.122 . . . . 0.0 114.594 -176.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.45 154.98 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.501 0 CA-C-N 120.826 2.313 . . . . 0.0 111.78 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 79.1 mt -126.54 127.06 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-N 112.368 -2.196 . . . . 0.0 108.217 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -106.21 179.03 4.39 Favored 'General case' 0 CA--C 1.578 2.042 0 CA-C-O 121.857 0.837 . . . . 0.0 110.673 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -69.73 -42.32 74.12 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.15 -45.25 93.7 Favored 'General case' 0 N--CA 1.505 2.281 0 CA-C-N 120.566 1.53 . . . . 0.0 113.829 177.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -63.52 -46.3 86.69 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.917 0.887 . . . . 0.0 112.139 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -62.76 -50.96 68.99 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 117.0 -1.476 . . . . 0.0 110.983 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.0 pptp? -58.27 -39.9 80.44 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 121.235 1.834 . . . . 0.0 114.318 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -65.31 -49.32 69.9 Favored 'General case' 0 CA--C 1.575 1.909 0 C-N-CA 123.407 0.683 . . . . 0.0 112.385 175.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -79.56 -32.37 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 118.723 2.86 . . . . 0.0 118.723 -177.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.495 ' HG2' HG22 ' A' ' 127' ' ' VAL . 14.0 tpt -53.09 -53.42 50.65 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.692 1.597 . . . . 0.0 114.548 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -76.53 47.83 0.51 Allowed 'General case' 0 CA--C 1.579 2.066 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . 0.284 0.0 OUTLIER 25.58 -110.36 0.02 OUTLIER 'General case' 0 N--CA 1.519 2.999 0 N-CA-C 118.715 2.857 . . . . 0.0 118.715 173.137 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 42.9 t -77.21 107.54 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 CA-C-N 121.387 1.903 . . . . 0.0 107.639 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.37 -141.22 38.65 Favored Glycine 0 CA--C 1.549 2.19 0 N-CA-C 111.671 -0.572 . . . . 0.0 111.671 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 52.34 170.03 0.01 OUTLIER 'General case' 0 CA--C 1.589 2.453 0 N-CA-C 118.958 2.947 . . . . 0.0 118.958 176.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -168.18 133.0 1.47 Allowed Pre-proline 0 N--CA 1.502 2.165 0 CA-C-O 113.396 -3.192 . . . . 0.0 107.318 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . 0.371 0.1 OUTLIER 9.94 58.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.388 2.632 0 N-CA-C 121.683 3.686 . . . . 0.0 121.683 -176.26 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.469 0.3 OUTLIER -74.31 -72.05 0.3 Allowed 'General case' 0 CA--C 1.566 1.589 0 CA-C-N 109.836 -3.347 . . . . 0.0 103.668 -177.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 10.0 p -95.46 112.75 24.41 Favored 'General case' 0 C--N 1.37 1.464 2 CA-C-N 126.44 4.2 . . . . 0.0 99.775 169.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -53.47 -38.36 63.55 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 118.565 2.802 . . . . 0.0 118.565 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.44 -42.16 91.28 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 117.052 -1.452 . . . . 0.0 113.597 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -55.19 -53.43 56.11 Favored 'General case' 0 CA--C 1.573 1.842 0 CA-C-N 120.255 1.388 . . . . 0.0 112.63 176.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.495 HG22 ' HG2' ' A' ' 114' ' ' MET . 18.2 t -73.74 -53.79 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-O 117.197 -1.382 . . . . 0.0 113.829 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -64.2 -40.72 96.68 Favored 'General case' 0 CA--C 1.564 1.514 0 CA-C-N 120.061 1.3 . . . . 0.0 112.52 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -69.56 -43.87 72.04 Favored 'General case' 0 CA--C 1.574 1.891 0 CA-C-N 120.036 1.289 . . . . 0.0 111.228 176.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.57 -46.51 89.58 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 120.616 1.553 . . . . 0.0 113.247 176.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 19.8 ttt -70.27 -39.12 75.12 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 114.818 -2.515 . . . . 0.0 111.761 177.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -64.52 -35.38 80.78 Favored 'General case' 0 CA--C 1.574 1.872 0 CA-C-N 123.99 3.086 . . . . 0.0 111.595 175.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -62.85 -48.43 79.07 Favored 'General case' 0 CA--C 1.579 2.08 0 CA-C-N 121.654 2.025 . . . . 0.0 109.083 172.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.46 -25.08 63.91 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 177.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -90.06 100.57 13.37 Favored 'General case' 0 CA--C 1.573 1.856 0 N-CA-C 103.071 -2.937 . . . . 0.0 103.071 171.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -72.88 -16.56 61.57 Favored 'General case' 0 CA--C 1.579 2.095 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -98.55 -14.57 19.9 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 119.016 2.969 . . . . 0.0 119.016 -175.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.03 5.9 89.33 Favored Glycine 0 CA--C 1.57 3.482 0 CA-C-N 120.411 1.46 . . . . 0.0 115.138 -173.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -75.82 -47.18 26.7 Favored 'General case' 0 CA--C 1.563 1.466 0 C-N-CA 125.441 1.496 . . . . 0.0 112.195 176.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 111.84 -25.04 13.66 Favored Glycine 0 CA--C 1.553 2.455 0 CA-C-O 117.354 -1.803 . . . . 0.0 114.311 -176.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -100.68 143.16 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 N-CA-C 103.725 -2.694 . . . . 0.0 103.725 174.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.7 mt -121.84 124.87 72.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 111.982 -2.372 . . . . 0.0 112.665 -176.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 39.0 p30 -91.43 155.06 18.72 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 170.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.4 mt -52.13 -42.45 86.08 Favored Pre-proline 0 CA--C 1.583 2.237 0 CA-C-O 114.902 -2.475 . . . . 0.0 113.285 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -58.59 -17.8 36.8 Favored 'Trans proline' 0 C--N 1.376 1.992 0 CA-C-N 125.27 2.918 . . . . 0.0 117.976 176.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -72.53 -63.22 1.2 Allowed 'General case' 0 N--CA 1.505 2.28 0 CA-C-N 123.102 2.683 . . . . 0.0 109.469 176.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -54.55 -49.05 71.24 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 125.128 1.371 . . . . 0.0 110.908 173.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.3 mmt -64.6 -34.93 79.43 Favored 'General case' 0 CA--C 1.565 1.556 0 CA-C-O 115.454 -2.212 . . . . 0.0 111.868 175.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.913 ' OD2' ' HD2' ' A' ' 153' ' ' LYS . 6.7 t70 -66.67 -46.49 75.52 Favored 'General case' 0 N--CA 1.507 2.382 0 CA-C-N 125.537 3.79 . . . . 0.0 109.14 174.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.461 HD23 HG13 ' A' ' 151' ' ' ILE . 0.2 OUTLIER -46.89 -54.63 9.57 Favored 'General case' 0 C--N 1.368 1.386 0 C-N-CA 126.189 1.795 . . . . 0.0 111.215 176.584 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.461 HG13 HD23 ' A' ' 150' ' ' LEU . 33.8 mt -98.36 -28.52 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-N 121.648 2.022 . . . . 0.0 116.318 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.39 -18.37 23.38 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 118.659 2.837 . . . . 0.0 118.659 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.913 ' HD2' ' OD2' ' A' ' 149' ' ' ASP . 74.6 tttt -74.48 -9.71 58.85 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 121.64 3.941 . . . . 0.0 121.64 -176.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 84.7 p . . . . . 0 N--CA 1.532 3.633 0 N-CA-C 120.93 3.678 . . . . 0.0 120.93 -179.966 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 . . . . . 0 CA--C 1.617 3.527 0 N-CA-C 104.143 -2.54 . . . . 0.0 104.143 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.419 ' HA ' ' HG ' ' A' ' 91' ' ' LEU . 8.4 mm-40 -10.62 -28.96 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.657 2 C-N-CA 133.845 4.858 . . . . 0.0 122.105 -170.566 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.26 -66.85 0.6 Allowed 'General case' 0 N--CA 1.51 2.532 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 170.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.6 HG23 ' CE2' ' A' ' 147' ' ' PHE . 4.0 mp -58.14 -44.77 88.25 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.753 0 CA-C-N 112.036 -2.347 . . . . 0.0 108.963 172.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.474 ' HB2' ' HE3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -67.26 -39.03 86.04 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 116.322 -1.799 . . . . 0.0 111.685 176.623 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.445 ' O ' ' HB ' ' A' ' 96' ' ' VAL . 0.0 OUTLIER -57.22 -53.26 60.09 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 122.863 2.574 . . . . 0.0 107.888 176.396 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.71 -66.14 0.6 Allowed 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.496 ' CE2' HD12 ' A' ' 105' ' ' ILE . 9.5 t80 -66.62 -51.91 51.11 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.474 ' HE3' ' HB2' ' A' ' 91' ' ' LEU 0.382 7.7 mttt -67.81 -17.54 64.55 Favored 'General case' 0 CA--C 1.589 2.446 0 CA-C-O 114.821 -2.514 . . . . 0.0 110.234 -177.603 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 92' ' ' ARG . 1.0 OUTLIER -74.19 -46.5 44.56 Favored 'Isoleucine or valine' 0 C--N 1.395 2.547 0 CA-C-N 124.582 3.355 . . . . 0.0 106.186 167.159 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -53.61 -35.88 61.39 Favored 'General case' 0 CA--C 1.582 2.185 0 N-CA-C 117.23 2.308 . . . . 0.0 117.23 178.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -56.51 110.06 0.72 Allowed 'General case' 0 CA--C 1.575 1.905 0 C-N-CA 126.14 1.776 . . . . 0.0 115.469 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.644 ' HB2' ' HG2' ' A' ' 109' ' ' GLU . . . -73.76 -51.77 15.39 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -67.21 -24.53 65.85 Favored 'General case' 0 CA--C 1.578 2.052 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.8 1.71 90.31 Favored Glycine 0 CA--C 1.562 2.992 0 CA-C-N 121.773 2.079 . . . . 0.0 116.987 -175.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -107.19 0.64 23.47 Favored 'General case' 0 CA--C 1.587 2.382 0 CA-C-N 120.027 1.914 . . . . 0.0 112.419 172.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 114.06 -20.09 17.22 Favored Glycine 0 CA--C 1.547 2.083 0 CA-C-O 115.459 -2.856 . . . . 0.0 115.262 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.6 m -83.74 138.15 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.612 0 CA-C-N 123.797 3.799 . . . . 0.0 114.306 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.496 HD12 ' CE2' ' A' ' 94' ' ' PHE . 88.2 mt -116.25 123.36 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 101.713 -3.44 . . . . 0.0 101.713 174.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.491 ' HA ' HG12 ' A' ' 141' ' ' VAL . 2.1 p30 -91.88 162.64 14.34 Favored 'General case' 0 CA--C 1.56 1.329 0 CA-C-O 122.433 1.111 . . . . 0.0 111.577 176.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.77 -47.23 78.91 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.762 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -61.37 -44.2 97.56 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 117.906 -1.045 . . . . 0.0 111.546 176.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.644 ' HG2' ' HB2' ' A' ' 99' ' ' ALA . 34.4 tp10 -63.67 -37.76 88.55 Favored 'General case' 0 CA--C 1.569 1.701 0 CA-C-N 121.097 1.771 . . . . 0.0 112.521 174.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -62.76 -52.3 63.74 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 120.113 1.324 . . . . 0.0 108.143 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.462 ' HA ' HG11 ' A' ' 127' ' ' VAL . 10.5 ptpp? -56.58 -38.54 72.13 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 116.139 -1.886 . . . . 0.0 111.606 175.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -61.76 -54.52 41.25 Favored 'General case' 0 CA--C 1.579 2.072 0 CA-C-N 121.267 1.849 . . . . 0.0 112.788 174.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 tt -73.2 -11.93 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 119.091 2.997 . . . . 0.0 119.091 -177.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 9.2 tpt -42.27 -58.29 2.22 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -126.04 98.89 5.68 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 124.576 1.173 . . . . 0.0 114.144 -177.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -108.69 58.47 0.61 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 92.7 t -142.28 82.98 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 1 N-CA-C 98.539 -4.615 . . . . 0.0 98.539 175.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.14 109.76 0.19 Allowed Glycine 0 CA--C 1.55 2.23 0 N-CA-C 106.117 -2.793 . . . . 0.0 106.117 -173.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -51.56 109.62 0.37 Allowed 'General case' 0 N--CA 1.505 2.316 0 CA-C-N 119.873 1.836 . . . . 0.0 114.305 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -134.69 -29.3 0.02 OUTLIER Pre-proline 0 CA--C 1.574 1.875 2 N-CA-C 122.958 4.429 . . . . 0.0 122.958 -175.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . 0.297 0.1 OUTLIER 7.15 68.42 0.0 OUTLIER 'Trans proline' 0 N--CA 1.522 3.153 1 CA-C-N 128.774 4.169 . . . . 0.0 119.793 -175.617 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.332 1.4 tm? -78.87 -85.0 0.08 Allowed 'General case' 0 CA--C 1.562 1.421 0 CA-C-N 110.708 -2.951 . . . . 0.0 117.729 -171.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 30.6 p -82.98 127.88 33.96 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 125.502 3.774 . . . . 0.0 109.454 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -66.12 -40.88 91.03 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 177.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.52 -43.59 72.04 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -46.5 82.67 Favored 'General case' 0 CA--C 1.584 2.253 0 CA-C-N 120.187 1.358 . . . . 0.0 113.847 177.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.462 HG11 ' HA ' ' A' ' 111' ' ' LYS . 15.7 t -66.08 -48.97 79.77 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.496 0 C-N-CA 125.126 1.37 . . . . 0.0 110.884 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -57.3 -49.95 74.47 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 117.093 -1.432 . . . . 0.0 110.061 176.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -55.16 -51.33 66.82 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 120.737 1.608 . . . . 0.0 112.568 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.91 -48.0 83.48 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 116.123 1.897 . . . . 0.0 116.123 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -44.32 50.31 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 115.8 -2.048 . . . . 0.0 111.277 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.33 -37.18 69.62 Favored 'General case' 0 CA--C 1.575 1.92 0 CA-C-N 122.466 2.394 . . . . 0.0 110.954 174.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -70.91 -39.46 72.72 Favored 'General case' 0 CA--C 1.578 2.024 0 CA-C-N 121.04 1.746 . . . . 0.0 111.94 175.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.08 -25.0 63.32 Favored 'General case' 0 CA--C 1.579 2.068 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 174.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -79.7 110.98 15.55 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 116.579 -3.826 . . . . 0.0 108.068 175.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -75.46 -22.75 57.01 Favored 'General case' 0 CA--C 1.57 1.723 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -107.11 -9.59 16.12 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 118.742 2.867 . . . . 0.0 118.742 -174.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.12 3.76 90.62 Favored Glycine 0 CA--C 1.569 3.408 0 CA-C-O 117.811 -1.55 . . . . 0.0 112.832 -172.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.457 ' O ' ' ND2' ' A' ' 139' ' ' ASN . 0.2 OUTLIER -92.75 42.84 1.11 Allowed 'General case' 0 C--N 1.367 1.335 1 CA-C-O 107.484 -6.008 . . . . 0.0 110.391 175.275 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 57.92 -23.21 0.02 OUTLIER Glycine 0 N--CA 1.503 3.107 3 O-C-N 105.214 -10.929 . . . . 0.0 129.104 162.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.491 HG12 ' HA ' ' A' ' 106' ' ' ASP . 6.4 m -134.04 140.97 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-N 121.196 2.498 . . . . 0.0 107.029 178.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.1 mt -104.23 131.02 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 113.861 -1.518 . . . . 0.0 112.899 -175.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -97.45 153.34 18.18 Favored 'General case' 0 CA--C 1.559 1.311 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 170.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.43 HD13 ' HD3' ' A' ' 95' ' ' LYS . 2.4 mt -52.68 -43.3 92.54 Favored Pre-proline 0 CA--C 1.583 2.247 0 CA-C-O 114.768 -2.539 . . . . 0.0 113.181 -178.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -51.37 -35.21 53.42 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.877 3.052 . . . . 0.0 115.802 176.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -59.93 -53.97 51.61 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 120.101 1.319 . . . . 0.0 110.81 174.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.6 ' CE2' HG23 ' A' ' 90' ' ' ILE . 36.0 t80 -56.21 -46.32 79.51 Favored 'General case' 0 CA--C 1.57 1.743 0 C-N-CA 125.041 1.336 . . . . 0.0 111.895 175.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.51 ' HG2' HG21 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -57.17 -45.13 83.93 Favored 'General case' 0 CA--C 1.591 2.548 0 C-N-CA 123.349 0.66 . . . . 0.0 110.708 176.105 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.1 -40.25 94.32 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 119.715 1.143 . . . . 0.0 112.111 176.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.55 -47.11 80.16 Favored 'General case' 0 CA--C 1.569 1.699 0 C-N-CA 124.538 1.135 . . . . 0.0 108.458 173.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 88.4 mt -61.78 -40.13 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 CA-C-N 120.389 1.45 . . . . 0.0 110.807 175.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -59.1 -49.71 76.85 Favored 'General case' 0 CA--C 1.586 2.342 0 CA-C-N 120.642 1.564 . . . . 0.0 112.499 175.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.696 ' HG3' ' H ' ' A' ' 154' ' ' SER . 59.4 pttt -94.53 -72.6 0.61 Allowed 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.696 ' H ' ' HG3' ' A' ' 153' ' ' LYS . 26.2 p . . . . . 0 N--CA 1.502 2.133 0 C-N-CA 124.662 1.185 . . . . 0.0 108.6 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.506 ' HA ' HD12 ' A' ' 90' ' ' ILE 0.262 55.8 tt0 . . . . . 0 N--CA 1.495 1.777 0 N-CA-C 117.366 2.358 . . . . 0.0 117.366 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -63.54 -40.34 96.76 Favored 'General case' 0 CA--C 1.586 2.346 0 CA-C-N 120.255 1.389 . . . . 0.0 109.529 173.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -60.39 -29.09 68.73 Favored 'General case' 0 CA--C 1.581 2.164 0 CA-C-O 117.511 -1.233 . . . . 0.0 110.568 172.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.745 HG21 ' HG2' ' A' ' 148' ' ' MET . 37.9 mt -71.01 -63.22 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.369 1.446 0 CA-C-O 115.686 -2.102 . . . . 0.0 107.05 174.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 pp -49.85 -47.77 51.51 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-N 122.472 2.396 . . . . 0.0 111.967 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.8 mtm105 -62.82 -55.19 28.54 Favored 'General case' 0 CA--C 1.571 1.787 0 CA-C-O 118.532 -0.746 . . . . 0.0 112.163 176.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.61 -59.47 3.92 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 114.59 -2.624 . . . . 0.0 113.685 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.413 ' CE2' HD12 ' A' ' 105' ' ' ILE . 14.7 t80 -54.89 -48.6 72.79 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 122.627 2.467 . . . . 0.0 112.437 178.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.252 93.0 mttt -64.83 -30.91 71.93 Favored 'General case' 0 CA--C 1.581 2.165 0 CA-C-N 119.796 1.18 . . . . 0.0 111.361 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.7 t -65.86 -48.96 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.507 0 CA-C-N 121.54 1.973 . . . . 0.0 108.534 169.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.1 -30.94 60.76 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 117.446 2.387 . . . . 0.0 117.446 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.318 0.0 OUTLIER -52.47 -14.28 0.47 Allowed 'General case' 0 CA--C 1.578 2.05 0 N-CA-C 119.895 3.295 . . . . 0.0 119.895 -177.404 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.761 ' HB2' ' HG2' ' A' ' 109' ' ' GLU . . . 75.35 -70.69 0.14 Allowed 'General case' 0 N--CA 1.502 2.167 0 CA-C-N 122.654 2.479 . . . . 0.0 116.33 176.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -76.35 -17.95 59.14 Favored 'General case' 0 CA--C 1.571 1.758 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 -177.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.02 3.92 90.21 Favored Glycine 0 CA--C 1.568 3.39 0 CA-C-O 117.437 -1.757 . . . . 0.0 114.333 -172.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 46.9 p-10 -98.47 -17.05 18.96 Favored 'General case' 0 CA--C 1.579 2.061 0 CA-C-N 120.881 2.341 . . . . 0.0 113.647 174.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.52 22.65 6.0 Favored Glycine 0 CA--C 1.546 2.002 0 CA-C-O 115.474 -2.848 . . . . 0.0 116.48 -178.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.6 t -134.39 121.96 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 CA-C-N 122.669 3.235 . . . . 0.0 112.555 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.413 HD12 ' CE2' ' A' ' 94' ' ' PHE . 62.3 mt -93.54 135.25 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 C-N-CA 126.432 1.893 . . . . 0.0 112.789 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -105.11 173.76 6.17 Favored 'General case' 0 CA--C 1.574 1.875 0 C-N-CA 124.193 0.997 . . . . 0.0 111.863 175.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -70.45 -50.15 41.24 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -62.94 -45.91 90.25 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 118.282 -0.866 . . . . 0.0 112.341 178.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.761 ' HG2' ' HB2' ' A' ' 99' ' ' ALA . 37.6 tp10 -61.21 -39.55 90.66 Favored 'General case' 0 CA--C 1.569 1.709 0 CA-C-N 120.49 1.495 . . . . 0.0 112.05 175.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -58.83 -53.66 55.93 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 120.127 1.331 . . . . 0.0 110.042 175.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -51.0 -42.68 60.51 Favored 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -73.2 -55.34 6.59 Favored 'General case' 0 CA--C 1.577 1.986 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 176.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.6 tt -67.98 -34.77 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 118.726 2.862 . . . . 0.0 118.726 -176.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.433 ' SD ' HG13 ' A' ' 127' ' ' VAL . 40.2 ttp -27.39 -43.23 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 117.936 2.569 . . . . 0.0 117.936 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -94.8 72.76 3.56 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-N 113.825 -1.534 . . . . 0.0 113.097 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.546 ' HD3' ' H ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -128.87 -58.03 1.16 Allowed 'General case' 0 CA--C 1.575 1.935 0 CA-C-N 112.928 -1.942 . . . . 0.0 115.57 -179.009 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.8 p -176.81 128.32 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.572 1.812 0 CA-C-N 120.702 1.592 . . . . 0.0 107.916 -177.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 94.24 -117.05 5.42 Favored Glycine 0 CA--C 1.542 1.721 0 N-CA-C 116.341 1.296 . . . . 0.0 116.341 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.32 103.93 4.9 Favored 'General case' 0 CA--C 1.57 1.746 0 CA-C-O 122.69 1.233 . . . . 0.0 112.172 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.5 84.09 6.0 Favored Pre-proline 0 CA--C 1.58 2.127 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 -177.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -83.82 63.8 7.22 Favored 'Trans proline' 0 CA--C 1.574 2.495 0 C-N-CA 123.491 2.794 . . . . 0.0 109.456 175.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.293 7.2 tt -51.91 -43.47 63.41 Favored 'General case' 0 CA--C 1.563 1.468 0 N-CA-C 120.868 3.655 . . . . 0.0 120.868 -175.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 67.6 p -69.37 150.59 47.14 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 124.577 3.353 . . . . 0.0 111.61 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -42.0 -49.12 4.68 Favored 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 177.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.81 -48.51 76.54 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 112.292 -2.231 . . . . 0.0 111.429 176.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -61.52 -29.02 69.73 Favored 'General case' 0 CA--C 1.576 1.959 0 CA-C-N 120.438 1.472 . . . . 0.0 112.737 174.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.433 HG13 ' SD ' ' A' ' 114' ' ' MET . 1.5 t -70.36 -57.66 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 CA-C-N 121.374 1.897 . . . . 0.0 109.043 177.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -64.22 -38.98 93.0 Favored 'General case' 0 N--CA 1.508 2.442 0 CA-C-N 120.24 1.382 . . . . 0.0 113.263 178.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -65.08 -44.59 88.41 Favored 'General case' 0 CA--C 1.567 1.614 0 CA-C-O 117.839 -1.076 . . . . 0.0 112.02 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -64.31 -45.33 88.38 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 120.012 1.278 . . . . 0.0 112.234 176.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 19.6 ttt -70.24 -41.83 73.03 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 114.238 -2.791 . . . . 0.0 111.055 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -64.51 -33.24 75.45 Favored 'General case' 0 CA--C 1.576 1.978 0 CA-C-N 125.087 3.585 . . . . 0.0 111.293 175.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -62.49 -44.02 97.4 Favored 'General case' 0 CA--C 1.585 2.31 0 CA-C-N 122.023 2.192 . . . . 0.0 110.376 171.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.44 -29.36 56.96 Favored 'General case' 0 CA--C 1.576 1.961 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 178.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -90.77 100.16 13.06 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 103.12 -2.919 . . . . 0.0 103.12 172.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -56.48 -29.62 61.98 Favored 'General case' 0 CA--C 1.593 2.61 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.407 54.2 t0 160.88 -22.96 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.676 1 CA-C-O 108.925 -5.321 . . . . 0.0 103.811 175.808 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 11.04 5.88 0.0 OUTLIER Glycine 0 CA--C 1.564 3.136 3 O-C-N 99.065 -14.772 . . . . 0.0 125.131 160.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.46 ' OD1' HG23 ' A' ' 141' ' ' VAL . 2.3 p-10 79.03 15.14 1.06 Allowed 'General case' 0 CA--C 1.595 2.674 0 CA-C-N 121.3 2.55 . . . . 0.0 111.626 -172.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 97.38 -22.88 38.4 Favored Glycine 0 CA--C 1.563 3.042 0 CA-C-N 122.974 2.624 . . . . 0.0 115.636 -176.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.46 HG23 ' OD1' ' A' ' 139' ' ' ASN . 0.1 OUTLIER -105.46 146.52 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.378 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 178.396 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -115.22 129.72 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 113.815 -1.539 . . . . 0.0 114.513 -176.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 47.9 p30 -92.18 164.86 13.41 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 171.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 7.6 mt -55.96 -42.95 98.75 Favored Pre-proline 0 CA--C 1.585 2.327 0 CA-C-O 115.028 -2.415 . . . . 0.0 112.584 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -59.16 -22.53 64.96 Favored 'Trans proline' 0 C--N 1.376 2.007 0 CA-C-N 125.338 2.942 . . . . 0.0 119.74 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -69.92 0.3 Allowed 'General case' 0 CA--C 1.562 1.407 0 CA-C-N 122.996 2.635 . . . . 0.0 110.357 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.658 ' CE2' HG23 ' A' ' 90' ' ' ILE . 77.8 t80 -49.54 -43.39 45.73 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 124.716 1.206 . . . . 0.0 113.468 174.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.745 ' HG2' HG21 ' A' ' 90' ' ' ILE . 5.8 mtp -67.37 -40.35 85.76 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-O 114.898 -2.477 . . . . 0.0 112.004 177.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.79 ' OD1' ' HE3' ' A' ' 153' ' ' LYS . 1.9 t0 -63.83 -43.67 95.52 Favored 'General case' 0 N--CA 1.505 2.281 0 CA-C-N 124.458 3.299 . . . . 0.0 109.626 173.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.95 -47.89 21.64 Favored 'General case' 0 CA--C 1.575 1.916 0 C-N-CA 127.173 2.189 . . . . 0.0 112.07 174.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 68.0 mt -89.06 -34.47 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.891 0 CA-C-O 117.286 -1.34 . . . . 0.0 111.513 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 41.2 mmtt -53.49 -42.06 66.89 Favored 'General case' 0 N--CA 1.503 2.217 0 CA-C-N 122.126 2.239 . . . . 0.0 112.739 176.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.79 ' HE3' ' OD1' ' A' ' 149' ' ' ASP . 96.1 mttt -63.49 -53.6 49.54 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 119.016 0.825 . . . . 0.0 112.137 176.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 177.691 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 . . . . . 0 CA--C 1.586 2.347 0 CA-C-O 118.012 -0.994 . . . . 0.0 113.101 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -43.87 -55.35 4.6 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 118.213 2.672 . . . . 0.0 118.213 -177.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -58.88 -54.2 49.76 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.662 HG23 ' CE2' ' A' ' 147' ' ' PHE . 1.6 mp -66.38 -45.71 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 116.748 -1.596 . . . . 0.0 109.995 177.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.46 -46.13 84.0 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 121.617 2.008 . . . . 0.0 110.541 177.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.91 -55.96 28.42 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 117.326 -1.321 . . . . 0.0 110.574 176.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.83 -57.62 6.66 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.521 ' CE2' HD12 ' A' ' 105' ' ' ILE . 15.8 t80 -64.97 -50.53 66.02 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 120.899 1.681 . . . . 0.0 113.401 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.424 ' HE2' HD13 ' A' ' 144' ' ' ILE 0.335 65.8 mttt -68.07 -22.4 64.94 Favored 'General case' 0 CA--C 1.59 2.515 0 CA-C-O 116.495 -1.717 . . . . 0.0 110.455 -178.804 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.9 t -71.25 -48.87 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.421 0 CA-C-N 122.818 2.554 . . . . 0.0 107.213 168.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -49.02 -34.75 13.91 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.11 102.15 0.35 Allowed 'General case' 0 CA--C 1.576 1.976 0 C-N-CA 126.038 1.735 . . . . 0.0 109.191 176.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.28 -43.03 71.27 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.9 p30 -69.91 -8.03 45.33 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 117.236 2.31 . . . . 0.0 117.236 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.79 29.4 71.09 Favored Glycine 0 CA--C 1.558 2.75 0 CA-C-N 120.823 1.647 . . . . 0.0 116.418 -177.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.19 76.04 1.53 Allowed 'General case' 0 N--CA 1.477 0.882 1 CA-C-O 109.068 -5.253 . . . . 0.0 106.606 178.631 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 52.88 -30.24 0.01 OUTLIER Glycine 0 N--CA 1.491 2.305 2 N-CA-C 127.952 5.941 . . . . 0.0 127.952 165.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.6 p -107.15 155.05 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.455 0 CA-C-O 122.692 1.234 . . . . 0.0 114.112 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.521 HD12 ' CE2' ' A' ' 94' ' ' PHE . 87.8 mt -115.6 134.7 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-N 113.09 -1.868 . . . . 0.0 108.855 177.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.94 -179.29 3.82 Favored 'General case' 0 CA--C 1.576 1.972 0 CA-C-N 119.86 1.209 . . . . 0.0 112.965 175.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -74.78 -51.57 13.77 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.445 -1.409 . . . . 0.0 113.601 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.39 -33.63 75.97 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 178.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.18 -40.92 82.12 Favored 'General case' 0 CA--C 1.581 2.147 0 CA-C-N 120.44 1.473 . . . . 0.0 110.765 174.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.74 -46.66 86.9 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 117.521 -1.228 . . . . 0.0 108.892 172.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.45 ' HA ' HG21 ' A' ' 127' ' ' VAL . 2.9 tppt? -52.05 -61.82 2.02 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 125.012 1.325 . . . . 0.0 109.12 174.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -48.81 -48.51 41.42 Favored 'General case' 0 CA--C 1.575 1.929 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 176.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -82.14 -13.68 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 118.059 2.614 . . . . 0.0 118.059 -178.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.48 ' SD ' HG23 ' A' ' 127' ' ' VAL . 9.4 tpt -52.1 -49.59 63.3 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 119.246 3.054 . . . . 0.0 119.246 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -64.24 14.41 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 121.355 3.835 . . . . 0.0 121.355 -174.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.5 mptt 60.35 -90.14 0.03 OUTLIER 'General case' 0 N--CA 1.524 3.248 0 C-N-CA 124.465 1.106 . . . . 0.0 112.658 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.7 p -94.63 109.08 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.463 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 85.12 -178.28 50.83 Favored Glycine 0 CA--C 1.549 2.157 0 N-CA-C 115.596 0.998 . . . . 0.0 115.596 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -90.15 -140.09 0.15 Allowed 'General case' 0 CA--C 1.582 2.204 0 CA-C-N 114.32 -0.94 . . . . 0.0 112.457 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.265 8.1 pt-20 57.57 67.7 2.28 Favored Pre-proline 0 N--CA 1.5 2.069 0 N-CA-C 121.014 3.709 . . . . 0.0 121.014 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo -65.73 79.86 0.26 Allowed 'Trans proline' 0 C--N 1.377 2.026 0 C-N-CA 124.678 3.585 . . . . 0.0 114.706 174.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.411 7.7 tt -74.73 -59.19 2.85 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 109.213 -3.631 . . . . 0.0 110.892 -177.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.2 p -94.43 123.68 38.0 Favored 'General case' 0 C--N 1.37 1.479 0 CA-C-N 125.604 3.82 . . . . 0.0 107.558 176.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.38 -20.54 58.91 Favored 'General case' 0 CA--C 1.577 1.982 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.741 174.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -58.04 -40.1 80.04 Favored 'General case' 0 CA--C 1.561 1.381 0 CA-C-O 117.023 -1.465 . . . . 0.0 111.424 174.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -54.56 -53.9 48.33 Favored 'General case' 0 CA--C 1.585 2.323 0 CA-C-N 120.419 1.463 . . . . 0.0 111.477 175.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.48 HG23 ' SD ' ' A' ' 114' ' ' MET 0.251 4.2 p -73.43 -41.33 56.78 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -178.201 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -68.86 -45.78 70.17 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 120.675 1.58 . . . . 0.0 110.205 176.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -62.74 -48.85 77.42 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-N 121.341 1.882 . . . . 0.0 112.019 176.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -64.2 -45.85 86.49 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-N 120.378 1.445 . . . . 0.0 114.692 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -73.98 -34.34 64.18 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 115.934 -1.984 . . . . 0.0 112.767 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.12 -32.61 67.12 Favored 'General case' 0 CA--C 1.566 1.59 0 CA-C-N 122.64 2.473 . . . . 0.0 110.755 173.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.96 -35.51 80.12 Favored 'General case' 0 CA--C 1.58 2.126 0 CA-C-N 123.388 2.813 . . . . 0.0 110.495 172.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.99 -30.9 27.81 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 176.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -90.81 105.71 18.01 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 122.339 2.336 . . . . 0.0 107.115 174.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -62.65 -32.49 73.55 Favored 'General case' 0 CA--C 1.598 2.825 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 175.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.391 57.1 t0 163.54 -21.9 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.041 1 CA-C-O 108.768 -5.396 . . . . 0.0 103.326 176.673 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 13.03 8.04 0.0 OUTLIER Glycine 0 N--CA 1.5 2.928 3 O-C-N 98.666 -15.021 . . . . 0.0 125.028 161.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 77.84 4.58 2.92 Favored 'General case' 0 CA--C 1.581 2.145 0 CA-C-N 121.622 2.711 . . . . 0.0 111.179 -172.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 95.34 -12.09 68.3 Favored Glycine 0 C--N 1.372 2.561 0 CA-C-N 123.746 2.976 . . . . 0.0 114.584 -175.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . 0.298 3.4 m -130.24 121.11 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 102.181 -3.266 . . . . 0.0 102.181 175.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.62 125.62 38.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 111.299 -2.682 . . . . 0.0 114.001 -173.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -92.88 151.99 19.65 Favored 'General case' 0 CA--C 1.558 1.251 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 172.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.424 HD13 ' HE2' ' A' ' 95' ' ' LYS . 1.4 mt -53.32 -41.7 87.77 Favored Pre-proline 0 CA--C 1.582 2.176 0 CA-C-O 114.615 -2.612 . . . . 0.0 112.628 -178.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -55.63 -26.23 54.45 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 123.93 3.087 . . . . 0.0 116.511 176.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -63.85 -62.41 1.66 Allowed 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 122.051 2.205 . . . . 0.0 108.918 174.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.662 ' CE2' HG23 ' A' ' 90' ' ' ILE . 87.2 t80 -55.22 -47.08 75.85 Favored 'General case' 0 CA--C 1.57 1.739 0 C-N-CA 125.638 1.575 . . . . 0.0 113.842 173.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.49 ' HG2' HG21 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -59.12 -39.03 81.01 Favored 'General case' 0 CA--C 1.588 2.418 0 CA-C-O 117.673 -1.156 . . . . 0.0 109.857 174.749 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -67.15 -47.47 70.94 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 121.214 1.825 . . . . 0.0 110.104 173.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.33 -44.58 11.74 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 127.608 2.363 . . . . 0.0 112.26 176.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 58.5 mt -92.61 -56.23 5.39 Favored 'Isoleucine or valine' 0 C--N 1.366 1.295 0 CA-C-O 116.911 -1.519 . . . . 0.0 113.933 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -90.31 -41.97 11.22 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 118.368 2.729 . . . . 0.0 118.368 -176.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -100.09 -78.01 0.52 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 118.886 2.921 . . . . 0.0 118.886 -174.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.527 3.377 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 -174.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 . . . . . 0 CA--C 1.604 3.022 0 CA-C-O 118.88 -0.581 . . . . 0.0 112.296 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -28.04 -70.92 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 130.797 3.639 . . . . 0.0 118.112 -177.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -56.31 -50.52 71.19 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.753 HG23 ' HE2' ' A' ' 147' ' ' PHE . 5.3 mp -72.04 -48.1 51.51 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 CA-C-O 117.053 -1.451 . . . . 0.0 112.496 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.21 -51.93 67.85 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 121.671 2.032 . . . . 0.0 110.266 178.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -65.18 -46.77 79.45 Favored 'General case' 0 CA--C 1.566 1.595 0 CA-C-O 116.532 -1.699 . . . . 0.0 111.146 178.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.28 -61.59 1.73 Allowed 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 121.925 2.148 . . . . 0.0 114.404 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.517 ' CE2' HD12 ' A' ' 105' ' ' ILE . 19.9 t80 -59.15 -50.94 72.14 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 121.979 2.172 . . . . 0.0 112.858 178.022 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.418 ' HE2' HD13 ' A' ' 144' ' ' ILE 0.353 71.7 mttt -67.78 -23.82 65.25 Favored 'General case' 0 CA--C 1.591 2.53 0 CA-C-O 116.558 -1.687 . . . . 0.0 110.262 -177.42 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.8 t -69.66 -48.23 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.485 0 CA-C-N 122.732 2.515 . . . . 0.0 107.491 167.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -48.28 -33.95 9.63 Favored 'General case' 0 CA--C 1.577 1.991 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.42 95.9 0.48 Allowed 'General case' 0 CA--C 1.577 1.983 0 C-N-CA 126.936 2.094 . . . . 0.0 107.873 175.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.92 -46.49 71.4 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.633 -0.667 . . . . 0.0 112.322 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -47.94 -24.55 1.07 Allowed 'General case' 0 CA--C 1.583 2.233 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 176.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.14 7.43 87.78 Favored Glycine 0 CA--C 1.563 3.036 0 CA-C-N 122.216 2.28 . . . . 0.0 117.34 -176.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.67 78.21 1.69 Allowed 'General case' 0 N--CA 1.478 0.932 1 CA-C-O 109.938 -4.839 . . . . 0.0 104.76 175.356 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 52.68 -26.93 0.01 OUTLIER Glycine 0 N--CA 1.486 2.028 2 N-CA-C 129.079 6.392 . . . . 0.0 129.079 166.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.7 t -103.03 136.19 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-N 118.919 1.359 . . . . 0.0 113.036 -177.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.517 HD12 ' CE2' ' A' ' 94' ' ' PHE . 67.5 mt -111.04 133.59 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 113.082 -1.872 . . . . 0.0 110.347 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -110.51 173.04 6.52 Favored 'General case' 0 CA--C 1.571 1.76 0 C-N-CA 124.378 1.071 . . . . 0.0 111.49 176.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -64.01 -45.52 88.6 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 116.82 -1.562 . . . . 0.0 114.504 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -61.56 -46.87 88.08 Favored 'General case' 0 N--CA 1.508 2.457 0 CA-C-N 121.196 1.816 . . . . 0.0 112.185 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -51.53 -50.3 60.29 Favored 'General case' 0 CA--C 1.574 1.892 0 C-N-CA 124.557 1.143 . . . . 0.0 112.059 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -64.38 -52.6 57.44 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 125.986 1.714 . . . . 0.0 109.791 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 19.1 ttpt -46.87 -49.93 19.45 Favored 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 124.85 1.26 . . . . 0.0 113.534 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -70.57 -53.54 15.63 Favored 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 176.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -70.88 -27.29 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 119.302 3.075 . . . . 0.0 119.302 -175.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 15.3 tmm? -45.53 -68.0 0.23 Allowed 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 126.518 1.927 . . . . 0.0 109.577 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . 0.289 15.7 pt20 -118.2 84.08 2.11 Favored 'General case' 0 CA--C 1.579 2.076 0 N-CA-C 101.733 -3.432 . . . . 0.0 101.733 171.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -23.62 -68.61 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.8 1 N-CA-C 123.711 4.708 . . . . 0.0 123.711 -176.896 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.8 p -87.96 80.19 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -175.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.08 -13.18 2.71 Favored Glycine 0 CA--C 1.545 1.929 0 N-CA-C 123.0 3.96 . . . . 0.0 123.0 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.34 26.23 0.67 Allowed 'General case' 0 CA--C 1.597 2.762 0 CA-C-N 122.684 3.242 . . . . 0.0 115.729 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -39.29 157.04 0.13 Allowed Pre-proline 0 N--CA 1.504 2.264 0 N-CA-C 120.883 3.66 . . . . 0.0 120.883 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . 0.315 0.1 OUTLIER -3.66 65.55 0.0 OUTLIER 'Trans proline' 0 C--N 1.394 2.964 1 C-N-CA 126.327 4.685 . . . . 0.0 122.209 179.987 . . . . . . . . 4 3 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.508 2.2 tt -79.19 -73.09 0.36 Allowed 'General case' 0 CA--C 1.563 1.473 1 CA-C-N 107.891 -4.231 . . . . 0.0 103.042 -178.728 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.3 p -92.66 112.1 23.93 Favored 'General case' 0 C--N 1.374 1.653 2 CA-C-N 126.771 4.351 . . . . 0.0 99.36 169.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -62.19 -33.45 74.57 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 116.99 2.219 . . . . 0.0 116.99 -177.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.48 -40.28 96.68 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 117.418 -1.277 . . . . 0.0 113.624 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -59.56 -52.11 66.98 Favored 'General case' 0 CA--C 1.572 1.81 0 CA-C-N 120.633 1.56 . . . . 0.0 113.036 178.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.8 t -73.73 -48.36 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-O 117.001 -1.476 . . . . 0.0 112.464 -178.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -65.0 -44.57 88.83 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-N 120.768 1.622 . . . . 0.0 111.356 177.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -64.82 -43.51 92.86 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-N 121.464 1.938 . . . . 0.0 112.084 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.0 -47.62 82.34 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 120.662 1.574 . . . . 0.0 112.92 176.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.583 ' SD ' HD11 ' A' ' 142' ' ' ILE . 13.3 tpt -67.65 -37.67 82.74 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 115.189 -2.338 . . . . 0.0 112.075 176.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -66.64 -43.08 85.63 Favored 'General case' 0 CA--C 1.567 1.609 0 CA-C-N 123.053 2.66 . . . . 0.0 110.712 174.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -59.94 -41.39 91.72 Favored 'General case' 0 CA--C 1.578 2.053 0 CA-C-N 122.568 2.44 . . . . 0.0 110.351 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.59 -16.65 62.87 Favored 'General case' 0 CA--C 1.581 2.148 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.572 ' OD2' ' N ' ' A' ' 140' ' ' GLY . 7.3 t0 -91.8 103.25 15.82 Favored 'General case' 0 CA--C 1.586 2.327 0 N-CA-C 101.679 -3.452 . . . . 0.0 101.679 164.044 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -73.81 -21.12 60.26 Favored 'General case' 0 CA--C 1.58 2.125 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 178.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -91.82 -11.87 35.32 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 119.514 3.153 . . . . 0.0 119.514 -175.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.13 5.96 89.24 Favored Glycine 0 CA--C 1.573 3.709 0 CA-C-N 120.241 1.382 . . . . 0.0 115.323 -173.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.38 -44.86 20.65 Favored 'General case' 0 CA--C 1.573 1.849 0 C-N-CA 126.139 1.776 . . . . 0.0 113.33 176.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.572 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . 111.13 20.25 7.21 Favored Glycine 0 CA--C 1.558 2.73 0 N-CA-C 116.891 1.516 . . . . 0.0 116.891 -178.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.27 158.73 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-N 118.676 1.238 . . . . 0.0 108.041 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.583 HD11 ' SD ' ' A' ' 131' ' ' MET . 1.1 mt -136.91 128.83 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 117.702 2.482 . . . . 0.0 117.702 -174.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 33.1 p30 -95.74 153.98 17.46 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 170.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.418 HD13 ' HE2' ' A' ' 95' ' ' LYS . 2.3 mt -51.17 -43.08 84.38 Favored Pre-proline 0 CA--C 1.586 2.339 0 CA-C-O 115.006 -2.426 . . . . 0.0 114.198 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -56.01 -29.8 75.47 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 123.787 2.991 . . . . 0.0 117.646 177.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -61.8 -62.51 1.75 Allowed 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 120.831 1.65 . . . . 0.0 110.926 176.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.753 ' HE2' HG23 ' A' ' 90' ' ' ILE . 57.9 t80 -54.85 -42.56 72.13 Favored 'General case' 0 CA--C 1.578 2.04 0 C-N-CA 123.989 0.915 . . . . 0.0 112.809 174.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.682 ' HG2' HG21 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -56.89 -42.27 79.54 Favored 'General case' 0 CA--C 1.583 2.22 0 CA-C-O 117.403 -1.284 . . . . 0.0 109.716 174.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.52 -33.63 73.09 Favored 'General case' 0 CA--C 1.577 1.992 0 CA-C-N 121.187 1.812 . . . . 0.0 110.736 174.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.3 mp -58.52 -45.74 88.2 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 120.661 1.573 . . . . 0.0 111.542 174.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 66.6 mt -79.9 -45.62 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 120.445 1.475 . . . . 0.0 110.982 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -62.87 -49.71 73.78 Favored 'General case' 0 CA--C 1.575 1.915 0 CA-C-N 120.931 1.696 . . . . 0.0 114.702 177.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -93.2 -71.16 0.67 Allowed 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 124.807 1.243 . . . . 0.0 111.926 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.528 3.447 0 C-N-CA 126.999 2.119 . . . . 0.0 113.322 179.721 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 . . . . . 0 CA--C 1.574 1.889 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -40.7 -69.9 0.12 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.762 2.025 . . . . 0.0 115.884 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.52 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 13.0 pt-20 -58.54 -45.1 89.61 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 114.827 1.418 . . . . 0.0 114.827 -177.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.416 HG23 ' CD2' ' A' ' 147' ' ' PHE . 4.2 mp -76.83 -67.61 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 114.42 -2.705 . . . . 0.0 114.572 -177.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . 0.336 0.0 OUTLIER -73.95 -33.63 63.97 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 123.546 2.885 . . . . 0.0 110.36 -178.247 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 46.9 mtt180 -69.04 -45.69 69.8 Favored 'General case' 0 CA--C 1.58 2.133 0 CA-C-N 125.52 3.782 . . . . 0.0 108.992 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 89' ' ' GLU . . . -70.79 -57.25 4.84 Favored 'General case' 0 C--N 1.384 2.09 0 CA-C-N 122.376 2.353 . . . . 0.0 112.121 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.595 ' CE2' HD12 ' A' ' 105' ' ' ILE . 4.8 t80 -57.07 -51.59 68.67 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 121.919 2.145 . . . . 0.0 113.267 178.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.602 ' HE2' HD13 ' A' ' 144' ' ' ILE . 56.0 mttt -62.01 -31.0 71.34 Favored 'General case' 0 CA--C 1.576 1.948 0 CA-C-O 115.491 -2.195 . . . . 0.0 111.548 -178.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -69.2 -45.23 79.86 Favored 'Isoleucine or valine' 0 CA--C 1.591 2.523 0 CA-C-N 123.604 2.911 . . . . 0.0 109.355 170.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.91 -31.13 38.27 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.965 ' OD2' ' HA ' ' A' ' 102' ' ' ASP . 1.7 t0 -56.9 125.39 22.32 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 119.997 1.271 . . . . 0.0 109.087 177.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.46 28.35 0.03 OUTLIER 'General case' 0 N--CA 1.527 3.422 0 N-CA-C 120.445 3.498 . . . . 0.0 120.445 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.497 ' H ' ' C ' ' A' ' 98' ' ' ASP 0.422 13.7 t-20 72.44 148.23 0.09 Allowed 'General case' 0 CA--C 1.604 3.033 2 C-N-CA 135.223 5.409 . . . . 0.0 101.825 -175.813 . . . . . . . . 4 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 109.39 60.49 0.52 Allowed Glycine 0 C--N 1.285 -2.254 2 C-N-CA 135.547 6.308 . . . . 0.0 109.621 -177.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.965 ' HA ' ' OD2' ' A' ' 98' ' ' ASP 0.832 0.2 OUTLIER -30.13 113.5 0.09 Allowed 'General case' 0 C--N 1.393 2.474 0 CA-C-O 127.626 3.584 . . . . 0.0 118.268 -174.511 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 126.62 28.92 0.93 Allowed Glycine 0 N--CA 1.43 -1.724 1 CA-C-N 103.376 -6.284 . . . . 0.0 110.716 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . 0.273 0.0 OUTLIER -166.67 142.57 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 N-CA-C 118.376 2.732 . . . . 0.0 118.376 177.306 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.595 HD12 ' CE2' ' A' ' 94' ' ' PHE . 96.1 mt -136.64 134.58 48.98 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.676 0 C-N-CA 128.331 2.652 . . . . 0.0 104.99 175.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -105.01 -178.56 3.69 Favored 'General case' 0 CA--C 1.569 1.692 0 C-N-CA 124.462 1.105 . . . . 0.0 111.621 175.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.49 -46.62 25.96 Favored 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -178.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -62.95 -53.09 59.49 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 117.023 -1.465 . . . . 0.0 111.328 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -58.03 -30.72 66.36 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 121.838 2.108 . . . . 0.0 113.124 175.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -66.97 -51.65 52.56 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 120.554 1.524 . . . . 0.0 109.187 176.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.1 tppt? -54.98 -35.33 64.21 Favored 'General case' 0 CA--C 1.58 2.118 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 174.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 11.3 m-30 -74.76 -57.98 3.57 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 125.699 1.6 . . . . 0.0 113.043 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.9 -36.4 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 125.814 1.645 . . . . 0.0 113.684 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -53.97 -48.16 70.62 Favored 'General case' 0 CA--C 1.588 2.432 0 CA-C-O 121.157 0.503 . . . . 0.0 110.198 171.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -102.65 72.35 1.23 Allowed 'General case' 0 CA--C 1.58 2.113 0 C-N-CA 126.594 1.957 . . . . 0.0 114.477 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.6 mmtt -99.53 142.16 31.38 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 119.733 -1.854 . . . . 0.0 111.795 177.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.3 p 48.67 95.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 C-N-CA 126.355 1.862 . . . . 0.0 112.028 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 97.56 -43.05 2.02 Favored Glycine 0 CA--C 1.554 2.518 0 CA-C-O 119.065 -0.853 . . . . 0.0 113.012 -176.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 75.08 102.54 0.07 Allowed 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 125.758 1.623 . . . . 0.0 112.866 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -125.09 -34.38 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.619 1 CA-C-O 111.505 -4.093 . . . . 0.0 119.45 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -80.92 74.58 5.47 Favored 'Trans proline' 0 CA--C 1.574 2.491 1 CA-C-N 130.762 4.879 . . . . 0.0 106.681 175.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.264 0.5 OUTLIER -68.82 -33.32 73.64 Favored 'General case' 0 CA--C 1.558 1.263 1 N-CA-C 123.121 4.489 . . . . 0.0 123.121 -171.478 . . . . . . . . 4 3 . 1 . 013 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 78.3 p -78.92 140.11 38.14 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 123.7 2.954 . . . . 0.0 110.124 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -60.09 -37.58 80.35 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.37 -36.84 71.73 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 117.346 -1.311 . . . . 0.0 114.478 176.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -61.76 -51.11 69.66 Favored 'General case' 0 CA--C 1.58 2.133 0 CA-C-N 120.786 1.63 . . . . 0.0 111.841 175.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.2 t -63.53 -51.83 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 C-N-CA 125.804 1.642 . . . . 0.0 110.706 178.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.3 -38.78 84.71 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-O 117.569 -1.205 . . . . 0.0 111.314 176.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -62.87 -50.45 70.87 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 121.673 2.033 . . . . 0.0 112.094 175.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.49 -47.26 86.92 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 177.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.429 ' SD ' HD11 ' A' ' 142' ' ' ILE . 12.8 tpt -70.02 -38.72 75.98 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 115.434 -2.222 . . . . 0.0 111.303 176.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -36.16 83.37 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 123.724 2.965 . . . . 0.0 111.372 175.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -61.78 -49.21 77.26 Favored 'General case' 0 CA--C 1.573 1.848 0 CA-C-O 118.121 -0.942 . . . . 0.0 109.478 173.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -77.33 -23.82 50.87 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 117.724 2.49 . . . . 0.0 117.724 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -91.29 116.67 29.01 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 103.356 -2.831 . . . . 0.0 103.356 170.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -61.59 -22.33 65.12 Favored 'General case' 0 CA--C 1.586 2.347 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.281 29.6 t0 96.97 159.68 0.02 OUTLIER 'General case' 0 CA--C 1.609 3.218 0 CA-C-O 127.402 3.477 . . . . 0.0 103.085 178.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 94.48 36.79 5.52 Favored Glycine 0 CA--C 1.567 3.319 2 C-N-CA 132.006 4.622 . . . . 0.0 102.492 -173.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -173.7 -65.43 0.01 OUTLIER 'General case' 0 C--N 1.399 2.722 0 CA-C-N 121.821 2.811 . . . . 0.0 115.488 -174.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 87.39 20.6 51.5 Favored Glycine 0 CA--C 1.574 3.751 0 CA-C-N 119.31 0.959 . . . . 0.0 114.384 -174.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.88 168.25 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 128.053 2.541 . . . . 0.0 104.227 -178.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.429 HD11 ' SD ' ' A' ' 131' ' ' MET . 0.9 OUTLIER -144.75 133.06 17.4 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 O-C-N 120.979 -1.075 . . . . 0.0 112.816 -178.385 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 53.6 p30 -103.58 155.65 18.38 Favored 'General case' 0 CA--C 1.561 1.384 0 N-CA-C 104.467 -2.42 . . . . 0.0 104.467 169.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.602 HD13 ' HE2' ' A' ' 95' ' ' LYS . 0.6 OUTLIER -52.45 -44.89 95.3 Favored Pre-proline 0 N--CA 1.492 1.669 0 CA-C-O 115.184 -2.341 . . . . 0.0 113.219 -178.4 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.44 ' O ' ' HB2' ' A' ' 149' ' ' ASP . 43.1 Cg_exo -55.51 -21.21 29.67 Favored 'Trans proline' 0 C--N 1.375 1.942 0 CA-C-O 114.139 -2.526 . . . . 0.0 116.455 177.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.66 -56.21 6.97 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 123.217 2.735 . . . . 0.0 110.488 175.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.416 ' CD2' HG23 ' A' ' 90' ' ' ILE . 18.6 t80 -61.45 -44.76 96.54 Favored 'General case' 0 CA--C 1.591 2.552 0 CA-C-O 123.727 1.727 . . . . 0.0 111.99 175.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 2.1 mmt -56.62 -45.14 81.67 Favored 'General case' 0 CA--C 1.56 1.36 0 CA-C-O 115.111 -2.376 . . . . 0.0 108.884 173.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 145' ' ' PRO . 1.2 m-20 -66.97 -27.33 67.37 Favored 'General case' 0 CA--C 1.567 1.599 0 CA-C-N 122.468 2.394 . . . . 0.0 112.115 173.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.5 mp -52.32 -41.04 62.64 Favored 'General case' 0 N--CA 1.504 2.262 0 CA-C-N 121.98 2.173 . . . . 0.0 106.324 168.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -81.34 -69.46 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.612 3.348 0 CA-C-O 122.481 1.134 . . . . 0.0 111.447 173.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -72.94 8.44 1.55 Allowed 'General case' 0 CA--C 1.579 2.081 2 C-N-CA 133.249 4.62 . . . . 0.0 122.55 -178.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 59.8 pttt 3.04 2.55 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.699 1 N-CA-C 128.607 6.521 . . . . 0.0 128.607 -166.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 35.9 m . . . . . 0 N--CA 1.5 2.034 0 C-N-CA 123.994 0.918 . . . . 0.0 112.486 175.883 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.522 3.138 0 N-CA-C 117.924 2.564 . . . . 0.0 117.924 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.89 -53.11 61.75 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-N 124.608 3.367 . . . . 0.0 111.732 177.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -64.44 -46.49 82.94 Favored 'General case' 0 CA--C 1.58 2.107 0 O-C-N 120.136 -1.602 . . . . 0.0 114.353 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.603 HG21 ' HG2' ' A' ' 148' ' ' MET . 3.6 mp -64.79 -42.88 96.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-O 117.467 -1.254 . . . . 0.0 110.405 177.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.12 -45.38 93.71 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 120.938 1.699 . . . . 0.0 109.278 175.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 76.8 mtt180 -52.97 -62.67 1.5 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 120.107 1.321 . . . . 0.0 110.283 176.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.86 -58.78 4.34 Favored 'General case' 0 C--N 1.358 0.968 0 CA-C-O 115.871 -2.014 . . . . 0.0 116.185 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.48 ' CE2' HD12 ' A' ' 105' ' ' ILE . 14.4 t80 -63.23 -52.66 61.26 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 121.42 1.918 . . . . 0.0 113.723 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.367 58.1 mttt -66.51 -19.53 65.81 Favored 'General case' 0 CA--C 1.596 2.719 0 CA-C-O 116.614 -1.66 . . . . 0.0 110.354 -177.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.7 t -72.64 -50.97 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 CA-C-N 122.566 2.439 . . . . 0.0 107.383 166.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -51.06 -30.39 15.6 Favored 'General case' 0 CA--C 1.568 1.655 0 N-CA-C 117.508 2.41 . . . . 0.0 117.508 -178.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.265 0.0 OUTLIER -55.04 115.52 2.26 Favored 'General case' 0 CA--C 1.585 2.299 0 C-N-CA 126.272 1.829 . . . . 0.0 110.274 178.335 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.9 -54.7 41.5 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 117.678 2.473 . . . . 0.0 117.678 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.6 p30 -88.66 6.28 39.16 Favored 'General case' 0 CA--C 1.562 1.442 0 N-CA-C 118.622 2.823 . . . . 0.0 118.622 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.65 29.13 71.48 Favored Glycine 0 CA--C 1.568 3.358 0 CA-C-N 121.078 1.763 . . . . 0.0 115.462 -175.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -143.3 78.29 1.6 Allowed 'General case' 0 N--CA 1.476 0.825 1 CA-C-O 109.544 -5.027 . . . . 0.0 107.362 178.829 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 54.82 -25.83 0.01 OUTLIER Glycine 0 N--CA 1.491 2.348 3 N-CA-C 129.504 6.562 . . . . 0.0 129.504 164.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.8 p -107.4 153.26 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.089 0 CA-C-N 119.129 1.465 . . . . 0.0 112.426 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.48 HD12 ' CE2' ' A' ' 94' ' ' PHE . 83.6 mt -123.19 137.39 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 C-N-CA 126.281 1.832 . . . . 0.0 108.909 178.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -108.69 -170.51 1.68 Allowed 'General case' 0 CA--C 1.589 2.459 0 C-N-CA 124.154 0.982 . . . . 0.0 112.34 176.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -80.64 -52.98 6.95 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -57.88 -47.4 82.86 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 123.021 0.528 . . . . 0.0 112.23 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -56.0 -48.52 75.73 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 118.033 -0.984 . . . . 0.0 111.157 174.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -60.37 -50.9 71.77 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 117.39 -1.29 . . . . 0.0 112.497 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -56.9 -39.24 74.05 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 120.342 1.428 . . . . 0.0 114.433 176.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -69.18 -45.49 69.82 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 175.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -91.07 -24.21 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 1 N-CA-C 122.054 4.094 . . . . 0.0 122.054 -174.496 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 1.4 tpt -29.34 -48.69 0.08 Allowed 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.59 93.1 3.93 Favored 'General case' 0 CA--C 1.556 1.19 0 CA-C-N 112.821 -1.99 . . . . 0.0 110.704 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -75.87 -72.2 0.33 Allowed 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 113.772 -1.558 . . . . 0.0 114.032 -177.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.6 p -100.3 106.4 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 83.29 94.05 0.61 Allowed Glycine 0 CA--C 1.543 1.781 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -64.13 125.26 23.92 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -142.15 -52.47 0.02 OUTLIER Pre-proline 0 CA--C 1.581 2.165 0 CA-C-O 112.192 -3.766 . . . . 0.0 121.089 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -76.67 88.33 1.38 Allowed 'Trans proline' 0 N--CA 1.508 2.379 1 CA-C-N 130.405 4.752 . . . . 0.0 103.895 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.277 12.4 tp -127.2 80.52 1.96 Allowed 'General case' 0 CA--C 1.545 0.764 1 N-CA-C 121.978 4.066 . . . . 0.0 121.978 -167.488 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 46.5 p -164.84 152.26 11.33 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 103.697 -2.705 . . . . 0.0 103.697 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -61.05 -41.53 96.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.91 -1.119 . . . . 0.0 112.149 176.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.49 -45.82 82.1 Favored 'General case' 0 CA--C 1.554 1.103 0 CA-C-O 116.929 -1.51 . . . . 0.0 113.338 176.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.82 -39.76 94.99 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 121.659 2.027 . . . . 0.0 112.965 176.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 90.0 t -69.99 -50.72 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.613 0 CA-C-O 117.739 -1.124 . . . . 0.0 109.307 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.68 -45.55 89.19 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 120.154 1.343 . . . . 0.0 111.718 176.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -61.61 -47.06 87.18 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 119.701 1.137 . . . . 0.0 112.621 176.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.21 -46.14 90.76 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 119.396 0.998 . . . . 0.0 112.975 176.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 9.6 ttt -70.84 -43.56 68.26 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 115.74 -2.076 . . . . 0.0 111.189 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -35.63 75.77 Favored 'General case' 0 CA--C 1.578 2.052 0 CA-C-N 122.899 2.59 . . . . 0.0 110.685 174.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.48 -42.68 91.92 Favored 'General case' 0 CA--C 1.571 1.774 0 CA-C-N 121.633 2.015 . . . . 0.0 110.557 172.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -72.21 -24.5 61.41 Favored 'General case' 0 CA--C 1.576 1.946 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 176.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -81.3 108.53 15.0 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 103.041 -2.948 . . . . 0.0 103.041 172.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -72.71 -14.64 61.61 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -108.95 -11.61 14.96 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 119.257 3.058 . . . . 0.0 119.257 -174.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.63 5.6 89.76 Favored Glycine 0 CA--C 1.571 3.561 0 CA-C-N 120.447 1.476 . . . . 0.0 114.618 -173.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -72.03 -44.62 63.12 Favored 'General case' 0 CA--C 1.565 1.547 0 C-N-CA 125.342 1.457 . . . . 0.0 113.39 176.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 102.98 3.77 48.53 Favored Glycine 0 CA--C 1.563 3.035 0 N-CA-C 117.312 1.685 . . . . 0.0 117.312 -177.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 1.8 t -135.43 141.85 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 101.592 -3.484 . . . . 0.0 101.592 176.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.2 mt -120.58 124.48 72.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 111.967 -2.379 . . . . 0.0 112.789 -176.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 53.7 p30 -92.48 157.67 16.44 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 170.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.8 mt -52.75 -41.2 82.93 Favored Pre-proline 0 CA--C 1.585 2.302 0 CA-C-O 115.126 -2.369 . . . . 0.0 112.967 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -57.08 -31.25 89.73 Favored 'Trans proline' 0 C--N 1.38 2.214 0 C-N-CA 123.702 2.935 . . . . 0.0 116.813 176.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -67.2 -46.57 73.5 Favored 'General case' 0 N--CA 1.505 2.291 0 CA-C-N 123.074 2.67 . . . . 0.0 111.279 176.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.591 ' CE2' HG23 ' A' ' 90' ' ' ILE . 31.2 t80 -63.28 -45.16 92.72 Favored 'General case' 0 CA--C 1.583 2.222 0 CA-C-N 120.643 1.565 . . . . 0.0 110.761 173.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.603 ' HG2' HG21 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -60.0 -41.36 91.93 Favored 'General case' 0 CA--C 1.579 2.06 0 CA-C-O 117.064 -1.446 . . . . 0.0 109.725 175.17 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.23 -25.06 63.21 Favored 'General case' 0 CA--C 1.579 2.067 0 CA-C-N 121.714 2.052 . . . . 0.0 111.783 173.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.1 tp -62.41 -47.13 85.45 Favored 'General case' 0 CA--C 1.573 1.828 0 CA-C-N 120.797 1.635 . . . . 0.0 108.875 172.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . 0.276 31.7 mt -68.12 -46.78 80.81 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.597 0 CA-C-N 119.13 0.877 . . . . 0.0 109.567 175.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -71.94 9.89 0.83 Allowed 'General case' 0 CA--C 1.606 3.127 0 C-N-CA 127.334 2.254 . . . . 0.0 116.807 174.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -3.92 -6.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.769 2 N-CA-C 128.448 6.462 . . . . 0.0 128.448 -171.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.693 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 173.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 . . . . . 0 CA--C 1.572 1.805 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . 0.25 0.4 OUTLIER -49.79 -48.99 50.22 Favored 'General case' 0 CA--C 1.573 1.831 0 CA-C-N 122.454 2.388 . . . . 0.0 116.195 -177.706 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -69.63 -40.46 76.54 Favored 'General case' 0 CA--C 1.574 1.888 0 CA-C-N 120.427 1.467 . . . . 0.0 114.146 177.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.51 HG23 ' CE2' ' A' ' 147' ' ' PHE . 4.1 mp -64.99 -55.22 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 116.226 -1.845 . . . . 0.0 109.635 178.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.402 ' HA ' ' HG3' ' A' ' 95' ' ' LYS 0.259 0.6 OUTLIER -62.75 -34.07 76.44 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 122.011 2.187 . . . . 0.0 111.225 177.148 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.0 mtm-85 -52.88 -62.3 1.74 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 121.175 1.807 . . . . 0.0 108.397 173.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.64 -61.54 1.84 Allowed 'General case' 0 C--N 1.355 0.822 0 CA-C-O 114.07 -2.871 . . . . 0.0 115.696 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.586 ' CE2' HD12 ' A' ' 105' ' ' ILE . 3.7 t80 -69.04 -52.86 24.21 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 124.387 3.267 . . . . 0.0 114.128 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.402 ' HG3' ' HA ' ' A' ' 91' ' ' LEU 0.375 26.0 mttt -63.04 -16.34 59.53 Favored 'General case' 0 CA--C 1.593 2.63 0 CA-C-O 115.51 -2.186 . . . . 0.0 111.368 -176.586 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -84.8 -46.83 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.598 2.823 0 CA-C-N 123.188 2.722 . . . . 0.0 108.558 167.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -57.71 -24.32 56.26 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 119.076 2.991 . . . . 0.0 119.076 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -39.24 -45.09 1.32 Allowed 'General case' 0 CA--C 1.589 2.443 0 CA-C-N 121.718 2.054 . . . . 0.0 116.421 176.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 65.29 -58.04 0.29 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 117.792 2.516 . . . . 0.0 117.792 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.54 -13.52 62.39 Favored 'General case' 0 CA--C 1.577 1.994 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.59 8.58 86.77 Favored Glycine 0 CA--C 1.551 2.319 0 N-CA-C 120.66 3.024 . . . . 0.0 120.66 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -114.58 -10.39 12.53 Favored 'General case' 0 CA--C 1.578 2.036 0 CA-C-N 119.366 1.583 . . . . 0.0 114.764 177.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 110.41 0.63 29.49 Favored Glycine 0 CA--C 1.55 2.266 0 CA-C-O 116.144 -2.476 . . . . 0.0 116.49 -178.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.55 153.26 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 CA-C-N 121.471 2.636 . . . . 0.0 112.199 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.586 HD12 ' CE2' ' A' ' 94' ' ' PHE . 97.5 mt -121.38 130.57 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-N 112.402 -2.181 . . . . 0.0 106.709 178.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -106.43 -173.27 2.26 Favored 'General case' 0 CA--C 1.573 1.829 0 CA-C-O 122.033 0.92 . . . . 0.0 110.582 176.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -72.31 -38.33 68.74 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.829 -1.17 . . . . 0.0 112.588 178.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -58.76 -46.02 88.42 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 123.542 0.737 . . . . 0.0 112.057 175.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -62.04 -37.79 86.25 Favored 'General case' 0 CA--C 1.586 2.35 0 CA-C-N 120.675 1.58 . . . . 0.0 112.364 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -60.51 -44.89 95.53 Favored 'General case' 0 CA--C 1.571 1.768 0 C-N-CA 124.202 1.001 . . . . 0.0 109.557 173.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -55.43 -46.59 76.69 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 125.049 1.34 . . . . 0.0 112.014 173.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -60.38 -53.39 58.22 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 176.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.99 -28.13 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 -177.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 7.3 tpt -61.02 -63.78 1.18 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -98.16 99.71 10.97 Favored 'General case' 0 CA--C 1.555 1.135 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 176.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.518 ' HD3' ' H ' ' A' ' 116' ' ' LYS . 0.5 OUTLIER -48.43 -49.64 34.36 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 116.731 2.122 . . . . 0.0 116.731 -178.774 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.6 p -155.32 100.23 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 154.13 -99.09 0.19 Allowed Glycine 0 CA--C 1.54 1.617 0 N-CA-C 113.886 0.315 . . . . 0.0 113.886 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -80.06 -165.31 0.81 Allowed 'General case' 0 CA--C 1.58 2.108 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 -178.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.5 -154.16 0.01 OUTLIER Pre-proline 0 CA--C 1.582 2.193 0 CA-C-O 116.051 -1.928 . . . . 0.0 109.771 178.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -68.74 77.39 0.75 Allowed 'Trans proline' 0 C--N 1.38 2.205 0 CA-C-N 124.941 2.8 . . . . 0.0 111.493 172.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.457 0.5 OUTLIER -66.36 -72.81 0.15 Allowed 'General case' 0 CA--C 1.562 1.412 0 CA-C-N 109.555 -3.475 . . . . 0.0 107.016 -177.568 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.4 p -91.61 118.08 30.31 Favored 'General case' 0 C--N 1.367 1.328 0 CA-C-N 125.709 3.868 . . . . 0.0 102.081 172.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -57.62 -40.31 78.89 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 117.324 2.342 . . . . 0.0 117.324 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.94 -38.79 76.59 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 114.708 1.374 . . . . 0.0 114.708 178.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -63.83 -51.99 62.16 Favored 'General case' 0 CA--C 1.574 1.868 0 CA-C-N 120.41 1.459 . . . . 0.0 112.713 177.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.1 t -70.98 -46.32 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-O 118.004 -0.998 . . . . 0.0 111.734 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -60.98 -49.14 78.65 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 117.067 -1.444 . . . . 0.0 110.611 176.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -61.91 -43.32 99.08 Favored 'General case' 0 CA--C 1.561 1.368 0 CA-C-N 120.927 1.694 . . . . 0.0 112.977 178.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.7 -45.48 78.64 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-N 120.612 1.551 . . . . 0.0 114.399 177.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -37.87 62.14 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 120.592 1.542 . . . . 0.0 111.903 178.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -63.83 -45.78 88.03 Favored 'General case' 0 CA--C 1.57 1.729 0 CA-C-N 121.71 2.05 . . . . 0.0 109.228 174.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -34.46 78.0 Favored 'General case' 0 CA--C 1.58 2.101 0 CA-C-N 122.229 2.286 . . . . 0.0 112.211 175.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.17 -32.03 58.83 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -77.99 114.21 16.64 Favored 'General case' 0 N--CA 1.513 2.676 0 O-C-N 117.408 -3.307 . . . . 0.0 109.454 175.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -82.06 -30.49 31.33 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 117.419 2.377 . . . . 0.0 117.419 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -86.3 -14.12 44.62 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 121.124 3.75 . . . . 0.0 121.124 -172.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.99 5.2 90.31 Favored Glycine 0 CA--C 1.572 3.61 0 CA-C-N 120.152 1.342 . . . . 0.0 113.895 -172.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -80.6 -51.36 8.83 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 119.145 1.472 . . . . 0.0 110.986 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 110.27 -7.95 30.76 Favored Glycine 0 CA--C 1.548 2.12 0 CA-C-O 115.965 -2.575 . . . . 0.0 116.907 -177.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . 0.307 3.4 m -134.97 121.04 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 101.402 -3.555 . . . . 0.0 101.402 174.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.0 mt -82.18 128.83 38.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 110.672 -2.967 . . . . 0.0 116.592 -172.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 39.3 p30 -93.95 155.5 17.12 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 172.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.61 -43.87 99.37 Favored Pre-proline 0 CA--C 1.583 2.224 0 CA-C-O 114.951 -2.452 . . . . 0.0 112.679 -178.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.37 -32.1 70.85 Favored 'Trans proline' 0 C--N 1.381 2.275 0 CA-C-N 125.1 2.857 . . . . 0.0 115.393 176.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -62.24 -57.87 9.83 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 116.743 -1.599 . . . . 0.0 110.18 175.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.567 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 75.5 t80 -53.14 -41.46 65.12 Favored 'General case' 0 N--CA 1.504 2.249 0 CA-C-N 120.624 1.556 . . . . 0.0 114.54 176.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.3 mtp -65.73 -49.16 69.47 Favored 'General case' 0 CA--C 1.573 1.862 0 O-C-N 121.591 -0.693 . . . . 0.0 110.623 176.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.67 -37.28 83.51 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 123.451 0.7 . . . . 0.0 112.789 175.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -57.66 -49.17 77.37 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 128.437 2.695 . . . . 0.0 110.491 173.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 91.0 mt -68.82 -40.32 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-N 119.698 1.135 . . . . 0.0 110.636 176.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.777 ' HE2' ' HE3' ' A' ' 153' ' ' LYS . 1.7 ttpm? -60.38 -66.79 0.47 Allowed 'General case' 0 CA--C 1.578 2.052 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 177.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.777 ' HE3' ' HE2' ' A' ' 152' ' ' LYS . 96.8 mttt -101.12 -71.75 0.7 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 121.639 3.94 . . . . 0.0 121.639 -176.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 54.4 p . . . . . 0 N--CA 1.499 1.977 0 N-CA-C 118.952 2.945 . . . . 0.0 118.952 -172.802 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.668 ' HA ' HD13 ' A' ' 90' ' ' ILE 0.253 3.2 tp10 . . . . . 1 N--CA 1.558 4.934 0 N-CA-C 118.744 2.868 . . . . 0.0 118.744 . . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -58.76 -39.64 81.6 Favored 'General case' 0 CA--C 1.589 2.471 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 170.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.262 1.4 tm-20 -72.0 -18.2 61.99 Favored 'General case' 0 CA--C 1.584 2.272 0 CA-C-O 113.76 -3.019 . . . . 0.0 109.534 171.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.668 HD13 ' HA ' ' A' ' 87' ' ' GLU 0.381 1.2 mp -68.67 -58.43 5.84 Favored 'Isoleucine or valine' 0 C--N 1.389 2.305 1 CA-C-N 128.832 5.287 . . . . 0.0 103.275 170.95 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 pp -56.99 -49.58 75.32 Favored 'General case' 0 N--CA 1.503 2.19 0 CA-C-N 121.576 1.989 . . . . 0.0 113.034 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 43.9 mtt85 -67.56 -40.38 84.93 Favored 'General case' 0 CA--C 1.567 1.634 0 CA-C-O 117.397 -1.287 . . . . 0.0 114.013 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.44 -50.62 43.95 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 115.098 -2.382 . . . . 0.0 111.64 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -62.42 -49.26 76.18 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 122.766 2.53 . . . . 0.0 110.136 176.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -60.07 -34.47 73.49 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 116.87 -1.538 . . . . 0.0 114.524 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -77.07 -43.95 31.56 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.949 0 CA-C-N 121.248 1.84 . . . . 0.0 109.729 173.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -49.01 -44.26 41.15 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 125.525 1.53 . . . . 0.0 109.864 177.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -54.63 98.79 0.02 OUTLIER 'General case' 0 CA--C 1.58 2.114 0 C-N-CA 125.65 1.58 . . . . 0.0 110.962 175.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -77.24 -36.69 54.4 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.1 p30 -67.36 -14.68 63.14 Favored 'General case' 0 CA--C 1.579 2.074 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.78 9.64 85.23 Favored Glycine 0 CA--C 1.551 2.334 0 N-CA-C 120.897 3.119 . . . . 0.0 120.897 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 26.7 p30 -115.45 -8.76 12.18 Favored 'General case' 0 CA--C 1.577 2.019 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 177.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 110.58 20.6 7.25 Favored Glycine 0 CA--C 1.552 2.359 0 CA-C-O 117.095 -1.947 . . . . 0.0 114.589 -177.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.5 t -133.34 143.29 39.53 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.718 0 CA-C-N 120.605 2.202 . . . . 0.0 111.446 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 79.3 mt -106.57 136.16 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 126.477 1.911 . . . . 0.0 108.194 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -108.78 -175.8 2.87 Favored 'General case' 0 CA--C 1.575 1.935 0 C-N-CA 123.299 0.639 . . . . 0.0 112.299 176.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -72.03 -52.73 15.56 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 117.126 -1.416 . . . . 0.0 114.64 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -59.05 -37.96 78.26 Favored 'General case' 0 N--CA 1.515 2.803 0 CA-C-N 120.416 1.462 . . . . 0.0 113.864 177.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . 0.362 0.9 OUTLIER -58.29 -48.32 80.84 Favored 'General case' 0 CA--C 1.598 2.8 0 CA-C-O 124.286 1.993 . . . . 0.0 112.4 174.266 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.18 -46.41 90.6 Favored 'General case' 0 CA--C 1.574 1.885 0 CA-C-O 116.582 -1.675 . . . . 0.0 107.212 172.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.439 ' O ' ' SD ' ' A' ' 114' ' ' MET . 60.8 mttt -51.0 -32.52 21.45 Favored 'General case' 0 N--CA 1.515 2.777 0 CA-C-N 122.078 2.217 . . . . 0.0 112.899 172.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -71.86 -49.92 34.01 Favored 'General case' 0 CA--C 1.583 2.235 0 C-N-CA 123.774 0.83 . . . . 0.0 111.92 174.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.7 mt -90.08 -7.64 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.738 0 N-CA-C 118.077 2.621 . . . . 0.0 118.077 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.439 ' SD ' ' O ' ' A' ' 111' ' ' LYS . 13.9 ptm -34.74 -31.91 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.428 1 N-CA-C 123.485 4.624 . . . . 0.0 123.485 -178.172 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -82.45 20.94 1.01 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 118.055 2.613 . . . . 0.0 118.055 -177.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 4.2 mptt 58.69 -88.33 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.249 0 C-N-CA 124.79 1.236 . . . . 0.0 113.301 175.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.0 p -82.12 110.15 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.91 -139.73 22.39 Favored Glycine 0 CA--C 1.545 1.953 0 N-CA-C 111.076 -0.809 . . . . 0.0 111.076 -177.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -164.07 117.32 1.42 Allowed 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.908 0.861 . . . . 0.0 111.784 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -126.79 8.34 0.05 OUTLIER Pre-proline 0 CA--C 1.581 2.166 0 CA-C-O 114.168 -2.825 . . . . 0.0 117.096 176.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . 0.328 57.0 Cg_exo 15.77 58.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.388 2.619 1 C-N-CA 126.872 5.048 . . . . 0.0 118.944 -176.867 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.351 12.9 tp -90.39 -94.98 0.12 Allowed 'General case' 0 CA--C 1.556 1.196 0 CA-C-N 110.885 -2.87 . . . . 0.0 112.622 -174.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 75.0 p -92.73 130.91 38.21 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 123.045 2.657 . . . . 0.0 111.377 -178.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -69.4 -27.98 65.76 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -55.56 -42.1 74.2 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-O 117.689 -1.148 . . . . 0.0 110.762 174.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -53.44 -50.33 65.49 Favored 'General case' 0 CA--C 1.57 1.728 0 CA-C-N 119.299 0.954 . . . . 0.0 112.996 174.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.1 p -71.04 -43.48 76.18 Favored 'Isoleucine or valine' 0 C--N 1.359 0.981 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -178.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.37 -49.08 70.67 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 120.037 1.29 . . . . 0.0 110.656 177.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -62.13 -49.43 75.92 Favored 'General case' 0 CA--C 1.573 1.841 0 CA-C-O 118.093 -0.956 . . . . 0.0 112.868 177.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.74 -45.05 90.55 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 177.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 15.9 ttt -69.68 -38.8 77.18 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 116.104 -1.903 . . . . 0.0 111.709 176.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -59.08 -42.07 89.53 Favored 'General case' 0 CA--C 1.576 1.973 0 CA-C-N 122.719 2.509 . . . . 0.0 110.485 173.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -57.45 -44.62 84.9 Favored 'General case' 0 CA--C 1.578 2.054 0 CA-C-N 120.099 1.318 . . . . 0.0 111.351 174.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.33 -18.79 40.94 Favored 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 118.311 2.708 . . . . 0.0 118.311 178.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.43 ' OD2' ' N ' ' A' ' 140' ' ' GLY . 23.0 t0 -82.41 102.99 11.64 Favored 'General case' 0 CA--C 1.574 1.874 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 174.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -81.89 -19.7 40.33 Favored 'General case' 0 CA--C 1.58 2.122 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 177.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -88.03 -14.34 39.26 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 119.128 3.01 . . . . 0.0 119.128 -175.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.94 5.11 90.03 Favored Glycine 0 CA--C 1.568 3.354 0 CA-C-N 119.964 1.256 . . . . 0.0 115.221 -174.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -80.72 -48.09 13.05 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 118.942 1.371 . . . . 0.0 111.353 175.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.43 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . 111.43 -20.12 23.47 Favored Glycine 0 CA--C 1.546 2.028 0 CA-C-O 116.27 -2.406 . . . . 0.0 115.346 -177.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . 0.303 5.7 m -122.28 122.22 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-N 121.438 2.619 . . . . 0.0 103.999 178.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -79.51 130.83 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 117.488 2.403 . . . . 0.0 117.488 -173.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 32.7 p30 -93.95 161.69 14.2 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 170.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 17.4 mt -54.99 -48.4 96.09 Favored Pre-proline 0 CA--C 1.579 2.077 0 CA-C-O 113.994 -2.908 . . . . 0.0 113.73 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -51.45 -27.22 23.81 Favored 'Trans proline' 0 C--N 1.373 1.85 0 CA-C-N 125.932 3.154 . . . . 0.0 119.849 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -72.18 -64.8 0.87 Allowed 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 121.237 1.835 . . . . 0.0 111.012 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.485 ' CE1' HG23 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -48.81 -53.59 18.58 Favored 'General case' 0 N--CA 1.506 2.346 0 C-N-CA 124.717 1.207 . . . . 0.0 110.729 173.738 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.417 ' O ' ' HB2' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -60.82 -40.25 92.04 Favored 'General case' 0 C--N 1.358 0.957 0 CA-C-O 113.681 -3.057 . . . . 0.0 113.938 -179.775 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.02 -48.18 79.86 Favored 'General case' 0 CA--C 1.594 2.651 0 CA-C-N 125.01 3.55 . . . . 0.0 111.533 174.092 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . 0.295 0.3 OUTLIER -44.55 -47.73 10.24 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 127.851 2.46 . . . . 0.0 111.072 176.937 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 9.6 mt -92.09 -44.14 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.238 0 CA-C-O 117.527 -1.225 . . . . 0.0 111.157 175.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 148' ' ' MET . 33.1 mttp -56.63 -10.1 0.92 Allowed 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 118.453 2.76 . . . . 0.0 118.453 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -39.54 -50.32 2.18 Favored 'General case' 0 N--CA 1.513 2.702 0 CA-C-N 123.518 2.872 . . . . 0.0 111.194 172.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.509 2.499 0 C-N-CA 126.452 1.901 . . . . 0.0 109.909 171.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 . . . . . 0 CA--C 1.547 0.844 0 CA-C-O 115.647 -2.12 . . . . 0.0 113.535 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -24.16 -60.79 0.05 Allowed 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 119.59 3.181 . . . . 0.0 119.59 -173.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -67.16 -58.7 4.37 Favored 'General case' 0 N--CA 1.506 2.333 0 CA-C-O 122.455 1.121 . . . . 0.0 113.718 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.642 HG23 ' CE2' ' A' ' 147' ' ' PHE . 1.1 mp -55.65 -53.38 37.57 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.711 0 C-N-CA 126.452 1.901 . . . . 0.0 110.412 177.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.9 -46.03 74.77 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.878 1.671 . . . . 0.0 110.656 175.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.8 mtm105 -57.82 -55.57 33.21 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-N 121.011 1.732 . . . . 0.0 110.44 176.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.84 -55.81 15.11 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.477 ' CE2' HD12 ' A' ' 105' ' ' ILE . 18.1 t80 -64.16 -50.58 67.61 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.342 36.2 mttt -67.13 -22.02 65.81 Favored 'General case' 0 CA--C 1.585 2.309 0 CA-C-O 116.556 -1.688 . . . . 0.0 110.068 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.6 t -69.6 -49.73 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 CA-C-N 122.394 2.361 . . . . 0.0 107.534 167.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -54.47 -34.91 62.42 Favored 'General case' 0 CA--C 1.58 2.113 0 N-CA-C 118.09 2.626 . . . . 0.0 118.09 -178.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.271 2.3 t0 -55.92 134.39 52.09 Favored 'General case' 0 CA--C 1.585 2.321 0 C-N-CA 127.513 2.325 . . . . 0.0 115.561 178.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.481 ' HB2' ' HG2' ' A' ' 109' ' ' GLU . . . -67.65 -60.79 2.26 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -76.21 -19.17 58.64 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 117.598 2.444 . . . . 0.0 117.598 -177.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.92 3.74 90.34 Favored Glycine 0 CA--C 1.568 3.346 0 CA-C-N 120.843 1.656 . . . . 0.0 114.754 -173.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -91.48 -17.55 25.54 Favored 'General case' 0 CA--C 1.58 2.126 0 CA-C-N 120.532 2.166 . . . . 0.0 113.395 173.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 113.36 24.46 4.75 Favored Glycine 0 CA--C 1.54 1.64 0 CA-C-O 115.541 -2.81 . . . . 0.0 116.987 -178.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.3 t -127.51 138.69 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 121.826 2.813 . . . . 0.0 109.783 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.477 HD12 ' CE2' ' A' ' 94' ' ' PHE . 61.5 mt -118.5 138.79 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 126.573 1.949 . . . . 0.0 109.582 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -110.22 -169.82 1.53 Allowed 'General case' 0 CA--C 1.585 2.308 0 C-N-CA 125.001 1.32 . . . . 0.0 110.834 176.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -81.59 -54.97 4.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.134 -1.604 . . . . 0.0 114.318 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -60.63 -43.87 97.03 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 117.534 -1.222 . . . . 0.0 112.807 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.481 ' HG2' ' HB2' ' A' ' 99' ' ' ALA . 11.2 tp10 -59.49 -44.44 93.08 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 121.025 1.739 . . . . 0.0 111.268 174.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.96 -51.75 68.34 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 119.486 1.039 . . . . 0.0 109.777 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -52.52 -42.25 64.19 Favored 'General case' 0 CA--C 1.573 1.864 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 175.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -69.75 -53.66 17.35 Favored 'General case' 0 CA--C 1.577 1.994 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 176.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.9 tt -72.72 -29.08 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 118.7 2.852 . . . . 0.0 118.7 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 6.2 tpt -45.92 -50.68 14.31 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.035 1.334 . . . . 0.0 112.342 178.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -100.46 88.4 3.64 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-O 123.781 1.753 . . . . 0.0 110.515 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.696 ' HD3' ' H ' ' A' ' 116' ' ' LYS . 0.5 OUTLIER -54.69 -52.24 63.01 Favored 'General case' 0 CA--C 1.57 1.74 0 CA-C-N 112.156 -2.293 . . . . 0.0 114.079 178.059 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 8.2 p -153.5 107.23 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.409 0 N-CA-C 104.53 -2.396 . . . . 0.0 104.53 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 108.5 -148.75 16.84 Favored Glycine 0 CA--C 1.546 2.0 0 C-N-CA 123.623 0.63 . . . . 0.0 114.247 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -126.22 135.01 51.07 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 124.138 0.975 . . . . 0.0 112.967 -178.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.34 10.3 pt-20 -144.63 -120.62 0.0 OUTLIER Pre-proline 0 CA--C 1.587 2.404 0 CA-C-O 111.704 -3.998 . . . . 0.0 106.695 178.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -81.87 87.49 1.42 Allowed 'Trans proline' 0 C--N 1.385 2.486 1 CA-C-N 132.107 5.36 . . . . 0.0 105.376 176.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.257 0.2 OUTLIER -110.11 77.72 1.07 Allowed 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 -172.771 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 18.8 p -165.62 158.08 15.19 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 175.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.64 -36.81 85.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.792 -1.192 . . . . 0.0 111.934 175.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.61 -49.65 67.95 Favored 'General case' 0 CA--C 1.56 1.329 0 CA-C-O 117.557 -1.211 . . . . 0.0 112.848 176.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -58.09 -46.14 86.01 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-N 120.309 1.413 . . . . 0.0 112.483 176.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 62.4 t -69.34 -43.43 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.346 0 CA-C-O 116.627 -1.654 . . . . 0.0 110.992 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -63.46 -43.73 96.51 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 121.871 2.123 . . . . 0.0 112.467 177.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -64.73 -52.97 54.24 Favored 'General case' 0 CA--C 1.572 1.797 0 CA-C-N 119.517 1.053 . . . . 0.0 110.617 175.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.26 -43.36 96.22 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 177.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -69.68 -42.26 74.37 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 117.318 -1.325 . . . . 0.0 111.521 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -64.96 -36.74 85.38 Favored 'General case' 0 CA--C 1.572 1.813 0 CA-C-N 120.621 1.555 . . . . 0.0 111.252 175.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -64.88 -41.03 95.98 Favored 'General case' 0 CA--C 1.581 2.157 0 CA-C-N 120.884 1.674 . . . . 0.0 109.719 172.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.41 -23.88 67.06 Favored 'General case' 0 CA--C 1.576 1.965 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 174.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -88.39 100.85 13.35 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 171.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -62.13 -16.18 50.83 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 117.912 2.56 . . . . 0.0 117.912 177.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.94 -2.95 20.71 Favored 'General case' 0 N--CA 1.491 1.577 1 N-CA-C 121.958 4.059 . . . . 0.0 121.958 -173.75 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.35 6.98 88.97 Favored Glycine 0 CA--C 1.556 2.633 0 N-CA-C 118.289 2.076 . . . . 0.0 118.289 -178.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -78.56 -36.77 44.1 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 120.246 2.023 . . . . 0.0 114.083 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 96.85 21.92 19.63 Favored Glycine 0 CA--C 1.555 2.584 0 N-CA-C 117.063 1.585 . . . . 0.0 117.063 -177.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -149.67 145.22 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 103.383 -2.821 . . . . 0.0 103.383 176.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.41 HG22 ' O ' ' A' ' 143' ' ' ASP . 0.3 OUTLIER -129.19 133.9 64.91 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -176.405 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.41 ' O ' HG22 ' A' ' 142' ' ' ILE . 19.3 p30 -103.83 165.01 11.31 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 169.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.6 mt -53.19 -45.17 98.44 Favored Pre-proline 0 N--CA 1.505 2.317 0 O-C-N 118.071 -2.893 . . . . 0.0 112.812 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -50.2 -35.03 41.68 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 123.937 3.091 . . . . 0.0 118.601 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -72.98 -45.79 55.95 Favored 'General case' 0 CA--C 1.591 2.53 0 CA-C-N 122.614 2.461 . . . . 0.0 112.937 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.642 ' CE2' HG23 ' A' ' 90' ' ' ILE . 4.7 t80 -56.32 -52.13 65.66 Favored 'General case' 0 N--CA 1.506 2.331 0 CA-C-N 120.726 1.603 . . . . 0.0 110.932 172.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.712 ' HE2' ' HD3' ' A' ' 153' ' ' LYS 0.259 4.1 ptp -60.59 -39.12 86.93 Favored 'General case' 0 CA--C 1.589 2.452 0 CA-C-O 121.499 0.666 . . . . 0.0 111.057 176.737 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.53 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 17.6 t0 -52.65 -54.34 34.65 Favored 'General case' 0 N--CA 1.492 1.632 1 CA-C-O 109.296 -5.145 . . . . 0.0 106.006 171.823 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.43 -43.39 23.8 Favored 'General case' 0 N--CA 1.515 2.783 0 CA-C-N 123.699 2.954 . . . . 0.0 112.502 174.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.1 mt -73.76 30.26 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.613 3.376 0 C-N-CA 127.12 2.168 . . . . 0.0 109.61 169.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 149' ' ' ASP . 1.3 mmpt? 28.98 27.24 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.301 2 C-N-CA 132.888 4.475 . . . . 0.0 122.146 -167.326 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.712 ' HD3' ' HE2' ' A' ' 148' ' ' MET . 85.3 tttt -87.94 -73.38 0.49 Allowed 'General case' 0 CA--C 1.573 1.858 0 CA-C-N 110.641 -2.982 . . . . 0.0 115.99 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.534 3.741 0 C-N-CA 124.916 1.286 . . . . 0.0 111.711 -178.494 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 . . . . . 0 CA--C 1.559 1.299 0 N-CA-C 114.295 1.221 . . . . 0.0 114.295 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -52.63 -44.41 66.05 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 117.921 2.563 . . . . 0.0 117.921 -177.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -64.0 -60.72 2.9 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 121.693 2.042 . . . . 0.0 113.413 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.625 HG23 ' CE ' ' A' ' 148' ' ' MET 0.297 1.1 mp -58.26 -50.9 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-O 117.164 -1.398 . . . . 0.0 111.209 178.004 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 pp -59.58 -42.89 93.53 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 116.967 -1.492 . . . . 0.0 111.668 177.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.86 -54.96 40.96 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 121.273 1.851 . . . . 0.0 111.43 176.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.13 -57.72 11.62 Favored 'General case' 0 C--N 1.358 0.961 0 CA-C-O 116.091 -1.909 . . . . 0.0 114.048 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.441 ' HB3' ' HE1' ' A' ' 148' ' ' MET . 19.2 t80 -58.97 -46.71 87.41 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 120.862 1.665 . . . . 0.0 114.336 178.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -63.72 -34.64 78.34 Favored 'General case' 0 CA--C 1.568 1.664 0 CA-C-O 116.341 -1.79 . . . . 0.0 111.483 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 75.1 t -64.73 -43.78 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 CA-C-N 122.146 2.248 . . . . 0.0 108.181 169.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.56 -31.19 63.96 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 117.272 2.323 . . . . 0.0 117.272 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -75.71 119.26 19.48 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 174.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.85 -71.57 0.06 Allowed 'General case' 0 N--CA 1.514 2.727 0 CA-C-O 123.908 1.813 . . . . 0.0 106.833 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -134.03 -55.3 0.87 Allowed 'General case' 0 CA--C 1.577 2.006 0 CA-C-N 109.682 -3.417 . . . . 0.0 103.977 167.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 30.87 9.58 0.0 OUTLIER Glycine 0 C--N 1.355 1.586 1 N-CA-C 125.548 4.979 . . . . 0.0 125.548 -175.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.2 p30 63.72 12.99 7.05 Favored 'General case' 0 CA--C 1.59 2.517 0 CA-C-N 122.231 3.015 . . . . 0.0 113.047 -171.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 110.76 -15.85 28.79 Favored Glycine 0 CA--C 1.57 3.478 0 CA-C-O 115.796 -2.669 . . . . 0.0 109.211 -170.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -99.59 138.89 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-N 122.436 3.118 . . . . 0.0 116.416 -179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 18.6 mt -105.98 132.32 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 C-N-CA 125.108 1.363 . . . . 0.0 109.806 178.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.54 -174.89 2.64 Favored 'General case' 0 CA--C 1.584 2.263 0 CA-C-O 122.0 0.905 . . . . 0.0 112.398 176.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -72.41 -46.65 54.21 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.672 -1.267 . . . . 0.0 114.021 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -57.54 -49.01 77.75 Favored 'General case' 0 N--CA 1.504 2.273 0 CA-C-O 117.925 -1.036 . . . . 0.0 112.451 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -54.49 -43.72 72.03 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 120.201 1.364 . . . . 0.0 112.948 173.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.61 -55.14 33.94 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 116.981 -1.485 . . . . 0.0 107.642 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.444 ' HA ' ' SD ' ' A' ' 114' ' ' MET . 33.5 mtmm -55.54 -29.15 58.43 Favored 'General case' 0 N--CA 1.503 2.185 0 CA-C-N 121.131 1.787 . . . . 0.0 115.264 176.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -74.91 -53.59 8.76 Favored 'General case' 0 CA--C 1.574 1.902 0 C-N-CA 124.505 1.122 . . . . 0.0 110.746 175.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 tt -79.01 -16.56 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 118.492 2.775 . . . . 0.0 118.492 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.444 ' SD ' ' HA ' ' A' ' 111' ' ' LYS . 15.1 ptm -36.25 -38.37 0.14 Allowed 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 118.062 2.615 . . . . 0.0 118.062 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.81 98.39 3.11 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 102.739 -3.06 . . . . 0.0 102.739 176.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.461 ' H ' ' HD2' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -62.17 -22.55 65.97 Favored 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 120.969 3.692 . . . . 0.0 120.969 -176.331 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 8.9 p -75.56 108.16 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-N 120.345 1.43 . . . . 0.0 110.982 -178.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.6 -113.87 5.57 Favored Glycine 0 CA--C 1.542 1.755 0 C-N-CA 123.589 0.614 . . . . 0.0 113.971 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -138.08 64.45 1.5 Allowed 'General case' 0 CA--C 1.57 1.732 0 CA-C-O 122.934 1.35 . . . . 0.0 109.765 178.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -76.91 -55.9 1.39 Allowed Pre-proline 0 CA--C 1.573 1.844 0 CA-C-O 112.697 -3.525 . . . . 0.0 116.885 -178.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . 0.282 61.4 Cg_exo 19.72 66.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.387 2.604 1 C-N-CA 125.487 4.125 . . . . 0.0 120.279 179.842 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.335 61.7 tp -79.92 -94.23 0.04 OUTLIER 'General case' 0 CA--C 1.563 1.474 0 CA-C-O 114.752 -2.547 . . . . 0.0 114.356 -175.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 41.6 p -103.72 126.12 50.65 Favored 'General case' 0 C--N 1.365 1.26 0 CA-C-N 124.73 3.423 . . . . 0.0 110.631 -178.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -71.44 -31.24 66.98 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-N 113.276 -1.784 . . . . 0.0 114.601 178.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.46 -40.85 75.54 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.52 1.128 . . . . 0.0 113.893 176.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -58.2 -48.78 79.28 Favored 'General case' 0 CA--C 1.584 2.284 0 CA-C-O 122.989 1.376 . . . . 0.0 112.567 176.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.0 t -63.17 -49.69 82.22 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.483 0 C-N-CA 126.852 2.061 . . . . 0.0 111.129 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -58.78 -42.99 90.31 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 124.253 1.021 . . . . 0.0 112.601 176.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -64.51 -48.02 76.72 Favored 'General case' 0 CA--C 1.577 1.989 0 CA-C-N 119.531 1.06 . . . . 0.0 111.828 176.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.57 -44.51 93.29 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 176.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 23.1 ttt -67.35 -39.46 85.76 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 116.866 -1.54 . . . . 0.0 112.412 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -62.07 -39.64 93.11 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 121.283 1.856 . . . . 0.0 111.093 175.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -62.87 -43.46 98.74 Favored 'General case' 0 CA--C 1.58 2.103 0 CA-C-N 119.565 1.075 . . . . 0.0 111.11 172.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -85.73 -8.08 58.39 Favored 'General case' 0 N--CA 1.486 1.338 1 N-CA-C 122.873 4.397 . . . . 0.0 122.873 -179.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.422 ' OD2' ' HA2' ' A' ' 140' ' ' GLY . 24.6 t0 -78.05 114.48 16.97 Favored 'General case' 0 N--CA 1.506 2.328 1 CA-C-O 96.312 -11.327 . . . . 0.0 109.467 177.255 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -81.07 26.49 0.43 Allowed 'General case' 0 C--N 1.26 -3.309 2 O-C-N 62.843 -37.411 . . . . 0.0 116.029 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.372 32.8 t0 92.14 -103.2 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 101.907 -3.368 . . . . 0.0 101.907 -177.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 37.64 7.65 0.0 OUTLIER Glycine 0 CA--C 1.557 2.668 0 N-CA-C 120.564 2.985 . . . . 0.0 120.564 -174.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 157.45 -49.32 0.0 OUTLIER 'General case' 0 CA--C 1.572 1.813 0 C-N-CA 126.856 2.062 . . . . 0.0 114.337 -173.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.422 ' HA2' ' OD2' ' A' ' 135' ' ' ASP . . . 112.65 -23.46 15.09 Favored Glycine 0 CA--C 1.561 2.963 0 CA-C-N 123.241 2.746 . . . . 0.0 113.76 -173.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 19.7 m -115.63 127.55 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 101.921 -3.363 . . . . 0.0 101.921 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.6 mt -79.64 126.77 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 N-CA-C 118.366 2.728 . . . . 0.0 118.366 -172.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -94.0 149.78 20.93 Favored 'General case' 0 CA--C 1.561 1.393 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 171.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -49.58 -46.62 79.05 Favored Pre-proline 0 CA--C 1.574 1.869 0 CA-C-O 115.035 -2.412 . . . . 0.0 114.434 -177.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -57.42 -26.72 72.61 Favored 'Trans proline' 0 C--N 1.371 1.723 0 CA-C-N 124.926 2.795 . . . . 0.0 116.401 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -68.71 -54.86 13.63 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 123.138 2.699 . . . . 0.0 112.113 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -60.48 -46.47 89.97 Favored 'General case' 0 CA--C 1.578 2.057 0 CA-C-N 121.756 2.071 . . . . 0.0 112.612 176.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.625 ' CE ' HG23 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -62.4 -41.25 98.52 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-O 116.895 -1.526 . . . . 0.0 111.684 176.971 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.749 ' O ' ' HG2' ' A' ' 153' ' ' LYS . 2.3 t70 -68.91 -38.41 79.54 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 121.873 2.124 . . . . 0.0 111.902 175.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.09 -43.36 77.98 Favored 'General case' 0 CA--C 1.565 1.558 0 C-N-CA 126.011 1.725 . . . . 0.0 110.708 175.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 66.7 mt -87.31 -51.83 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 121.279 1.854 . . . . 0.0 112.368 177.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -65.62 -49.49 68.55 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.749 ' HG2' ' O ' ' A' ' 149' ' ' ASP . 59.5 pttt -94.38 -59.27 1.99 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 116.385 1.995 . . . . 0.0 116.385 -178.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.406 ' N ' ' HG3' ' A' ' 153' ' ' LYS . 11.4 p . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 -176.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 . . . . . 0 CA--C 1.61 3.25 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.44 ' HA ' HD12 ' A' ' 91' ' ' LEU . 3.1 tm-20 -4.89 -20.18 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.455 2 C-N-CA 133.478 4.711 . . . . 0.0 123.47 -169.773 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -79.3 -68.42 0.66 Allowed 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 174.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.867 HG23 ' HE2' ' A' ' 147' ' ' PHE . 1.6 mp -65.1 -35.79 76.25 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.013 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 172.144 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -54.0 -45.8 71.57 Favored 'General case' 0 N--CA 1.515 2.793 0 CA-C-N 124.048 3.113 . . . . 0.0 109.384 173.002 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.7 mtm105 -59.81 -56.15 25.37 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 120.642 1.564 . . . . 0.0 110.65 176.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.77 -59.93 3.94 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 116.074 -1.917 . . . . 0.0 114.904 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.495 ' CE2' HD12 ' A' ' 105' ' ' ILE . 24.4 t80 -59.65 -49.13 78.96 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 121.087 1.767 . . . . 0.0 113.297 178.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.371 36.5 mttt -69.11 -23.63 64.02 Favored 'General case' 0 CA--C 1.583 2.227 0 CA-C-O 116.631 -1.652 . . . . 0.0 110.333 -178.083 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.1 t -68.73 -48.91 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 CA-C-N 122.15 2.25 . . . . 0.0 107.103 166.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -53.3 -33.21 52.33 Favored 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.256 3.7 t0 -67.22 -3.62 8.27 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 117.83 2.53 . . . . 0.0 117.83 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 50.04 24.63 1.43 Allowed 'General case' 0 N--CA 1.524 3.258 0 CA-C-N 124.533 3.333 . . . . 0.0 115.404 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . 0.284 11.4 t-20 82.49 -53.1 0.21 Allowed 'General case' 0 CA--C 1.575 1.915 0 C-N-CA 129.834 3.254 . . . . 0.0 105.795 -170.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 30.94 20.55 0.0 OUTLIER Glycine 0 C--N 1.363 2.034 1 N-CA-C 125.272 4.869 . . . . 0.0 125.272 178.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 67.04 14.08 9.7 Favored 'General case' 0 CA--C 1.593 2.612 0 CA-C-N 120.821 2.311 . . . . 0.0 113.61 -173.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.89 -5.89 56.67 Favored Glycine 0 CA--C 1.568 3.373 0 CA-C-O 116.688 -2.173 . . . . 0.0 111.127 -172.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.4 t -117.37 136.42 54.57 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.94 0 CA-C-N 121.059 2.429 . . . . 0.0 113.385 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.495 HD12 ' CE2' ' A' ' 94' ' ' PHE . 67.9 mt -92.23 140.56 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 C-N-CA 126.587 1.955 . . . . 0.0 108.282 176.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.3 p30 -110.12 179.52 4.08 Favored 'General case' 0 CA--C 1.572 1.803 0 CA-C-O 122.666 1.222 . . . . 0.0 110.795 175.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -70.94 -43.01 69.09 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 117.391 -1.29 . . . . 0.0 114.437 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -63.62 -45.89 88.21 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 120.124 1.329 . . . . 0.0 112.157 177.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -58.86 -48.54 81.03 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 121.464 1.938 . . . . 0.0 112.731 175.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -59.1 -49.02 79.46 Favored 'General case' 0 CA--C 1.568 1.661 0 C-N-CA 123.502 0.721 . . . . 0.0 109.36 175.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 21.8 tptp -62.73 -12.81 26.28 Favored 'General case' 0 CA--C 1.577 2.01 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 175.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -93.3 -43.55 8.75 Favored 'General case' 0 CA--C 1.584 2.266 0 O-C-N 120.448 -1.407 . . . . 0.0 111.334 173.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -92.66 -29.24 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 1 N-CA-C 122.064 4.098 . . . . 0.0 122.064 -174.906 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 19.3 tpt -37.31 -65.25 0.32 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 126.001 1.72 . . . . 0.0 115.166 -176.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -97.31 77.11 2.64 Favored 'General case' 0 CA--C 1.569 1.686 0 CA-C-O 124.554 2.121 . . . . 0.0 110.746 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.37 153.37 1.55 Allowed 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 118.847 2.906 . . . . 0.0 118.847 177.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 41.1 t 60.54 98.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 C-N-CA 125.56 1.544 . . . . 0.0 112.917 177.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 81.03 -79.81 1.77 Allowed Glycine 0 CA--C 1.54 1.625 0 N-CA-C 116.013 1.165 . . . . 0.0 116.013 178.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.45 78.3 0.77 Allowed 'General case' 0 CA--C 1.568 1.644 0 CA-C-O 112.109 -3.805 . . . . 0.0 114.583 -178.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -97.62 131.03 27.77 Favored Pre-proline 0 N--CA 1.527 3.416 1 O-C-N 83.992 -24.193 . . . . 0.0 113.074 -170.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . 2.514 10.0 Cg_endo 35.21 43.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.505 2.175 0 N-CA-C 122.252 3.904 . . . . 0.0 122.252 -178.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.454 0.8 OUTLIER -91.68 -76.16 0.46 Allowed 'General case' 0 CA--C 1.564 1.507 0 CA-C-O 113.484 -3.151 . . . . 0.0 110.849 -175.204 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 38.0 p -84.86 127.12 34.0 Favored 'General case' 0 N--CA 1.487 1.41 1 CA-C-N 127.082 4.492 . . . . 0.0 107.313 177.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.17 -32.53 70.52 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.43 -44.45 96.4 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-O 116.594 -1.67 . . . . 0.0 113.619 177.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -43.36 97.19 Favored 'General case' 0 CA--C 1.577 1.996 0 CA-C-N 121.557 1.98 . . . . 0.0 113.68 178.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.5 t -70.62 -52.77 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-O 117.667 -1.159 . . . . 0.0 112.174 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -60.84 -47.15 87.65 Favored 'General case' 0 CA--C 1.558 1.272 0 CA-C-N 119.672 1.124 . . . . 0.0 111.451 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -61.57 -46.91 87.89 Favored 'General case' 0 CA--C 1.57 1.735 0 CA-C-N 120.653 1.57 . . . . 0.0 112.417 177.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.3 -43.77 96.91 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 177.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 17.5 ttt -73.7 -36.48 65.27 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 116.594 -1.67 . . . . 0.0 112.163 177.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -61.36 -44.15 97.67 Favored 'General case' 0 CA--C 1.569 1.692 0 CA-C-N 122.116 2.234 . . . . 0.0 109.982 173.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -64.74 -42.63 95.05 Favored 'General case' 0 CA--C 1.577 2.016 0 CA-C-N 120.922 1.692 . . . . 0.0 111.81 175.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -77.08 -21.15 54.79 Favored 'General case' 0 CA--C 1.564 1.484 0 N-CA-C 118.431 2.752 . . . . 0.0 118.431 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -87.53 113.46 23.25 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 103.66 -2.718 . . . . 0.0 103.66 175.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . 0.256 5.9 mt-10 -80.27 -18.17 50.08 Favored 'General case' 0 CA--C 1.576 1.948 0 CA-C-N 113.523 -1.672 . . . . 0.0 115.312 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -92.13 -15.61 27.44 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 117.035 2.235 . . . . 0.0 117.035 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.14 5.97 89.72 Favored Glycine 0 CA--C 1.564 3.108 0 CA-C-N 120.196 1.362 . . . . 0.0 116.081 -175.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -93.39 -45.85 7.61 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-O 117.267 -1.349 . . . . 0.0 114.088 177.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 114.29 22.63 5.12 Favored Glycine 0 CA--C 1.561 2.95 0 N-CA-C 118.111 2.004 . . . . 0.0 118.111 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.97 143.49 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.527 0 N-CA-C 102.836 -3.024 . . . . 0.0 102.836 174.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.445 HD13 HG21 ' A' ' 142' ' ' ILE . 1.0 OUTLIER -132.69 139.97 48.55 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -175.736 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 59.6 p30 -96.96 165.57 12.02 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 170.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.3 mt -56.13 -43.64 99.34 Favored Pre-proline 0 N--CA 1.5 2.048 0 CA-C-O 115.007 -2.425 . . . . 0.0 112.826 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.441 ' O ' ' HB2' ' A' ' 149' ' ' ASP . 69.2 Cg_exo -55.25 -40.74 84.08 Favored 'Trans proline' 0 C--N 1.372 1.816 0 CA-C-N 124.491 2.64 . . . . 0.0 116.124 178.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -65.23 -52.85 51.95 Favored 'General case' 0 N--CA 1.505 2.276 0 CA-C-N 124.507 3.322 . . . . 0.0 113.321 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.867 ' HE2' HG23 ' A' ' 90' ' ' ILE . 22.9 t80 -54.33 -52.13 62.51 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 120.265 1.393 . . . . 0.0 113.053 172.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.487 ' HB2' ' HE2' ' A' ' 148' ' ' MET . 0.0 OUTLIER -68.62 -34.91 76.57 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 117.734 -1.127 . . . . 0.0 113.405 179.36 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 145' ' ' PRO . 4.1 t70 -64.3 -35.25 80.23 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 119.478 1.035 . . . . 0.0 111.346 171.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -58.44 -52.13 66.91 Favored 'General case' 0 CA--C 1.562 1.431 0 C-N-CA 125.295 1.438 . . . . 0.0 110.07 173.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 95.9 mt -70.08 -53.5 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-O 117.592 -1.194 . . . . 0.0 113.321 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 17.5 pttm -67.87 -50.14 58.1 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -97.19 -65.88 0.94 Allowed 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 4.6 t . . . . . 0 N--CA 1.521 3.089 0 N-CA-C 103.716 -2.698 . . . . 0.0 103.716 -176.148 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 . . . . . 0 CA--C 1.579 2.064 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -48.06 -54.05 14.38 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 117.183 2.29 . . . . 0.0 117.183 -177.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -59.1 -52.28 66.4 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.502 ' H ' HD12 ' A' ' 90' ' ' ILE . 2.7 mp -61.58 -55.65 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 124.338 1.055 . . . . 0.0 111.482 178.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.1 pp -59.28 -41.97 90.16 Favored 'General case' 0 CA--C 1.556 1.211 0 CA-C-O 118.732 -0.652 . . . . 0.0 112.139 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 25.4 ttp85 -57.29 -55.47 34.37 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 117.617 -1.182 . . . . 0.0 110.008 176.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.34 -59.76 3.69 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.535 ' HB2' ' CE2' ' A' ' 147' ' ' PHE . 5.3 t80 -69.69 -48.7 58.75 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 121.652 2.024 . . . . 0.0 114.285 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.455 ' HG2' HD13 ' A' ' 144' ' ' ILE 0.326 47.5 mttt -64.16 -20.48 66.02 Favored 'General case' 0 CA--C 1.586 2.36 0 CA-C-O 115.635 -2.126 . . . . 0.0 110.737 -178.666 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -80.29 -46.73 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.403 0 CA-C-N 123.09 2.677 . . . . 0.0 108.497 169.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -54.78 -38.45 67.28 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -49.35 110.2 0.35 Allowed 'General case' 0 CA--C 1.575 1.909 0 C-N-CA 126.258 1.823 . . . . 0.0 112.262 178.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.466 ' HB2' ' HG2' ' A' ' 109' ' ' GLU . . . -41.97 -75.59 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 -177.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -94.55 0.69 55.43 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 117.425 2.38 . . . . 0.0 117.425 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.94 6.49 88.33 Favored Glycine 0 CA--C 1.554 2.518 0 CA-C-O 116.476 -2.291 . . . . 0.0 118.316 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -88.96 -3.72 58.65 Favored 'General case' 0 CA--C 1.585 2.301 0 CA-C-N 121.902 2.851 . . . . 0.0 113.987 174.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.14 -22.31 18.47 Favored Glycine 0 CA--C 1.54 1.595 0 CA-C-O 115.814 -2.659 . . . . 0.0 116.869 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.1 m -92.52 140.64 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.358 0 CA-C-N 122.333 3.066 . . . . 0.0 112.371 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.47 HD12 ' CE2' ' A' ' 94' ' ' PHE . 89.7 mt -110.35 121.56 63.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 N-CA-C 100.477 -3.897 . . . . 0.0 100.477 172.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.438 ' HA ' HG12 ' A' ' 141' ' ' VAL . 2.4 p30 -92.93 169.13 10.68 Favored 'General case' 0 CA--C 1.559 1.305 0 CA-C-O 122.31 1.052 . . . . 0.0 113.327 178.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -67.67 -45.0 76.47 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 117.661 -1.161 . . . . 0.0 113.501 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -65.65 -45.86 81.38 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 117.284 -1.341 . . . . 0.0 112.224 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.466 ' HG2' ' HB2' ' A' ' 99' ' ' ALA . 25.3 tp10 -64.42 -40.67 96.21 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 121.439 1.927 . . . . 0.0 112.409 176.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -63.38 -51.78 64.44 Favored 'General case' 0 CA--C 1.577 2.017 0 CA-C-N 120.26 1.391 . . . . 0.0 108.838 175.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -49.01 -42.83 39.4 Favored 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 125.384 1.474 . . . . 0.0 112.709 175.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -68.54 -60.47 2.4 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 123.675 0.79 . . . . 0.0 111.441 175.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.7 tt -62.16 -16.29 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 117.508 2.41 . . . . 0.0 117.508 -177.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 13.7 tpt -63.26 -68.24 0.36 Allowed 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 125.202 1.401 . . . . 0.0 109.006 175.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -133.73 115.22 14.31 Favored 'General case' 0 CA--C 1.566 1.595 1 N-CA-C 99.291 -4.337 . . . . 0.0 99.291 175.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.94 65.7 0.66 Allowed 'General case' 0 CA--C 1.573 1.846 1 N-CA-C 122.552 4.278 . . . . 0.0 122.552 -171.803 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -135.2 83.26 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 101.553 -3.499 . . . . 0.0 101.553 173.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.87 -126.99 18.31 Favored Glycine 0 CA--C 1.552 2.365 0 N-CA-C 107.327 -2.309 . . . . 0.0 107.327 -175.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -99.52 69.4 1.64 Allowed 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 174.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -68.83 -30.62 2.45 Favored Pre-proline 0 CA--C 1.56 1.336 1 CA-C-O 110.173 -4.727 . . . . 0.0 117.212 -177.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -38.88 90.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.385 2.471 1 CA-C-N 128.737 4.156 . . . . 0.0 117.823 178.491 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.396 2.7 tm? -69.75 -76.9 0.09 Allowed 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 109.583 -3.462 . . . . 0.0 110.779 -175.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 18.4 p -88.38 115.13 25.67 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 125.619 3.827 . . . . 0.0 103.118 175.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -64.12 -30.83 71.87 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 116.817 2.155 . . . . 0.0 116.817 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.18 -36.91 83.31 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-O 117.297 -1.335 . . . . 0.0 113.54 177.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -59.94 -51.11 71.06 Favored 'General case' 0 CA--C 1.576 1.963 0 CA-C-N 120.269 1.395 . . . . 0.0 112.595 177.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 24.4 t -68.28 -51.77 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.311 0 C-N-CA 124.617 1.167 . . . . 0.0 111.936 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -60.01 -46.4 89.62 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 120.057 1.299 . . . . 0.0 112.22 178.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -62.42 -43.1 99.61 Favored 'General case' 0 CA--C 1.57 1.748 0 CA-C-N 120.087 1.312 . . . . 0.0 111.928 176.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.7 -47.81 79.67 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-N 119.904 1.229 . . . . 0.0 114.113 176.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 14.7 ttt -70.46 -39.41 74.31 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 114.417 -2.706 . . . . 0.0 109.874 177.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -58.5 -39.27 79.59 Favored 'General case' 0 CA--C 1.582 2.199 0 CA-C-N 124.867 3.485 . . . . 0.0 110.224 173.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -60.7 -45.27 94.85 Favored 'General case' 0 CA--C 1.582 2.178 0 CA-C-N 121.494 1.952 . . . . 0.0 110.954 173.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.65 -11.44 59.08 Favored 'General case' 0 CA--C 1.58 2.104 0 N-CA-C 117.173 2.286 . . . . 0.0 117.173 178.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -91.84 115.2 27.86 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 101.22 -3.622 . . . . 0.0 101.22 167.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -69.18 -20.6 64.0 Favored 'General case' 0 CA--C 1.561 1.38 0 N-CA-C 119.846 3.276 . . . . 0.0 119.846 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -145.96 25.93 1.26 Allowed 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 120.99 3.7 . . . . 0.0 120.99 -174.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.29 7.68 88.31 Favored Glycine 0 CA--C 1.555 2.59 0 N-CA-C 117.237 1.655 . . . . 0.0 117.237 -177.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -66.78 -44.8 80.37 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-N 120.303 2.052 . . . . 0.0 112.99 176.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 103.0 -21.43 40.15 Favored Glycine 0 CA--C 1.55 2.254 0 N-CA-C 117.032 1.573 . . . . 0.0 117.032 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.438 HG12 ' HA ' ' A' ' 106' ' ' ASP . 13.8 m -126.12 138.6 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 103.693 -2.706 . . . . 0.0 103.693 176.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.1 mt -104.71 133.7 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 114.032 -1.44 . . . . 0.0 113.622 -174.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 28.0 p30 -95.44 152.12 18.69 Favored 'General case' 0 CA--C 1.565 1.52 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 171.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.455 HD13 ' HG2' ' A' ' 95' ' ' LYS . 0.4 OUTLIER -52.28 -45.16 94.62 Favored Pre-proline 0 CA--C 1.583 2.241 0 CA-C-O 114.772 -2.537 . . . . 0.0 114.001 -177.836 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.43 -29.65 78.56 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 123.735 2.957 . . . . 0.0 117.716 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -60.01 -55.57 32.34 Favored 'General case' 0 N--CA 1.505 2.286 0 CA-C-N 121.209 1.822 . . . . 0.0 112.125 176.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.535 ' CE2' ' HB2' ' A' ' 94' ' ' PHE . 36.4 t80 -55.67 -51.91 65.63 Favored 'General case' 0 CA--C 1.577 2.005 0 C-N-CA 126.61 1.964 . . . . 0.0 111.075 173.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 4.7 mtp -56.59 -46.84 80.62 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 117.015 -1.469 . . . . 0.0 111.793 177.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.25 -35.75 74.02 Favored 'General case' 0 CA--C 1.576 1.949 0 CA-C-N 120.837 1.653 . . . . 0.0 111.016 176.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.46 -35.87 65.96 Favored 'General case' 0 CA--C 1.577 2.016 0 CA-C-N 120.327 1.421 . . . . 0.0 110.205 172.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 85.7 mt -82.57 -59.6 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.451 0 CA-C-N 120.572 1.533 . . . . 0.0 109.987 175.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -85.74 6.32 28.36 Favored 'General case' 0 CA--C 1.578 2.028 1 N-CA-C 122.243 4.164 . . . . 0.0 122.243 -176.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -25.5 -38.11 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 121.292 3.812 . . . . 0.0 121.292 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 12.0 t . . . . . 0 N--CA 1.512 2.66 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 175.899 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 . . . . . 0 N--CA 1.5 2.026 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.636 HG23 ' CE2' ' A' ' 147' ' ' PHE . 2.0 mp -68.84 -48.3 71.48 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.43 0 CA-C-O 116.762 -1.59 . . . . 0.0 109.92 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.5 pp -62.92 -38.43 90.95 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 121.559 1.981 . . . . 0.0 110.372 176.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -56.88 -58.0 10.06 Favored 'General case' 0 CA--C 1.574 1.883 0 CA-C-N 120.945 1.702 . . . . 0.0 109.429 174.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.85 -57.72 11.24 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 117.283 -1.342 . . . . 0.0 114.337 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.468 ' CE2' HD12 ' A' ' 105' ' ' ILE . 18.1 t80 -57.23 -46.42 82.98 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 119.905 1.23 . . . . 0.0 112.518 177.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -62.41 -35.3 78.81 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-O 116.037 -1.935 . . . . 0.0 112.363 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.2 t -66.6 -43.28 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 CA-C-N 122.451 2.387 . . . . 0.0 107.935 170.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -55.82 -41.24 73.93 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -66.07 114.17 5.02 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 174.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.29 50.83 0.66 Allowed 'General case' 0 N--CA 1.507 2.397 0 CA-C-O 123.304 1.526 . . . . 0.0 111.577 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . 0.296 10.1 t-20 84.9 -61.93 0.08 Allowed 'General case' 0 CA--C 1.57 1.716 0 C-N-CA 128.699 2.799 . . . . 0.0 103.968 -170.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 28.97 15.23 0.0 OUTLIER Glycine 0 C--N 1.357 1.699 1 N-CA-C 125.074 4.79 . . . . 0.0 125.074 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.2 p30 64.51 13.34 8.11 Favored 'General case' 0 CA--C 1.597 2.783 0 CA-C-N 121.74 2.77 . . . . 0.0 112.269 -169.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.85 -6.49 54.49 Favored Glycine 0 CA--C 1.559 2.84 0 CA-C-O 115.968 -2.573 . . . . 0.0 111.264 -171.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -101.86 144.44 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.709 0 CA-C-N 121.818 2.809 . . . . 0.0 113.985 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.468 HD12 ' CE2' ' A' ' 94' ' ' PHE . 57.3 mt -111.78 128.68 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-N 113.196 -1.82 . . . . 0.0 108.681 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -106.58 -176.72 3.16 Favored 'General case' 0 CA--C 1.572 1.822 0 CA-C-O 121.739 0.78 . . . . 0.0 112.102 176.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -70.69 -49.63 45.19 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.861 -1.15 . . . . 0.0 113.793 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -62.49 -42.91 99.82 Favored 'General case' 0 CA--C 1.578 2.052 0 CA-C-O 117.427 -1.273 . . . . 0.0 111.461 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -54.13 -44.81 71.68 Favored 'General case' 0 CA--C 1.573 1.842 0 CA-C-N 121.558 1.981 . . . . 0.0 112.332 173.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -69.38 -49.53 54.56 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -58.75 -15.86 14.08 Favored 'General case' 0 CA--C 1.58 2.1 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 173.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -93.33 -53.32 4.14 Favored 'General case' 0 CA--C 1.582 2.18 0 CA-C-N 120.129 1.331 . . . . 0.0 110.995 173.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.48 -23.12 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 120.13 3.382 . . . . 0.0 120.13 -175.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.502 2.142 0 C-N-CA 125.034 1.334 . . . . 0.0 112.078 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 10.4 p . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.96 -34.82 75.96 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 113.239 -1.8 . . . . 0.0 115.468 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.24 -39.79 76.29 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -59.85 -49.47 77.59 Favored 'General case' 0 CA--C 1.584 2.285 0 CA-C-O 122.261 1.029 . . . . 0.0 112.317 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.3 t -64.54 -50.44 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.793 0 C-N-CA 126.101 1.76 . . . . 0.0 111.184 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -58.3 -42.99 87.86 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 123.52 0.728 . . . . 0.0 112.674 176.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -61.41 -51.15 69.96 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.531 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.18 -45.32 93.53 Favored 'General case' 0 CA--C 1.561 1.393 0 N-CA-C 115.435 1.642 . . . . 0.0 115.435 177.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.6 ttt -71.44 -42.1 68.66 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 117.328 -1.32 . . . . 0.0 111.748 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.46 -43.85 84.35 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 120.907 1.685 . . . . 0.0 110.744 174.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.59 -30.11 68.79 Favored 'General case' 0 CA--C 1.581 2.146 0 CA-C-N 121.165 1.802 . . . . 0.0 113.043 174.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.37 -23.51 37.65 Favored 'General case' 0 CA--C 1.582 2.183 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.603 ' OD2' ' HA2' ' A' ' 140' ' ' GLY . 17.8 t0 -84.72 108.17 17.28 Favored 'General case' 0 CA--C 1.578 2.043 0 N-CA-C 104.079 -2.563 . . . . 0.0 104.079 171.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -76.09 -29.05 57.78 Favored 'General case' 0 CA--C 1.587 2.382 0 CA-C-N 120.556 1.525 . . . . 0.0 113.515 177.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.274 0.1 OUTLIER -166.02 -75.93 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.376 1 N-CA-C 99.075 -4.416 . . . . 0.0 99.075 177.127 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 34.15 30.13 0.01 OUTLIER Glycine 0 C--N 1.372 2.531 0 CA-C-N 123.309 2.777 . . . . 0.0 119.399 175.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.38 -3.21 0.68 Allowed 'General case' 0 CA--C 1.593 2.615 0 CA-C-N 119.629 1.715 . . . . 0.0 114.438 -172.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.603 ' HA2' ' OD2' ' A' ' 135' ' ' ASP . . . 106.41 -23.34 28.75 Favored Glycine 0 CA--C 1.559 2.817 0 CA-C-N 122.983 2.629 . . . . 0.0 113.78 -175.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . 0.257 27.8 m -118.6 133.43 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 103.542 -2.762 . . . . 0.0 103.542 178.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.03 126.93 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 117.492 2.404 . . . . 0.0 117.492 -172.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.4 p30 -90.76 156.2 18.23 Favored 'General case' 0 CA--C 1.564 1.502 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 172.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 5.5 mt -55.72 -49.31 93.56 Favored Pre-proline 0 CA--C 1.574 1.886 0 CA-C-O 114.482 -2.675 . . . . 0.0 114.191 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -52.26 -31.62 47.21 Favored 'Trans proline' 0 C--N 1.374 1.908 0 CA-C-N 125.434 2.977 . . . . 0.0 116.444 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -63.21 -61.06 2.62 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 121.142 1.792 . . . . 0.0 114.326 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.636 ' CE2' HG23 ' A' ' 90' ' ' ILE . 27.9 t80 -53.26 -50.78 64.12 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 120.179 1.354 . . . . 0.0 113.682 177.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . 0.255 0.1 OUTLIER -68.77 -47.23 66.74 Favored 'General case' 0 C--N 1.352 0.711 0 CA-C-O 113.924 -2.941 . . . . 0.0 111.18 179.229 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.28 -29.45 69.87 Favored 'General case' 0 CA--C 1.586 2.345 0 CA-C-N 125.585 3.812 . . . . 0.0 112.715 175.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . 0.291 5.3 tt -57.98 -40.95 81.94 Favored 'General case' 0 CA--C 1.575 1.922 0 C-N-CA 125.711 1.605 . . . . 0.0 109.799 172.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 55.7 mt -90.4 -64.73 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.604 3.034 0 CA-C-N 120.312 1.414 . . . . 0.0 109.941 173.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.591 2.556 0 N-CA-C 121.018 3.71 . . . . 0.0 121.018 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.571 1.753 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.654 HG21 ' HB3' ' A' ' 148' ' ' MET . 6.7 mt -69.22 -52.67 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.118 0 CA-C-O 116.153 -1.879 . . . . 0.0 110.986 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.2 pp -55.66 -43.66 76.5 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 121.555 1.98 . . . . 0.0 108.84 176.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -54.67 -49.31 70.93 Favored 'General case' 0 CA--C 1.571 1.782 0 CA-C-N 121.184 1.811 . . . . 0.0 112.69 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.95 -56.72 10.27 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-O 116.03 -1.938 . . . . 0.0 114.666 178.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.482 ' CE2' HD12 ' A' ' 105' ' ' ILE . 10.1 t80 -64.83 -42.3 95.05 Favored 'General case' 0 N--CA 1.509 2.479 0 CA-C-N 122.47 2.396 . . . . 0.0 112.734 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.285 6.1 mmpt? -62.56 -30.44 71.32 Favored 'General case' 0 CA--C 1.577 1.995 0 CA-C-O 117.625 -1.178 . . . . 0.0 110.869 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.8 t -71.69 -50.16 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-N 120.451 1.478 . . . . 0.0 108.324 169.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -58.0 -37.91 75.14 Favored 'General case' 0 CA--C 1.579 2.063 0 N-CA-C 116.728 2.121 . . . . 0.0 116.728 -177.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.297 6.5 t0 -59.33 90.6 0.02 OUTLIER 'General case' 0 CA--C 1.571 1.761 0 C-N-CA 128.495 2.718 . . . . 0.0 109.967 176.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.07 -49.06 66.33 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.534 -0.729 . . . . 0.0 112.106 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -48.68 -24.86 1.52 Allowed 'General case' 0 CA--C 1.585 2.298 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 175.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.59 8.59 86.76 Favored Glycine 0 CA--C 1.56 2.884 0 CA-C-N 122.04 2.2 . . . . 0.0 116.953 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.06 86.61 2.22 Favored 'General case' 0 N--CA 1.473 0.723 1 CA-C-O 110.533 -4.556 . . . . 0.0 107.039 176.596 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 54.72 -25.11 0.01 OUTLIER Glycine 0 N--CA 1.489 2.214 2 N-CA-C 130.798 7.079 . . . . 0.0 130.798 162.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.7 p -114.39 151.95 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.811 0 CA-C-O 122.726 1.25 . . . . 0.0 112.887 -178.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.482 HD12 ' CE2' ' A' ' 94' ' ' PHE . 63.4 mt -129.34 136.25 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 CA-C-N 113.55 -1.659 . . . . 0.0 111.317 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -115.75 -177.8 3.24 Favored 'General case' 0 CA--C 1.589 2.471 0 C-N-CA 124.087 0.955 . . . . 0.0 110.062 174.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -74.21 -47.25 36.66 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 -176.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -61.65 -42.78 99.37 Favored 'General case' 0 N--CA 1.514 2.729 0 CA-C-N 122.256 2.298 . . . . 0.0 113.539 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -56.03 -39.89 72.63 Favored 'General case' 0 N--CA 1.504 2.243 0 CA-C-N 119.325 0.966 . . . . 0.0 111.678 173.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -63.38 -46.57 85.85 Favored 'General case' 0 CA--C 1.571 1.787 0 C-N-CA 124.914 1.286 . . . . 0.0 109.36 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -53.5 -50.86 64.5 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 123.89 0.876 . . . . 0.0 111.668 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -57.77 -53.83 53.78 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 176.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.5 tt -74.0 -29.3 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 119.366 3.099 . . . . 0.0 119.366 -176.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.443 ' SD ' ' HA ' ' A' ' 127' ' ' VAL . 6.3 tpt . . . . . 0 N--CA 1.498 1.957 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.418 ' OG1' ' HG2' ' A' ' 126' ' ' GLU . 1.4 p . . . . . 0 CA--C 1.557 1.239 0 N-CA-C 102.273 -3.232 . . . . 0.0 102.273 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -67.6 -34.75 77.64 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 115.925 1.824 . . . . 0.0 115.925 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.75 -38.7 75.81 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-O 116.74 -1.6 . . . . 0.0 113.279 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.418 ' HG2' ' OG1' ' A' ' 123' ' ' THR . 9.2 pt-20 -68.29 -39.46 82.08 Favored 'General case' 0 CA--C 1.572 1.812 0 CA-C-N 121.442 1.928 . . . . 0.0 112.456 176.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.443 ' HA ' ' SD ' ' A' ' 114' ' ' MET . 0.4 OUTLIER -70.39 -48.56 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 119.216 0.916 . . . . 0.0 112.32 177.766 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -66.59 -49.4 66.46 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 116.77 -1.586 . . . . 0.0 109.504 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -55.98 -47.96 76.71 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 122.256 2.298 . . . . 0.0 113.526 176.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.78 -46.2 89.12 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-O 117.644 -1.169 . . . . 0.0 113.85 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 14.8 ttt -77.21 -37.21 53.9 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 116.478 -1.725 . . . . 0.0 110.658 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -32.9 69.83 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 123.927 3.058 . . . . 0.0 109.977 172.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -73.3 -44.22 59.5 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-O 116.309 -1.805 . . . . 0.0 110.477 176.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -80.73 -35.38 33.53 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 117.611 2.448 . . . . 0.0 117.611 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -90.3 119.81 30.92 Favored 'General case' 0 N--CA 1.514 2.771 1 O-C-N 116.099 -4.126 . . . . 0.0 106.069 176.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -75.27 -32.9 61.18 Favored 'General case' 0 CA--C 1.58 2.109 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 177.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.301 0.1 OUTLIER 175.75 -73.49 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.368 1 N-CA-C 96.516 -5.364 . . . . 0.0 96.516 178.771 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 34.92 32.16 0.02 OUTLIER Glycine 0 C--N 1.373 2.616 0 CA-C-N 123.681 2.946 . . . . 0.0 118.696 174.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 55.0 17.79 2.0 Favored 'General case' 0 CA--C 1.592 2.59 0 CA-C-O 115.739 -2.077 . . . . 0.0 115.18 -173.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 92.81 -22.36 34.29 Favored Glycine 0 C--N 1.38 3.009 0 CA-C-N 124.486 3.312 . . . . 0.0 114.979 -176.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.27 146.68 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 176.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.7 mt -123.1 131.42 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 112.594 -2.094 . . . . 0.0 110.375 -177.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 42.3 p30 -97.88 158.64 15.41 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 105.199 -2.149 . . . . 0.0 105.199 171.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -56.33 -44.57 99.78 Favored Pre-proline 0 CA--C 1.587 2.385 0 CA-C-O 114.971 -2.442 . . . . 0.0 112.833 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.18 -36.15 35.75 Favored 'Trans proline' 0 C--N 1.382 2.342 0 C-N-CA 124.294 3.329 . . . . 0.0 117.107 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -65.61 -56.17 13.67 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 121.623 2.01 . . . . 0.0 110.835 175.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.451 ' CE2' ' HB2' ' A' ' 94' ' ' PHE . 21.4 t80 -55.38 -50.14 70.49 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.654 ' HB3' HG21 ' A' ' 90' ' ' ILE 0.257 4.0 ptp -66.34 -41.73 89.16 Favored 'General case' 0 CA--C 1.577 2.019 0 CA-C-O 117.478 -1.249 . . . . 0.0 111.316 178.204 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -60.2 -35.07 74.57 Favored 'General case' 0 N--CA 1.508 2.46 0 CA-C-N 121.018 1.736 . . . . 0.0 114.258 173.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . 0.356 6.8 tt -69.15 -34.73 75.44 Favored 'General case' 0 CA--C 1.567 1.627 0 C-N-CA 127.838 2.455 . . . . 0.0 110.302 176.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 79.2 mt -69.52 -48.79 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 CA-C-N 121.051 1.751 . . . . 0.0 106.879 171.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.581 2.135 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 . . . . . 0 CA--C 1.581 2.145 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.455 ' H ' HD12 ' A' ' 90' ' ' ILE . 0.7 OUTLIER -78.12 -52.71 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -178.341 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -63.51 -50.32 70.08 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 115.754 -2.069 . . . . 0.0 111.258 -177.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.97 -28.89 63.73 Favored 'General case' 0 CA--C 1.571 1.775 0 CA-C-O 114.374 -2.727 . . . . 0.0 111.243 176.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.98 -53.2 53.92 Favored 'General case' 0 C--N 1.38 1.925 0 CA-C-N 124.5 3.318 . . . . 0.0 111.378 174.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.472 ' CE2' HD12 ' A' ' 105' ' ' ILE . 21.1 t80 -62.03 -42.9 99.67 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 119.81 1.186 . . . . 0.0 112.821 176.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.492 ' HE2' HD13 ' A' ' 144' ' ' ILE . 58.1 mttt -63.68 -34.51 78.01 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 116.589 -1.672 . . . . 0.0 111.9 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -70.34 -44.84 77.14 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.197 0 CA-C-N 121.711 2.05 . . . . 0.0 108.557 171.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -56.34 -31.94 64.22 Favored 'General case' 0 CA--C 1.576 1.967 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -60.33 118.97 7.07 Favored 'General case' 0 CA--C 1.575 1.927 0 C-N-CA 125.812 1.645 . . . . 0.0 111.951 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.483 ' CB ' ' HG2' ' A' ' 109' ' ' GLU . . . -77.33 -52.51 9.04 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 -178.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.9 p30 -72.74 -8.67 56.52 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 117.88 2.548 . . . . 0.0 117.88 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.2 8.92 87.16 Favored Glycine 0 CA--C 1.555 2.539 0 N-CA-C 119.523 2.569 . . . . 0.0 119.523 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.6 p30 -114.4 -12.56 12.35 Favored 'General case' 0 CA--C 1.575 1.928 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 177.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.34 22.21 5.92 Favored Glycine 0 CA--C 1.548 2.132 0 CA-C-O 116.325 -2.375 . . . . 0.0 115.985 -178.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.3 t -132.61 138.74 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-N 121.366 2.583 . . . . 0.0 109.734 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.472 HD12 ' CE2' ' A' ' 94' ' ' PHE . 44.0 mt -119.76 136.71 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 126.059 1.744 . . . . 0.0 110.746 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -99.13 -175.08 2.92 Favored 'General case' 0 CA--C 1.576 1.969 0 C-N-CA 124.083 0.953 . . . . 0.0 112.678 176.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -82.23 -51.66 7.72 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 119.961 -1.712 . . . . 0.0 113.833 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -62.28 -46.33 89.27 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 119.681 1.128 . . . . 0.0 112.59 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.483 ' HG2' ' CB ' ' A' ' 99' ' ' ALA . 37.1 tp10 -63.81 -35.49 80.77 Favored 'General case' 0 CA--C 1.57 1.723 0 CA-C-N 119.68 1.127 . . . . 0.0 113.064 176.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -61.07 -48.85 79.82 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 119.845 1.202 . . . . 0.0 107.815 171.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 56.6 tttt -64.64 -9.27 18.41 Favored 'General case' 0 CA--C 1.581 2.164 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 174.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -94.37 -50.05 5.42 Favored 'General case' 0 CA--C 1.593 2.601 0 C-N-CA 125.336 1.454 . . . . 0.0 111.017 171.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.6 tt -80.21 -28.31 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 120.889 3.663 . . . . 0.0 120.889 -175.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 1.1 tpt . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 -178.883 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 30.6 p . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 122.952 1.358 . . . . 0.0 107.47 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -59.16 -37.99 78.67 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 112.223 -2.262 . . . . 0.0 115.369 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.27 -39.37 90.12 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-O 117.243 -1.36 . . . . 0.0 114.305 177.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -61.28 -52.89 62.84 Favored 'General case' 0 CA--C 1.577 1.982 0 CA-C-N 120.967 1.712 . . . . 0.0 112.631 177.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.6 t -69.43 -49.92 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 CA-C-O 117.529 -1.224 . . . . 0.0 112.255 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.19 -44.18 97.17 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 116.688 -1.625 . . . . 0.0 110.486 177.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -59.3 -52.04 67.35 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 122.488 2.404 . . . . 0.0 112.199 176.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.62 -44.56 95.98 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.521 ' SD ' HD11 ' A' ' 142' ' ' ILE . 18.4 tpt -73.56 -37.44 65.53 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 115.94 -1.981 . . . . 0.0 111.992 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -60.15 -49.12 78.89 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 122.92 2.6 . . . . 0.0 110.788 174.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -69.67 -26.94 64.62 Favored 'General case' 0 CA--C 1.575 1.936 0 CA-C-O 118.048 -0.977 . . . . 0.0 112.761 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.15 -21.34 27.62 Favored 'General case' 0 CA--C 1.58 2.108 0 CA-C-N 119.996 1.271 . . . . 0.0 114.347 175.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -88.46 109.28 19.9 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 122.757 2.526 . . . . 0.0 105.234 171.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -77.31 -25.17 50.98 Favored 'General case' 0 CA--C 1.576 1.958 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -86.61 -16.31 37.1 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 118.206 2.669 . . . . 0.0 118.206 -176.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.61 5.23 90.06 Favored Glycine 0 CA--C 1.565 3.173 0 CA-C-N 119.936 1.244 . . . . 0.0 115.367 -174.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -86.82 -29.82 21.96 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-N 119.167 1.483 . . . . 0.0 114.885 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 104.93 23.35 7.82 Favored Glycine 0 CA--C 1.554 2.497 0 CA-C-N 120.581 1.537 . . . . 0.0 116.607 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.88 152.69 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 123.543 1.64 . . . . 0.0 107.858 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.521 HD11 ' SD ' ' A' ' 131' ' ' MET . 0.8 OUTLIER -136.82 130.78 46.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 112.535 -2.121 . . . . 0.0 112.06 -177.504 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 34.1 p30 -97.67 162.27 13.36 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 104.72 -2.326 . . . . 0.0 104.72 170.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.492 HD13 ' HE2' ' A' ' 95' ' ' LYS . 4.4 mt -56.22 -49.25 94.33 Favored Pre-proline 0 CA--C 1.582 2.194 0 CA-C-O 113.413 -3.184 . . . . 0.0 110.905 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -47.73 -31.63 15.09 Favored 'Trans proline' 0 C--N 1.377 2.035 0 CA-C-N 127.011 3.54 . . . . 0.0 120.555 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -71.62 -66.34 0.64 Allowed 'General case' 0 N--CA 1.506 2.331 0 CA-C-N 122.663 2.483 . . . . 0.0 110.053 177.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -51.04 -41.76 60.05 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 124.596 1.158 . . . . 0.0 112.884 173.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.4 ' HA ' HG21 ' A' ' 90' ' ' ILE 0.268 0.0 OUTLIER -70.65 -45.21 65.55 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-O 113.658 -3.068 . . . . 0.0 110.808 -179.538 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.78 -44.25 90.63 Favored 'General case' 0 CA--C 1.583 2.232 0 CA-C-N 124.051 3.114 . . . . 0.0 111.776 175.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 7.9 tt -50.98 -47.59 61.4 Favored 'General case' 0 C--N 1.365 1.279 0 C-N-CA 126.216 1.807 . . . . 0.0 112.701 176.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 45.8 mt -90.24 -33.06 5.72 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.212 0 CA-C-N 121.099 1.772 . . . . 0.0 110.992 176.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt . . . . . 0 N--CA 1.503 2.193 0 CA-C-N 120.836 1.653 . . . . 0.0 114.599 176.343 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 . . . . . 0 CA--C 1.564 1.486 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.592 HG23 ' CE2' ' A' ' 147' ' ' PHE . 3.6 mp -74.68 -58.37 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 CA-C-N 122.274 2.306 . . . . 0.0 109.334 177.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . 0.254 0.3 OUTLIER -62.92 -42.01 99.66 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 121.843 2.11 . . . . 0.0 110.038 179.167 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -60.88 -52.73 63.81 Favored 'General case' 0 CA--C 1.572 1.815 0 CA-C-N 121.921 2.146 . . . . 0.0 110.772 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.31 -54.94 16.21 Favored 'General case' 0 C--N 1.363 1.166 0 CA-C-O 116.009 -1.948 . . . . 0.0 115.49 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.499 ' CE2' HD12 ' A' ' 105' ' ' ILE . 9.8 t80 -63.32 -50.79 68.65 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 121.74 2.064 . . . . 0.0 112.28 178.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.332 78.5 mttt -64.52 -22.78 67.06 Favored 'General case' 0 CA--C 1.591 2.536 0 CA-C-O 117.372 -1.299 . . . . 0.0 111.199 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -73.14 -49.85 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 CA-C-N 121.266 1.848 . . . . 0.0 108.233 168.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -50.13 -37.62 35.13 Favored 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -61.2 115.72 4.02 Favored 'General case' 0 CA--C 1.578 2.024 0 C-N-CA 125.558 1.543 . . . . 0.0 112.722 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -77.65 -51.62 10.32 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.4 p30 -68.92 -13.19 62.28 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 117.777 2.51 . . . . 0.0 117.777 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.5 7.51 88.47 Favored Glycine 0 CA--C 1.553 2.422 0 N-CA-C 119.559 2.584 . . . . 0.0 119.559 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.1 p30 -104.33 -15.13 15.53 Favored 'General case' 0 CA--C 1.576 1.977 0 CA-C-N 119.535 1.667 . . . . 0.0 114.773 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.59 20.83 6.73 Favored Glycine 0 CA--C 1.545 1.941 0 CA-C-O 116.201 -2.444 . . . . 0.0 116.415 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -131.8 137.04 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 121.654 2.727 . . . . 0.0 110.856 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.499 HD12 ' CE2' ' A' ' 94' ' ' PHE . 58.8 mt -109.35 139.74 31.01 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 CA-C-N 112.058 -2.337 . . . . 0.0 108.36 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -118.83 -173.7 2.54 Favored 'General case' 0 CA--C 1.574 1.881 0 C-N-CA 124.242 1.017 . . . . 0.0 111.215 176.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -72.27 -53.42 12.54 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.657 -1.277 . . . . 0.0 113.877 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -56.61 -47.26 80.01 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 118.278 0.49 . . . . 0.0 112.305 177.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.26 -50.49 67.12 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 174.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.96 -51.77 66.76 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 124.621 1.168 . . . . 0.0 110.419 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.24 -8.95 50.61 Favored 'General case' 0 CA--C 1.577 1.991 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 176.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -92.08 -40.57 10.98 Favored 'General case' 0 CA--C 1.584 2.27 0 C-N-CA 124.902 1.281 . . . . 0.0 110.711 172.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.6 tt -91.41 -36.33 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 121.317 3.821 . . . . 0.0 121.317 -174.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 7.1 tpt . . . . . 0 N--CA 1.499 1.986 0 N-CA-C 117.525 2.416 . . . . 0.0 117.525 -176.114 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 16.8 p . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 122.401 1.096 . . . . 0.0 108.507 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -59.67 -38.02 80.35 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 116.963 2.209 . . . . 0.0 116.963 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.0 -45.37 79.07 Favored 'General case' 0 CA--C 1.554 1.12 0 O-C-N 124.493 1.121 . . . . 0.0 113.612 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -57.88 -50.79 72.14 Favored 'General case' 0 CA--C 1.579 2.068 0 CA-C-O 122.287 1.041 . . . . 0.0 112.517 176.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.9 t -67.51 -41.49 85.99 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.612 0 CA-C-N 114.003 -1.453 . . . . 0.0 112.162 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -63.66 -46.46 85.52 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 120.415 1.462 . . . . 0.0 109.91 175.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -57.54 -51.1 70.86 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 120.753 1.615 . . . . 0.0 112.199 175.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.4 -46.68 88.0 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.5 ttt -69.05 -39.24 79.27 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.806 177.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.87 -41.43 95.96 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 121.423 1.92 . . . . 0.0 109.827 174.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -64.64 -32.76 74.56 Favored 'General case' 0 CA--C 1.584 2.288 0 CA-C-N 121.017 1.735 . . . . 0.0 112.146 173.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.61 -26.72 34.64 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -78.97 109.43 13.25 Favored 'General case' 0 N--CA 1.516 2.861 0 CA-C-N 123.188 2.722 . . . . 0.0 109.98 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -86.58 -19.74 28.95 Favored 'General case' 0 CA--C 1.58 2.129 0 N-CA-C 117.142 2.275 . . . . 0.0 117.142 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -85.01 -14.42 47.46 Favored 'General case' 0 N--CA 1.507 2.409 1 N-CA-C 122.641 4.312 . . . . 0.0 122.641 -171.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.68 6.34 85.63 Favored Glycine 0 CA--C 1.57 3.507 0 CA-C-N 121.032 1.742 . . . . 0.0 114.958 -172.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -88.11 -51.41 5.81 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.187 1.395 . . . . 0.0 110.478 175.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 110.76 -20.18 24.91 Favored Glycine 0 CA--C 1.543 1.799 0 CA-C-O 115.695 -2.725 . . . . 0.0 115.894 -177.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . 0.259 13.0 m -126.64 124.06 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 101.152 -3.647 . . . . 0.0 101.152 176.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.436 HG21 HD13 ' A' ' 142' ' ' ILE . 0.5 OUTLIER -77.77 124.72 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 -172.344 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -93.05 160.21 14.96 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 171.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.6 mt -57.32 -42.82 97.95 Favored Pre-proline 0 CA--C 1.579 2.081 0 CA-C-O 114.859 -2.496 . . . . 0.0 113.352 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.51 -38.45 74.82 Favored 'Trans proline' 0 C--N 1.376 1.99 0 CA-C-N 125.202 2.894 . . . . 0.0 116.703 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -68.17 -38.44 82.06 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 122.215 2.28 . . . . 0.0 113.947 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.592 ' CE2' HG23 ' A' ' 90' ' ' ILE . 69.4 t80 -64.9 -47.12 78.93 Favored 'General case' 0 CA--C 1.578 2.044 0 CA-C-N 121.411 1.914 . . . . 0.0 110.659 172.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.574 ' HG2' HG21 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -59.22 -44.07 92.31 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-N 118.45 0.568 . . . . 0.0 111.964 176.141 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -65.11 -44.95 87.07 Favored 'General case' 0 CA--C 1.568 1.672 0 C-N-CA 124.356 1.062 . . . . 0.0 109.85 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.28 -45.27 65.4 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.781 1.232 . . . . 0.0 111.915 174.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 97.0 mt -77.86 -50.57 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-O 116.862 -1.542 . . . . 0.0 114.187 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 84.3 mttt . . . . . 0 CA--C 1.565 1.542 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -176.615 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 . . . . . 0 CA--C 1.62 3.657 0 CA-C-O 127.938 3.732 . . . . 0.0 111.461 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.654 HG23 ' CE2' ' A' ' 147' ' ' PHE . 13.9 mm -70.71 -43.98 76.88 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.642 0 CA-C-N 109.066 -3.697 . . . . 0.0 109.167 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -58.35 -43.53 88.39 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 121.826 2.103 . . . . 0.0 109.476 175.756 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.436 ' O ' ' HB ' ' A' ' 96' ' ' VAL . 9.2 mmt-85 -55.25 -51.37 66.85 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 122.326 2.33 . . . . 0.0 107.536 175.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.83 -65.06 0.72 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 117.604 2.446 . . . . 0.0 117.604 177.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.589 ' HB2' ' CD2' ' A' ' 147' ' ' PHE . 18.3 t80 -67.36 -48.76 66.5 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 91' ' ' LEU 0.369 1.4 mmmp? -69.08 -19.2 64.07 Favored 'General case' 0 CA--C 1.589 2.443 0 CA-C-O 115.07 -2.395 . . . . 0.0 109.229 -179.328 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.436 ' HB ' ' O ' ' A' ' 92' ' ' ARG . 0.8 OUTLIER -73.57 -45.99 49.62 Favored 'Isoleucine or valine' 0 C--N 1.394 2.532 0 CA-C-N 124.388 3.267 . . . . 0.0 105.597 166.726 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -52.73 -35.66 56.37 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 176.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.4 105.68 0.79 Allowed 'General case' 0 CA--C 1.577 2.005 0 C-N-CA 125.106 1.362 . . . . 0.0 109.432 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.07 -44.43 97.39 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 115.764 1.765 . . . . 0.0 115.764 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -69.62 -19.31 63.64 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 117.647 2.462 . . . . 0.0 117.647 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.62 21.35 64.22 Favored Glycine 0 CA--C 1.558 2.755 0 N-CA-C 118.14 2.016 . . . . 0.0 118.14 -177.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.58 -28.1 7.27 Favored 'General case' 0 CA--C 1.578 2.026 0 CA-C-N 119.388 1.594 . . . . 0.0 114.402 177.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 121.33 21.3 3.1 Favored Glycine 0 CA--C 1.548 2.11 0 CA-C-O 116.943 -2.031 . . . . 0.0 117.232 -175.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 p -124.69 150.61 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.668 0 CA-C-N 120.581 2.191 . . . . 0.0 109.379 173.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.5 HD12 ' CE2' ' A' ' 94' ' ' PHE . 96.3 mt -122.02 132.92 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-N 114.249 -1.341 . . . . 0.0 109.061 178.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.498 ' H ' ' HG2' ' A' ' 109' ' ' GLU . 0.5 OUTLIER -109.75 179.12 4.21 Favored 'General case' 0 CA--C 1.582 2.173 0 CA-C-O 121.983 0.897 . . . . 0.0 111.749 175.196 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.29 -47.59 23.16 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.645 -1.284 . . . . 0.0 114.33 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -61.75 -38.72 89.0 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 117.706 -1.14 . . . . 0.0 110.443 175.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.498 ' HG2' ' H ' ' A' ' 106' ' ' ASP . 5.4 pt-20 -65.01 -36.4 84.27 Favored 'General case' 0 CA--C 1.576 1.945 0 CA-C-N 121.022 1.737 . . . . 0.0 111.346 173.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -62.94 -48.48 78.71 Favored 'General case' 0 C--N 1.376 1.759 0 CA-C-N 120.99 1.723 . . . . 0.0 109.433 175.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 35.0 mttp -54.99 -52.12 64.09 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 123.9 0.88 . . . . 0.0 111.656 174.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -52.43 -47.95 66.05 Favored 'General case' 0 CA--C 1.571 1.763 0 C-N-CA 124.332 1.053 . . . . 0.0 113.518 175.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -81.47 -14.17 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 12.8 tpt . . . . . 0 N--CA 1.493 1.688 0 C-N-CA 125.575 1.55 . . . . 0.0 109.536 176.13 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 38.0 p . . . . . 0 N--CA 1.486 1.332 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.77 -37.14 85.51 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.52 -35.89 61.18 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -62.06 -55.67 26.74 Favored 'General case' 0 CA--C 1.587 2.393 0 CA-C-N 120.458 1.481 . . . . 0.0 111.659 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.1 t -63.47 -47.35 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 124.846 1.259 . . . . 0.0 111.216 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -57.77 -48.59 79.23 Favored 'General case' 0 CA--C 1.559 1.319 0 CA-C-O 118.101 -0.952 . . . . 0.0 111.887 176.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -58.53 -48.13 81.9 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 120.211 1.369 . . . . 0.0 112.489 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.96 -51.61 68.92 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -68.49 -34.42 75.89 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 115.263 -2.303 . . . . 0.0 112.113 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -65.26 -39.45 92.64 Favored 'General case' 0 CA--C 1.57 1.747 0 CA-C-N 122.739 2.518 . . . . 0.0 110.243 173.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -59.41 -40.74 87.62 Favored 'General case' 0 CA--C 1.574 1.874 0 CA-C-N 122.085 2.22 . . . . 0.0 110.559 173.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -78.38 -25.34 46.21 Favored 'General case' 0 CA--C 1.577 1.993 0 N-CA-C 116.872 2.175 . . . . 0.0 116.872 175.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -89.43 115.43 26.87 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 118.938 -2.351 . . . . 0.0 107.191 175.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -76.48 -27.73 56.22 Favored 'General case' 0 CA--C 1.566 1.567 0 N-CA-C 117.779 2.511 . . . . 0.0 117.779 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -105.88 -12.54 15.81 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 119.293 3.071 . . . . 0.0 119.293 -174.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.65 4.69 90.22 Favored Glycine 0 CA--C 1.572 3.627 0 CA-C-N 120.129 1.331 . . . . 0.0 113.623 -172.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -71.73 -45.94 60.15 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 125.282 1.433 . . . . 0.0 110.661 175.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 110.83 -4.88 29.1 Favored Glycine 0 CA--C 1.541 1.661 0 CA-C-O 115.075 -3.069 . . . . 0.0 117.598 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . 0.336 0.9 OUTLIER -136.91 118.85 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-N 123.093 3.446 . . . . 0.0 104.362 175.507 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.9 mt -85.21 130.88 35.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 109.385 -3.552 . . . . 0.0 111.835 -175.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 41.4 p30 -94.22 155.1 17.21 Favored 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 171.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -53.55 -44.98 98.76 Favored Pre-proline 0 CA--C 1.586 2.364 0 CA-C-O 114.427 -2.702 . . . . 0.0 113.468 -178.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -46.08 -37.82 18.31 Favored 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 124.634 3.556 . . . . 0.0 117.211 177.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -61.37 -55.29 33.23 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 119.364 0.983 . . . . 0.0 112.029 175.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.654 ' CE2' HG23 ' A' ' 90' ' ' ILE . 66.7 t80 -57.61 -45.38 85.43 Favored 'General case' 0 CA--C 1.577 1.996 0 C-N-CA 125.805 1.642 . . . . 0.0 112.721 175.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.9 -36.25 82.73 Favored 'General case' 0 CA--C 1.586 2.337 0 CA-C-O 117.865 -1.064 . . . . 0.0 110.142 177.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -70.71 -40.33 72.9 Favored 'General case' 0 CA--C 1.583 2.216 0 CA-C-N 120.58 1.537 . . . . 0.0 110.797 172.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -50.66 -45.41 57.98 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 126.037 1.735 . . . . 0.0 109.254 173.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 62.2 mt -83.14 -63.05 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.484 0 CA-C-N 119.847 1.203 . . . . 0.0 112.18 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt . . . . . 0 N--CA 1.493 1.707 0 N-CA-C 117.62 2.452 . . . . 0.0 117.62 -177.12 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 . . . . . 0 N--CA 1.501 2.086 0 N-CA-C 115.378 1.621 . . . . 0.0 115.378 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.777 ' H ' HD12 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -70.82 -54.43 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-O 117.168 -1.396 . . . . 0.0 113.331 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . 0.279 0.0 OUTLIER -61.3 -40.05 92.71 Favored 'General case' 0 CA--C 1.568 1.663 0 CA-C-N 120.117 1.326 . . . . 0.0 110.315 -178.607 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.05 -57.93 9.74 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-N 120.767 1.621 . . . . 0.0 110.786 175.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.66 -57.41 8.16 Favored 'General case' 0 C--N 1.364 1.21 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -64.01 -47.69 79.28 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 117.141 -1.409 . . . . 0.0 113.091 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.293 31.1 mttm -66.3 -24.32 66.52 Favored 'General case' 0 CA--C 1.582 2.18 0 CA-C-O 117.008 -1.472 . . . . 0.0 110.601 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.6 t -68.88 -50.01 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-N 121.719 2.054 . . . . 0.0 108.167 168.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.54 -37.8 73.66 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 116.739 2.126 . . . . 0.0 116.739 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 1.245 ' OD2' ' HA ' ' A' ' 102' ' ' ASP . 12.1 t0 -62.46 111.21 1.94 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 126.103 1.761 . . . . 0.0 112.461 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.42 -28.2 41.74 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -76.23 8.98 2.84 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.0 7.0 84.38 Favored Glycine 0 CA--C 1.564 3.115 0 N-CA-C 120.03 2.772 . . . . 0.0 120.03 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 1.245 ' HA ' ' OD2' ' A' ' 98' ' ' ASP 0.79 0.2 OUTLIER 116.75 126.04 0.0 OUTLIER 'General case' 0 CA--C 1.584 2.273 0 C-N-CA 130.27 3.428 . . . . 0.0 118.025 171.092 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 114.81 12.25 10.44 Favored Glycine 0 N--CA 1.441 -1.032 2 C-N-CA 134.471 5.796 . . . . 0.0 115.291 176.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.743 ' O ' ' OD1' ' A' ' 98' ' ' ASP . 0.5 OUTLIER -170.53 156.4 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.571 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 179.225 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 78.5 mt -133.03 130.3 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 127.013 2.125 . . . . 0.0 107.77 175.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -108.72 171.47 7.41 Favored 'General case' 0 CA--C 1.595 2.696 0 C-N-CA 123.806 0.843 . . . . 0.0 110.532 175.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.414 ' HA ' ' SD ' ' A' ' 131' ' ' MET . 27.0 t80 -64.07 -60.41 3.27 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 117.787 2.514 . . . . 0.0 117.787 -176.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -59.84 -27.33 66.54 Favored 'General case' 0 N--CA 1.508 2.425 0 CA-C-N 119.823 1.192 . . . . 0.0 112.713 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -63.55 -42.17 98.4 Favored 'General case' 0 CA--C 1.578 2.023 0 CA-C-N 119.462 1.028 . . . . 0.0 110.455 172.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -62.41 -53.0 61.34 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 125.555 1.542 . . . . 0.0 109.65 174.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -51.23 -44.53 61.71 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 175.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -66.55 -53.83 30.34 Favored 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 125.515 1.526 . . . . 0.0 112.686 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -67.75 -21.87 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 -178.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.505 2.291 0 CA-C-N 119.283 0.947 . . . . 0.0 111.099 172.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.4 p . . . . . 0 CA--C 1.566 1.593 0 N-CA-C 102.351 -3.203 . . . . 0.0 102.351 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -54.74 -33.96 61.86 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.444 -1.41 . . . . 0.0 114.792 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.21 -46.05 88.84 Favored 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 124.259 1.024 . . . . 0.0 112.63 175.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -64.21 -40.0 95.15 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 119.682 1.128 . . . . 0.0 112.252 176.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.9 p -67.52 -37.62 79.14 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.908 0 CA-C-N 119.85 1.204 . . . . 0.0 110.648 176.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -66.02 -45.04 82.93 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 119.661 1.119 . . . . 0.0 111.771 175.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -66.63 -41.17 88.74 Favored 'General case' 0 CA--C 1.574 1.884 0 O-C-N 120.894 -1.129 . . . . 0.0 113.249 176.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.93 -48.28 79.61 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.686 176.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.414 ' SD ' ' HA ' ' A' ' 107' ' ' PHE . 21.2 ttt -67.42 -36.2 80.78 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 115.415 -2.231 . . . . 0.0 110.792 175.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.18 -36.7 84.48 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 123.358 2.799 . . . . 0.0 111.868 175.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -62.37 -44.61 96.05 Favored 'General case' 0 CA--C 1.583 2.217 0 CA-C-N 119.531 1.06 . . . . 0.0 109.883 172.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -72.99 -26.73 61.44 Favored 'General case' 0 CA--C 1.583 2.233 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 176.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -80.36 111.71 17.01 Favored 'General case' 0 CA--C 1.56 1.36 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 175.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -72.68 -20.71 61.19 Favored 'General case' 0 CA--C 1.579 2.059 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -91.19 -17.22 26.42 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 117.68 2.474 . . . . 0.0 117.68 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.07 5.45 89.69 Favored Glycine 0 CA--C 1.563 3.085 0 CA-C-N 120.17 1.35 . . . . 0.0 115.905 -175.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 53.5 p-10 -87.54 -32.54 19.33 Favored 'General case' 0 CA--C 1.568 1.666 0 CA-C-N 119.408 1.604 . . . . 0.0 115.101 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 107.92 20.11 8.63 Favored Glycine 0 CA--C 1.559 2.797 0 N-CA-C 116.926 1.53 . . . . 0.0 116.926 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.19 152.63 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 142' ' ' ILE . 1.4 mt -137.5 131.33 44.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 112.164 -2.289 . . . . 0.0 111.743 -178.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 51.3 p30 -96.39 163.74 12.93 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 171.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 3.3 mt -56.76 -45.76 99.91 Favored Pre-proline 0 CA--C 1.582 2.203 0 CA-C-O 114.225 -2.798 . . . . 0.0 112.181 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -48.45 -38.01 34.26 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 124.216 3.277 . . . . 0.0 117.474 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -67.57 -52.27 40.7 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 120.751 1.614 . . . . 0.0 111.632 177.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.643 ' CE1' HG23 ' A' ' 90' ' ' ILE . 6.9 t80 -58.23 -48.17 81.21 Favored 'General case' 0 CA--C 1.569 1.7 0 CA-C-N 120.589 1.54 . . . . 0.0 112.577 176.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.666 ' HB3' HG21 ' A' ' 90' ' ' ILE . 2.0 ptp -64.19 -39.79 94.73 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-O 116.984 -1.484 . . . . 0.0 113.523 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -68.8 -33.95 74.72 Favored 'General case' 0 CA--C 1.585 2.305 0 CA-C-N 121.053 1.751 . . . . 0.0 109.312 172.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.02 -46.39 71.8 Favored 'General case' 0 CA--C 1.576 1.975 0 CA-C-N 120.15 1.341 . . . . 0.0 111.368 174.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 82.6 mt -80.52 -62.46 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.58 2.125 0 C-N-CA 123.472 0.709 . . . . 0.0 111.725 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.777 ' HE2' HD11 ' A' ' 90' ' ' ILE . 22.9 mttm . . . . . 0 CA--C 1.583 2.242 0 N-CA-C 118.952 2.945 . . . . 0.0 118.952 -177.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 . . . . . 0 CA--C 1.569 1.7 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.573 HG23 ' CE2' ' A' ' 147' ' ' PHE . 0.1 OUTLIER -67.97 -58.7 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-N 119.855 1.207 . . . . 0.0 109.129 177.597 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.5 pp -59.39 -49.02 79.4 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 117.904 -1.046 . . . . 0.0 112.087 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -64.83 -45.07 87.73 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-N 120.327 1.421 . . . . 0.0 112.902 178.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.36 -54.85 16.92 Favored 'General case' 0 C--N 1.365 1.265 0 CA-C-O 115.355 -2.26 . . . . 0.0 112.172 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.534 ' CE2' HD12 ' A' ' 105' ' ' ILE . 6.9 t80 -60.74 -47.2 87.36 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 121.707 2.049 . . . . 0.0 112.719 177.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.25 91.3 mttt -62.13 -31.38 71.85 Favored 'General case' 0 CA--C 1.58 2.132 0 CA-C-O 117.276 -1.345 . . . . 0.0 111.909 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.4 t -70.01 -48.15 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 CA-C-N 121.166 1.803 . . . . 0.0 108.956 170.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -53.52 -36.69 62.03 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 -178.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -65.29 93.47 0.14 Allowed 'General case' 0 CA--C 1.57 1.712 0 C-N-CA 126.161 1.784 . . . . 0.0 110.802 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.01 -42.71 80.28 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -65.19 -28.05 69.12 Favored 'General case' 0 CA--C 1.581 2.149 0 CA-C-O 117.344 -1.312 . . . . 0.0 113.839 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.02 3.82 90.62 Favored Glycine 0 CA--C 1.554 2.509 0 CA-C-N 121.903 2.138 . . . . 0.0 118.276 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 27.1 p-10 -97.7 -5.26 35.57 Favored 'General case' 0 CA--C 1.581 2.151 0 CA-C-N 120.788 2.294 . . . . 0.0 114.084 174.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.13 8.46 21.78 Favored Glycine 0 CA--C 1.551 2.295 0 CA-C-O 115.756 -2.691 . . . . 0.0 115.999 -177.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -126.14 153.21 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-N 121.865 2.833 . . . . 0.0 114.153 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.534 HD12 ' CE2' ' A' ' 94' ' ' PHE . 74.0 mt -116.24 132.2 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 112.11 -2.314 . . . . 0.0 108.876 177.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -108.83 -169.61 1.52 Allowed 'General case' 0 CA--C 1.581 2.159 0 C-N-CA 122.977 0.511 . . . . 0.0 110.374 174.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -80.31 -47.16 14.94 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.065 -1.647 . . . . 0.0 114.353 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -57.01 -44.95 83.3 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 123.042 0.537 . . . . 0.0 112.259 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -61.51 -42.25 98.53 Favored 'General case' 0 CA--C 1.583 2.228 0 CA-C-N 119.094 0.861 . . . . 0.0 112.613 174.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -54.83 -49.15 71.76 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 125.124 1.37 . . . . 0.0 109.809 174.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.0 mmmt -59.09 -60.94 3.05 Favored 'General case' 0 CA--C 1.57 1.718 0 CA-C-O 118.256 -0.878 . . . . 0.0 109.382 174.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -41.89 -41.22 2.36 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 116.845 2.165 . . . . 0.0 116.845 177.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 10.7 mt -93.61 -45.63 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 N-CA-C 119.287 3.069 . . . . 0.0 119.287 -177.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 3.5 tpt . . . . . 0 N--CA 1.498 1.93 0 N-CA-C 119.63 3.196 . . . . 0.0 119.63 -175.509 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . 0.28 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.854 0 N-CA-C 118.621 2.822 . . . . 0.0 118.621 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -0.53 -7.07 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.974 2 N-CA-C 125.343 5.312 . . . . 0.0 125.343 -164.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.33 -48.67 19.18 Favored 'General case' 0 CA--C 1.564 1.509 0 C-N-CA 126.359 1.864 . . . . 0.0 108.3 173.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.1 -41.65 75.54 Favored 'General case' 0 CA--C 1.579 2.068 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 174.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.7 t -68.22 -49.33 68.14 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 C-N-CA 126.108 1.763 . . . . 0.0 109.692 178.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -58.37 -43.41 88.45 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 119.952 1.251 . . . . 0.0 111.754 175.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.01 -54.05 49.66 Favored 'General case' 0 CA--C 1.576 1.954 0 CA-C-N 120.573 1.533 . . . . 0.0 111.644 176.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.68 -43.79 93.88 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.58 -40.89 69.61 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 116.806 -1.568 . . . . 0.0 110.616 177.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -37.95 82.49 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 121.621 2.009 . . . . 0.0 110.319 173.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -69.95 -34.54 73.57 Favored 'General case' 0 CA--C 1.571 1.75 0 CA-C-N 120.744 1.611 . . . . 0.0 112.316 175.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -78.94 -25.94 43.59 Favored 'General case' 0 CA--C 1.578 2.021 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -87.71 98.45 11.45 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 102.869 -3.011 . . . . 0.0 102.869 171.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -83.0 -13.71 55.41 Favored 'General case' 0 CA--C 1.579 2.07 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -91.18 -14.53 30.91 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 118.763 2.875 . . . . 0.0 118.763 -175.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.15 6.2 89.02 Favored Glycine 0 CA--C 1.565 3.186 0 CA-C-O 118.454 -1.192 . . . . 0.0 115.115 -174.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.93 -50.11 15.89 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 119.454 1.627 . . . . 0.0 110.984 176.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 111.66 -15.54 26.7 Favored Glycine 0 CA--C 1.546 1.978 0 CA-C-O 115.78 -2.678 . . . . 0.0 116.773 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . 0.302 3.8 m -133.34 120.63 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 100.823 -3.769 . . . . 0.0 100.823 175.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.3 mt -77.87 125.88 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 111.489 -2.596 . . . . 0.0 115.755 -172.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 36.5 p30 -91.68 152.9 20.01 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 172.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -51.34 -42.43 81.65 Favored Pre-proline 0 CA--C 1.583 2.239 0 CA-C-O 114.802 -2.523 . . . . 0.0 113.706 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.66 -29.5 80.02 Favored 'Trans proline' 0 C--N 1.376 1.998 0 CA-C-N 125.454 2.983 . . . . 0.0 116.991 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -66.97 -54.84 17.93 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 122.83 2.559 . . . . 0.0 111.446 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.573 ' CE2' HG23 ' A' ' 90' ' ' ILE . 74.2 t80 -61.89 -45.88 91.81 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-N 120.202 1.365 . . . . 0.0 110.515 175.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.26 -47.22 75.78 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-O 116.359 -1.781 . . . . 0.0 111.089 176.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.65 -36.86 76.45 Favored 'General case' 0 CA--C 1.574 1.876 0 CA-C-N 122.288 2.313 . . . . 0.0 113.437 177.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.48 -41.89 81.57 Favored 'General case' 0 CA--C 1.57 1.738 0 C-N-CA 124.84 1.256 . . . . 0.0 110.503 174.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.439 HG21 HD11 ' A' ' 90' ' ' ILE . 5.4 mm -80.0 -43.52 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.8 0 CA-C-O 116.263 -1.827 . . . . 0.0 109.363 176.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 8.7 mttp . . . . . 0 N--CA 1.511 2.592 0 CA-C-N 122.426 2.375 . . . . 0.0 112.589 176.973 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.419 HD11 HG21 ' A' ' 151' ' ' ILE . 1.3 mp -72.78 -45.83 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-O 115.625 -2.131 . . . . 0.0 108.71 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.0 pp -59.66 -46.94 87.52 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 123.111 2.687 . . . . 0.0 110.329 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -57.09 -58.88 6.28 Favored 'General case' 0 CA--C 1.568 1.647 0 C-N-CA 124.286 1.034 . . . . 0.0 112.378 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.46 -58.15 9.7 Favored 'General case' 0 C--N 1.353 0.735 0 CA-C-O 115.711 -2.09 . . . . 0.0 113.346 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -55.66 -50.96 68.83 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 121.551 1.978 . . . . 0.0 113.228 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -62.6 -33.19 74.48 Favored 'General case' 0 CA--C 1.562 1.412 0 CA-C-O 116.307 -1.806 . . . . 0.0 112.553 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -72.35 -44.39 63.13 Favored 'Isoleucine or valine' 0 CA--C 1.59 2.496 0 CA-C-N 121.854 2.115 . . . . 0.0 109.626 171.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -51.7 -35.72 43.89 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 127.098 2.159 . . . . 0.0 115.094 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.255 1.3 t0 -67.26 96.52 0.48 Allowed 'General case' 0 CA--C 1.576 1.967 0 C-N-CA 126.202 1.801 . . . . 0.0 107.342 177.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.04 -49.7 71.34 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.273 1.582 . . . . 0.0 115.273 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -62.33 -24.05 67.11 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.35 7.98 87.7 Favored Glycine 0 CA--C 1.551 2.32 0 N-CA-C 120.327 2.891 . . . . 0.0 120.327 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.8 p30 -96.97 -11.33 24.72 Favored 'General case' 0 CA--C 1.575 1.932 0 CA-C-N 119.78 1.79 . . . . 0.0 115.563 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.49 18.4 8.07 Favored Glycine 0 CA--C 1.552 2.396 0 CA-C-O 116.781 -2.122 . . . . 0.0 114.594 -176.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.45 154.98 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.501 0 CA-C-N 120.826 2.313 . . . . 0.0 111.78 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 79.1 mt -126.54 127.06 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-N 112.368 -2.196 . . . . 0.0 108.217 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -106.21 179.03 4.39 Favored 'General case' 0 CA--C 1.578 2.042 0 CA-C-O 121.857 0.837 . . . . 0.0 110.673 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -69.73 -42.32 74.12 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.15 -45.25 93.7 Favored 'General case' 0 N--CA 1.505 2.281 0 CA-C-N 120.566 1.53 . . . . 0.0 113.829 177.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -63.52 -46.3 86.69 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.917 0.887 . . . . 0.0 112.139 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -62.76 -50.96 68.99 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 117.0 -1.476 . . . . 0.0 110.983 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.0 pptp? -58.27 -39.9 80.44 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 121.235 1.834 . . . . 0.0 114.318 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -65.31 -49.32 69.9 Favored 'General case' 0 CA--C 1.575 1.909 0 C-N-CA 123.407 0.683 . . . . 0.0 112.385 175.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -79.56 -32.37 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 118.723 2.86 . . . . 0.0 118.723 -177.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.495 ' HG2' HG22 ' A' ' 127' ' ' VAL . 14.0 tpt . . . . . 0 N--CA 1.488 1.434 0 C-N-CA 125.692 1.597 . . . . 0.0 114.548 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 10.0 p . . . . . 0 N--CA 1.485 1.314 1 N-CA-C 99.775 -4.157 . . . . 0.0 99.775 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -53.47 -38.36 63.55 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 118.565 2.802 . . . . 0.0 118.565 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.44 -42.16 91.28 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 117.052 -1.452 . . . . 0.0 113.597 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -55.19 -53.43 56.11 Favored 'General case' 0 CA--C 1.573 1.842 0 CA-C-N 120.255 1.388 . . . . 0.0 112.63 176.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.495 HG22 ' HG2' ' A' ' 114' ' ' MET . 18.2 t -73.74 -53.79 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-O 117.197 -1.382 . . . . 0.0 113.829 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -64.2 -40.72 96.68 Favored 'General case' 0 CA--C 1.564 1.514 0 CA-C-N 120.061 1.3 . . . . 0.0 112.52 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -69.56 -43.87 72.04 Favored 'General case' 0 CA--C 1.574 1.891 0 CA-C-N 120.036 1.289 . . . . 0.0 111.228 176.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.57 -46.51 89.58 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 120.616 1.553 . . . . 0.0 113.247 176.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 19.8 ttt -70.27 -39.12 75.12 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 114.818 -2.515 . . . . 0.0 111.761 177.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -64.52 -35.38 80.78 Favored 'General case' 0 CA--C 1.574 1.872 0 CA-C-N 123.99 3.086 . . . . 0.0 111.595 175.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -62.85 -48.43 79.07 Favored 'General case' 0 CA--C 1.579 2.08 0 CA-C-N 121.654 2.025 . . . . 0.0 109.083 172.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.46 -25.08 63.91 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 177.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -90.06 100.57 13.37 Favored 'General case' 0 CA--C 1.573 1.856 0 N-CA-C 103.071 -2.937 . . . . 0.0 103.071 171.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -72.88 -16.56 61.57 Favored 'General case' 0 CA--C 1.579 2.095 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -98.55 -14.57 19.9 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 119.016 2.969 . . . . 0.0 119.016 -175.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.03 5.9 89.33 Favored Glycine 0 CA--C 1.57 3.482 0 CA-C-N 120.411 1.46 . . . . 0.0 115.138 -173.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -75.82 -47.18 26.7 Favored 'General case' 0 CA--C 1.563 1.466 0 C-N-CA 125.441 1.496 . . . . 0.0 112.195 176.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 111.84 -25.04 13.66 Favored Glycine 0 CA--C 1.553 2.455 0 CA-C-O 117.354 -1.803 . . . . 0.0 114.311 -176.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -100.68 143.16 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 N-CA-C 103.725 -2.694 . . . . 0.0 103.725 174.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.7 mt -121.84 124.87 72.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 111.982 -2.372 . . . . 0.0 112.665 -176.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 39.0 p30 -91.43 155.06 18.72 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 170.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.4 mt -52.13 -42.45 86.08 Favored Pre-proline 0 CA--C 1.583 2.237 0 CA-C-O 114.902 -2.475 . . . . 0.0 113.285 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -58.59 -17.8 36.8 Favored 'Trans proline' 0 C--N 1.376 1.992 0 CA-C-N 125.27 2.918 . . . . 0.0 117.976 176.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -72.53 -63.22 1.2 Allowed 'General case' 0 N--CA 1.505 2.28 0 CA-C-N 123.102 2.683 . . . . 0.0 109.469 176.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -54.55 -49.05 71.24 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 125.128 1.371 . . . . 0.0 110.908 173.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.3 mmt -64.6 -34.93 79.43 Favored 'General case' 0 CA--C 1.565 1.556 0 CA-C-O 115.454 -2.212 . . . . 0.0 111.868 175.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -66.67 -46.49 75.52 Favored 'General case' 0 N--CA 1.507 2.382 0 CA-C-N 125.537 3.79 . . . . 0.0 109.14 174.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.461 HD23 HG13 ' A' ' 151' ' ' ILE . 0.2 OUTLIER -46.89 -54.63 9.57 Favored 'General case' 0 C--N 1.368 1.386 0 C-N-CA 126.189 1.795 . . . . 0.0 111.215 176.584 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.461 HG13 HD23 ' A' ' 150' ' ' LEU . 33.8 mt -98.36 -28.52 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-N 121.648 2.022 . . . . 0.0 116.318 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.734 0 N-CA-C 118.659 2.837 . . . . 0.0 118.659 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.51 2.532 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.6 HG23 ' CE2' ' A' ' 147' ' ' PHE . 4.0 mp -58.14 -44.77 88.25 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.753 0 CA-C-N 112.036 -2.347 . . . . 0.0 108.963 172.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.474 ' HB2' ' HE3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -67.26 -39.03 86.04 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 116.322 -1.799 . . . . 0.0 111.685 176.623 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.445 ' O ' ' HB ' ' A' ' 96' ' ' VAL . 0.0 OUTLIER -57.22 -53.26 60.09 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 122.863 2.574 . . . . 0.0 107.888 176.396 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.71 -66.14 0.6 Allowed 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.496 ' CE2' HD12 ' A' ' 105' ' ' ILE . 9.5 t80 -66.62 -51.91 51.11 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.474 ' HE3' ' HB2' ' A' ' 91' ' ' LEU 0.382 7.7 mttt -67.81 -17.54 64.55 Favored 'General case' 0 CA--C 1.589 2.446 0 CA-C-O 114.821 -2.514 . . . . 0.0 110.234 -177.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 92' ' ' ARG . 1.0 OUTLIER -74.19 -46.5 44.56 Favored 'Isoleucine or valine' 0 C--N 1.395 2.547 0 CA-C-N 124.582 3.355 . . . . 0.0 106.186 167.159 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -53.61 -35.88 61.39 Favored 'General case' 0 CA--C 1.582 2.185 0 N-CA-C 117.23 2.308 . . . . 0.0 117.23 178.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -56.51 110.06 0.72 Allowed 'General case' 0 CA--C 1.575 1.905 0 C-N-CA 126.14 1.776 . . . . 0.0 115.469 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.644 ' HB2' ' HG2' ' A' ' 109' ' ' GLU . . . -73.76 -51.77 15.39 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -67.21 -24.53 65.85 Favored 'General case' 0 CA--C 1.578 2.052 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.8 1.71 90.31 Favored Glycine 0 CA--C 1.562 2.992 0 CA-C-N 121.773 2.079 . . . . 0.0 116.987 -175.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -107.19 0.64 23.47 Favored 'General case' 0 CA--C 1.587 2.382 0 CA-C-N 120.027 1.914 . . . . 0.0 112.419 172.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 114.06 -20.09 17.22 Favored Glycine 0 CA--C 1.547 2.083 0 CA-C-O 115.459 -2.856 . . . . 0.0 115.262 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.6 m -83.74 138.15 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.612 0 CA-C-N 123.797 3.799 . . . . 0.0 114.306 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.496 HD12 ' CE2' ' A' ' 94' ' ' PHE . 88.2 mt -116.25 123.36 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 101.713 -3.44 . . . . 0.0 101.713 174.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.491 ' HA ' HG12 ' A' ' 141' ' ' VAL . 2.1 p30 -91.88 162.64 14.34 Favored 'General case' 0 CA--C 1.56 1.329 0 CA-C-O 122.433 1.111 . . . . 0.0 111.577 176.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.77 -47.23 78.91 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.762 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -61.37 -44.2 97.56 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 117.906 -1.045 . . . . 0.0 111.546 176.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.644 ' HG2' ' HB2' ' A' ' 99' ' ' ALA . 34.4 tp10 -63.67 -37.76 88.55 Favored 'General case' 0 CA--C 1.569 1.701 0 CA-C-N 121.097 1.771 . . . . 0.0 112.521 174.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -62.76 -52.3 63.74 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 120.113 1.324 . . . . 0.0 108.143 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.462 ' HA ' HG11 ' A' ' 127' ' ' VAL . 10.5 ptpp? -56.58 -38.54 72.13 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 116.139 -1.886 . . . . 0.0 111.606 175.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -61.76 -54.52 41.25 Favored 'General case' 0 CA--C 1.579 2.072 0 CA-C-N 121.267 1.849 . . . . 0.0 112.788 174.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 tt -73.2 -11.93 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 119.091 2.997 . . . . 0.0 119.091 -177.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 9.2 tpt . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 177.551 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 30.6 p . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 122.656 1.217 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -66.12 -40.88 91.03 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 177.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.52 -43.59 72.04 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -46.5 82.67 Favored 'General case' 0 CA--C 1.584 2.253 0 CA-C-N 120.187 1.358 . . . . 0.0 113.847 177.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.462 HG11 ' HA ' ' A' ' 111' ' ' LYS . 15.7 t -66.08 -48.97 79.77 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.496 0 C-N-CA 125.126 1.37 . . . . 0.0 110.884 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -57.3 -49.95 74.47 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 117.093 -1.432 . . . . 0.0 110.061 176.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -55.16 -51.33 66.82 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 120.737 1.608 . . . . 0.0 112.568 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.91 -48.0 83.48 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 116.123 1.897 . . . . 0.0 116.123 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -44.32 50.31 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 115.8 -2.048 . . . . 0.0 111.277 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.33 -37.18 69.62 Favored 'General case' 0 CA--C 1.575 1.92 0 CA-C-N 122.466 2.394 . . . . 0.0 110.954 174.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -70.91 -39.46 72.72 Favored 'General case' 0 CA--C 1.578 2.024 0 CA-C-N 121.04 1.746 . . . . 0.0 111.94 175.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.08 -25.0 63.32 Favored 'General case' 0 CA--C 1.579 2.068 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 174.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -79.7 110.98 15.55 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 116.579 -3.826 . . . . 0.0 108.068 175.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -75.46 -22.75 57.01 Favored 'General case' 0 CA--C 1.57 1.723 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -107.11 -9.59 16.12 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 118.742 2.867 . . . . 0.0 118.742 -174.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.12 3.76 90.62 Favored Glycine 0 CA--C 1.569 3.408 0 CA-C-O 117.811 -1.55 . . . . 0.0 112.832 -172.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -92.75 42.84 1.11 Allowed 'General case' 0 C--N 1.367 1.335 1 CA-C-O 107.484 -6.008 . . . . 0.0 110.391 175.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 57.92 -23.21 0.02 OUTLIER Glycine 0 N--CA 1.503 3.107 3 O-C-N 105.214 -10.929 . . . . 0.0 129.104 162.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.491 HG12 ' HA ' ' A' ' 106' ' ' ASP . 6.4 m -134.04 140.97 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-N 121.196 2.498 . . . . 0.0 107.029 178.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.1 mt -104.23 131.02 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 113.861 -1.518 . . . . 0.0 112.899 -175.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -97.45 153.34 18.18 Favored 'General case' 0 CA--C 1.559 1.311 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 170.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.43 HD13 ' HD3' ' A' ' 95' ' ' LYS . 2.4 mt -52.68 -43.3 92.54 Favored Pre-proline 0 CA--C 1.583 2.247 0 CA-C-O 114.768 -2.539 . . . . 0.0 113.181 -178.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -51.37 -35.21 53.42 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.877 3.052 . . . . 0.0 115.802 176.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -59.93 -53.97 51.61 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 120.101 1.319 . . . . 0.0 110.81 174.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.6 ' CE2' HG23 ' A' ' 90' ' ' ILE . 36.0 t80 -56.21 -46.32 79.51 Favored 'General case' 0 CA--C 1.57 1.743 0 C-N-CA 125.041 1.336 . . . . 0.0 111.895 175.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.51 ' HG2' HG21 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -57.17 -45.13 83.93 Favored 'General case' 0 CA--C 1.591 2.548 0 C-N-CA 123.349 0.66 . . . . 0.0 110.708 176.105 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.1 -40.25 94.32 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 119.715 1.143 . . . . 0.0 112.111 176.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.55 -47.11 80.16 Favored 'General case' 0 CA--C 1.569 1.699 0 C-N-CA 124.538 1.135 . . . . 0.0 108.458 173.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 88.4 mt -61.78 -40.13 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 CA-C-N 120.389 1.45 . . . . 0.0 110.807 175.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.7 pttt . . . . . 0 CA--C 1.586 2.342 0 CA-C-N 120.642 1.564 . . . . 0.0 112.499 175.842 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 . . . . . 0 CA--C 1.581 2.164 0 CA-C-O 117.511 -1.233 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.745 HG21 ' HG2' ' A' ' 148' ' ' MET . 37.9 mt -71.01 -63.22 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.369 1.446 0 CA-C-O 115.686 -2.102 . . . . 0.0 107.05 174.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 pp -49.85 -47.77 51.51 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-N 122.472 2.396 . . . . 0.0 111.967 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.8 mtm105 -62.82 -55.19 28.54 Favored 'General case' 0 CA--C 1.571 1.787 0 CA-C-O 118.532 -0.746 . . . . 0.0 112.163 176.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.61 -59.47 3.92 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 114.59 -2.624 . . . . 0.0 113.685 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.413 ' CE2' HD12 ' A' ' 105' ' ' ILE . 14.7 t80 -54.89 -48.6 72.79 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 122.627 2.467 . . . . 0.0 112.437 178.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.252 93.0 mttt -64.83 -30.91 71.93 Favored 'General case' 0 CA--C 1.581 2.165 0 CA-C-N 119.796 1.18 . . . . 0.0 111.361 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.7 t -65.86 -48.96 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.507 0 CA-C-N 121.54 1.973 . . . . 0.0 108.534 169.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.1 -30.94 60.76 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 117.446 2.387 . . . . 0.0 117.446 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.318 0.0 OUTLIER -52.47 -14.28 0.47 Allowed 'General case' 0 CA--C 1.578 2.05 0 N-CA-C 119.895 3.295 . . . . 0.0 119.895 -177.404 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.761 ' HB2' ' HG2' ' A' ' 109' ' ' GLU . . . 75.35 -70.69 0.14 Allowed 'General case' 0 N--CA 1.502 2.167 0 CA-C-N 122.654 2.479 . . . . 0.0 116.33 176.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -76.35 -17.95 59.14 Favored 'General case' 0 CA--C 1.571 1.758 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 -177.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.02 3.92 90.21 Favored Glycine 0 CA--C 1.568 3.39 0 CA-C-O 117.437 -1.757 . . . . 0.0 114.333 -172.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 46.9 p-10 -98.47 -17.05 18.96 Favored 'General case' 0 CA--C 1.579 2.061 0 CA-C-N 120.881 2.341 . . . . 0.0 113.647 174.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.52 22.65 6.0 Favored Glycine 0 CA--C 1.546 2.002 0 CA-C-O 115.474 -2.848 . . . . 0.0 116.48 -178.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.6 t -134.39 121.96 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 CA-C-N 122.669 3.235 . . . . 0.0 112.555 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.413 HD12 ' CE2' ' A' ' 94' ' ' PHE . 62.3 mt -93.54 135.25 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 C-N-CA 126.432 1.893 . . . . 0.0 112.789 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -105.11 173.76 6.17 Favored 'General case' 0 CA--C 1.574 1.875 0 C-N-CA 124.193 0.997 . . . . 0.0 111.863 175.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -70.45 -50.15 41.24 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -62.94 -45.91 90.25 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 118.282 -0.866 . . . . 0.0 112.341 178.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.761 ' HG2' ' HB2' ' A' ' 99' ' ' ALA . 37.6 tp10 -61.21 -39.55 90.66 Favored 'General case' 0 CA--C 1.569 1.709 0 CA-C-N 120.49 1.495 . . . . 0.0 112.05 175.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -58.83 -53.66 55.93 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 120.127 1.331 . . . . 0.0 110.042 175.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -51.0 -42.68 60.51 Favored 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -73.2 -55.34 6.59 Favored 'General case' 0 CA--C 1.577 1.986 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 176.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.6 tt -67.98 -34.77 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 118.726 2.862 . . . . 0.0 118.726 -176.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.433 ' SD ' HG13 ' A' ' 127' ' ' VAL . 40.2 ttp . . . . . 0 N--CA 1.503 2.215 0 N-CA-C 117.936 2.569 . . . . 0.0 117.936 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 67.6 p . . . . . 0 N--CA 1.499 1.982 0 CA-C-O 119.377 -0.344 . . . . 0.0 111.61 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -42.0 -49.12 4.68 Favored 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 177.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.81 -48.51 76.54 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 112.292 -2.231 . . . . 0.0 111.429 176.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -61.52 -29.02 69.73 Favored 'General case' 0 CA--C 1.576 1.959 0 CA-C-N 120.438 1.472 . . . . 0.0 112.737 174.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.433 HG13 ' SD ' ' A' ' 114' ' ' MET . 1.5 t -70.36 -57.66 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 CA-C-N 121.374 1.897 . . . . 0.0 109.043 177.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -64.22 -38.98 93.0 Favored 'General case' 0 N--CA 1.508 2.442 0 CA-C-N 120.24 1.382 . . . . 0.0 113.263 178.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -65.08 -44.59 88.41 Favored 'General case' 0 CA--C 1.567 1.614 0 CA-C-O 117.839 -1.076 . . . . 0.0 112.02 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -64.31 -45.33 88.38 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 120.012 1.278 . . . . 0.0 112.234 176.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 19.6 ttt -70.24 -41.83 73.03 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 114.238 -2.791 . . . . 0.0 111.055 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -64.51 -33.24 75.45 Favored 'General case' 0 CA--C 1.576 1.978 0 CA-C-N 125.087 3.585 . . . . 0.0 111.293 175.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -62.49 -44.02 97.4 Favored 'General case' 0 CA--C 1.585 2.31 0 CA-C-N 122.023 2.192 . . . . 0.0 110.376 171.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.44 -29.36 56.96 Favored 'General case' 0 CA--C 1.576 1.961 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 178.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -90.77 100.16 13.06 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 103.12 -2.919 . . . . 0.0 103.12 172.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -56.48 -29.62 61.98 Favored 'General case' 0 CA--C 1.593 2.61 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.407 54.2 t0 160.88 -22.96 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.676 1 CA-C-O 108.925 -5.321 . . . . 0.0 103.811 175.808 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 11.04 5.88 0.0 OUTLIER Glycine 0 CA--C 1.564 3.136 3 O-C-N 99.065 -14.772 . . . . 0.0 125.131 160.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . 0.46 ' OD1' HG23 ' A' ' 141' ' ' VAL . 2.3 p-10 79.03 15.14 1.06 Allowed 'General case' 0 CA--C 1.595 2.674 0 CA-C-N 121.3 2.55 . . . . 0.0 111.626 -172.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 97.38 -22.88 38.4 Favored Glycine 0 CA--C 1.563 3.042 0 CA-C-N 122.974 2.624 . . . . 0.0 115.636 -176.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.46 HG23 ' OD1' ' A' ' 139' ' ' ASN . 0.1 OUTLIER -105.46 146.52 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.378 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 178.396 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -115.22 129.72 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 113.815 -1.539 . . . . 0.0 114.513 -176.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 47.9 p30 -92.18 164.86 13.41 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 171.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 7.6 mt -55.96 -42.95 98.75 Favored Pre-proline 0 CA--C 1.585 2.327 0 CA-C-O 115.028 -2.415 . . . . 0.0 112.584 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -59.16 -22.53 64.96 Favored 'Trans proline' 0 C--N 1.376 2.007 0 CA-C-N 125.338 2.942 . . . . 0.0 119.74 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -69.92 0.3 Allowed 'General case' 0 CA--C 1.562 1.407 0 CA-C-N 122.996 2.635 . . . . 0.0 110.357 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.658 ' CE2' HG23 ' A' ' 90' ' ' ILE . 77.8 t80 -49.54 -43.39 45.73 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 124.716 1.206 . . . . 0.0 113.468 174.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.745 ' HG2' HG21 ' A' ' 90' ' ' ILE . 5.8 mtp -67.37 -40.35 85.76 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-O 114.898 -2.477 . . . . 0.0 112.004 177.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -63.83 -43.67 95.52 Favored 'General case' 0 N--CA 1.505 2.281 0 CA-C-N 124.458 3.299 . . . . 0.0 109.626 173.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.95 -47.89 21.64 Favored 'General case' 0 CA--C 1.575 1.916 0 C-N-CA 127.173 2.189 . . . . 0.0 112.07 174.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 68.0 mt -89.06 -34.47 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.891 0 CA-C-O 117.286 -1.34 . . . . 0.0 111.513 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 41.2 mmtt . . . . . 0 N--CA 1.503 2.217 0 CA-C-N 122.126 2.239 . . . . 0.0 112.739 176.143 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 . . . . . 0 N--CA 1.501 2.078 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.662 HG23 ' CE2' ' A' ' 147' ' ' PHE . 1.6 mp -66.38 -45.71 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 116.748 -1.596 . . . . 0.0 109.995 177.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.46 -46.13 84.0 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 121.617 2.008 . . . . 0.0 110.541 177.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.91 -55.96 28.42 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 117.326 -1.321 . . . . 0.0 110.574 176.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.83 -57.62 6.66 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.521 ' CE2' HD12 ' A' ' 105' ' ' ILE . 15.8 t80 -64.97 -50.53 66.02 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 120.899 1.681 . . . . 0.0 113.401 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.424 ' HE2' HD13 ' A' ' 144' ' ' ILE 0.335 65.8 mttt -68.07 -22.4 64.94 Favored 'General case' 0 CA--C 1.59 2.515 0 CA-C-O 116.495 -1.717 . . . . 0.0 110.455 -178.804 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.9 t -71.25 -48.87 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.421 0 CA-C-N 122.818 2.554 . . . . 0.0 107.213 168.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -49.02 -34.75 13.91 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.11 102.15 0.35 Allowed 'General case' 0 CA--C 1.576 1.976 0 C-N-CA 126.038 1.735 . . . . 0.0 109.191 176.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.28 -43.03 71.27 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.9 p30 -69.91 -8.03 45.33 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 117.236 2.31 . . . . 0.0 117.236 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.79 29.4 71.09 Favored Glycine 0 CA--C 1.558 2.75 0 CA-C-N 120.823 1.647 . . . . 0.0 116.418 -177.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.19 76.04 1.53 Allowed 'General case' 0 N--CA 1.477 0.882 1 CA-C-O 109.068 -5.253 . . . . 0.0 106.606 178.631 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 52.88 -30.24 0.01 OUTLIER Glycine 0 N--CA 1.491 2.305 2 N-CA-C 127.952 5.941 . . . . 0.0 127.952 165.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.6 p -107.15 155.05 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.455 0 CA-C-O 122.692 1.234 . . . . 0.0 114.112 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.521 HD12 ' CE2' ' A' ' 94' ' ' PHE . 87.8 mt -115.6 134.7 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-N 113.09 -1.868 . . . . 0.0 108.855 177.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.94 -179.29 3.82 Favored 'General case' 0 CA--C 1.576 1.972 0 CA-C-N 119.86 1.209 . . . . 0.0 112.965 175.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -74.78 -51.57 13.77 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.445 -1.409 . . . . 0.0 113.601 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.39 -33.63 75.97 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 178.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.18 -40.92 82.12 Favored 'General case' 0 CA--C 1.581 2.147 0 CA-C-N 120.44 1.473 . . . . 0.0 110.765 174.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.74 -46.66 86.9 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 117.521 -1.228 . . . . 0.0 108.892 172.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.45 ' HA ' HG21 ' A' ' 127' ' ' VAL . 2.9 tppt? -52.05 -61.82 2.02 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 125.012 1.325 . . . . 0.0 109.12 174.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -48.81 -48.51 41.42 Favored 'General case' 0 CA--C 1.575 1.929 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 176.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -82.14 -13.68 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 118.059 2.614 . . . . 0.0 118.059 -178.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.48 ' SD ' HG23 ' A' ' 127' ' ' VAL . 9.4 tpt . . . . . 0 N--CA 1.485 1.288 0 N-CA-C 119.246 3.054 . . . . 0.0 119.246 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.2 p . . . . . 0 CA--C 1.55 0.969 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.38 -20.54 58.91 Favored 'General case' 0 CA--C 1.577 1.982 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.741 174.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -58.04 -40.1 80.04 Favored 'General case' 0 CA--C 1.561 1.381 0 CA-C-O 117.023 -1.465 . . . . 0.0 111.424 174.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -54.56 -53.9 48.33 Favored 'General case' 0 CA--C 1.585 2.323 0 CA-C-N 120.419 1.463 . . . . 0.0 111.477 175.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.48 HG23 ' SD ' ' A' ' 114' ' ' MET 0.251 4.2 p -73.43 -41.33 56.78 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -178.201 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -68.86 -45.78 70.17 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 120.675 1.58 . . . . 0.0 110.205 176.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -62.74 -48.85 77.42 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-N 121.341 1.882 . . . . 0.0 112.019 176.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -64.2 -45.85 86.49 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-N 120.378 1.445 . . . . 0.0 114.692 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -73.98 -34.34 64.18 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 115.934 -1.984 . . . . 0.0 112.767 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.12 -32.61 67.12 Favored 'General case' 0 CA--C 1.566 1.59 0 CA-C-N 122.64 2.473 . . . . 0.0 110.755 173.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.96 -35.51 80.12 Favored 'General case' 0 CA--C 1.58 2.126 0 CA-C-N 123.388 2.813 . . . . 0.0 110.495 172.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.99 -30.9 27.81 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 176.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -90.81 105.71 18.01 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 122.339 2.336 . . . . 0.0 107.115 174.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -62.65 -32.49 73.55 Favored 'General case' 0 CA--C 1.598 2.825 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 175.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.391 57.1 t0 163.54 -21.9 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.041 1 CA-C-O 108.768 -5.396 . . . . 0.0 103.326 176.673 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 13.03 8.04 0.0 OUTLIER Glycine 0 N--CA 1.5 2.928 3 O-C-N 98.666 -15.021 . . . . 0.0 125.028 161.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 77.84 4.58 2.92 Favored 'General case' 0 CA--C 1.581 2.145 0 CA-C-N 121.622 2.711 . . . . 0.0 111.179 -172.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 95.34 -12.09 68.3 Favored Glycine 0 C--N 1.372 2.561 0 CA-C-N 123.746 2.976 . . . . 0.0 114.584 -175.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . 0.298 3.4 m -130.24 121.11 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 102.181 -3.266 . . . . 0.0 102.181 175.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.62 125.62 38.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 111.299 -2.682 . . . . 0.0 114.001 -173.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -92.88 151.99 19.65 Favored 'General case' 0 CA--C 1.558 1.251 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 172.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.424 HD13 ' HE2' ' A' ' 95' ' ' LYS . 1.4 mt -53.32 -41.7 87.77 Favored Pre-proline 0 CA--C 1.582 2.176 0 CA-C-O 114.615 -2.612 . . . . 0.0 112.628 -178.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -55.63 -26.23 54.45 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 123.93 3.087 . . . . 0.0 116.511 176.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -63.85 -62.41 1.66 Allowed 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 122.051 2.205 . . . . 0.0 108.918 174.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.662 ' CE2' HG23 ' A' ' 90' ' ' ILE . 87.2 t80 -55.22 -47.08 75.85 Favored 'General case' 0 CA--C 1.57 1.739 0 C-N-CA 125.638 1.575 . . . . 0.0 113.842 173.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.49 ' HG2' HG21 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -59.12 -39.03 81.01 Favored 'General case' 0 CA--C 1.588 2.418 0 CA-C-O 117.673 -1.156 . . . . 0.0 109.857 174.749 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -67.15 -47.47 70.94 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 121.214 1.825 . . . . 0.0 110.104 173.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.33 -44.58 11.74 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 127.608 2.363 . . . . 0.0 112.26 176.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 58.5 mt -92.61 -56.23 5.39 Favored 'Isoleucine or valine' 0 C--N 1.366 1.295 0 CA-C-O 116.911 -1.519 . . . . 0.0 113.933 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt . . . . . 0 N--CA 1.482 1.175 0 N-CA-C 118.368 2.729 . . . . 0.0 118.368 -176.66 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.753 HG23 ' HE2' ' A' ' 147' ' ' PHE . 5.3 mp -72.04 -48.1 51.51 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 CA-C-O 117.053 -1.451 . . . . 0.0 112.496 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.21 -51.93 67.85 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 121.671 2.032 . . . . 0.0 110.266 178.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -65.18 -46.77 79.45 Favored 'General case' 0 CA--C 1.566 1.595 0 CA-C-O 116.532 -1.699 . . . . 0.0 111.146 178.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.28 -61.59 1.73 Allowed 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 121.925 2.148 . . . . 0.0 114.404 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.517 ' CE2' HD12 ' A' ' 105' ' ' ILE . 19.9 t80 -59.15 -50.94 72.14 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 121.979 2.172 . . . . 0.0 112.858 178.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.418 ' HE2' HD13 ' A' ' 144' ' ' ILE 0.353 71.7 mttt -67.78 -23.82 65.25 Favored 'General case' 0 CA--C 1.591 2.53 0 CA-C-O 116.558 -1.687 . . . . 0.0 110.262 -177.42 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.8 t -69.66 -48.23 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.485 0 CA-C-N 122.732 2.515 . . . . 0.0 107.491 167.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -48.28 -33.95 9.63 Favored 'General case' 0 CA--C 1.577 1.991 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.42 95.9 0.48 Allowed 'General case' 0 CA--C 1.577 1.983 0 C-N-CA 126.936 2.094 . . . . 0.0 107.873 175.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.92 -46.49 71.4 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.633 -0.667 . . . . 0.0 112.322 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -47.94 -24.55 1.07 Allowed 'General case' 0 CA--C 1.583 2.233 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 176.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.14 7.43 87.78 Favored Glycine 0 CA--C 1.563 3.036 0 CA-C-N 122.216 2.28 . . . . 0.0 117.34 -176.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.67 78.21 1.69 Allowed 'General case' 0 N--CA 1.478 0.932 1 CA-C-O 109.938 -4.839 . . . . 0.0 104.76 175.356 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 52.68 -26.93 0.01 OUTLIER Glycine 0 N--CA 1.486 2.028 2 N-CA-C 129.079 6.392 . . . . 0.0 129.079 166.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.7 t -103.03 136.19 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-N 118.919 1.359 . . . . 0.0 113.036 -177.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.517 HD12 ' CE2' ' A' ' 94' ' ' PHE . 67.5 mt -111.04 133.59 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 113.082 -1.872 . . . . 0.0 110.347 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -110.51 173.04 6.52 Favored 'General case' 0 CA--C 1.571 1.76 0 C-N-CA 124.378 1.071 . . . . 0.0 111.49 176.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -64.01 -45.52 88.6 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 116.82 -1.562 . . . . 0.0 114.504 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -61.56 -46.87 88.08 Favored 'General case' 0 N--CA 1.508 2.457 0 CA-C-N 121.196 1.816 . . . . 0.0 112.185 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -51.53 -50.3 60.29 Favored 'General case' 0 CA--C 1.574 1.892 0 C-N-CA 124.557 1.143 . . . . 0.0 112.059 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -64.38 -52.6 57.44 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 125.986 1.714 . . . . 0.0 109.791 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 19.1 ttpt -46.87 -49.93 19.45 Favored 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 124.85 1.26 . . . . 0.0 113.534 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -70.57 -53.54 15.63 Favored 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 176.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -70.88 -27.29 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 119.302 3.075 . . . . 0.0 119.302 -175.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 15.3 tmm? . . . . . 0 N--CA 1.498 1.973 0 C-N-CA 126.518 1.927 . . . . 0.0 109.577 178.376 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.485 1.284 1 N-CA-C 99.36 -4.311 . . . . 0.0 99.36 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -62.19 -33.45 74.57 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 116.99 2.219 . . . . 0.0 116.99 -177.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.48 -40.28 96.68 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 117.418 -1.277 . . . . 0.0 113.624 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -59.56 -52.11 66.98 Favored 'General case' 0 CA--C 1.572 1.81 0 CA-C-N 120.633 1.56 . . . . 0.0 113.036 178.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.8 t -73.73 -48.36 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-O 117.001 -1.476 . . . . 0.0 112.464 -178.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -65.0 -44.57 88.83 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-N 120.768 1.622 . . . . 0.0 111.356 177.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -64.82 -43.51 92.86 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-N 121.464 1.938 . . . . 0.0 112.084 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.0 -47.62 82.34 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 120.662 1.574 . . . . 0.0 112.92 176.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.583 ' SD ' HD11 ' A' ' 142' ' ' ILE . 13.3 tpt -67.65 -37.67 82.74 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 115.189 -2.338 . . . . 0.0 112.075 176.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -66.64 -43.08 85.63 Favored 'General case' 0 CA--C 1.567 1.609 0 CA-C-N 123.053 2.66 . . . . 0.0 110.712 174.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -59.94 -41.39 91.72 Favored 'General case' 0 CA--C 1.578 2.053 0 CA-C-N 122.568 2.44 . . . . 0.0 110.351 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.59 -16.65 62.87 Favored 'General case' 0 CA--C 1.581 2.148 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.572 ' OD2' ' N ' ' A' ' 140' ' ' GLY . 7.3 t0 -91.8 103.25 15.82 Favored 'General case' 0 CA--C 1.586 2.327 0 N-CA-C 101.679 -3.452 . . . . 0.0 101.679 164.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -73.81 -21.12 60.26 Favored 'General case' 0 CA--C 1.58 2.125 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 178.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -91.82 -11.87 35.32 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 119.514 3.153 . . . . 0.0 119.514 -175.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.13 5.96 89.24 Favored Glycine 0 CA--C 1.573 3.709 0 CA-C-N 120.241 1.382 . . . . 0.0 115.323 -173.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.38 -44.86 20.65 Favored 'General case' 0 CA--C 1.573 1.849 0 C-N-CA 126.139 1.776 . . . . 0.0 113.33 176.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.572 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . 111.13 20.25 7.21 Favored Glycine 0 CA--C 1.558 2.73 0 N-CA-C 116.891 1.516 . . . . 0.0 116.891 -178.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.27 158.73 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-N 118.676 1.238 . . . . 0.0 108.041 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.583 HD11 ' SD ' ' A' ' 131' ' ' MET . 1.1 mt -136.91 128.83 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 117.702 2.482 . . . . 0.0 117.702 -174.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 33.1 p30 -95.74 153.98 17.46 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 170.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.418 HD13 ' HE2' ' A' ' 95' ' ' LYS . 2.3 mt -51.17 -43.08 84.38 Favored Pre-proline 0 CA--C 1.586 2.339 0 CA-C-O 115.006 -2.426 . . . . 0.0 114.198 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -56.01 -29.8 75.47 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 123.787 2.991 . . . . 0.0 117.646 177.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -61.8 -62.51 1.75 Allowed 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 120.831 1.65 . . . . 0.0 110.926 176.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.753 ' HE2' HG23 ' A' ' 90' ' ' ILE . 57.9 t80 -54.85 -42.56 72.13 Favored 'General case' 0 CA--C 1.578 2.04 0 C-N-CA 123.989 0.915 . . . . 0.0 112.809 174.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.682 ' HG2' HG21 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -56.89 -42.27 79.54 Favored 'General case' 0 CA--C 1.583 2.22 0 CA-C-O 117.403 -1.284 . . . . 0.0 109.716 174.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.52 -33.63 73.09 Favored 'General case' 0 CA--C 1.577 1.992 0 CA-C-N 121.187 1.812 . . . . 0.0 110.736 174.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.3 mp -58.52 -45.74 88.2 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 120.661 1.573 . . . . 0.0 111.542 174.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 66.6 mt -79.9 -45.62 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 120.445 1.475 . . . . 0.0 110.982 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 94.4 mttt . . . . . 0 CA--C 1.575 1.915 0 CA-C-N 120.931 1.696 . . . . 0.0 114.702 177.98 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.52 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 13.0 pt-20 . . . . . 0 CA--C 1.548 0.9 0 N-CA-C 114.827 1.418 . . . . 0.0 114.827 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.416 HG23 ' CD2' ' A' ' 147' ' ' PHE . 4.2 mp -76.83 -67.61 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 114.42 -2.705 . . . . 0.0 114.572 -177.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . 0.336 0.0 OUTLIER -73.95 -33.63 63.97 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 123.546 2.885 . . . . 0.0 110.36 -178.247 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 46.9 mtt180 -69.04 -45.69 69.8 Favored 'General case' 0 CA--C 1.58 2.133 0 CA-C-N 125.52 3.782 . . . . 0.0 108.992 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 89' ' ' GLU . . . -70.79 -57.25 4.84 Favored 'General case' 0 C--N 1.384 2.09 0 CA-C-N 122.376 2.353 . . . . 0.0 112.121 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.595 ' CE2' HD12 ' A' ' 105' ' ' ILE . 4.8 t80 -57.07 -51.59 68.67 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 121.919 2.145 . . . . 0.0 113.267 178.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.602 ' HE2' HD13 ' A' ' 144' ' ' ILE . 56.0 mttt -62.01 -31.0 71.34 Favored 'General case' 0 CA--C 1.576 1.948 0 CA-C-O 115.491 -2.195 . . . . 0.0 111.548 -178.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -69.2 -45.23 79.86 Favored 'Isoleucine or valine' 0 CA--C 1.591 2.523 0 CA-C-N 123.604 2.911 . . . . 0.0 109.355 170.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.91 -31.13 38.27 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.965 ' OD2' ' HA ' ' A' ' 102' ' ' ASP . 1.7 t0 -56.9 125.39 22.32 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 119.997 1.271 . . . . 0.0 109.087 177.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.46 28.35 0.03 OUTLIER 'General case' 0 N--CA 1.527 3.422 0 N-CA-C 120.445 3.498 . . . . 0.0 120.445 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.497 ' H ' ' C ' ' A' ' 98' ' ' ASP 0.422 13.7 t-20 72.44 148.23 0.09 Allowed 'General case' 0 CA--C 1.604 3.033 2 C-N-CA 135.223 5.409 . . . . 0.0 101.825 -175.813 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 109.39 60.49 0.52 Allowed Glycine 0 C--N 1.285 -2.254 2 C-N-CA 135.547 6.308 . . . . 0.0 109.621 -177.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.965 ' HA ' ' OD2' ' A' ' 98' ' ' ASP 0.832 0.2 OUTLIER -30.13 113.5 0.09 Allowed 'General case' 0 C--N 1.393 2.474 0 CA-C-O 127.626 3.584 . . . . 0.0 118.268 -174.511 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 126.62 28.92 0.93 Allowed Glycine 0 N--CA 1.43 -1.724 1 CA-C-N 103.376 -6.284 . . . . 0.0 110.716 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . 0.273 0.0 OUTLIER -166.67 142.57 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 N-CA-C 118.376 2.732 . . . . 0.0 118.376 177.306 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.595 HD12 ' CE2' ' A' ' 94' ' ' PHE . 96.1 mt -136.64 134.58 48.98 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.676 0 C-N-CA 128.331 2.652 . . . . 0.0 104.99 175.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -105.01 -178.56 3.69 Favored 'General case' 0 CA--C 1.569 1.692 0 C-N-CA 124.462 1.105 . . . . 0.0 111.621 175.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.49 -46.62 25.96 Favored 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -178.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -62.95 -53.09 59.49 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 117.023 -1.465 . . . . 0.0 111.328 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -58.03 -30.72 66.36 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 121.838 2.108 . . . . 0.0 113.124 175.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -66.97 -51.65 52.56 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 120.554 1.524 . . . . 0.0 109.187 176.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.1 tppt? -54.98 -35.33 64.21 Favored 'General case' 0 CA--C 1.58 2.118 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 174.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 11.3 m-30 -74.76 -57.98 3.57 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 125.699 1.6 . . . . 0.0 113.043 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.9 -36.4 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 125.814 1.645 . . . . 0.0 113.684 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.588 2.432 0 CA-C-O 121.157 0.503 . . . . 0.0 110.198 171.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 78.3 p . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 121.665 0.745 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -60.09 -37.58 80.35 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.37 -36.84 71.73 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 117.346 -1.311 . . . . 0.0 114.478 176.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -61.76 -51.11 69.66 Favored 'General case' 0 CA--C 1.58 2.133 0 CA-C-N 120.786 1.63 . . . . 0.0 111.841 175.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.2 t -63.53 -51.83 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 C-N-CA 125.804 1.642 . . . . 0.0 110.706 178.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.3 -38.78 84.71 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-O 117.569 -1.205 . . . . 0.0 111.314 176.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -62.87 -50.45 70.87 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 121.673 2.033 . . . . 0.0 112.094 175.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.49 -47.26 86.92 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 177.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.429 ' SD ' HD11 ' A' ' 142' ' ' ILE . 12.8 tpt -70.02 -38.72 75.98 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 115.434 -2.222 . . . . 0.0 111.303 176.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -36.16 83.37 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 123.724 2.965 . . . . 0.0 111.372 175.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -61.78 -49.21 77.26 Favored 'General case' 0 CA--C 1.573 1.848 0 CA-C-O 118.121 -0.942 . . . . 0.0 109.478 173.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -77.33 -23.82 50.87 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 117.724 2.49 . . . . 0.0 117.724 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -91.29 116.67 29.01 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 103.356 -2.831 . . . . 0.0 103.356 170.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -61.59 -22.33 65.12 Favored 'General case' 0 CA--C 1.586 2.347 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.281 29.6 t0 96.97 159.68 0.02 OUTLIER 'General case' 0 CA--C 1.609 3.218 0 CA-C-O 127.402 3.477 . . . . 0.0 103.085 178.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 94.48 36.79 5.52 Favored Glycine 0 CA--C 1.567 3.319 2 C-N-CA 132.006 4.622 . . . . 0.0 102.492 -173.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -173.7 -65.43 0.01 OUTLIER 'General case' 0 C--N 1.399 2.722 0 CA-C-N 121.821 2.811 . . . . 0.0 115.488 -174.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 87.39 20.6 51.5 Favored Glycine 0 CA--C 1.574 3.751 0 CA-C-N 119.31 0.959 . . . . 0.0 114.384 -174.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.88 168.25 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 128.053 2.541 . . . . 0.0 104.227 -178.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.429 HD11 ' SD ' ' A' ' 131' ' ' MET . 0.9 OUTLIER -144.75 133.06 17.4 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 O-C-N 120.979 -1.075 . . . . 0.0 112.816 -178.385 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 53.6 p30 -103.58 155.65 18.38 Favored 'General case' 0 CA--C 1.561 1.384 0 N-CA-C 104.467 -2.42 . . . . 0.0 104.467 169.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.602 HD13 ' HE2' ' A' ' 95' ' ' LYS . 0.6 OUTLIER -52.45 -44.89 95.3 Favored Pre-proline 0 N--CA 1.492 1.669 0 CA-C-O 115.184 -2.341 . . . . 0.0 113.219 -178.4 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.44 ' O ' ' HB2' ' A' ' 149' ' ' ASP . 43.1 Cg_exo -55.51 -21.21 29.67 Favored 'Trans proline' 0 C--N 1.375 1.942 0 CA-C-O 114.139 -2.526 . . . . 0.0 116.455 177.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.66 -56.21 6.97 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 123.217 2.735 . . . . 0.0 110.488 175.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.416 ' CD2' HG23 ' A' ' 90' ' ' ILE . 18.6 t80 -61.45 -44.76 96.54 Favored 'General case' 0 CA--C 1.591 2.552 0 CA-C-O 123.727 1.727 . . . . 0.0 111.99 175.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 2.1 mmt -56.62 -45.14 81.67 Favored 'General case' 0 CA--C 1.56 1.36 0 CA-C-O 115.111 -2.376 . . . . 0.0 108.884 173.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 145' ' ' PRO . 1.2 m-20 -66.97 -27.33 67.37 Favored 'General case' 0 CA--C 1.567 1.599 0 CA-C-N 122.468 2.394 . . . . 0.0 112.115 173.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.5 mp -52.32 -41.04 62.64 Favored 'General case' 0 N--CA 1.504 2.262 0 CA-C-N 121.98 2.173 . . . . 0.0 106.324 168.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -81.34 -69.46 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.612 3.348 0 CA-C-O 122.481 1.134 . . . . 0.0 111.447 173.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? . . . . . 0 CA--C 1.579 2.081 2 C-N-CA 133.249 4.62 . . . . 0.0 122.55 -178.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 . . . . . 0 CA--C 1.58 2.107 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.603 HG21 ' HG2' ' A' ' 148' ' ' MET . 3.6 mp -64.79 -42.88 96.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-O 117.467 -1.254 . . . . 0.0 110.405 177.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.12 -45.38 93.71 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 120.938 1.699 . . . . 0.0 109.278 175.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 76.8 mtt180 -52.97 -62.67 1.5 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 120.107 1.321 . . . . 0.0 110.283 176.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.86 -58.78 4.34 Favored 'General case' 0 C--N 1.358 0.968 0 CA-C-O 115.871 -2.014 . . . . 0.0 116.185 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.48 ' CE2' HD12 ' A' ' 105' ' ' ILE . 14.4 t80 -63.23 -52.66 61.26 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 121.42 1.918 . . . . 0.0 113.723 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.367 58.1 mttt -66.51 -19.53 65.81 Favored 'General case' 0 CA--C 1.596 2.719 0 CA-C-O 116.614 -1.66 . . . . 0.0 110.354 -177.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.7 t -72.64 -50.97 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 CA-C-N 122.566 2.439 . . . . 0.0 107.383 166.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -51.06 -30.39 15.6 Favored 'General case' 0 CA--C 1.568 1.655 0 N-CA-C 117.508 2.41 . . . . 0.0 117.508 -178.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.265 0.0 OUTLIER -55.04 115.52 2.26 Favored 'General case' 0 CA--C 1.585 2.299 0 C-N-CA 126.272 1.829 . . . . 0.0 110.274 178.335 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.9 -54.7 41.5 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 117.678 2.473 . . . . 0.0 117.678 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.6 p30 -88.66 6.28 39.16 Favored 'General case' 0 CA--C 1.562 1.442 0 N-CA-C 118.622 2.823 . . . . 0.0 118.622 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.65 29.13 71.48 Favored Glycine 0 CA--C 1.568 3.358 0 CA-C-N 121.078 1.763 . . . . 0.0 115.462 -175.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -143.3 78.29 1.6 Allowed 'General case' 0 N--CA 1.476 0.825 1 CA-C-O 109.544 -5.027 . . . . 0.0 107.362 178.829 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 54.82 -25.83 0.01 OUTLIER Glycine 0 N--CA 1.491 2.348 3 N-CA-C 129.504 6.562 . . . . 0.0 129.504 164.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.8 p -107.4 153.26 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.089 0 CA-C-N 119.129 1.465 . . . . 0.0 112.426 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.48 HD12 ' CE2' ' A' ' 94' ' ' PHE . 83.6 mt -123.19 137.39 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 C-N-CA 126.281 1.832 . . . . 0.0 108.909 178.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -108.69 -170.51 1.68 Allowed 'General case' 0 CA--C 1.589 2.459 0 C-N-CA 124.154 0.982 . . . . 0.0 112.34 176.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -80.64 -52.98 6.95 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -57.88 -47.4 82.86 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 123.021 0.528 . . . . 0.0 112.23 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -56.0 -48.52 75.73 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 118.033 -0.984 . . . . 0.0 111.157 174.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -60.37 -50.9 71.77 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 117.39 -1.29 . . . . 0.0 112.497 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -56.9 -39.24 74.05 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 120.342 1.428 . . . . 0.0 114.433 176.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -69.18 -45.49 69.82 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 175.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -91.07 -24.21 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 1 N-CA-C 122.054 4.094 . . . . 0.0 122.054 -174.496 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 1.4 tpt . . . . . 0 N--CA 1.505 2.294 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 -179.017 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 46.5 p . . . . . 0 CA--C 1.554 1.11 0 N-CA-C 103.697 -2.705 . . . . 0.0 103.697 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -61.05 -41.53 96.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.91 -1.119 . . . . 0.0 112.149 176.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.49 -45.82 82.1 Favored 'General case' 0 CA--C 1.554 1.103 0 CA-C-O 116.929 -1.51 . . . . 0.0 113.338 176.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.82 -39.76 94.99 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 121.659 2.027 . . . . 0.0 112.965 176.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 90.0 t -69.99 -50.72 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.613 0 CA-C-O 117.739 -1.124 . . . . 0.0 109.307 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.68 -45.55 89.19 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 120.154 1.343 . . . . 0.0 111.718 176.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -61.61 -47.06 87.18 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 119.701 1.137 . . . . 0.0 112.621 176.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.21 -46.14 90.76 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 119.396 0.998 . . . . 0.0 112.975 176.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 9.6 ttt -70.84 -43.56 68.26 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 115.74 -2.076 . . . . 0.0 111.189 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -35.63 75.77 Favored 'General case' 0 CA--C 1.578 2.052 0 CA-C-N 122.899 2.59 . . . . 0.0 110.685 174.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.48 -42.68 91.92 Favored 'General case' 0 CA--C 1.571 1.774 0 CA-C-N 121.633 2.015 . . . . 0.0 110.557 172.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -72.21 -24.5 61.41 Favored 'General case' 0 CA--C 1.576 1.946 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 176.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -81.3 108.53 15.0 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 103.041 -2.948 . . . . 0.0 103.041 172.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -72.71 -14.64 61.61 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -108.95 -11.61 14.96 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 119.257 3.058 . . . . 0.0 119.257 -174.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.63 5.6 89.76 Favored Glycine 0 CA--C 1.571 3.561 0 CA-C-N 120.447 1.476 . . . . 0.0 114.618 -173.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -72.03 -44.62 63.12 Favored 'General case' 0 CA--C 1.565 1.547 0 C-N-CA 125.342 1.457 . . . . 0.0 113.39 176.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 102.98 3.77 48.53 Favored Glycine 0 CA--C 1.563 3.035 0 N-CA-C 117.312 1.685 . . . . 0.0 117.312 -177.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 1.8 t -135.43 141.85 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 101.592 -3.484 . . . . 0.0 101.592 176.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.2 mt -120.58 124.48 72.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 111.967 -2.379 . . . . 0.0 112.789 -176.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 53.7 p30 -92.48 157.67 16.44 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 170.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.8 mt -52.75 -41.2 82.93 Favored Pre-proline 0 CA--C 1.585 2.302 0 CA-C-O 115.126 -2.369 . . . . 0.0 112.967 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -57.08 -31.25 89.73 Favored 'Trans proline' 0 C--N 1.38 2.214 0 C-N-CA 123.702 2.935 . . . . 0.0 116.813 176.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -67.2 -46.57 73.5 Favored 'General case' 0 N--CA 1.505 2.291 0 CA-C-N 123.074 2.67 . . . . 0.0 111.279 176.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.591 ' CE2' HG23 ' A' ' 90' ' ' ILE . 31.2 t80 -63.28 -45.16 92.72 Favored 'General case' 0 CA--C 1.583 2.222 0 CA-C-N 120.643 1.565 . . . . 0.0 110.761 173.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.603 ' HG2' HG21 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -60.0 -41.36 91.93 Favored 'General case' 0 CA--C 1.579 2.06 0 CA-C-O 117.064 -1.446 . . . . 0.0 109.725 175.17 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.23 -25.06 63.21 Favored 'General case' 0 CA--C 1.579 2.067 0 CA-C-N 121.714 2.052 . . . . 0.0 111.783 173.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.1 tp -62.41 -47.13 85.45 Favored 'General case' 0 CA--C 1.573 1.828 0 CA-C-N 120.797 1.635 . . . . 0.0 108.875 172.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . 0.276 31.7 mt -68.12 -46.78 80.81 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.597 0 CA-C-N 119.13 0.877 . . . . 0.0 109.567 175.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt . . . . . 0 CA--C 1.606 3.127 0 C-N-CA 127.334 2.254 . . . . 0.0 116.807 174.047 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 . . . . . 0 CA--C 1.574 1.888 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.51 HG23 ' CE2' ' A' ' 147' ' ' PHE . 4.1 mp -64.99 -55.22 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 116.226 -1.845 . . . . 0.0 109.635 178.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.402 ' HA ' ' HG3' ' A' ' 95' ' ' LYS 0.259 0.6 OUTLIER -62.75 -34.07 76.44 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 122.011 2.187 . . . . 0.0 111.225 177.148 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.0 mtm-85 -52.88 -62.3 1.74 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 121.175 1.807 . . . . 0.0 108.397 173.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.64 -61.54 1.84 Allowed 'General case' 0 C--N 1.355 0.822 0 CA-C-O 114.07 -2.871 . . . . 0.0 115.696 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.586 ' CE2' HD12 ' A' ' 105' ' ' ILE . 3.7 t80 -69.04 -52.86 24.21 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 124.387 3.267 . . . . 0.0 114.128 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.402 ' HG3' ' HA ' ' A' ' 91' ' ' LEU 0.375 26.0 mttt -63.04 -16.34 59.53 Favored 'General case' 0 CA--C 1.593 2.63 0 CA-C-O 115.51 -2.186 . . . . 0.0 111.368 -176.586 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -84.8 -46.83 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.598 2.823 0 CA-C-N 123.188 2.722 . . . . 0.0 108.558 167.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -57.71 -24.32 56.26 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 119.076 2.991 . . . . 0.0 119.076 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -39.24 -45.09 1.32 Allowed 'General case' 0 CA--C 1.589 2.443 0 CA-C-N 121.718 2.054 . . . . 0.0 116.421 176.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 65.29 -58.04 0.29 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 117.792 2.516 . . . . 0.0 117.792 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.559 HD21 HG12 ' A' ' 104' ' ' VAL . 55.8 p30 -68.54 -13.52 62.39 Favored 'General case' 0 CA--C 1.577 1.994 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.59 8.58 86.77 Favored Glycine 0 CA--C 1.551 2.319 0 N-CA-C 120.66 3.024 . . . . 0.0 120.66 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -114.58 -10.39 12.53 Favored 'General case' 0 CA--C 1.578 2.036 0 CA-C-N 119.366 1.583 . . . . 0.0 114.764 177.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 110.41 0.63 29.49 Favored Glycine 0 CA--C 1.55 2.266 0 CA-C-O 116.144 -2.476 . . . . 0.0 116.49 -178.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.559 HG12 HD21 ' A' ' 100' ' ' ASN . 0.5 OUTLIER -115.55 153.26 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 CA-C-N 121.471 2.636 . . . . 0.0 112.199 179.541 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.586 HD12 ' CE2' ' A' ' 94' ' ' PHE . 97.5 mt -121.38 130.57 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-N 112.402 -2.181 . . . . 0.0 106.709 178.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -106.43 -173.27 2.26 Favored 'General case' 0 CA--C 1.573 1.829 0 CA-C-O 122.033 0.92 . . . . 0.0 110.582 176.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -72.31 -38.33 68.74 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.829 -1.17 . . . . 0.0 112.588 178.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -58.76 -46.02 88.42 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 123.542 0.737 . . . . 0.0 112.057 175.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -62.04 -37.79 86.25 Favored 'General case' 0 CA--C 1.586 2.35 0 CA-C-N 120.675 1.58 . . . . 0.0 112.364 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -60.51 -44.89 95.53 Favored 'General case' 0 CA--C 1.571 1.768 0 C-N-CA 124.202 1.001 . . . . 0.0 109.557 173.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -55.43 -46.59 76.69 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 125.049 1.34 . . . . 0.0 112.014 173.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -60.38 -53.39 58.22 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 176.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.99 -28.13 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 -177.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 7.3 tpt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.909 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.485 1.32 0 N-CA-C 102.081 -3.303 . . . . 0.0 102.081 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -57.62 -40.31 78.89 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 117.324 2.342 . . . . 0.0 117.324 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.94 -38.79 76.59 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 114.708 1.374 . . . . 0.0 114.708 178.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -63.83 -51.99 62.16 Favored 'General case' 0 CA--C 1.574 1.868 0 CA-C-N 120.41 1.459 . . . . 0.0 112.713 177.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.1 t -70.98 -46.32 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-O 118.004 -0.998 . . . . 0.0 111.734 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -60.98 -49.14 78.65 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 117.067 -1.444 . . . . 0.0 110.611 176.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -61.91 -43.32 99.08 Favored 'General case' 0 CA--C 1.561 1.368 0 CA-C-N 120.927 1.694 . . . . 0.0 112.977 178.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.7 -45.48 78.64 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-N 120.612 1.551 . . . . 0.0 114.399 177.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -37.87 62.14 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 120.592 1.542 . . . . 0.0 111.903 178.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -63.83 -45.78 88.03 Favored 'General case' 0 CA--C 1.57 1.729 0 CA-C-N 121.71 2.05 . . . . 0.0 109.228 174.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -34.46 78.0 Favored 'General case' 0 CA--C 1.58 2.101 0 CA-C-N 122.229 2.286 . . . . 0.0 112.211 175.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.17 -32.03 58.83 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -77.99 114.21 16.64 Favored 'General case' 0 N--CA 1.513 2.676 0 O-C-N 117.408 -3.307 . . . . 0.0 109.454 175.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -82.06 -30.49 31.33 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 117.419 2.377 . . . . 0.0 117.419 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -86.3 -14.12 44.62 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 121.124 3.75 . . . . 0.0 121.124 -172.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.99 5.2 90.31 Favored Glycine 0 CA--C 1.572 3.61 0 CA-C-N 120.152 1.342 . . . . 0.0 113.895 -172.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -80.6 -51.36 8.83 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 119.145 1.472 . . . . 0.0 110.986 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 110.27 -7.95 30.76 Favored Glycine 0 CA--C 1.548 2.12 0 CA-C-O 115.965 -2.575 . . . . 0.0 116.907 -177.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . 0.307 3.4 m -134.97 121.04 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 101.402 -3.555 . . . . 0.0 101.402 174.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.0 mt -82.18 128.83 38.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 110.672 -2.967 . . . . 0.0 116.592 -172.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 39.3 p30 -93.95 155.5 17.12 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 172.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.61 -43.87 99.37 Favored Pre-proline 0 CA--C 1.583 2.224 0 CA-C-O 114.951 -2.452 . . . . 0.0 112.679 -178.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.37 -32.1 70.85 Favored 'Trans proline' 0 C--N 1.381 2.275 0 CA-C-N 125.1 2.857 . . . . 0.0 115.393 176.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -62.24 -57.87 9.83 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 116.743 -1.599 . . . . 0.0 110.18 175.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.567 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 75.5 t80 -53.14 -41.46 65.12 Favored 'General case' 0 N--CA 1.504 2.249 0 CA-C-N 120.624 1.556 . . . . 0.0 114.54 176.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.3 mtp -65.73 -49.16 69.47 Favored 'General case' 0 CA--C 1.573 1.862 0 O-C-N 121.591 -0.693 . . . . 0.0 110.623 176.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.67 -37.28 83.51 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 123.451 0.7 . . . . 0.0 112.789 175.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -57.66 -49.17 77.37 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 128.437 2.695 . . . . 0.0 110.491 173.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 91.0 mt -68.82 -40.32 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-N 119.698 1.135 . . . . 0.0 110.636 176.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? . . . . . 0 CA--C 1.578 2.052 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 177.888 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.262 1.4 tm-20 . . . . . 0 CA--C 1.584 2.272 0 CA-C-O 113.76 -3.019 . . . . 0.0 109.534 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.485 HG23 ' CE1' ' A' ' 147' ' ' PHE 0.381 1.2 mp -68.67 -58.43 5.84 Favored 'Isoleucine or valine' 0 C--N 1.389 2.305 1 CA-C-N 128.832 5.287 . . . . 0.0 103.275 170.95 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 pp -56.99 -49.58 75.32 Favored 'General case' 0 N--CA 1.503 2.19 0 CA-C-N 121.576 1.989 . . . . 0.0 113.034 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 43.9 mtt85 -67.56 -40.38 84.93 Favored 'General case' 0 CA--C 1.567 1.634 0 CA-C-O 117.397 -1.287 . . . . 0.0 114.013 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.44 -50.62 43.95 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 115.098 -2.382 . . . . 0.0 111.64 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -62.42 -49.26 76.18 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 122.766 2.53 . . . . 0.0 110.136 176.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -60.07 -34.47 73.49 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 116.87 -1.538 . . . . 0.0 114.524 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -77.07 -43.95 31.56 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.949 0 CA-C-N 121.248 1.84 . . . . 0.0 109.729 173.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -49.01 -44.26 41.15 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 125.525 1.53 . . . . 0.0 109.864 177.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -54.63 98.79 0.02 OUTLIER 'General case' 0 CA--C 1.58 2.114 0 C-N-CA 125.65 1.58 . . . . 0.0 110.962 175.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -77.24 -36.69 54.4 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.1 p30 -67.36 -14.68 63.14 Favored 'General case' 0 CA--C 1.579 2.074 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.78 9.64 85.23 Favored Glycine 0 CA--C 1.551 2.334 0 N-CA-C 120.897 3.119 . . . . 0.0 120.897 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 26.7 p30 -115.45 -8.76 12.18 Favored 'General case' 0 CA--C 1.577 2.019 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 177.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 110.58 20.6 7.25 Favored Glycine 0 CA--C 1.552 2.359 0 CA-C-O 117.095 -1.947 . . . . 0.0 114.589 -177.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.5 t -133.34 143.29 39.53 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.718 0 CA-C-N 120.605 2.202 . . . . 0.0 111.446 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 79.3 mt -106.57 136.16 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 126.477 1.911 . . . . 0.0 108.194 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -108.78 -175.8 2.87 Favored 'General case' 0 CA--C 1.575 1.935 0 C-N-CA 123.299 0.639 . . . . 0.0 112.299 176.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -72.03 -52.73 15.56 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 117.126 -1.416 . . . . 0.0 114.64 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -59.05 -37.96 78.26 Favored 'General case' 0 N--CA 1.515 2.803 0 CA-C-N 120.416 1.462 . . . . 0.0 113.864 177.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . 0.362 0.9 OUTLIER -58.29 -48.32 80.84 Favored 'General case' 0 CA--C 1.598 2.8 0 CA-C-O 124.286 1.993 . . . . 0.0 112.4 174.266 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.18 -46.41 90.6 Favored 'General case' 0 CA--C 1.574 1.885 0 CA-C-O 116.582 -1.675 . . . . 0.0 107.212 172.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.439 ' O ' ' SD ' ' A' ' 114' ' ' MET . 60.8 mttt -51.0 -32.52 21.45 Favored 'General case' 0 N--CA 1.515 2.777 0 CA-C-N 122.078 2.217 . . . . 0.0 112.899 172.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -71.86 -49.92 34.01 Favored 'General case' 0 CA--C 1.583 2.235 0 C-N-CA 123.774 0.83 . . . . 0.0 111.92 174.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.7 mt -90.08 -7.64 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.738 0 N-CA-C 118.077 2.621 . . . . 0.0 118.077 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.439 ' SD ' ' O ' ' A' ' 111' ' ' LYS . 13.9 ptm . . . . . 0 N--CA 1.488 1.428 1 N-CA-C 123.485 4.624 . . . . 0.0 123.485 -178.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 75.0 p . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 121.581 0.705 . . . . 0.0 111.377 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -69.4 -27.98 65.76 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -55.56 -42.1 74.2 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-O 117.689 -1.148 . . . . 0.0 110.762 174.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -53.44 -50.33 65.49 Favored 'General case' 0 CA--C 1.57 1.728 0 CA-C-N 119.299 0.954 . . . . 0.0 112.996 174.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.1 p -71.04 -43.48 76.18 Favored 'Isoleucine or valine' 0 C--N 1.359 0.981 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -178.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.37 -49.08 70.67 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 120.037 1.29 . . . . 0.0 110.656 177.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -62.13 -49.43 75.92 Favored 'General case' 0 CA--C 1.573 1.841 0 CA-C-O 118.093 -0.956 . . . . 0.0 112.868 177.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.74 -45.05 90.55 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 177.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 15.9 ttt -69.68 -38.8 77.18 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 116.104 -1.903 . . . . 0.0 111.709 176.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -59.08 -42.07 89.53 Favored 'General case' 0 CA--C 1.576 1.973 0 CA-C-N 122.719 2.509 . . . . 0.0 110.485 173.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -57.45 -44.62 84.9 Favored 'General case' 0 CA--C 1.578 2.054 0 CA-C-N 120.099 1.318 . . . . 0.0 111.351 174.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.33 -18.79 40.94 Favored 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 118.311 2.708 . . . . 0.0 118.311 178.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.43 ' OD2' ' N ' ' A' ' 140' ' ' GLY . 23.0 t0 -82.41 102.99 11.64 Favored 'General case' 0 CA--C 1.574 1.874 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 174.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -81.89 -19.7 40.33 Favored 'General case' 0 CA--C 1.58 2.122 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 177.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -88.03 -14.34 39.26 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 119.128 3.01 . . . . 0.0 119.128 -175.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.94 5.11 90.03 Favored Glycine 0 CA--C 1.568 3.354 0 CA-C-N 119.964 1.256 . . . . 0.0 115.221 -174.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -80.72 -48.09 13.05 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 118.942 1.371 . . . . 0.0 111.353 175.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.43 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . 111.43 -20.12 23.47 Favored Glycine 0 CA--C 1.546 2.028 0 CA-C-O 116.27 -2.406 . . . . 0.0 115.346 -177.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . 0.303 5.7 m -122.28 122.22 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-N 121.438 2.619 . . . . 0.0 103.999 178.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -79.51 130.83 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 117.488 2.403 . . . . 0.0 117.488 -173.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 32.7 p30 -93.95 161.69 14.2 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 170.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 17.4 mt -54.99 -48.4 96.09 Favored Pre-proline 0 CA--C 1.579 2.077 0 CA-C-O 113.994 -2.908 . . . . 0.0 113.73 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -51.45 -27.22 23.81 Favored 'Trans proline' 0 C--N 1.373 1.85 0 CA-C-N 125.932 3.154 . . . . 0.0 119.849 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -72.18 -64.8 0.87 Allowed 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 121.237 1.835 . . . . 0.0 111.012 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.485 ' CE1' HG23 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -48.81 -53.59 18.58 Favored 'General case' 0 N--CA 1.506 2.346 0 C-N-CA 124.717 1.207 . . . . 0.0 110.729 173.738 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.417 ' O ' ' HB2' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -60.82 -40.25 92.04 Favored 'General case' 0 C--N 1.358 0.957 0 CA-C-O 113.681 -3.057 . . . . 0.0 113.938 -179.775 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.02 -48.18 79.86 Favored 'General case' 0 CA--C 1.594 2.651 0 CA-C-N 125.01 3.55 . . . . 0.0 111.533 174.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . 0.295 0.3 OUTLIER -44.55 -47.73 10.24 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 127.851 2.46 . . . . 0.0 111.072 176.937 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 9.6 mt -92.09 -44.14 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.238 0 CA-C-O 117.527 -1.225 . . . . 0.0 111.157 175.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 148' ' ' MET . 33.1 mttp . . . . . 0 N--CA 1.504 2.244 0 N-CA-C 118.453 2.76 . . . . 0.0 118.453 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 . . . . . 0 N--CA 1.506 2.333 0 CA-C-O 122.455 1.121 . . . . 0.0 113.718 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.642 HG23 ' CE2' ' A' ' 147' ' ' PHE . 1.1 mp -55.65 -53.38 37.57 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.711 0 C-N-CA 126.452 1.901 . . . . 0.0 110.412 177.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.9 -46.03 74.77 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.878 1.671 . . . . 0.0 110.656 175.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.8 mtm105 -57.82 -55.57 33.21 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-N 121.011 1.732 . . . . 0.0 110.44 176.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.84 -55.81 15.11 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.477 ' CE2' HD12 ' A' ' 105' ' ' ILE . 18.1 t80 -64.16 -50.58 67.61 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.342 36.2 mttt -67.13 -22.02 65.81 Favored 'General case' 0 CA--C 1.585 2.309 0 CA-C-O 116.556 -1.688 . . . . 0.0 110.068 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.6 t -69.6 -49.73 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 CA-C-N 122.394 2.361 . . . . 0.0 107.534 167.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -54.47 -34.91 62.42 Favored 'General case' 0 CA--C 1.58 2.113 0 N-CA-C 118.09 2.626 . . . . 0.0 118.09 -178.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.271 2.3 t0 -55.92 134.39 52.09 Favored 'General case' 0 CA--C 1.585 2.321 0 C-N-CA 127.513 2.325 . . . . 0.0 115.561 178.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.481 ' HB2' ' HG2' ' A' ' 109' ' ' GLU . . . -67.65 -60.79 2.26 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -76.21 -19.17 58.64 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 117.598 2.444 . . . . 0.0 117.598 -177.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.92 3.74 90.34 Favored Glycine 0 CA--C 1.568 3.346 0 CA-C-N 120.843 1.656 . . . . 0.0 114.754 -173.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -91.48 -17.55 25.54 Favored 'General case' 0 CA--C 1.58 2.126 0 CA-C-N 120.532 2.166 . . . . 0.0 113.395 173.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 113.36 24.46 4.75 Favored Glycine 0 CA--C 1.54 1.64 0 CA-C-O 115.541 -2.81 . . . . 0.0 116.987 -178.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.3 t -127.51 138.69 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 121.826 2.813 . . . . 0.0 109.783 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.477 HD12 ' CE2' ' A' ' 94' ' ' PHE . 61.5 mt -118.5 138.79 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 126.573 1.949 . . . . 0.0 109.582 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -110.22 -169.82 1.53 Allowed 'General case' 0 CA--C 1.585 2.308 0 C-N-CA 125.001 1.32 . . . . 0.0 110.834 176.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -81.59 -54.97 4.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.134 -1.604 . . . . 0.0 114.318 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -60.63 -43.87 97.03 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 117.534 -1.222 . . . . 0.0 112.807 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.481 ' HG2' ' HB2' ' A' ' 99' ' ' ALA . 11.2 tp10 -59.49 -44.44 93.08 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 121.025 1.739 . . . . 0.0 111.268 174.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.96 -51.75 68.34 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 119.486 1.039 . . . . 0.0 109.777 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -52.52 -42.25 64.19 Favored 'General case' 0 CA--C 1.573 1.864 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 175.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -69.75 -53.66 17.35 Favored 'General case' 0 CA--C 1.577 1.994 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 176.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.9 tt -72.72 -29.08 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 118.7 2.852 . . . . 0.0 118.7 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 6.2 tpt . . . . . 0 N--CA 1.491 1.623 0 C-N-CA 125.035 1.334 . . . . 0.0 112.342 178.116 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 18.8 p . . . . . 0 CA--C 1.565 1.544 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.64 -36.81 85.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.792 -1.192 . . . . 0.0 111.934 175.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.61 -49.65 67.95 Favored 'General case' 0 CA--C 1.56 1.329 0 CA-C-O 117.557 -1.211 . . . . 0.0 112.848 176.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -58.09 -46.14 86.01 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-N 120.309 1.413 . . . . 0.0 112.483 176.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 62.4 t -69.34 -43.43 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.346 0 CA-C-O 116.627 -1.654 . . . . 0.0 110.992 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -63.46 -43.73 96.51 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 121.871 2.123 . . . . 0.0 112.467 177.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -64.73 -52.97 54.24 Favored 'General case' 0 CA--C 1.572 1.797 0 CA-C-N 119.517 1.053 . . . . 0.0 110.617 175.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.26 -43.36 96.22 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 177.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -69.68 -42.26 74.37 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 117.318 -1.325 . . . . 0.0 111.521 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -64.96 -36.74 85.38 Favored 'General case' 0 CA--C 1.572 1.813 0 CA-C-N 120.621 1.555 . . . . 0.0 111.252 175.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -64.88 -41.03 95.98 Favored 'General case' 0 CA--C 1.581 2.157 0 CA-C-N 120.884 1.674 . . . . 0.0 109.719 172.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.41 -23.88 67.06 Favored 'General case' 0 CA--C 1.576 1.965 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 174.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -88.39 100.85 13.35 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 171.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -62.13 -16.18 50.83 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 117.912 2.56 . . . . 0.0 117.912 177.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.94 -2.95 20.71 Favored 'General case' 0 N--CA 1.491 1.577 1 N-CA-C 121.958 4.059 . . . . 0.0 121.958 -173.75 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.35 6.98 88.97 Favored Glycine 0 CA--C 1.556 2.633 0 N-CA-C 118.289 2.076 . . . . 0.0 118.289 -178.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -78.56 -36.77 44.1 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 120.246 2.023 . . . . 0.0 114.083 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 96.85 21.92 19.63 Favored Glycine 0 CA--C 1.555 2.584 0 N-CA-C 117.063 1.585 . . . . 0.0 117.063 -177.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -149.67 145.22 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 103.383 -2.821 . . . . 0.0 103.383 176.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.41 HG22 ' O ' ' A' ' 143' ' ' ASP . 0.3 OUTLIER -129.19 133.9 64.91 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -176.405 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.41 ' O ' HG22 ' A' ' 142' ' ' ILE . 19.3 p30 -103.83 165.01 11.31 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 169.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.6 mt -53.19 -45.17 98.44 Favored Pre-proline 0 N--CA 1.505 2.317 0 O-C-N 118.071 -2.893 . . . . 0.0 112.812 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -50.2 -35.03 41.68 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 123.937 3.091 . . . . 0.0 118.601 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -72.98 -45.79 55.95 Favored 'General case' 0 CA--C 1.591 2.53 0 CA-C-N 122.614 2.461 . . . . 0.0 112.937 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.642 ' CE2' HG23 ' A' ' 90' ' ' ILE . 4.7 t80 -56.32 -52.13 65.66 Favored 'General case' 0 N--CA 1.506 2.331 0 CA-C-N 120.726 1.603 . . . . 0.0 110.932 172.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.488 ' HB3' HG21 ' A' ' 90' ' ' ILE 0.259 4.1 ptp -60.59 -39.12 86.93 Favored 'General case' 0 CA--C 1.589 2.452 0 CA-C-O 121.499 0.666 . . . . 0.0 111.057 176.737 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.53 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 17.6 t0 -52.65 -54.34 34.65 Favored 'General case' 0 N--CA 1.492 1.632 1 CA-C-O 109.296 -5.145 . . . . 0.0 106.006 171.823 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.43 -43.39 23.8 Favored 'General case' 0 N--CA 1.515 2.783 0 CA-C-N 123.699 2.954 . . . . 0.0 112.502 174.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.1 mt -73.76 30.26 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.613 3.376 0 C-N-CA 127.12 2.168 . . . . 0.0 109.61 169.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 149' ' ' ASP . 1.3 mmpt? . . . . . 0 N--CA 1.525 3.301 2 C-N-CA 132.888 4.475 . . . . 0.0 122.146 -167.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 . . . . . 0 N--CA 1.5 2.041 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.625 HG23 ' CE ' ' A' ' 148' ' ' MET 0.297 1.1 mp -58.26 -50.9 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-O 117.164 -1.398 . . . . 0.0 111.209 178.004 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 pp -59.58 -42.89 93.53 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 116.967 -1.492 . . . . 0.0 111.668 177.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.86 -54.96 40.96 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 121.273 1.851 . . . . 0.0 111.43 176.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.13 -57.72 11.62 Favored 'General case' 0 C--N 1.358 0.961 0 CA-C-O 116.091 -1.909 . . . . 0.0 114.048 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.441 ' HB3' ' HE1' ' A' ' 148' ' ' MET . 19.2 t80 -58.97 -46.71 87.41 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 120.862 1.665 . . . . 0.0 114.336 178.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -63.72 -34.64 78.34 Favored 'General case' 0 CA--C 1.568 1.664 0 CA-C-O 116.341 -1.79 . . . . 0.0 111.483 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 75.1 t -64.73 -43.78 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 CA-C-N 122.146 2.248 . . . . 0.0 108.181 169.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.56 -31.19 63.96 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 117.272 2.323 . . . . 0.0 117.272 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -75.71 119.26 19.48 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 174.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.85 -71.57 0.06 Allowed 'General case' 0 N--CA 1.514 2.727 0 CA-C-O 123.908 1.813 . . . . 0.0 106.833 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -134.03 -55.3 0.87 Allowed 'General case' 0 CA--C 1.577 2.006 0 CA-C-N 109.682 -3.417 . . . . 0.0 103.977 167.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 30.87 9.58 0.0 OUTLIER Glycine 0 C--N 1.355 1.586 1 N-CA-C 125.548 4.979 . . . . 0.0 125.548 -175.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.2 p30 63.72 12.99 7.05 Favored 'General case' 0 CA--C 1.59 2.517 0 CA-C-N 122.231 3.015 . . . . 0.0 113.047 -171.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 110.76 -15.85 28.79 Favored Glycine 0 CA--C 1.57 3.478 0 CA-C-O 115.796 -2.669 . . . . 0.0 109.211 -170.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -99.59 138.89 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-N 122.436 3.118 . . . . 0.0 116.416 -179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 18.6 mt -105.98 132.32 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 C-N-CA 125.108 1.363 . . . . 0.0 109.806 178.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.54 -174.89 2.64 Favored 'General case' 0 CA--C 1.584 2.263 0 CA-C-O 122.0 0.905 . . . . 0.0 112.398 176.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -72.41 -46.65 54.21 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.672 -1.267 . . . . 0.0 114.021 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -57.54 -49.01 77.75 Favored 'General case' 0 N--CA 1.504 2.273 0 CA-C-O 117.925 -1.036 . . . . 0.0 112.451 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -54.49 -43.72 72.03 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 120.201 1.364 . . . . 0.0 112.948 173.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.61 -55.14 33.94 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 116.981 -1.485 . . . . 0.0 107.642 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.444 ' HA ' ' SD ' ' A' ' 114' ' ' MET . 33.5 mtmm -55.54 -29.15 58.43 Favored 'General case' 0 N--CA 1.503 2.185 0 CA-C-N 121.131 1.787 . . . . 0.0 115.264 176.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -74.91 -53.59 8.76 Favored 'General case' 0 CA--C 1.574 1.902 0 C-N-CA 124.505 1.122 . . . . 0.0 110.746 175.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 tt -79.01 -16.56 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 118.492 2.775 . . . . 0.0 118.492 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.444 ' SD ' ' HA ' ' A' ' 111' ' ' LYS . 15.1 ptm . . . . . 0 N--CA 1.501 2.079 0 N-CA-C 118.062 2.615 . . . . 0.0 118.062 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 41.6 p . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 122.595 1.188 . . . . 0.0 110.631 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -71.44 -31.24 66.98 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-N 113.276 -1.784 . . . . 0.0 114.601 178.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.46 -40.85 75.54 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.52 1.128 . . . . 0.0 113.893 176.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -58.2 -48.78 79.28 Favored 'General case' 0 CA--C 1.584 2.284 0 CA-C-O 122.989 1.376 . . . . 0.0 112.567 176.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.0 t -63.17 -49.69 82.22 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.483 0 C-N-CA 126.852 2.061 . . . . 0.0 111.129 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -58.78 -42.99 90.31 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 124.253 1.021 . . . . 0.0 112.601 176.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -64.51 -48.02 76.72 Favored 'General case' 0 CA--C 1.577 1.989 0 CA-C-N 119.531 1.06 . . . . 0.0 111.828 176.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.57 -44.51 93.29 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 176.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 23.1 ttt -67.35 -39.46 85.76 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 116.866 -1.54 . . . . 0.0 112.412 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -62.07 -39.64 93.11 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 121.283 1.856 . . . . 0.0 111.093 175.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -62.87 -43.46 98.74 Favored 'General case' 0 CA--C 1.58 2.103 0 CA-C-N 119.565 1.075 . . . . 0.0 111.11 172.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -85.73 -8.08 58.39 Favored 'General case' 0 N--CA 1.486 1.338 1 N-CA-C 122.873 4.397 . . . . 0.0 122.873 -179.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.422 ' OD2' ' HA2' ' A' ' 140' ' ' GLY . 24.6 t0 -78.05 114.48 16.97 Favored 'General case' 0 N--CA 1.506 2.328 1 CA-C-O 96.312 -11.327 . . . . 0.0 109.467 177.255 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -81.07 26.49 0.43 Allowed 'General case' 0 C--N 1.26 -3.309 2 O-C-N 62.843 -37.411 . . . . 0.0 116.029 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.372 32.8 t0 92.14 -103.2 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 101.907 -3.368 . . . . 0.0 101.907 -177.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 37.64 7.65 0.0 OUTLIER Glycine 0 CA--C 1.557 2.668 0 N-CA-C 120.564 2.985 . . . . 0.0 120.564 -174.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 157.45 -49.32 0.0 OUTLIER 'General case' 0 CA--C 1.572 1.813 0 C-N-CA 126.856 2.062 . . . . 0.0 114.337 -173.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.422 ' HA2' ' OD2' ' A' ' 135' ' ' ASP . . . 112.65 -23.46 15.09 Favored Glycine 0 CA--C 1.561 2.963 0 CA-C-N 123.241 2.746 . . . . 0.0 113.76 -173.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 19.7 m -115.63 127.55 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 101.921 -3.363 . . . . 0.0 101.921 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.6 mt -79.64 126.77 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 N-CA-C 118.366 2.728 . . . . 0.0 118.366 -172.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -94.0 149.78 20.93 Favored 'General case' 0 CA--C 1.561 1.393 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 171.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -49.58 -46.62 79.05 Favored Pre-proline 0 CA--C 1.574 1.869 0 CA-C-O 115.035 -2.412 . . . . 0.0 114.434 -177.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -57.42 -26.72 72.61 Favored 'Trans proline' 0 C--N 1.371 1.723 0 CA-C-N 124.926 2.795 . . . . 0.0 116.401 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -68.71 -54.86 13.63 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 123.138 2.699 . . . . 0.0 112.113 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -60.48 -46.47 89.97 Favored 'General case' 0 CA--C 1.578 2.057 0 CA-C-N 121.756 2.071 . . . . 0.0 112.612 176.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.625 ' CE ' HG23 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -62.4 -41.25 98.52 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-O 116.895 -1.526 . . . . 0.0 111.684 176.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -68.91 -38.41 79.54 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 121.873 2.124 . . . . 0.0 111.902 175.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.09 -43.36 77.98 Favored 'General case' 0 CA--C 1.565 1.558 0 C-N-CA 126.011 1.725 . . . . 0.0 110.708 175.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 66.7 mt -87.31 -51.83 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 121.279 1.854 . . . . 0.0 112.368 177.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 -178.815 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 . . . . . 0 N--CA 1.504 2.23 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.867 HG23 ' HE2' ' A' ' 147' ' ' PHE . 1.6 mp -65.1 -35.79 76.25 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.013 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 172.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.0 -45.8 71.57 Favored 'General case' 0 N--CA 1.515 2.793 0 CA-C-N 124.048 3.113 . . . . 0.0 109.384 173.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.7 mtm105 -59.81 -56.15 25.37 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 120.642 1.564 . . . . 0.0 110.65 176.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.77 -59.93 3.94 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 116.074 -1.917 . . . . 0.0 114.904 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.495 ' CE2' HD12 ' A' ' 105' ' ' ILE . 24.4 t80 -59.65 -49.13 78.96 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 121.087 1.767 . . . . 0.0 113.297 178.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.371 36.5 mttt -69.11 -23.63 64.02 Favored 'General case' 0 CA--C 1.583 2.227 0 CA-C-O 116.631 -1.652 . . . . 0.0 110.333 -178.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.1 t -68.73 -48.91 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 CA-C-N 122.15 2.25 . . . . 0.0 107.103 166.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -53.3 -33.21 52.33 Favored 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.256 3.7 t0 -67.22 -3.62 8.27 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 117.83 2.53 . . . . 0.0 117.83 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 50.04 24.63 1.43 Allowed 'General case' 0 N--CA 1.524 3.258 0 CA-C-N 124.533 3.333 . . . . 0.0 115.404 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . 0.284 11.4 t-20 82.49 -53.1 0.21 Allowed 'General case' 0 CA--C 1.575 1.915 0 C-N-CA 129.834 3.254 . . . . 0.0 105.795 -170.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 30.94 20.55 0.0 OUTLIER Glycine 0 C--N 1.363 2.034 1 N-CA-C 125.272 4.869 . . . . 0.0 125.272 178.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 67.04 14.08 9.7 Favored 'General case' 0 CA--C 1.593 2.612 0 CA-C-N 120.821 2.311 . . . . 0.0 113.61 -173.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.89 -5.89 56.67 Favored Glycine 0 CA--C 1.568 3.373 0 CA-C-O 116.688 -2.173 . . . . 0.0 111.127 -172.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.4 t -117.37 136.42 54.57 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.94 0 CA-C-N 121.059 2.429 . . . . 0.0 113.385 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.495 HD12 ' CE2' ' A' ' 94' ' ' PHE . 67.9 mt -92.23 140.56 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 C-N-CA 126.587 1.955 . . . . 0.0 108.282 176.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.3 p30 -110.12 179.52 4.08 Favored 'General case' 0 CA--C 1.572 1.803 0 CA-C-O 122.666 1.222 . . . . 0.0 110.795 175.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -70.94 -43.01 69.09 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 117.391 -1.29 . . . . 0.0 114.437 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -63.62 -45.89 88.21 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 120.124 1.329 . . . . 0.0 112.157 177.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -58.86 -48.54 81.03 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 121.464 1.938 . . . . 0.0 112.731 175.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -59.1 -49.02 79.46 Favored 'General case' 0 CA--C 1.568 1.661 0 C-N-CA 123.502 0.721 . . . . 0.0 109.36 175.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 21.8 tptp -62.73 -12.81 26.28 Favored 'General case' 0 CA--C 1.577 2.01 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 175.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -93.3 -43.55 8.75 Favored 'General case' 0 CA--C 1.584 2.266 0 O-C-N 120.448 -1.407 . . . . 0.0 111.334 173.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -92.66 -29.24 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 1 N-CA-C 122.064 4.098 . . . . 0.0 122.064 -174.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 19.3 tpt . . . . . 0 N--CA 1.492 1.66 0 C-N-CA 126.001 1.72 . . . . 0.0 115.166 -176.775 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 38.0 p . . . . . 0 N--CA 1.487 1.41 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.17 -32.53 70.52 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.43 -44.45 96.4 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-O 116.594 -1.67 . . . . 0.0 113.619 177.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -43.36 97.19 Favored 'General case' 0 CA--C 1.577 1.996 0 CA-C-N 121.557 1.98 . . . . 0.0 113.68 178.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.5 t -70.62 -52.77 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-O 117.667 -1.159 . . . . 0.0 112.174 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -60.84 -47.15 87.65 Favored 'General case' 0 CA--C 1.558 1.272 0 CA-C-N 119.672 1.124 . . . . 0.0 111.451 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -61.57 -46.91 87.89 Favored 'General case' 0 CA--C 1.57 1.735 0 CA-C-N 120.653 1.57 . . . . 0.0 112.417 177.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.3 -43.77 96.91 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 177.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 17.5 ttt -73.7 -36.48 65.27 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 116.594 -1.67 . . . . 0.0 112.163 177.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -61.36 -44.15 97.67 Favored 'General case' 0 CA--C 1.569 1.692 0 CA-C-N 122.116 2.234 . . . . 0.0 109.982 173.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -64.74 -42.63 95.05 Favored 'General case' 0 CA--C 1.577 2.016 0 CA-C-N 120.922 1.692 . . . . 0.0 111.81 175.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -77.08 -21.15 54.79 Favored 'General case' 0 CA--C 1.564 1.484 0 N-CA-C 118.431 2.752 . . . . 0.0 118.431 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -87.53 113.46 23.25 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 103.66 -2.718 . . . . 0.0 103.66 175.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . 0.256 5.9 mt-10 -80.27 -18.17 50.08 Favored 'General case' 0 CA--C 1.576 1.948 0 CA-C-N 113.523 -1.672 . . . . 0.0 115.312 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -92.13 -15.61 27.44 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 117.035 2.235 . . . . 0.0 117.035 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.14 5.97 89.72 Favored Glycine 0 CA--C 1.564 3.108 0 CA-C-N 120.196 1.362 . . . . 0.0 116.081 -175.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -93.39 -45.85 7.61 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-O 117.267 -1.349 . . . . 0.0 114.088 177.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 114.29 22.63 5.12 Favored Glycine 0 CA--C 1.561 2.95 0 N-CA-C 118.111 2.004 . . . . 0.0 118.111 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.97 143.49 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.527 0 N-CA-C 102.836 -3.024 . . . . 0.0 102.836 174.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.445 HD13 HG21 ' A' ' 142' ' ' ILE . 1.0 OUTLIER -132.69 139.97 48.55 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -175.736 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 59.6 p30 -96.96 165.57 12.02 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 170.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.3 mt -56.13 -43.64 99.34 Favored Pre-proline 0 N--CA 1.5 2.048 0 CA-C-O 115.007 -2.425 . . . . 0.0 112.826 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.441 ' O ' ' HB2' ' A' ' 149' ' ' ASP . 69.2 Cg_exo -55.25 -40.74 84.08 Favored 'Trans proline' 0 C--N 1.372 1.816 0 CA-C-N 124.491 2.64 . . . . 0.0 116.124 178.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -65.23 -52.85 51.95 Favored 'General case' 0 N--CA 1.505 2.276 0 CA-C-N 124.507 3.322 . . . . 0.0 113.321 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.867 ' HE2' HG23 ' A' ' 90' ' ' ILE . 22.9 t80 -54.33 -52.13 62.51 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 120.265 1.393 . . . . 0.0 113.053 172.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.524 ' HE2' ' HB2' ' A' ' 148' ' ' MET . 0.0 OUTLIER -68.62 -34.91 76.57 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 117.734 -1.127 . . . . 0.0 113.405 179.36 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 145' ' ' PRO . 4.1 t70 -64.3 -35.25 80.23 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 119.478 1.035 . . . . 0.0 111.346 171.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -58.44 -52.13 66.91 Favored 'General case' 0 CA--C 1.562 1.431 0 C-N-CA 125.295 1.438 . . . . 0.0 110.07 173.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 95.9 mt -70.08 -53.5 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-O 117.592 -1.194 . . . . 0.0 113.321 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 17.5 pttm . . . . . 0 CA--C 1.569 1.704 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -179.598 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 . . . . . 0 N--CA 1.498 1.962 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.502 ' H ' HD12 ' A' ' 90' ' ' ILE . 2.7 mp -61.58 -55.65 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 124.338 1.055 . . . . 0.0 111.482 178.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.1 pp -59.28 -41.97 90.16 Favored 'General case' 0 CA--C 1.556 1.211 0 CA-C-O 118.732 -0.652 . . . . 0.0 112.139 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 25.4 ttp85 -57.29 -55.47 34.37 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 117.617 -1.182 . . . . 0.0 110.008 176.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.34 -59.76 3.69 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.535 ' HB2' ' CE2' ' A' ' 147' ' ' PHE . 5.3 t80 -69.69 -48.7 58.75 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 121.652 2.024 . . . . 0.0 114.285 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.455 ' HG2' HD13 ' A' ' 144' ' ' ILE 0.326 47.5 mttt -64.16 -20.48 66.02 Favored 'General case' 0 CA--C 1.586 2.36 0 CA-C-O 115.635 -2.126 . . . . 0.0 110.737 -178.666 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -80.29 -46.73 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.403 0 CA-C-N 123.09 2.677 . . . . 0.0 108.497 169.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -54.78 -38.45 67.28 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -49.35 110.2 0.35 Allowed 'General case' 0 CA--C 1.575 1.909 0 C-N-CA 126.258 1.823 . . . . 0.0 112.262 178.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.466 ' HB2' ' HG2' ' A' ' 109' ' ' GLU . . . -41.97 -75.59 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 -177.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -94.55 0.69 55.43 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 117.425 2.38 . . . . 0.0 117.425 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.94 6.49 88.33 Favored Glycine 0 CA--C 1.554 2.518 0 CA-C-O 116.476 -2.291 . . . . 0.0 118.316 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -88.96 -3.72 58.65 Favored 'General case' 0 CA--C 1.585 2.301 0 CA-C-N 121.902 2.851 . . . . 0.0 113.987 174.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.14 -22.31 18.47 Favored Glycine 0 CA--C 1.54 1.595 0 CA-C-O 115.814 -2.659 . . . . 0.0 116.869 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.1 m -92.52 140.64 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.358 0 CA-C-N 122.333 3.066 . . . . 0.0 112.371 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.47 HD12 ' CE2' ' A' ' 94' ' ' PHE . 89.7 mt -110.35 121.56 63.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 N-CA-C 100.477 -3.897 . . . . 0.0 100.477 172.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.438 ' HA ' HG12 ' A' ' 141' ' ' VAL . 2.4 p30 -92.93 169.13 10.68 Favored 'General case' 0 CA--C 1.559 1.305 0 CA-C-O 122.31 1.052 . . . . 0.0 113.327 178.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -67.67 -45.0 76.47 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 117.661 -1.161 . . . . 0.0 113.501 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -65.65 -45.86 81.38 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 117.284 -1.341 . . . . 0.0 112.224 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.466 ' HG2' ' HB2' ' A' ' 99' ' ' ALA . 25.3 tp10 -64.42 -40.67 96.21 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 121.439 1.927 . . . . 0.0 112.409 176.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -63.38 -51.78 64.44 Favored 'General case' 0 CA--C 1.577 2.017 0 CA-C-N 120.26 1.391 . . . . 0.0 108.838 175.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -49.01 -42.83 39.4 Favored 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 125.384 1.474 . . . . 0.0 112.709 175.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -68.54 -60.47 2.4 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 123.675 0.79 . . . . 0.0 111.441 175.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.7 tt -62.16 -16.29 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 117.508 2.41 . . . . 0.0 117.508 -177.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 13.7 tpt . . . . . 0 N--CA 1.493 1.701 0 C-N-CA 125.202 1.401 . . . . 0.0 109.006 175.488 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 18.4 p . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 103.118 -2.919 . . . . 0.0 103.118 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -64.12 -30.83 71.87 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 116.817 2.155 . . . . 0.0 116.817 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.18 -36.91 83.31 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-O 117.297 -1.335 . . . . 0.0 113.54 177.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -59.94 -51.11 71.06 Favored 'General case' 0 CA--C 1.576 1.963 0 CA-C-N 120.269 1.395 . . . . 0.0 112.595 177.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 24.4 t -68.28 -51.77 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.311 0 C-N-CA 124.617 1.167 . . . . 0.0 111.936 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -60.01 -46.4 89.62 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 120.057 1.299 . . . . 0.0 112.22 178.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -62.42 -43.1 99.61 Favored 'General case' 0 CA--C 1.57 1.748 0 CA-C-N 120.087 1.312 . . . . 0.0 111.928 176.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.7 -47.81 79.67 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-N 119.904 1.229 . . . . 0.0 114.113 176.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 14.7 ttt -70.46 -39.41 74.31 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 114.417 -2.706 . . . . 0.0 109.874 177.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -58.5 -39.27 79.59 Favored 'General case' 0 CA--C 1.582 2.199 0 CA-C-N 124.867 3.485 . . . . 0.0 110.224 173.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -60.7 -45.27 94.85 Favored 'General case' 0 CA--C 1.582 2.178 0 CA-C-N 121.494 1.952 . . . . 0.0 110.954 173.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.65 -11.44 59.08 Favored 'General case' 0 CA--C 1.58 2.104 0 N-CA-C 117.173 2.286 . . . . 0.0 117.173 178.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -91.84 115.2 27.86 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 101.22 -3.622 . . . . 0.0 101.22 167.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -69.18 -20.6 64.0 Favored 'General case' 0 CA--C 1.561 1.38 0 N-CA-C 119.846 3.276 . . . . 0.0 119.846 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -145.96 25.93 1.26 Allowed 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 120.99 3.7 . . . . 0.0 120.99 -174.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.29 7.68 88.31 Favored Glycine 0 CA--C 1.555 2.59 0 N-CA-C 117.237 1.655 . . . . 0.0 117.237 -177.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -66.78 -44.8 80.37 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-N 120.303 2.052 . . . . 0.0 112.99 176.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 103.0 -21.43 40.15 Favored Glycine 0 CA--C 1.55 2.254 0 N-CA-C 117.032 1.573 . . . . 0.0 117.032 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.438 HG12 ' HA ' ' A' ' 106' ' ' ASP . 13.8 m -126.12 138.6 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 103.693 -2.706 . . . . 0.0 103.693 176.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.1 mt -104.71 133.7 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 114.032 -1.44 . . . . 0.0 113.622 -174.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 28.0 p30 -95.44 152.12 18.69 Favored 'General case' 0 CA--C 1.565 1.52 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 171.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.455 HD13 ' HG2' ' A' ' 95' ' ' LYS . 0.4 OUTLIER -52.28 -45.16 94.62 Favored Pre-proline 0 CA--C 1.583 2.241 0 CA-C-O 114.772 -2.537 . . . . 0.0 114.001 -177.836 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.43 -29.65 78.56 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 123.735 2.957 . . . . 0.0 117.716 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -60.01 -55.57 32.34 Favored 'General case' 0 N--CA 1.505 2.286 0 CA-C-N 121.209 1.822 . . . . 0.0 112.125 176.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.535 ' CE2' ' HB2' ' A' ' 94' ' ' PHE . 36.4 t80 -55.67 -51.91 65.63 Favored 'General case' 0 CA--C 1.577 2.005 0 C-N-CA 126.61 1.964 . . . . 0.0 111.075 173.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 4.7 mtp -56.59 -46.84 80.62 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 117.015 -1.469 . . . . 0.0 111.793 177.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.25 -35.75 74.02 Favored 'General case' 0 CA--C 1.576 1.949 0 CA-C-N 120.837 1.653 . . . . 0.0 111.016 176.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.46 -35.87 65.96 Favored 'General case' 0 CA--C 1.577 2.016 0 CA-C-N 120.327 1.421 . . . . 0.0 110.205 172.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 85.7 mt -82.57 -59.6 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.451 0 CA-C-N 120.572 1.533 . . . . 0.0 109.987 175.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 96.8 mttt . . . . . 0 CA--C 1.578 2.028 1 N-CA-C 122.243 4.164 . . . . 0.0 122.243 -176.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 117.58 2.437 . . . . 0.0 117.58 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -57.16 -46.33 82.86 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 -176.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.19 -42.36 96.69 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 120.132 1.333 . . . . 0.0 114.524 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.636 HG23 ' CE2' ' A' ' 147' ' ' PHE . 2.0 mp -68.84 -48.3 71.48 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.43 0 CA-C-O 116.762 -1.59 . . . . 0.0 109.92 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.5 pp -62.92 -38.43 90.95 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 121.559 1.981 . . . . 0.0 110.372 176.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -56.88 -58.0 10.06 Favored 'General case' 0 CA--C 1.574 1.883 0 CA-C-N 120.945 1.702 . . . . 0.0 109.429 174.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.85 -57.72 11.24 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 117.283 -1.342 . . . . 0.0 114.337 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.468 ' CE2' HD12 ' A' ' 105' ' ' ILE . 18.1 t80 -57.23 -46.42 82.98 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 119.905 1.23 . . . . 0.0 112.518 177.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -62.41 -35.3 78.81 Favored 'General case' 0 CA--C 1.565 1.532 0 CA-C-O 116.037 -1.935 . . . . 0.0 112.363 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.2 t -66.6 -43.28 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 CA-C-N 122.451 2.387 . . . . 0.0 107.935 170.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -55.82 -41.24 73.93 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -66.07 114.17 5.02 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 174.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.29 50.83 0.66 Allowed 'General case' 0 N--CA 1.507 2.397 0 CA-C-O 123.304 1.526 . . . . 0.0 111.577 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . 0.296 10.1 t-20 84.9 -61.93 0.08 Allowed 'General case' 0 CA--C 1.57 1.716 0 C-N-CA 128.699 2.799 . . . . 0.0 103.968 -170.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 28.97 15.23 0.0 OUTLIER Glycine 0 C--N 1.357 1.699 1 N-CA-C 125.074 4.79 . . . . 0.0 125.074 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.2 p30 64.51 13.34 8.11 Favored 'General case' 0 CA--C 1.597 2.783 0 CA-C-N 121.74 2.77 . . . . 0.0 112.269 -169.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.85 -6.49 54.49 Favored Glycine 0 CA--C 1.559 2.84 0 CA-C-O 115.968 -2.573 . . . . 0.0 111.264 -171.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -101.86 144.44 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.709 0 CA-C-N 121.818 2.809 . . . . 0.0 113.985 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.468 HD12 ' CE2' ' A' ' 94' ' ' PHE . 57.3 mt -111.78 128.68 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-N 113.196 -1.82 . . . . 0.0 108.681 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -106.58 -176.72 3.16 Favored 'General case' 0 CA--C 1.572 1.822 0 CA-C-O 121.739 0.78 . . . . 0.0 112.102 176.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -70.69 -49.63 45.19 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.861 -1.15 . . . . 0.0 113.793 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -62.49 -42.91 99.82 Favored 'General case' 0 CA--C 1.578 2.052 0 CA-C-O 117.427 -1.273 . . . . 0.0 111.461 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -54.13 -44.81 71.68 Favored 'General case' 0 CA--C 1.573 1.842 0 CA-C-N 121.558 1.981 . . . . 0.0 112.332 173.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -69.38 -49.53 54.56 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -58.75 -15.86 14.08 Favored 'General case' 0 CA--C 1.58 2.1 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 173.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -93.33 -53.32 4.14 Favored 'General case' 0 CA--C 1.582 2.18 0 CA-C-N 120.129 1.331 . . . . 0.0 110.995 173.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.48 -23.12 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 120.13 3.382 . . . . 0.0 120.13 -175.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -44.76 -56.28 4.6 Favored 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 125.034 1.334 . . . . 0.0 112.078 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.486 ' H ' ' HG3' ' A' ' 121' ' ' PRO . 36.6 mm-40 -94.5 88.1 5.36 Favored 'General case' 0 CA--C 1.562 1.437 0 N-CA-C 103.179 -2.897 . . . . 0.0 103.179 174.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -32.71 -29.76 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.724 1 N-CA-C 122.236 4.162 . . . . 0.0 122.236 -179.767 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 26.1 t -91.76 94.32 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-N 122.186 2.267 . . . . 0.0 108.046 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.05 -140.67 45.69 Favored Glycine 0 CA--C 1.549 2.16 0 N-CA-C 116.143 1.217 . . . . 0.0 116.143 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -89.73 47.75 1.5 Allowed 'General case' 0 CA--C 1.581 2.15 0 N-CA-C 114.86 1.429 . . . . 0.0 114.86 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.303 55.0 tt0 -77.42 -16.59 0.26 Allowed Pre-proline 0 CA--C 1.575 1.926 0 CA-C-O 111.944 -3.884 . . . . 0.0 117.693 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.486 ' HG3' ' H ' ' A' ' 115' ' ' GLN . 27.2 Cg_exo -52.05 99.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.386 2.548 1 CA-C-N 128.462 4.058 . . . . 0.0 115.735 177.854 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.4 0.0 OUTLIER -74.18 -56.95 4.3 Favored 'General case' 0 CA--C 1.576 1.969 0 CA-C-N 109.706 -3.406 . . . . 0.0 114.717 -174.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 10.4 p -112.87 125.78 54.73 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 125.918 3.963 . . . . 0.0 104.89 175.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.96 -34.82 75.96 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 113.239 -1.8 . . . . 0.0 115.468 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.24 -39.79 76.29 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -59.85 -49.47 77.59 Favored 'General case' 0 CA--C 1.584 2.285 0 CA-C-O 122.261 1.029 . . . . 0.0 112.317 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.3 t -64.54 -50.44 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.793 0 C-N-CA 126.101 1.76 . . . . 0.0 111.184 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -58.3 -42.99 87.86 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 123.52 0.728 . . . . 0.0 112.674 176.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -61.41 -51.15 69.96 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.531 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.18 -45.32 93.53 Favored 'General case' 0 CA--C 1.561 1.393 0 N-CA-C 115.435 1.642 . . . . 0.0 115.435 177.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.6 ttt -71.44 -42.1 68.66 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 117.328 -1.32 . . . . 0.0 111.748 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.46 -43.85 84.35 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 120.907 1.685 . . . . 0.0 110.744 174.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.59 -30.11 68.79 Favored 'General case' 0 CA--C 1.581 2.146 0 CA-C-N 121.165 1.802 . . . . 0.0 113.043 174.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.37 -23.51 37.65 Favored 'General case' 0 CA--C 1.582 2.183 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.603 ' OD2' ' HA2' ' A' ' 140' ' ' GLY . 17.8 t0 -84.72 108.17 17.28 Favored 'General case' 0 CA--C 1.578 2.043 0 N-CA-C 104.079 -2.563 . . . . 0.0 104.079 171.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -76.09 -29.05 57.78 Favored 'General case' 0 CA--C 1.587 2.382 0 CA-C-N 120.556 1.525 . . . . 0.0 113.515 177.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.274 0.1 OUTLIER -166.02 -75.93 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.376 1 N-CA-C 99.075 -4.416 . . . . 0.0 99.075 177.127 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 34.15 30.13 0.01 OUTLIER Glycine 0 C--N 1.372 2.531 0 CA-C-N 123.309 2.777 . . . . 0.0 119.399 175.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.38 -3.21 0.68 Allowed 'General case' 0 CA--C 1.593 2.615 0 CA-C-N 119.629 1.715 . . . . 0.0 114.438 -172.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.603 ' HA2' ' OD2' ' A' ' 135' ' ' ASP . . . 106.41 -23.34 28.75 Favored Glycine 0 CA--C 1.559 2.817 0 CA-C-N 122.983 2.629 . . . . 0.0 113.78 -175.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . 0.257 27.8 m -118.6 133.43 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 103.542 -2.762 . . . . 0.0 103.542 178.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.03 126.93 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 117.492 2.404 . . . . 0.0 117.492 -172.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.4 p30 -90.76 156.2 18.23 Favored 'General case' 0 CA--C 1.564 1.502 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 172.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 5.5 mt -55.72 -49.31 93.56 Favored Pre-proline 0 CA--C 1.574 1.886 0 CA-C-O 114.482 -2.675 . . . . 0.0 114.191 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -52.26 -31.62 47.21 Favored 'Trans proline' 0 C--N 1.374 1.908 0 CA-C-N 125.434 2.977 . . . . 0.0 116.444 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -63.21 -61.06 2.62 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 121.142 1.792 . . . . 0.0 114.326 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.636 ' CE2' HG23 ' A' ' 90' ' ' ILE . 27.9 t80 -53.26 -50.78 64.12 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 120.179 1.354 . . . . 0.0 113.682 177.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.461 ' HE3' HG22 ' A' ' 90' ' ' ILE 0.255 0.1 OUTLIER -68.77 -47.23 66.74 Favored 'General case' 0 C--N 1.352 0.711 0 CA-C-O 113.924 -2.941 . . . . 0.0 111.18 179.229 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.28 -29.45 69.87 Favored 'General case' 0 CA--C 1.586 2.345 0 CA-C-N 125.585 3.812 . . . . 0.0 112.715 175.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . 0.291 5.3 tt -57.98 -40.95 81.94 Favored 'General case' 0 CA--C 1.575 1.922 0 C-N-CA 125.711 1.605 . . . . 0.0 109.799 172.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 55.7 mt -90.4 -64.73 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.604 3.034 0 CA-C-N 120.312 1.414 . . . . 0.0 109.941 173.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.24 7.76 2.03 Favored 'General case' 0 CA--C 1.591 2.556 0 N-CA-C 121.018 3.71 . . . . 0.0 121.018 -179.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -12.89 -8.04 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.886 1 N-CA-C 129.212 6.745 . . . . 0.0 129.212 -172.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 52.2 m . . . . . 0 N--CA 1.502 2.143 0 C-N-CA 124.072 0.949 . . . . 0.0 110.109 175.918 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 . . . . . 0 N--CA 1.5 2.027 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -62.0 -54.17 45.41 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 120.543 1.52 . . . . 0.0 112.835 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.42 -44.3 84.51 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.654 HG21 ' HB3' ' A' ' 148' ' ' MET . 6.7 mt -69.22 -52.67 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.118 0 CA-C-O 116.153 -1.879 . . . . 0.0 110.986 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.2 pp -55.66 -43.66 76.5 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 121.555 1.98 . . . . 0.0 108.84 176.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -54.67 -49.31 70.93 Favored 'General case' 0 CA--C 1.571 1.782 0 CA-C-N 121.184 1.811 . . . . 0.0 112.69 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.95 -56.72 10.27 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-O 116.03 -1.938 . . . . 0.0 114.666 178.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.482 ' CE2' HD12 ' A' ' 105' ' ' ILE . 10.1 t80 -64.83 -42.3 95.05 Favored 'General case' 0 N--CA 1.509 2.479 0 CA-C-N 122.47 2.396 . . . . 0.0 112.734 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.285 6.1 mmpt? -62.56 -30.44 71.32 Favored 'General case' 0 CA--C 1.577 1.995 0 CA-C-O 117.625 -1.178 . . . . 0.0 110.869 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.8 t -71.69 -50.16 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-N 120.451 1.478 . . . . 0.0 108.324 169.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -58.0 -37.91 75.14 Favored 'General case' 0 CA--C 1.579 2.063 0 N-CA-C 116.728 2.121 . . . . 0.0 116.728 -177.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.297 6.5 t0 -59.33 90.6 0.02 OUTLIER 'General case' 0 CA--C 1.571 1.761 0 C-N-CA 128.495 2.718 . . . . 0.0 109.967 176.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.07 -49.06 66.33 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.534 -0.729 . . . . 0.0 112.106 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -48.68 -24.86 1.52 Allowed 'General case' 0 CA--C 1.585 2.298 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 175.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.59 8.59 86.76 Favored Glycine 0 CA--C 1.56 2.884 0 CA-C-N 122.04 2.2 . . . . 0.0 116.953 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.06 86.61 2.22 Favored 'General case' 0 N--CA 1.473 0.723 1 CA-C-O 110.533 -4.556 . . . . 0.0 107.039 176.596 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 54.72 -25.11 0.01 OUTLIER Glycine 0 N--CA 1.489 2.214 2 N-CA-C 130.798 7.079 . . . . 0.0 130.798 162.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.7 p -114.39 151.95 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.811 0 CA-C-O 122.726 1.25 . . . . 0.0 112.887 -178.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.482 HD12 ' CE2' ' A' ' 94' ' ' PHE . 63.4 mt -129.34 136.25 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 CA-C-N 113.55 -1.659 . . . . 0.0 111.317 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -115.75 -177.8 3.24 Favored 'General case' 0 CA--C 1.589 2.471 0 C-N-CA 124.087 0.955 . . . . 0.0 110.062 174.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -74.21 -47.25 36.66 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 -176.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -61.65 -42.78 99.37 Favored 'General case' 0 N--CA 1.514 2.729 0 CA-C-N 122.256 2.298 . . . . 0.0 113.539 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -56.03 -39.89 72.63 Favored 'General case' 0 N--CA 1.504 2.243 0 CA-C-N 119.325 0.966 . . . . 0.0 111.678 173.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -63.38 -46.57 85.85 Favored 'General case' 0 CA--C 1.571 1.787 0 C-N-CA 124.914 1.286 . . . . 0.0 109.36 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -53.5 -50.86 64.5 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 123.89 0.876 . . . . 0.0 111.668 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -57.77 -53.83 53.78 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 176.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.5 tt -74.0 -29.3 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 119.366 3.099 . . . . 0.0 119.366 -176.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.443 ' SD ' ' HA ' ' A' ' 127' ' ' VAL . 6.3 tpt -48.56 -49.04 38.12 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 177.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -66.4 35.84 0.02 OUTLIER 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 121.487 3.884 . . . . 0.0 121.487 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 31.07 -85.34 0.0 OUTLIER 'General case' 0 N--CA 1.531 3.582 0 N-CA-C 118.439 2.755 . . . . 0.0 118.439 174.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.6 t -117.48 95.36 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 82.83 -144.57 23.03 Favored Glycine 0 CA--C 1.547 2.072 0 CA-C-N 114.819 -1.082 . . . . 0.0 113.478 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 54.96 167.2 0.02 OUTLIER 'General case' 0 N--CA 1.511 2.584 0 N-CA-C 116.323 1.972 . . . . 0.0 116.323 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -144.75 112.8 4.96 Favored Pre-proline 0 CA--C 1.576 1.969 0 CA-C-O 113.407 -3.187 . . . . 0.0 107.804 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . 0.49 0.1 OUTLIER 20.25 47.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.393 2.876 0 CA-C-N 127.823 3.83 . . . . 0.0 121.989 -174.51 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.415 2.2 tm? -63.28 -71.28 0.17 Allowed 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 109.004 -3.725 . . . . 0.0 105.493 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.418 ' OG1' ' HG2' ' A' ' 126' ' ' GLU . 1.4 p -92.76 116.28 28.88 Favored 'General case' 0 CA--C 1.557 1.239 0 N-CA-C 102.273 -3.232 . . . . 0.0 102.273 171.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -67.6 -34.75 77.64 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 115.925 1.824 . . . . 0.0 115.925 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.75 -38.7 75.81 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-O 116.74 -1.6 . . . . 0.0 113.279 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.418 ' HG2' ' OG1' ' A' ' 123' ' ' THR . 9.2 pt-20 -68.29 -39.46 82.08 Favored 'General case' 0 CA--C 1.572 1.812 0 CA-C-N 121.442 1.928 . . . . 0.0 112.456 176.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.443 ' HA ' ' SD ' ' A' ' 114' ' ' MET . 0.4 OUTLIER -70.39 -48.56 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 119.216 0.916 . . . . 0.0 112.32 177.766 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -66.59 -49.4 66.46 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 116.77 -1.586 . . . . 0.0 109.504 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -55.98 -47.96 76.71 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 122.256 2.298 . . . . 0.0 113.526 176.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.78 -46.2 89.12 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-O 117.644 -1.169 . . . . 0.0 113.85 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 14.8 ttt -77.21 -37.21 53.9 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 116.478 -1.725 . . . . 0.0 110.658 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -32.9 69.83 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 123.927 3.058 . . . . 0.0 109.977 172.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -73.3 -44.22 59.5 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-O 116.309 -1.805 . . . . 0.0 110.477 176.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -80.73 -35.38 33.53 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 117.611 2.448 . . . . 0.0 117.611 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -90.3 119.81 30.92 Favored 'General case' 0 N--CA 1.514 2.771 1 O-C-N 116.099 -4.126 . . . . 0.0 106.069 176.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -75.27 -32.9 61.18 Favored 'General case' 0 CA--C 1.58 2.109 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 177.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.301 0.1 OUTLIER 175.75 -73.49 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.368 1 N-CA-C 96.516 -5.364 . . . . 0.0 96.516 178.771 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 34.92 32.16 0.02 OUTLIER Glycine 0 C--N 1.373 2.616 0 CA-C-N 123.681 2.946 . . . . 0.0 118.696 174.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 55.0 17.79 2.0 Favored 'General case' 0 CA--C 1.592 2.59 0 CA-C-O 115.739 -2.077 . . . . 0.0 115.18 -173.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 92.81 -22.36 34.29 Favored Glycine 0 C--N 1.38 3.009 0 CA-C-N 124.486 3.312 . . . . 0.0 114.979 -176.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.27 146.68 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 176.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.7 mt -123.1 131.42 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 112.594 -2.094 . . . . 0.0 110.375 -177.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 42.3 p30 -97.88 158.64 15.41 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 105.199 -2.149 . . . . 0.0 105.199 171.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -56.33 -44.57 99.78 Favored Pre-proline 0 CA--C 1.587 2.385 0 CA-C-O 114.971 -2.442 . . . . 0.0 112.833 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.18 -36.15 35.75 Favored 'Trans proline' 0 C--N 1.382 2.342 0 C-N-CA 124.294 3.329 . . . . 0.0 117.107 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -65.61 -56.17 13.67 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 121.623 2.01 . . . . 0.0 110.835 175.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.451 ' CE2' ' HB2' ' A' ' 94' ' ' PHE . 21.4 t80 -55.38 -50.14 70.49 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.654 ' HB3' HG21 ' A' ' 90' ' ' ILE 0.257 4.0 ptp -66.34 -41.73 89.16 Favored 'General case' 0 CA--C 1.577 2.019 0 CA-C-O 117.478 -1.249 . . . . 0.0 111.316 178.204 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -60.2 -35.07 74.57 Favored 'General case' 0 N--CA 1.508 2.46 0 CA-C-N 121.018 1.736 . . . . 0.0 114.258 173.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . 0.356 6.8 tt -69.15 -34.73 75.44 Favored 'General case' 0 CA--C 1.567 1.627 0 C-N-CA 127.838 2.455 . . . . 0.0 110.302 176.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 79.2 mt -69.52 -48.79 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 CA-C-N 121.051 1.751 . . . . 0.0 106.879 171.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.71 -56.2 15.12 Favored 'General case' 0 CA--C 1.581 2.135 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 177.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -96.42 -70.74 0.7 Allowed 'General case' 0 CA--C 1.565 1.527 0 C-N-CA 125.122 1.369 . . . . 0.0 113.752 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.529 3.479 0 C-N-CA 126.228 1.811 . . . . 0.0 108.785 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.508 2.429 0 N-CA-C 115.954 1.835 . . . . 0.0 115.954 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -39.77 -47.84 2.13 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 127.496 2.318 . . . . 0.0 114.545 174.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -45.45 -73.07 0.05 OUTLIER 'General case' 0 CA--C 1.581 2.145 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.455 ' H ' HD12 ' A' ' 90' ' ' ILE . 0.7 OUTLIER -78.12 -52.71 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -178.341 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -63.51 -50.32 70.08 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 115.754 -2.069 . . . . 0.0 111.258 -177.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.97 -28.89 63.73 Favored 'General case' 0 CA--C 1.571 1.775 0 CA-C-O 114.374 -2.727 . . . . 0.0 111.243 176.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.98 -53.2 53.92 Favored 'General case' 0 C--N 1.38 1.925 0 CA-C-N 124.5 3.318 . . . . 0.0 111.378 174.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.472 ' CE2' HD12 ' A' ' 105' ' ' ILE . 21.1 t80 -62.03 -42.9 99.67 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 119.81 1.186 . . . . 0.0 112.821 176.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.492 ' HE2' HD13 ' A' ' 144' ' ' ILE . 58.1 mttt -63.68 -34.51 78.01 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 116.589 -1.672 . . . . 0.0 111.9 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -70.34 -44.84 77.14 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.197 0 CA-C-N 121.711 2.05 . . . . 0.0 108.557 171.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -56.34 -31.94 64.22 Favored 'General case' 0 CA--C 1.576 1.967 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -60.33 118.97 7.07 Favored 'General case' 0 CA--C 1.575 1.927 0 C-N-CA 125.812 1.645 . . . . 0.0 111.951 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.483 ' CB ' ' HG2' ' A' ' 109' ' ' GLU . . . -77.33 -52.51 9.04 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 -178.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.9 p30 -72.74 -8.67 56.52 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 117.88 2.548 . . . . 0.0 117.88 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.2 8.92 87.16 Favored Glycine 0 CA--C 1.555 2.539 0 N-CA-C 119.523 2.569 . . . . 0.0 119.523 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.6 p30 -114.4 -12.56 12.35 Favored 'General case' 0 CA--C 1.575 1.928 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 177.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.34 22.21 5.92 Favored Glycine 0 CA--C 1.548 2.132 0 CA-C-O 116.325 -2.375 . . . . 0.0 115.985 -178.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.3 t -132.61 138.74 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-N 121.366 2.583 . . . . 0.0 109.734 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.472 HD12 ' CE2' ' A' ' 94' ' ' PHE . 44.0 mt -119.76 136.71 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 126.059 1.744 . . . . 0.0 110.746 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -99.13 -175.08 2.92 Favored 'General case' 0 CA--C 1.576 1.969 0 C-N-CA 124.083 0.953 . . . . 0.0 112.678 176.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -82.23 -51.66 7.72 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 119.961 -1.712 . . . . 0.0 113.833 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -62.28 -46.33 89.27 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 119.681 1.128 . . . . 0.0 112.59 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.483 ' HG2' ' CB ' ' A' ' 99' ' ' ALA . 37.1 tp10 -63.81 -35.49 80.77 Favored 'General case' 0 CA--C 1.57 1.723 0 CA-C-N 119.68 1.127 . . . . 0.0 113.064 176.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -61.07 -48.85 79.82 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 119.845 1.202 . . . . 0.0 107.815 171.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 56.6 tttt -64.64 -9.27 18.41 Favored 'General case' 0 CA--C 1.581 2.164 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 174.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -94.37 -50.05 5.42 Favored 'General case' 0 CA--C 1.593 2.601 0 C-N-CA 125.336 1.454 . . . . 0.0 111.017 171.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.6 tt -80.21 -28.31 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 120.889 3.663 . . . . 0.0 120.889 -175.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 1.1 tpt -40.36 -48.2 2.66 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 47.0 mm-40 -91.68 84.61 5.48 Favored 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 27.1 mmtt -88.52 35.48 0.77 Allowed 'General case' 0 N--CA 1.51 2.53 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 172.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 91.4 t -151.61 93.94 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.351 1 N-CA-C 97.174 -5.121 . . . . 0.0 97.174 176.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.7 92.3 0.33 Allowed Glycine 0 CA--C 1.552 2.396 0 N-CA-C 106.617 -2.593 . . . . 0.0 106.617 -174.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -66.96 79.1 0.12 Allowed 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 117.003 2.223 . . . . 0.0 117.003 -176.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -168.03 94.19 0.62 Allowed Pre-proline 0 CA--C 1.566 1.591 0 CA-C-O 117.551 -1.214 . . . . 0.0 112.307 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -77.16 77.22 3.88 Favored 'Trans proline' 0 N--CA 1.509 2.439 0 CA-C-O 125.271 2.113 . . . . 0.0 109.294 174.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.312 3.2 tm? -72.01 -59.54 2.69 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 109.386 -3.552 . . . . 0.0 118.728 -173.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 30.6 p -77.93 122.27 25.27 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 125.397 3.726 . . . . 0.0 107.47 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -59.16 -37.99 78.67 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 112.223 -2.262 . . . . 0.0 115.369 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.27 -39.37 90.12 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-O 117.243 -1.36 . . . . 0.0 114.305 177.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -61.28 -52.89 62.84 Favored 'General case' 0 CA--C 1.577 1.982 0 CA-C-N 120.967 1.712 . . . . 0.0 112.631 177.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.6 t -69.43 -49.92 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 CA-C-O 117.529 -1.224 . . . . 0.0 112.255 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.19 -44.18 97.17 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 116.688 -1.625 . . . . 0.0 110.486 177.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -59.3 -52.04 67.35 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 122.488 2.404 . . . . 0.0 112.199 176.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.62 -44.56 95.98 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.521 ' SD ' HD11 ' A' ' 142' ' ' ILE . 18.4 tpt -73.56 -37.44 65.53 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 115.94 -1.981 . . . . 0.0 111.992 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -60.15 -49.12 78.89 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 122.92 2.6 . . . . 0.0 110.788 174.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -69.67 -26.94 64.62 Favored 'General case' 0 CA--C 1.575 1.936 0 CA-C-O 118.048 -0.977 . . . . 0.0 112.761 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.15 -21.34 27.62 Favored 'General case' 0 CA--C 1.58 2.108 0 CA-C-N 119.996 1.271 . . . . 0.0 114.347 175.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -88.46 109.28 19.9 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 122.757 2.526 . . . . 0.0 105.234 171.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -77.31 -25.17 50.98 Favored 'General case' 0 CA--C 1.576 1.958 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -86.61 -16.31 37.1 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 118.206 2.669 . . . . 0.0 118.206 -176.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.61 5.23 90.06 Favored Glycine 0 CA--C 1.565 3.173 0 CA-C-N 119.936 1.244 . . . . 0.0 115.367 -174.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -86.82 -29.82 21.96 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-N 119.167 1.483 . . . . 0.0 114.885 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 104.93 23.35 7.82 Favored Glycine 0 CA--C 1.554 2.497 0 CA-C-N 120.581 1.537 . . . . 0.0 116.607 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.88 152.69 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 123.543 1.64 . . . . 0.0 107.858 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.521 HD11 ' SD ' ' A' ' 131' ' ' MET . 0.8 OUTLIER -136.82 130.78 46.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 112.535 -2.121 . . . . 0.0 112.06 -177.504 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 34.1 p30 -97.67 162.27 13.36 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 104.72 -2.326 . . . . 0.0 104.72 170.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.492 HD13 ' HE2' ' A' ' 95' ' ' LYS . 4.4 mt -56.22 -49.25 94.33 Favored Pre-proline 0 CA--C 1.582 2.194 0 CA-C-O 113.413 -3.184 . . . . 0.0 110.905 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -47.73 -31.63 15.09 Favored 'Trans proline' 0 C--N 1.377 2.035 0 CA-C-N 127.011 3.54 . . . . 0.0 120.555 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -71.62 -66.34 0.64 Allowed 'General case' 0 N--CA 1.506 2.331 0 CA-C-N 122.663 2.483 . . . . 0.0 110.053 177.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -51.04 -41.76 60.05 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 124.596 1.158 . . . . 0.0 112.884 173.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.4 ' HA ' HG21 ' A' ' 90' ' ' ILE 0.268 0.0 OUTLIER -70.65 -45.21 65.55 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-O 113.658 -3.068 . . . . 0.0 110.808 -179.538 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.78 -44.25 90.63 Favored 'General case' 0 CA--C 1.583 2.232 0 CA-C-N 124.051 3.114 . . . . 0.0 111.776 175.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 7.9 tt -50.98 -47.59 61.4 Favored 'General case' 0 C--N 1.365 1.279 0 C-N-CA 126.216 1.807 . . . . 0.0 112.701 176.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 45.8 mt -90.24 -33.06 5.72 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.212 0 CA-C-N 121.099 1.772 . . . . 0.0 110.992 176.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -50.88 -37.09 41.4 Favored 'General case' 0 N--CA 1.503 2.193 0 CA-C-N 120.836 1.653 . . . . 0.0 114.599 176.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -45.82 -42.16 11.93 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 60.5 p . . . . . 0 CA--C 1.578 2.048 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 176.88 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.5 2.053 0 N-CA-C 120.47 3.508 . . . . 0.0 120.47 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -50.43 -64.39 0.82 Allowed 'General case' 0 CA--C 1.564 1.482 0 O-C-N 123.777 0.673 . . . . 0.0 111.801 176.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -74.55 -26.13 59.76 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.592 HG23 ' CE2' ' A' ' 147' ' ' PHE . 3.6 mp -74.68 -58.37 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 CA-C-N 122.274 2.306 . . . . 0.0 109.334 177.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . 0.254 0.3 OUTLIER -62.92 -42.01 99.66 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 121.843 2.11 . . . . 0.0 110.038 179.167 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -60.88 -52.73 63.81 Favored 'General case' 0 CA--C 1.572 1.815 0 CA-C-N 121.921 2.146 . . . . 0.0 110.772 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.31 -54.94 16.21 Favored 'General case' 0 C--N 1.363 1.166 0 CA-C-O 116.009 -1.948 . . . . 0.0 115.49 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.499 ' CE2' HD12 ' A' ' 105' ' ' ILE . 9.8 t80 -63.32 -50.79 68.65 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 121.74 2.064 . . . . 0.0 112.28 178.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.332 78.5 mttt -64.52 -22.78 67.06 Favored 'General case' 0 CA--C 1.591 2.536 0 CA-C-O 117.372 -1.299 . . . . 0.0 111.199 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -73.14 -49.85 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 CA-C-N 121.266 1.848 . . . . 0.0 108.233 168.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -50.13 -37.62 35.13 Favored 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -61.2 115.72 4.02 Favored 'General case' 0 CA--C 1.578 2.024 0 C-N-CA 125.558 1.543 . . . . 0.0 112.722 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -77.65 -51.62 10.32 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.4 p30 -68.92 -13.19 62.28 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 117.777 2.51 . . . . 0.0 117.777 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.5 7.51 88.47 Favored Glycine 0 CA--C 1.553 2.422 0 N-CA-C 119.559 2.584 . . . . 0.0 119.559 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.1 p30 -104.33 -15.13 15.53 Favored 'General case' 0 CA--C 1.576 1.977 0 CA-C-N 119.535 1.667 . . . . 0.0 114.773 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.59 20.83 6.73 Favored Glycine 0 CA--C 1.545 1.941 0 CA-C-O 116.201 -2.444 . . . . 0.0 116.415 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -131.8 137.04 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-N 121.654 2.727 . . . . 0.0 110.856 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.499 HD12 ' CE2' ' A' ' 94' ' ' PHE . 58.8 mt -109.35 139.74 31.01 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 CA-C-N 112.058 -2.337 . . . . 0.0 108.36 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -118.83 -173.7 2.54 Favored 'General case' 0 CA--C 1.574 1.881 0 C-N-CA 124.242 1.017 . . . . 0.0 111.215 176.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -72.27 -53.42 12.54 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.657 -1.277 . . . . 0.0 113.877 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -56.61 -47.26 80.01 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 118.278 0.49 . . . . 0.0 112.305 177.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.26 -50.49 67.12 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 174.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.96 -51.77 66.76 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 124.621 1.168 . . . . 0.0 110.419 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.24 -8.95 50.61 Favored 'General case' 0 CA--C 1.577 1.991 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 176.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -92.08 -40.57 10.98 Favored 'General case' 0 CA--C 1.584 2.27 0 C-N-CA 124.902 1.281 . . . . 0.0 110.711 172.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.6 tt -91.41 -36.33 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 121.317 3.821 . . . . 0.0 121.317 -174.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.45 ' HB3' ' HG3' ' A' ' 121' ' ' PRO . 7.1 tpt -37.75 -53.51 1.26 Allowed 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 117.525 2.416 . . . . 0.0 117.525 -176.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.573 ' H ' ' HG3' ' A' ' 121' ' ' PRO . 67.8 mm-40 -74.39 -43.17 57.58 Favored 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 117.538 2.422 . . . . 0.0 117.538 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 9.9 mptt 77.63 -72.39 0.09 Allowed 'General case' 0 N--CA 1.521 3.106 0 C-N-CA 126.397 1.879 . . . . 0.0 113.062 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.9 p -123.61 144.75 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 CA-C-N 120.092 1.315 . . . . 0.0 111.579 -178.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.65 80.87 0.5 Allowed Glycine 0 CA--C 1.539 1.573 0 CA-C-O 118.929 -0.928 . . . . 0.0 111.4 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 69.54 122.14 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 124.419 1.088 . . . . 0.0 110.636 -177.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -70.26 -177.69 0.45 Allowed Pre-proline 0 CA--C 1.571 1.781 0 CA-C-O 116.559 -1.686 . . . . 0.0 114.966 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.573 ' HG3' ' H ' ' A' ' 115' ' ' GLN . 17.0 Cg_exo -76.95 81.98 2.46 Favored 'Trans proline' 0 N--CA 1.507 2.313 0 CA-C-O 127.015 2.84 . . . . 0.0 107.948 175.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.453 7.4 tp -63.01 -65.91 0.62 Allowed 'General case' 0 CA--C 1.564 1.505 1 CA-C-N 106.548 -4.842 . . . . 0.0 115.092 -173.357 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 16.8 p -83.04 126.32 32.42 Favored 'General case' 0 N--CA 1.491 1.579 1 CA-C-N 126.183 4.083 . . . . 0.0 108.507 177.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -59.67 -38.02 80.35 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 116.963 2.209 . . . . 0.0 116.963 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.0 -45.37 79.07 Favored 'General case' 0 CA--C 1.554 1.12 0 O-C-N 124.493 1.121 . . . . 0.0 113.612 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -57.88 -50.79 72.14 Favored 'General case' 0 CA--C 1.579 2.068 0 CA-C-O 122.287 1.041 . . . . 0.0 112.517 176.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.9 t -67.51 -41.49 85.99 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.612 0 CA-C-N 114.003 -1.453 . . . . 0.0 112.162 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -63.66 -46.46 85.52 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 120.415 1.462 . . . . 0.0 109.91 175.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -57.54 -51.1 70.86 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 120.753 1.615 . . . . 0.0 112.199 175.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.4 -46.68 88.0 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.5 ttt -69.05 -39.24 79.27 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 117.227 -1.368 . . . . 0.0 111.806 177.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.87 -41.43 95.96 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 121.423 1.92 . . . . 0.0 109.827 174.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -64.64 -32.76 74.56 Favored 'General case' 0 CA--C 1.584 2.288 0 CA-C-N 121.017 1.735 . . . . 0.0 112.146 173.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.61 -26.72 34.64 Favored 'General case' 0 CA--C 1.576 1.964 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -78.97 109.43 13.25 Favored 'General case' 0 N--CA 1.516 2.861 0 CA-C-N 123.188 2.722 . . . . 0.0 109.98 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -86.58 -19.74 28.95 Favored 'General case' 0 CA--C 1.58 2.129 0 N-CA-C 117.142 2.275 . . . . 0.0 117.142 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -85.01 -14.42 47.46 Favored 'General case' 0 N--CA 1.507 2.409 1 N-CA-C 122.641 4.312 . . . . 0.0 122.641 -171.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.68 6.34 85.63 Favored Glycine 0 CA--C 1.57 3.507 0 CA-C-N 121.032 1.742 . . . . 0.0 114.958 -172.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -88.11 -51.41 5.81 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.187 1.395 . . . . 0.0 110.478 175.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 110.76 -20.18 24.91 Favored Glycine 0 CA--C 1.543 1.799 0 CA-C-O 115.695 -2.725 . . . . 0.0 115.894 -177.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . 0.259 13.0 m -126.64 124.06 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 101.152 -3.647 . . . . 0.0 101.152 176.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.436 HG21 HD13 ' A' ' 142' ' ' ILE . 0.5 OUTLIER -77.77 124.72 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 -172.344 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -93.05 160.21 14.96 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 171.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.6 mt -57.32 -42.82 97.95 Favored Pre-proline 0 CA--C 1.579 2.081 0 CA-C-O 114.859 -2.496 . . . . 0.0 113.352 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.51 -38.45 74.82 Favored 'Trans proline' 0 C--N 1.376 1.99 0 CA-C-N 125.202 2.894 . . . . 0.0 116.703 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -68.17 -38.44 82.06 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 122.215 2.28 . . . . 0.0 113.947 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.592 ' CE2' HG23 ' A' ' 90' ' ' ILE . 69.4 t80 -64.9 -47.12 78.93 Favored 'General case' 0 CA--C 1.578 2.044 0 CA-C-N 121.411 1.914 . . . . 0.0 110.659 172.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.574 ' HG2' HG21 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -59.22 -44.07 92.31 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-N 118.45 0.568 . . . . 0.0 111.964 176.141 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -65.11 -44.95 87.07 Favored 'General case' 0 CA--C 1.568 1.672 0 C-N-CA 124.356 1.062 . . . . 0.0 109.85 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.28 -45.27 65.4 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.781 1.232 . . . . 0.0 111.915 174.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 97.0 mt -77.86 -50.57 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-O 116.862 -1.542 . . . . 0.0 114.187 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -90.95 -47.12 7.77 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -176.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -105.52 -75.83 0.62 Allowed 'General case' 0 N--CA 1.505 2.29 1 N-CA-C 121.905 4.039 . . . . 0.0 121.905 -177.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 43.9 t . . . . . 0 N--CA 1.503 2.218 0 N-CA-C 120.96 3.689 . . . . 0.0 120.96 -175.047 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 . . . . . 0 CA--C 1.592 2.571 0 CA-C-O 117.207 -1.378 . . . . 0.0 109.115 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -20.56 -43.54 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.221 0 C-N-CA 130.652 3.581 . . . . 0.0 120.304 -172.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -53.31 -71.1 0.08 Allowed 'General case' 0 CA--C 1.62 3.657 0 CA-C-O 127.938 3.732 . . . . 0.0 111.461 174.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.654 HG23 ' CE2' ' A' ' 147' ' ' PHE . 13.9 mm -70.71 -43.98 76.88 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.642 0 CA-C-N 109.066 -3.697 . . . . 0.0 109.167 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -58.35 -43.53 88.39 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 121.826 2.103 . . . . 0.0 109.476 175.756 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.436 ' O ' ' HB ' ' A' ' 96' ' ' VAL . 9.2 mmt-85 -55.25 -51.37 66.85 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 122.326 2.33 . . . . 0.0 107.536 175.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.83 -65.06 0.72 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 117.604 2.446 . . . . 0.0 117.604 177.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.589 ' HB2' ' CD2' ' A' ' 147' ' ' PHE . 18.3 t80 -67.36 -48.76 66.5 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 91' ' ' LEU 0.369 1.4 mmmp? -69.08 -19.2 64.07 Favored 'General case' 0 CA--C 1.589 2.443 0 CA-C-O 115.07 -2.395 . . . . 0.0 109.229 -179.328 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.436 ' HB ' ' O ' ' A' ' 92' ' ' ARG . 0.8 OUTLIER -73.57 -45.99 49.62 Favored 'Isoleucine or valine' 0 C--N 1.394 2.532 0 CA-C-N 124.388 3.267 . . . . 0.0 105.597 166.726 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -52.73 -35.66 56.37 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 176.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.4 105.68 0.79 Allowed 'General case' 0 CA--C 1.577 2.005 0 C-N-CA 125.106 1.362 . . . . 0.0 109.432 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.07 -44.43 97.39 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 115.764 1.765 . . . . 0.0 115.764 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -69.62 -19.31 63.64 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 117.647 2.462 . . . . 0.0 117.647 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.62 21.35 64.22 Favored Glycine 0 CA--C 1.558 2.755 0 N-CA-C 118.14 2.016 . . . . 0.0 118.14 -177.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.58 -28.1 7.27 Favored 'General case' 0 CA--C 1.578 2.026 0 CA-C-N 119.388 1.594 . . . . 0.0 114.402 177.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 121.33 21.3 3.1 Favored Glycine 0 CA--C 1.548 2.11 0 CA-C-O 116.943 -2.031 . . . . 0.0 117.232 -175.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 p -124.69 150.61 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.668 0 CA-C-N 120.581 2.191 . . . . 0.0 109.379 173.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.5 HD12 ' CE2' ' A' ' 94' ' ' PHE . 96.3 mt -122.02 132.92 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-N 114.249 -1.341 . . . . 0.0 109.061 178.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.498 ' H ' ' HG2' ' A' ' 109' ' ' GLU . 0.5 OUTLIER -109.75 179.12 4.21 Favored 'General case' 0 CA--C 1.582 2.173 0 CA-C-O 121.983 0.897 . . . . 0.0 111.749 175.196 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.29 -47.59 23.16 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.645 -1.284 . . . . 0.0 114.33 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -61.75 -38.72 89.0 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 117.706 -1.14 . . . . 0.0 110.443 175.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.498 ' HG2' ' H ' ' A' ' 106' ' ' ASP . 5.4 pt-20 -65.01 -36.4 84.27 Favored 'General case' 0 CA--C 1.576 1.945 0 CA-C-N 121.022 1.737 . . . . 0.0 111.346 173.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -62.94 -48.48 78.71 Favored 'General case' 0 C--N 1.376 1.759 0 CA-C-N 120.99 1.723 . . . . 0.0 109.433 175.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 35.0 mttp -54.99 -52.12 64.09 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 123.9 0.88 . . . . 0.0 111.656 174.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -52.43 -47.95 66.05 Favored 'General case' 0 CA--C 1.571 1.763 0 C-N-CA 124.332 1.053 . . . . 0.0 113.518 175.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -81.47 -14.17 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 12.8 tpt -62.77 -58.99 5.51 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 125.575 1.55 . . . . 0.0 109.536 176.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -101.79 103.7 14.44 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 103.172 -2.899 . . . . 0.0 103.172 175.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -27.8 65.94 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.9 p -82.11 132.92 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.773 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 175.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -48.4 130.99 20.69 Favored Glycine 0 CA--C 1.55 2.277 0 N-CA-C 119.366 2.506 . . . . 0.0 119.366 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 56.91 79.59 0.18 Allowed 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 124.928 1.291 . . . . 0.0 114.371 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -144.44 -31.05 0.0 OUTLIER Pre-proline 0 CA--C 1.566 1.576 1 CA-C-O 109.051 -5.261 . . . . 0.0 117.605 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER -36.31 94.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.39 2.739 1 CA-C-N 131.797 5.249 . . . . 0.0 118.079 -179.599 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.381 36.6 tp -76.69 -84.91 0.06 Allowed 'General case' 0 CA--C 1.559 1.31 0 CA-C-N 110.417 -3.083 . . . . 0.0 112.297 -175.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 38.0 p -84.84 124.01 31.11 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 124.69 3.405 . . . . 0.0 106.287 177.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.77 -37.14 85.51 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -53.52 -35.89 61.18 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -62.06 -55.67 26.74 Favored 'General case' 0 CA--C 1.587 2.393 0 CA-C-N 120.458 1.481 . . . . 0.0 111.659 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.1 t -63.47 -47.35 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 124.846 1.259 . . . . 0.0 111.216 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -57.77 -48.59 79.23 Favored 'General case' 0 CA--C 1.559 1.319 0 CA-C-O 118.101 -0.952 . . . . 0.0 111.887 176.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -58.53 -48.13 81.9 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 120.211 1.369 . . . . 0.0 112.489 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.96 -51.61 68.92 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -68.49 -34.42 75.89 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 115.263 -2.303 . . . . 0.0 112.113 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -65.26 -39.45 92.64 Favored 'General case' 0 CA--C 1.57 1.747 0 CA-C-N 122.739 2.518 . . . . 0.0 110.243 173.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -59.41 -40.74 87.62 Favored 'General case' 0 CA--C 1.574 1.874 0 CA-C-N 122.085 2.22 . . . . 0.0 110.559 173.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -78.38 -25.34 46.21 Favored 'General case' 0 CA--C 1.577 1.993 0 N-CA-C 116.872 2.175 . . . . 0.0 116.872 175.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -89.43 115.43 26.87 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 118.938 -2.351 . . . . 0.0 107.191 175.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -76.48 -27.73 56.22 Favored 'General case' 0 CA--C 1.566 1.567 0 N-CA-C 117.779 2.511 . . . . 0.0 117.779 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -105.88 -12.54 15.81 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 119.293 3.071 . . . . 0.0 119.293 -174.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.65 4.69 90.22 Favored Glycine 0 CA--C 1.572 3.627 0 CA-C-N 120.129 1.331 . . . . 0.0 113.623 -172.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -71.73 -45.94 60.15 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 125.282 1.433 . . . . 0.0 110.661 175.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 110.83 -4.88 29.1 Favored Glycine 0 CA--C 1.541 1.661 0 CA-C-O 115.075 -3.069 . . . . 0.0 117.598 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . 0.336 0.9 OUTLIER -136.91 118.85 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-N 123.093 3.446 . . . . 0.0 104.362 175.507 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.9 mt -85.21 130.88 35.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 109.385 -3.552 . . . . 0.0 111.835 -175.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 41.4 p30 -94.22 155.1 17.21 Favored 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 171.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -53.55 -44.98 98.76 Favored Pre-proline 0 CA--C 1.586 2.364 0 CA-C-O 114.427 -2.702 . . . . 0.0 113.468 -178.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -46.08 -37.82 18.31 Favored 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 124.634 3.556 . . . . 0.0 117.211 177.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -61.37 -55.29 33.23 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 119.364 0.983 . . . . 0.0 112.029 175.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.654 ' CE2' HG23 ' A' ' 90' ' ' ILE . 66.7 t80 -57.61 -45.38 85.43 Favored 'General case' 0 CA--C 1.577 1.996 0 C-N-CA 125.805 1.642 . . . . 0.0 112.721 175.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.9 -36.25 82.73 Favored 'General case' 0 CA--C 1.586 2.337 0 CA-C-O 117.865 -1.064 . . . . 0.0 110.142 177.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -70.71 -40.33 72.9 Favored 'General case' 0 CA--C 1.583 2.216 0 CA-C-N 120.58 1.537 . . . . 0.0 110.797 172.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -50.66 -45.41 57.98 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 126.037 1.735 . . . . 0.0 109.254 173.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 62.2 mt -83.14 -63.05 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.484 0 CA-C-N 119.847 1.203 . . . . 0.0 112.18 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -62.79 -43.76 97.95 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 117.62 2.452 . . . . 0.0 117.62 -177.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -95.48 -71.4 0.67 Allowed 'General case' 0 CA--C 1.561 1.371 0 N-CA-C 119.961 3.319 . . . . 0.0 119.961 -176.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 97.3 p . . . . . 0 N--CA 1.502 2.145 1 N-CA-C 124.208 4.892 . . . . 0.0 124.208 -171.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 . . . . . 0 N--CA 1.5 2.062 0 N-CA-C 118.083 2.623 . . . . 0.0 118.083 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.94 -50.76 63.37 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 120.694 1.588 . . . . 0.0 114.711 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -45.63 -60.2 2.33 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 115.378 1.621 . . . . 0.0 115.378 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.777 ' H ' HD12 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -70.82 -54.43 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-O 117.168 -1.396 . . . . 0.0 113.331 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . 0.279 0.0 OUTLIER -61.3 -40.05 92.71 Favored 'General case' 0 CA--C 1.568 1.663 0 CA-C-N 120.117 1.326 . . . . 0.0 110.315 -178.607 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.05 -57.93 9.74 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-N 120.767 1.621 . . . . 0.0 110.786 175.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.66 -57.41 8.16 Favored 'General case' 0 C--N 1.364 1.21 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -64.01 -47.69 79.28 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 117.141 -1.409 . . . . 0.0 113.091 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.293 31.1 mttm -66.3 -24.32 66.52 Favored 'General case' 0 CA--C 1.582 2.18 0 CA-C-O 117.008 -1.472 . . . . 0.0 110.601 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.6 t -68.88 -50.01 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-N 121.719 2.054 . . . . 0.0 108.167 168.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.54 -37.8 73.66 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 116.739 2.126 . . . . 0.0 116.739 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 1.245 ' OD2' ' HA ' ' A' ' 102' ' ' ASP . 12.1 t0 -62.46 111.21 1.94 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 126.103 1.761 . . . . 0.0 112.461 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -79.42 -28.2 41.74 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -76.23 8.98 2.84 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.0 7.0 84.38 Favored Glycine 0 CA--C 1.564 3.115 0 N-CA-C 120.03 2.772 . . . . 0.0 120.03 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 1.245 ' HA ' ' OD2' ' A' ' 98' ' ' ASP 0.79 0.2 OUTLIER 116.75 126.04 0.0 OUTLIER 'General case' 0 CA--C 1.584 2.273 0 C-N-CA 130.27 3.428 . . . . 0.0 118.025 171.092 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 114.81 12.25 10.44 Favored Glycine 0 N--CA 1.441 -1.032 2 C-N-CA 134.471 5.796 . . . . 0.0 115.291 176.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.743 ' O ' ' OD1' ' A' ' 98' ' ' ASP . 0.5 OUTLIER -170.53 156.4 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.571 0 N-CA-C 116.962 2.208 . . . . 0.0 116.962 179.225 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 78.5 mt -133.03 130.3 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 127.013 2.125 . . . . 0.0 107.77 175.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -108.72 171.47 7.41 Favored 'General case' 0 CA--C 1.595 2.696 0 C-N-CA 123.806 0.843 . . . . 0.0 110.532 175.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.414 ' HA ' ' SD ' ' A' ' 131' ' ' MET . 27.0 t80 -64.07 -60.41 3.27 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 117.787 2.514 . . . . 0.0 117.787 -176.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -59.84 -27.33 66.54 Favored 'General case' 0 N--CA 1.508 2.425 0 CA-C-N 119.823 1.192 . . . . 0.0 112.713 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -63.55 -42.17 98.4 Favored 'General case' 0 CA--C 1.578 2.023 0 CA-C-N 119.462 1.028 . . . . 0.0 110.455 172.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -62.41 -53.0 61.34 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 125.555 1.542 . . . . 0.0 109.65 174.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -51.23 -44.53 61.71 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 175.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -66.55 -53.83 30.34 Favored 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 125.515 1.526 . . . . 0.0 112.686 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -67.75 -21.87 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 -178.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -50.68 -46.76 58.89 Favored 'General case' 0 N--CA 1.505 2.291 0 CA-C-N 119.283 0.947 . . . . 0.0 111.099 172.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -105.59 106.09 16.42 Favored 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 125.589 1.555 . . . . 0.0 109.49 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -92.2 -60.55 1.82 Allowed 'General case' 0 CA--C 1.565 1.549 0 CA-C-N 113.681 -1.6 . . . . 0.0 114.878 -177.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.5 p -147.9 105.54 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.16 54.32 33.68 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 115.42 0.928 . . . . 0.0 115.42 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -138.47 144.12 39.92 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 124.663 1.185 . . . . 0.0 111.796 -177.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -156.3 66.87 4.4 Favored Pre-proline 0 CA--C 1.58 2.108 0 C-N-CA 123.299 0.64 . . . . 0.0 109.999 175.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -102.22 51.93 0.03 OUTLIER 'Trans proline' 0 CA--C 1.56 1.821 0 C-N-CA 123.086 2.524 . . . . 0.0 109.59 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.284 2.8 tt -160.92 162.03 31.89 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 -169.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.4 p -134.6 144.42 47.91 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 102.351 -3.203 . . . . 0.0 102.351 172.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -54.74 -33.96 61.86 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.444 -1.41 . . . . 0.0 114.792 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.21 -46.05 88.84 Favored 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 124.259 1.024 . . . . 0.0 112.63 175.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -64.21 -40.0 95.15 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 119.682 1.128 . . . . 0.0 112.252 176.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.9 p -67.52 -37.62 79.14 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.908 0 CA-C-N 119.85 1.204 . . . . 0.0 110.648 176.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -66.02 -45.04 82.93 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 119.661 1.119 . . . . 0.0 111.771 175.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -66.63 -41.17 88.74 Favored 'General case' 0 CA--C 1.574 1.884 0 O-C-N 120.894 -1.129 . . . . 0.0 113.249 176.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.93 -48.28 79.61 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.686 176.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.414 ' SD ' ' HA ' ' A' ' 107' ' ' PHE . 21.2 ttt -67.42 -36.2 80.78 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 115.415 -2.231 . . . . 0.0 110.792 175.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.18 -36.7 84.48 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 123.358 2.799 . . . . 0.0 111.868 175.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -62.37 -44.61 96.05 Favored 'General case' 0 CA--C 1.583 2.217 0 CA-C-N 119.531 1.06 . . . . 0.0 109.883 172.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -72.99 -26.73 61.44 Favored 'General case' 0 CA--C 1.583 2.233 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 176.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -80.36 111.71 17.01 Favored 'General case' 0 CA--C 1.56 1.36 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 175.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -72.68 -20.71 61.19 Favored 'General case' 0 CA--C 1.579 2.059 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -91.19 -17.22 26.42 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 117.68 2.474 . . . . 0.0 117.68 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.07 5.45 89.69 Favored Glycine 0 CA--C 1.563 3.085 0 CA-C-N 120.17 1.35 . . . . 0.0 115.905 -175.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 53.5 p-10 -87.54 -32.54 19.33 Favored 'General case' 0 CA--C 1.568 1.666 0 CA-C-N 119.408 1.604 . . . . 0.0 115.101 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 107.92 20.11 8.63 Favored Glycine 0 CA--C 1.559 2.797 0 N-CA-C 116.926 1.53 . . . . 0.0 116.926 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.19 152.63 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 142' ' ' ILE . 1.4 mt -137.5 131.33 44.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 112.164 -2.289 . . . . 0.0 111.743 -178.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 51.3 p30 -96.39 163.74 12.93 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 171.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 3.3 mt -56.76 -45.76 99.91 Favored Pre-proline 0 CA--C 1.582 2.203 0 CA-C-O 114.225 -2.798 . . . . 0.0 112.181 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -48.45 -38.01 34.26 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 124.216 3.277 . . . . 0.0 117.474 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -67.57 -52.27 40.7 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 120.751 1.614 . . . . 0.0 111.632 177.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.643 ' CE1' HG23 ' A' ' 90' ' ' ILE . 6.9 t80 -58.23 -48.17 81.21 Favored 'General case' 0 CA--C 1.569 1.7 0 CA-C-N 120.589 1.54 . . . . 0.0 112.577 176.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.666 ' HB3' HG21 ' A' ' 90' ' ' ILE . 2.0 ptp -64.19 -39.79 94.73 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-O 116.984 -1.484 . . . . 0.0 113.523 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -68.8 -33.95 74.72 Favored 'General case' 0 CA--C 1.585 2.305 0 CA-C-N 121.053 1.751 . . . . 0.0 109.312 172.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.02 -46.39 71.8 Favored 'General case' 0 CA--C 1.576 1.975 0 CA-C-N 120.15 1.341 . . . . 0.0 111.368 174.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 82.6 mt -80.52 -62.46 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.58 2.125 0 C-N-CA 123.472 0.709 . . . . 0.0 111.725 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.777 ' HE2' HD11 ' A' ' 90' ' ' ILE . 22.9 mttm -79.75 5.85 12.4 Favored 'General case' 0 CA--C 1.583 2.242 0 N-CA-C 118.952 2.945 . . . . 0.0 118.952 -177.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -19.09 -18.96 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.191 1 N-CA-C 127.205 6.002 . . . . 0.0 127.205 -174.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.525 3.28 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 177.867 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.606 ' HA ' HD13 ' A' ' 90' ' ' ILE . 12.5 tt0 . . . . . 0 N--CA 1.514 2.756 0 N-CA-C 118.049 2.611 . . . . 0.0 118.049 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -58.77 -45.29 90.1 Favored 'General case' 0 CA--C 1.575 1.924 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.444 174.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -61.9 -32.97 73.41 Favored 'General case' 0 CA--C 1.569 1.7 0 CA-C-N 119.435 1.016 . . . . 0.0 113.011 175.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.606 HD13 ' HA ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -67.97 -58.7 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-N 119.855 1.207 . . . . 0.0 109.129 177.597 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.5 pp -59.39 -49.02 79.4 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 117.904 -1.046 . . . . 0.0 112.087 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -64.83 -45.07 87.73 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-N 120.327 1.421 . . . . 0.0 112.902 178.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.36 -54.85 16.92 Favored 'General case' 0 C--N 1.365 1.265 0 CA-C-O 115.355 -2.26 . . . . 0.0 112.172 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.534 ' CE2' HD12 ' A' ' 105' ' ' ILE . 6.9 t80 -60.74 -47.2 87.36 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 121.707 2.049 . . . . 0.0 112.719 177.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.25 91.3 mttt -62.13 -31.38 71.85 Favored 'General case' 0 CA--C 1.58 2.132 0 CA-C-O 117.276 -1.345 . . . . 0.0 111.909 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.4 t -70.01 -48.15 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 CA-C-N 121.166 1.803 . . . . 0.0 108.956 170.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -53.52 -36.69 62.03 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 -178.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -65.29 93.47 0.14 Allowed 'General case' 0 CA--C 1.57 1.712 0 C-N-CA 126.161 1.784 . . . . 0.0 110.802 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.01 -42.71 80.28 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -65.19 -28.05 69.12 Favored 'General case' 0 CA--C 1.581 2.149 0 CA-C-O 117.344 -1.312 . . . . 0.0 113.839 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.02 3.82 90.62 Favored Glycine 0 CA--C 1.554 2.509 0 CA-C-N 121.903 2.138 . . . . 0.0 118.276 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 27.1 p-10 -97.7 -5.26 35.57 Favored 'General case' 0 CA--C 1.581 2.151 0 CA-C-N 120.788 2.294 . . . . 0.0 114.084 174.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.13 8.46 21.78 Favored Glycine 0 CA--C 1.551 2.295 0 CA-C-O 115.756 -2.691 . . . . 0.0 115.999 -177.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -126.14 153.21 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-N 121.865 2.833 . . . . 0.0 114.153 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.534 HD12 ' CE2' ' A' ' 94' ' ' PHE . 74.0 mt -116.24 132.2 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 112.11 -2.314 . . . . 0.0 108.876 177.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -108.83 -169.61 1.52 Allowed 'General case' 0 CA--C 1.581 2.159 0 C-N-CA 122.977 0.511 . . . . 0.0 110.374 174.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -80.31 -47.16 14.94 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.065 -1.647 . . . . 0.0 114.353 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -57.01 -44.95 83.3 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 123.042 0.537 . . . . 0.0 112.259 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -61.51 -42.25 98.53 Favored 'General case' 0 CA--C 1.583 2.228 0 CA-C-N 119.094 0.861 . . . . 0.0 112.613 174.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -54.83 -49.15 71.76 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 125.124 1.37 . . . . 0.0 109.809 174.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.0 mmmt -59.09 -60.94 3.05 Favored 'General case' 0 CA--C 1.57 1.718 0 CA-C-O 118.256 -0.878 . . . . 0.0 109.382 174.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -41.89 -41.22 2.36 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 116.845 2.165 . . . . 0.0 116.845 177.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 10.7 mt -93.61 -45.63 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 N-CA-C 119.287 3.069 . . . . 0.0 119.287 -177.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 3.5 tpt -33.71 -52.73 0.42 Allowed 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 119.63 3.196 . . . . 0.0 119.63 -175.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -71.9 -49.0 41.6 Favored 'General case' 0 N--CA 1.508 2.464 0 N-CA-C 117.401 2.371 . . . . 0.0 117.401 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 9.2 mptt 74.02 -63.43 0.43 Allowed 'General case' 0 N--CA 1.523 3.212 0 C-N-CA 125.547 1.539 . . . . 0.0 112.928 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.6 t -81.23 112.39 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 CA-C-N 119.653 1.115 . . . . 0.0 110.854 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.48 -123.55 11.89 Favored Glycine 0 CA--C 1.543 1.829 0 N-CA-C 116.911 1.524 . . . . 0.0 116.911 178.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -58.36 155.47 11.76 Favored 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.51 179.34 1.56 Allowed Pre-proline 0 CA--C 1.579 2.089 0 CA-C-O 116.515 -1.707 . . . . 0.0 113.731 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -77.57 74.91 4.95 Favored 'Trans proline' 0 C--N 1.381 2.264 0 CA-C-N 124.845 2.766 . . . . 0.0 111.255 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.474 1.1 tt -64.34 13.81 0.03 OUTLIER 'General case' 0 CA--C 1.583 2.242 1 CA-C-N 106.957 -4.656 . . . . 0.0 117.659 -177.83 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . 0.28 0.2 OUTLIER -130.6 13.85 5.43 Favored 'General case' 0 C--N 1.356 0.865 0 N-CA-C 118.621 2.822 . . . . 0.0 118.621 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -0.53 -7.07 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.974 2 N-CA-C 125.343 5.312 . . . . 0.0 125.343 -164.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.33 -48.67 19.18 Favored 'General case' 0 CA--C 1.564 1.509 0 C-N-CA 126.359 1.864 . . . . 0.0 108.3 173.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.1 -41.65 75.54 Favored 'General case' 0 CA--C 1.579 2.068 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 174.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.7 t -68.22 -49.33 68.14 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 C-N-CA 126.108 1.763 . . . . 0.0 109.692 178.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -58.37 -43.41 88.45 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 119.952 1.251 . . . . 0.0 111.754 175.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.01 -54.05 49.66 Favored 'General case' 0 CA--C 1.576 1.954 0 CA-C-N 120.573 1.533 . . . . 0.0 111.644 176.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.68 -43.79 93.88 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.58 -40.89 69.61 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 116.806 -1.568 . . . . 0.0 110.616 177.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -37.95 82.49 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 121.621 2.009 . . . . 0.0 110.319 173.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -69.95 -34.54 73.57 Favored 'General case' 0 CA--C 1.571 1.75 0 CA-C-N 120.744 1.611 . . . . 0.0 112.316 175.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -78.94 -25.94 43.59 Favored 'General case' 0 CA--C 1.578 2.021 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -87.71 98.45 11.45 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 102.869 -3.011 . . . . 0.0 102.869 171.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -83.0 -13.71 55.41 Favored 'General case' 0 CA--C 1.579 2.07 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -91.18 -14.53 30.91 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 118.763 2.875 . . . . 0.0 118.763 -175.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.15 6.2 89.02 Favored Glycine 0 CA--C 1.565 3.186 0 CA-C-O 118.454 -1.192 . . . . 0.0 115.115 -174.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.93 -50.11 15.89 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 119.454 1.627 . . . . 0.0 110.984 176.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 111.66 -15.54 26.7 Favored Glycine 0 CA--C 1.546 1.978 0 CA-C-O 115.78 -2.678 . . . . 0.0 116.773 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . 0.302 3.8 m -133.34 120.63 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 100.823 -3.769 . . . . 0.0 100.823 175.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.3 mt -77.87 125.88 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 111.489 -2.596 . . . . 0.0 115.755 -172.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 36.5 p30 -91.68 152.9 20.01 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 172.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -51.34 -42.43 81.65 Favored Pre-proline 0 CA--C 1.583 2.239 0 CA-C-O 114.802 -2.523 . . . . 0.0 113.706 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.66 -29.5 80.02 Favored 'Trans proline' 0 C--N 1.376 1.998 0 CA-C-N 125.454 2.983 . . . . 0.0 116.991 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -66.97 -54.84 17.93 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 122.83 2.559 . . . . 0.0 111.446 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.573 ' CE2' HG23 ' A' ' 90' ' ' ILE . 74.2 t80 -61.89 -45.88 91.81 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-N 120.202 1.365 . . . . 0.0 110.515 175.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.26 -47.22 75.78 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-O 116.359 -1.781 . . . . 0.0 111.089 176.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.65 -36.86 76.45 Favored 'General case' 0 CA--C 1.574 1.876 0 CA-C-N 122.288 2.313 . . . . 0.0 113.437 177.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.48 -41.89 81.57 Favored 'General case' 0 CA--C 1.57 1.738 0 C-N-CA 124.84 1.256 . . . . 0.0 110.503 174.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.439 HG21 HD11 ' A' ' 90' ' ' ILE . 5.4 mm -80.0 -43.52 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.8 0 CA-C-O 116.263 -1.827 . . . . 0.0 109.363 176.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -48.81 -49.69 37.83 Favored 'General case' 0 N--CA 1.511 2.592 0 CA-C-N 122.426 2.375 . . . . 0.0 112.589 176.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -66.4 -39.06 88.79 Favored 'General case' 0 CA--C 1.566 1.578 0 CA-C-O 117.833 -1.079 . . . . 0.0 113.157 176.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.527 3.4 0 CA-C-N 119.525 1.057 . . . . 0.0 110.345 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 . . . . . 0 N--CA 1.493 1.708 0 N-CA-C 119.354 3.094 . . . . 0.0 119.354 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -52.91 -46.24 67.94 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 116.752 2.13 . . . . 0.0 116.752 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -68.46 -38.2 80.89 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.419 HD11 HG21 ' A' ' 151' ' ' ILE . 1.3 mp -72.78 -45.83 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-O 115.625 -2.131 . . . . 0.0 108.71 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.0 pp -59.66 -46.94 87.52 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 123.111 2.687 . . . . 0.0 110.329 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 52.1 ttp180 -57.09 -58.88 6.28 Favored 'General case' 0 CA--C 1.568 1.647 0 C-N-CA 124.286 1.034 . . . . 0.0 112.378 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.46 -58.15 9.7 Favored 'General case' 0 C--N 1.353 0.735 0 CA-C-O 115.711 -2.09 . . . . 0.0 113.346 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -55.66 -50.96 68.83 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 121.551 1.978 . . . . 0.0 113.228 178.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -62.6 -33.19 74.48 Favored 'General case' 0 CA--C 1.562 1.412 0 CA-C-O 116.307 -1.806 . . . . 0.0 112.553 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -72.35 -44.39 63.13 Favored 'Isoleucine or valine' 0 CA--C 1.59 2.496 0 CA-C-N 121.854 2.115 . . . . 0.0 109.626 171.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -51.7 -35.72 43.89 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 127.098 2.159 . . . . 0.0 115.094 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.255 1.3 t0 -67.26 96.52 0.48 Allowed 'General case' 0 CA--C 1.576 1.967 0 C-N-CA 126.202 1.801 . . . . 0.0 107.342 177.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.04 -49.7 71.34 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.273 1.582 . . . . 0.0 115.273 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -62.33 -24.05 67.11 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.35 7.98 87.7 Favored Glycine 0 CA--C 1.551 2.32 0 N-CA-C 120.327 2.891 . . . . 0.0 120.327 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.8 p30 -96.97 -11.33 24.72 Favored 'General case' 0 CA--C 1.575 1.932 0 CA-C-N 119.78 1.79 . . . . 0.0 115.563 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.49 18.4 8.07 Favored Glycine 0 CA--C 1.552 2.396 0 CA-C-O 116.781 -2.122 . . . . 0.0 114.594 -176.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.45 154.98 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.501 0 CA-C-N 120.826 2.313 . . . . 0.0 111.78 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 79.1 mt -126.54 127.06 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-N 112.368 -2.196 . . . . 0.0 108.217 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -106.21 179.03 4.39 Favored 'General case' 0 CA--C 1.578 2.042 0 CA-C-O 121.857 0.837 . . . . 0.0 110.673 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -69.73 -42.32 74.12 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.15 -45.25 93.7 Favored 'General case' 0 N--CA 1.505 2.281 0 CA-C-N 120.566 1.53 . . . . 0.0 113.829 177.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -63.52 -46.3 86.69 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.917 0.887 . . . . 0.0 112.139 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -62.76 -50.96 68.99 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 117.0 -1.476 . . . . 0.0 110.983 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.0 pptp? -58.27 -39.9 80.44 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 121.235 1.834 . . . . 0.0 114.318 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -65.31 -49.32 69.9 Favored 'General case' 0 CA--C 1.575 1.909 0 C-N-CA 123.407 0.683 . . . . 0.0 112.385 175.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -79.56 -32.37 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 118.723 2.86 . . . . 0.0 118.723 -177.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.495 ' HG2' HG22 ' A' ' 127' ' ' VAL . 14.0 tpt -53.09 -53.42 50.65 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.692 1.597 . . . . 0.0 114.548 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -76.53 47.83 0.51 Allowed 'General case' 0 CA--C 1.579 2.066 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . 0.284 0.0 OUTLIER 25.58 -110.36 0.02 OUTLIER 'General case' 0 N--CA 1.519 2.999 0 N-CA-C 118.715 2.857 . . . . 0.0 118.715 173.137 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 42.9 t -77.21 107.54 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 CA-C-N 121.387 1.903 . . . . 0.0 107.639 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.37 -141.22 38.65 Favored Glycine 0 CA--C 1.549 2.19 0 N-CA-C 111.671 -0.572 . . . . 0.0 111.671 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 52.34 170.03 0.01 OUTLIER 'General case' 0 CA--C 1.589 2.453 0 N-CA-C 118.958 2.947 . . . . 0.0 118.958 176.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -168.18 133.0 1.47 Allowed Pre-proline 0 N--CA 1.502 2.165 0 CA-C-O 113.396 -3.192 . . . . 0.0 107.318 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . 0.371 0.1 OUTLIER 9.94 58.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.388 2.632 0 N-CA-C 121.683 3.686 . . . . 0.0 121.683 -176.26 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.469 0.3 OUTLIER -74.31 -72.05 0.3 Allowed 'General case' 0 CA--C 1.566 1.589 0 CA-C-N 109.836 -3.347 . . . . 0.0 103.668 -177.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 10.0 p -95.46 112.75 24.41 Favored 'General case' 0 C--N 1.37 1.464 2 CA-C-N 126.44 4.2 . . . . 0.0 99.775 169.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -53.47 -38.36 63.55 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 118.565 2.802 . . . . 0.0 118.565 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.44 -42.16 91.28 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 117.052 -1.452 . . . . 0.0 113.597 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -55.19 -53.43 56.11 Favored 'General case' 0 CA--C 1.573 1.842 0 CA-C-N 120.255 1.388 . . . . 0.0 112.63 176.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.495 HG22 ' HG2' ' A' ' 114' ' ' MET . 18.2 t -73.74 -53.79 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-O 117.197 -1.382 . . . . 0.0 113.829 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -64.2 -40.72 96.68 Favored 'General case' 0 CA--C 1.564 1.514 0 CA-C-N 120.061 1.3 . . . . 0.0 112.52 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -69.56 -43.87 72.04 Favored 'General case' 0 CA--C 1.574 1.891 0 CA-C-N 120.036 1.289 . . . . 0.0 111.228 176.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.57 -46.51 89.58 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 120.616 1.553 . . . . 0.0 113.247 176.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 19.8 ttt -70.27 -39.12 75.12 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 114.818 -2.515 . . . . 0.0 111.761 177.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -64.52 -35.38 80.78 Favored 'General case' 0 CA--C 1.574 1.872 0 CA-C-N 123.99 3.086 . . . . 0.0 111.595 175.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -62.85 -48.43 79.07 Favored 'General case' 0 CA--C 1.579 2.08 0 CA-C-N 121.654 2.025 . . . . 0.0 109.083 172.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.46 -25.08 63.91 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 177.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -90.06 100.57 13.37 Favored 'General case' 0 CA--C 1.573 1.856 0 N-CA-C 103.071 -2.937 . . . . 0.0 103.071 171.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -72.88 -16.56 61.57 Favored 'General case' 0 CA--C 1.579 2.095 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -98.55 -14.57 19.9 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 119.016 2.969 . . . . 0.0 119.016 -175.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.03 5.9 89.33 Favored Glycine 0 CA--C 1.57 3.482 0 CA-C-N 120.411 1.46 . . . . 0.0 115.138 -173.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -75.82 -47.18 26.7 Favored 'General case' 0 CA--C 1.563 1.466 0 C-N-CA 125.441 1.496 . . . . 0.0 112.195 176.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 111.84 -25.04 13.66 Favored Glycine 0 CA--C 1.553 2.455 0 CA-C-O 117.354 -1.803 . . . . 0.0 114.311 -176.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -100.68 143.16 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 N-CA-C 103.725 -2.694 . . . . 0.0 103.725 174.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.7 mt -121.84 124.87 72.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 111.982 -2.372 . . . . 0.0 112.665 -176.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 39.0 p30 -91.43 155.06 18.72 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 170.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.4 mt -52.13 -42.45 86.08 Favored Pre-proline 0 CA--C 1.583 2.237 0 CA-C-O 114.902 -2.475 . . . . 0.0 113.285 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -58.59 -17.8 36.8 Favored 'Trans proline' 0 C--N 1.376 1.992 0 CA-C-N 125.27 2.918 . . . . 0.0 117.976 176.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -72.53 -63.22 1.2 Allowed 'General case' 0 N--CA 1.505 2.28 0 CA-C-N 123.102 2.683 . . . . 0.0 109.469 176.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -54.55 -49.05 71.24 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 125.128 1.371 . . . . 0.0 110.908 173.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.3 mmt -64.6 -34.93 79.43 Favored 'General case' 0 CA--C 1.565 1.556 0 CA-C-O 115.454 -2.212 . . . . 0.0 111.868 175.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.913 ' OD2' ' HD2' ' A' ' 153' ' ' LYS . 6.7 t70 -66.67 -46.49 75.52 Favored 'General case' 0 N--CA 1.507 2.382 0 CA-C-N 125.537 3.79 . . . . 0.0 109.14 174.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.461 HD23 HG13 ' A' ' 151' ' ' ILE . 0.2 OUTLIER -46.89 -54.63 9.57 Favored 'General case' 0 C--N 1.368 1.386 0 C-N-CA 126.189 1.795 . . . . 0.0 111.215 176.584 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.461 HG13 HD23 ' A' ' 150' ' ' LEU . 33.8 mt -98.36 -28.52 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-N 121.648 2.022 . . . . 0.0 116.318 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.39 -18.37 23.38 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 118.659 2.837 . . . . 0.0 118.659 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.913 ' HD2' ' OD2' ' A' ' 149' ' ' ASP . 74.6 tttt -74.48 -9.71 58.85 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 121.64 3.941 . . . . 0.0 121.64 -176.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 84.7 p . . . . . 0 N--CA 1.532 3.633 0 N-CA-C 120.93 3.678 . . . . 0.0 120.93 -179.966 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 . . . . . 0 CA--C 1.617 3.527 0 N-CA-C 104.143 -2.54 . . . . 0.0 104.143 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.419 ' HA ' ' HG ' ' A' ' 91' ' ' LEU . 8.4 mm-40 -10.62 -28.96 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.657 2 C-N-CA 133.845 4.858 . . . . 0.0 122.105 -170.566 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.26 -66.85 0.6 Allowed 'General case' 0 N--CA 1.51 2.532 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 170.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.6 HG23 ' CE2' ' A' ' 147' ' ' PHE . 4.0 mp -58.14 -44.77 88.25 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.753 0 CA-C-N 112.036 -2.347 . . . . 0.0 108.963 172.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.474 ' HB2' ' HE3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -67.26 -39.03 86.04 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 116.322 -1.799 . . . . 0.0 111.685 176.623 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.445 ' O ' ' HB ' ' A' ' 96' ' ' VAL . 0.0 OUTLIER -57.22 -53.26 60.09 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 122.863 2.574 . . . . 0.0 107.888 176.396 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.71 -66.14 0.6 Allowed 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.496 ' CE2' HD12 ' A' ' 105' ' ' ILE . 9.5 t80 -66.62 -51.91 51.11 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.474 ' HE3' ' HB2' ' A' ' 91' ' ' LEU 0.382 7.7 mttt -67.81 -17.54 64.55 Favored 'General case' 0 CA--C 1.589 2.446 0 CA-C-O 114.821 -2.514 . . . . 0.0 110.234 -177.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 92' ' ' ARG . 1.0 OUTLIER -74.19 -46.5 44.56 Favored 'Isoleucine or valine' 0 C--N 1.395 2.547 0 CA-C-N 124.582 3.355 . . . . 0.0 106.186 167.159 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -53.61 -35.88 61.39 Favored 'General case' 0 CA--C 1.582 2.185 0 N-CA-C 117.23 2.308 . . . . 0.0 117.23 178.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -56.51 110.06 0.72 Allowed 'General case' 0 CA--C 1.575 1.905 0 C-N-CA 126.14 1.776 . . . . 0.0 115.469 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.644 ' HB2' ' HG2' ' A' ' 109' ' ' GLU . . . -73.76 -51.77 15.39 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -67.21 -24.53 65.85 Favored 'General case' 0 CA--C 1.578 2.052 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.8 1.71 90.31 Favored Glycine 0 CA--C 1.562 2.992 0 CA-C-N 121.773 2.079 . . . . 0.0 116.987 -175.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -107.19 0.64 23.47 Favored 'General case' 0 CA--C 1.587 2.382 0 CA-C-N 120.027 1.914 . . . . 0.0 112.419 172.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 114.06 -20.09 17.22 Favored Glycine 0 CA--C 1.547 2.083 0 CA-C-O 115.459 -2.856 . . . . 0.0 115.262 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.6 m -83.74 138.15 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.612 0 CA-C-N 123.797 3.799 . . . . 0.0 114.306 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.496 HD12 ' CE2' ' A' ' 94' ' ' PHE . 88.2 mt -116.25 123.36 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 101.713 -3.44 . . . . 0.0 101.713 174.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.491 ' HA ' HG12 ' A' ' 141' ' ' VAL . 2.1 p30 -91.88 162.64 14.34 Favored 'General case' 0 CA--C 1.56 1.329 0 CA-C-O 122.433 1.111 . . . . 0.0 111.577 176.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.77 -47.23 78.91 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.762 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -61.37 -44.2 97.56 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 117.906 -1.045 . . . . 0.0 111.546 176.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.644 ' HG2' ' HB2' ' A' ' 99' ' ' ALA . 34.4 tp10 -63.67 -37.76 88.55 Favored 'General case' 0 CA--C 1.569 1.701 0 CA-C-N 121.097 1.771 . . . . 0.0 112.521 174.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -62.76 -52.3 63.74 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 120.113 1.324 . . . . 0.0 108.143 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.462 ' HA ' HG11 ' A' ' 127' ' ' VAL . 10.5 ptpp? -56.58 -38.54 72.13 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 116.139 -1.886 . . . . 0.0 111.606 175.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -61.76 -54.52 41.25 Favored 'General case' 0 CA--C 1.579 2.072 0 CA-C-N 121.267 1.849 . . . . 0.0 112.788 174.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 tt -73.2 -11.93 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 119.091 2.997 . . . . 0.0 119.091 -177.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 9.2 tpt -42.27 -58.29 2.22 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -126.04 98.89 5.68 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 124.576 1.173 . . . . 0.0 114.144 -177.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -108.69 58.47 0.61 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 92.7 t -142.28 82.98 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 1 N-CA-C 98.539 -4.615 . . . . 0.0 98.539 175.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.14 109.76 0.19 Allowed Glycine 0 CA--C 1.55 2.23 0 N-CA-C 106.117 -2.793 . . . . 0.0 106.117 -173.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -51.56 109.62 0.37 Allowed 'General case' 0 N--CA 1.505 2.316 0 CA-C-N 119.873 1.836 . . . . 0.0 114.305 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -134.69 -29.3 0.02 OUTLIER Pre-proline 0 CA--C 1.574 1.875 2 N-CA-C 122.958 4.429 . . . . 0.0 122.958 -175.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . 0.297 0.1 OUTLIER 7.15 68.42 0.0 OUTLIER 'Trans proline' 0 N--CA 1.522 3.153 1 CA-C-N 128.774 4.169 . . . . 0.0 119.793 -175.617 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.332 1.4 tm? -78.87 -85.0 0.08 Allowed 'General case' 0 CA--C 1.562 1.421 0 CA-C-N 110.708 -2.951 . . . . 0.0 117.729 -171.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 30.6 p -82.98 127.88 33.96 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 125.502 3.774 . . . . 0.0 109.454 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -66.12 -40.88 91.03 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 177.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -54.52 -43.59 72.04 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -46.5 82.67 Favored 'General case' 0 CA--C 1.584 2.253 0 CA-C-N 120.187 1.358 . . . . 0.0 113.847 177.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.462 HG11 ' HA ' ' A' ' 111' ' ' LYS . 15.7 t -66.08 -48.97 79.77 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.496 0 C-N-CA 125.126 1.37 . . . . 0.0 110.884 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -57.3 -49.95 74.47 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 117.093 -1.432 . . . . 0.0 110.061 176.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -55.16 -51.33 66.82 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 120.737 1.608 . . . . 0.0 112.568 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.91 -48.0 83.48 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 116.123 1.897 . . . . 0.0 116.123 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -44.32 50.31 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 115.8 -2.048 . . . . 0.0 111.277 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.33 -37.18 69.62 Favored 'General case' 0 CA--C 1.575 1.92 0 CA-C-N 122.466 2.394 . . . . 0.0 110.954 174.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -70.91 -39.46 72.72 Favored 'General case' 0 CA--C 1.578 2.024 0 CA-C-N 121.04 1.746 . . . . 0.0 111.94 175.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.08 -25.0 63.32 Favored 'General case' 0 CA--C 1.579 2.068 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 174.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -79.7 110.98 15.55 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 116.579 -3.826 . . . . 0.0 108.068 175.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -75.46 -22.75 57.01 Favored 'General case' 0 CA--C 1.57 1.723 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -107.11 -9.59 16.12 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 118.742 2.867 . . . . 0.0 118.742 -174.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.12 3.76 90.62 Favored Glycine 0 CA--C 1.569 3.408 0 CA-C-O 117.811 -1.55 . . . . 0.0 112.832 -172.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -92.75 42.84 1.11 Allowed 'General case' 0 C--N 1.367 1.335 1 CA-C-O 107.484 -6.008 . . . . 0.0 110.391 175.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 57.92 -23.21 0.02 OUTLIER Glycine 0 N--CA 1.503 3.107 3 O-C-N 105.214 -10.929 . . . . 0.0 129.104 162.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.491 HG12 ' HA ' ' A' ' 106' ' ' ASP . 6.4 m -134.04 140.97 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-N 121.196 2.498 . . . . 0.0 107.029 178.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.1 mt -104.23 131.02 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 113.861 -1.518 . . . . 0.0 112.899 -175.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -97.45 153.34 18.18 Favored 'General case' 0 CA--C 1.559 1.311 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 170.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.43 HD13 ' HD3' ' A' ' 95' ' ' LYS . 2.4 mt -52.68 -43.3 92.54 Favored Pre-proline 0 CA--C 1.583 2.247 0 CA-C-O 114.768 -2.539 . . . . 0.0 113.181 -178.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -51.37 -35.21 53.42 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.877 3.052 . . . . 0.0 115.802 176.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -59.93 -53.97 51.61 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 120.101 1.319 . . . . 0.0 110.81 174.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.6 ' CE2' HG23 ' A' ' 90' ' ' ILE . 36.0 t80 -56.21 -46.32 79.51 Favored 'General case' 0 CA--C 1.57 1.743 0 C-N-CA 125.041 1.336 . . . . 0.0 111.895 175.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.51 ' HG2' HG21 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -57.17 -45.13 83.93 Favored 'General case' 0 CA--C 1.591 2.548 0 C-N-CA 123.349 0.66 . . . . 0.0 110.708 176.105 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.1 -40.25 94.32 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 119.715 1.143 . . . . 0.0 112.111 176.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.55 -47.11 80.16 Favored 'General case' 0 CA--C 1.569 1.699 0 C-N-CA 124.538 1.135 . . . . 0.0 108.458 173.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 88.4 mt -61.78 -40.13 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 CA-C-N 120.389 1.45 . . . . 0.0 110.807 175.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -59.1 -49.71 76.85 Favored 'General case' 0 CA--C 1.586 2.342 0 CA-C-N 120.642 1.564 . . . . 0.0 112.499 175.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.696 ' HG3' ' H ' ' A' ' 154' ' ' SER . 59.4 pttt -94.53 -72.6 0.61 Allowed 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.696 ' H ' ' HG3' ' A' ' 153' ' ' LYS . 26.2 p . . . . . 0 N--CA 1.502 2.133 0 C-N-CA 124.662 1.185 . . . . 0.0 108.6 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.506 ' HA ' HD12 ' A' ' 90' ' ' ILE 0.262 55.8 tt0 . . . . . 0 N--CA 1.495 1.777 0 N-CA-C 117.366 2.358 . . . . 0.0 117.366 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -63.54 -40.34 96.76 Favored 'General case' 0 CA--C 1.586 2.346 0 CA-C-N 120.255 1.389 . . . . 0.0 109.529 173.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -60.39 -29.09 68.73 Favored 'General case' 0 CA--C 1.581 2.164 0 CA-C-O 117.511 -1.233 . . . . 0.0 110.568 172.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.745 HG21 ' HG2' ' A' ' 148' ' ' MET . 37.9 mt -71.01 -63.22 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.369 1.446 0 CA-C-O 115.686 -2.102 . . . . 0.0 107.05 174.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 pp -49.85 -47.77 51.51 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-N 122.472 2.396 . . . . 0.0 111.967 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.8 mtm105 -62.82 -55.19 28.54 Favored 'General case' 0 CA--C 1.571 1.787 0 CA-C-O 118.532 -0.746 . . . . 0.0 112.163 176.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.61 -59.47 3.92 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 114.59 -2.624 . . . . 0.0 113.685 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.413 ' CE2' HD12 ' A' ' 105' ' ' ILE . 14.7 t80 -54.89 -48.6 72.79 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 122.627 2.467 . . . . 0.0 112.437 178.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.252 93.0 mttt -64.83 -30.91 71.93 Favored 'General case' 0 CA--C 1.581 2.165 0 CA-C-N 119.796 1.18 . . . . 0.0 111.361 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.7 t -65.86 -48.96 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.507 0 CA-C-N 121.54 1.973 . . . . 0.0 108.534 169.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.1 -30.94 60.76 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 117.446 2.387 . . . . 0.0 117.446 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.318 0.0 OUTLIER -52.47 -14.28 0.47 Allowed 'General case' 0 CA--C 1.578 2.05 0 N-CA-C 119.895 3.295 . . . . 0.0 119.895 -177.404 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.761 ' HB2' ' HG2' ' A' ' 109' ' ' GLU . . . 75.35 -70.69 0.14 Allowed 'General case' 0 N--CA 1.502 2.167 0 CA-C-N 122.654 2.479 . . . . 0.0 116.33 176.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -76.35 -17.95 59.14 Favored 'General case' 0 CA--C 1.571 1.758 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 -177.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.02 3.92 90.21 Favored Glycine 0 CA--C 1.568 3.39 0 CA-C-O 117.437 -1.757 . . . . 0.0 114.333 -172.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 46.9 p-10 -98.47 -17.05 18.96 Favored 'General case' 0 CA--C 1.579 2.061 0 CA-C-N 120.881 2.341 . . . . 0.0 113.647 174.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.52 22.65 6.0 Favored Glycine 0 CA--C 1.546 2.002 0 CA-C-O 115.474 -2.848 . . . . 0.0 116.48 -178.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.6 t -134.39 121.96 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 CA-C-N 122.669 3.235 . . . . 0.0 112.555 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.413 HD12 ' CE2' ' A' ' 94' ' ' PHE . 62.3 mt -93.54 135.25 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 C-N-CA 126.432 1.893 . . . . 0.0 112.789 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -105.11 173.76 6.17 Favored 'General case' 0 CA--C 1.574 1.875 0 C-N-CA 124.193 0.997 . . . . 0.0 111.863 175.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -70.45 -50.15 41.24 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -62.94 -45.91 90.25 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 118.282 -0.866 . . . . 0.0 112.341 178.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.761 ' HG2' ' HB2' ' A' ' 99' ' ' ALA . 37.6 tp10 -61.21 -39.55 90.66 Favored 'General case' 0 CA--C 1.569 1.709 0 CA-C-N 120.49 1.495 . . . . 0.0 112.05 175.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -58.83 -53.66 55.93 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 120.127 1.331 . . . . 0.0 110.042 175.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -51.0 -42.68 60.51 Favored 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -73.2 -55.34 6.59 Favored 'General case' 0 CA--C 1.577 1.986 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 176.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.6 tt -67.98 -34.77 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 118.726 2.862 . . . . 0.0 118.726 -176.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.433 ' SD ' HG13 ' A' ' 127' ' ' VAL . 40.2 ttp -27.39 -43.23 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 117.936 2.569 . . . . 0.0 117.936 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -94.8 72.76 3.56 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-N 113.825 -1.534 . . . . 0.0 113.097 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.546 ' HD3' ' H ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -128.87 -58.03 1.16 Allowed 'General case' 0 CA--C 1.575 1.935 0 CA-C-N 112.928 -1.942 . . . . 0.0 115.57 -179.009 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.8 p -176.81 128.32 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.572 1.812 0 CA-C-N 120.702 1.592 . . . . 0.0 107.916 -177.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 94.24 -117.05 5.42 Favored Glycine 0 CA--C 1.542 1.721 0 N-CA-C 116.341 1.296 . . . . 0.0 116.341 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.32 103.93 4.9 Favored 'General case' 0 CA--C 1.57 1.746 0 CA-C-O 122.69 1.233 . . . . 0.0 112.172 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.5 84.09 6.0 Favored Pre-proline 0 CA--C 1.58 2.127 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 -177.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -83.82 63.8 7.22 Favored 'Trans proline' 0 CA--C 1.574 2.495 0 C-N-CA 123.491 2.794 . . . . 0.0 109.456 175.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.293 7.2 tt -51.91 -43.47 63.41 Favored 'General case' 0 CA--C 1.563 1.468 0 N-CA-C 120.868 3.655 . . . . 0.0 120.868 -175.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 67.6 p -69.37 150.59 47.14 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 124.577 3.353 . . . . 0.0 111.61 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -42.0 -49.12 4.68 Favored 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 177.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.81 -48.51 76.54 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 112.292 -2.231 . . . . 0.0 111.429 176.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -61.52 -29.02 69.73 Favored 'General case' 0 CA--C 1.576 1.959 0 CA-C-N 120.438 1.472 . . . . 0.0 112.737 174.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.433 HG13 ' SD ' ' A' ' 114' ' ' MET . 1.5 t -70.36 -57.66 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 CA-C-N 121.374 1.897 . . . . 0.0 109.043 177.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -64.22 -38.98 93.0 Favored 'General case' 0 N--CA 1.508 2.442 0 CA-C-N 120.24 1.382 . . . . 0.0 113.263 178.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -65.08 -44.59 88.41 Favored 'General case' 0 CA--C 1.567 1.614 0 CA-C-O 117.839 -1.076 . . . . 0.0 112.02 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -64.31 -45.33 88.38 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 120.012 1.278 . . . . 0.0 112.234 176.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 19.6 ttt -70.24 -41.83 73.03 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 114.238 -2.791 . . . . 0.0 111.055 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -64.51 -33.24 75.45 Favored 'General case' 0 CA--C 1.576 1.978 0 CA-C-N 125.087 3.585 . . . . 0.0 111.293 175.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -62.49 -44.02 97.4 Favored 'General case' 0 CA--C 1.585 2.31 0 CA-C-N 122.023 2.192 . . . . 0.0 110.376 171.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.44 -29.36 56.96 Favored 'General case' 0 CA--C 1.576 1.961 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 178.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -90.77 100.16 13.06 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 103.12 -2.919 . . . . 0.0 103.12 172.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -56.48 -29.62 61.98 Favored 'General case' 0 CA--C 1.593 2.61 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.407 54.2 t0 160.88 -22.96 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.676 1 CA-C-O 108.925 -5.321 . . . . 0.0 103.811 175.808 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 11.04 5.88 0.0 OUTLIER Glycine 0 CA--C 1.564 3.136 3 O-C-N 99.065 -14.772 . . . . 0.0 125.131 160.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.46 ' OD1' HG23 ' A' ' 141' ' ' VAL . 2.3 p-10 79.03 15.14 1.06 Allowed 'General case' 0 CA--C 1.595 2.674 0 CA-C-N 121.3 2.55 . . . . 0.0 111.626 -172.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 97.38 -22.88 38.4 Favored Glycine 0 CA--C 1.563 3.042 0 CA-C-N 122.974 2.624 . . . . 0.0 115.636 -176.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.46 HG23 ' OD1' ' A' ' 139' ' ' ASN . 0.1 OUTLIER -105.46 146.52 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.378 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 178.396 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -115.22 129.72 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 113.815 -1.539 . . . . 0.0 114.513 -176.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 47.9 p30 -92.18 164.86 13.41 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 171.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 7.6 mt -55.96 -42.95 98.75 Favored Pre-proline 0 CA--C 1.585 2.327 0 CA-C-O 115.028 -2.415 . . . . 0.0 112.584 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -59.16 -22.53 64.96 Favored 'Trans proline' 0 C--N 1.376 2.007 0 CA-C-N 125.338 2.942 . . . . 0.0 119.74 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -69.92 0.3 Allowed 'General case' 0 CA--C 1.562 1.407 0 CA-C-N 122.996 2.635 . . . . 0.0 110.357 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.658 ' CE2' HG23 ' A' ' 90' ' ' ILE . 77.8 t80 -49.54 -43.39 45.73 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 124.716 1.206 . . . . 0.0 113.468 174.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.745 ' HG2' HG21 ' A' ' 90' ' ' ILE . 5.8 mtp -67.37 -40.35 85.76 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-O 114.898 -2.477 . . . . 0.0 112.004 177.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.79 ' OD1' ' HE3' ' A' ' 153' ' ' LYS . 1.9 t0 -63.83 -43.67 95.52 Favored 'General case' 0 N--CA 1.505 2.281 0 CA-C-N 124.458 3.299 . . . . 0.0 109.626 173.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.95 -47.89 21.64 Favored 'General case' 0 CA--C 1.575 1.916 0 C-N-CA 127.173 2.189 . . . . 0.0 112.07 174.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 68.0 mt -89.06 -34.47 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.891 0 CA-C-O 117.286 -1.34 . . . . 0.0 111.513 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 41.2 mmtt -53.49 -42.06 66.89 Favored 'General case' 0 N--CA 1.503 2.217 0 CA-C-N 122.126 2.239 . . . . 0.0 112.739 176.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.79 ' HE3' ' OD1' ' A' ' 149' ' ' ASP . 96.1 mttt -63.49 -53.6 49.54 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 119.016 0.825 . . . . 0.0 112.137 176.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 177.691 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 . . . . . 0 CA--C 1.586 2.347 0 CA-C-O 118.012 -0.994 . . . . 0.0 113.101 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -43.87 -55.35 4.6 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 118.213 2.672 . . . . 0.0 118.213 -177.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -58.88 -54.2 49.76 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.662 HG23 ' CE2' ' A' ' 147' ' ' PHE . 1.6 mp -66.38 -45.71 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 116.748 -1.596 . . . . 0.0 109.995 177.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.46 -46.13 84.0 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 121.617 2.008 . . . . 0.0 110.541 177.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.91 -55.96 28.42 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 117.326 -1.321 . . . . 0.0 110.574 176.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.83 -57.62 6.66 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.521 ' CE2' HD12 ' A' ' 105' ' ' ILE . 15.8 t80 -64.97 -50.53 66.02 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 120.899 1.681 . . . . 0.0 113.401 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.424 ' HE2' HD13 ' A' ' 144' ' ' ILE 0.335 65.8 mttt -68.07 -22.4 64.94 Favored 'General case' 0 CA--C 1.59 2.515 0 CA-C-O 116.495 -1.717 . . . . 0.0 110.455 -178.804 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.9 t -71.25 -48.87 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.421 0 CA-C-N 122.818 2.554 . . . . 0.0 107.213 168.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -49.02 -34.75 13.91 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.11 102.15 0.35 Allowed 'General case' 0 CA--C 1.576 1.976 0 C-N-CA 126.038 1.735 . . . . 0.0 109.191 176.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.28 -43.03 71.27 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.9 p30 -69.91 -8.03 45.33 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 117.236 2.31 . . . . 0.0 117.236 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.79 29.4 71.09 Favored Glycine 0 CA--C 1.558 2.75 0 CA-C-N 120.823 1.647 . . . . 0.0 116.418 -177.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.19 76.04 1.53 Allowed 'General case' 0 N--CA 1.477 0.882 1 CA-C-O 109.068 -5.253 . . . . 0.0 106.606 178.631 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 52.88 -30.24 0.01 OUTLIER Glycine 0 N--CA 1.491 2.305 2 N-CA-C 127.952 5.941 . . . . 0.0 127.952 165.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.6 p -107.15 155.05 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.455 0 CA-C-O 122.692 1.234 . . . . 0.0 114.112 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.521 HD12 ' CE2' ' A' ' 94' ' ' PHE . 87.8 mt -115.6 134.7 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-N 113.09 -1.868 . . . . 0.0 108.855 177.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.94 -179.29 3.82 Favored 'General case' 0 CA--C 1.576 1.972 0 CA-C-N 119.86 1.209 . . . . 0.0 112.965 175.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -74.78 -51.57 13.77 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.445 -1.409 . . . . 0.0 113.601 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.39 -33.63 75.97 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 178.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.18 -40.92 82.12 Favored 'General case' 0 CA--C 1.581 2.147 0 CA-C-N 120.44 1.473 . . . . 0.0 110.765 174.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.74 -46.66 86.9 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 117.521 -1.228 . . . . 0.0 108.892 172.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.45 ' HA ' HG21 ' A' ' 127' ' ' VAL . 2.9 tppt? -52.05 -61.82 2.02 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 125.012 1.325 . . . . 0.0 109.12 174.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -48.81 -48.51 41.42 Favored 'General case' 0 CA--C 1.575 1.929 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 176.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -82.14 -13.68 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 118.059 2.614 . . . . 0.0 118.059 -178.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.48 ' SD ' HG23 ' A' ' 127' ' ' VAL . 9.4 tpt -52.1 -49.59 63.3 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 119.246 3.054 . . . . 0.0 119.246 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -64.24 14.41 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 121.355 3.835 . . . . 0.0 121.355 -174.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.5 mptt 60.35 -90.14 0.03 OUTLIER 'General case' 0 N--CA 1.524 3.248 0 C-N-CA 124.465 1.106 . . . . 0.0 112.658 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.7 p -94.63 109.08 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.463 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 85.12 -178.28 50.83 Favored Glycine 0 CA--C 1.549 2.157 0 N-CA-C 115.596 0.998 . . . . 0.0 115.596 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -90.15 -140.09 0.15 Allowed 'General case' 0 CA--C 1.582 2.204 0 CA-C-N 114.32 -0.94 . . . . 0.0 112.457 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.265 8.1 pt-20 57.57 67.7 2.28 Favored Pre-proline 0 N--CA 1.5 2.069 0 N-CA-C 121.014 3.709 . . . . 0.0 121.014 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo -65.73 79.86 0.26 Allowed 'Trans proline' 0 C--N 1.377 2.026 0 C-N-CA 124.678 3.585 . . . . 0.0 114.706 174.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.411 7.7 tt -74.73 -59.19 2.85 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 109.213 -3.631 . . . . 0.0 110.892 -177.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.2 p -94.43 123.68 38.0 Favored 'General case' 0 C--N 1.37 1.479 0 CA-C-N 125.604 3.82 . . . . 0.0 107.558 176.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.38 -20.54 58.91 Favored 'General case' 0 CA--C 1.577 1.982 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.741 174.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -58.04 -40.1 80.04 Favored 'General case' 0 CA--C 1.561 1.381 0 CA-C-O 117.023 -1.465 . . . . 0.0 111.424 174.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -54.56 -53.9 48.33 Favored 'General case' 0 CA--C 1.585 2.323 0 CA-C-N 120.419 1.463 . . . . 0.0 111.477 175.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.48 HG23 ' SD ' ' A' ' 114' ' ' MET 0.251 4.2 p -73.43 -41.33 56.78 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -178.201 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -68.86 -45.78 70.17 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 120.675 1.58 . . . . 0.0 110.205 176.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -62.74 -48.85 77.42 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-N 121.341 1.882 . . . . 0.0 112.019 176.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -64.2 -45.85 86.49 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-N 120.378 1.445 . . . . 0.0 114.692 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -73.98 -34.34 64.18 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 115.934 -1.984 . . . . 0.0 112.767 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.12 -32.61 67.12 Favored 'General case' 0 CA--C 1.566 1.59 0 CA-C-N 122.64 2.473 . . . . 0.0 110.755 173.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.96 -35.51 80.12 Favored 'General case' 0 CA--C 1.58 2.126 0 CA-C-N 123.388 2.813 . . . . 0.0 110.495 172.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.99 -30.9 27.81 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 176.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -90.81 105.71 18.01 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 122.339 2.336 . . . . 0.0 107.115 174.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -62.65 -32.49 73.55 Favored 'General case' 0 CA--C 1.598 2.825 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 175.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.391 57.1 t0 163.54 -21.9 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.041 1 CA-C-O 108.768 -5.396 . . . . 0.0 103.326 176.673 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 13.03 8.04 0.0 OUTLIER Glycine 0 N--CA 1.5 2.928 3 O-C-N 98.666 -15.021 . . . . 0.0 125.028 161.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 77.84 4.58 2.92 Favored 'General case' 0 CA--C 1.581 2.145 0 CA-C-N 121.622 2.711 . . . . 0.0 111.179 -172.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 95.34 -12.09 68.3 Favored Glycine 0 C--N 1.372 2.561 0 CA-C-N 123.746 2.976 . . . . 0.0 114.584 -175.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . 0.298 3.4 m -130.24 121.11 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 102.181 -3.266 . . . . 0.0 102.181 175.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.62 125.62 38.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 111.299 -2.682 . . . . 0.0 114.001 -173.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -92.88 151.99 19.65 Favored 'General case' 0 CA--C 1.558 1.251 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 172.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.424 HD13 ' HE2' ' A' ' 95' ' ' LYS . 1.4 mt -53.32 -41.7 87.77 Favored Pre-proline 0 CA--C 1.582 2.176 0 CA-C-O 114.615 -2.612 . . . . 0.0 112.628 -178.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -55.63 -26.23 54.45 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 123.93 3.087 . . . . 0.0 116.511 176.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -63.85 -62.41 1.66 Allowed 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 122.051 2.205 . . . . 0.0 108.918 174.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.662 ' CE2' HG23 ' A' ' 90' ' ' ILE . 87.2 t80 -55.22 -47.08 75.85 Favored 'General case' 0 CA--C 1.57 1.739 0 C-N-CA 125.638 1.575 . . . . 0.0 113.842 173.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.49 ' HG2' HG21 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -59.12 -39.03 81.01 Favored 'General case' 0 CA--C 1.588 2.418 0 CA-C-O 117.673 -1.156 . . . . 0.0 109.857 174.749 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -67.15 -47.47 70.94 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 121.214 1.825 . . . . 0.0 110.104 173.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.33 -44.58 11.74 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 127.608 2.363 . . . . 0.0 112.26 176.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 58.5 mt -92.61 -56.23 5.39 Favored 'Isoleucine or valine' 0 C--N 1.366 1.295 0 CA-C-O 116.911 -1.519 . . . . 0.0 113.933 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -90.31 -41.97 11.22 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 118.368 2.729 . . . . 0.0 118.368 -176.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -100.09 -78.01 0.52 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 118.886 2.921 . . . . 0.0 118.886 -174.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.527 3.377 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 -174.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 . . . . . 0 CA--C 1.604 3.022 0 CA-C-O 118.88 -0.581 . . . . 0.0 112.296 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -28.04 -70.92 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 130.797 3.639 . . . . 0.0 118.112 -177.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -56.31 -50.52 71.19 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.753 HG23 ' HE2' ' A' ' 147' ' ' PHE . 5.3 mp -72.04 -48.1 51.51 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 CA-C-O 117.053 -1.451 . . . . 0.0 112.496 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.21 -51.93 67.85 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 121.671 2.032 . . . . 0.0 110.266 178.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -65.18 -46.77 79.45 Favored 'General case' 0 CA--C 1.566 1.595 0 CA-C-O 116.532 -1.699 . . . . 0.0 111.146 178.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.28 -61.59 1.73 Allowed 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 121.925 2.148 . . . . 0.0 114.404 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.517 ' CE2' HD12 ' A' ' 105' ' ' ILE . 19.9 t80 -59.15 -50.94 72.14 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 121.979 2.172 . . . . 0.0 112.858 178.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.418 ' HE2' HD13 ' A' ' 144' ' ' ILE 0.353 71.7 mttt -67.78 -23.82 65.25 Favored 'General case' 0 CA--C 1.591 2.53 0 CA-C-O 116.558 -1.687 . . . . 0.0 110.262 -177.42 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.8 t -69.66 -48.23 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.485 0 CA-C-N 122.732 2.515 . . . . 0.0 107.491 167.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -48.28 -33.95 9.63 Favored 'General case' 0 CA--C 1.577 1.991 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.42 95.9 0.48 Allowed 'General case' 0 CA--C 1.577 1.983 0 C-N-CA 126.936 2.094 . . . . 0.0 107.873 175.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.92 -46.49 71.4 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.633 -0.667 . . . . 0.0 112.322 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -47.94 -24.55 1.07 Allowed 'General case' 0 CA--C 1.583 2.233 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 176.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.14 7.43 87.78 Favored Glycine 0 CA--C 1.563 3.036 0 CA-C-N 122.216 2.28 . . . . 0.0 117.34 -176.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.67 78.21 1.69 Allowed 'General case' 0 N--CA 1.478 0.932 1 CA-C-O 109.938 -4.839 . . . . 0.0 104.76 175.356 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 52.68 -26.93 0.01 OUTLIER Glycine 0 N--CA 1.486 2.028 2 N-CA-C 129.079 6.392 . . . . 0.0 129.079 166.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.7 t -103.03 136.19 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-N 118.919 1.359 . . . . 0.0 113.036 -177.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.517 HD12 ' CE2' ' A' ' 94' ' ' PHE . 67.5 mt -111.04 133.59 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 113.082 -1.872 . . . . 0.0 110.347 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -110.51 173.04 6.52 Favored 'General case' 0 CA--C 1.571 1.76 0 C-N-CA 124.378 1.071 . . . . 0.0 111.49 176.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -64.01 -45.52 88.6 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 116.82 -1.562 . . . . 0.0 114.504 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -61.56 -46.87 88.08 Favored 'General case' 0 N--CA 1.508 2.457 0 CA-C-N 121.196 1.816 . . . . 0.0 112.185 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -51.53 -50.3 60.29 Favored 'General case' 0 CA--C 1.574 1.892 0 C-N-CA 124.557 1.143 . . . . 0.0 112.059 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -64.38 -52.6 57.44 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 125.986 1.714 . . . . 0.0 109.791 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 19.1 ttpt -46.87 -49.93 19.45 Favored 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 124.85 1.26 . . . . 0.0 113.534 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -70.57 -53.54 15.63 Favored 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 176.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -70.88 -27.29 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 119.302 3.075 . . . . 0.0 119.302 -175.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.444 ' HE3' ' HG2' ' A' ' 115' ' ' GLN . 15.3 tmm? -45.53 -68.0 0.23 Allowed 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 126.518 1.927 . . . . 0.0 109.577 178.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.444 ' HG2' ' HE3' ' A' ' 114' ' ' MET 0.289 11.6 pt20 -118.2 84.08 2.11 Favored 'General case' 0 CA--C 1.579 2.076 0 N-CA-C 101.733 -3.432 . . . . 0.0 101.733 171.826 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -23.62 -68.61 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.8 1 N-CA-C 123.711 4.708 . . . . 0.0 123.711 -176.896 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.8 p -87.96 80.19 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -175.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.08 -13.18 2.71 Favored Glycine 0 CA--C 1.545 1.929 0 N-CA-C 123.0 3.96 . . . . 0.0 123.0 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.34 26.23 0.67 Allowed 'General case' 0 CA--C 1.597 2.762 0 CA-C-N 122.684 3.242 . . . . 0.0 115.729 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -39.29 157.04 0.13 Allowed Pre-proline 0 N--CA 1.504 2.264 0 N-CA-C 120.883 3.66 . . . . 0.0 120.883 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . 0.315 0.1 OUTLIER -3.66 65.55 0.0 OUTLIER 'Trans proline' 0 C--N 1.394 2.964 1 C-N-CA 126.327 4.685 . . . . 0.0 122.209 179.987 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.508 2.2 tt -79.19 -73.09 0.36 Allowed 'General case' 0 CA--C 1.563 1.473 1 CA-C-N 107.891 -4.231 . . . . 0.0 103.042 -178.728 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.3 p -92.66 112.1 23.93 Favored 'General case' 0 C--N 1.374 1.653 2 CA-C-N 126.771 4.351 . . . . 0.0 99.36 169.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -62.19 -33.45 74.57 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 116.99 2.219 . . . . 0.0 116.99 -177.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.48 -40.28 96.68 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 117.418 -1.277 . . . . 0.0 113.624 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -59.56 -52.11 66.98 Favored 'General case' 0 CA--C 1.572 1.81 0 CA-C-N 120.633 1.56 . . . . 0.0 113.036 178.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.8 t -73.73 -48.36 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-O 117.001 -1.476 . . . . 0.0 112.464 -178.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -65.0 -44.57 88.83 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-N 120.768 1.622 . . . . 0.0 111.356 177.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -64.82 -43.51 92.86 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-N 121.464 1.938 . . . . 0.0 112.084 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.0 -47.62 82.34 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 120.662 1.574 . . . . 0.0 112.92 176.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.583 ' SD ' HD11 ' A' ' 142' ' ' ILE . 13.3 tpt -67.65 -37.67 82.74 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 115.189 -2.338 . . . . 0.0 112.075 176.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -66.64 -43.08 85.63 Favored 'General case' 0 CA--C 1.567 1.609 0 CA-C-N 123.053 2.66 . . . . 0.0 110.712 174.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -59.94 -41.39 91.72 Favored 'General case' 0 CA--C 1.578 2.053 0 CA-C-N 122.568 2.44 . . . . 0.0 110.351 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.59 -16.65 62.87 Favored 'General case' 0 CA--C 1.581 2.148 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.572 ' OD2' ' N ' ' A' ' 140' ' ' GLY . 7.3 t0 -91.8 103.25 15.82 Favored 'General case' 0 CA--C 1.586 2.327 0 N-CA-C 101.679 -3.452 . . . . 0.0 101.679 164.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -73.81 -21.12 60.26 Favored 'General case' 0 CA--C 1.58 2.125 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 178.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -91.82 -11.87 35.32 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 119.514 3.153 . . . . 0.0 119.514 -175.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.13 5.96 89.24 Favored Glycine 0 CA--C 1.573 3.709 0 CA-C-N 120.241 1.382 . . . . 0.0 115.323 -173.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.38 -44.86 20.65 Favored 'General case' 0 CA--C 1.573 1.849 0 C-N-CA 126.139 1.776 . . . . 0.0 113.33 176.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.572 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . 111.13 20.25 7.21 Favored Glycine 0 CA--C 1.558 2.73 0 N-CA-C 116.891 1.516 . . . . 0.0 116.891 -178.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.27 158.73 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-N 118.676 1.238 . . . . 0.0 108.041 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.583 HD11 ' SD ' ' A' ' 131' ' ' MET . 1.1 mt -136.91 128.83 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 117.702 2.482 . . . . 0.0 117.702 -174.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 33.1 p30 -95.74 153.98 17.46 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 170.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.418 HD13 ' HE2' ' A' ' 95' ' ' LYS . 2.3 mt -51.17 -43.08 84.38 Favored Pre-proline 0 CA--C 1.586 2.339 0 CA-C-O 115.006 -2.426 . . . . 0.0 114.198 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -56.01 -29.8 75.47 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 123.787 2.991 . . . . 0.0 117.646 177.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -61.8 -62.51 1.75 Allowed 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 120.831 1.65 . . . . 0.0 110.926 176.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.753 ' HE2' HG23 ' A' ' 90' ' ' ILE . 57.9 t80 -54.85 -42.56 72.13 Favored 'General case' 0 CA--C 1.578 2.04 0 C-N-CA 123.989 0.915 . . . . 0.0 112.809 174.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.682 ' HG2' HG21 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -56.89 -42.27 79.54 Favored 'General case' 0 CA--C 1.583 2.22 0 CA-C-O 117.403 -1.284 . . . . 0.0 109.716 174.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.52 -33.63 73.09 Favored 'General case' 0 CA--C 1.577 1.992 0 CA-C-N 121.187 1.812 . . . . 0.0 110.736 174.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.3 mp -58.52 -45.74 88.2 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 120.661 1.573 . . . . 0.0 111.542 174.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 66.6 mt -79.9 -45.62 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 120.445 1.475 . . . . 0.0 110.982 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -62.87 -49.71 73.78 Favored 'General case' 0 CA--C 1.575 1.915 0 CA-C-N 120.931 1.696 . . . . 0.0 114.702 177.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -93.2 -71.16 0.67 Allowed 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 124.807 1.243 . . . . 0.0 111.926 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.528 3.447 0 C-N-CA 126.999 2.119 . . . . 0.0 113.322 179.721 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 . . . . . 0 CA--C 1.574 1.889 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -40.7 -69.9 0.12 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.762 2.025 . . . . 0.0 115.884 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.52 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 13.0 pt-20 -58.54 -45.1 89.61 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 114.827 1.418 . . . . 0.0 114.827 -177.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.416 HG23 ' CD2' ' A' ' 147' ' ' PHE . 4.2 mp -76.83 -67.61 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 114.42 -2.705 . . . . 0.0 114.572 -177.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . 0.336 0.0 OUTLIER -73.95 -33.63 63.97 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 123.546 2.885 . . . . 0.0 110.36 -178.247 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 46.9 mtt180 -69.04 -45.69 69.8 Favored 'General case' 0 CA--C 1.58 2.133 0 CA-C-N 125.52 3.782 . . . . 0.0 108.992 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 89' ' ' GLU . . . -70.79 -57.25 4.84 Favored 'General case' 0 C--N 1.384 2.09 0 CA-C-N 122.376 2.353 . . . . 0.0 112.121 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.595 ' CE2' HD12 ' A' ' 105' ' ' ILE . 4.8 t80 -57.07 -51.59 68.67 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 121.919 2.145 . . . . 0.0 113.267 178.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.602 ' HE2' HD13 ' A' ' 144' ' ' ILE . 56.0 mttt -62.01 -31.0 71.34 Favored 'General case' 0 CA--C 1.576 1.948 0 CA-C-O 115.491 -2.195 . . . . 0.0 111.548 -178.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -69.2 -45.23 79.86 Favored 'Isoleucine or valine' 0 CA--C 1.591 2.523 0 CA-C-N 123.604 2.911 . . . . 0.0 109.355 170.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.91 -31.13 38.27 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.965 ' OD2' ' HA ' ' A' ' 102' ' ' ASP . 1.7 t0 -56.9 125.39 22.32 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 119.997 1.271 . . . . 0.0 109.087 177.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.46 28.35 0.03 OUTLIER 'General case' 0 N--CA 1.527 3.422 0 N-CA-C 120.445 3.498 . . . . 0.0 120.445 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.497 ' H ' ' C ' ' A' ' 98' ' ' ASP 0.422 13.7 t-20 72.44 148.23 0.09 Allowed 'General case' 0 CA--C 1.604 3.033 2 C-N-CA 135.223 5.409 . . . . 0.0 101.825 -175.813 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 109.39 60.49 0.52 Allowed Glycine 0 C--N 1.285 -2.254 2 C-N-CA 135.547 6.308 . . . . 0.0 109.621 -177.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.965 ' HA ' ' OD2' ' A' ' 98' ' ' ASP 0.832 0.2 OUTLIER -30.13 113.5 0.09 Allowed 'General case' 0 C--N 1.393 2.474 0 CA-C-O 127.626 3.584 . . . . 0.0 118.268 -174.511 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 126.62 28.92 0.93 Allowed Glycine 0 N--CA 1.43 -1.724 1 CA-C-N 103.376 -6.284 . . . . 0.0 110.716 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . 0.273 0.0 OUTLIER -166.67 142.57 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 N-CA-C 118.376 2.732 . . . . 0.0 118.376 177.306 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.595 HD12 ' CE2' ' A' ' 94' ' ' PHE . 96.1 mt -136.64 134.58 48.98 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.676 0 C-N-CA 128.331 2.652 . . . . 0.0 104.99 175.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -105.01 -178.56 3.69 Favored 'General case' 0 CA--C 1.569 1.692 0 C-N-CA 124.462 1.105 . . . . 0.0 111.621 175.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.49 -46.62 25.96 Favored 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -178.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -62.95 -53.09 59.49 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 117.023 -1.465 . . . . 0.0 111.328 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -58.03 -30.72 66.36 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 121.838 2.108 . . . . 0.0 113.124 175.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -66.97 -51.65 52.56 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 120.554 1.524 . . . . 0.0 109.187 176.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.1 tppt? -54.98 -35.33 64.21 Favored 'General case' 0 CA--C 1.58 2.118 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 174.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 11.3 m-30 -74.76 -57.98 3.57 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 125.699 1.6 . . . . 0.0 113.043 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.9 -36.4 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 125.814 1.645 . . . . 0.0 113.684 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -53.97 -48.16 70.62 Favored 'General case' 0 CA--C 1.588 2.432 0 CA-C-O 121.157 0.503 . . . . 0.0 110.198 171.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -102.65 72.35 1.23 Allowed 'General case' 0 CA--C 1.58 2.113 0 C-N-CA 126.594 1.957 . . . . 0.0 114.477 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.6 mmtt -99.53 142.16 31.38 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 119.733 -1.854 . . . . 0.0 111.795 177.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.3 p 48.67 95.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 C-N-CA 126.355 1.862 . . . . 0.0 112.028 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 97.56 -43.05 2.02 Favored Glycine 0 CA--C 1.554 2.518 0 CA-C-O 119.065 -0.853 . . . . 0.0 113.012 -176.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 75.08 102.54 0.07 Allowed 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 125.758 1.623 . . . . 0.0 112.866 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -125.09 -34.38 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.619 1 CA-C-O 111.505 -4.093 . . . . 0.0 119.45 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -80.92 74.58 5.47 Favored 'Trans proline' 0 CA--C 1.574 2.491 1 CA-C-N 130.762 4.879 . . . . 0.0 106.681 175.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.264 0.5 OUTLIER -68.82 -33.32 73.64 Favored 'General case' 0 CA--C 1.558 1.263 1 N-CA-C 123.121 4.489 . . . . 0.0 123.121 -171.478 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 78.3 p -78.92 140.11 38.14 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 123.7 2.954 . . . . 0.0 110.124 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -60.09 -37.58 80.35 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.37 -36.84 71.73 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 117.346 -1.311 . . . . 0.0 114.478 176.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -61.76 -51.11 69.66 Favored 'General case' 0 CA--C 1.58 2.133 0 CA-C-N 120.786 1.63 . . . . 0.0 111.841 175.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.2 t -63.53 -51.83 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 C-N-CA 125.804 1.642 . . . . 0.0 110.706 178.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.3 -38.78 84.71 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-O 117.569 -1.205 . . . . 0.0 111.314 176.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -62.87 -50.45 70.87 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 121.673 2.033 . . . . 0.0 112.094 175.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.49 -47.26 86.92 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 177.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.429 ' SD ' HD11 ' A' ' 142' ' ' ILE . 12.8 tpt -70.02 -38.72 75.98 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 115.434 -2.222 . . . . 0.0 111.303 176.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -36.16 83.37 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 123.724 2.965 . . . . 0.0 111.372 175.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -61.78 -49.21 77.26 Favored 'General case' 0 CA--C 1.573 1.848 0 CA-C-O 118.121 -0.942 . . . . 0.0 109.478 173.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -77.33 -23.82 50.87 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 117.724 2.49 . . . . 0.0 117.724 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -91.29 116.67 29.01 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 103.356 -2.831 . . . . 0.0 103.356 170.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -61.59 -22.33 65.12 Favored 'General case' 0 CA--C 1.586 2.347 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.281 29.6 t0 96.97 159.68 0.02 OUTLIER 'General case' 0 CA--C 1.609 3.218 0 CA-C-O 127.402 3.477 . . . . 0.0 103.085 178.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 94.48 36.79 5.52 Favored Glycine 0 CA--C 1.567 3.319 2 C-N-CA 132.006 4.622 . . . . 0.0 102.492 -173.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -173.7 -65.43 0.01 OUTLIER 'General case' 0 C--N 1.399 2.722 0 CA-C-N 121.821 2.811 . . . . 0.0 115.488 -174.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 87.39 20.6 51.5 Favored Glycine 0 CA--C 1.574 3.751 0 CA-C-N 119.31 0.959 . . . . 0.0 114.384 -174.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.88 168.25 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 128.053 2.541 . . . . 0.0 104.227 -178.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.429 HD11 ' SD ' ' A' ' 131' ' ' MET . 0.9 OUTLIER -144.75 133.06 17.4 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 O-C-N 120.979 -1.075 . . . . 0.0 112.816 -178.385 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 53.6 p30 -103.58 155.65 18.38 Favored 'General case' 0 CA--C 1.561 1.384 0 N-CA-C 104.467 -2.42 . . . . 0.0 104.467 169.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.602 HD13 ' HE2' ' A' ' 95' ' ' LYS . 0.6 OUTLIER -52.45 -44.89 95.3 Favored Pre-proline 0 N--CA 1.492 1.669 0 CA-C-O 115.184 -2.341 . . . . 0.0 113.219 -178.4 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.44 ' O ' ' HB2' ' A' ' 149' ' ' ASP . 43.1 Cg_exo -55.51 -21.21 29.67 Favored 'Trans proline' 0 C--N 1.375 1.942 0 CA-C-O 114.139 -2.526 . . . . 0.0 116.455 177.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.66 -56.21 6.97 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 123.217 2.735 . . . . 0.0 110.488 175.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.416 ' CD2' HG23 ' A' ' 90' ' ' ILE . 18.6 t80 -61.45 -44.76 96.54 Favored 'General case' 0 CA--C 1.591 2.552 0 CA-C-O 123.727 1.727 . . . . 0.0 111.99 175.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 2.1 mmt -56.62 -45.14 81.67 Favored 'General case' 0 CA--C 1.56 1.36 0 CA-C-O 115.111 -2.376 . . . . 0.0 108.884 173.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 145' ' ' PRO . 1.2 m-20 -66.97 -27.33 67.37 Favored 'General case' 0 CA--C 1.567 1.599 0 CA-C-N 122.468 2.394 . . . . 0.0 112.115 173.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.5 mp -52.32 -41.04 62.64 Favored 'General case' 0 N--CA 1.504 2.262 0 CA-C-N 121.98 2.173 . . . . 0.0 106.324 168.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -81.34 -69.46 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.612 3.348 0 CA-C-O 122.481 1.134 . . . . 0.0 111.447 173.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -72.94 8.44 1.55 Allowed 'General case' 0 CA--C 1.579 2.081 2 C-N-CA 133.249 4.62 . . . . 0.0 122.55 -178.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 59.8 pttt 3.04 2.55 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.699 1 N-CA-C 128.607 6.521 . . . . 0.0 128.607 -166.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 35.9 m . . . . . 0 N--CA 1.5 2.034 0 C-N-CA 123.994 0.918 . . . . 0.0 112.486 175.883 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.522 3.138 0 N-CA-C 117.924 2.564 . . . . 0.0 117.924 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.89 -53.11 61.75 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-N 124.608 3.367 . . . . 0.0 111.732 177.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -64.44 -46.49 82.94 Favored 'General case' 0 CA--C 1.58 2.107 0 O-C-N 120.136 -1.602 . . . . 0.0 114.353 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.603 HG21 ' HG2' ' A' ' 148' ' ' MET . 3.6 mp -64.79 -42.88 96.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-O 117.467 -1.254 . . . . 0.0 110.405 177.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.12 -45.38 93.71 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 120.938 1.699 . . . . 0.0 109.278 175.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 76.8 mtt180 -52.97 -62.67 1.5 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 120.107 1.321 . . . . 0.0 110.283 176.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.86 -58.78 4.34 Favored 'General case' 0 C--N 1.358 0.968 0 CA-C-O 115.871 -2.014 . . . . 0.0 116.185 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.48 ' CE2' HD12 ' A' ' 105' ' ' ILE . 14.4 t80 -63.23 -52.66 61.26 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 121.42 1.918 . . . . 0.0 113.723 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.367 58.1 mttt -66.51 -19.53 65.81 Favored 'General case' 0 CA--C 1.596 2.719 0 CA-C-O 116.614 -1.66 . . . . 0.0 110.354 -177.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.7 t -72.64 -50.97 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 CA-C-N 122.566 2.439 . . . . 0.0 107.383 166.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -51.06 -30.39 15.6 Favored 'General case' 0 CA--C 1.568 1.655 0 N-CA-C 117.508 2.41 . . . . 0.0 117.508 -178.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.265 0.0 OUTLIER -55.04 115.52 2.26 Favored 'General case' 0 CA--C 1.585 2.299 0 C-N-CA 126.272 1.829 . . . . 0.0 110.274 178.335 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.9 -54.7 41.5 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 117.678 2.473 . . . . 0.0 117.678 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.6 p30 -88.66 6.28 39.16 Favored 'General case' 0 CA--C 1.562 1.442 0 N-CA-C 118.622 2.823 . . . . 0.0 118.622 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.65 29.13 71.48 Favored Glycine 0 CA--C 1.568 3.358 0 CA-C-N 121.078 1.763 . . . . 0.0 115.462 -175.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -143.3 78.29 1.6 Allowed 'General case' 0 N--CA 1.476 0.825 1 CA-C-O 109.544 -5.027 . . . . 0.0 107.362 178.829 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 54.82 -25.83 0.01 OUTLIER Glycine 0 N--CA 1.491 2.348 3 N-CA-C 129.504 6.562 . . . . 0.0 129.504 164.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.8 p -107.4 153.26 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.089 0 CA-C-N 119.129 1.465 . . . . 0.0 112.426 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.48 HD12 ' CE2' ' A' ' 94' ' ' PHE . 83.6 mt -123.19 137.39 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 C-N-CA 126.281 1.832 . . . . 0.0 108.909 178.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -108.69 -170.51 1.68 Allowed 'General case' 0 CA--C 1.589 2.459 0 C-N-CA 124.154 0.982 . . . . 0.0 112.34 176.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -80.64 -52.98 6.95 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -57.88 -47.4 82.86 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 123.021 0.528 . . . . 0.0 112.23 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -56.0 -48.52 75.73 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 118.033 -0.984 . . . . 0.0 111.157 174.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -60.37 -50.9 71.77 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 117.39 -1.29 . . . . 0.0 112.497 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -56.9 -39.24 74.05 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 120.342 1.428 . . . . 0.0 114.433 176.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -69.18 -45.49 69.82 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 175.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -91.07 -24.21 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 1 N-CA-C 122.054 4.094 . . . . 0.0 122.054 -174.496 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 1.4 tpt -29.34 -48.69 0.08 Allowed 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.59 93.1 3.93 Favored 'General case' 0 CA--C 1.556 1.19 0 CA-C-N 112.821 -1.99 . . . . 0.0 110.704 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -75.87 -72.2 0.33 Allowed 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 113.772 -1.558 . . . . 0.0 114.032 -177.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.6 p -100.3 106.4 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 83.29 94.05 0.61 Allowed Glycine 0 CA--C 1.543 1.781 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -64.13 125.26 23.92 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -142.15 -52.47 0.02 OUTLIER Pre-proline 0 CA--C 1.581 2.165 0 CA-C-O 112.192 -3.766 . . . . 0.0 121.089 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -76.67 88.33 1.38 Allowed 'Trans proline' 0 N--CA 1.508 2.379 1 CA-C-N 130.405 4.752 . . . . 0.0 103.895 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.277 12.4 tp -127.2 80.52 1.96 Allowed 'General case' 0 CA--C 1.545 0.764 1 N-CA-C 121.978 4.066 . . . . 0.0 121.978 -167.488 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 46.5 p -164.84 152.26 11.33 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 103.697 -2.705 . . . . 0.0 103.697 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -61.05 -41.53 96.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.91 -1.119 . . . . 0.0 112.149 176.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.49 -45.82 82.1 Favored 'General case' 0 CA--C 1.554 1.103 0 CA-C-O 116.929 -1.51 . . . . 0.0 113.338 176.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.82 -39.76 94.99 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 121.659 2.027 . . . . 0.0 112.965 176.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 90.0 t -69.99 -50.72 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.613 0 CA-C-O 117.739 -1.124 . . . . 0.0 109.307 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.68 -45.55 89.19 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 120.154 1.343 . . . . 0.0 111.718 176.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -61.61 -47.06 87.18 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 119.701 1.137 . . . . 0.0 112.621 176.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.21 -46.14 90.76 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 119.396 0.998 . . . . 0.0 112.975 176.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 9.6 ttt -70.84 -43.56 68.26 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 115.74 -2.076 . . . . 0.0 111.189 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -35.63 75.77 Favored 'General case' 0 CA--C 1.578 2.052 0 CA-C-N 122.899 2.59 . . . . 0.0 110.685 174.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.48 -42.68 91.92 Favored 'General case' 0 CA--C 1.571 1.774 0 CA-C-N 121.633 2.015 . . . . 0.0 110.557 172.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -72.21 -24.5 61.41 Favored 'General case' 0 CA--C 1.576 1.946 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 176.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -81.3 108.53 15.0 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 103.041 -2.948 . . . . 0.0 103.041 172.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -72.71 -14.64 61.61 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -108.95 -11.61 14.96 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 119.257 3.058 . . . . 0.0 119.257 -174.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.63 5.6 89.76 Favored Glycine 0 CA--C 1.571 3.561 0 CA-C-N 120.447 1.476 . . . . 0.0 114.618 -173.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -72.03 -44.62 63.12 Favored 'General case' 0 CA--C 1.565 1.547 0 C-N-CA 125.342 1.457 . . . . 0.0 113.39 176.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 102.98 3.77 48.53 Favored Glycine 0 CA--C 1.563 3.035 0 N-CA-C 117.312 1.685 . . . . 0.0 117.312 -177.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 1.8 t -135.43 141.85 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 101.592 -3.484 . . . . 0.0 101.592 176.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.2 mt -120.58 124.48 72.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 111.967 -2.379 . . . . 0.0 112.789 -176.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 53.7 p30 -92.48 157.67 16.44 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 170.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.8 mt -52.75 -41.2 82.93 Favored Pre-proline 0 CA--C 1.585 2.302 0 CA-C-O 115.126 -2.369 . . . . 0.0 112.967 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -57.08 -31.25 89.73 Favored 'Trans proline' 0 C--N 1.38 2.214 0 C-N-CA 123.702 2.935 . . . . 0.0 116.813 176.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -67.2 -46.57 73.5 Favored 'General case' 0 N--CA 1.505 2.291 0 CA-C-N 123.074 2.67 . . . . 0.0 111.279 176.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.591 ' CE2' HG23 ' A' ' 90' ' ' ILE . 31.2 t80 -63.28 -45.16 92.72 Favored 'General case' 0 CA--C 1.583 2.222 0 CA-C-N 120.643 1.565 . . . . 0.0 110.761 173.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.603 ' HG2' HG21 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -60.0 -41.36 91.93 Favored 'General case' 0 CA--C 1.579 2.06 0 CA-C-O 117.064 -1.446 . . . . 0.0 109.725 175.17 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.23 -25.06 63.21 Favored 'General case' 0 CA--C 1.579 2.067 0 CA-C-N 121.714 2.052 . . . . 0.0 111.783 173.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.1 tp -62.41 -47.13 85.45 Favored 'General case' 0 CA--C 1.573 1.828 0 CA-C-N 120.797 1.635 . . . . 0.0 108.875 172.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . 0.276 31.7 mt -68.12 -46.78 80.81 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.597 0 CA-C-N 119.13 0.877 . . . . 0.0 109.567 175.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -71.94 9.89 0.83 Allowed 'General case' 0 CA--C 1.606 3.127 0 C-N-CA 127.334 2.254 . . . . 0.0 116.807 174.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -3.92 -6.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.769 2 N-CA-C 128.448 6.462 . . . . 0.0 128.448 -171.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.693 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 173.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 . . . . . 0 CA--C 1.572 1.805 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . 0.25 0.4 OUTLIER -49.79 -48.99 50.22 Favored 'General case' 0 CA--C 1.573 1.831 0 CA-C-N 122.454 2.388 . . . . 0.0 116.195 -177.706 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -69.63 -40.46 76.54 Favored 'General case' 0 CA--C 1.574 1.888 0 CA-C-N 120.427 1.467 . . . . 0.0 114.146 177.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.51 HG23 ' CE2' ' A' ' 147' ' ' PHE . 4.1 mp -64.99 -55.22 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 116.226 -1.845 . . . . 0.0 109.635 178.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.402 ' HA ' ' HG3' ' A' ' 95' ' ' LYS 0.259 0.6 OUTLIER -62.75 -34.07 76.44 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 122.011 2.187 . . . . 0.0 111.225 177.148 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.0 mtm-85 -52.88 -62.3 1.74 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 121.175 1.807 . . . . 0.0 108.397 173.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.64 -61.54 1.84 Allowed 'General case' 0 C--N 1.355 0.822 0 CA-C-O 114.07 -2.871 . . . . 0.0 115.696 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.586 ' CE2' HD12 ' A' ' 105' ' ' ILE . 3.7 t80 -69.04 -52.86 24.21 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 124.387 3.267 . . . . 0.0 114.128 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.402 ' HG3' ' HA ' ' A' ' 91' ' ' LEU 0.375 26.0 mttt -63.04 -16.34 59.53 Favored 'General case' 0 CA--C 1.593 2.63 0 CA-C-O 115.51 -2.186 . . . . 0.0 111.368 -176.586 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -84.8 -46.83 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.598 2.823 0 CA-C-N 123.188 2.722 . . . . 0.0 108.558 167.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -57.71 -24.32 56.26 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 119.076 2.991 . . . . 0.0 119.076 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -39.24 -45.09 1.32 Allowed 'General case' 0 CA--C 1.589 2.443 0 CA-C-N 121.718 2.054 . . . . 0.0 116.421 176.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 65.29 -58.04 0.29 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 117.792 2.516 . . . . 0.0 117.792 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.559 HD21 HG12 ' A' ' 104' ' ' VAL . 55.8 p30 -68.54 -13.52 62.39 Favored 'General case' 0 CA--C 1.577 1.994 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.59 8.58 86.77 Favored Glycine 0 CA--C 1.551 2.319 0 N-CA-C 120.66 3.024 . . . . 0.0 120.66 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -114.58 -10.39 12.53 Favored 'General case' 0 CA--C 1.578 2.036 0 CA-C-N 119.366 1.583 . . . . 0.0 114.764 177.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 110.41 0.63 29.49 Favored Glycine 0 CA--C 1.55 2.266 0 CA-C-O 116.144 -2.476 . . . . 0.0 116.49 -178.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.559 HG12 HD21 ' A' ' 100' ' ' ASN . 0.5 OUTLIER -115.55 153.26 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 CA-C-N 121.471 2.636 . . . . 0.0 112.199 179.541 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.586 HD12 ' CE2' ' A' ' 94' ' ' PHE . 97.5 mt -121.38 130.57 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-N 112.402 -2.181 . . . . 0.0 106.709 178.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -106.43 -173.27 2.26 Favored 'General case' 0 CA--C 1.573 1.829 0 CA-C-O 122.033 0.92 . . . . 0.0 110.582 176.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -72.31 -38.33 68.74 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.829 -1.17 . . . . 0.0 112.588 178.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -58.76 -46.02 88.42 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 123.542 0.737 . . . . 0.0 112.057 175.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -62.04 -37.79 86.25 Favored 'General case' 0 CA--C 1.586 2.35 0 CA-C-N 120.675 1.58 . . . . 0.0 112.364 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -60.51 -44.89 95.53 Favored 'General case' 0 CA--C 1.571 1.768 0 C-N-CA 124.202 1.001 . . . . 0.0 109.557 173.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -55.43 -46.59 76.69 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 125.049 1.34 . . . . 0.0 112.014 173.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -60.38 -53.39 58.22 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 176.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.99 -28.13 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 -177.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 7.3 tpt -61.02 -63.78 1.18 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -98.16 99.71 10.97 Favored 'General case' 0 CA--C 1.555 1.135 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 176.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.518 ' HD3' ' H ' ' A' ' 116' ' ' LYS . 0.5 OUTLIER -48.43 -49.64 34.36 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 116.731 2.122 . . . . 0.0 116.731 -178.774 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.6 p -155.32 100.23 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 154.13 -99.09 0.19 Allowed Glycine 0 CA--C 1.54 1.617 0 N-CA-C 113.886 0.315 . . . . 0.0 113.886 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -80.06 -165.31 0.81 Allowed 'General case' 0 CA--C 1.58 2.108 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 -178.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.5 -154.16 0.01 OUTLIER Pre-proline 0 CA--C 1.582 2.193 0 CA-C-O 116.051 -1.928 . . . . 0.0 109.771 178.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -68.74 77.39 0.75 Allowed 'Trans proline' 0 C--N 1.38 2.205 0 CA-C-N 124.941 2.8 . . . . 0.0 111.493 172.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.457 0.5 OUTLIER -66.36 -72.81 0.15 Allowed 'General case' 0 CA--C 1.562 1.412 0 CA-C-N 109.555 -3.475 . . . . 0.0 107.016 -177.568 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.4 p -91.61 118.08 30.31 Favored 'General case' 0 C--N 1.367 1.328 0 CA-C-N 125.709 3.868 . . . . 0.0 102.081 172.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -57.62 -40.31 78.89 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 117.324 2.342 . . . . 0.0 117.324 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -57.94 -38.79 76.59 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 114.708 1.374 . . . . 0.0 114.708 178.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -63.83 -51.99 62.16 Favored 'General case' 0 CA--C 1.574 1.868 0 CA-C-N 120.41 1.459 . . . . 0.0 112.713 177.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.1 t -70.98 -46.32 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-O 118.004 -0.998 . . . . 0.0 111.734 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -60.98 -49.14 78.65 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 117.067 -1.444 . . . . 0.0 110.611 176.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -61.91 -43.32 99.08 Favored 'General case' 0 CA--C 1.561 1.368 0 CA-C-N 120.927 1.694 . . . . 0.0 112.977 178.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -66.7 -45.48 78.64 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-N 120.612 1.551 . . . . 0.0 114.399 177.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -37.87 62.14 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 120.592 1.542 . . . . 0.0 111.903 178.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -63.83 -45.78 88.03 Favored 'General case' 0 CA--C 1.57 1.729 0 CA-C-N 121.71 2.05 . . . . 0.0 109.228 174.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -34.46 78.0 Favored 'General case' 0 CA--C 1.58 2.101 0 CA-C-N 122.229 2.286 . . . . 0.0 112.211 175.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.17 -32.03 58.83 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -77.99 114.21 16.64 Favored 'General case' 0 N--CA 1.513 2.676 0 O-C-N 117.408 -3.307 . . . . 0.0 109.454 175.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -82.06 -30.49 31.33 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 117.419 2.377 . . . . 0.0 117.419 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -86.3 -14.12 44.62 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 121.124 3.75 . . . . 0.0 121.124 -172.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.99 5.2 90.31 Favored Glycine 0 CA--C 1.572 3.61 0 CA-C-N 120.152 1.342 . . . . 0.0 113.895 -172.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -80.6 -51.36 8.83 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 119.145 1.472 . . . . 0.0 110.986 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 110.27 -7.95 30.76 Favored Glycine 0 CA--C 1.548 2.12 0 CA-C-O 115.965 -2.575 . . . . 0.0 116.907 -177.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . 0.307 3.4 m -134.97 121.04 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 101.402 -3.555 . . . . 0.0 101.402 174.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.0 mt -82.18 128.83 38.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 110.672 -2.967 . . . . 0.0 116.592 -172.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 39.3 p30 -93.95 155.5 17.12 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 172.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.61 -43.87 99.37 Favored Pre-proline 0 CA--C 1.583 2.224 0 CA-C-O 114.951 -2.452 . . . . 0.0 112.679 -178.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.37 -32.1 70.85 Favored 'Trans proline' 0 C--N 1.381 2.275 0 CA-C-N 125.1 2.857 . . . . 0.0 115.393 176.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -62.24 -57.87 9.83 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 116.743 -1.599 . . . . 0.0 110.18 175.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.567 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 75.5 t80 -53.14 -41.46 65.12 Favored 'General case' 0 N--CA 1.504 2.249 0 CA-C-N 120.624 1.556 . . . . 0.0 114.54 176.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.3 mtp -65.73 -49.16 69.47 Favored 'General case' 0 CA--C 1.573 1.862 0 O-C-N 121.591 -0.693 . . . . 0.0 110.623 176.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.67 -37.28 83.51 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 123.451 0.7 . . . . 0.0 112.789 175.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -57.66 -49.17 77.37 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 128.437 2.695 . . . . 0.0 110.491 173.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 91.0 mt -68.82 -40.32 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-N 119.698 1.135 . . . . 0.0 110.636 176.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.777 ' HE2' ' HE3' ' A' ' 153' ' ' LYS . 1.7 ttpm? -60.38 -66.79 0.47 Allowed 'General case' 0 CA--C 1.578 2.052 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 177.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.777 ' HE3' ' HE2' ' A' ' 152' ' ' LYS . 96.8 mttt -101.12 -71.75 0.7 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 121.639 3.94 . . . . 0.0 121.639 -176.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 54.4 p . . . . . 0 N--CA 1.499 1.977 0 N-CA-C 118.952 2.945 . . . . 0.0 118.952 -172.802 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.668 ' HA ' HD13 ' A' ' 90' ' ' ILE 0.253 3.2 tp10 . . . . . 1 N--CA 1.558 4.934 0 N-CA-C 118.744 2.868 . . . . 0.0 118.744 . . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -58.76 -39.64 81.6 Favored 'General case' 0 CA--C 1.589 2.471 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 170.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.262 1.4 tm-20 -72.0 -18.2 61.99 Favored 'General case' 0 CA--C 1.584 2.272 0 CA-C-O 113.76 -3.019 . . . . 0.0 109.534 171.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.668 HD13 ' HA ' ' A' ' 87' ' ' GLU 0.381 1.2 mp -68.67 -58.43 5.84 Favored 'Isoleucine or valine' 0 C--N 1.389 2.305 1 CA-C-N 128.832 5.287 . . . . 0.0 103.275 170.95 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 pp -56.99 -49.58 75.32 Favored 'General case' 0 N--CA 1.503 2.19 0 CA-C-N 121.576 1.989 . . . . 0.0 113.034 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 43.9 mtt85 -67.56 -40.38 84.93 Favored 'General case' 0 CA--C 1.567 1.634 0 CA-C-O 117.397 -1.287 . . . . 0.0 114.013 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.44 -50.62 43.95 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 115.098 -2.382 . . . . 0.0 111.64 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -62.42 -49.26 76.18 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 122.766 2.53 . . . . 0.0 110.136 176.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -60.07 -34.47 73.49 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 116.87 -1.538 . . . . 0.0 114.524 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -77.07 -43.95 31.56 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.949 0 CA-C-N 121.248 1.84 . . . . 0.0 109.729 173.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -49.01 -44.26 41.15 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 125.525 1.53 . . . . 0.0 109.864 177.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -54.63 98.79 0.02 OUTLIER 'General case' 0 CA--C 1.58 2.114 0 C-N-CA 125.65 1.58 . . . . 0.0 110.962 175.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -77.24 -36.69 54.4 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.1 p30 -67.36 -14.68 63.14 Favored 'General case' 0 CA--C 1.579 2.074 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.78 9.64 85.23 Favored Glycine 0 CA--C 1.551 2.334 0 N-CA-C 120.897 3.119 . . . . 0.0 120.897 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 26.7 p30 -115.45 -8.76 12.18 Favored 'General case' 0 CA--C 1.577 2.019 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 177.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 110.58 20.6 7.25 Favored Glycine 0 CA--C 1.552 2.359 0 CA-C-O 117.095 -1.947 . . . . 0.0 114.589 -177.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.5 t -133.34 143.29 39.53 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.718 0 CA-C-N 120.605 2.202 . . . . 0.0 111.446 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 79.3 mt -106.57 136.16 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 126.477 1.911 . . . . 0.0 108.194 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -108.78 -175.8 2.87 Favored 'General case' 0 CA--C 1.575 1.935 0 C-N-CA 123.299 0.639 . . . . 0.0 112.299 176.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -72.03 -52.73 15.56 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 117.126 -1.416 . . . . 0.0 114.64 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -59.05 -37.96 78.26 Favored 'General case' 0 N--CA 1.515 2.803 0 CA-C-N 120.416 1.462 . . . . 0.0 113.864 177.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . 0.362 0.9 OUTLIER -58.29 -48.32 80.84 Favored 'General case' 0 CA--C 1.598 2.8 0 CA-C-O 124.286 1.993 . . . . 0.0 112.4 174.266 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.18 -46.41 90.6 Favored 'General case' 0 CA--C 1.574 1.885 0 CA-C-O 116.582 -1.675 . . . . 0.0 107.212 172.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.439 ' O ' ' SD ' ' A' ' 114' ' ' MET . 60.8 mttt -51.0 -32.52 21.45 Favored 'General case' 0 N--CA 1.515 2.777 0 CA-C-N 122.078 2.217 . . . . 0.0 112.899 172.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -71.86 -49.92 34.01 Favored 'General case' 0 CA--C 1.583 2.235 0 C-N-CA 123.774 0.83 . . . . 0.0 111.92 174.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.7 mt -90.08 -7.64 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.738 0 N-CA-C 118.077 2.621 . . . . 0.0 118.077 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.441 ' HG3' HE21 ' A' ' 115' ' ' GLN . 13.9 ptm -34.74 -31.91 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.428 1 N-CA-C 123.485 4.624 . . . . 0.0 123.485 -178.172 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.441 HE21 ' HG3' ' A' ' 114' ' ' MET . 36.9 mm-40 -82.45 20.94 1.01 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 118.055 2.613 . . . . 0.0 118.055 -177.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 4.2 mptt 58.69 -88.33 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.249 0 C-N-CA 124.79 1.236 . . . . 0.0 113.301 175.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.0 p -82.12 110.15 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.91 -139.73 22.39 Favored Glycine 0 CA--C 1.545 1.953 0 N-CA-C 111.076 -0.809 . . . . 0.0 111.076 -177.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -164.07 117.32 1.42 Allowed 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.908 0.861 . . . . 0.0 111.784 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -126.79 8.34 0.05 OUTLIER Pre-proline 0 CA--C 1.581 2.166 0 CA-C-O 114.168 -2.825 . . . . 0.0 117.096 176.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . 0.328 57.0 Cg_exo 15.77 58.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.388 2.619 1 C-N-CA 126.872 5.048 . . . . 0.0 118.944 -176.867 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.351 12.9 tp -90.39 -94.98 0.12 Allowed 'General case' 0 CA--C 1.556 1.196 0 CA-C-N 110.885 -2.87 . . . . 0.0 112.622 -174.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 75.0 p -92.73 130.91 38.21 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 123.045 2.657 . . . . 0.0 111.377 -178.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -69.4 -27.98 65.76 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -55.56 -42.1 74.2 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-O 117.689 -1.148 . . . . 0.0 110.762 174.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -53.44 -50.33 65.49 Favored 'General case' 0 CA--C 1.57 1.728 0 CA-C-N 119.299 0.954 . . . . 0.0 112.996 174.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.1 p -71.04 -43.48 76.18 Favored 'Isoleucine or valine' 0 C--N 1.359 0.981 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -178.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.37 -49.08 70.67 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 120.037 1.29 . . . . 0.0 110.656 177.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -62.13 -49.43 75.92 Favored 'General case' 0 CA--C 1.573 1.841 0 CA-C-O 118.093 -0.956 . . . . 0.0 112.868 177.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.74 -45.05 90.55 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 177.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 15.9 ttt -69.68 -38.8 77.18 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 116.104 -1.903 . . . . 0.0 111.709 176.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -59.08 -42.07 89.53 Favored 'General case' 0 CA--C 1.576 1.973 0 CA-C-N 122.719 2.509 . . . . 0.0 110.485 173.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -57.45 -44.62 84.9 Favored 'General case' 0 CA--C 1.578 2.054 0 CA-C-N 120.099 1.318 . . . . 0.0 111.351 174.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.33 -18.79 40.94 Favored 'General case' 0 CA--C 1.575 1.94 0 N-CA-C 118.311 2.708 . . . . 0.0 118.311 178.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.43 ' OD2' ' N ' ' A' ' 140' ' ' GLY . 23.0 t0 -82.41 102.99 11.64 Favored 'General case' 0 CA--C 1.574 1.874 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 174.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -81.89 -19.7 40.33 Favored 'General case' 0 CA--C 1.58 2.122 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 177.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -88.03 -14.34 39.26 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 119.128 3.01 . . . . 0.0 119.128 -175.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.94 5.11 90.03 Favored Glycine 0 CA--C 1.568 3.354 0 CA-C-N 119.964 1.256 . . . . 0.0 115.221 -174.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -80.72 -48.09 13.05 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 118.942 1.371 . . . . 0.0 111.353 175.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.43 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . 111.43 -20.12 23.47 Favored Glycine 0 CA--C 1.546 2.028 0 CA-C-O 116.27 -2.406 . . . . 0.0 115.346 -177.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . 0.303 5.7 m -122.28 122.22 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-N 121.438 2.619 . . . . 0.0 103.999 178.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -79.51 130.83 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 117.488 2.403 . . . . 0.0 117.488 -173.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 32.7 p30 -93.95 161.69 14.2 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 170.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 17.4 mt -54.99 -48.4 96.09 Favored Pre-proline 0 CA--C 1.579 2.077 0 CA-C-O 113.994 -2.908 . . . . 0.0 113.73 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -51.45 -27.22 23.81 Favored 'Trans proline' 0 C--N 1.373 1.85 0 CA-C-N 125.932 3.154 . . . . 0.0 119.849 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -72.18 -64.8 0.87 Allowed 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 121.237 1.835 . . . . 0.0 111.012 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.485 ' CE1' HG23 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -48.81 -53.59 18.58 Favored 'General case' 0 N--CA 1.506 2.346 0 C-N-CA 124.717 1.207 . . . . 0.0 110.729 173.738 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.417 ' O ' ' HB2' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -60.82 -40.25 92.04 Favored 'General case' 0 C--N 1.358 0.957 0 CA-C-O 113.681 -3.057 . . . . 0.0 113.938 -179.775 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.02 -48.18 79.86 Favored 'General case' 0 CA--C 1.594 2.651 0 CA-C-N 125.01 3.55 . . . . 0.0 111.533 174.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . 0.295 0.3 OUTLIER -44.55 -47.73 10.24 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 127.851 2.46 . . . . 0.0 111.072 176.937 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 9.6 mt -92.09 -44.14 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.238 0 CA-C-O 117.527 -1.225 . . . . 0.0 111.157 175.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 148' ' ' MET . 33.1 mttp -56.63 -10.1 0.92 Allowed 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 118.453 2.76 . . . . 0.0 118.453 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -39.54 -50.32 2.18 Favored 'General case' 0 N--CA 1.513 2.702 0 CA-C-N 123.518 2.872 . . . . 0.0 111.194 172.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.509 2.499 0 C-N-CA 126.452 1.901 . . . . 0.0 109.909 171.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 . . . . . 0 CA--C 1.547 0.844 0 CA-C-O 115.647 -2.12 . . . . 0.0 113.535 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -24.16 -60.79 0.05 Allowed 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 119.59 3.181 . . . . 0.0 119.59 -173.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -67.16 -58.7 4.37 Favored 'General case' 0 N--CA 1.506 2.333 0 CA-C-O 122.455 1.121 . . . . 0.0 113.718 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.642 HG23 ' CE2' ' A' ' 147' ' ' PHE . 1.1 mp -55.65 -53.38 37.57 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.711 0 C-N-CA 126.452 1.901 . . . . 0.0 110.412 177.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.9 -46.03 74.77 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.878 1.671 . . . . 0.0 110.656 175.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.8 mtm105 -57.82 -55.57 33.21 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-N 121.011 1.732 . . . . 0.0 110.44 176.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.84 -55.81 15.11 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.477 ' CE2' HD12 ' A' ' 105' ' ' ILE . 18.1 t80 -64.16 -50.58 67.61 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.342 36.2 mttt -67.13 -22.02 65.81 Favored 'General case' 0 CA--C 1.585 2.309 0 CA-C-O 116.556 -1.688 . . . . 0.0 110.068 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.6 t -69.6 -49.73 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 CA-C-N 122.394 2.361 . . . . 0.0 107.534 167.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -54.47 -34.91 62.42 Favored 'General case' 0 CA--C 1.58 2.113 0 N-CA-C 118.09 2.626 . . . . 0.0 118.09 -178.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.271 2.3 t0 -55.92 134.39 52.09 Favored 'General case' 0 CA--C 1.585 2.321 0 C-N-CA 127.513 2.325 . . . . 0.0 115.561 178.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.481 ' HB2' ' HG2' ' A' ' 109' ' ' GLU . . . -67.65 -60.79 2.26 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -76.21 -19.17 58.64 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 117.598 2.444 . . . . 0.0 117.598 -177.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.92 3.74 90.34 Favored Glycine 0 CA--C 1.568 3.346 0 CA-C-N 120.843 1.656 . . . . 0.0 114.754 -173.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -91.48 -17.55 25.54 Favored 'General case' 0 CA--C 1.58 2.126 0 CA-C-N 120.532 2.166 . . . . 0.0 113.395 173.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 113.36 24.46 4.75 Favored Glycine 0 CA--C 1.54 1.64 0 CA-C-O 115.541 -2.81 . . . . 0.0 116.987 -178.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.3 t -127.51 138.69 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 121.826 2.813 . . . . 0.0 109.783 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.477 HD12 ' CE2' ' A' ' 94' ' ' PHE . 61.5 mt -118.5 138.79 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 126.573 1.949 . . . . 0.0 109.582 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -110.22 -169.82 1.53 Allowed 'General case' 0 CA--C 1.585 2.308 0 C-N-CA 125.001 1.32 . . . . 0.0 110.834 176.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -81.59 -54.97 4.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.134 -1.604 . . . . 0.0 114.318 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -60.63 -43.87 97.03 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 117.534 -1.222 . . . . 0.0 112.807 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.481 ' HG2' ' HB2' ' A' ' 99' ' ' ALA . 11.2 tp10 -59.49 -44.44 93.08 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 121.025 1.739 . . . . 0.0 111.268 174.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.96 -51.75 68.34 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 119.486 1.039 . . . . 0.0 109.777 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -52.52 -42.25 64.19 Favored 'General case' 0 CA--C 1.573 1.864 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 175.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -69.75 -53.66 17.35 Favored 'General case' 0 CA--C 1.577 1.994 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 176.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.9 tt -72.72 -29.08 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 118.7 2.852 . . . . 0.0 118.7 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 6.2 tpt -45.92 -50.68 14.31 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.035 1.334 . . . . 0.0 112.342 178.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -100.46 88.4 3.64 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-O 123.781 1.753 . . . . 0.0 110.515 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.696 ' HD3' ' H ' ' A' ' 116' ' ' LYS . 0.5 OUTLIER -54.69 -52.24 63.01 Favored 'General case' 0 CA--C 1.57 1.74 0 CA-C-N 112.156 -2.293 . . . . 0.0 114.079 178.059 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 8.2 p -153.5 107.23 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.409 0 N-CA-C 104.53 -2.396 . . . . 0.0 104.53 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 108.5 -148.75 16.84 Favored Glycine 0 CA--C 1.546 2.0 0 C-N-CA 123.623 0.63 . . . . 0.0 114.247 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -126.22 135.01 51.07 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 124.138 0.975 . . . . 0.0 112.967 -178.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . 0.34 10.3 pt-20 -144.63 -120.62 0.0 OUTLIER Pre-proline 0 CA--C 1.587 2.404 0 CA-C-O 111.704 -3.998 . . . . 0.0 106.695 178.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -81.87 87.49 1.42 Allowed 'Trans proline' 0 C--N 1.385 2.486 1 CA-C-N 132.107 5.36 . . . . 0.0 105.376 176.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.257 0.2 OUTLIER -110.11 77.72 1.07 Allowed 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 -172.771 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 18.8 p -165.62 158.08 15.19 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 175.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.64 -36.81 85.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.792 -1.192 . . . . 0.0 111.934 175.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.61 -49.65 67.95 Favored 'General case' 0 CA--C 1.56 1.329 0 CA-C-O 117.557 -1.211 . . . . 0.0 112.848 176.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -58.09 -46.14 86.01 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-N 120.309 1.413 . . . . 0.0 112.483 176.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 62.4 t -69.34 -43.43 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.346 0 CA-C-O 116.627 -1.654 . . . . 0.0 110.992 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -63.46 -43.73 96.51 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 121.871 2.123 . . . . 0.0 112.467 177.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -64.73 -52.97 54.24 Favored 'General case' 0 CA--C 1.572 1.797 0 CA-C-N 119.517 1.053 . . . . 0.0 110.617 175.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.26 -43.36 96.22 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 177.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -69.68 -42.26 74.37 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 117.318 -1.325 . . . . 0.0 111.521 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -64.96 -36.74 85.38 Favored 'General case' 0 CA--C 1.572 1.813 0 CA-C-N 120.621 1.555 . . . . 0.0 111.252 175.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -64.88 -41.03 95.98 Favored 'General case' 0 CA--C 1.581 2.157 0 CA-C-N 120.884 1.674 . . . . 0.0 109.719 172.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.41 -23.88 67.06 Favored 'General case' 0 CA--C 1.576 1.965 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 174.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -88.39 100.85 13.35 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 171.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -62.13 -16.18 50.83 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 117.912 2.56 . . . . 0.0 117.912 177.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.94 -2.95 20.71 Favored 'General case' 0 N--CA 1.491 1.577 1 N-CA-C 121.958 4.059 . . . . 0.0 121.958 -173.75 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.35 6.98 88.97 Favored Glycine 0 CA--C 1.556 2.633 0 N-CA-C 118.289 2.076 . . . . 0.0 118.289 -178.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -78.56 -36.77 44.1 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 120.246 2.023 . . . . 0.0 114.083 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 96.85 21.92 19.63 Favored Glycine 0 CA--C 1.555 2.584 0 N-CA-C 117.063 1.585 . . . . 0.0 117.063 -177.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -149.67 145.22 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 103.383 -2.821 . . . . 0.0 103.383 176.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.41 HG22 ' O ' ' A' ' 143' ' ' ASP . 0.3 OUTLIER -129.19 133.9 64.91 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -176.405 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.41 ' O ' HG22 ' A' ' 142' ' ' ILE . 19.3 p30 -103.83 165.01 11.31 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 169.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.6 mt -53.19 -45.17 98.44 Favored Pre-proline 0 N--CA 1.505 2.317 0 O-C-N 118.071 -2.893 . . . . 0.0 112.812 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -50.2 -35.03 41.68 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 123.937 3.091 . . . . 0.0 118.601 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -72.98 -45.79 55.95 Favored 'General case' 0 CA--C 1.591 2.53 0 CA-C-N 122.614 2.461 . . . . 0.0 112.937 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.642 ' CE2' HG23 ' A' ' 90' ' ' ILE . 4.7 t80 -56.32 -52.13 65.66 Favored 'General case' 0 N--CA 1.506 2.331 0 CA-C-N 120.726 1.603 . . . . 0.0 110.932 172.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.712 ' HE2' ' HD3' ' A' ' 153' ' ' LYS 0.259 4.1 ptp -60.59 -39.12 86.93 Favored 'General case' 0 CA--C 1.589 2.452 0 CA-C-O 121.499 0.666 . . . . 0.0 111.057 176.737 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.53 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 17.6 t0 -52.65 -54.34 34.65 Favored 'General case' 0 N--CA 1.492 1.632 1 CA-C-O 109.296 -5.145 . . . . 0.0 106.006 171.823 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.43 -43.39 23.8 Favored 'General case' 0 N--CA 1.515 2.783 0 CA-C-N 123.699 2.954 . . . . 0.0 112.502 174.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.1 mt -73.76 30.26 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.613 3.376 0 C-N-CA 127.12 2.168 . . . . 0.0 109.61 169.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 149' ' ' ASP . 1.3 mmpt? 28.98 27.24 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.301 2 C-N-CA 132.888 4.475 . . . . 0.0 122.146 -167.326 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.712 ' HD3' ' HE2' ' A' ' 148' ' ' MET . 85.3 tttt -87.94 -73.38 0.49 Allowed 'General case' 0 CA--C 1.573 1.858 0 CA-C-N 110.641 -2.982 . . . . 0.0 115.99 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.534 3.741 0 C-N-CA 124.916 1.286 . . . . 0.0 111.711 -178.494 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 . . . . . 0 CA--C 1.559 1.299 0 N-CA-C 114.295 1.221 . . . . 0.0 114.295 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -52.63 -44.41 66.05 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 117.921 2.563 . . . . 0.0 117.921 -177.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -64.0 -60.72 2.9 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 121.693 2.042 . . . . 0.0 113.413 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.625 HG23 ' CE ' ' A' ' 148' ' ' MET 0.297 1.1 mp -58.26 -50.9 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-O 117.164 -1.398 . . . . 0.0 111.209 178.004 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 pp -59.58 -42.89 93.53 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 116.967 -1.492 . . . . 0.0 111.668 177.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.86 -54.96 40.96 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 121.273 1.851 . . . . 0.0 111.43 176.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.13 -57.72 11.62 Favored 'General case' 0 C--N 1.358 0.961 0 CA-C-O 116.091 -1.909 . . . . 0.0 114.048 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.441 ' HB3' ' HE1' ' A' ' 148' ' ' MET . 19.2 t80 -58.97 -46.71 87.41 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 120.862 1.665 . . . . 0.0 114.336 178.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -63.72 -34.64 78.34 Favored 'General case' 0 CA--C 1.568 1.664 0 CA-C-O 116.341 -1.79 . . . . 0.0 111.483 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 75.1 t -64.73 -43.78 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 CA-C-N 122.146 2.248 . . . . 0.0 108.181 169.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.56 -31.19 63.96 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 117.272 2.323 . . . . 0.0 117.272 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -75.71 119.26 19.48 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 174.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.85 -71.57 0.06 Allowed 'General case' 0 N--CA 1.514 2.727 0 CA-C-O 123.908 1.813 . . . . 0.0 106.833 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -134.03 -55.3 0.87 Allowed 'General case' 0 CA--C 1.577 2.006 0 CA-C-N 109.682 -3.417 . . . . 0.0 103.977 167.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 30.87 9.58 0.0 OUTLIER Glycine 0 C--N 1.355 1.586 1 N-CA-C 125.548 4.979 . . . . 0.0 125.548 -175.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.2 p30 63.72 12.99 7.05 Favored 'General case' 0 CA--C 1.59 2.517 0 CA-C-N 122.231 3.015 . . . . 0.0 113.047 -171.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 110.76 -15.85 28.79 Favored Glycine 0 CA--C 1.57 3.478 0 CA-C-O 115.796 -2.669 . . . . 0.0 109.211 -170.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -99.59 138.89 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-N 122.436 3.118 . . . . 0.0 116.416 -179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 18.6 mt -105.98 132.32 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 C-N-CA 125.108 1.363 . . . . 0.0 109.806 178.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.54 -174.89 2.64 Favored 'General case' 0 CA--C 1.584 2.263 0 CA-C-O 122.0 0.905 . . . . 0.0 112.398 176.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -72.41 -46.65 54.21 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.672 -1.267 . . . . 0.0 114.021 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -57.54 -49.01 77.75 Favored 'General case' 0 N--CA 1.504 2.273 0 CA-C-O 117.925 -1.036 . . . . 0.0 112.451 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -54.49 -43.72 72.03 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 120.201 1.364 . . . . 0.0 112.948 173.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.61 -55.14 33.94 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 116.981 -1.485 . . . . 0.0 107.642 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.444 ' HA ' ' SD ' ' A' ' 114' ' ' MET . 33.5 mtmm -55.54 -29.15 58.43 Favored 'General case' 0 N--CA 1.503 2.185 0 CA-C-N 121.131 1.787 . . . . 0.0 115.264 176.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -74.91 -53.59 8.76 Favored 'General case' 0 CA--C 1.574 1.902 0 C-N-CA 124.505 1.122 . . . . 0.0 110.746 175.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 tt -79.01 -16.56 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 118.492 2.775 . . . . 0.0 118.492 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.444 ' SD ' ' HA ' ' A' ' 111' ' ' LYS . 15.1 ptm -36.25 -38.37 0.14 Allowed 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 118.062 2.615 . . . . 0.0 118.062 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.81 98.39 3.11 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 102.739 -3.06 . . . . 0.0 102.739 176.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.461 ' H ' ' HD2' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -62.17 -22.55 65.97 Favored 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 120.969 3.692 . . . . 0.0 120.969 -176.331 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 8.9 p -75.56 108.16 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-N 120.345 1.43 . . . . 0.0 110.982 -178.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.6 -113.87 5.57 Favored Glycine 0 CA--C 1.542 1.755 0 C-N-CA 123.589 0.614 . . . . 0.0 113.971 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -138.08 64.45 1.5 Allowed 'General case' 0 CA--C 1.57 1.732 0 CA-C-O 122.934 1.35 . . . . 0.0 109.765 178.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -76.91 -55.9 1.39 Allowed Pre-proline 0 CA--C 1.573 1.844 0 CA-C-O 112.697 -3.525 . . . . 0.0 116.885 -178.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . 0.282 61.4 Cg_exo 19.72 66.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.387 2.604 1 C-N-CA 125.487 4.125 . . . . 0.0 120.279 179.842 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.335 61.7 tp -79.92 -94.23 0.04 OUTLIER 'General case' 0 CA--C 1.563 1.474 0 CA-C-O 114.752 -2.547 . . . . 0.0 114.356 -175.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 41.6 p -103.72 126.12 50.65 Favored 'General case' 0 C--N 1.365 1.26 0 CA-C-N 124.73 3.423 . . . . 0.0 110.631 -178.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -71.44 -31.24 66.98 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-N 113.276 -1.784 . . . . 0.0 114.601 178.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.46 -40.85 75.54 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.52 1.128 . . . . 0.0 113.893 176.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -58.2 -48.78 79.28 Favored 'General case' 0 CA--C 1.584 2.284 0 CA-C-O 122.989 1.376 . . . . 0.0 112.567 176.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.0 t -63.17 -49.69 82.22 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.483 0 C-N-CA 126.852 2.061 . . . . 0.0 111.129 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -58.78 -42.99 90.31 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 124.253 1.021 . . . . 0.0 112.601 176.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -64.51 -48.02 76.72 Favored 'General case' 0 CA--C 1.577 1.989 0 CA-C-N 119.531 1.06 . . . . 0.0 111.828 176.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.57 -44.51 93.29 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 176.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 23.1 ttt -67.35 -39.46 85.76 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 116.866 -1.54 . . . . 0.0 112.412 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -62.07 -39.64 93.11 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 121.283 1.856 . . . . 0.0 111.093 175.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -62.87 -43.46 98.74 Favored 'General case' 0 CA--C 1.58 2.103 0 CA-C-N 119.565 1.075 . . . . 0.0 111.11 172.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -85.73 -8.08 58.39 Favored 'General case' 0 N--CA 1.486 1.338 1 N-CA-C 122.873 4.397 . . . . 0.0 122.873 -179.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.422 ' OD2' ' HA2' ' A' ' 140' ' ' GLY . 24.6 t0 -78.05 114.48 16.97 Favored 'General case' 0 N--CA 1.506 2.328 1 CA-C-O 96.312 -11.327 . . . . 0.0 109.467 177.255 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -81.07 26.49 0.43 Allowed 'General case' 0 C--N 1.26 -3.309 2 O-C-N 62.843 -37.411 . . . . 0.0 116.029 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . 0.372 32.8 t0 92.14 -103.2 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 101.907 -3.368 . . . . 0.0 101.907 -177.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 37.64 7.65 0.0 OUTLIER Glycine 0 CA--C 1.557 2.668 0 N-CA-C 120.564 2.985 . . . . 0.0 120.564 -174.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 157.45 -49.32 0.0 OUTLIER 'General case' 0 CA--C 1.572 1.813 0 C-N-CA 126.856 2.062 . . . . 0.0 114.337 -173.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.422 ' HA2' ' OD2' ' A' ' 135' ' ' ASP . . . 112.65 -23.46 15.09 Favored Glycine 0 CA--C 1.561 2.963 0 CA-C-N 123.241 2.746 . . . . 0.0 113.76 -173.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 19.7 m -115.63 127.55 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 101.921 -3.363 . . . . 0.0 101.921 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.6 mt -79.64 126.77 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 N-CA-C 118.366 2.728 . . . . 0.0 118.366 -172.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -94.0 149.78 20.93 Favored 'General case' 0 CA--C 1.561 1.393 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 171.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -49.58 -46.62 79.05 Favored Pre-proline 0 CA--C 1.574 1.869 0 CA-C-O 115.035 -2.412 . . . . 0.0 114.434 -177.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -57.42 -26.72 72.61 Favored 'Trans proline' 0 C--N 1.371 1.723 0 CA-C-N 124.926 2.795 . . . . 0.0 116.401 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -68.71 -54.86 13.63 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 123.138 2.699 . . . . 0.0 112.113 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -60.48 -46.47 89.97 Favored 'General case' 0 CA--C 1.578 2.057 0 CA-C-N 121.756 2.071 . . . . 0.0 112.612 176.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.625 ' CE ' HG23 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -62.4 -41.25 98.52 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-O 116.895 -1.526 . . . . 0.0 111.684 176.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.749 ' O ' ' HG2' ' A' ' 153' ' ' LYS . 2.3 t70 -68.91 -38.41 79.54 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 121.873 2.124 . . . . 0.0 111.902 175.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.09 -43.36 77.98 Favored 'General case' 0 CA--C 1.565 1.558 0 C-N-CA 126.011 1.725 . . . . 0.0 110.708 175.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 66.7 mt -87.31 -51.83 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 121.279 1.854 . . . . 0.0 112.368 177.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -65.62 -49.49 68.55 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.749 ' HG2' ' O ' ' A' ' 149' ' ' ASP . 59.5 pttt -94.38 -59.27 1.99 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 116.385 1.995 . . . . 0.0 116.385 -178.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.406 ' N ' ' HG3' ' A' ' 153' ' ' LYS . 11.4 p . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 -176.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 . . . . . 0 CA--C 1.61 3.25 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.44 ' HA ' HD12 ' A' ' 91' ' ' LEU . 3.1 tm-20 -4.89 -20.18 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.455 2 C-N-CA 133.478 4.711 . . . . 0.0 123.47 -169.773 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -79.3 -68.42 0.66 Allowed 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 174.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.867 HG23 ' HE2' ' A' ' 147' ' ' PHE . 1.6 mp -65.1 -35.79 76.25 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.013 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 172.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -54.0 -45.8 71.57 Favored 'General case' 0 N--CA 1.515 2.793 0 CA-C-N 124.048 3.113 . . . . 0.0 109.384 173.002 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.7 mtm105 -59.81 -56.15 25.37 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 120.642 1.564 . . . . 0.0 110.65 176.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.77 -59.93 3.94 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 116.074 -1.917 . . . . 0.0 114.904 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.495 ' CE2' HD12 ' A' ' 105' ' ' ILE . 24.4 t80 -59.65 -49.13 78.96 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 121.087 1.767 . . . . 0.0 113.297 178.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.371 36.5 mttt -69.11 -23.63 64.02 Favored 'General case' 0 CA--C 1.583 2.227 0 CA-C-O 116.631 -1.652 . . . . 0.0 110.333 -178.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.1 t -68.73 -48.91 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 CA-C-N 122.15 2.25 . . . . 0.0 107.103 166.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -53.3 -33.21 52.33 Favored 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . 0.256 3.7 t0 -67.22 -3.62 8.27 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 117.83 2.53 . . . . 0.0 117.83 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 50.04 24.63 1.43 Allowed 'General case' 0 N--CA 1.524 3.258 0 CA-C-N 124.533 3.333 . . . . 0.0 115.404 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . 0.284 11.4 t-20 82.49 -53.1 0.21 Allowed 'General case' 0 CA--C 1.575 1.915 0 C-N-CA 129.834 3.254 . . . . 0.0 105.795 -170.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 30.94 20.55 0.0 OUTLIER Glycine 0 C--N 1.363 2.034 1 N-CA-C 125.272 4.869 . . . . 0.0 125.272 178.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 67.04 14.08 9.7 Favored 'General case' 0 CA--C 1.593 2.612 0 CA-C-N 120.821 2.311 . . . . 0.0 113.61 -173.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.89 -5.89 56.67 Favored Glycine 0 CA--C 1.568 3.373 0 CA-C-O 116.688 -2.173 . . . . 0.0 111.127 -172.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.4 t -117.37 136.42 54.57 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.94 0 CA-C-N 121.059 2.429 . . . . 0.0 113.385 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.495 HD12 ' CE2' ' A' ' 94' ' ' PHE . 67.9 mt -92.23 140.56 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 C-N-CA 126.587 1.955 . . . . 0.0 108.282 176.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.3 p30 -110.12 179.52 4.08 Favored 'General case' 0 CA--C 1.572 1.803 0 CA-C-O 122.666 1.222 . . . . 0.0 110.795 175.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -70.94 -43.01 69.09 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 117.391 -1.29 . . . . 0.0 114.437 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -63.62 -45.89 88.21 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 120.124 1.329 . . . . 0.0 112.157 177.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -58.86 -48.54 81.03 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 121.464 1.938 . . . . 0.0 112.731 175.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -59.1 -49.02 79.46 Favored 'General case' 0 CA--C 1.568 1.661 0 C-N-CA 123.502 0.721 . . . . 0.0 109.36 175.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 21.8 tptp -62.73 -12.81 26.28 Favored 'General case' 0 CA--C 1.577 2.01 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 175.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -93.3 -43.55 8.75 Favored 'General case' 0 CA--C 1.584 2.266 0 O-C-N 120.448 -1.407 . . . . 0.0 111.334 173.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -92.66 -29.24 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 1 N-CA-C 122.064 4.098 . . . . 0.0 122.064 -174.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 19.3 tpt -37.31 -65.25 0.32 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 126.001 1.72 . . . . 0.0 115.166 -176.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -97.31 77.11 2.64 Favored 'General case' 0 CA--C 1.569 1.686 0 CA-C-O 124.554 2.121 . . . . 0.0 110.746 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.37 153.37 1.55 Allowed 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 118.847 2.906 . . . . 0.0 118.847 177.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 41.1 t 60.54 98.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 C-N-CA 125.56 1.544 . . . . 0.0 112.917 177.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 81.03 -79.81 1.77 Allowed Glycine 0 CA--C 1.54 1.625 0 N-CA-C 116.013 1.165 . . . . 0.0 116.013 178.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.45 78.3 0.77 Allowed 'General case' 0 CA--C 1.568 1.644 0 CA-C-O 112.109 -3.805 . . . . 0.0 114.583 -178.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -97.62 131.03 27.77 Favored Pre-proline 0 N--CA 1.527 3.416 1 O-C-N 83.992 -24.193 . . . . 0.0 113.074 -170.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . 2.514 10.0 Cg_endo 35.21 43.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.505 2.175 0 N-CA-C 122.252 3.904 . . . . 0.0 122.252 -178.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.454 0.8 OUTLIER -91.68 -76.16 0.46 Allowed 'General case' 0 CA--C 1.564 1.507 0 CA-C-O 113.484 -3.151 . . . . 0.0 110.849 -175.204 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 38.0 p -84.86 127.12 34.0 Favored 'General case' 0 N--CA 1.487 1.41 1 CA-C-N 127.082 4.492 . . . . 0.0 107.313 177.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.17 -32.53 70.52 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.43 -44.45 96.4 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-O 116.594 -1.67 . . . . 0.0 113.619 177.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -43.36 97.19 Favored 'General case' 0 CA--C 1.577 1.996 0 CA-C-N 121.557 1.98 . . . . 0.0 113.68 178.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.5 t -70.62 -52.77 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-O 117.667 -1.159 . . . . 0.0 112.174 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -60.84 -47.15 87.65 Favored 'General case' 0 CA--C 1.558 1.272 0 CA-C-N 119.672 1.124 . . . . 0.0 111.451 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -61.57 -46.91 87.89 Favored 'General case' 0 CA--C 1.57 1.735 0 CA-C-N 120.653 1.57 . . . . 0.0 112.417 177.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.3 -43.77 96.91 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 177.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 17.5 ttt -73.7 -36.48 65.27 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 116.594 -1.67 . . . . 0.0 112.163 177.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -61.36 -44.15 97.67 Favored 'General case' 0 CA--C 1.569 1.692 0 CA-C-N 122.116 2.234 . . . . 0.0 109.982 173.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -64.74 -42.63 95.05 Favored 'General case' 0 CA--C 1.577 2.016 0 CA-C-N 120.922 1.692 . . . . 0.0 111.81 175.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -77.08 -21.15 54.79 Favored 'General case' 0 CA--C 1.564 1.484 0 N-CA-C 118.431 2.752 . . . . 0.0 118.431 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -87.53 113.46 23.25 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 103.66 -2.718 . . . . 0.0 103.66 175.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . 0.256 5.9 mt-10 -80.27 -18.17 50.08 Favored 'General case' 0 CA--C 1.576 1.948 0 CA-C-N 113.523 -1.672 . . . . 0.0 115.312 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -92.13 -15.61 27.44 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 117.035 2.235 . . . . 0.0 117.035 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.14 5.97 89.72 Favored Glycine 0 CA--C 1.564 3.108 0 CA-C-N 120.196 1.362 . . . . 0.0 116.081 -175.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -93.39 -45.85 7.61 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-O 117.267 -1.349 . . . . 0.0 114.088 177.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 114.29 22.63 5.12 Favored Glycine 0 CA--C 1.561 2.95 0 N-CA-C 118.111 2.004 . . . . 0.0 118.111 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.97 143.49 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.527 0 N-CA-C 102.836 -3.024 . . . . 0.0 102.836 174.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.445 HD13 HG21 ' A' ' 142' ' ' ILE . 1.0 OUTLIER -132.69 139.97 48.55 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -175.736 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 59.6 p30 -96.96 165.57 12.02 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 170.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.3 mt -56.13 -43.64 99.34 Favored Pre-proline 0 N--CA 1.5 2.048 0 CA-C-O 115.007 -2.425 . . . . 0.0 112.826 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.441 ' O ' ' HB2' ' A' ' 149' ' ' ASP . 69.2 Cg_exo -55.25 -40.74 84.08 Favored 'Trans proline' 0 C--N 1.372 1.816 0 CA-C-N 124.491 2.64 . . . . 0.0 116.124 178.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -65.23 -52.85 51.95 Favored 'General case' 0 N--CA 1.505 2.276 0 CA-C-N 124.507 3.322 . . . . 0.0 113.321 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.867 ' HE2' HG23 ' A' ' 90' ' ' ILE . 22.9 t80 -54.33 -52.13 62.51 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 120.265 1.393 . . . . 0.0 113.053 172.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.487 ' HB2' ' HE2' ' A' ' 148' ' ' MET . 0.0 OUTLIER -68.62 -34.91 76.57 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 117.734 -1.127 . . . . 0.0 113.405 179.36 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 145' ' ' PRO . 4.1 t70 -64.3 -35.25 80.23 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 119.478 1.035 . . . . 0.0 111.346 171.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -58.44 -52.13 66.91 Favored 'General case' 0 CA--C 1.562 1.431 0 C-N-CA 125.295 1.438 . . . . 0.0 110.07 173.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 95.9 mt -70.08 -53.5 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-O 117.592 -1.194 . . . . 0.0 113.321 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 17.5 pttm -67.87 -50.14 58.1 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -97.19 -65.88 0.94 Allowed 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 4.6 t . . . . . 0 N--CA 1.521 3.089 0 N-CA-C 103.716 -2.698 . . . . 0.0 103.716 -176.148 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 . . . . . 0 CA--C 1.579 2.064 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -48.06 -54.05 14.38 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 117.183 2.29 . . . . 0.0 117.183 -177.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -59.1 -52.28 66.4 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.502 ' H ' HD12 ' A' ' 90' ' ' ILE . 2.7 mp -61.58 -55.65 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 124.338 1.055 . . . . 0.0 111.482 178.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.1 pp -59.28 -41.97 90.16 Favored 'General case' 0 CA--C 1.556 1.211 0 CA-C-O 118.732 -0.652 . . . . 0.0 112.139 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 25.4 ttp85 -57.29 -55.47 34.37 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 117.617 -1.182 . . . . 0.0 110.008 176.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.34 -59.76 3.69 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.535 ' HB2' ' CE2' ' A' ' 147' ' ' PHE . 5.3 t80 -69.69 -48.7 58.75 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 121.652 2.024 . . . . 0.0 114.285 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.455 ' HG2' HD13 ' A' ' 144' ' ' ILE 0.326 47.5 mttt -64.16 -20.48 66.02 Favored 'General case' 0 CA--C 1.586 2.36 0 CA-C-O 115.635 -2.126 . . . . 0.0 110.737 -178.666 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -80.29 -46.73 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.403 0 CA-C-N 123.09 2.677 . . . . 0.0 108.497 169.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -54.78 -38.45 67.28 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -49.35 110.2 0.35 Allowed 'General case' 0 CA--C 1.575 1.909 0 C-N-CA 126.258 1.823 . . . . 0.0 112.262 178.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.466 ' HB2' ' HG2' ' A' ' 109' ' ' GLU . . . -41.97 -75.59 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 -177.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -94.55 0.69 55.43 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 117.425 2.38 . . . . 0.0 117.425 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.94 6.49 88.33 Favored Glycine 0 CA--C 1.554 2.518 0 CA-C-O 116.476 -2.291 . . . . 0.0 118.316 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -88.96 -3.72 58.65 Favored 'General case' 0 CA--C 1.585 2.301 0 CA-C-N 121.902 2.851 . . . . 0.0 113.987 174.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.14 -22.31 18.47 Favored Glycine 0 CA--C 1.54 1.595 0 CA-C-O 115.814 -2.659 . . . . 0.0 116.869 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.1 m -92.52 140.64 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.358 0 CA-C-N 122.333 3.066 . . . . 0.0 112.371 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.47 HD12 ' CE2' ' A' ' 94' ' ' PHE . 89.7 mt -110.35 121.56 63.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 N-CA-C 100.477 -3.897 . . . . 0.0 100.477 172.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.438 ' HA ' HG12 ' A' ' 141' ' ' VAL . 2.4 p30 -92.93 169.13 10.68 Favored 'General case' 0 CA--C 1.559 1.305 0 CA-C-O 122.31 1.052 . . . . 0.0 113.327 178.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -67.67 -45.0 76.47 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 117.661 -1.161 . . . . 0.0 113.501 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -65.65 -45.86 81.38 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 117.284 -1.341 . . . . 0.0 112.224 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.466 ' HG2' ' HB2' ' A' ' 99' ' ' ALA . 25.3 tp10 -64.42 -40.67 96.21 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 121.439 1.927 . . . . 0.0 112.409 176.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -63.38 -51.78 64.44 Favored 'General case' 0 CA--C 1.577 2.017 0 CA-C-N 120.26 1.391 . . . . 0.0 108.838 175.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -49.01 -42.83 39.4 Favored 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 125.384 1.474 . . . . 0.0 112.709 175.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -68.54 -60.47 2.4 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 123.675 0.79 . . . . 0.0 111.441 175.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.7 tt -62.16 -16.29 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 117.508 2.41 . . . . 0.0 117.508 -177.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 13.7 tpt -63.26 -68.24 0.36 Allowed 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 125.202 1.401 . . . . 0.0 109.006 175.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -133.73 115.22 14.31 Favored 'General case' 0 CA--C 1.566 1.595 1 N-CA-C 99.291 -4.337 . . . . 0.0 99.291 175.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.94 65.7 0.66 Allowed 'General case' 0 CA--C 1.573 1.846 1 N-CA-C 122.552 4.278 . . . . 0.0 122.552 -171.803 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -135.2 83.26 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 101.553 -3.499 . . . . 0.0 101.553 173.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.87 -126.99 18.31 Favored Glycine 0 CA--C 1.552 2.365 0 N-CA-C 107.327 -2.309 . . . . 0.0 107.327 -175.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -99.52 69.4 1.64 Allowed 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 174.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -68.83 -30.62 2.45 Favored Pre-proline 0 CA--C 1.56 1.336 1 CA-C-O 110.173 -4.727 . . . . 0.0 117.212 -177.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -38.88 90.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.385 2.471 1 CA-C-N 128.737 4.156 . . . . 0.0 117.823 178.491 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . 0.396 2.7 tm? -69.75 -76.9 0.09 Allowed 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 109.583 -3.462 . . . . 0.0 110.779 -175.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 18.4 p -88.38 115.13 25.67 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 125.619 3.827 . . . . 0.0 103.118 175.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -64.12 -30.83 71.87 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 116.817 2.155 . . . . 0.0 116.817 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.18 -36.91 83.31 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-O 117.297 -1.335 . . . . 0.0 113.54 177.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -59.94 -51.11 71.06 Favored 'General case' 0 CA--C 1.576 1.963 0 CA-C-N 120.269 1.395 . . . . 0.0 112.595 177.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 24.4 t -68.28 -51.77 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.311 0 C-N-CA 124.617 1.167 . . . . 0.0 111.936 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -60.01 -46.4 89.62 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 120.057 1.299 . . . . 0.0 112.22 178.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -62.42 -43.1 99.61 Favored 'General case' 0 CA--C 1.57 1.748 0 CA-C-N 120.087 1.312 . . . . 0.0 111.928 176.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.7 -47.81 79.67 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-N 119.904 1.229 . . . . 0.0 114.113 176.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 14.7 ttt -70.46 -39.41 74.31 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 114.417 -2.706 . . . . 0.0 109.874 177.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -58.5 -39.27 79.59 Favored 'General case' 0 CA--C 1.582 2.199 0 CA-C-N 124.867 3.485 . . . . 0.0 110.224 173.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -60.7 -45.27 94.85 Favored 'General case' 0 CA--C 1.582 2.178 0 CA-C-N 121.494 1.952 . . . . 0.0 110.954 173.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.65 -11.44 59.08 Favored 'General case' 0 CA--C 1.58 2.104 0 N-CA-C 117.173 2.286 . . . . 0.0 117.173 178.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -91.84 115.2 27.86 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 101.22 -3.622 . . . . 0.0 101.22 167.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -69.18 -20.6 64.0 Favored 'General case' 0 CA--C 1.561 1.38 0 N-CA-C 119.846 3.276 . . . . 0.0 119.846 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -145.96 25.93 1.26 Allowed 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 120.99 3.7 . . . . 0.0 120.99 -174.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.29 7.68 88.31 Favored Glycine 0 CA--C 1.555 2.59 0 N-CA-C 117.237 1.655 . . . . 0.0 117.237 -177.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -66.78 -44.8 80.37 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-N 120.303 2.052 . . . . 0.0 112.99 176.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 103.0 -21.43 40.15 Favored Glycine 0 CA--C 1.55 2.254 0 N-CA-C 117.032 1.573 . . . . 0.0 117.032 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.438 HG12 ' HA ' ' A' ' 106' ' ' ASP . 13.8 m -126.12 138.6 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 103.693 -2.706 . . . . 0.0 103.693 176.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.1 mt -104.71 133.7 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 114.032 -1.44 . . . . 0.0 113.622 -174.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 28.0 p30 -95.44 152.12 18.69 Favored 'General case' 0 CA--C 1.565 1.52 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 171.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.455 HD13 ' HG2' ' A' ' 95' ' ' LYS . 0.4 OUTLIER -52.28 -45.16 94.62 Favored Pre-proline 0 CA--C 1.583 2.241 0 CA-C-O 114.772 -2.537 . . . . 0.0 114.001 -177.836 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.43 -29.65 78.56 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 123.735 2.957 . . . . 0.0 117.716 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -60.01 -55.57 32.34 Favored 'General case' 0 N--CA 1.505 2.286 0 CA-C-N 121.209 1.822 . . . . 0.0 112.125 176.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.535 ' CE2' ' HB2' ' A' ' 94' ' ' PHE . 36.4 t80 -55.67 -51.91 65.63 Favored 'General case' 0 CA--C 1.577 2.005 0 C-N-CA 126.61 1.964 . . . . 0.0 111.075 173.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 4.7 mtp -56.59 -46.84 80.62 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 117.015 -1.469 . . . . 0.0 111.793 177.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.25 -35.75 74.02 Favored 'General case' 0 CA--C 1.576 1.949 0 CA-C-N 120.837 1.653 . . . . 0.0 111.016 176.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.46 -35.87 65.96 Favored 'General case' 0 CA--C 1.577 2.016 0 CA-C-N 120.327 1.421 . . . . 0.0 110.205 172.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 85.7 mt -82.57 -59.6 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.451 0 CA-C-N 120.572 1.533 . . . . 0.0 109.987 175.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -85.74 6.32 28.36 Favored 'General case' 0 CA--C 1.578 2.028 1 N-CA-C 122.243 4.164 . . . . 0.0 122.243 -176.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -25.5 -38.11 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 121.292 3.812 . . . . 0.0 121.292 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 12.0 t . . . . . 0 N--CA 1.512 2.66 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 175.899 . . . . . . . . 0 0 . 1 stop_ save_